data_2k75_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k75 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.8 0.81 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 54.3 tp -76.19 124.34 27.31 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.62 0.724 . . . . 0.0 110.348 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.4 m -139.18 164.26 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.829 0.823 . . . . 0.0 110.144 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -80.69 161.02 24.81 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.708 0.766 . . . . 0.0 110.26 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.81 -43.27 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.216 0.531 . . . . 0.0 109.678 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -67.47 -18.8 65.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.783 -0.573 . . . . 0.0 109.649 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -86.04 -0.09 54.7 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.558 -0.714 . . . . 0.0 109.713 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.9 t -67.22 130.16 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.908 0.861 . . . . 0.0 110.344 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.9 p -160.86 167.27 27.01 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.769 0.795 . . . . 0.0 109.971 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.7 mt -66.72 -21.62 66.07 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.3 t -61.4 -20.24 62.83 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 51.6 p -124.92 80.96 62.81 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.749 -0.594 . . . . 0.0 109.461 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.73 -40.62 73.5 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.681 2.254 . . . . 0.0 111.705 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -112.8 125.81 54.75 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.647 0.736 . . . . 0.0 109.207 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.4 m -149.76 160.22 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 122.155 0.978 . . . . 0.0 111.058 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.2 t -118.33 134.17 55.27 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.49 162.38 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 121.972 0.891 . . . . 0.0 110.391 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.6 tt -140.97 135.57 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.637 0.732 . . . . 0.0 109.675 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.0 -165.99 37.42 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -113.44 136.67 52.52 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.733 0.777 . . . . 0.0 110.115 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 63' ' ' SER . 2.5 mp -96.19 137.08 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.475 0.655 . . . . 0.0 109.72 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.4 p -131.1 158.68 39.75 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.009 0.909 . . . . 0.0 110.348 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.62 93.55 0.01 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 25' ' ' ILE . 22.8 mm -93.4 124.52 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.804 -0.821 . . . . 0.0 109.829 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -120.39 139.66 52.49 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.807 0.813 . . . . 0.0 109.53 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -108.04 134.46 50.89 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.838 0.828 . . . . 0.0 110.234 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -144.04 154.93 43.76 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.675 0.75 . . . . 0.0 109.452 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -123.54 144.87 49.29 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.842 0.83 . . . . 0.0 110.23 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -144.21 158.44 43.73 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.827 0.822 . . . . 0.0 109.861 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -87.92 115.44 25.39 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.601 0.715 . . . . 0.0 110.075 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 t -113.35 113.07 24.72 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.733 0.778 . . . . 0.0 109.492 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.1 t0 55.93 29.46 14.27 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.279 0.561 . . . . 0.0 109.743 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.99 2.45 80.92 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.4 m -118.13 127.6 53.93 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.758 -0.848 . . . . 0.0 109.928 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.8 m -69.31 129.63 40.33 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.632 0.73 . . . . 0.0 110.317 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -130.99 139.86 50.06 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.746 0.784 . . . . 0.0 109.72 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.5 m -86.26 141.76 29.05 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.015 0.912 . . . . 0.0 110.723 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -136.49 135.53 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.856 0.836 . . . . 0.0 109.485 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -101.61 133.48 46.23 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.692 0.758 . . . . 0.0 109.791 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -121.78 151.96 40.01 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.837 0.827 . . . . 0.0 109.667 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.41 -172.93 39.99 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.577 ' CB ' HH21 ' A' ' 50' ' ' ARG . 68.0 m-85 -117.35 142.99 46.43 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.695 0.759 . . . . 0.0 109.863 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.5 tt -125.84 139.87 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -133.56 159.54 40.14 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.128 0.966 . . . . 0.0 110.653 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.57 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 37.3 t0 -145.08 -148.77 0.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.471 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.57 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 97.5 m-20 -80.02 -6.64 57.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.648 -0.657 . . . . 0.0 109.536 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.5 p -105.67 -91.11 0.4 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.73 -0.607 . . . . 0.0 109.888 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.51 -145.14 0.24 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.576 -0.703 . . . . 0.0 110.066 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.577 HH21 ' CB ' ' A' ' 43' ' ' TYR . 17.5 ptm180 -145.89 156.09 43.31 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.821 0.819 . . . . 0.0 110.783 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.8 tt -148.1 161.99 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.911 0.862 . . . . 0.0 110.297 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -79.44 147.77 32.18 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.589 0.709 . . . . 0.0 110.17 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.8 pt -134.98 157.0 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.912 0.863 . . . . 0.0 110.37 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 m -141.35 125.43 17.29 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.649 0.737 . . . . 0.0 109.558 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.5 t -116.43 130.23 56.65 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.963 0.887 . . . . 0.0 109.629 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -98.91 119.49 37.77 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.656 0.741 . . . . 0.0 109.86 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.69 -51.68 4.05 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -71.71 135.14 46.68 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.667 -0.902 . . . . 0.0 110.436 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -89.09 155.58 19.36 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.842 0.83 . . . . 0.0 110.903 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.2 mt -119.34 151.02 39.18 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.57 0.7 . . . . 0.0 109.563 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.406 ' O ' ' OD1' ' A' ' 64' ' ' ASP . 21.5 mp0 -112.49 142.29 45.23 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 122.385 1.088 . . . . 0.0 110.156 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 63' ' ' SER . 68.1 t0 -64.18 135.58 56.43 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.966 0.888 . . . . 0.0 111.876 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.522 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 2.1 p 53.47 23.7 3.58 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.527 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 20.4 p-10 -87.65 126.12 34.77 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.748 0.785 . . . . 0.0 110.426 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.3 m -82.47 115.8 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-O 121.657 0.742 . . . . 0.0 108.998 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.8 m -140.67 162.77 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 122.041 0.924 . . . . 0.0 110.416 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.525 ' NH1' ' OD1' ' A' ' 69' ' ' ASP . 68.9 ttp85 -117.39 127.82 54.42 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.701 0.762 . . . . 0.0 109.288 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.7 mt -107.25 129.48 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.754 0.787 . . . . 0.0 109.495 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.525 ' OD1' ' NH1' ' A' ' 67' ' ' ARG . 96.5 m-20 -116.41 144.27 44.51 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.688 0.756 . . . . 0.0 109.969 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.1 t30 62.91 39.57 10.33 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.842 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.26 146.74 47.04 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.4 0.619 . . . . 0.0 110.047 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -104.91 125.83 51.34 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.805 0.812 . . . . 0.0 110.095 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.0 t -86.55 133.22 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.699 0.761 . . . . 0.0 110.052 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.7 160.03 43.14 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.848 0.833 . . . . 0.0 109.955 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -107.44 114.37 28.34 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.699 0.762 . . . . 0.0 110.143 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -115.65 125.45 52.89 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.695 0.759 . . . . 0.0 109.472 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.2 m120 57.22 29.61 17.0 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.48 13.33 82.75 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -120.27 135.92 54.84 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.831 0.824 . . . . 0.0 109.987 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.2 mt -77.28 143.77 38.62 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.591 0.71 . . . . 0.0 109.899 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.0 p -156.3 163.3 39.69 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.957 0.884 . . . . 0.0 110.491 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.6 mt -103.63 124.11 48.22 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.757 0.789 . . . . 0.0 109.341 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.0 m -103.2 122.76 45.4 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.671 0.748 . . . . 0.0 110.104 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.422 ' CG1' ' HG ' ' A' ' 88' ' ' SER . 6.9 t -99.23 105.55 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.65 0.738 . . . . 0.0 109.596 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.435 ' O ' ' OG ' ' A' ' 88' ' ' SER . . . -91.76 -176.43 42.72 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.82 -16.71 62.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.95 -0.735 . . . . 0.0 109.322 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 87.6 p -85.91 -15.36 41.95 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 85' ' ' GLY . 25.5 p -82.68 167.16 18.5 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.567 0.699 . . . . 0.0 110.05 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -126.74 138.3 53.36 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.785 0.802 . . . . 0.0 109.879 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.32 127.55 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.493 0.664 . . . . 0.0 109.447 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -124.39 126.59 46.21 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.925 0.869 . . . . 0.0 110.253 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.0 p -76.35 150.02 36.91 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.455 0.645 . . . . 0.0 110.17 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.7 t . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 121.775 0.798 . . . . 0.0 109.712 -179.875 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 55.7 t0 . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.753 0.787 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.539 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 38.8 tp -69.5 128.7 37.45 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.504 0.669 . . . . 0.0 110.027 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.1 m -138.89 163.59 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.9 0.857 . . . . 0.0 109.968 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -75.32 156.65 35.33 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.75 0.786 . . . . 0.0 110.076 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.1 mm -62.65 -44.58 99.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.797 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -68.61 -20.96 64.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.562 -0.711 . . . . 0.0 109.504 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -82.77 -3.86 57.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.539 -0.726 . . . . 0.0 109.166 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.8 t -69.99 128.86 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.975 0.893 . . . . 0.0 109.915 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.444 ' C ' ' H ' ' A' ' 12' ' ' SER . 29.7 m -163.6 162.66 24.43 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.566 0.698 . . . . 0.0 109.399 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.7 mt -64.58 -2.31 2.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.784 -0.573 . . . . 0.0 109.555 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 10' ' ' SER . 78.6 p -61.0 -32.64 72.21 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.542 ' HG1' ' CG1' ' A' ' 16' ' ' VAL . 69.6 p -117.07 145.22 35.22 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.729 -0.607 . . . . 0.0 110.168 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.28 -61.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.999 2.466 . . . . 0.0 112.422 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 100.0 m-85 -119.75 136.53 54.4 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.858 0.837 . . . . 0.0 110.339 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.542 ' CG1' ' HG1' ' A' ' 13' ' ' THR . 29.9 m -140.52 164.0 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.688 0.756 . . . . 0.0 109.973 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.2 m -118.96 145.09 46.09 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.756 0.789 . . . . 0.0 109.494 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.24 160.27 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 122.114 0.959 . . . . 0.0 110.639 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.406 ' O ' ' OD2' ' A' ' 46' ' ' ASP . 19.5 tt -138.27 130.25 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.665 0.745 . . . . 0.0 109.457 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.58 -156.24 21.53 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -124.93 139.11 54.12 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.919 -0.753 . . . . 0.0 109.839 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.475 ' N ' ' CD1' ' A' ' 22' ' ' ILE . 3.0 mp -92.2 132.18 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.391 0.615 . . . . 0.0 110.08 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.0 m -125.76 143.87 50.87 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.058 0.932 . . . . 0.0 109.866 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.76 97.02 0.04 OUTLIER Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.6 mm -95.01 125.88 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.962 0.887 . . . . 0.0 110.408 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -123.4 134.51 53.96 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.556 0.693 . . . . 0.0 109.226 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -108.31 132.9 53.23 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.947 0.88 . . . . 0.0 110.037 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -140.76 158.27 44.21 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.772 0.796 . . . . 0.0 109.718 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -120.43 145.05 47.6 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.783 0.801 . . . . 0.0 109.983 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.441 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 13.7 p90 -141.61 159.42 42.27 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.18 0.99 . . . . 0.0 110.088 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -96.69 132.26 42.54 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.532 0.682 . . . . 0.0 109.471 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.0 t -159.16 141.1 13.54 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.743 0.782 . . . . 0.0 110.189 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 55.65 28.37 11.93 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.25 0.548 . . . . 0.0 109.759 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.36 14.66 79.2 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.7 p -135.87 155.06 50.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.61 -0.935 . . . . 0.0 109.874 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.6 m -98.2 126.24 43.58 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.88 0.848 . . . . 0.0 109.818 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.441 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 98.9 mttt -125.62 142.1 51.68 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.819 0.818 . . . . 0.0 109.325 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 90.8 p -84.57 146.37 27.57 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.841 0.829 . . . . 0.0 110.368 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -133.51 136.99 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.822 0.82 . . . . 0.0 109.821 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.514 ' CZ ' ' OE1' ' A' ' 59' ' ' GLN . 94.4 m-85 -101.95 131.2 48.49 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.763 0.792 . . . . 0.0 109.725 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -126.12 155.24 41.96 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.93 0.871 . . . . 0.0 109.943 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.9 -166.93 35.19 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.618 ' CD2' ' NH2' ' A' ' 50' ' ' ARG . 97.2 m-85 -119.79 140.37 50.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.81 -0.818 . . . . 0.0 110.072 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.4 tt -122.79 133.19 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -134.32 156.23 48.84 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 122.277 1.037 . . . . 0.0 110.561 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 48' ' ' THR . 5.4 p30 -168.09 95.32 0.41 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.646 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' THR . 66.8 t0 52.4 -77.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 120.936 0.398 . . . . 0.0 110.571 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.589 ' N ' ' O ' ' A' ' 46' ' ' ASP . 73.9 p -38.62 -80.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.086 0.47 . . . . 0.0 110.456 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.21 -143.67 0.11 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.698 0.761 . . . . 0.0 110.087 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.618 ' NH2' ' CD2' ' A' ' 43' ' ' TYR . 8.9 ptm180 -142.87 150.68 40.18 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.761 0.791 . . . . 0.0 110.4 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.6 tt -146.54 156.26 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.747 0.784 . . . . 0.0 110.085 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -76.69 147.2 37.57 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.735 0.779 . . . . 0.0 109.973 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.2 pt -135.05 154.47 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.644 0.735 . . . . 0.0 110.273 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 t -143.17 133.42 24.54 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.858 0.837 . . . . 0.0 109.551 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 p -131.09 135.28 47.38 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.973 0.892 . . . . 0.0 109.887 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.486 ' C ' ' H ' ' A' ' 58' ' ' LYS . 90.7 m-85 -94.8 122.33 37.3 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.699 0.761 . . . . 0.0 111.025 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.47 -29.46 0.58 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 56' ' ' PHE . 98.9 mttt -74.11 136.84 42.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.568 -0.96 . . . . 0.0 110.607 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.514 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 68.7 tp60 -94.68 146.92 23.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.776 0.798 . . . . 0.0 110.495 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.9 mt -129.48 152.44 49.01 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.721 0.772 . . . . 0.0 109.927 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -122.93 137.64 54.89 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.216 1.008 . . . . 0.0 110.074 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 63' ' ' SER . 65.6 t0 -64.78 134.69 54.66 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.865 0.84 . . . . 0.0 111.462 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.53 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 2.8 p 78.29 8.19 2.31 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.862 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 7.3 p-10 -84.45 124.08 30.95 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.307 0.575 . . . . 0.0 110.803 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 t -87.02 116.76 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.637 0.732 . . . . 0.0 109.117 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.48 163.22 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.221 1.01 . . . . 0.0 110.945 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -119.27 128.99 54.68 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.7 mt -106.23 129.45 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.773 0.797 . . . . 0.0 109.543 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -114.81 143.51 44.99 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.849 0.833 . . . . 0.0 110.149 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.6 t30 62.12 37.89 14.19 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.2 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.95 145.7 46.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.583 -0.698 . . . . 0.0 109.426 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -96.04 132.34 41.5 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.828 0.823 . . . . 0.0 110.209 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 89.6 t -83.15 131.66 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 121.532 0.682 . . . . 0.0 109.974 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.64 154.28 43.37 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.683 0.754 . . . . 0.0 109.973 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -119.79 117.38 28.03 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.816 0.817 . . . . 0.0 109.924 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -119.85 131.51 55.29 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.852 0.834 . . . . 0.0 110.01 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.8 t30 56.64 24.32 8.73 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.239 0.542 . . . . 0.0 110.249 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.88 10.51 82.93 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -114.99 138.17 51.15 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.91 0.862 . . . . 0.0 109.755 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.527 ' N ' ' CD2' ' A' ' 80' ' ' LEU . 3.7 mm? -76.94 141.61 40.4 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.93 0.872 . . . . 0.0 110.699 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.3 p -153.52 159.24 42.19 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.752 0.787 . . . . 0.0 110.008 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.7 mt -108.56 126.39 52.88 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.791 0.805 . . . . 0.0 110.175 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.2 m -101.43 123.54 45.65 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.825 0.822 . . . . 0.0 109.656 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.7 t -101.02 111.29 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.843 0.83 . . . . 0.0 109.204 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.23 -178.71 37.22 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -68.2 -18.35 64.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 122.149 -0.618 . . . . 0.0 109.543 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 97.1 p -87.65 -7.53 57.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.669 -0.645 . . . . 0.0 109.455 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.1 t -83.69 164.92 19.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.456 -0.778 . . . . 0.0 109.556 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -128.54 139.27 52.39 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.754 0.788 . . . . 0.0 109.911 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.15 130.47 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.651 0.739 . . . . 0.0 109.45 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 91' ' ' GLU . 56.7 mp0 -115.72 125.53 52.93 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.83 0.824 . . . . 0.0 109.93 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.0 p -71.33 144.87 49.78 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.596 0.712 . . . . 0.0 110.559 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.2 t . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 121.936 0.874 . . . . 0.0 109.924 -179.772 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 60.5 t0 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.75 0.786 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.532 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 4.9 tt -71.17 133.82 46.46 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.686 -0.634 . . . . 0.0 110.726 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.2 m -135.84 162.91 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-O 121.567 0.698 . . . . 0.0 109.884 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -79.04 155.98 28.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.589 -0.695 . . . . 0.0 110.062 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.9 mt -63.54 -43.66 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.712 -0.618 . . . . 0.0 109.866 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 -72.31 -14.38 61.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.117 -0.989 . . . . 0.0 109.864 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -93.25 2.22 56.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.321 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.51 132.05 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.155 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.3 p -159.35 165.82 32.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.355 -0.841 . . . . 0.0 109.837 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.66 -19.07 65.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.523 -0.735 . . . . 0.0 109.762 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.2 m -57.51 -25.25 59.56 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.118 -0.989 . . . . 0.0 109.24 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 45.8 p -123.29 82.64 52.24 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.46 -40.36 71.79 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.641 2.227 . . . . 0.0 112.088 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -115.87 128.76 56.05 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.419 0.628 . . . . 0.0 109.832 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.2 m -153.04 -176.41 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.445 -0.785 . . . . 0.0 109.906 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.3 m -130.18 144.29 51.28 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.4 m -139.88 162.61 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.376 -0.827 . . . . 0.0 110.245 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 tp -141.52 127.93 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.68 -168.53 38.06 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.058 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -110.27 144.11 39.44 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.621 -0.929 . . . . 0.0 109.545 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.0 mm -95.07 133.44 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.364 0.602 . . . . 0.0 110.254 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -143.02 156.84 44.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.37 -0.831 . . . . 0.0 109.983 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.11 62.14 4.41 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.0 mm -76.94 129.78 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -1.125 . . . . 0.0 110.624 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -130.09 122.69 28.79 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.509 ' NZ ' ' OE2' ' A' ' 29' ' ' GLU . 66.0 tttm -86.41 136.93 32.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.355 -0.841 . . . . 0.0 110.022 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -146.64 139.85 25.57 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.509 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 97.2 mt-10 -115.1 148.15 39.32 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.664 -0.647 . . . . 0.0 110.154 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.541 ' CE2' ' OG ' ' A' ' 32' ' ' SER . 9.8 p90 -147.28 159.29 43.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.819 . . . . 0.0 109.188 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -84.07 119.98 25.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.4 -0.812 . . . . 0.0 110.318 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.541 ' OG ' ' CE2' ' A' ' 30' ' ' TYR . 3.1 m -119.41 114.17 21.91 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 55.36 31.94 17.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.56 -0.713 . . . . 0.0 109.881 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.74 6.43 88.49 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.2 m -120.89 128.56 52.91 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.525 -0.985 . . . . 0.0 109.874 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.4 m -68.25 134.72 50.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.602 -0.686 . . . . 0.0 110.042 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -131.58 147.29 52.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.441 -0.787 . . . . 0.0 109.34 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.5 t -99.9 135.09 41.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.631 -0.668 . . . . 0.0 109.939 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.94 138.09 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -105.41 134.35 48.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.527 -0.733 . . . . 0.0 109.476 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -123.51 150.86 43.42 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.391 0.615 . . . . 0.0 109.385 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.431 ' C ' ' CD1' ' A' ' 53' ' ' ILE . . . -173.82 -147.44 6.0 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.48 ' OH ' ' NH1' ' A' ' 52' ' ' ARG . 79.6 m-85 -132.92 141.58 48.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.573 -0.957 . . . . 0.0 109.549 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 tt -116.04 134.39 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -133.26 150.23 51.93 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.756 0.788 . . . . 0.0 110.719 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 48' ' ' THR . 62.8 t0 -167.36 95.55 0.47 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' THR . 38.8 t70 48.37 -79.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.812 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.601 ' N ' ' O ' ' A' ' 46' ' ' ASP . 14.5 m -36.29 -77.31 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.767 -0.583 . . . . 0.0 110.803 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -161.12 -153.99 0.34 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.032 -1.042 . . . . 0.0 109.426 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 -138.97 152.12 47.42 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.39 0.614 . . . . 0.0 110.572 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.0 tt -150.67 163.52 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.783 . . . . 0.0 110.167 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.48 ' NH1' ' OH ' ' A' ' 43' ' ' TYR . 77.2 mtp85 -79.31 149.19 31.85 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.514 0.673 . . . . 0.0 110.838 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.543 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -141.79 164.44 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.511 -0.743 . . . . 0.0 109.792 179.587 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 p -140.42 127.13 20.39 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -109.98 118.08 35.5 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.619 -0.675 . . . . 0.0 109.21 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.474 ' C ' ' H ' ' A' ' 58' ' ' LYS . 72.1 m-85 -95.4 123.85 39.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.448 -0.782 . . . . 0.0 110.806 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.15 -33.55 0.65 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' A' ' 56' ' ' PHE . 31.1 mmtp -87.92 130.13 35.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.893 -1.357 . . . . 0.0 109.955 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -90.45 146.41 24.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.501 -0.749 . . . . 0.0 110.283 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.7 mt -132.67 151.39 51.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.625 -0.672 . . . . 0.0 109.346 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -112.34 148.23 34.69 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.948 0.88 . . . . 0.0 110.153 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.6 t0 -65.27 136.68 56.89 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.656 0.741 . . . . 0.0 111.389 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.503 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 3.1 p 75.26 6.73 4.14 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.28 0.562 . . . . 0.0 109.94 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -83.98 122.61 28.99 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.13 -0.981 . . . . 0.0 110.135 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.4 t -85.57 119.19 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.4 160.48 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.422 0.629 . . . . 0.0 109.666 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -116.37 123.51 47.77 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 75.9 mt -107.41 130.36 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.572 -0.705 . . . . 0.0 109.401 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -116.98 144.65 44.33 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.447 0.641 . . . . 0.0 109.911 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.3 t30 64.75 35.86 8.47 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.445 0.64 . . . . 0.0 109.542 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.87 146.21 53.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.425 -0.797 . . . . 0.0 109.164 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.3 ttp85 -100.27 125.18 46.43 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.507 0.67 . . . . 0.0 110.056 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.3 t -85.25 133.3 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.521 -0.737 . . . . 0.0 109.651 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.38 164.85 30.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.365 -0.834 . . . . 0.0 109.349 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -103.33 114.37 28.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.6 -0.687 . . . . 0.0 109.609 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -110.3 121.87 46.32 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.6 m120 56.05 31.27 17.76 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.411 0.624 . . . . 0.0 109.392 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.89 13.07 83.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -121.47 138.47 54.28 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.514 -0.992 . . . . 0.0 110.059 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.7 mt -71.37 139.8 49.93 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.583 -0.698 . . . . 0.0 110.283 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.66 163.04 40.43 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.8 mt -103.59 127.83 50.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.602 -0.686 . . . . 0.0 109.585 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.4 t -107.38 126.91 53.07 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 t -103.39 106.01 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.484 -0.76 . . . . 0.0 109.79 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -90.83 179.67 42.93 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -65.44 -37.7 87.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.482 -1.011 . . . . 0.0 109.603 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.4 m -60.66 -36.14 77.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 0.0 110.008 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.1 p -63.25 163.21 10.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.192 -0.942 . . . . 0.0 110.328 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -111.35 140.04 46.26 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.722 -0.611 . . . . 0.0 109.525 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.28 131.38 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -128.13 108.65 10.81 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.497 -0.752 . . . . 0.0 109.181 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.9 t -72.69 140.89 48.17 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.49 -0.756 . . . . 0.0 110.132 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.1 t . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.577 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 . . . . . 0 N--CA 1.497 1.916 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.26 121.7 30.05 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.149 -0.969 . . . . 0.0 111.528 -174.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.7 m -131.29 161.63 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -75.75 162.92 27.78 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.813 0.816 . . . . 0.0 110.265 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.5 mm -62.79 -43.51 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.615 -0.678 . . . . 0.0 109.253 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -65.78 -18.21 65.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.383 -0.823 . . . . 0.0 110.055 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -85.28 -0.05 53.51 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.136 -0.977 . . . . 0.0 110.281 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.39 133.05 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.174 -0.954 . . . . 0.0 110.254 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.1 m -157.5 162.8 38.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.473 -0.767 . . . . 0.0 109.742 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.74 -30.16 70.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.376 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -59.33 -20.23 52.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.347 -0.846 . . . . 0.0 109.293 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 13' ' ' THR . 11.5 p -118.39 80.2 16.03 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.72 -15.21 33.5 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.015 1.81 . . . . 0.0 112.581 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -133.11 105.97 7.34 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.423 -0.798 . . . . 0.0 109.792 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.1 m -145.57 164.61 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.379 -0.826 . . . . 0.0 109.881 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.1 t -108.54 141.45 40.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.339 -0.85 . . . . 0.0 108.825 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.52 160.27 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.365 -0.834 . . . . 0.0 109.724 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.5 tt -142.73 137.35 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.389 -0.819 . . . . 0.0 109.373 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.67 -166.27 35.94 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.227 -1.463 . . . . 0.0 110.683 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -104.57 132.41 50.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.818 -0.813 . . . . 0.0 109.402 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.416 HD12 HG23 ' A' ' 22' ' ' ILE . 21.2 mm -89.29 130.02 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.221 0.534 . . . . 0.0 109.915 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.0 p -137.87 161.54 36.36 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.325 -0.859 . . . . 0.0 109.884 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.57 79.29 0.1 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.8 mm -91.44 120.07 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.193 -1.181 . . . . 0.0 109.709 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -119.56 125.76 49.6 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -93.85 134.43 36.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.284 -0.885 . . . . 0.0 109.967 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -148.12 143.58 27.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.426 -0.796 . . . . 0.0 109.001 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -123.89 144.91 49.47 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.415 -0.803 . . . . 0.0 109.344 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.531 ' CE2' ' OG ' ' A' ' 32' ' ' SER . 24.9 p90 -141.71 160.73 39.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.215 -0.928 . . . . 0.0 109.558 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -79.6 114.52 18.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.56 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.531 ' OG ' ' CE2' ' A' ' 30' ' ' TYR . 5.1 m -109.61 112.82 25.13 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.533 -0.729 . . . . 0.0 109.531 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 53.37 31.07 11.3 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 0.0 110.201 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.67 -2.45 82.52 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.3 p -118.36 124.87 48.8 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.299 -1.118 . . . . 0.0 109.296 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.4 m -69.68 135.67 50.14 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.432 -0.792 . . . . 0.0 110.221 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -131.84 147.87 52.51 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.2 t -96.95 131.79 43.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.506 -0.746 . . . . 0.0 109.747 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.67 135.36 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -104.81 135.53 46.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.528 -0.733 . . . . 0.0 109.129 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -124.56 153.88 41.47 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.445 0.64 . . . . 0.0 109.371 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.76 -151.72 8.41 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -130.37 145.92 51.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.81 -0.818 . . . . 0.0 109.377 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.8 tt -123.57 142.36 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -127.71 151.51 48.89 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.434 0.635 . . . . 0.0 109.667 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.555 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 36.9 t0 -141.78 -153.16 0.45 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.485 -0.759 . . . . 0.0 109.381 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.555 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 95.5 m-20 -78.91 -7.47 58.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.88 . . . . 0.0 109.935 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.5 p -108.75 -85.8 0.52 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.335 -0.853 . . . . 0.0 110.363 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.0 -148.86 0.32 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.473 -0.767 . . . . 0.0 109.622 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -145.44 156.36 43.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.271 -0.893 . . . . 0.0 110.087 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.7 tt -148.91 164.8 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.368 -0.833 . . . . 0.0 109.978 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.63 144.17 35.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.158 -0.964 . . . . 0.0 110.148 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.521 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -135.21 161.23 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.485 -0.759 . . . . 0.0 109.665 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.2 m -137.79 139.98 40.33 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 58' ' ' LYS . 4.7 p -119.58 116.24 25.64 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.444 ' C ' ' H ' ' A' ' 58' ' ' LYS . 85.6 m-85 -96.78 117.09 30.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.382 -0.824 . . . . 0.0 110.273 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.83 -13.26 3.23 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.444 ' H ' ' C ' ' A' ' 56' ' ' PHE . 28.3 mmtp -103.77 107.15 17.89 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.365 -1.08 . . . . 0.0 109.352 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -72.64 145.02 47.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.569 -0.707 . . . . 0.0 109.728 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.1 mt -127.14 153.25 46.27 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -105.75 141.56 36.97 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.613 0.721 . . . . 0.0 109.847 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 63' ' ' SER . 57.1 t0 -66.25 138.42 57.64 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.592 0.711 . . . . 0.0 110.782 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.528 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 5.0 m 61.56 78.85 0.27 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.354 0.597 . . . . 0.0 110.749 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.416 ' CG ' ' O ' ' A' ' 63' ' ' SER . 56.7 m-20 -163.33 126.92 2.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.691 -0.631 . . . . 0.0 109.422 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.7 t -78.24 121.63 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.1 m -137.72 160.67 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.43 -0.794 . . . . 0.0 109.855 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -117.36 128.74 55.34 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.4 mt -106.95 126.57 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -109.85 141.22 42.85 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.72 -0.612 . . . . 0.0 109.729 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 61.7 t30 62.74 41.01 9.47 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.484 0.659 . . . . 0.0 109.385 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.57 147.31 49.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.422 -0.799 . . . . 0.0 109.087 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -103.37 125.53 50.04 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.537 -0.727 . . . . 0.0 109.578 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.0 t -86.25 132.7 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.482 -0.761 . . . . 0.0 109.69 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.66 152.92 41.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.321 -0.862 . . . . 0.0 109.174 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -107.35 122.3 46.3 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.446 -0.784 . . . . 0.0 109.556 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -126.08 138.91 53.74 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.1 t30 56.25 24.06 7.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.559 -0.713 . . . . 0.0 109.507 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.64 8.35 87.72 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -118.19 138.97 51.95 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.42 -1.047 . . . . 0.0 109.698 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.9 mt -75.53 145.15 41.54 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.629 0.728 . . . . 0.0 110.342 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.5 p -154.77 160.62 41.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.552 -0.717 . . . . 0.0 109.139 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.7 mt -105.16 126.27 51.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.414 -0.804 . . . . 0.0 109.331 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.9 p -109.2 134.37 51.83 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.558 -0.714 . . . . 0.0 109.6 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.8 t -100.51 114.08 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.306 -0.871 . . . . 0.0 108.749 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.14 175.85 44.99 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 87' ' ' SER . 43.3 p-10 -67.43 -24.24 65.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.571 -0.958 . . . . 0.0 109.822 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.453 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 66.2 m -84.17 -6.4 59.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.238 -0.914 . . . . 0.0 109.634 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.674 ' HG ' ' N ' ' A' ' 89' ' ' ARG . 39.9 t -81.96 170.84 15.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.756 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.674 ' N ' ' HG ' ' A' ' 88' ' ' SER . 79.0 mtp85 -131.52 141.25 49.69 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.619 -0.675 . . . . 0.0 109.751 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.8 130.51 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.645 -0.66 . . . . 0.0 109.438 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -121.33 120.39 34.92 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.55 0.69 . . . . 0.0 109.374 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.2 m -75.69 147.15 39.64 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.506 -0.746 . . . . 0.0 110.176 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.7 t . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.283 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.9 p30 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.524 0.678 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 3' ' ' LEU . 3.8 mm? -83.7 130.44 34.96 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.457 -0.777 . . . . 0.0 109.994 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.4 m -138.32 161.68 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.544 0.687 . . . . 0.0 109.559 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -86.7 163.55 17.27 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.539 0.685 . . . . 0.0 109.883 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.2 mm -62.87 -43.78 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.613 -0.679 . . . . 0.0 109.85 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -66.76 -18.99 65.65 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.019 -1.051 . . . . 0.0 109.435 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -84.18 -1.68 55.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 0.0 109.566 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.47 131.59 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.204 -0.935 . . . . 0.0 110.136 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 12' ' ' SER . 46.4 t -163.41 160.07 23.04 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.3 -3.66 6.33 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 10' ' ' SER . 37.9 m -59.75 -35.63 74.98 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.63 -0.668 . . . . 0.0 109.248 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.7 p -115.28 133.63 22.69 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.66 -0.65 . . . . 0.0 109.701 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.61 -53.05 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.127 1.885 . . . . 0.0 111.781 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -119.66 130.73 55.2 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.368 0.604 . . . . 0.0 109.866 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.0 m -146.93 163.93 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.537 -0.727 . . . . 0.0 109.591 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.9 t -110.15 138.24 46.8 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.435 -0.791 . . . . 0.0 109.505 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.02 160.52 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.529 -0.732 . . . . 0.0 109.713 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.0 tt -142.96 137.58 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 109.599 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.48 -161.94 28.9 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.866 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -110.4 129.11 55.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.671 -0.899 . . . . 0.0 109.438 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.2 mt -101.75 131.12 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.766 -0.584 . . . . 0.0 109.991 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.425 ' HA ' ' H ' ' A' ' 63' ' ' SER . 23.0 m -145.27 153.45 41.3 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.591 0.71 . . . . 0.0 109.997 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.51 65.18 1.75 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.406 HG22 HD12 ' A' ' 25' ' ' ILE . 30.9 mm -81.58 129.1 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -1.138 . . . . 0.0 109.94 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -123.89 132.71 53.79 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -94.27 134.14 37.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.0 109.876 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -145.21 157.95 43.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.454 -0.779 . . . . 0.0 109.284 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -123.6 144.23 49.72 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.518 -0.739 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -142.38 160.63 39.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.375 -0.828 . . . . 0.0 109.321 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -80.1 148.29 31.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.434 -0.792 . . . . 0.0 109.832 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.581 ' O ' ' N ' ' A' ' 34' ' ' GLY . 34.1 m -144.97 -149.5 0.28 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.474 -0.766 . . . . 0.0 109.114 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -50.95 84.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.758 0.79 . . . . 0.0 110.13 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 47.69 19.98 1.01 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -147.91 151.16 35.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.072 -1.252 . . . . 0.0 110.156 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.8 m -89.66 131.12 35.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.451 -0.78 . . . . 0.0 109.171 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -119.33 146.75 45.03 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.579 0.704 . . . . 0.0 109.942 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 89.2 p -83.77 146.35 28.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.49 -0.757 . . . . 0.0 109.924 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -139.54 137.81 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -104.25 128.9 52.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.499 -0.751 . . . . 0.0 109.401 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -113.85 154.61 27.19 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.18 -169.53 37.79 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -124.85 146.36 49.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.659 -0.906 . . . . 0.0 109.611 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.2 tt -125.39 139.44 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -126.95 149.35 49.88 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.528 -0.732 . . . . 0.0 110.234 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.554 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 42.7 t0 -136.13 -160.44 1.05 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.554 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 1.4 p30 -81.29 -3.53 52.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 110.056 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.9 p -107.06 -62.11 1.45 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.278 -0.889 . . . . 0.0 109.438 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -160.71 -151.46 0.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.23 -0.919 . . . . 0.0 109.583 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -144.8 156.96 44.31 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.4 tt -146.63 159.49 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.297 -0.877 . . . . 0.0 110.053 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -76.42 144.5 39.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.381 -0.824 . . . . 0.0 109.697 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.2 pt -128.73 157.96 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.491 -0.756 . . . . 0.0 110.076 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -145.0 126.43 14.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.4 t -114.84 127.52 55.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.486 -0.759 . . . . 0.0 109.492 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -97.44 117.78 32.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.577 -0.702 . . . . 0.0 110.349 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.64 -54.58 4.97 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -70.31 138.18 51.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.128 -1.219 . . . . 0.0 110.669 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -88.41 158.37 18.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.618 -0.676 . . . . 0.0 110.077 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.6 mt -121.27 153.63 37.42 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -106.88 135.47 48.38 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.685 0.755 . . . . 0.0 109.838 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -66.42 136.84 56.32 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.751 0.786 . . . . 0.0 110.948 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.425 ' H ' ' HA ' ' A' ' 23' ' ' THR . 67.0 m 45.82 78.85 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.605 0.717 . . . . 0.0 110.145 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -150.68 126.52 10.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.626 -0.671 . . . . 0.0 109.358 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.5 t -78.55 115.87 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.498 -0.751 . . . . 0.0 109.23 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.1 m -140.58 166.87 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.487 -0.758 . . . . 0.0 109.94 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -121.8 130.38 53.35 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 74.8 mt -107.33 129.55 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.55 -0.719 . . . . 0.0 109.221 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -111.25 143.05 42.64 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.343 0.592 . . . . 0.0 109.955 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.5 t30 62.67 38.61 11.92 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.154 0.502 . . . . 0.0 109.883 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.13 139.2 46.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -0.854 . . . . 0.0 108.98 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -92.61 132.89 36.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.283 -0.886 . . . . 0.0 110.173 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -87.01 132.03 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.456 -0.778 . . . . 0.0 109.828 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.85 155.23 48.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.301 -0.874 . . . . 0.0 109.509 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -120.78 120.27 35.13 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -123.37 132.51 54.0 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.495 0.664 . . . . 0.0 109.602 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 55.84 32.02 18.81 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.42 0.628 . . . . 0.0 109.804 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.54 4.93 81.86 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -112.48 136.23 52.24 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.39 -1.065 . . . . 0.0 109.828 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.42 148.44 37.31 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.694 0.759 . . . . 0.0 110.77 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.0 t -156.25 154.44 30.71 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.5 mt -100.38 127.43 46.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.229 -0.92 . . . . 0.0 109.296 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 m -106.06 124.19 49.18 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.466 0.65 . . . . 0.0 109.354 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.4 t -96.8 112.43 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.291 -0.881 . . . . 0.0 108.919 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.92 178.44 43.71 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.14 -21.16 62.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.653 -0.91 . . . . 0.0 110.254 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.3 p -85.72 -5.44 59.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.167 -0.958 . . . . 0.0 109.28 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.1 p -79.03 167.6 20.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.447 -0.783 . . . . 0.0 109.883 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -131.45 141.74 49.86 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.421 0.629 . . . . 0.0 109.411 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.05 130.98 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -124.9 138.66 54.24 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.558 0.694 . . . . 0.0 109.443 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.2 m -70.58 150.26 46.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.628 -0.67 . . . . 0.0 110.126 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 51.7 t . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.608 0.718 . . . . 0.0 109.438 179.927 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 54.0 t0 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.652 0.739 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.487 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 47.3 tp -74.25 124.45 26.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.474 -0.766 . . . . 0.0 110.09 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 m -140.69 167.46 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.731 0.777 . . . . 0.0 110.116 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.18 156.5 29.81 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.732 0.777 . . . . 0.0 110.556 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.28 -43.09 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.715 -0.615 . . . . 0.0 109.881 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -65.34 -19.45 65.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.933 . . . . 0.0 109.855 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -85.82 -2.29 58.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 109.206 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.7 t -66.83 132.9 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.42 -0.8 . . . . 0.0 110.431 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.5 p -156.55 168.22 28.06 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.637 0.732 . . . . 0.0 109.556 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.36 -37.33 85.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.494 -0.754 . . . . 0.0 109.306 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.4 m -55.94 -20.81 17.6 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.367 -0.833 . . . . 0.0 109.548 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 p -113.77 79.57 4.56 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.65 -20.42 35.39 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.572 2.181 . . . . 0.0 112.036 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -128.07 106.18 8.9 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.581 -0.699 . . . . 0.0 109.549 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.4 m -139.2 162.9 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.61 -0.681 . . . . 0.0 110.123 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.9 t -118.33 135.96 54.0 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.3 m -133.41 162.27 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.773 0.797 . . . . 0.0 110.068 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.1 tt -136.64 142.55 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.553 -0.717 . . . . 0.0 109.53 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.65 -167.0 39.72 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.403 -1.379 . . . . 0.0 110.076 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -110.65 133.86 52.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.651 -0.911 . . . . 0.0 109.398 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 63' ' ' SER . 89.0 mt -102.55 132.42 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.254 0.55 . . . . 0.0 109.798 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.487 ' HG1' ' N ' ' A' ' 24' ' ' GLY . 2.4 t -141.7 158.18 44.14 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.723 0.773 . . . . 0.0 109.944 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.487 ' N ' ' HG1' ' A' ' 23' ' ' THR . . . 83.17 53.38 3.48 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.507 ' N ' ' CD1' ' A' ' 25' ' ' ILE . 1.5 mp -78.14 125.6 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.371 -1.076 . . . . 0.0 109.652 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -126.85 124.21 39.07 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -83.28 128.47 34.52 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.664 0.745 . . . . 0.0 110.043 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -141.61 159.38 42.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.448 -0.782 . . . . 0.0 109.122 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -116.93 140.59 49.29 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.698 -0.626 . . . . 0.0 109.688 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 18.3 p90 -137.29 158.74 43.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -90.01 100.76 13.52 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.664 0.745 . . . . 0.0 110.357 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.596 ' O ' ' N ' ' A' ' 34' ' ' GLY . 10.7 t -82.83 -151.18 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.503 -0.748 . . . . 0.0 110.097 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -55.69 77.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.765 0.793 . . . . 0.0 110.217 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 58.3 23.41 53.25 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.8 m -145.89 133.36 20.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.265 -1.138 . . . . 0.0 109.702 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.4 m -79.82 130.65 35.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.3 -0.875 . . . . 0.0 109.805 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.402 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 68.7 mttm -133.48 148.13 51.7 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.815 0.817 . . . . 0.0 110.129 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.8 t -77.52 144.95 37.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.562 -0.712 . . . . 0.0 110.494 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -140.5 137.81 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.378 -0.826 . . . . 0.0 109.579 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -106.35 132.07 52.82 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.444 -0.785 . . . . 0.0 109.277 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -118.27 153.53 33.78 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.595 -0.691 . . . . 0.0 109.694 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.52 -157.13 16.06 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -135.88 146.8 47.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.483 -1.01 . . . . 0.0 109.643 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 tt -122.0 143.33 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -133.76 152.57 51.91 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.634 0.73 . . . . 0.0 110.027 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -147.86 -157.18 0.79 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.609 0.718 . . . . 0.0 109.725 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -80.33 -7.03 58.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.392 -0.817 . . . . 0.0 109.893 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 49' ' ' ALA . 81.5 p -100.91 -68.64 0.8 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.277 -0.89 . . . . 0.0 109.606 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.401 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -159.78 -148.55 0.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.175 -0.953 . . . . 0.0 109.956 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -144.75 152.57 40.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.126 -0.984 . . . . 0.0 110.362 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.0 tt -150.61 147.98 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.224 -0.922 . . . . 0.0 110.222 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -74.22 138.13 43.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.496 -0.752 . . . . 0.0 109.872 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.533 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -133.58 164.48 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.333 -0.855 . . . . 0.0 110.038 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.1 t -142.09 140.43 32.53 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.428 -0.795 . . . . 0.0 109.297 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.6 t -115.59 129.77 56.63 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.452 0.644 . . . . 0.0 109.512 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -97.66 119.38 36.13 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.583 0.706 . . . . 0.0 110.832 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.85 -46.91 1.8 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -73.6 134.81 43.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.284 -1.127 . . . . 0.0 110.603 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -91.56 153.42 19.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.49 -0.756 . . . . 0.0 110.093 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.9 mt -133.0 157.77 44.37 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.463 0.649 . . . . 0.0 109.649 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -103.12 157.11 17.22 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.016 0.913 . . . . 0.0 110.395 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 62' ' ' ASP . 47.4 p30 -76.71 150.39 36.3 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.66 0.743 . . . . 0.0 111.312 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 22' ' ' ILE . 4.2 p 39.02 36.79 0.17 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.31 0.576 . . . . 0.0 110.073 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 47.1 p-10 -98.96 129.89 45.29 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.489 -0.757 . . . . 0.0 110.353 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.8 t -79.07 112.95 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.601 -0.687 . . . . 0.0 109.207 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.23 164.78 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.43 -0.794 . . . . 0.0 110.148 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.6 ttm-85 -119.08 130.12 55.44 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 74.3 mt -105.84 124.84 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.561 -0.712 . . . . 0.0 109.183 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -114.84 142.41 46.59 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.454 0.645 . . . . 0.0 109.714 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.9 t30 63.99 40.35 7.3 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.613 0.721 . . . . 0.0 109.308 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.56 147.02 48.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.603 -0.685 . . . . 0.0 109.829 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -101.97 121.63 42.52 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.6 0.714 . . . . 0.0 109.467 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.16 134.25 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.569 -0.707 . . . . 0.0 110.324 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.37 153.82 45.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.465 -0.772 . . . . 0.0 109.094 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -114.82 114.27 25.33 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.458 -0.776 . . . . 0.0 109.452 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -112.96 126.34 55.37 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.692 0.758 . . . . 0.0 110.187 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 55.73 27.36 10.6 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.321 0.582 . . . . 0.0 110.658 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.84 4.64 84.71 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -112.31 131.04 55.73 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.48 -1.012 . . . . 0.0 109.768 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.02 144.4 40.89 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.747 0.784 . . . . 0.0 110.451 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.7 p -152.89 160.04 43.04 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.9 mt -106.91 131.73 53.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.425 -0.797 . . . . 0.0 109.662 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 t -109.14 125.83 52.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.666 -0.646 . . . . 0.0 109.377 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 t -102.85 100.89 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.488 -0.758 . . . . 0.0 109.011 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.46 176.66 49.96 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -65.92 -29.44 69.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.574 -0.956 . . . . 0.0 109.647 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.4 m -74.79 -7.48 53.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 109.433 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.5 p -80.96 167.84 19.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.319 -0.863 . . . . 0.0 110.273 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -125.7 138.12 53.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.545 -0.722 . . . . 0.0 109.347 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.0 mt -125.17 129.96 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.536 -0.727 . . . . 0.0 109.65 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -118.71 113.28 20.92 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.3 t -75.05 150.31 38.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.461 -0.775 . . . . 0.0 110.517 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.6 t . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 110.054 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.764 0.792 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.2 tt -75.99 129.75 37.37 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.531 0.681 . . . . 0.0 109.957 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.9 m -140.17 163.62 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.934 0.874 . . . . 0.0 110.834 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -72.88 149.59 43.36 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.78 0.8 . . . . 0.0 110.247 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 92.0 mt -63.74 -42.6 96.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -69.65 -17.22 63.49 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.729 -0.607 . . . . 0.0 109.812 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -92.61 6.44 47.3 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.508 -0.745 . . . . 0.0 109.247 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.56 133.2 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.71 0.767 . . . . 0.0 109.947 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.1 p -153.27 166.85 31.27 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.962 0.887 . . . . 0.0 110.324 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.0 mt -73.07 -9.29 58.57 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.6 m -74.44 -14.72 60.88 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.3 p -121.49 84.09 41.66 Favored Pre-proline 0 N--CA 1.499 1.995 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.39 -41.19 74.84 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.613 2.209 . . . . 0.0 111.594 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -116.89 131.92 56.83 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.761 0.791 . . . . 0.0 109.992 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.4 m -149.77 175.71 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 122.273 1.035 . . . . 0.0 110.617 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.441 ' HG ' ' CG ' ' A' ' 69' ' ' ASP . 48.4 m -134.71 137.17 43.29 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -140.21 163.26 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.074 0.94 . . . . 0.0 110.643 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.6 tt -137.93 135.51 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.709 0.766 . . . . 0.0 109.893 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.29 -168.47 40.97 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -110.95 136.29 50.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.941 -0.741 . . . . 0.0 109.489 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.506 ' N ' ' CD1' ' A' ' 22' ' ' ILE . 2.4 mp -96.33 133.32 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.406 0.622 . . . . 0.0 109.714 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 t -136.07 159.78 40.65 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.75 0.786 . . . . 0.0 109.929 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 25' ' ' ILE . . . 99.63 -69.29 0.54 Allowed Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 24' ' ' GLY . 25.8 mm 59.11 128.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.844 0.83 . . . . 0.0 110.592 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.69 ' HD1' ' H ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -149.74 138.62 21.03 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.437 0.637 . . . . 0.0 109.358 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.69 ' H ' ' HD1' ' A' ' 26' ' ' HIS . 88.7 tttt -106.0 129.13 54.18 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.002 0.906 . . . . 0.0 110.175 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -141.09 157.41 45.34 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.736 0.779 . . . . 0.0 110.074 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 56.5 mp0 -113.99 142.8 45.71 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.806 0.812 . . . . 0.0 110.243 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 31.7 p90 -143.66 161.96 37.19 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.598 0.713 . . . . 0.0 109.485 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -94.19 107.0 18.97 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.751 0.786 . . . . 0.0 110.388 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 34' ' ' GLY . 4.4 p -88.19 -161.54 0.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -52.18 80.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.597 0.713 . . . . 0.0 110.259 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 59.94 11.0 16.05 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.421 ' O ' ' OG ' ' A' ' 32' ' ' SER . 92.8 m -131.86 131.21 42.59 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.863 0.84 . . . . 0.0 110.791 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.2 m -79.48 128.32 33.22 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.55 0.69 . . . . 0.0 109.192 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.451 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 98.6 mttt -136.13 147.83 47.94 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.885 0.85 . . . . 0.0 110.15 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 87.5 p -82.03 149.91 27.86 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.846 0.831 . . . . 0.0 110.019 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -130.64 133.94 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.835 0.826 . . . . 0.0 109.836 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -98.2 133.36 42.74 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -130.62 150.82 51.64 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.742 0.782 . . . . 0.0 109.829 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.72 -169.43 35.31 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -122.24 139.62 53.57 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.622 0.725 . . . . 0.0 109.699 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.2 tt -113.08 136.43 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -121.5 149.79 42.55 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.948 0.88 . . . . 0.0 110.361 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 38.3 t0 -148.8 -164.57 2.05 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.62 0.724 . . . . 0.0 109.479 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.541 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 48.9 t0 -65.04 -38.59 91.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.609 -0.682 . . . . 0.0 109.825 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.1 p -73.22 -85.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.263 0.554 . . . . 0.0 109.712 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -143.49 -142.26 0.13 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.643 0.735 . . . . 0.0 109.971 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.7 ptt85 -148.96 158.32 44.09 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.758 0.79 . . . . 0.0 110.042 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.2 tt -152.65 158.94 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 122.033 0.921 . . . . 0.0 110.631 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.541 ' NH2' ' CG ' ' A' ' 76' ' ' PHE . 51.2 ttp180 -74.47 143.47 44.63 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.705 0.764 . . . . 0.0 110.107 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 pt -133.38 161.39 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.732 0.777 . . . . 0.0 110.327 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.0 m -144.76 138.93 27.5 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.747 0.784 . . . . 0.0 110.19 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 p -134.57 135.55 42.34 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.87 0.843 . . . . 0.0 109.579 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.498 ' C ' ' H ' ' A' ' 58' ' ' LYS . 88.0 m-85 -94.4 124.85 38.67 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.752 0.787 . . . . 0.0 110.796 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.57 -38.56 0.48 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.498 ' H ' ' C ' ' A' ' 56' ' ' PHE . 72.2 mmtt -68.42 133.66 49.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.66 -0.906 . . . . 0.0 110.001 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -97.71 148.49 23.29 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.765 0.793 . . . . 0.0 110.341 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.8 mt -129.94 152.78 49.04 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.568 0.699 . . . . 0.0 109.696 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -115.79 158.38 22.96 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.225 1.012 . . . . 0.0 110.421 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.9 t0 -62.01 138.19 58.34 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.815 0.817 . . . . 0.0 110.873 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.523 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 10.9 t 52.33 31.01 8.77 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.269 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -78.24 112.06 14.84 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.571 -0.705 . . . . 0.0 110.372 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 t -81.2 105.76 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.663 0.744 . . . . 0.0 109.281 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.7 m -140.99 164.65 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.647 0.736 . . . . 0.0 110.113 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.8 ttp85 -115.21 127.83 55.77 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.759 0.79 . . . . 0.0 109.582 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.3 mt -108.39 130.62 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.608 0.718 . . . . 0.0 109.844 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 67.8 t0 -125.32 142.44 51.5 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.556 0.693 . . . . 0.0 109.902 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.55 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 52.6 t30 71.92 35.09 1.39 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.387 0.613 . . . . 0.0 109.949 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.14 141.54 43.68 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.394 0.616 . . . . 0.0 110.407 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -95.17 128.37 41.95 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.755 0.788 . . . . 0.0 109.893 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.8 t -80.64 132.4 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 121.679 0.752 . . . . 0.0 110.179 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -117.92 146.19 44.13 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.744 0.783 . . . . 0.0 109.549 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -108.47 97.64 7.28 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.525 0.679 . . . . 0.0 109.454 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.633 ' O ' ' N ' ' A' ' 78' ' ' GLY . 28.4 m-85 -82.83 -177.88 6.9 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.409 0.624 . . . . 0.0 110.55 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -51.94 75.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.499 0.666 . . . . 0.0 110.493 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 76' ' ' PHE . . . 74.71 15.56 80.64 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -130.62 144.62 51.55 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.565 -0.962 . . . . 0.0 110.395 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.5 mt -103.1 140.35 37.43 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.859 0.838 . . . . 0.0 110.126 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 96.3 p -152.53 163.52 39.41 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.701 0.763 . . . . 0.0 109.854 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.7 mt -106.07 131.03 53.83 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.651 0.739 . . . . 0.0 110.176 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.2 p -107.67 123.97 49.29 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.838 0.828 . . . . 0.0 109.761 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.2 t -100.41 112.26 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.854 0.835 . . . . 0.0 109.6 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -97.19 -179.26 34.22 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -66.11 -29.14 69.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.914 -0.756 . . . . 0.0 109.736 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 89.4 p -78.67 -4.91 51.42 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.8 t -80.39 167.65 19.95 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.467 0.651 . . . . 0.0 110.087 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 24.7 mmt85 -124.96 137.79 54.25 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.716 0.77 . . . . 0.0 109.953 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.8 mt -127.19 130.47 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.511 0.672 . . . . 0.0 110.386 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -124.59 125.76 44.68 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.78 0.8 . . . . 0.0 109.402 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.2 p -75.73 152.95 37.35 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.714 0.768 . . . . 0.0 110.433 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 64.2 t . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.566 0.698 . . . . 0.0 109.399 179.505 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 55.4 t0 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.674 0.749 . . . . 0.0 110.552 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.54 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 43.2 tp -77.6 123.24 26.37 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.425 -0.797 . . . . 0.0 109.744 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.1 m -140.28 165.03 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.385 -0.822 . . . . 0.0 110.067 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.6 157.56 31.84 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.81 0.814 . . . . 0.0 110.492 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.457 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 2.3 mp -63.97 -42.72 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.619 -0.676 . . . . 0.0 109.256 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -64.25 -24.15 67.56 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.239 -0.913 . . . . 0.0 109.557 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -83.21 -0.16 48.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.952 -1.093 . . . . 0.0 109.496 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.2 131.99 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.074 -1.016 . . . . 0.0 110.562 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.3 p -158.99 167.37 29.54 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.55 -0.719 . . . . 0.0 109.331 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.19 -19.54 66.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.89 . . . . 0.0 108.888 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -63.86 -17.24 62.97 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.318 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.6 p -124.36 82.02 58.38 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.318 -0.864 . . . . 0.0 109.231 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.32 -41.42 66.53 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.958 2.439 . . . . 0.0 112.151 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.415 ' HH ' HH12 ' A' ' 72' ' ' ARG . 74.8 m-85 -119.28 128.1 53.84 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.422 -0.799 . . . . 0.0 109.814 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.6 m -147.17 161.11 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.256 -0.903 . . . . 0.0 110.116 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.5 m -115.46 134.17 55.34 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.69 162.38 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.873 0.844 . . . . 0.0 110.324 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.0 tt -140.49 137.98 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.428 -0.795 . . . . 0.0 109.524 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.45 -162.91 29.41 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -111.58 128.81 56.15 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.58 -0.953 . . . . 0.0 109.359 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.546 ' N ' ' CD1' ' A' ' 22' ' ' ILE . 1.8 mp -94.53 125.74 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.533 0.682 . . . . 0.0 109.737 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.7 p -132.7 159.29 40.06 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.836 0.827 . . . . 0.0 110.091 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.9 82.02 0.19 Allowed Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.4 mm -92.1 129.81 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.092 -1.24 . . . . 0.0 110.267 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -133.73 139.1 46.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.534 -0.729 . . . . 0.0 109.132 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -103.28 136.45 43.03 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.766 0.793 . . . . 0.0 109.917 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.593 ' NZ ' ' NH2' ' A' ' 52' ' ' ARG . 53.1 mtmt -144.25 160.24 41.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.488 -0.757 . . . . 0.0 109.317 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -122.11 144.73 48.75 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.626 0.727 . . . . 0.0 109.701 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -142.63 160.92 39.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 109.289 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -93.98 116.23 28.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.293 -0.879 . . . . 0.0 109.889 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 t -109.23 110.2 21.34 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.822 0.82 . . . . 0.0 109.362 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 53.34 33.6 16.07 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.57 0.7 . . . . 0.0 110.722 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.27 -2.01 77.73 Favored Glycine 0 N--CA 1.496 2.643 0 O-C-N 120.962 -1.086 . . . . 0.0 111.047 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.7 p -115.95 125.22 52.25 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.089 -1.242 . . . . 0.0 109.928 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.1 m -69.6 133.42 47.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.55 -0.719 . . . . 0.0 110.094 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -136.71 144.94 44.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.367 -0.833 . . . . 0.0 109.889 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.4 m -83.25 144.83 29.48 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.771 0.796 . . . . 0.0 110.311 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.2 p -140.51 137.81 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.898 . . . . 0.0 108.85 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -102.1 135.29 43.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.436 -0.79 . . . . 0.0 109.495 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.606 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 1.1 mp0 -117.05 152.12 35.35 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.631 0.729 . . . . 0.0 109.176 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.34 -171.86 35.43 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -130.49 139.05 50.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.481 -1.011 . . . . 0.0 109.271 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.2 tt -114.62 130.9 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -123.6 151.56 42.83 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.655 0.741 . . . . 0.0 109.932 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.573 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 30.7 t0 -155.72 -161.87 1.23 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.489 -0.757 . . . . 0.0 109.673 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.573 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 95.8 m-20 -74.26 -3.48 30.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.283 -0.886 . . . . 0.0 110.383 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.504 ' OG1' ' N ' ' A' ' 49' ' ' ALA . 8.1 p -101.15 -62.46 1.24 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.849 -1.157 . . . . 0.0 109.323 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.504 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -171.29 -150.51 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.96 -1.087 . . . . 0.0 110.364 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -135.32 145.63 47.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.514 -0.741 . . . . 0.0 109.894 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.2 tt -150.2 150.2 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.166 -0.959 . . . . 0.0 110.025 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.593 ' NH2' ' NZ ' ' A' ' 28' ' ' LYS . 72.9 ttt180 -73.01 146.55 45.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.457 -0.777 . . . . 0.0 110.383 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.6 pt -132.3 158.6 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.455 -0.778 . . . . 0.0 109.744 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.8 m -143.72 126.54 16.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.178 -0.951 . . . . 0.0 109.073 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.4 t -114.13 128.31 56.32 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.566 -0.709 . . . . 0.0 109.357 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -95.38 121.41 37.02 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.738 0.78 . . . . 0.0 110.95 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.19 -47.72 3.22 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -82.59 135.14 35.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.287 . . . . 0.0 110.674 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.573 ' H ' ' CD ' ' A' ' 59' ' ' GLN . 1.8 pm0 -89.98 165.71 13.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.679 -0.638 . . . . 0.0 110.119 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.6 mt -124.03 158.43 32.15 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.547 0.689 . . . . 0.0 109.478 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -107.51 133.46 51.95 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.376 1.084 . . . . 0.0 109.889 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 63' ' ' SER . 66.2 t0 -60.86 142.79 55.9 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.986 0.898 . . . . 0.0 111.304 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.555 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 2.0 m 50.98 29.57 4.61 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.496 0.665 . . . . 0.0 110.171 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -94.48 129.31 41.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.064 -1.022 . . . . 0.0 110.807 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.6 t -89.55 111.36 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.34 -0.85 . . . . 0.0 108.8 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.27 166.27 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.216 -0.928 . . . . 0.0 110.318 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -118.58 127.11 53.3 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.2 mt -107.01 127.69 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.257 -0.902 . . . . 0.0 109.435 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -111.17 145.46 38.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.699 -0.626 . . . . 0.0 109.72 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.6 t30 63.39 38.68 9.92 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.851 0.834 . . . . 0.0 109.401 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.82 134.94 41.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.812 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.415 HH12 ' HH ' ' A' ' 15' ' ' TYR . 60.5 ttt85 -88.06 136.96 32.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.414 -0.804 . . . . 0.0 110.237 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.0 t -96.62 132.7 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -0.856 . . . . 0.0 109.487 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.7 155.03 48.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 109.394 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -117.87 115.94 25.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.612 -0.68 . . . . 0.0 109.197 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -125.2 134.74 52.25 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.703 0.764 . . . . 0.0 109.812 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.6 m120 56.28 29.68 15.37 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.731 0.777 . . . . 0.0 109.974 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.29 7.84 85.11 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -114.42 134.59 54.88 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.435 -1.038 . . . . 0.0 109.92 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.7 mt -79.91 143.17 34.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.4 -0.813 . . . . 0.0 110.093 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.5 m -151.71 158.67 43.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 109.289 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.2 mt -104.19 127.54 51.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.393 -0.817 . . . . 0.0 109.328 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -107.07 125.43 51.03 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.648 0.737 . . . . 0.0 109.541 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 t -98.43 111.85 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.411 -0.806 . . . . 0.0 109.416 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.07 -179.32 42.97 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 87' ' ' SER . 47.4 p30 -70.89 -18.17 62.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.448 -1.031 . . . . 0.0 109.484 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.509 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 98.7 p -85.33 -7.89 58.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.152 -0.968 . . . . 0.0 109.487 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 m -80.93 165.7 21.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.103 -0.998 . . . . 0.0 110.336 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 24.9 tpt85 -127.66 133.56 49.63 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.549 0.69 . . . . 0.0 109.542 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -114.97 129.62 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.582 -0.699 . . . . 0.0 109.703 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -123.35 117.62 25.64 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.775 0.797 . . . . 0.0 109.067 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 73.6 m -77.36 147.18 36.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.549 -0.72 . . . . 0.0 110.368 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.029 179.571 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 67.0 t0 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.477 0.656 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.541 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 35.6 tp -71.75 130.23 40.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.554 -0.716 . . . . 0.0 109.782 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.18 164.5 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.417 -0.802 . . . . 0.0 109.648 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -80.29 159.1 25.95 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.608 -0.683 . . . . 0.0 110.569 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.509 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 1.4 mp -63.42 -45.49 97.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.626 -0.671 . . . . 0.0 109.255 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -63.43 -20.31 65.45 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.512 -0.743 . . . . 0.0 109.841 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 8' ' ' ASP . 53.2 t0 -87.44 -2.8 58.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.377 -0.827 . . . . 0.0 109.529 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.0 t -70.04 132.65 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -0.938 . . . . 0.0 110.144 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.7 m -158.24 172.59 18.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.478 -0.764 . . . . 0.0 109.555 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.33 -38.95 93.15 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.427 -0.796 . . . . 0.0 109.652 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.5 t -55.0 -17.13 3.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.388 -0.82 . . . . 0.0 109.8 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.416 ' O ' ' OG1' ' A' ' 13' ' ' THR . 7.4 p -114.37 79.59 5.37 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.462 -0.774 . . . . 0.0 109.113 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.92 -20.63 29.15 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.229 1.953 . . . . 0.0 112.324 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -131.71 110.06 10.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.537 -0.727 . . . . 0.0 109.299 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.9 m -142.21 163.97 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.359 -0.838 . . . . 0.0 110.306 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.3 t -113.0 141.52 46.75 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.2 t -135.33 155.98 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.239 -0.913 . . . . 0.0 109.775 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.0 tt -140.13 132.76 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.329 -0.857 . . . . 0.0 109.384 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.61 -160.51 30.78 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 118.909 -1.615 . . . . 0.0 110.366 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -111.83 136.82 50.62 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.796 -0.826 . . . . 0.0 109.638 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 63' ' ' SER . 92.9 mt -103.5 130.75 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.474 -0.766 . . . . 0.0 109.636 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.4 p -134.86 159.53 41.1 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.508 -0.745 . . . . 0.0 109.787 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.84 78.13 0.39 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.5 mm -95.08 123.37 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.189 -1.183 . . . . 0.0 109.366 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -115.81 137.98 51.57 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -101.61 129.78 47.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.524 -0.735 . . . . 0.0 109.594 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -144.25 161.07 39.85 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.5 137.05 55.0 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.326 -0.859 . . . . 0.0 109.779 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -130.15 153.8 48.17 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.549 ' N ' ' OE1' ' A' ' 31' ' ' GLU . 58.1 mp0 -88.32 136.42 32.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -0.909 . . . . 0.0 109.731 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.7 t -137.03 109.72 7.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.498 -0.751 . . . . 0.0 109.166 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 54.2 t0 58.69 32.04 21.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.523 -0.736 . . . . 0.0 110.134 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.66 11.27 83.2 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.1 m -121.0 130.17 53.69 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.602 -0.94 . . . . 0.0 109.305 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.3 m -80.68 130.44 35.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 109.661 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -132.8 140.54 48.05 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.383 -0.823 . . . . 0.0 109.675 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.2 t -79.86 142.27 35.38 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.385 -0.822 . . . . 0.0 109.701 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 p -133.43 136.53 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -102.08 139.04 38.24 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.469 -0.769 . . . . 0.0 109.359 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -135.79 153.91 51.38 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.391 -0.818 . . . . 0.0 109.779 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.54 -150.37 7.93 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.564 ' HH ' ' NH1' ' A' ' 52' ' ' ARG . 89.4 m-85 -134.77 143.51 47.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.588 -0.948 . . . . 0.0 109.511 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.6 tt -120.94 134.83 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -117.6 148.34 42.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.665 -0.647 . . . . 0.0 109.746 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -136.71 -164.82 1.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -72.15 -19.1 61.82 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.517 -0.739 . . . . 0.0 109.462 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.9 m -93.67 -76.35 0.48 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.28 -0.888 . . . . 0.0 110.087 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.89 -148.68 0.25 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.388 -0.82 . . . . 0.0 109.925 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -144.53 157.01 44.42 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.351 -0.843 . . . . 0.0 110.069 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.2 tt -151.46 157.28 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.24 -0.912 . . . . 0.0 110.011 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.564 ' NH1' ' HH ' ' A' ' 43' ' ' TYR . 60.0 ttt85 -78.8 141.43 37.77 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.469 -0.769 . . . . 0.0 109.531 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.537 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -133.77 164.55 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.558 -0.714 . . . . 0.0 109.744 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.7 p -141.63 151.27 42.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 t -136.51 133.47 36.54 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.436 -0.79 . . . . 0.0 109.114 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -94.4 123.39 37.78 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.303 -0.873 . . . . 0.0 110.922 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.47 -57.41 2.03 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -61.07 130.6 47.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -1.184 . . . . 0.0 110.071 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -84.03 158.0 21.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.456 -0.777 . . . . 0.0 109.82 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.3 mt -120.67 153.22 37.19 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -115.75 130.66 56.93 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.833 0.825 . . . . 0.0 109.507 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 62' ' ' ASP . 54.8 p-10 -66.28 142.99 57.48 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 110.835 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 22' ' ' ILE . 1.5 m 65.87 4.06 2.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.955 -0.466 . . . . 0.0 110.946 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 21.1 p-10 -81.47 136.27 35.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.632 -1.292 . . . . 0.0 110.154 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 t -95.6 113.29 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.166 -0.959 . . . . 0.0 108.841 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.6 m -139.24 165.53 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.746 0.784 . . . . 0.0 110.23 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -117.78 133.0 56.38 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.9 mt -106.17 129.55 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.511 -0.743 . . . . 0.0 109.137 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -111.36 143.28 42.42 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.638 -0.664 . . . . 0.0 109.538 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.2 t30 60.88 39.42 16.89 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.194 0.521 . . . . 0.0 109.834 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.58 146.47 50.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 0.0 108.969 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -99.99 121.03 40.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.595 -0.691 . . . . 0.0 109.748 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.1 t -83.79 133.91 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.463 -0.773 . . . . 0.0 109.763 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.24 155.19 45.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.249 -0.907 . . . . 0.0 109.326 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -114.12 119.49 37.29 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.534 -0.729 . . . . 0.0 109.29 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -124.42 135.37 53.21 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.617 -0.677 . . . . 0.0 109.614 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.1 m120 54.61 31.69 15.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.703 -0.623 . . . . 0.0 109.58 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.55 10.84 82.85 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -120.37 139.52 52.67 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.471 -1.017 . . . . 0.0 110.113 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.463 ' N ' ' CD2' ' A' ' 80' ' ' LEU . 4.0 mm? -76.84 144.26 39.16 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.825 0.822 . . . . 0.0 110.546 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.9 m -150.92 152.54 33.77 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.2 mt -103.94 128.65 51.47 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.33 -0.856 . . . . 0.0 108.845 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.2 t -109.83 125.92 53.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.642 -0.661 . . . . 0.0 109.491 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.2 t -99.58 109.44 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.32 -177.05 38.94 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.89 -31.71 72.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.725 -0.868 . . . . 0.0 109.765 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.9 m -76.43 -5.76 48.77 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.277 -0.889 . . . . 0.0 109.496 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.6 t -85.09 165.35 17.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.499 -0.751 . . . . 0.0 109.428 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -134.06 137.46 44.66 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.542 -0.724 . . . . 0.0 109.459 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.429 HD12 HG21 ' A' ' 90' ' ' ILE . 96.7 mt -116.05 131.18 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -118.32 130.57 56.1 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.9 p -71.85 152.13 42.88 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.518 -0.739 . . . . 0.0 109.697 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.497 1.899 0 O-C-N 121.524 -0.735 . . . . 0.0 109.628 -179.833 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.677 0.751 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.2 tp -71.61 127.38 32.39 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.726 0.774 . . . . 0.0 110.074 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.57 163.93 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.882 0.848 . . . . 0.0 110.381 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.557 ' N ' ' OD2' ' A' ' 8' ' ' ASP . 63.5 mttp -76.89 148.26 36.54 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.856 0.836 . . . . 0.0 110.222 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.9 mm -59.72 -39.4 79.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.454 0.645 . . . . 0.0 109.786 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -62.7 -33.53 75.27 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.67 -0.644 . . . . 0.0 110.369 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.557 ' OD2' ' N ' ' A' ' 5' ' ' LYS . 7.5 p30 -83.32 12.39 5.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.476 -0.765 . . . . 0.0 110.269 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.9 t -71.4 130.2 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.737 0.779 . . . . 0.0 109.743 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.9 p -159.23 165.31 33.87 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.887 0.851 . . . . 0.0 109.983 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.2 mt -62.96 -30.2 71.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.662 -0.649 . . . . 0.0 109.487 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.9 m -52.8 -21.32 4.03 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 13' ' ' THR . 2.4 p -112.05 95.14 28.33 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.68 -18.85 19.26 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.701 2.267 . . . . 0.0 111.411 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -142.39 123.72 14.75 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.573 0.702 . . . . 0.0 109.601 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.5 m -153.74 173.24 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.897 0.856 . . . . 0.0 110.436 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.1 m -128.41 149.43 50.55 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.65 0.738 . . . . 0.0 109.575 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.83 159.17 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.946 0.879 . . . . 0.0 110.403 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.491 ' CD1' ' HE ' ' A' ' 67' ' ' ARG . 97.0 mt -135.92 133.45 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.599 0.714 . . . . 0.0 109.894 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.52 -158.51 25.79 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.404 ' O ' ' OE2' ' A' ' 45' ' ' GLU . 36.8 ttpt -112.98 130.51 56.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.624 -0.927 . . . . 0.0 110.194 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.459 ' C ' ' HG1' ' A' ' 23' ' ' THR . 94.6 mt -99.61 133.1 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.404 0.621 . . . . 0.0 109.65 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.459 ' HG1' ' C ' ' A' ' 22' ' ' ILE . 9.5 m -146.0 147.32 31.54 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.806 0.812 . . . . 0.0 110.205 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.42 76.28 1.22 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.476 ' N ' ' CD1' ' A' ' 25' ' ' ILE . 1.4 mp -94.59 115.18 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.647 -0.914 . . . . 0.0 109.865 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -111.55 121.92 46.44 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.573 0.702 . . . . 0.0 109.286 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -88.85 133.33 34.31 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.892 0.853 . . . . 0.0 110.215 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -148.2 151.48 35.59 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.488 0.661 . . . . 0.0 109.341 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 57.7 mp0 -111.8 140.61 46.29 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.831 0.824 . . . . 0.0 110.421 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.472 ' OH ' ' CD1' ' A' ' 56' ' ' PHE . 6.6 p90 -141.5 159.68 41.71 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.757 0.789 . . . . 0.0 109.708 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -91.23 95.93 10.3 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.765 0.793 . . . . 0.0 109.527 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.621 ' O ' ' N ' ' A' ' 34' ' ' GLY . 2.5 t -77.17 -149.5 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.263 0.554 . . . . 0.0 110.169 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -54.11 75.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.732 0.777 . . . . 0.0 110.402 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.621 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 58.83 24.85 58.24 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 t -147.49 141.01 25.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.631 -0.923 . . . . 0.0 109.661 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.8 m -88.61 125.85 35.01 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.682 0.753 . . . . 0.0 110.126 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -136.59 147.31 46.9 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.837 0.827 . . . . 0.0 109.734 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.9 t -81.62 145.01 30.82 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.676 0.75 . . . . 0.0 110.077 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 p -132.89 136.02 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.749 0.785 . . . . 0.0 109.662 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -104.86 130.23 53.03 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.584 0.707 . . . . 0.0 109.183 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -121.86 144.63 48.73 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.831 0.824 . . . . 0.0 109.927 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.54 -171.57 34.51 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -119.69 144.11 47.38 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.97 0.891 . . . . 0.0 110.396 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.68 136.96 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 21' ' ' LYS . 2.4 pm0 -125.31 154.93 41.02 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.037 0.922 . . . . 0.0 110.422 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.561 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 29.5 t0 -143.12 -156.56 0.69 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.507 0.67 . . . . 0.0 109.51 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.561 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 98.5 m-20 -73.82 -19.93 60.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.661 -0.649 . . . . 0.0 109.569 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 41.4 p -94.11 -88.5 0.24 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.584 -0.698 . . . . 0.0 109.486 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.79 -146.09 0.23 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.5 -0.75 . . . . 0.0 110.185 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -148.2 158.42 44.07 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.707 0.765 . . . . 0.0 110.482 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.2 tt -151.02 160.3 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-O 121.935 0.874 . . . . 0.0 110.477 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.8 ttp85 -78.82 145.01 34.51 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.832 0.825 . . . . 0.0 110.621 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.6 pt -131.27 159.6 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.634 0.73 . . . . 0.0 109.816 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.2 m -143.63 118.77 10.11 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.643 0.735 . . . . 0.0 109.695 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.4 p -109.35 142.4 40.34 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.838 0.828 . . . . 0.0 109.79 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.546 ' C ' ' H ' ' A' ' 58' ' ' LYS . 76.1 m-85 -102.72 117.36 34.47 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.64 0.733 . . . . 0.0 110.845 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.25 -31.48 0.26 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.546 ' H ' ' C ' ' A' ' 56' ' ' PHE . 13.9 tptp -66.55 129.94 41.52 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.684 -0.892 . . . . 0.0 110.915 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -83.71 138.0 33.5 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.85 0.833 . . . . 0.0 110.761 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.2 mt -128.47 150.73 50.02 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -109.53 143.66 38.87 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.762 0.792 . . . . 0.0 110.134 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -67.11 137.95 56.72 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.884 0.849 . . . . 0.0 110.182 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.41 ' H ' ' HA ' ' A' ' 23' ' ' THR . 7.3 t 51.68 80.64 0.08 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.725 0.774 . . . . 0.0 109.396 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -153.26 121.83 6.34 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.723 0.773 . . . . 0.0 110.151 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.8 m -74.1 119.46 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.915 0.864 . . . . 0.0 109.487 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.2 m -141.04 167.93 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-O 122.479 1.133 . . . . 0.0 110.242 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.491 ' HE ' ' CD1' ' A' ' 19' ' ' ILE . 39.2 ttm180 -113.76 126.28 55.04 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.031 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 94.0 mt -106.04 118.34 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.638 0.733 . . . . 0.0 109.484 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -122.03 151.43 40.84 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.917 0.865 . . . . 0.0 110.123 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 61.48 37.01 16.84 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.794 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -92.27 147.21 23.1 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.602 -0.687 . . . . 0.0 109.454 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -103.64 153.18 20.91 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.26 1.029 . . . . 0.0 110.839 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.26 132.61 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.738 0.78 . . . . 0.0 109.548 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.26 155.48 43.87 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.758 0.79 . . . . 0.0 110.038 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -112.6 119.21 37.36 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.613 0.72 . . . . 0.0 109.318 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -121.53 132.76 54.88 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.813 0.816 . . . . 0.0 109.881 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 58.04 23.0 9.52 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.334 0.588 . . . . 0.0 109.979 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.91 6.84 81.85 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -117.53 136.64 53.1 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.509 -0.995 . . . . 0.0 110.254 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.7 mt -75.58 145.19 41.39 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.711 0.767 . . . . 0.0 110.181 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 93.9 p -156.9 160.21 38.89 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.626 0.727 . . . . 0.0 109.914 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.7 mt -104.92 108.76 20.43 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.796 0.807 . . . . 0.0 109.082 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.8 m -88.93 141.21 28.68 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.745 0.783 . . . . 0.0 109.748 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.404 ' CG1' ' OG ' ' A' ' 88' ' ' SER . 41.5 t -121.85 126.87 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.871 0.843 . . . . 0.0 109.7 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.66 173.35 25.81 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.29 -17.97 63.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.777 -0.837 . . . . 0.0 109.029 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.0 m -84.55 -5.76 59.32 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.404 ' OG ' ' CG1' ' A' ' 84' ' ' VAL . 13.5 p -76.87 168.97 19.17 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.599 0.714 . . . . 0.0 110.309 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.415 ' NH2' ' OE2' ' A' ' 91' ' ' GLU . 77.6 ttt180 -121.87 123.53 41.97 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.855 0.836 . . . . 0.0 109.856 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.4 mt -124.22 129.04 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.654 0.74 . . . . 0.0 109.746 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.415 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 97.7 mt-10 -126.03 123.12 37.74 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.797 0.808 . . . . 0.0 110.005 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.6 t -74.17 144.12 44.95 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.309 0.576 . . . . 0.0 109.713 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 121.929 0.871 . . . . 0.0 110.254 -179.771 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 67.9 t0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.365 0.602 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.446 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 49.7 tp -70.89 127.06 31.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 109.609 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.17 162.64 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.548 -0.72 . . . . 0.0 109.57 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -78.31 154.25 31.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.458 -0.776 . . . . 0.0 110.265 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.98 -43.59 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.464 -0.772 . . . . 0.0 109.475 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -66.79 -18.2 65.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.66 2.6 56.36 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.176 -0.952 . . . . 0.0 109.808 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.7 t -67.03 133.69 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.325 -0.859 . . . . 0.0 110.198 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.5 p -158.02 164.93 36.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.571 -0.705 . . . . 0.0 109.515 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.2 mt -63.96 -22.44 66.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.323 -0.861 . . . . 0.0 109.067 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.9 t -58.23 -17.62 20.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.416 -0.803 . . . . 0.0 109.227 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.9 p -126.34 80.25 69.27 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.525 -0.734 . . . . 0.0 109.563 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.02 -39.98 77.87 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.524 2.149 . . . . 0.0 111.749 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -115.02 130.81 57.02 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.6 m -152.01 178.33 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.224 -0.923 . . . . 0.0 110.185 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.4 m -130.23 131.31 45.47 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.4 m -137.5 161.44 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.197 -0.939 . . . . 0.0 110.147 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.4 tt -143.77 146.57 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.381 -0.824 . . . . 0.0 109.408 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.05 -161.53 35.2 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.047 -1.549 . . . . 0.0 110.476 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -104.45 144.76 31.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.674 -0.898 . . . . 0.0 109.572 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 mm -98.73 132.46 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 56.5 p -134.95 158.09 45.2 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.438 -0.789 . . . . 0.0 109.652 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 25' ' ' ILE . . . 96.01 -72.34 0.86 Allowed Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.444 ' O ' ' O ' ' A' ' 24' ' ' GLY . 24.8 mm 50.01 101.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.458 -1.025 . . . . 0.0 110.158 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -129.66 131.25 46.35 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -93.44 133.3 36.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.307 -0.871 . . . . 0.0 109.637 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -146.76 152.4 38.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.417 -0.802 . . . . 0.0 109.284 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -111.31 144.82 39.87 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.725 -0.609 . . . . 0.0 109.372 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -146.15 164.13 33.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.33 -0.857 . . . . 0.0 109.391 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -87.52 142.73 27.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.643 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.4 t -147.08 110.59 4.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.343 -0.848 . . . . 0.0 108.761 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 55.76 31.7 18.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.702 -0.624 . . . . 0.0 109.609 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.55 14.7 75.41 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.2 p -128.15 134.48 49.09 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.371 -1.076 . . . . 0.0 109.609 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.9 m -83.36 128.84 34.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.542 -0.724 . . . . 0.0 109.668 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -136.42 144.44 44.48 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.416 -0.803 . . . . 0.0 109.295 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.1 p -79.78 153.4 29.21 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.238 -0.914 . . . . 0.0 110.211 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -141.83 140.74 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -103.13 131.45 50.13 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.4 -0.813 . . . . 0.0 109.614 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.485 ' OE1' ' NH2' ' A' ' 52' ' ' ARG . 78.0 mt-30 -121.28 153.52 37.57 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.72 -156.72 14.55 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.644 -1.265 . . . . 0.0 109.953 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -137.36 139.98 41.13 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 tt -116.65 131.06 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.344 -0.847 . . . . 0.0 109.322 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -117.67 155.75 29.38 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.376 0.608 . . . . 0.0 109.824 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -141.12 -146.13 0.19 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.805 . . . . 0.0 109.497 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -78.55 -8.37 58.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.411 -0.805 . . . . 0.0 110.743 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.3 p -113.42 -86.61 0.57 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.279 -0.888 . . . . 0.0 110.697 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.69 -147.72 0.36 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.583 -0.698 . . . . 0.0 110.245 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.8 ptt-85 -148.07 156.23 42.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.47 -0.768 . . . . 0.0 110.203 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.8 tt -142.85 150.19 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.33 -0.856 . . . . 0.0 110.177 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.485 ' NH2' ' OE1' ' A' ' 41' ' ' GLN . 76.5 ttt180 -72.5 136.36 45.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.515 -0.741 . . . . 0.0 109.847 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.528 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -138.67 167.67 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.34 -0.85 . . . . 0.0 109.463 179.403 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 97.4 p -147.74 152.79 38.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 0.0 109.756 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.6 p -135.44 124.55 24.4 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -87.98 130.03 35.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.393 -0.817 . . . . 0.0 110.838 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.35 -48.75 1.5 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -70.68 136.02 48.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.095 -1.238 . . . . 0.0 110.272 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -95.91 153.94 17.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.522 -0.736 . . . . 0.0 109.879 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.8 mt -128.91 157.03 42.74 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.653 -0.655 . . . . 0.0 109.512 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.445 ' OE1' ' OD2' ' A' ' 64' ' ' ASP . 91.1 mt-30 -117.3 135.25 53.97 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.626 0.727 . . . . 0.0 109.954 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.7 t0 -66.71 136.25 55.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.421 -0.799 . . . . 0.0 110.731 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.52 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 0.8 OUTLIER 80.31 -5.4 1.79 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.818 -0.551 . . . . 0.0 110.799 178.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.445 ' OD2' ' OE1' ' A' ' 61' ' ' GLN . 9.8 m-20 -80.8 143.03 33.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.708 -1.245 . . . . 0.0 110.013 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.41 123.81 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.76 160.43 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 110.191 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -122.18 126.17 47.71 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 77.6 mt -110.0 127.43 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -114.88 141.71 47.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.818 -0.551 . . . . 0.0 109.793 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.2 t30 62.91 38.17 11.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.745 -0.597 . . . . 0.0 109.679 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.58 141.92 55.33 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -93.98 121.97 36.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.642 0.734 . . . . 0.0 109.604 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.0 t -82.29 133.12 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.572 -0.705 . . . . 0.0 109.677 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.43 155.49 46.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.495 -0.753 . . . . 0.0 109.066 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -114.42 117.6 31.48 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.538 -0.726 . . . . 0.0 109.346 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -122.2 135.13 54.72 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.718 -0.614 . . . . 0.0 109.383 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 55.09 30.57 14.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.624 -0.672 . . . . 0.0 109.688 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.1 7.22 84.22 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -114.72 135.01 54.64 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.371 -1.076 . . . . 0.0 109.952 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.51 145.85 41.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.589 -0.694 . . . . 0.0 109.984 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.0 p -155.07 161.9 41.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.502 -0.749 . . . . 0.0 109.199 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.4 mt -107.39 127.87 53.96 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.448 -0.782 . . . . 0.0 109.492 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 m -100.58 125.19 46.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.687 -0.633 . . . . 0.0 109.343 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 t -112.4 130.2 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.53 -0.732 . . . . 0.0 109.092 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -153.13 -149.01 5.04 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.45 -42.3 99.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.533 -0.981 . . . . 0.0 110.263 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -60.83 -41.96 96.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.377 -0.827 . . . . 0.0 110.277 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.2 p -78.89 165.93 22.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.265 -0.897 . . . . 0.0 110.44 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -127.38 132.37 50.17 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.6 mt -113.34 129.67 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.537 -0.727 . . . . 0.0 109.092 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -132.27 123.34 26.72 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.433 -0.792 . . . . 0.0 109.081 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.1 p -76.65 156.55 32.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.998 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.438 -0.789 . . . . 0.0 109.203 179.351 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.508 0.67 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.5 tp -77.93 125.48 29.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.467 -0.77 . . . . 0.0 109.951 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.66 161.95 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.491 -0.756 . . . . 0.0 109.777 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -78.81 152.58 31.29 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.633 0.73 . . . . 0.0 110.523 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.9 -42.99 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.378 -0.826 . . . . 0.0 109.416 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -67.5 -18.26 64.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.024 -1.048 . . . . 0.0 109.361 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -90.15 -18.64 25.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.144 -0.972 . . . . 0.0 109.55 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.3 t -52.1 135.59 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.198 -0.939 . . . . 0.0 110.501 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.6 p -153.91 166.82 31.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.585 -0.697 . . . . 0.0 109.337 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' A' ' 11' ' ' LEU . 3.6 mm? -68.94 -13.59 62.53 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.405 -0.809 . . . . 0.0 109.508 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.3 p -60.66 -31.19 70.42 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.157 -0.964 . . . . 0.0 109.003 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.44 ' OG1' ' CG1' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -122.95 85.33 50.55 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.17 -39.63 70.86 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.477 2.118 . . . . 0.0 112.018 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -106.52 131.64 53.46 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.56 -0.713 . . . . 0.0 109.887 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.44 ' CG1' ' OG1' ' A' ' 13' ' ' THR . 15.5 m -153.13 -177.25 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.353 -0.842 . . . . 0.0 109.716 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.8 m -137.62 137.91 38.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.432 -0.792 . . . . 0.0 109.09 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.3 m -140.44 161.91 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.388 -0.82 . . . . 0.0 109.822 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.402 ' CD1' ' HE ' ' A' ' 67' ' ' ARG . 86.3 mt -130.43 132.88 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.97 -167.62 37.39 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.054 -1.546 . . . . 0.0 110.017 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -113.01 138.11 50.38 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.709 -0.877 . . . . 0.0 109.432 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.567 ' N ' ' CD1' ' A' ' 22' ' ' ILE . 1.8 mp -97.95 131.33 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.424 -0.798 . . . . 0.0 109.615 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.6 p -133.45 160.31 37.77 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.315 0.579 . . . . 0.0 109.944 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 25' ' ' ILE . . . 100.28 -75.76 0.44 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 24' ' ' GLY . 38.1 mm 58.39 119.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.535 -0.979 . . . . 0.0 110.6 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -145.85 142.41 28.79 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -98.7 130.18 45.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.403 -0.811 . . . . 0.0 109.745 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -141.74 160.76 39.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.361 -0.837 . . . . 0.0 108.952 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 57.9 mp0 -121.84 142.53 50.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.49 -0.756 . . . . 0.0 109.374 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -141.96 160.27 40.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.286 -0.884 . . . . 0.0 108.874 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -90.17 115.65 27.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.982 . . . . 0.0 109.919 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.4 t -110.76 115.14 29.03 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.692 . . . . 0.0 109.214 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 54.38 31.33 14.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.47 -0.769 . . . . 0.0 109.896 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.8 1.8 84.85 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.8 m -117.99 128.69 55.03 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.321 -1.105 . . . . 0.0 109.649 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.1 m -67.99 128.49 36.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 110.381 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -133.1 146.0 51.24 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.43 -0.794 . . . . 0.0 109.58 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.1 m -81.25 144.14 31.78 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.441 -0.787 . . . . 0.0 109.982 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.8 p -136.43 138.96 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.474 -0.766 . . . . 0.0 109.0 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -103.7 131.21 51.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.423 -0.798 . . . . 0.0 108.977 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -124.1 155.76 37.81 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.579 -0.7 . . . . 0.0 109.478 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.38 -160.31 22.93 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -127.59 140.68 51.96 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.605 -0.938 . . . . 0.0 109.62 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 tt -117.73 136.85 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -134.24 151.47 51.31 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.467 -0.771 . . . . 0.0 109.836 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -144.99 -150.12 0.31 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.645 -0.66 . . . . 0.0 109.368 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 31.7 p-10 -85.72 -1.76 57.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 109.732 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.9 p -103.62 -63.0 1.23 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.175 -0.953 . . . . 0.0 109.556 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -166.47 -149.15 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 109.92 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -140.65 151.86 44.93 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.46 -0.775 . . . . 0.0 109.93 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 tt -149.48 158.93 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.188 -0.945 . . . . 0.0 110.196 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.6 mtp85 -71.93 146.98 47.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.9 . . . . 0.0 109.814 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.0 pt -136.76 150.11 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.399 -0.813 . . . . 0.0 110.235 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 t -142.57 138.21 30.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.531 -0.73 . . . . 0.0 109.135 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.3 t -130.35 133.64 46.57 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.508 -0.745 . . . . 0.0 109.175 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -92.87 123.83 36.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.38 -0.825 . . . . 0.0 111.03 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.08 -55.23 3.13 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -70.95 131.81 44.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.875 -1.368 . . . . 0.0 110.403 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -96.69 155.17 16.89 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.499 -0.75 . . . . 0.0 110.085 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.9 mt -123.16 151.68 41.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -103.59 160.5 14.69 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.645 0.736 . . . . 0.0 110.176 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 63' ' ' SER . 38.8 t70 -66.14 150.15 49.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.658 -0.651 . . . . 0.0 111.24 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 22' ' ' ILE . 11.1 p 37.57 42.56 0.37 Allowed 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.31 0.576 . . . . 0.0 110.439 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -90.69 120.1 31.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.229 -0.919 . . . . 0.0 110.031 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.78 110.49 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.5 m -143.78 168.32 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.126 -0.984 . . . . 0.0 110.109 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.402 ' HE ' ' CD1' ' A' ' 19' ' ' ILE . 41.5 ttm180 -118.21 124.37 47.76 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.3 mt -103.7 126.13 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -117.54 141.18 48.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.742 -0.599 . . . . 0.0 109.783 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.3 t30 65.47 37.57 6.06 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.47 0.653 . . . . 0.0 109.837 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.76 137.94 46.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.134 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -86.65 121.19 28.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.537 -0.727 . . . . 0.0 109.96 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.2 t -83.49 133.93 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.458 -0.776 . . . . 0.0 109.586 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -136.57 154.94 50.55 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.284 -0.885 . . . . 0.0 109.449 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -115.49 111.59 20.97 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -116.14 125.96 53.04 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.505 -0.747 . . . . 0.0 109.936 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.5 m120 55.26 33.25 20.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.639 -0.663 . . . . 0.0 110.13 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.26 3.24 88.4 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -111.05 133.63 53.28 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.344 -1.092 . . . . 0.0 109.954 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.2 mt -76.72 148.76 36.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.499 -0.751 . . . . 0.0 110.514 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.0 p -152.99 158.66 42.37 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.1 mt -111.55 126.52 55.07 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.282 -0.886 . . . . 0.0 109.379 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.4 m -107.68 123.55 48.68 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.5 t -99.15 112.0 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.266 -0.897 . . . . 0.0 109.47 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.24 -173.05 31.25 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.62 -35.41 80.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.589 -0.948 . . . . 0.0 109.527 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.0 t -66.84 -16.77 64.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 0.0 109.655 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.9 m -74.98 159.42 31.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 110.141 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.1 ttt85 -124.0 134.51 53.44 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.663 -0.648 . . . . 0.0 109.337 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.411 HD13 HG23 ' A' ' 90' ' ' ILE . 96.9 mt -119.02 131.9 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.683 -0.636 . . . . 0.0 109.527 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -122.28 130.18 52.91 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.6 0.715 . . . . 0.0 109.286 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.4 p -70.6 147.0 49.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.503 -0.748 . . . . 0.0 110.287 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.2 t . . . . . 0 N--CA 1.498 1.964 0 O-C-N 121.591 -0.693 . . . . 0.0 109.666 179.61 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.2 t70 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.376 0.608 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.529 ' CD2' ' N ' ' A' ' 3' ' ' LEU . 4.0 mm? -81.94 130.0 34.94 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.378 -0.826 . . . . 0.0 110.248 -178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.79 163.87 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.576 -0.703 . . . . 0.0 109.647 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.61 156.46 27.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.418 -0.801 . . . . 0.0 110.622 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.45 -43.13 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 0.0 109.535 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -67.34 -14.75 63.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.014 -1.054 . . . . 0.0 109.795 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -89.7 -0.03 57.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 109.159 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.11 132.68 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 110.056 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.4 t -158.73 170.25 22.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.358 -0.839 . . . . 0.0 109.619 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 11' ' ' LEU . 3.7 mm? -64.4 -35.45 80.95 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.438 -0.789 . . . . 0.0 109.285 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.7 p -57.96 -20.47 38.15 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.742 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.443 ' O ' ' OG1' ' A' ' 13' ' ' THR . 8.7 p -113.32 79.19 3.75 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.348 -0.845 . . . . 0.0 108.885 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.9 -24.91 39.36 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.254 1.969 . . . . 0.0 112.384 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -125.57 110.1 13.45 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.467 -0.77 . . . . 0.0 109.018 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.8 m -141.65 162.09 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.233 -0.917 . . . . 0.0 110.307 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 t -117.25 135.49 53.77 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.7 m -136.14 161.33 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.278 -0.888 . . . . 0.0 110.171 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.3 tt -139.4 140.74 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.401 -0.812 . . . . 0.0 109.341 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.33 -166.04 36.81 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 118.959 -1.591 . . . . 0.0 110.13 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -106.38 131.08 54.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.557 -0.967 . . . . 0.0 109.625 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.3 mt -102.58 133.7 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.575 -0.703 . . . . 0.0 109.839 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.3 p -135.47 159.6 41.09 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.335 0.588 . . . . 0.0 109.672 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.29 -84.08 0.99 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.5 mm 56.12 107.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.536 -0.979 . . . . 0.0 110.421 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -129.27 138.54 51.7 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -90.48 136.51 33.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 110.372 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -148.66 151.28 34.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.378 -0.826 . . . . 0.0 108.907 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -117.86 144.74 45.14 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.352 -0.842 . . . . 0.0 110.063 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.405 ' N ' ' CD1' ' A' ' 30' ' ' TYR . 10.0 p90 -144.69 162.32 37.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.333 -0.854 . . . . 0.0 109.822 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -80.96 141.64 34.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.42 -0.8 . . . . 0.0 109.823 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.3 t -144.87 106.37 4.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.136 -0.978 . . . . 0.0 109.511 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.5 t0 57.96 33.41 23.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.422 -0.799 . . . . 0.0 110.329 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.66 6.0 87.68 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 92.4 m -126.62 127.44 45.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.372 -1.075 . . . . 0.0 109.31 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.0 m -73.0 134.41 44.66 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.221 -0.924 . . . . 0.0 110.042 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -131.82 143.4 50.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.428 -0.795 . . . . 0.0 109.054 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 86.8 p -87.27 146.07 26.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.214 -0.929 . . . . 0.0 109.813 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.91 140.26 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.384 -0.823 . . . . 0.0 109.547 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -104.82 130.49 52.93 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -121.35 152.77 38.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.454 -0.778 . . . . 0.0 109.417 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.09 -169.23 33.84 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -123.11 138.97 54.53 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.617 -0.931 . . . . 0.0 109.235 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 tt -118.1 143.18 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -133.33 153.21 51.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.574 -0.704 . . . . 0.0 109.621 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.572 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 40.4 t0 -149.17 -164.01 1.92 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.373 -0.83 . . . . 0.0 108.942 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.572 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 60.2 t0 -64.32 -33.75 76.56 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.442 -0.786 . . . . 0.0 109.295 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 p -77.31 -86.9 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 110.281 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.06 -147.06 0.2 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.344 -0.848 . . . . 0.0 110.233 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -143.9 157.96 44.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.475 -0.766 . . . . 0.0 109.454 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.2 tt -153.77 161.52 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.953 -1.092 . . . . 0.0 110.326 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -73.82 145.29 45.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.556 -0.715 . . . . 0.0 109.749 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.4 pt -135.24 152.98 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.198 -0.939 . . . . 0.0 109.499 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.6 p -142.31 129.69 21.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.183 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 58' ' ' LYS . 1.6 t -113.94 121.0 42.58 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -96.27 121.12 37.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.322 -0.861 . . . . 0.0 110.72 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.46 -44.68 2.94 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.423 ' O ' ' OG ' ' A' ' 55' ' ' SER . 70.4 mmtt -78.05 138.77 38.96 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.99 -1.3 . . . . 0.0 110.303 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -94.08 151.76 19.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -0.824 . . . . 0.0 109.923 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.15 157.21 43.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.565 -0.709 . . . . 0.0 109.331 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -112.09 136.89 50.88 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.518 0.675 . . . . 0.0 109.687 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -64.65 142.75 58.32 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.884 0.85 . . . . 0.0 111.222 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.1 t 58.34 81.19 0.16 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.65 0.738 . . . . 0.0 110.268 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -162.69 126.67 3.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.522 -0.736 . . . . 0.0 110.12 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 t -78.12 120.12 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.389 -0.819 . . . . 0.0 109.444 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.43 163.78 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.465 -0.772 . . . . 0.0 109.823 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.4 ttp85 -119.23 128.23 54.0 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.1 mt -107.38 129.32 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.402 -0.811 . . . . 0.0 109.382 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 66.5 t0 -114.64 142.11 46.9 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.544 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 64.6 t30 63.3 40.58 8.5 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.345 0.593 . . . . 0.0 109.918 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.45 148.87 42.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.334 -0.854 . . . . 0.0 109.417 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -100.87 125.53 47.41 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.565 0.698 . . . . 0.0 109.729 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.9 t -89.19 135.28 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.369 -0.832 . . . . 0.0 110.038 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.74 157.0 43.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 0.0 108.889 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -113.36 116.92 30.44 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.454 -0.779 . . . . 0.0 109.44 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -125.94 138.69 53.78 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.425 -0.797 . . . . 0.0 110.094 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 57.04 23.5 8.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.665 -0.647 . . . . 0.0 109.484 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.08 7.88 88.19 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -118.21 137.76 52.79 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.546 -0.973 . . . . 0.0 109.898 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.1 mt -77.12 148.52 35.98 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.425 -0.797 . . . . 0.0 110.212 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.9 p -155.04 161.67 41.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.317 -0.864 . . . . 0.0 109.016 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.4 mt -106.32 125.59 51.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.426 -0.796 . . . . 0.0 109.246 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.9 m -105.66 123.34 47.76 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.5 t -98.97 114.13 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.301 -0.874 . . . . 0.0 108.997 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.57 -177.42 37.02 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -67.42 -27.31 66.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.598 -0.942 . . . . 0.0 109.611 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.1 m -78.8 -6.51 56.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.148 -0.97 . . . . 0.0 109.487 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.7 m -83.66 165.59 18.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.041 -1.037 . . . . 0.0 109.841 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.75 141.05 51.69 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.435 -0.791 . . . . 0.0 109.318 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.03 130.98 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.563 -0.71 . . . . 0.0 109.609 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -123.72 116.32 22.84 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.9 m -77.54 140.2 39.7 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.35 -0.844 . . . . 0.0 110.099 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.497 1.913 0 O-C-N 121.546 -0.721 . . . . 0.0 109.29 179.47 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.3 p30 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.754 0.788 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.7 tp -81.58 128.48 33.97 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.415 -0.803 . . . . 0.0 109.956 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.01 162.87 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-O 121.719 0.771 . . . . 0.0 110.165 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -77.18 159.47 29.68 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.796 0.808 . . . . 0.0 110.354 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.8 mm -63.78 -42.91 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 121.701 0.762 . . . . 0.0 109.887 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -66.07 -18.08 65.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.193 -0.942 . . . . 0.0 110.486 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 8' ' ' ASP . 59.2 t0 -86.45 -1.79 57.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.858 -1.151 . . . . 0.0 109.384 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 87.1 t -66.29 133.3 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.338 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.4 p -156.16 167.44 30.41 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.508 -0.745 . . . . 0.0 109.357 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.5 -34.96 79.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.821 . . . . 0.0 109.309 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.6 p -56.84 -19.4 17.23 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 109.475 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 13' ' ' THR . 11.1 p -115.23 81.07 7.82 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.835 . . . . 0.0 109.248 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -71.92 -16.08 29.36 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.598 2.199 . . . . 0.0 111.288 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -128.66 110.07 11.89 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.4 m -145.44 161.68 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.357 -0.84 . . . . 0.0 110.397 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.3 t -116.55 136.96 52.55 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.61 160.29 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 121.894 0.854 . . . . 0.0 110.256 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.3 tt -144.36 133.73 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.682 -0.636 . . . . 0.0 109.606 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.82 -162.55 30.33 Favored Glycine 0 N--CA 1.487 2.051 0 C-N-CA 119.693 -1.241 . . . . 0.0 110.019 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -105.98 134.79 48.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.708 -0.878 . . . . 0.0 109.985 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 63' ' ' SER . 97.0 mt -103.64 130.64 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.527 0.679 . . . . 0.0 110.086 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 p -134.15 163.31 29.88 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.49 0.662 . . . . 0.0 109.371 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.479 ' N ' ' OD1' ' A' ' 62' ' ' ASP . . . 97.03 -76.74 0.68 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 24' ' ' GLY . 36.9 mm 57.91 120.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 122.039 0.923 . . . . 0.0 110.405 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -143.63 138.97 29.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.451 -0.781 . . . . 0.0 108.986 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -104.36 130.3 52.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.481 -0.762 . . . . 0.0 109.919 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -144.34 165.29 28.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.545 -0.722 . . . . 0.0 109.402 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -120.57 146.57 46.2 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.593 -0.692 . . . . 0.0 110.008 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -142.6 163.16 33.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 109.85 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.536 ' N ' ' OE1' ' A' ' 31' ' ' GLU . 57.0 mp0 -88.04 114.16 24.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.528 -0.733 . . . . 0.0 109.721 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.8 t -110.77 107.29 16.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.493 -0.755 . . . . 0.0 109.758 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 54.7 t0 54.79 28.56 10.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.533 -0.73 . . . . 0.0 110.526 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.88 8.18 67.55 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.4 m -123.11 127.51 48.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.409 -1.053 . . . . 0.0 109.11 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.9 m -72.83 131.05 41.79 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.392 -0.818 . . . . 0.0 110.402 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -136.89 146.61 45.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.473 -0.767 . . . . 0.0 109.529 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 99.8 p -81.43 148.6 29.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.401 -0.812 . . . . 0.0 110.343 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.32 138.3 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 109.678 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.498 ' CD1' ' O ' ' A' ' 58' ' ' LYS . 83.7 m-85 -104.35 132.72 50.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.447 -0.783 . . . . 0.0 109.481 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -129.2 156.64 43.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.634 -0.666 . . . . 0.0 109.457 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.55 -165.32 31.97 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.045 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -120.36 143.89 48.17 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.698 -0.883 . . . . 0.0 109.798 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 tt -131.85 134.37 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -139.45 155.02 47.85 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.855 0.836 . . . . 0.0 110.553 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.547 ' O ' ' C ' ' A' ' 47' ' ' ASP . 41.8 p-10 -152.89 99.47 2.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.432 -0.792 . . . . 0.0 109.385 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.547 ' C ' ' O ' ' A' ' 46' ' ' ASP . 29.5 p-10 13.72 57.94 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.736 0 CA-C-O 122.169 0.985 . . . . 0.0 110.944 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 46' ' ' ASP . 8.2 m -168.7 -55.6 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -173.39 -167.93 0.42 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.367 -0.833 . . . . 0.0 109.397 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -139.05 149.98 45.24 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.632 0.73 . . . . 0.0 110.482 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.8 tt -147.24 152.81 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.33 -0.856 . . . . 0.0 109.687 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.418 HH21 ' HB2' ' A' ' 79' ' ' TYR . 81.0 mtm-85 -77.53 147.57 35.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.521 -0.737 . . . . 0.0 109.856 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.0 pt -132.48 158.3 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.617 -0.677 . . . . 0.0 109.907 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 t -147.14 127.73 14.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 p -122.89 138.7 54.59 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.477 0.656 . . . . 0.0 109.613 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -97.8 118.15 33.71 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.679 0.752 . . . . 0.0 111.527 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.09 -19.66 1.69 Allowed Glycine 0 N--CA 1.496 2.671 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.608 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.498 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 68.8 mttm -83.63 137.82 33.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.689 -1.477 . . . . 0.0 110.484 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -96.6 140.73 30.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.602 -0.687 . . . . 0.0 110.159 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.1 mt -130.18 153.32 48.67 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.598 -0.689 . . . . 0.0 109.381 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -113.33 155.31 25.4 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.653 0.74 . . . . 0.0 109.893 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 7.7 m-20 -70.78 148.3 48.05 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.92 0.867 . . . . 0.0 110.995 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 22' ' ' ILE . 1.8 m 53.34 32.98 14.68 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.779 0.8 . . . . 0.0 109.409 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -96.84 114.57 26.21 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.353 -0.842 . . . . 0.0 110.573 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 m -84.08 117.14 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.343 -0.848 . . . . 0.0 109.889 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.9 m -148.45 175.12 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.501 0.667 . . . . 0.0 109.541 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -122.68 132.26 54.18 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.55 125.28 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.597 -0.689 . . . . 0.0 109.477 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -111.21 152.38 27.16 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 59.57 35.23 22.57 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.708 0.766 . . . . 0.0 109.664 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.65 143.97 56.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.51 -0.744 . . . . 0.0 109.442 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -105.62 118.57 36.93 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.935 0.874 . . . . 0.0 109.572 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -88.91 131.44 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.425 -0.797 . . . . 0.0 110.124 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.46 157.58 41.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.394 -0.816 . . . . 0.0 109.015 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -100.75 125.45 47.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.455 -0.778 . . . . 0.0 109.655 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -115.52 133.18 56.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.61 -0.681 . . . . 0.0 109.354 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m120 67.89 -63.23 0.32 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.627 0.727 . . . . 0.0 109.844 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.43 29.15 0.04 OUTLIER Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.418 ' HB2' HH21 ' A' ' 52' ' ' ARG . 31.5 p90 -146.82 155.43 42.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.292 -1.122 . . . . 0.0 109.837 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.8 mt -83.06 145.65 29.15 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.77 0.795 . . . . 0.0 110.974 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.1 t -157.8 163.72 37.75 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 70.7 mt -101.15 130.22 47.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.165 -0.959 . . . . 0.0 109.694 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.6 m -109.88 122.6 47.91 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.665 0.745 . . . . 0.0 109.319 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.6 t -98.62 110.04 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.826 0.822 . . . . 0.0 109.11 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.13 -174.85 40.8 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -71.22 -19.23 62.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.553 -0.969 . . . . 0.0 110.34 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -84.55 -8.83 58.78 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.711 -1.243 . . . . 0.0 109.057 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.497 ' HG ' ' H ' ' A' ' 89' ' ' ARG . 46.8 t -79.34 162.63 25.46 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.395 -0.816 . . . . 0.0 110.434 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.497 ' H ' ' HG ' ' A' ' 88' ' ' SER . 63.2 ttm-85 -129.66 136.37 49.64 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.594 -0.691 . . . . 0.0 109.384 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.84 130.46 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -120.53 132.19 55.06 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.701 0.762 . . . . 0.0 109.128 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.0 m -74.31 147.85 41.91 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.383 0.611 . . . . 0.0 110.525 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.304 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 65.9 t0 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.691 0.758 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.545 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 42.8 tp -70.92 121.78 18.76 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.551 0.691 . . . . 0.0 110.097 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.1 m -137.78 163.65 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 121.582 0.706 . . . . 0.0 109.939 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -76.03 156.85 33.62 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.587 0.708 . . . . 0.0 110.26 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.84 -43.41 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.563 -0.71 . . . . 0.0 109.728 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -62.62 -24.84 67.79 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.403 -0.811 . . . . 0.0 110.382 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -82.62 -0.21 46.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.549 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.2 t -65.76 131.54 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.371 -0.831 . . . . 0.0 110.539 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 99.1 p -160.31 169.3 23.44 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.685 0.755 . . . . 0.0 109.535 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.74 -33.89 76.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.766 . . . . 0.0 109.823 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -59.74 -18.59 44.04 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.243 -0.91 . . . . 0.0 109.271 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 13' ' ' THR . 13.6 p -111.45 80.13 2.54 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.65 -23.19 36.72 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.383 2.055 . . . . 0.0 111.744 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -126.22 110.08 13.04 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 m -138.15 162.62 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.589 -0.695 . . . . 0.0 110.353 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 t -125.67 134.85 51.7 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.5 m -139.88 162.24 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 121.579 0.704 . . . . 0.0 110.303 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.3 tt -137.98 139.48 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.58 -0.7 . . . . 0.0 109.647 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.76 -162.94 29.85 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.661 -1.257 . . . . 0.0 109.993 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -106.15 144.4 32.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.749 -0.854 . . . . 0.0 109.491 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.5 mm -94.2 130.59 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.302 0.573 . . . . 0.0 110.427 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.2 p -138.42 156.93 47.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.468 -0.77 . . . . 0.0 110.479 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.08 65.84 2.74 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.8 mm -80.21 128.15 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -1.12 . . . . 0.0 110.242 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -134.66 140.93 46.39 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' NZ ' ' OG ' ' A' ' 38' ' ' SER . 51.0 tttp -104.53 134.65 47.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.644 -0.66 . . . . 0.0 109.884 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -140.61 162.73 34.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.645 -0.66 . . . . 0.0 109.716 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -125.76 140.1 52.97 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.754 -0.591 . . . . 0.0 109.72 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -140.38 159.01 43.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.455 -0.778 . . . . 0.0 109.586 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -86.98 111.19 20.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.575 -0.703 . . . . 0.0 109.752 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 p -112.81 119.78 39.19 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.524 0.678 . . . . 0.0 109.807 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.9 t0 55.23 29.71 13.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.619 -0.676 . . . . 0.0 109.916 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.52 5.82 86.45 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.8 m -124.87 128.74 49.13 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.447 -1.031 . . . . 0.0 109.613 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 33.2 m -66.77 130.4 43.03 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.645 -0.659 . . . . 0.0 110.3 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -132.18 143.0 49.65 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.833 0.825 . . . . 0.0 109.612 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.522 ' OG ' ' NZ ' ' A' ' 27' ' ' LYS . 36.6 t -78.25 145.36 35.51 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.425 0.631 . . . . 0.0 110.137 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.79 137.71 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.6 -0.688 . . . . 0.0 109.303 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -103.76 132.7 49.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.72 -0.613 . . . . 0.0 109.456 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -125.41 149.05 48.54 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.7 -165.51 29.84 Favored Glycine 0 N--CA 1.485 1.956 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.139 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -123.28 142.85 50.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.836 -0.802 . . . . 0.0 109.398 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.6 tt -120.39 144.34 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -131.16 150.42 52.15 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.613 0.72 . . . . 0.0 110.162 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.551 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 41.4 t0 -151.76 -166.66 2.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.587 -0.695 . . . . 0.0 109.391 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.551 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 47.6 t0 -70.29 -9.94 57.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 109.938 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.677 ' HG1' ' H ' ' A' ' 49' ' ' ALA . 45.3 p -94.72 -71.31 0.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 109.625 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.677 ' H ' ' HG1' ' A' ' 48' ' ' THR . . . -162.22 -141.13 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.396 -0.815 . . . . 0.0 109.49 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -143.42 151.82 40.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.446 -0.784 . . . . 0.0 109.976 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.6 tt -151.9 161.44 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.712 . . . . 0.0 110.158 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -74.11 147.26 42.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.492 -0.755 . . . . 0.0 109.628 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.0 pt -136.07 154.5 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.482 -0.761 . . . . 0.0 110.042 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.0 t -145.67 131.14 18.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.528 -0.733 . . . . 0.0 109.325 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.9 t -120.39 134.95 55.18 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.459 0.647 . . . . 0.0 109.435 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.428 ' C ' ' H ' ' A' ' 58' ' ' LYS . 62.3 m-85 -95.8 122.14 38.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.518 -0.739 . . . . 0.0 111.021 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.53 -44.45 0.47 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' A' ' 56' ' ' PHE . 9.4 ttmm -79.01 130.99 36.12 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.168 -1.195 . . . . 0.0 110.678 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -91.89 164.59 13.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.51 0.671 . . . . 0.0 110.462 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.6 mt -126.9 157.74 38.59 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -105.8 133.85 49.86 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.327 1.061 . . . . 0.0 110.223 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -69.92 143.89 52.6 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.627 -0.67 . . . . 0.0 111.153 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.5 t 65.12 4.57 2.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -90.81 134.95 34.05 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.478 -0.764 . . . . 0.0 109.942 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.0 t -86.85 121.58 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.59 159.97 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.586 0.708 . . . . 0.0 109.876 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -123.75 125.08 44.11 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.2 mt -99.14 128.05 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -112.53 138.53 49.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.5 t30 62.54 39.24 11.83 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.334 0.587 . . . . 0.0 109.708 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.08 148.41 51.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.417 -0.802 . . . . 0.0 109.605 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -99.57 121.07 40.66 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.736 0.779 . . . . 0.0 109.882 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.6 t -80.87 133.75 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.609 -0.682 . . . . 0.0 109.874 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.44 155.54 42.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.397 -0.814 . . . . 0.0 109.509 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -114.09 119.14 36.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.766 -0.584 . . . . 0.0 109.621 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -118.27 126.2 51.67 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.507 0.67 . . . . 0.0 109.738 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.7 m120 55.63 32.98 20.31 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.454 0.645 . . . . 0.0 110.196 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.15 6.05 89.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.73 133.9 55.08 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.385 -1.068 . . . . 0.0 110.022 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.9 mt -77.54 145.96 36.6 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.484 0.659 . . . . 0.0 110.117 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.8 p -154.34 160.27 41.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.531 -0.73 . . . . 0.0 109.353 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.4 mt -105.58 118.9 37.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.594 -0.692 . . . . 0.0 109.406 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.7 m -98.32 126.89 44.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.672 -0.642 . . . . 0.0 109.403 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 t -103.67 109.44 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.541 -0.725 . . . . 0.0 109.608 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -96.59 -176.24 35.55 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -68.24 -17.01 64.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.515 -0.991 . . . . 0.0 109.605 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 96.8 p -83.08 -9.41 59.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 109.107 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.7 t -88.5 167.85 13.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.457 -0.777 . . . . 0.0 110.14 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.5 tpt85 -132.44 135.05 45.81 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.6 mt -115.65 130.78 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.795 -0.566 . . . . 0.0 109.722 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -119.0 122.3 41.88 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.393 0.616 . . . . 0.0 109.661 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.2 m -80.8 149.16 29.71 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.418 0.628 . . . . 0.0 110.298 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.14 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.68 0.752 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.6 tp -79.93 124.42 28.66 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.562 -0.711 . . . . 0.0 109.878 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.99 163.46 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.443 -0.786 . . . . 0.0 109.724 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -76.16 159.43 30.7 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.683 0.754 . . . . 0.0 110.218 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.1 -42.9 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.527 -0.733 . . . . 0.0 110.037 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 -67.13 -18.52 65.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.903 -1.123 . . . . 0.0 109.617 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -83.57 -2.05 55.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.09 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.7 t -66.69 132.22 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 110.362 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 m -156.45 167.37 30.64 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.517 -0.74 . . . . 0.0 109.392 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.91 -37.65 88.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.338 -0.851 . . . . 0.0 109.716 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 93.8 p -54.71 -22.2 13.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.973 . . . . 0.0 109.31 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.444 ' O ' ' OG1' ' A' ' 13' ' ' THR . 10.7 p -113.03 80.9 4.3 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.75 -21.87 24.56 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.258 1.972 . . . . 0.0 111.673 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -125.26 109.98 13.48 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.399 0.619 . . . . 0.0 109.459 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.8 m -147.16 162.03 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.148 -0.97 . . . . 0.0 110.143 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.2 m -115.0 135.68 53.96 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.46 161.35 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.327 -0.858 . . . . 0.0 110.001 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.2 tt -138.5 137.51 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.377 -0.827 . . . . 0.0 109.711 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.36 -165.06 27.12 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 119.567 -1.301 . . . . 0.0 109.876 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HZ3' ' C ' ' A' ' 63' ' ' SER . 54.5 tttp -105.46 126.85 52.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.652 -0.91 . . . . 0.0 109.069 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.8 mm -83.32 129.51 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-O 121.495 0.664 . . . . 0.0 110.313 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 44.5 p -140.04 163.7 31.99 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.697 0.761 . . . . 0.0 110.035 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.35 89.71 0.01 OUTLIER Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.5 mm -99.61 126.05 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -1.118 . . . . 0.0 109.416 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.494 ' HD1' ' N ' ' A' ' 27' ' ' LYS . 9.4 t-80 -131.13 132.36 44.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' N ' ' HD1' ' A' ' 26' ' ' HIS . 88.4 tttt -98.81 131.52 44.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.431 -0.793 . . . . 0.0 109.547 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -133.71 153.21 51.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.531 -0.731 . . . . 0.0 109.405 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -119.64 139.81 51.62 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.481 0.658 . . . . 0.0 109.799 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -142.0 161.16 38.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.292 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -90.36 99.18 12.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.959 . . . . 0.0 109.157 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.602 ' O ' ' N ' ' A' ' 34' ' ' GLY . 5.3 p -81.27 -156.5 0.15 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.484 -0.76 . . . . 0.0 110.073 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.46 ' N ' ' HG ' ' A' ' 32' ' ' SER . 99.4 m-20 -48.28 82.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.53 0.681 . . . . 0.0 110.142 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 52.8 11.73 1.42 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.419 ' H ' ' C ' ' A' ' 33' ' ' ASP . 87.3 m -135.59 133.37 38.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.222 -1.163 . . . . 0.0 110.001 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.6 m -75.49 129.68 37.66 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.458 -0.776 . . . . 0.0 109.651 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -133.16 145.87 51.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.378 -0.826 . . . . 0.0 109.745 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.6 p -86.18 148.11 25.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.505 -0.747 . . . . 0.0 110.087 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 p -137.9 137.59 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.517 ' CZ ' ' OE1' ' A' ' 59' ' ' GLN . 88.3 m-85 -103.5 135.09 45.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.482 -0.761 . . . . 0.0 109.64 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -125.07 155.22 40.15 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.94 -167.29 34.62 Favored Glycine 0 N--CA 1.482 1.745 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.433 ' HH ' HH21 ' A' ' 52' ' ' ARG . 80.3 m-85 -126.74 141.84 51.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.587 -0.949 . . . . 0.0 109.529 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.7 tt -114.55 143.68 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.45 ' OE2' ' O ' ' A' ' 49' ' ' ALA . 10.1 tp10 -130.46 149.14 52.27 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.582 0.706 . . . . 0.0 109.694 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.557 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 42.7 t0 -148.26 -164.39 2.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.464 -0.772 . . . . 0.0 109.478 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.557 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 96.7 m-20 -73.79 -17.06 61.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 109.657 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.1 m -92.94 -73.82 0.54 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.188 -0.945 . . . . 0.0 109.795 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.45 ' O ' ' OE2' ' A' ' 45' ' ' GLU . . . -154.15 -157.0 0.73 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.727 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -137.76 156.67 47.73 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.497 -0.752 . . . . 0.0 110.229 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 tt -151.4 159.41 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.268 -0.895 . . . . 0.0 110.3 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.433 HH21 ' HH ' ' A' ' 43' ' ' TYR . 42.3 ttm180 -76.15 144.26 40.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.858 . . . . 0.0 109.689 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -130.37 157.37 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.777 0.799 . . . . 0.0 110.245 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.2 t -143.61 134.87 25.85 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.8 t -127.57 131.68 49.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.262 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -102.17 123.25 45.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.441 -0.787 . . . . 0.0 111.011 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.66 -51.17 3.01 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.481 ' NZ ' ' O ' ' A' ' 88' ' ' SER . 98.6 mttt -63.93 135.72 56.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.098 -1.237 . . . . 0.0 110.58 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.517 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 69.8 tp60 -85.16 149.58 25.42 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.688 0.756 . . . . 0.0 110.52 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.2 mt -130.58 157.18 43.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -124.63 148.98 47.58 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.806 0.812 . . . . 0.0 110.051 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.2 p-10 -67.17 146.53 54.13 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.102 0.954 . . . . 0.0 111.377 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.448 ' C ' ' HZ3' ' A' ' 21' ' ' LYS . 4.3 p 47.16 81.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.631 0.729 . . . . 0.0 110.384 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -151.79 124.78 8.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.39 -0.819 . . . . 0.0 110.205 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 t -79.63 114.59 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.352 -0.842 . . . . 0.0 109.266 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.14 163.65 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.494 -0.754 . . . . 0.0 109.795 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -122.71 132.63 54.34 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 78.9 mt -107.14 128.57 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 68.1 t0 -110.34 143.07 41.1 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.548 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 64.6 t30 60.64 39.87 17.2 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.45 149.75 46.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.569 -0.707 . . . . 0.0 109.796 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -102.74 126.79 49.99 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.57 0.7 . . . . 0.0 110.016 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.4 t -92.29 133.0 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.498 -0.751 . . . . 0.0 109.397 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.67 156.27 45.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.148 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -113.0 119.28 37.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.469 -0.769 . . . . 0.0 109.609 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -125.15 134.09 52.56 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.559 0.695 . . . . 0.0 109.555 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 56.13 30.98 17.38 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.468 0.651 . . . . 0.0 109.787 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.77 4.69 77.18 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -114.39 136.62 52.79 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.316 -1.108 . . . . 0.0 109.742 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.91 146.37 37.65 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.655 0.74 . . . . 0.0 110.4 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.9 p -152.74 160.5 43.13 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.443 -0.786 . . . . 0.0 109.155 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.29 126.43 52.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.382 -0.824 . . . . 0.0 109.213 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 t -108.49 129.66 55.28 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.13 112.39 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.67 0.748 . . . . 0.0 109.1 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.71 -177.58 38.24 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -69.64 -17.4 63.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.58 -0.953 . . . . 0.0 109.434 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.3 m -84.91 -12.37 53.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.17 -0.956 . . . . 0.0 109.398 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.481 ' O ' ' NZ ' ' A' ' 58' ' ' LYS . 14.7 m -86.79 163.89 17.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.293 -0.879 . . . . 0.0 109.777 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -126.85 142.66 51.48 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.521 -0.737 . . . . 0.0 109.857 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -118.04 129.79 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -125.25 121.46 34.13 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.698 0.761 . . . . 0.0 109.36 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.0 p -78.57 156.59 29.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.498 -0.751 . . . . 0.0 109.94 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.519 -0.738 . . . . 0.0 109.276 179.591 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 65.7 t0 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.494 0.664 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.542 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 50.1 tp -71.69 127.62 33.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.332 -0.855 . . . . 0.0 109.612 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.79 163.62 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.342 -0.849 . . . . 0.0 110.434 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -76.53 154.54 34.47 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.426 0.631 . . . . 0.0 110.38 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.35 -43.22 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 109.604 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 -64.11 -21.04 66.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.146 -0.971 . . . . 0.0 109.964 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -88.07 1.66 53.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.097 -1.002 . . . . 0.0 109.742 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.07 131.78 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.09 -1.006 . . . . 0.0 110.297 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.6 p -158.33 166.45 32.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.441 -0.787 . . . . 0.0 109.67 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.31 -20.5 66.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.402 -0.811 . . . . 0.0 109.185 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.9 t -63.96 -16.3 61.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 109.57 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.4 p -119.82 84.24 31.2 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.48 -0.763 . . . . 0.0 109.11 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.53 -40.67 71.65 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.591 2.194 . . . . 0.0 112.203 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -121.84 127.69 50.82 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.673 -0.642 . . . . 0.0 109.758 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.6 m -144.76 161.61 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.293 -0.879 . . . . 0.0 109.735 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 t -116.59 136.29 53.1 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.84 162.3 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.377 -0.827 . . . . 0.0 109.738 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.06 143.5 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.405 -0.809 . . . . 0.0 109.792 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.16 -161.32 35.07 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -111.73 139.05 47.51 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.439 -1.036 . . . . 0.0 109.604 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.46 ' O ' ' N ' ' A' ' 63' ' ' SER . 97.1 mt -97.93 131.32 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.868 -0.52 . . . . 0.0 109.852 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.3 p -133.7 156.63 47.59 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.468 -0.77 . . . . 0.0 109.952 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.1 71.4 1.01 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.8 mm -79.76 128.6 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.982 -1.305 . . . . 0.0 109.207 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -128.75 131.31 47.86 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -104.61 135.98 44.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.534 -0.729 . . . . 0.0 109.78 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -148.74 156.99 43.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.491 -0.756 . . . . 0.0 109.035 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -111.94 146.02 38.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.567 -0.708 . . . . 0.0 109.655 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.434 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 10.7 p90 -143.55 159.19 42.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.347 -0.846 . . . . 0.0 109.672 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -83.15 136.12 34.56 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.444 -0.785 . . . . 0.0 110.004 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.8 t -147.76 118.24 7.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.376 -0.828 . . . . 0.0 109.158 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 56.53 32.05 20.12 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.749 -0.594 . . . . 0.0 110.176 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.81 13.25 83.33 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.488 ' OG1' ' NZ ' ' A' ' 37' ' ' LYS . 6.1 p -127.76 158.56 37.35 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.323 -1.104 . . . . 0.0 109.892 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.1 m -94.76 123.7 38.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.603 -0.686 . . . . 0.0 109.768 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.488 ' NZ ' ' OG1' ' A' ' 35' ' ' THR . 42.8 mmtm -127.26 141.96 51.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.565 -0.709 . . . . 0.0 109.195 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.1 m -84.81 146.65 27.24 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.621 -0.674 . . . . 0.0 109.816 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.7 137.63 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.521 -0.737 . . . . 0.0 109.169 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -102.49 131.9 48.88 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -127.1 155.0 44.01 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.619 -0.675 . . . . 0.0 109.672 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.6 -166.81 34.32 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.775 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -119.34 139.96 51.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.662 -0.905 . . . . 0.0 109.516 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 tt -122.96 132.99 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -132.84 156.4 47.22 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.28 -0.888 . . . . 0.0 111.142 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -143.67 -144.33 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 23.4 p-10 -88.22 -1.39 57.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 109.14 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.531 ' OG1' ' N ' ' A' ' 49' ' ' ALA . 30.4 p -101.23 -69.69 0.77 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.507 -0.745 . . . . 0.0 109.613 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.531 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -162.86 -148.2 0.13 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 109.788 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -137.92 153.51 49.5 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.497 -0.752 . . . . 0.0 109.901 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.0 tt -152.24 154.87 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.174 -0.954 . . . . 0.0 109.998 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.85 143.42 41.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.419 -0.801 . . . . 0.0 110.355 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.1 pt -132.46 153.9 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.724 -0.61 . . . . 0.0 109.568 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.1 p -143.71 121.34 11.82 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 p -113.36 138.86 49.44 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.603 -0.686 . . . . 0.0 109.418 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.546 ' C ' ' H ' ' A' ' 58' ' ' LYS . 67.7 m-85 -95.91 121.26 37.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.405 -0.809 . . . . 0.0 111.332 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.74 -31.45 0.28 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.546 ' H ' ' C ' ' A' ' 56' ' ' PHE . 68.9 mttm -72.9 135.02 45.03 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.962 -1.316 . . . . 0.0 110.061 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -88.26 155.36 19.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.368 -0.833 . . . . 0.0 109.893 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.7 mt -127.67 152.48 47.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.632 -0.668 . . . . 0.0 109.277 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -114.45 132.41 56.27 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.061 0.934 . . . . 0.0 110.149 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.7 t0 -65.0 139.18 58.73 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.818 0.818 . . . . 0.0 111.622 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.538 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.7 m 61.8 5.53 1.36 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.588 -0.695 . . . . 0.0 110.338 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 65' ' ' VAL . 64.1 t0 -81.78 129.24 34.66 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.005 -1.06 . . . . 0.0 110.26 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.405 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 1.7 m -83.34 119.36 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.7 m -138.16 163.27 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.72 0.771 . . . . 0.0 109.86 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.483 ' NH1' ' OD2' ' A' ' 69' ' ' ASP . 75.7 ttt-85 -123.28 125.53 45.23 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 77.7 mt -107.52 129.02 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.521 -0.737 . . . . 0.0 109.524 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.483 ' OD2' ' NH1' ' A' ' 67' ' ' ARG . 95.4 m-20 -113.76 148.9 35.68 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.415 0.626 . . . . 0.0 109.849 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 60.85 36.95 18.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.734 -0.604 . . . . 0.0 109.546 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.32 133.4 42.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 109.511 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -84.57 131.11 34.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 110.253 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.4 t -87.62 134.14 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.488 -0.757 . . . . 0.0 109.47 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.57 154.74 44.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.152 -0.968 . . . . 0.0 109.527 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -116.48 117.82 30.95 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -126.45 133.17 51.29 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.668 -0.645 . . . . 0.0 109.766 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 56.57 31.79 19.72 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.274 0.559 . . . . 0.0 110.097 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.66 5.11 82.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -113.63 133.1 55.49 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.379 -1.071 . . . . 0.0 110.119 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.64 146.26 36.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.517 -0.739 . . . . 0.0 109.793 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 97.3 p -156.22 161.97 40.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.398 -0.814 . . . . 0.0 109.767 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.2 mt -105.84 130.61 53.78 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.5 t -107.76 127.83 54.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.0 109.413 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.08 107.67 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.46 -0.775 . . . . 0.0 109.356 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -96.0 -177.29 36.39 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -69.14 -17.27 63.81 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.254 -1.145 . . . . 0.0 109.315 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.6 m -84.45 -8.8 58.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.16 -0.963 . . . . 0.0 109.135 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.6 t -85.2 168.19 15.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.404 -0.81 . . . . 0.0 109.75 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -129.25 139.85 51.67 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.475 -0.765 . . . . 0.0 109.882 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.51 130.92 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -122.57 111.11 16.39 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.2 t -73.62 146.68 44.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.531 -0.731 . . . . 0.0 110.12 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 51.6 t . . . . . 0 N--CA 1.498 1.939 0 O-C-N 121.491 -0.756 . . . . 0.0 109.506 179.547 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.7 t70 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.403 0.621 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.5 tp -77.19 129.55 36.1 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.315 -0.866 . . . . 0.0 109.786 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.2 m -137.43 162.27 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.626 0.727 . . . . 0.0 109.424 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -88.53 162.44 16.41 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.48 0.657 . . . . 0.0 109.965 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.415 HG22 HD11 ' A' ' 6' ' ' ILE . 96.8 mt -62.63 -42.74 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -72.49 -14.13 61.59 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.2 -0.938 . . . . 0.0 109.701 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -91.38 1.94 56.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.065 -1.022 . . . . 0.0 108.822 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.45 132.97 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 110.567 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.5 p -156.21 162.45 40.17 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.8 mt -71.92 -11.14 60.64 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.225 -0.922 . . . . 0.0 109.155 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.3 p -66.78 -17.83 65.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 13' ' ' THR . 10.4 p -123.04 84.17 50.9 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.51 -0.744 . . . . 0.0 109.528 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.73 -41.5 69.08 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.27 1.98 . . . . 0.0 111.609 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -119.26 131.41 55.78 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.365 0.602 . . . . 0.0 109.918 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.1 m -154.87 -173.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.246 -0.909 . . . . 0.0 109.744 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.8 p -131.39 137.02 48.5 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.49 158.63 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.415 -0.803 . . . . 0.0 109.865 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.5 mt -134.3 133.72 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.83 -171.16 36.6 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 118.741 -1.695 . . . . 0.0 110.351 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -114.67 121.2 42.66 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.766 -0.843 . . . . 0.0 108.984 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.11 133.56 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.929 -0.482 . . . . 0.0 109.727 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.3 p -136.85 158.38 44.58 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.442 0.639 . . . . 0.0 109.732 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.35 83.53 0.07 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.5 mm -85.44 130.76 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.227 -1.161 . . . . 0.0 109.728 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -131.28 136.37 48.12 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -106.37 137.74 43.81 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.469 -0.77 . . . . 0.0 110.308 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -144.35 159.62 42.4 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -133.97 146.5 50.51 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.165 -0.96 . . . . 0.0 110.089 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -144.25 163.76 32.73 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.367 -0.833 . . . . 0.0 109.113 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -83.57 138.46 33.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.314 -0.866 . . . . 0.0 110.828 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 t -152.63 130.71 11.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.841 . . . . 0.0 108.925 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.6 t0 60.86 21.99 12.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.551 -0.718 . . . . 0.0 109.456 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.17 14.44 76.84 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 82.2 p -135.43 148.56 49.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.513 -0.992 . . . . 0.0 109.955 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.3 m -85.25 129.93 34.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.435 -0.791 . . . . 0.0 109.618 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -124.38 143.13 50.77 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.687 0.756 . . . . 0.0 110.029 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.9 m -83.84 141.13 31.57 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.377 0.608 . . . . 0.0 110.123 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 p -137.49 137.63 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -102.51 133.41 47.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.379 -0.826 . . . . 0.0 109.198 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -124.3 158.52 32.39 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.56 -170.56 37.87 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -120.38 142.8 48.84 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.6 -0.941 . . . . 0.0 109.267 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 tt -125.91 140.07 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -132.78 156.9 46.26 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.514 -0.741 . . . . 0.0 110.267 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.562 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 39.4 t0 -146.16 -142.28 0.13 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.562 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 66.3 t0 -87.55 -21.03 25.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.351 -0.843 . . . . 0.0 109.634 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.3 p -91.04 -76.61 0.44 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.086 -1.009 . . . . 0.0 109.866 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.11 -148.47 0.26 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 109.748 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.6 ptt-85 -142.57 159.17 42.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.577 -0.702 . . . . 0.0 109.702 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.4 tt -153.17 162.07 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.039 -1.038 . . . . 0.0 109.969 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -76.53 142.92 40.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.681 -0.637 . . . . 0.0 109.793 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.4 pt -129.22 153.75 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.532 -0.73 . . . . 0.0 109.433 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 p -142.25 132.57 24.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.59 -0.693 . . . . 0.0 109.259 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.2 t -119.23 128.67 54.41 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -92.73 122.76 35.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.183 -0.948 . . . . 0.0 110.409 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.48 -51.29 3.31 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -77.43 134.28 38.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.953 -1.322 . . . . 0.0 110.822 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -93.07 160.0 15.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.584 -0.697 . . . . 0.0 110.116 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.8 mt -121.72 153.55 38.07 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -102.23 147.58 26.48 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.736 0.779 . . . . 0.0 110.32 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 63' ' ' SER . 66.7 t0 -67.23 137.52 56.24 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.998 0.904 . . . . 0.0 111.947 -178.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.541 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 55.5 m 48.79 80.64 0.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.557 0.694 . . . . 0.0 110.803 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -152.46 126.2 8.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.535 -0.728 . . . . 0.0 109.929 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.0 t -80.81 120.23 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.395 -0.816 . . . . 0.0 109.265 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.6 m -138.52 163.99 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.929 0.871 . . . . 0.0 110.575 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -115.69 124.01 49.78 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 87.9 mt -109.5 124.66 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -111.53 144.65 40.42 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.636 -0.665 . . . . 0.0 109.836 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.6 t30 65.42 37.25 6.31 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.554 0.692 . . . . 0.0 109.231 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.38 143.03 53.81 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -96.39 125.76 41.11 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.704 . . . . 0.0 109.536 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.1 t -85.51 130.23 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.811 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.86 141.47 30.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.378 -0.826 . . . . 0.0 108.782 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.417 ' OE1' ' O ' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -116.18 138.03 51.62 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.657 -0.652 . . . . 0.0 109.351 -179.737 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -132.36 135.63 46.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.536 -0.728 . . . . 0.0 109.965 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.2 t30 57.78 24.72 11.06 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.364 0.602 . . . . 0.0 109.703 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.79 33.62 29.83 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -138.33 121.31 16.66 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.321 -1.105 . . . . 0.0 109.48 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.3 mt -67.76 143.74 55.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.616 -0.677 . . . . 0.0 110.449 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.8 m -152.67 154.25 34.93 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.1 mt -101.85 126.5 48.75 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.214 -0.928 . . . . 0.0 109.711 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.7 m -106.91 125.55 51.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.718 -0.614 . . . . 0.0 109.443 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.8 t -98.81 108.33 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.349 -0.845 . . . . 0.0 108.834 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.39 179.82 42.17 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 87' ' ' SER . 38.4 p30 -67.83 -21.03 65.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.545 -0.973 . . . . 0.0 109.546 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.522 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 92.2 p -81.52 -7.96 59.66 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.143 -0.973 . . . . 0.0 109.207 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.5 t -80.42 158.47 25.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.965 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -117.69 127.8 54.28 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.1 mt -111.93 130.32 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.545 -0.722 . . . . 0.0 109.692 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -130.21 114.47 15.71 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.9 m -79.71 131.33 35.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.565 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.5 t . . . . . 0 N--CA 1.498 1.932 0 O-C-N 121.497 -0.752 . . . . 0.0 109.578 179.868 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 36.1 p-10 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.5 tp -76.19 123.92 26.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.331 -0.856 . . . . 0.0 109.809 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.48 163.66 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.71 0.767 . . . . 0.0 110.142 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -79.29 156.88 27.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.753 -0.592 . . . . 0.0 110.084 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.22 -43.35 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.17 -21.89 66.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 109.609 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -86.87 -1.38 57.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.204 -0.935 . . . . 0.0 109.666 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.6 t -70.3 130.86 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.165 -0.959 . . . . 0.0 110.316 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.2 p -162.73 166.82 23.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.564 -0.71 . . . . 0.0 109.579 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 11' ' ' LEU . 3.7 mm? -67.84 -3.5 9.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -0.8 . . . . 0.0 109.027 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.1 p -63.72 -32.02 73.38 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.362 -0.836 . . . . 0.0 109.472 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 p -114.67 134.42 22.39 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.45 -0.781 . . . . 0.0 109.783 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.69 -55.01 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.151 1.901 . . . . 0.0 112.148 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -115.5 134.88 54.65 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.554 -0.716 . . . . 0.0 110.09 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.8 m -141.4 160.6 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.504 -0.747 . . . . 0.0 109.809 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.4 t -116.05 134.49 54.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.77 162.54 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.447 -0.783 . . . . 0.0 110.1 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.2 tt -140.26 139.48 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.537 -0.727 . . . . 0.0 109.337 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 172.63 -169.0 42.15 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.997 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -106.69 133.07 51.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.541 -0.976 . . . . 0.0 109.414 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.443 ' N ' ' CD1' ' A' ' 22' ' ' ILE . 2.0 mp -94.0 129.98 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.208 0.527 . . . . 0.0 109.907 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.5 p -139.93 155.92 46.92 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.397 -0.814 . . . . 0.0 110.233 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.35 71.26 1.17 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 25' ' ' ILE . 37.2 mm -81.35 130.58 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -1.177 . . . . 0.0 110.329 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -132.83 139.22 47.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -108.82 136.33 48.55 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.475 -0.766 . . . . 0.0 109.922 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -148.51 153.76 38.88 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -114.83 145.22 42.39 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.53 -0.732 . . . . 0.0 109.727 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -138.43 159.72 41.35 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.53 -0.732 . . . . 0.0 109.437 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -91.81 99.12 12.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.432 -0.792 . . . . 0.0 110.192 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 34' ' ' GLY . 8.3 t -77.9 -151.7 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.59 -0.694 . . . . 0.0 109.768 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -54.6 75.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.292 0.568 . . . . 0.0 110.474 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 61.97 19.56 59.05 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.3 m -140.02 133.11 29.54 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.262 -1.14 . . . . 0.0 110.166 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.4 m -78.38 128.86 34.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.327 -0.858 . . . . 0.0 109.367 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -132.72 144.49 50.32 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.397 -0.814 . . . . 0.0 109.945 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.5 p -84.78 146.41 27.39 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.424 -0.798 . . . . 0.0 109.773 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -139.0 138.55 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.613 -0.68 . . . . 0.0 109.46 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -100.36 135.34 41.95 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -127.97 157.36 40.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.621 -0.674 . . . . 0.0 109.433 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.49 -168.2 35.59 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -122.89 141.71 51.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.619 -0.93 . . . . 0.0 109.572 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.14 144.41 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -129.83 153.13 48.58 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.285 0.564 . . . . 0.0 109.643 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 20.6 t0 -144.41 -147.63 0.22 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.441 -0.787 . . . . 0.0 109.614 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.553 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 36.8 t70 -84.65 -7.7 59.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.805 . . . . 0.0 110.982 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.3 p -108.31 -66.18 1.06 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.13 -0.981 . . . . 0.0 109.998 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -157.56 -147.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 109.664 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.7 ptt85 -140.24 154.82 47.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.44 -0.787 . . . . 0.0 110.325 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.9 tt -146.32 161.27 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.523 -0.736 . . . . 0.0 109.939 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.85 145.07 40.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.516 -0.74 . . . . 0.0 110.16 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.6 pt -133.26 153.13 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.536 -0.727 . . . . 0.0 109.969 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 t -144.47 141.6 29.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.726 -0.609 . . . . 0.0 109.365 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.6 p -132.71 137.59 46.96 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.456 -0.777 . . . . 0.0 109.06 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -94.77 125.99 39.79 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.365 -0.835 . . . . 0.0 110.905 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.76 -44.52 0.64 Allowed Glycine 0 N--CA 1.493 2.434 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.804 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -73.95 136.22 43.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.989 -1.3 . . . . 0.0 110.782 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -95.54 158.12 15.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.642 -0.661 . . . . 0.0 110.084 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.4 mt -123.11 153.42 39.99 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -111.93 137.31 50.08 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.669 0.747 . . . . 0.0 110.265 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.462 ' O ' ' OG ' ' A' ' 63' ' ' SER . 24.1 t70 -66.79 136.87 56.11 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.412 0.625 . . . . 0.0 110.907 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 62' ' ' ASP . 12.9 p 66.32 78.84 0.25 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.531 0.682 . . . . 0.0 110.363 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 46.1 p-10 -162.89 121.37 2.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 109.56 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 t -82.96 116.14 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.1 m -137.43 162.06 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.502 -0.749 . . . . 0.0 110.248 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -115.81 126.66 54.3 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.5 mt -106.15 127.31 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -111.68 145.5 39.14 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.251 0.548 . . . . 0.0 109.693 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.4 t30 66.2 35.81 5.85 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.35 136.52 42.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.476 -0.765 . . . . 0.0 109.137 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -91.55 133.51 35.46 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.102 -0.999 . . . . 0.0 110.121 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.2 t -88.1 132.03 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.431 -0.793 . . . . 0.0 109.548 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.03 164.11 26.11 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -122.99 124.27 42.78 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.75 0.786 . . . . 0.0 110.168 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.664 ' O ' ' N ' ' A' ' 78' ' ' GLY . 15.6 m-85 -84.5 -178.0 6.78 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 76' ' ' PHE . 97.6 m-20 -36.98 -18.39 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.074 0.464 . . . . 0.0 110.787 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.664 ' N ' ' O ' ' A' ' 76' ' ' PHE . . . 172.35 29.81 0.03 OUTLIER Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -141.46 140.7 33.62 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.313 -1.11 . . . . 0.0 110.345 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 80.4 mt -77.35 148.95 35.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.418 -0.801 . . . . 0.0 110.07 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.2 p -155.86 159.24 39.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.432 -0.793 . . . . 0.0 109.726 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.3 mt -113.29 126.23 55.16 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 p -106.17 131.12 53.8 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.571 -0.706 . . . . 0.0 109.41 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.4 t -101.13 114.91 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.37 -0.831 . . . . 0.0 109.298 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.37 177.01 37.5 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 37.2 p-10 -68.12 -23.25 64.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.503 -0.998 . . . . 0.0 110.106 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 95.4 p -85.0 -4.11 59.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.022 -1.048 . . . . 0.0 109.496 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.2 t -80.6 172.38 13.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 0.0 109.91 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -129.4 141.71 50.98 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.641 -0.662 . . . . 0.0 109.689 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -123.84 129.59 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -125.7 114.94 19.32 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.528 -0.732 . . . . 0.0 109.368 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.5 p -79.14 155.59 28.63 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.522 -0.736 . . . . 0.0 109.958 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.4 t . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.456 -0.778 . . . . 0.0 108.964 179.376 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.358 0.599 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.5 tp -74.27 125.06 27.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.411 -0.806 . . . . 0.0 109.742 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.3 m -138.99 162.74 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.474 -0.766 . . . . 0.0 109.21 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.55 ' N ' ' OD2' ' A' ' 8' ' ' ASP . 64.1 mttp -74.65 151.64 39.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 110.527 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.92 -43.03 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.606 -0.684 . . . . 0.0 109.634 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -59.2 -31.94 69.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.473 -0.767 . . . . 0.0 110.562 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.55 ' OD2' ' N ' ' A' ' 5' ' ' LYS . 6.9 p30 -83.43 11.18 7.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.114 -0.991 . . . . 0.0 110.504 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.4 t -68.57 132.24 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.917 . . . . 0.0 110.069 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 m -161.5 170.08 20.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.364 -0.835 . . . . 0.0 110.153 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.27 -34.51 78.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.428 -0.795 . . . . 0.0 109.619 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -50.63 -17.82 0.59 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.457 -0.777 . . . . 0.0 109.743 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 p -121.36 82.92 39.51 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.77 -41.59 61.58 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.43 2.087 . . . . 0.0 112.089 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -121.32 128.81 52.67 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.7 m -144.27 160.3 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.181 -0.949 . . . . 0.0 109.653 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.2 m -116.74 133.6 55.81 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.53 163.06 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.391 -0.818 . . . . 0.0 109.459 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.5 mt -127.58 133.27 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 174.66 -163.56 34.07 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.455 -1.355 . . . . 0.0 109.959 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -125.81 143.52 51.03 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.798 -0.824 . . . . 0.0 109.346 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 63' ' ' SER . 3.8 mp -98.21 132.8 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.378 0.609 . . . . 0.0 110.615 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.7 p -134.49 157.17 47.19 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.327 0.584 . . . . 0.0 109.876 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.85 78.02 0.4 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.519 ' N ' ' CD1' ' A' ' 25' ' ' ILE . 1.4 mp -90.89 120.28 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.267 -1.137 . . . . 0.0 109.614 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -114.74 122.58 46.85 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -86.13 134.65 33.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 110.157 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -146.67 153.33 40.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.383 -0.823 . . . . 0.0 108.861 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -116.3 144.04 44.75 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.434 -0.791 . . . . 0.0 109.64 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -141.64 162.88 34.39 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.229 -0.919 . . . . 0.0 109.327 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -88.08 98.87 11.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.997 . . . . 0.0 109.251 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.567 ' O ' ' N ' ' A' ' 34' ' ' GLY . 9.3 t -84.31 -151.68 0.13 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.488 -0.758 . . . . 0.0 110.188 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 35' ' ' THR . 99.4 m-20 -50.43 84.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.692 -0.63 . . . . 0.0 110.278 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 49.45 15.3 0.73 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.427 ' N ' ' O ' ' A' ' 33' ' ' ASP . 35.7 p -140.24 145.96 38.03 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.321 -1.105 . . . . 0.0 109.372 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.2 m -84.41 129.2 34.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.514 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -129.11 147.1 50.93 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.461 -0.774 . . . . 0.0 109.505 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 p -84.01 152.13 24.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.489 -0.757 . . . . 0.0 109.716 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.3 p -142.62 139.01 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -106.97 132.0 53.41 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -119.0 147.18 44.37 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.555 -0.715 . . . . 0.0 109.18 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.62 -169.67 33.18 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -117.23 141.6 48.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.754 -0.851 . . . . 0.0 109.386 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.2 tt -117.77 144.92 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -134.11 160.46 37.73 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.469 0.652 . . . . 0.0 110.205 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.549 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 45.0 t0 -157.84 -167.01 2.12 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.549 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 98.2 m-20 -68.13 -16.4 63.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.877 . . . . 0.0 109.756 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.3 p -90.0 -73.96 0.5 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.5 -144.68 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 109.788 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -146.49 153.75 40.77 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.976 . . . . 0.0 110.361 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.2 tt -152.93 159.59 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.365 -0.835 . . . . 0.0 109.766 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.5 ttp85 -75.21 146.13 41.45 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.24 -0.912 . . . . 0.0 110.288 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.3 pt -134.99 163.66 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.497 -0.752 . . . . 0.0 110.086 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.7 t -143.72 128.97 18.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.379 -0.826 . . . . 0.0 108.844 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.4 t -113.15 121.88 45.84 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.543 -0.723 . . . . 0.0 109.093 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -97.6 120.09 37.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.448 -0.783 . . . . 0.0 110.397 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.24 -63.21 4.02 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -71.96 136.79 46.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -1.124 . . . . 0.0 110.6 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -96.18 155.8 16.61 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.44 -0.787 . . . . 0.0 109.463 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.5 mt -128.18 161.62 28.87 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.543 -0.723 . . . . 0.0 109.773 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -112.57 152.99 28.22 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 122.108 0.956 . . . . 0.0 110.145 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 63' ' ' SER . 68.2 t0 -63.1 139.22 58.75 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 111.288 -178.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.543 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.7 m 58.59 28.58 17.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.584 -0.698 . . . . 0.0 109.566 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -82.78 114.68 21.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 109.792 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.45 113.5 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.269 -0.894 . . . . 0.0 108.998 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 m -141.19 165.07 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.398 -0.814 . . . . 0.0 110.185 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -106.4 126.3 52.07 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.2 mm -108.15 126.49 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -122.6 143.83 49.5 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.0 t30 62.64 40.94 9.82 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.73 131.5 41.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 0.0 108.989 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -82.4 131.8 35.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.219 -0.926 . . . . 0.0 110.098 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.1 t -91.32 131.19 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.426 -0.797 . . . . 0.0 109.52 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.92 153.25 49.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.448 -0.782 . . . . 0.0 108.96 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -116.18 119.14 34.85 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.538 -0.726 . . . . 0.0 109.278 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -125.02 133.25 53.04 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.604 -0.685 . . . . 0.0 109.496 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.1 m120 55.37 31.26 16.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.707 -0.621 . . . . 0.0 109.94 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.6 6.6 84.83 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.521 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -113.95 133.42 55.48 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.47 -1.018 . . . . 0.0 109.71 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.3 mt -76.68 146.37 38.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.508 -0.745 . . . . 0.0 110.036 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.5 t -154.65 154.13 32.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.518 -0.739 . . . . 0.0 109.016 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.1 mt -103.42 129.51 50.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.379 -0.826 . . . . 0.0 109.114 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.2 t -105.19 128.38 53.37 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.699 -0.626 . . . . 0.0 109.562 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.52 99.94 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -97.08 -169.73 33.52 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -68.89 -17.29 63.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.565 -0.962 . . . . 0.0 109.634 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.8 m -83.12 -8.42 59.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.389 -0.819 . . . . 0.0 109.681 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.6 t -88.9 166.68 13.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 109.982 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -125.1 133.53 52.83 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 94.0 mt -119.29 128.38 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -126.5 132.1 51.47 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.537 -0.727 . . . . 0.0 109.46 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.9 t -66.18 132.79 49.27 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.549 -0.719 . . . . 0.0 110.223 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.265 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -78.01 165.35 24.14 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.8 0.81 . . . . 0.0 110.461 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 54.3 tp -76.19 124.34 27.31 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.62 0.724 . . . . 0.0 110.348 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.4 m -139.18 164.26 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.829 0.823 . . . . 0.0 110.144 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -80.69 161.02 24.81 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.708 0.766 . . . . 0.0 110.26 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.81 -43.27 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.216 0.531 . . . . 0.0 109.678 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -67.47 -18.8 65.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.783 -0.573 . . . . 0.0 109.649 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -86.04 -0.09 54.7 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.558 -0.714 . . . . 0.0 109.713 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.9 t -67.22 130.16 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.908 0.861 . . . . 0.0 110.344 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.9 p -160.86 167.27 27.01 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.769 0.795 . . . . 0.0 109.971 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.7 mt -66.72 -21.62 66.07 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.3 t -61.4 -20.24 62.83 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 51.6 p -124.92 80.96 62.81 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.749 -0.594 . . . . 0.0 109.461 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.73 -40.62 73.5 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.681 2.254 . . . . 0.0 111.705 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -112.8 125.81 54.75 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.647 0.736 . . . . 0.0 109.207 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.4 m -149.76 160.22 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 122.155 0.978 . . . . 0.0 111.058 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.2 t -118.33 134.17 55.27 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.49 162.38 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 121.972 0.891 . . . . 0.0 110.391 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.6 tt -140.97 135.57 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.637 0.732 . . . . 0.0 109.675 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.0 -165.99 37.42 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -113.44 136.67 52.52 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.733 0.777 . . . . 0.0 110.115 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 63' ' ' SER . 2.5 mp -96.19 137.08 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.475 0.655 . . . . 0.0 109.72 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.4 p -131.1 158.68 39.75 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.009 0.909 . . . . 0.0 110.348 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.62 93.55 0.01 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 25' ' ' ILE . 22.8 mm -93.4 124.52 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.804 -0.821 . . . . 0.0 109.829 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -120.39 139.66 52.49 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.807 0.813 . . . . 0.0 109.53 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -108.04 134.46 50.89 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.838 0.828 . . . . 0.0 110.234 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -144.04 154.93 43.76 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.675 0.75 . . . . 0.0 109.452 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -123.54 144.87 49.29 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.842 0.83 . . . . 0.0 110.23 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -144.21 158.44 43.73 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.827 0.822 . . . . 0.0 109.861 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -87.92 115.44 25.39 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.601 0.715 . . . . 0.0 110.075 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 t -113.35 113.07 24.72 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.733 0.778 . . . . 0.0 109.492 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.1 t0 55.93 29.46 14.27 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.279 0.561 . . . . 0.0 109.743 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.99 2.45 80.92 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.4 m -118.13 127.6 53.93 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.758 -0.848 . . . . 0.0 109.928 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.8 m -69.31 129.63 40.33 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.632 0.73 . . . . 0.0 110.317 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -130.99 139.86 50.06 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.746 0.784 . . . . 0.0 109.72 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.5 m -86.26 141.76 29.05 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.015 0.912 . . . . 0.0 110.723 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -136.49 135.53 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.856 0.836 . . . . 0.0 109.485 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -101.61 133.48 46.23 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.692 0.758 . . . . 0.0 109.791 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -121.78 151.96 40.01 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.837 0.827 . . . . 0.0 109.667 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.41 -172.93 39.99 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.577 ' CB ' HH21 ' A' ' 50' ' ' ARG . 68.0 m-85 -117.35 142.99 46.43 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.695 0.759 . . . . 0.0 109.863 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.5 tt -125.84 139.87 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -133.56 159.54 40.14 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.128 0.966 . . . . 0.0 110.653 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.57 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 37.3 t0 -145.08 -148.77 0.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.471 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.57 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 97.5 m-20 -80.02 -6.64 57.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.648 -0.657 . . . . 0.0 109.536 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.5 p -105.67 -91.11 0.4 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.73 -0.607 . . . . 0.0 109.888 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.51 -145.14 0.24 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.576 -0.703 . . . . 0.0 110.066 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.577 HH21 ' CB ' ' A' ' 43' ' ' TYR . 17.5 ptm180 -145.89 156.09 43.31 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.821 0.819 . . . . 0.0 110.783 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.8 tt -148.1 161.99 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.911 0.862 . . . . 0.0 110.297 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -79.44 147.77 32.18 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.589 0.709 . . . . 0.0 110.17 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.8 pt -134.98 157.0 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.912 0.863 . . . . 0.0 110.37 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 m -141.35 125.43 17.29 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.649 0.737 . . . . 0.0 109.558 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.5 t -116.43 130.23 56.65 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.963 0.887 . . . . 0.0 109.629 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -98.91 119.49 37.77 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.656 0.741 . . . . 0.0 109.86 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.69 -51.68 4.05 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -71.71 135.14 46.68 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.667 -0.902 . . . . 0.0 110.436 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -89.09 155.58 19.36 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.842 0.83 . . . . 0.0 110.903 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.2 mt -119.34 151.02 39.18 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.57 0.7 . . . . 0.0 109.563 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.406 ' O ' ' OD1' ' A' ' 64' ' ' ASP . 21.5 mp0 -112.49 142.29 45.23 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 122.385 1.088 . . . . 0.0 110.156 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 63' ' ' SER . 68.1 t0 -64.18 135.58 56.43 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.966 0.888 . . . . 0.0 111.876 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.522 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 2.1 p 53.47 23.7 3.58 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.527 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 20.4 p-10 -87.65 126.12 34.77 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.748 0.785 . . . . 0.0 110.426 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.3 m -82.47 115.8 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-O 121.657 0.742 . . . . 0.0 108.998 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.8 m -140.67 162.77 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 122.041 0.924 . . . . 0.0 110.416 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.525 ' NH1' ' OD1' ' A' ' 69' ' ' ASP . 68.9 ttp85 -117.39 127.82 54.42 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.701 0.762 . . . . 0.0 109.288 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.7 mt -107.25 129.48 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.754 0.787 . . . . 0.0 109.495 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.525 ' OD1' ' NH1' ' A' ' 67' ' ' ARG . 96.5 m-20 -116.41 144.27 44.51 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.688 0.756 . . . . 0.0 109.969 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.1 t30 62.91 39.57 10.33 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.842 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.26 146.74 47.04 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.4 0.619 . . . . 0.0 110.047 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -104.91 125.83 51.34 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.805 0.812 . . . . 0.0 110.095 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.0 t -86.55 133.22 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.699 0.761 . . . . 0.0 110.052 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.7 160.03 43.14 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.848 0.833 . . . . 0.0 109.955 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -107.44 114.37 28.34 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.699 0.762 . . . . 0.0 110.143 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -115.65 125.45 52.89 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.695 0.759 . . . . 0.0 109.472 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.2 m120 57.22 29.61 17.0 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.48 13.33 82.75 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -120.27 135.92 54.84 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.831 0.824 . . . . 0.0 109.987 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.2 mt -77.28 143.77 38.62 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.591 0.71 . . . . 0.0 109.899 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.0 p -156.3 163.3 39.69 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.957 0.884 . . . . 0.0 110.491 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.6 mt -103.63 124.11 48.22 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.757 0.789 . . . . 0.0 109.341 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.0 m -103.2 122.76 45.4 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.671 0.748 . . . . 0.0 110.104 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.422 ' CG1' ' HG ' ' A' ' 88' ' ' SER . 6.9 t -99.23 105.55 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.65 0.738 . . . . 0.0 109.596 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.435 ' O ' ' OG ' ' A' ' 88' ' ' SER . . . -91.76 -176.43 42.72 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.82 -16.71 62.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.95 -0.735 . . . . 0.0 109.322 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 87.6 p -85.91 -15.36 41.95 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 85' ' ' GLY . 25.5 p -82.68 167.16 18.5 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.567 0.699 . . . . 0.0 110.05 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -126.74 138.3 53.36 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.785 0.802 . . . . 0.0 109.879 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.32 127.55 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.493 0.664 . . . . 0.0 109.447 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -124.39 126.59 46.21 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.925 0.869 . . . . 0.0 110.253 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.0 p -76.35 150.02 36.91 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.455 0.645 . . . . 0.0 110.17 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.7 t -109.94 98.35 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-O 121.775 0.798 . . . . 0.0 109.712 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -104.92 -0.54 26.91 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.7 m -110.03 128.94 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 CA-C-O 121.834 0.825 . . . . 0.0 110.167 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -73.59 146.18 44.89 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.889 0.852 . . . . 0.0 111.177 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.1 pt -146.07 67.96 12.4 Favored Pre-proline 0 N--CA 1.493 1.713 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.133 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.405 ' HG2' ' H ' ' A' ' 99' ' ' LEU . 55.5 Cg_endo -75.12 -78.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.584 2.189 . . . . 0.0 111.554 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 100' ' ' GLU . 50.9 mt 61.2 160.03 0.05 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.483 0.659 . . . . 0.0 110.031 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' A' ' 99' ' ' LEU . 97.5 mt-10 51.68 168.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.864 0.84 . . . . 0.0 111.208 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 101' ' ' HIS . 53.5 p-80 -89.2 116.59 27.55 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.725 0.774 . . . . 0.0 109.906 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -87.83 0.27 56.03 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -61.37 -43.14 99.38 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -115.37 137.17 52.33 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.833 0.825 . . . . 0.0 109.869 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.488 ' CE1' ' CE1' ' A' ' 106' ' ' HIS . 39.3 p-80 -67.66 -35.85 79.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.871 -0.518 . . . . 0.0 109.692 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.488 ' CE1' ' CE1' ' A' ' 105' ' ' HIS . 78.1 m80 . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 117.835 -1.079 . . . . 0.0 109.978 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.2 m . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 55.7 t0 -73.17 152.63 41.05 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.753 0.787 . . . . 0.0 110.39 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.539 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 38.8 tp -69.5 128.7 37.45 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.504 0.669 . . . . 0.0 110.027 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.1 m -138.89 163.59 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.9 0.857 . . . . 0.0 109.968 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -75.32 156.65 35.33 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.75 0.786 . . . . 0.0 110.076 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.1 mm -62.65 -44.58 99.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.797 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -68.61 -20.96 64.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.562 -0.711 . . . . 0.0 109.504 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -82.77 -3.86 57.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.539 -0.726 . . . . 0.0 109.166 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.8 t -69.99 128.86 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.975 0.893 . . . . 0.0 109.915 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.444 ' C ' ' H ' ' A' ' 12' ' ' SER . 29.7 m -163.6 162.66 24.43 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.566 0.698 . . . . 0.0 109.399 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.7 mt -64.58 -2.31 2.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.784 -0.573 . . . . 0.0 109.555 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 10' ' ' SER . 78.6 p -61.0 -32.64 72.21 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.542 ' HG1' ' CG1' ' A' ' 16' ' ' VAL . 69.6 p -117.07 145.22 35.22 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.729 -0.607 . . . . 0.0 110.168 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.28 -61.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.999 2.466 . . . . 0.0 112.422 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 100.0 m-85 -119.75 136.53 54.4 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.858 0.837 . . . . 0.0 110.339 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.542 ' CG1' ' HG1' ' A' ' 13' ' ' THR . 29.9 m -140.52 164.0 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.688 0.756 . . . . 0.0 109.973 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.2 m -118.96 145.09 46.09 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.756 0.789 . . . . 0.0 109.494 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.24 160.27 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 122.114 0.959 . . . . 0.0 110.639 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.406 ' O ' ' OD2' ' A' ' 46' ' ' ASP . 19.5 tt -138.27 130.25 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.665 0.745 . . . . 0.0 109.457 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.58 -156.24 21.53 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -124.93 139.11 54.12 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.919 -0.753 . . . . 0.0 109.839 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.475 ' N ' ' CD1' ' A' ' 22' ' ' ILE . 3.0 mp -92.2 132.18 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.391 0.615 . . . . 0.0 110.08 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.0 m -125.76 143.87 50.87 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.058 0.932 . . . . 0.0 109.866 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.76 97.02 0.04 OUTLIER Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.6 mm -95.01 125.88 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.962 0.887 . . . . 0.0 110.408 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -123.4 134.51 53.96 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.556 0.693 . . . . 0.0 109.226 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -108.31 132.9 53.23 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.947 0.88 . . . . 0.0 110.037 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -140.76 158.27 44.21 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.772 0.796 . . . . 0.0 109.718 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -120.43 145.05 47.6 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.783 0.801 . . . . 0.0 109.983 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.441 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 13.7 p90 -141.61 159.42 42.27 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.18 0.99 . . . . 0.0 110.088 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -96.69 132.26 42.54 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.532 0.682 . . . . 0.0 109.471 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.0 t -159.16 141.1 13.54 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.743 0.782 . . . . 0.0 110.189 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 55.65 28.37 11.93 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.25 0.548 . . . . 0.0 109.759 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.36 14.66 79.2 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.7 p -135.87 155.06 50.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.61 -0.935 . . . . 0.0 109.874 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.6 m -98.2 126.24 43.58 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.88 0.848 . . . . 0.0 109.818 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.441 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 98.9 mttt -125.62 142.1 51.68 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.819 0.818 . . . . 0.0 109.325 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 90.8 p -84.57 146.37 27.57 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.841 0.829 . . . . 0.0 110.368 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -133.51 136.99 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.822 0.82 . . . . 0.0 109.821 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.514 ' CZ ' ' OE1' ' A' ' 59' ' ' GLN . 94.4 m-85 -101.95 131.2 48.49 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.763 0.792 . . . . 0.0 109.725 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -126.12 155.24 41.96 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.93 0.871 . . . . 0.0 109.943 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.9 -166.93 35.19 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.618 ' CD2' ' NH2' ' A' ' 50' ' ' ARG . 97.2 m-85 -119.79 140.37 50.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.81 -0.818 . . . . 0.0 110.072 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.4 tt -122.79 133.19 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -134.32 156.23 48.84 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 122.277 1.037 . . . . 0.0 110.561 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 48' ' ' THR . 5.4 p30 -168.09 95.32 0.41 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.646 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' THR . 66.8 t0 52.4 -77.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 120.936 0.398 . . . . 0.0 110.571 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.589 ' N ' ' O ' ' A' ' 46' ' ' ASP . 73.9 p -38.62 -80.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.086 0.47 . . . . 0.0 110.456 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.21 -143.67 0.11 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.698 0.761 . . . . 0.0 110.087 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.618 ' NH2' ' CD2' ' A' ' 43' ' ' TYR . 8.9 ptm180 -142.87 150.68 40.18 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.761 0.791 . . . . 0.0 110.4 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.6 tt -146.54 156.26 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.747 0.784 . . . . 0.0 110.085 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -76.69 147.2 37.57 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.735 0.779 . . . . 0.0 109.973 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.2 pt -135.05 154.47 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.644 0.735 . . . . 0.0 110.273 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 t -143.17 133.42 24.54 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.858 0.837 . . . . 0.0 109.551 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 p -131.09 135.28 47.38 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.973 0.892 . . . . 0.0 109.887 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.486 ' C ' ' H ' ' A' ' 58' ' ' LYS . 90.7 m-85 -94.8 122.33 37.3 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.699 0.761 . . . . 0.0 111.025 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.47 -29.46 0.58 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 56' ' ' PHE . 98.9 mttt -74.11 136.84 42.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.568 -0.96 . . . . 0.0 110.607 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.514 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 68.7 tp60 -94.68 146.92 23.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.776 0.798 . . . . 0.0 110.495 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.9 mt -129.48 152.44 49.01 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.721 0.772 . . . . 0.0 109.927 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -122.93 137.64 54.89 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.216 1.008 . . . . 0.0 110.074 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 63' ' ' SER . 65.6 t0 -64.78 134.69 54.66 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.865 0.84 . . . . 0.0 111.462 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.53 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 2.8 p 78.29 8.19 2.31 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.862 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 7.3 p-10 -84.45 124.08 30.95 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.307 0.575 . . . . 0.0 110.803 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 t -87.02 116.76 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.637 0.732 . . . . 0.0 109.117 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.48 163.22 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.221 1.01 . . . . 0.0 110.945 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -119.27 128.99 54.68 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.7 mt -106.23 129.45 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.773 0.797 . . . . 0.0 109.543 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -114.81 143.51 44.99 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.849 0.833 . . . . 0.0 110.149 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.6 t30 62.12 37.89 14.19 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.2 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.95 145.7 46.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.583 -0.698 . . . . 0.0 109.426 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -96.04 132.34 41.5 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.828 0.823 . . . . 0.0 110.209 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 89.6 t -83.15 131.66 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 121.532 0.682 . . . . 0.0 109.974 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.64 154.28 43.37 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.683 0.754 . . . . 0.0 109.973 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -119.79 117.38 28.03 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.816 0.817 . . . . 0.0 109.924 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -119.85 131.51 55.29 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.852 0.834 . . . . 0.0 110.01 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.8 t30 56.64 24.32 8.73 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.239 0.542 . . . . 0.0 110.249 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.88 10.51 82.93 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -114.99 138.17 51.15 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.91 0.862 . . . . 0.0 109.755 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 3.7 mm? -76.94 141.61 40.4 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.93 0.872 . . . . 0.0 110.699 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.3 p -153.52 159.24 42.19 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.752 0.787 . . . . 0.0 110.008 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.7 mt -108.56 126.39 52.88 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.791 0.805 . . . . 0.0 110.175 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.2 m -101.43 123.54 45.65 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.825 0.822 . . . . 0.0 109.656 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.7 t -101.02 111.29 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.843 0.83 . . . . 0.0 109.204 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.23 -178.71 37.22 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -68.2 -18.35 64.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 122.149 -0.618 . . . . 0.0 109.543 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 97.1 p -87.65 -7.53 57.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.669 -0.645 . . . . 0.0 109.455 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.1 t -83.69 164.92 19.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.456 -0.778 . . . . 0.0 109.556 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -128.54 139.27 52.39 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.754 0.788 . . . . 0.0 109.911 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.15 130.47 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.651 0.739 . . . . 0.0 109.45 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 91' ' ' GLU . 56.7 mp0 -115.72 125.53 52.93 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.83 0.824 . . . . 0.0 109.93 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.0 p -71.33 144.87 49.78 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.596 0.712 . . . . 0.0 110.559 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.2 t -119.27 130.8 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-O 121.936 0.874 . . . . 0.0 109.924 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -132.46 -69.15 0.59 Allowed 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.97 115.59 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-O 121.88 0.847 . . . . 0.0 109.686 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -79.54 154.69 28.62 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.832 0.825 . . . . 0.0 110.419 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.2 mt -139.86 77.65 26.48 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.24 145.06 98.98 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.821 2.347 . . . . 0.0 112.136 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.4 ' CD2' ' C ' ' A' ' 99' ' ' LEU . 3.3 tt 55.98 93.99 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.778 0.799 . . . . 0.0 109.672 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 101' ' ' HIS . 83.4 tt0 -157.25 84.36 0.92 Allowed 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.74 0.781 . . . . 0.0 109.684 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' A' ' 100' ' ' GLU . 65.4 m170 58.6 129.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.727 0.775 . . . . 0.0 110.528 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.475 ' CD2' ' N ' ' A' ' 102' ' ' HIS . 0.3 OUTLIER -150.56 166.89 28.87 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.907 0.86 . . . . 0.0 110.445 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.555 ' C ' ' H ' ' A' ' 105' ' ' HIS . 51.1 p-80 -62.85 -47.44 83.36 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.537 ' N ' ' CG ' ' A' ' 103' ' ' HIS . 85.9 t60 54.11 6.02 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.555 ' H ' ' C ' ' A' ' 103' ' ' HIS . 94.5 m-70 -83.37 141.71 31.56 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.722 0.773 . . . . 0.0 110.827 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.1 t60 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 117.881 -1.057 . . . . 0.0 109.061 179.479 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 84.4 p . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 60.5 t0 -72.68 149.61 43.67 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.75 0.786 . . . . 0.0 110.209 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.532 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 4.9 tt -71.17 133.82 46.46 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.686 -0.634 . . . . 0.0 110.726 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.2 m -135.84 162.91 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-O 121.567 0.698 . . . . 0.0 109.884 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -79.04 155.98 28.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.589 -0.695 . . . . 0.0 110.062 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.9 mt -63.54 -43.66 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.712 -0.618 . . . . 0.0 109.866 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 -72.31 -14.38 61.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.117 -0.989 . . . . 0.0 109.864 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -93.25 2.22 56.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.321 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.51 132.05 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.155 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.3 p -159.35 165.82 32.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.355 -0.841 . . . . 0.0 109.837 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.66 -19.07 65.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.523 -0.735 . . . . 0.0 109.762 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.2 m -57.51 -25.25 59.56 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.118 -0.989 . . . . 0.0 109.24 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 45.8 p -123.29 82.64 52.24 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.46 -40.36 71.79 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.641 2.227 . . . . 0.0 112.088 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -115.87 128.76 56.05 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.419 0.628 . . . . 0.0 109.832 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.2 m -153.04 -176.41 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.445 -0.785 . . . . 0.0 109.906 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.3 m -130.18 144.29 51.28 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.4 m -139.88 162.61 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.376 -0.827 . . . . 0.0 110.245 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 tp -141.52 127.93 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.68 -168.53 38.06 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.058 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -110.27 144.11 39.44 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.621 -0.929 . . . . 0.0 109.545 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.0 mm -95.07 133.44 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.364 0.602 . . . . 0.0 110.254 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -143.02 156.84 44.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.37 -0.831 . . . . 0.0 109.983 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.11 62.14 4.41 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.0 mm -76.94 129.78 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -1.125 . . . . 0.0 110.624 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -130.09 122.69 28.79 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.509 ' NZ ' ' OE2' ' A' ' 29' ' ' GLU . 66.0 tttm -86.41 136.93 32.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.355 -0.841 . . . . 0.0 110.022 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -146.64 139.85 25.57 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.509 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 97.2 mt-10 -115.1 148.15 39.32 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.664 -0.647 . . . . 0.0 110.154 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.541 ' CE2' ' OG ' ' A' ' 32' ' ' SER . 9.8 p90 -147.28 159.29 43.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.819 . . . . 0.0 109.188 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -84.07 119.98 25.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.4 -0.812 . . . . 0.0 110.318 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.541 ' OG ' ' CE2' ' A' ' 30' ' ' TYR . 3.1 m -119.41 114.17 21.91 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 55.36 31.94 17.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.56 -0.713 . . . . 0.0 109.881 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.74 6.43 88.49 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.2 m -120.89 128.56 52.91 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.525 -0.985 . . . . 0.0 109.874 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.4 m -68.25 134.72 50.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.602 -0.686 . . . . 0.0 110.042 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -131.58 147.29 52.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.441 -0.787 . . . . 0.0 109.34 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.5 t -99.9 135.09 41.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.631 -0.668 . . . . 0.0 109.939 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.94 138.09 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -105.41 134.35 48.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.527 -0.733 . . . . 0.0 109.476 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -123.51 150.86 43.42 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.391 0.615 . . . . 0.0 109.385 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.431 ' C ' ' CD1' ' A' ' 53' ' ' ILE . . . -173.82 -147.44 6.0 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.48 ' OH ' ' NH1' ' A' ' 52' ' ' ARG . 79.6 m-85 -132.92 141.58 48.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.573 -0.957 . . . . 0.0 109.549 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 tt -116.04 134.39 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -133.26 150.23 51.93 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.756 0.788 . . . . 0.0 110.719 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 48' ' ' THR . 62.8 t0 -167.36 95.55 0.47 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' THR . 38.8 t70 48.37 -79.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.812 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.601 ' N ' ' O ' ' A' ' 46' ' ' ASP . 14.5 m -36.29 -77.31 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.767 -0.583 . . . . 0.0 110.803 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -161.12 -153.99 0.34 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.032 -1.042 . . . . 0.0 109.426 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 -138.97 152.12 47.42 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.39 0.614 . . . . 0.0 110.572 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.0 tt -150.67 163.52 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.783 . . . . 0.0 110.167 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.48 ' NH1' ' OH ' ' A' ' 43' ' ' TYR . 77.2 mtp85 -79.31 149.19 31.85 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.514 0.673 . . . . 0.0 110.838 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.543 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -141.79 164.44 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.511 -0.743 . . . . 0.0 109.792 179.587 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 p -140.42 127.13 20.39 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -109.98 118.08 35.5 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.619 -0.675 . . . . 0.0 109.21 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.474 ' C ' ' H ' ' A' ' 58' ' ' LYS . 72.1 m-85 -95.4 123.85 39.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.448 -0.782 . . . . 0.0 110.806 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.15 -33.55 0.65 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' A' ' 56' ' ' PHE . 31.1 mmtp -87.92 130.13 35.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.893 -1.357 . . . . 0.0 109.955 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -90.45 146.41 24.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.501 -0.749 . . . . 0.0 110.283 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.7 mt -132.67 151.39 51.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.625 -0.672 . . . . 0.0 109.346 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -112.34 148.23 34.69 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.948 0.88 . . . . 0.0 110.153 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.6 t0 -65.27 136.68 56.89 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.656 0.741 . . . . 0.0 111.389 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.503 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 3.1 p 75.26 6.73 4.14 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.28 0.562 . . . . 0.0 109.94 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -83.98 122.61 28.99 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.13 -0.981 . . . . 0.0 110.135 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.4 t -85.57 119.19 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.4 160.48 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.422 0.629 . . . . 0.0 109.666 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -116.37 123.51 47.77 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 75.9 mt -107.41 130.36 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.572 -0.705 . . . . 0.0 109.401 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -116.98 144.65 44.33 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.447 0.641 . . . . 0.0 109.911 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.3 t30 64.75 35.86 8.47 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.445 0.64 . . . . 0.0 109.542 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.87 146.21 53.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.425 -0.797 . . . . 0.0 109.164 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.3 ttp85 -100.27 125.18 46.43 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.507 0.67 . . . . 0.0 110.056 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.3 t -85.25 133.3 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.521 -0.737 . . . . 0.0 109.651 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.38 164.85 30.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.365 -0.834 . . . . 0.0 109.349 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -103.33 114.37 28.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.6 -0.687 . . . . 0.0 109.609 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -110.3 121.87 46.32 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.6 m120 56.05 31.27 17.76 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.411 0.624 . . . . 0.0 109.392 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.89 13.07 83.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -121.47 138.47 54.28 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.514 -0.992 . . . . 0.0 110.059 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.7 mt -71.37 139.8 49.93 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.583 -0.698 . . . . 0.0 110.283 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.66 163.04 40.43 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.8 mt -103.59 127.83 50.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.602 -0.686 . . . . 0.0 109.585 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.4 t -107.38 126.91 53.07 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 t -103.39 106.01 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.484 -0.76 . . . . 0.0 109.79 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -90.83 179.67 42.93 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -65.44 -37.7 87.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.482 -1.011 . . . . 0.0 109.603 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.4 m -60.66 -36.14 77.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 0.0 110.008 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.1 p -63.25 163.21 10.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.192 -0.942 . . . . 0.0 110.328 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -111.35 140.04 46.26 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.722 -0.611 . . . . 0.0 109.525 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.28 131.38 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -128.13 108.65 10.81 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.497 -0.752 . . . . 0.0 109.181 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.9 t -72.69 140.89 48.17 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.49 -0.756 . . . . 0.0 110.132 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 94' ' ' ASN . 98.1 t -103.24 -50.88 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 93' ' ' VAL . 13.2 m120 48.94 101.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.627 0.727 . . . . 0.0 110.004 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.5 t -73.61 107.32 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.253 -0.904 . . . . 0.0 110.014 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -156.96 112.03 2.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.513 -0.742 . . . . 0.0 109.019 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.6 pt -145.72 78.63 11.67 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.322 -0.861 . . . . 0.0 109.185 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.57 146.26 91.87 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.657 2.238 . . . . 0.0 112.585 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.433 ' CD1' ' N ' ' A' ' 99' ' ' LEU . 10.4 mp 56.69 108.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.707 0.765 . . . . 0.0 110.187 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -59.69 144.01 49.14 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.599 0.714 . . . . 0.0 110.607 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -74.36 69.99 1.66 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.514 -0.741 . . . . 0.0 109.511 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -65.14 -40.19 94.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.493 -0.754 . . . . 0.0 109.274 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -70.98 74.36 0.62 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.364 -0.835 . . . . 0.0 109.732 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -65.46 -34.35 78.08 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.505 ' CG ' ' N ' ' A' ' 106' ' ' HIS . 83.9 t60 55.84 -112.56 0.71 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.674 -0.642 . . . . 0.0 110.328 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.527 ' O ' ' CG ' ' A' ' 106' ' ' HIS . 56.5 p-80 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.205 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 122.032 0.92 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 146.42 158.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.26 121.7 30.05 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.149 -0.969 . . . . 0.0 111.528 -174.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.7 m -131.29 161.63 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -75.75 162.92 27.78 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.813 0.816 . . . . 0.0 110.265 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.5 mm -62.79 -43.51 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.615 -0.678 . . . . 0.0 109.253 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -65.78 -18.21 65.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.383 -0.823 . . . . 0.0 110.055 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -85.28 -0.05 53.51 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.136 -0.977 . . . . 0.0 110.281 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.39 133.05 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.174 -0.954 . . . . 0.0 110.254 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.1 m -157.5 162.8 38.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.473 -0.767 . . . . 0.0 109.742 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.74 -30.16 70.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.376 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -59.33 -20.23 52.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.347 -0.846 . . . . 0.0 109.293 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 13' ' ' THR . 11.5 p -118.39 80.2 16.03 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.72 -15.21 33.5 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.015 1.81 . . . . 0.0 112.581 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -133.11 105.97 7.34 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.423 -0.798 . . . . 0.0 109.792 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.1 m -145.57 164.61 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.379 -0.826 . . . . 0.0 109.881 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.1 t -108.54 141.45 40.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.339 -0.85 . . . . 0.0 108.825 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.52 160.27 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.365 -0.834 . . . . 0.0 109.724 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.5 tt -142.73 137.35 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.389 -0.819 . . . . 0.0 109.373 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.67 -166.27 35.94 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.227 -1.463 . . . . 0.0 110.683 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -104.57 132.41 50.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.818 -0.813 . . . . 0.0 109.402 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.416 HD12 HG23 ' A' ' 22' ' ' ILE . 21.2 mm -89.29 130.02 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.221 0.534 . . . . 0.0 109.915 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.0 p -137.87 161.54 36.36 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.325 -0.859 . . . . 0.0 109.884 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.57 79.29 0.1 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.8 mm -91.44 120.07 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.193 -1.181 . . . . 0.0 109.709 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -119.56 125.76 49.6 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -93.85 134.43 36.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.284 -0.885 . . . . 0.0 109.967 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -148.12 143.58 27.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.426 -0.796 . . . . 0.0 109.001 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -123.89 144.91 49.47 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.415 -0.803 . . . . 0.0 109.344 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.531 ' CE2' ' OG ' ' A' ' 32' ' ' SER . 24.9 p90 -141.71 160.73 39.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.215 -0.928 . . . . 0.0 109.558 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -79.6 114.52 18.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.56 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.531 ' OG ' ' CE2' ' A' ' 30' ' ' TYR . 5.1 m -109.61 112.82 25.13 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.533 -0.729 . . . . 0.0 109.531 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 53.37 31.07 11.3 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 0.0 110.201 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.67 -2.45 82.52 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.3 p -118.36 124.87 48.8 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.299 -1.118 . . . . 0.0 109.296 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.4 m -69.68 135.67 50.14 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.432 -0.792 . . . . 0.0 110.221 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -131.84 147.87 52.51 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.2 t -96.95 131.79 43.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.506 -0.746 . . . . 0.0 109.747 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.67 135.36 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -104.81 135.53 46.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.528 -0.733 . . . . 0.0 109.129 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -124.56 153.88 41.47 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.445 0.64 . . . . 0.0 109.371 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.76 -151.72 8.41 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -130.37 145.92 51.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.81 -0.818 . . . . 0.0 109.377 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.8 tt -123.57 142.36 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -127.71 151.51 48.89 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.434 0.635 . . . . 0.0 109.667 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.555 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 36.9 t0 -141.78 -153.16 0.45 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.485 -0.759 . . . . 0.0 109.381 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.555 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 95.5 m-20 -78.91 -7.47 58.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.88 . . . . 0.0 109.935 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.5 p -108.75 -85.8 0.52 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.335 -0.853 . . . . 0.0 110.363 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.0 -148.86 0.32 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.473 -0.767 . . . . 0.0 109.622 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -145.44 156.36 43.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.271 -0.893 . . . . 0.0 110.087 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.7 tt -148.91 164.8 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.368 -0.833 . . . . 0.0 109.978 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.63 144.17 35.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.158 -0.964 . . . . 0.0 110.148 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.521 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -135.21 161.23 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.485 -0.759 . . . . 0.0 109.665 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.2 m -137.79 139.98 40.33 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 58' ' ' LYS . 4.7 p -119.58 116.24 25.64 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.444 ' C ' ' H ' ' A' ' 58' ' ' LYS . 85.6 m-85 -96.78 117.09 30.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.382 -0.824 . . . . 0.0 110.273 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.83 -13.26 3.23 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.444 ' H ' ' C ' ' A' ' 56' ' ' PHE . 28.3 mmtp -103.77 107.15 17.89 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.365 -1.08 . . . . 0.0 109.352 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -72.64 145.02 47.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.569 -0.707 . . . . 0.0 109.728 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.1 mt -127.14 153.25 46.27 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -105.75 141.56 36.97 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.613 0.721 . . . . 0.0 109.847 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 63' ' ' SER . 57.1 t0 -66.25 138.42 57.64 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.592 0.711 . . . . 0.0 110.782 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.528 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 5.0 m 61.56 78.85 0.27 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.354 0.597 . . . . 0.0 110.749 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.416 ' CG ' ' O ' ' A' ' 63' ' ' SER . 56.7 m-20 -163.33 126.92 2.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.691 -0.631 . . . . 0.0 109.422 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.7 t -78.24 121.63 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.1 m -137.72 160.67 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.43 -0.794 . . . . 0.0 109.855 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -117.36 128.74 55.34 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.4 mt -106.95 126.57 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -109.85 141.22 42.85 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.72 -0.612 . . . . 0.0 109.729 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 61.7 t30 62.74 41.01 9.47 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.484 0.659 . . . . 0.0 109.385 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.57 147.31 49.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.422 -0.799 . . . . 0.0 109.087 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -103.37 125.53 50.04 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.537 -0.727 . . . . 0.0 109.578 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.0 t -86.25 132.7 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.482 -0.761 . . . . 0.0 109.69 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.66 152.92 41.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.321 -0.862 . . . . 0.0 109.174 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -107.35 122.3 46.3 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.446 -0.784 . . . . 0.0 109.556 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -126.08 138.91 53.74 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.1 t30 56.25 24.06 7.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.559 -0.713 . . . . 0.0 109.507 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.64 8.35 87.72 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -118.19 138.97 51.95 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.42 -1.047 . . . . 0.0 109.698 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.9 mt -75.53 145.15 41.54 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.629 0.728 . . . . 0.0 110.342 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.5 p -154.77 160.62 41.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.552 -0.717 . . . . 0.0 109.139 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.7 mt -105.16 126.27 51.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.414 -0.804 . . . . 0.0 109.331 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.9 p -109.2 134.37 51.83 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.558 -0.714 . . . . 0.0 109.6 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.8 t -100.51 114.08 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.306 -0.871 . . . . 0.0 108.749 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.14 175.85 44.99 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 87' ' ' SER . 43.3 p-10 -67.43 -24.24 65.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.571 -0.958 . . . . 0.0 109.822 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.453 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 66.2 m -84.17 -6.4 59.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.238 -0.914 . . . . 0.0 109.634 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.674 ' HG ' ' N ' ' A' ' 89' ' ' ARG . 39.9 t -81.96 170.84 15.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.756 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.674 ' N ' ' HG ' ' A' ' 88' ' ' SER . 79.0 mtp85 -131.52 141.25 49.69 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.619 -0.675 . . . . 0.0 109.751 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.8 130.51 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.645 -0.66 . . . . 0.0 109.438 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -121.33 120.39 34.92 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.55 0.69 . . . . 0.0 109.374 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.2 m -75.69 147.15 39.64 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.506 -0.746 . . . . 0.0 110.176 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.7 t -136.76 61.69 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -95.81 1.6 53.29 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.32 -0.863 . . . . 0.0 109.645 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.7 t -120.18 130.18 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.514 -0.741 . . . . 0.0 109.16 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 54.2 p30 -101.24 51.39 0.85 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.488 -0.758 . . . . 0.0 109.056 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.8 mt -143.85 69.87 16.77 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.428 -0.795 . . . . 0.0 109.31 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.78 -0.76 10.83 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.73 2.287 . . . . 0.0 111.238 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 73.7 mt -71.56 147.08 48.0 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.57 0.7 . . . . 0.0 110.168 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 102' ' ' HIS . 30.0 tp10 58.53 -123.76 1.39 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.593 -0.692 . . . . 0.0 109.951 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 57.8 m170 44.48 -93.88 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.255 -0.903 . . . . 0.0 109.729 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 100' ' ' GLU . 48.1 p-80 -154.97 153.54 31.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 109.34 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -96.5 122.33 39.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.222 -0.924 . . . . 0.0 109.889 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.9 -41.97 90.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.413 -0.805 . . . . 0.0 109.718 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -76.23 143.58 40.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.395 -0.816 . . . . 0.0 110.138 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.549 179.902 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 76.9 p . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.9 p30 -174.45 157.33 2.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.447 -0.783 . . . . 0.0 109.492 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 3' ' ' LEU . 3.8 mm? -83.7 130.44 34.96 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.457 -0.777 . . . . 0.0 109.994 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.4 m -138.32 161.68 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.544 0.687 . . . . 0.0 109.559 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -86.7 163.55 17.27 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.539 0.685 . . . . 0.0 109.883 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.2 mm -62.87 -43.78 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.613 -0.679 . . . . 0.0 109.85 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -66.76 -18.99 65.65 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.019 -1.051 . . . . 0.0 109.435 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -84.18 -1.68 55.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 0.0 109.566 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.47 131.59 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.204 -0.935 . . . . 0.0 110.136 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 12' ' ' SER . 46.4 t -163.41 160.07 23.04 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.3 -3.66 6.33 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 10' ' ' SER . 37.9 m -59.75 -35.63 74.98 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.63 -0.668 . . . . 0.0 109.248 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.7 p -115.28 133.63 22.69 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.66 -0.65 . . . . 0.0 109.701 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.61 -53.05 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.127 1.885 . . . . 0.0 111.781 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -119.66 130.73 55.2 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.368 0.604 . . . . 0.0 109.866 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.0 m -146.93 163.93 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.537 -0.727 . . . . 0.0 109.591 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.9 t -110.15 138.24 46.8 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.435 -0.791 . . . . 0.0 109.505 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.02 160.52 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.529 -0.732 . . . . 0.0 109.713 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.0 tt -142.96 137.58 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 109.599 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.48 -161.94 28.9 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.866 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -110.4 129.11 55.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.671 -0.899 . . . . 0.0 109.438 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.2 mt -101.75 131.12 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.766 -0.584 . . . . 0.0 109.991 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.425 ' HA ' ' H ' ' A' ' 63' ' ' SER . 23.0 m -145.27 153.45 41.3 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.591 0.71 . . . . 0.0 109.997 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.51 65.18 1.75 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.406 HG22 HD12 ' A' ' 25' ' ' ILE . 30.9 mm -81.58 129.1 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -1.138 . . . . 0.0 109.94 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -123.89 132.71 53.79 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -94.27 134.14 37.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.0 109.876 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -145.21 157.95 43.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.454 -0.779 . . . . 0.0 109.284 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -123.6 144.23 49.72 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.518 -0.739 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -142.38 160.63 39.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.375 -0.828 . . . . 0.0 109.321 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -80.1 148.29 31.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.434 -0.792 . . . . 0.0 109.832 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.581 ' O ' ' N ' ' A' ' 34' ' ' GLY . 34.1 m -144.97 -149.5 0.28 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.474 -0.766 . . . . 0.0 109.114 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -50.95 84.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.758 0.79 . . . . 0.0 110.13 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 47.69 19.98 1.01 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -147.91 151.16 35.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.072 -1.252 . . . . 0.0 110.156 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.8 m -89.66 131.12 35.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.451 -0.78 . . . . 0.0 109.171 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -119.33 146.75 45.03 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.579 0.704 . . . . 0.0 109.942 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 89.2 p -83.77 146.35 28.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.49 -0.757 . . . . 0.0 109.924 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -139.54 137.81 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -104.25 128.9 52.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.499 -0.751 . . . . 0.0 109.401 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -113.85 154.61 27.19 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.18 -169.53 37.79 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -124.85 146.36 49.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.659 -0.906 . . . . 0.0 109.611 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.2 tt -125.39 139.44 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -126.95 149.35 49.88 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.528 -0.732 . . . . 0.0 110.234 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.554 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 42.7 t0 -136.13 -160.44 1.05 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.554 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 1.4 p30 -81.29 -3.53 52.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 110.056 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.9 p -107.06 -62.11 1.45 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.278 -0.889 . . . . 0.0 109.438 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -160.71 -151.46 0.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.23 -0.919 . . . . 0.0 109.583 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -144.8 156.96 44.31 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.4 tt -146.63 159.49 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.297 -0.877 . . . . 0.0 110.053 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -76.42 144.5 39.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.381 -0.824 . . . . 0.0 109.697 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.2 pt -128.73 157.96 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.491 -0.756 . . . . 0.0 110.076 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -145.0 126.43 14.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.4 t -114.84 127.52 55.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.486 -0.759 . . . . 0.0 109.492 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -97.44 117.78 32.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.577 -0.702 . . . . 0.0 110.349 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.64 -54.58 4.97 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -70.31 138.18 51.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.128 -1.219 . . . . 0.0 110.669 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -88.41 158.37 18.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.618 -0.676 . . . . 0.0 110.077 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.6 mt -121.27 153.63 37.42 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -106.88 135.47 48.38 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.685 0.755 . . . . 0.0 109.838 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -66.42 136.84 56.32 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.751 0.786 . . . . 0.0 110.948 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.425 ' H ' ' HA ' ' A' ' 23' ' ' THR . 67.0 m 45.82 78.85 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.605 0.717 . . . . 0.0 110.145 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -150.68 126.52 10.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.626 -0.671 . . . . 0.0 109.358 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.5 t -78.55 115.87 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.498 -0.751 . . . . 0.0 109.23 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.1 m -140.58 166.87 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.487 -0.758 . . . . 0.0 109.94 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -121.8 130.38 53.35 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 74.8 mt -107.33 129.55 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.55 -0.719 . . . . 0.0 109.221 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -111.25 143.05 42.64 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.343 0.592 . . . . 0.0 109.955 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.5 t30 62.67 38.61 11.92 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.154 0.502 . . . . 0.0 109.883 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.13 139.2 46.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -0.854 . . . . 0.0 108.98 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -92.61 132.89 36.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.283 -0.886 . . . . 0.0 110.173 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -87.01 132.03 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.456 -0.778 . . . . 0.0 109.828 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.85 155.23 48.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.301 -0.874 . . . . 0.0 109.509 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -120.78 120.27 35.13 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -123.37 132.51 54.0 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.495 0.664 . . . . 0.0 109.602 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 55.84 32.02 18.81 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.42 0.628 . . . . 0.0 109.804 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.54 4.93 81.86 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -112.48 136.23 52.24 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.39 -1.065 . . . . 0.0 109.828 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.42 148.44 37.31 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.694 0.759 . . . . 0.0 110.77 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.0 t -156.25 154.44 30.71 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.5 mt -100.38 127.43 46.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.229 -0.92 . . . . 0.0 109.296 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 m -106.06 124.19 49.18 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.466 0.65 . . . . 0.0 109.354 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.4 t -96.8 112.43 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.291 -0.881 . . . . 0.0 108.919 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.92 178.44 43.71 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.14 -21.16 62.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.653 -0.91 . . . . 0.0 110.254 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.3 p -85.72 -5.44 59.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.167 -0.958 . . . . 0.0 109.28 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.1 p -79.03 167.6 20.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.447 -0.783 . . . . 0.0 109.883 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -131.45 141.74 49.86 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.421 0.629 . . . . 0.0 109.411 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.05 130.98 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -124.9 138.66 54.24 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.558 0.694 . . . . 0.0 109.443 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.2 m -70.58 150.26 46.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.628 -0.67 . . . . 0.0 110.126 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 51.7 t -113.63 133.15 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.608 0.718 . . . . 0.0 109.438 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.622 ' C ' ' H ' ' A' ' 96' ' ' ASN . 97.5 m-20 49.28 -118.65 1.13 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.753 -0.592 . . . . 0.0 110.528 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.413 ' O ' ' CG1' ' A' ' 95' ' ' VAL . 76.9 t 55.52 -0.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.602 -0.686 . . . . 0.0 109.455 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.622 ' H ' ' C ' ' A' ' 94' ' ' ASN . 23.3 m120 -78.26 176.4 9.32 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.204 -0.935 . . . . 0.0 110.072 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.6 pt -135.87 62.84 49.19 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.26 -5.84 16.61 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 123.154 2.569 . . . . 0.0 111.446 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 100' ' ' GLU . 1.8 tp -46.33 -84.59 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.996 0 O-C-N 121.503 -0.748 . . . . 0.0 111.101 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 99' ' ' LEU . 81.5 tt0 42.2 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.383 -1.448 . . . . 0.0 110.614 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.418 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 93.5 m-70 -65.39 -35.0 79.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.326 -0.859 . . . . 0.0 109.731 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -64.8 144.86 56.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -0.826 . . . . 0.0 110.286 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.418 ' CD2' ' O ' ' A' ' 101' ' ' HIS . 99.1 m-70 -131.67 147.05 52.48 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.636 -0.665 . . . . 0.0 109.71 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -153.43 79.31 1.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.488 -0.758 . . . . 0.0 109.081 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -174.63 37.57 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.961 179.882 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 54.0 t0 -66.74 155.42 38.16 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.652 0.739 . . . . 0.0 110.424 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.487 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 47.3 tp -74.25 124.45 26.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.474 -0.766 . . . . 0.0 110.09 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 m -140.69 167.46 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.731 0.777 . . . . 0.0 110.116 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.18 156.5 29.81 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.732 0.777 . . . . 0.0 110.556 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.28 -43.09 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.715 -0.615 . . . . 0.0 109.881 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -65.34 -19.45 65.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.933 . . . . 0.0 109.855 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -85.82 -2.29 58.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 109.206 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.7 t -66.83 132.9 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.42 -0.8 . . . . 0.0 110.431 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.5 p -156.55 168.22 28.06 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.637 0.732 . . . . 0.0 109.556 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.36 -37.33 85.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.494 -0.754 . . . . 0.0 109.306 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.4 m -55.94 -20.81 17.6 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.367 -0.833 . . . . 0.0 109.548 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 p -113.77 79.57 4.56 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.65 -20.42 35.39 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.572 2.181 . . . . 0.0 112.036 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -128.07 106.18 8.9 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.581 -0.699 . . . . 0.0 109.549 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.4 m -139.2 162.9 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.61 -0.681 . . . . 0.0 110.123 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.9 t -118.33 135.96 54.0 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.3 m -133.41 162.27 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.773 0.797 . . . . 0.0 110.068 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.1 tt -136.64 142.55 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.553 -0.717 . . . . 0.0 109.53 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.65 -167.0 39.72 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.403 -1.379 . . . . 0.0 110.076 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -110.65 133.86 52.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.651 -0.911 . . . . 0.0 109.398 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 63' ' ' SER . 89.0 mt -102.55 132.42 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.254 0.55 . . . . 0.0 109.798 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.487 ' HG1' ' N ' ' A' ' 24' ' ' GLY . 2.4 t -141.7 158.18 44.14 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.723 0.773 . . . . 0.0 109.944 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.487 ' N ' ' HG1' ' A' ' 23' ' ' THR . . . 83.17 53.38 3.48 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.507 ' N ' ' CD1' ' A' ' 25' ' ' ILE . 1.5 mp -78.14 125.6 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.371 -1.076 . . . . 0.0 109.652 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -126.85 124.21 39.07 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -83.28 128.47 34.52 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.664 0.745 . . . . 0.0 110.043 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -141.61 159.38 42.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.448 -0.782 . . . . 0.0 109.122 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -116.93 140.59 49.29 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.698 -0.626 . . . . 0.0 109.688 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 18.3 p90 -137.29 158.74 43.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -90.01 100.76 13.52 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.664 0.745 . . . . 0.0 110.357 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.596 ' O ' ' N ' ' A' ' 34' ' ' GLY . 10.7 t -82.83 -151.18 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.503 -0.748 . . . . 0.0 110.097 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -55.69 77.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.765 0.793 . . . . 0.0 110.217 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 58.3 23.41 53.25 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.8 m -145.89 133.36 20.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.265 -1.138 . . . . 0.0 109.702 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.4 m -79.82 130.65 35.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.3 -0.875 . . . . 0.0 109.805 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.402 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 68.7 mttm -133.48 148.13 51.7 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.815 0.817 . . . . 0.0 110.129 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.8 t -77.52 144.95 37.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.562 -0.712 . . . . 0.0 110.494 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -140.5 137.81 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.378 -0.826 . . . . 0.0 109.579 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -106.35 132.07 52.82 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.444 -0.785 . . . . 0.0 109.277 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -118.27 153.53 33.78 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.595 -0.691 . . . . 0.0 109.694 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.52 -157.13 16.06 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -135.88 146.8 47.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.483 -1.01 . . . . 0.0 109.643 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 tt -122.0 143.33 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -133.76 152.57 51.91 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.634 0.73 . . . . 0.0 110.027 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -147.86 -157.18 0.79 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.609 0.718 . . . . 0.0 109.725 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -80.33 -7.03 58.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.392 -0.817 . . . . 0.0 109.893 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 49' ' ' ALA . 81.5 p -100.91 -68.64 0.8 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.277 -0.89 . . . . 0.0 109.606 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.401 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -159.78 -148.55 0.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.175 -0.953 . . . . 0.0 109.956 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -144.75 152.57 40.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.126 -0.984 . . . . 0.0 110.362 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.0 tt -150.61 147.98 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.224 -0.922 . . . . 0.0 110.222 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -74.22 138.13 43.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.496 -0.752 . . . . 0.0 109.872 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.533 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -133.58 164.48 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.333 -0.855 . . . . 0.0 110.038 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.1 t -142.09 140.43 32.53 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.428 -0.795 . . . . 0.0 109.297 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.6 t -115.59 129.77 56.63 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.452 0.644 . . . . 0.0 109.512 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -97.66 119.38 36.13 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.583 0.706 . . . . 0.0 110.832 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.85 -46.91 1.8 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -73.6 134.81 43.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.284 -1.127 . . . . 0.0 110.603 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -91.56 153.42 19.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.49 -0.756 . . . . 0.0 110.093 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.9 mt -133.0 157.77 44.37 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.463 0.649 . . . . 0.0 109.649 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -103.12 157.11 17.22 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.016 0.913 . . . . 0.0 110.395 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 62' ' ' ASP . 47.4 p30 -76.71 150.39 36.3 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.66 0.743 . . . . 0.0 111.312 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 22' ' ' ILE . 4.2 p 39.02 36.79 0.17 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.31 0.576 . . . . 0.0 110.073 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 47.1 p-10 -98.96 129.89 45.29 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.489 -0.757 . . . . 0.0 110.353 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.8 t -79.07 112.95 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.601 -0.687 . . . . 0.0 109.207 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.23 164.78 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.43 -0.794 . . . . 0.0 110.148 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.6 ttm-85 -119.08 130.12 55.44 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 74.3 mt -105.84 124.84 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.561 -0.712 . . . . 0.0 109.183 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -114.84 142.41 46.59 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.454 0.645 . . . . 0.0 109.714 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.9 t30 63.99 40.35 7.3 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.613 0.721 . . . . 0.0 109.308 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.56 147.02 48.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.603 -0.685 . . . . 0.0 109.829 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -101.97 121.63 42.52 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.6 0.714 . . . . 0.0 109.467 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.16 134.25 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.569 -0.707 . . . . 0.0 110.324 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.37 153.82 45.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.465 -0.772 . . . . 0.0 109.094 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -114.82 114.27 25.33 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.458 -0.776 . . . . 0.0 109.452 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -112.96 126.34 55.37 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.692 0.758 . . . . 0.0 110.187 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 55.73 27.36 10.6 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.321 0.582 . . . . 0.0 110.658 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.84 4.64 84.71 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -112.31 131.04 55.73 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.48 -1.012 . . . . 0.0 109.768 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.02 144.4 40.89 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.747 0.784 . . . . 0.0 110.451 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.7 p -152.89 160.04 43.04 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.9 mt -106.91 131.73 53.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.425 -0.797 . . . . 0.0 109.662 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 t -109.14 125.83 52.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.666 -0.646 . . . . 0.0 109.377 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 t -102.85 100.89 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.488 -0.758 . . . . 0.0 109.011 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.46 176.66 49.96 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -65.92 -29.44 69.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.574 -0.956 . . . . 0.0 109.647 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.4 m -74.79 -7.48 53.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 109.433 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.5 p -80.96 167.84 19.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.319 -0.863 . . . . 0.0 110.273 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -125.7 138.12 53.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.545 -0.722 . . . . 0.0 109.347 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 87.0 mt -125.17 129.96 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.536 -0.727 . . . . 0.0 109.65 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -118.71 113.28 20.92 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.3 t -75.05 150.31 38.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.461 -0.775 . . . . 0.0 110.517 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.6 t -84.66 133.39 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 110.054 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -70.15 143.8 52.19 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.787 0.803 . . . . 0.0 110.716 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.84 147.32 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.83 0.824 . . . . 0.0 110.662 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 96' ' ' ASN . 56.6 p30 -55.81 152.09 10.33 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.808 0.813 . . . . 0.0 110.888 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.5 mt 56.52 71.64 1.13 Allowed Pre-proline 0 N--CA 1.49 1.55 0 CA-C-O 121.212 0.53 . . . . 0.0 110.122 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -61.78 148.16 93.69 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 123.048 2.498 . . . . 0.0 112.526 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.501 ' N ' ' CD1' ' A' ' 99' ' ' LEU . 9.5 mp -86.41 111.31 20.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.313 -0.867 . . . . 0.0 109.545 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -97.6 147.27 24.48 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.582 0.706 . . . . 0.0 110.343 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 51.26 46.51 26.35 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.718 0.77 . . . . 0.0 109.945 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.718 ' HD1' ' HD1' ' A' ' 103' ' ' HIS . 55.2 t-80 -63.13 -43.91 97.05 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.543 -0.723 . . . . 0.0 109.109 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.718 ' HD1' ' HD1' ' A' ' 102' ' ' HIS . 49.0 p-80 -159.26 102.35 1.59 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.407 -0.808 . . . . 0.0 109.646 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -66.4 -43.88 84.57 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.477 -0.765 . . . . 0.0 109.612 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -151.82 162.87 40.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.179 -0.951 . . . . 0.0 110.321 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.452 ' O ' ' CG ' ' A' ' 106' ' ' HIS . 55.8 p-80 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.756 -1.116 . . . . 0.0 109.084 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 121.377 0.608 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -69.85 147.32 50.48 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.764 0.792 . . . . 0.0 110.542 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.2 tt -75.99 129.75 37.37 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.531 0.681 . . . . 0.0 109.957 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.9 m -140.17 163.62 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.934 0.874 . . . . 0.0 110.834 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -72.88 149.59 43.36 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.78 0.8 . . . . 0.0 110.247 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 92.0 mt -63.74 -42.6 96.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -69.65 -17.22 63.49 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.729 -0.607 . . . . 0.0 109.812 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -92.61 6.44 47.3 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.508 -0.745 . . . . 0.0 109.247 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.56 133.2 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.71 0.767 . . . . 0.0 109.947 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.1 p -153.27 166.85 31.27 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.962 0.887 . . . . 0.0 110.324 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.0 mt -73.07 -9.29 58.57 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.6 m -74.44 -14.72 60.88 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.3 p -121.49 84.09 41.66 Favored Pre-proline 0 N--CA 1.499 1.995 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.39 -41.19 74.84 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.613 2.209 . . . . 0.0 111.594 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -116.89 131.92 56.83 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.761 0.791 . . . . 0.0 109.992 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.4 m -149.77 175.71 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 122.273 1.035 . . . . 0.0 110.617 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.441 ' HG ' ' CG ' ' A' ' 69' ' ' ASP . 48.4 m -134.71 137.17 43.29 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -140.21 163.26 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.074 0.94 . . . . 0.0 110.643 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.6 tt -137.93 135.51 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.709 0.766 . . . . 0.0 109.893 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.29 -168.47 40.97 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -110.95 136.29 50.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.941 -0.741 . . . . 0.0 109.489 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.506 ' N ' ' CD1' ' A' ' 22' ' ' ILE . 2.4 mp -96.33 133.32 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.406 0.622 . . . . 0.0 109.714 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 t -136.07 159.78 40.65 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.75 0.786 . . . . 0.0 109.929 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 25' ' ' ILE . . . 99.63 -69.29 0.54 Allowed Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 24' ' ' GLY . 25.8 mm 59.11 128.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.844 0.83 . . . . 0.0 110.592 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.69 ' HD1' ' H ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -149.74 138.62 21.03 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.437 0.637 . . . . 0.0 109.358 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.69 ' H ' ' HD1' ' A' ' 26' ' ' HIS . 88.7 tttt -106.0 129.13 54.18 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.002 0.906 . . . . 0.0 110.175 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -141.09 157.41 45.34 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.736 0.779 . . . . 0.0 110.074 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 56.5 mp0 -113.99 142.8 45.71 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.806 0.812 . . . . 0.0 110.243 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 31.7 p90 -143.66 161.96 37.19 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.598 0.713 . . . . 0.0 109.485 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -94.19 107.0 18.97 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.751 0.786 . . . . 0.0 110.388 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 34' ' ' GLY . 4.4 p -88.19 -161.54 0.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -52.18 80.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.597 0.713 . . . . 0.0 110.259 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 59.94 11.0 16.05 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.421 ' O ' ' OG ' ' A' ' 32' ' ' SER . 92.8 m -131.86 131.21 42.59 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.863 0.84 . . . . 0.0 110.791 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.2 m -79.48 128.32 33.22 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.55 0.69 . . . . 0.0 109.192 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.451 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 98.6 mttt -136.13 147.83 47.94 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.885 0.85 . . . . 0.0 110.15 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 87.5 p -82.03 149.91 27.86 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.846 0.831 . . . . 0.0 110.019 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -130.64 133.94 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.835 0.826 . . . . 0.0 109.836 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -98.2 133.36 42.74 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -130.62 150.82 51.64 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.742 0.782 . . . . 0.0 109.829 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.72 -169.43 35.31 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -122.24 139.62 53.57 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.622 0.725 . . . . 0.0 109.699 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.2 tt -113.08 136.43 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -121.5 149.79 42.55 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.948 0.88 . . . . 0.0 110.361 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 38.3 t0 -148.8 -164.57 2.05 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.62 0.724 . . . . 0.0 109.479 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.541 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 48.9 t0 -65.04 -38.59 91.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.609 -0.682 . . . . 0.0 109.825 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.1 p -73.22 -85.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.263 0.554 . . . . 0.0 109.712 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -143.49 -142.26 0.13 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.643 0.735 . . . . 0.0 109.971 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.7 ptt85 -148.96 158.32 44.09 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.758 0.79 . . . . 0.0 110.042 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.2 tt -152.65 158.94 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 122.033 0.921 . . . . 0.0 110.631 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.541 ' NH2' ' CG ' ' A' ' 76' ' ' PHE . 51.2 ttp180 -74.47 143.47 44.63 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.705 0.764 . . . . 0.0 110.107 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 pt -133.38 161.39 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.732 0.777 . . . . 0.0 110.327 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.0 m -144.76 138.93 27.5 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.747 0.784 . . . . 0.0 110.19 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 p -134.57 135.55 42.34 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.87 0.843 . . . . 0.0 109.579 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.498 ' C ' ' H ' ' A' ' 58' ' ' LYS . 88.0 m-85 -94.4 124.85 38.67 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.752 0.787 . . . . 0.0 110.796 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.57 -38.56 0.48 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.498 ' H ' ' C ' ' A' ' 56' ' ' PHE . 72.2 mmtt -68.42 133.66 49.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.66 -0.906 . . . . 0.0 110.001 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -97.71 148.49 23.29 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.765 0.793 . . . . 0.0 110.341 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.8 mt -129.94 152.78 49.04 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.568 0.699 . . . . 0.0 109.696 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -115.79 158.38 22.96 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.225 1.012 . . . . 0.0 110.421 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.9 t0 -62.01 138.19 58.34 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.815 0.817 . . . . 0.0 110.873 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.523 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 10.9 t 52.33 31.01 8.77 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.269 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -78.24 112.06 14.84 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.571 -0.705 . . . . 0.0 110.372 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 t -81.2 105.76 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.663 0.744 . . . . 0.0 109.281 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.7 m -140.99 164.65 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.647 0.736 . . . . 0.0 110.113 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.8 ttp85 -115.21 127.83 55.77 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.759 0.79 . . . . 0.0 109.582 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.3 mt -108.39 130.62 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.608 0.718 . . . . 0.0 109.844 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 67.8 t0 -125.32 142.44 51.5 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.556 0.693 . . . . 0.0 109.902 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.55 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 52.6 t30 71.92 35.09 1.39 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.387 0.613 . . . . 0.0 109.949 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.14 141.54 43.68 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.394 0.616 . . . . 0.0 110.407 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -95.17 128.37 41.95 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.755 0.788 . . . . 0.0 109.893 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.8 t -80.64 132.4 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 121.679 0.752 . . . . 0.0 110.179 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -117.92 146.19 44.13 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.744 0.783 . . . . 0.0 109.549 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -108.47 97.64 7.28 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.525 0.679 . . . . 0.0 109.454 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.633 ' O ' ' N ' ' A' ' 78' ' ' GLY . 28.4 m-85 -82.83 -177.88 6.9 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.409 0.624 . . . . 0.0 110.55 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -51.94 75.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.499 0.666 . . . . 0.0 110.493 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 76' ' ' PHE . . . 74.71 15.56 80.64 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -130.62 144.62 51.55 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.565 -0.962 . . . . 0.0 110.395 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.5 mt -103.1 140.35 37.43 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.859 0.838 . . . . 0.0 110.126 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 96.3 p -152.53 163.52 39.41 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.701 0.763 . . . . 0.0 109.854 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.7 mt -106.07 131.03 53.83 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.651 0.739 . . . . 0.0 110.176 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.2 p -107.67 123.97 49.29 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.838 0.828 . . . . 0.0 109.761 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.2 t -100.41 112.26 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.854 0.835 . . . . 0.0 109.6 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -97.19 -179.26 34.22 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -66.11 -29.14 69.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.914 -0.756 . . . . 0.0 109.736 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 89.4 p -78.67 -4.91 51.42 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.8 t -80.39 167.65 19.95 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.467 0.651 . . . . 0.0 110.087 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 24.7 mmt85 -124.96 137.79 54.25 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.716 0.77 . . . . 0.0 109.953 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.8 mt -127.19 130.47 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.511 0.672 . . . . 0.0 110.386 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -124.59 125.76 44.68 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.78 0.8 . . . . 0.0 109.402 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.2 p -75.73 152.95 37.35 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.714 0.768 . . . . 0.0 110.433 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 64.2 t -143.16 98.31 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.566 0.698 . . . . 0.0 109.399 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -87.23 106.81 18.16 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.594 0.711 . . . . 0.0 109.377 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.418 ' O ' ' CG ' ' A' ' 96' ' ' ASN . 97.0 t -93.8 -85.38 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 95' ' ' VAL . 21.3 p30 43.16 45.72 4.86 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.335 0.588 . . . . 0.0 109.677 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.2 mt 52.88 74.5 0.77 Allowed Pre-proline 0 N--CA 1.495 1.779 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.26 143.47 28.3 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.608 2.206 . . . . 0.0 113.25 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.31 16.29 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -164.23 126.03 2.3 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.639 0.733 . . . . 0.0 109.629 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.463 ' CG ' ' O ' ' A' ' 101' ' ' HIS . 53.3 t-80 52.32 36.79 20.6 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.41 0.624 . . . . 0.0 109.86 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -65.87 -41.98 90.93 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -79.6 141.16 36.81 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.747 0.784 . . . . 0.0 110.105 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -135.22 10.68 3.53 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.52 ' CG ' ' N ' ' A' ' 106' ' ' HIS . 52.9 p-80 -67.04 -43.31 83.07 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.583 -0.698 . . . . 0.0 109.841 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.52 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 86.2 t60 . . . . . 0 N--CA 1.499 1.985 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.826 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.8 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.61 0.719 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 55.4 t0 -74.56 152.21 39.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 0.0 110.552 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.54 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 43.2 tp -77.6 123.24 26.37 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.425 -0.797 . . . . 0.0 109.744 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.1 m -140.28 165.03 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.385 -0.822 . . . . 0.0 110.067 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.6 157.56 31.84 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.81 0.814 . . . . 0.0 110.492 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.457 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 2.3 mp -63.97 -42.72 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.619 -0.676 . . . . 0.0 109.256 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -64.25 -24.15 67.56 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.239 -0.913 . . . . 0.0 109.557 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -83.21 -0.16 48.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.952 -1.093 . . . . 0.0 109.496 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.2 131.99 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.074 -1.016 . . . . 0.0 110.562 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.3 p -158.99 167.37 29.54 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.55 -0.719 . . . . 0.0 109.331 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.19 -19.54 66.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.89 . . . . 0.0 108.888 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -63.86 -17.24 62.97 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.318 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.6 p -124.36 82.02 58.38 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.318 -0.864 . . . . 0.0 109.231 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.32 -41.42 66.53 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.958 2.439 . . . . 0.0 112.151 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.415 ' HH ' HH12 ' A' ' 72' ' ' ARG . 74.8 m-85 -119.28 128.1 53.84 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.422 -0.799 . . . . 0.0 109.814 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.6 m -147.17 161.11 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.256 -0.903 . . . . 0.0 110.116 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.5 m -115.46 134.17 55.34 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.69 162.38 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.873 0.844 . . . . 0.0 110.324 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.0 tt -140.49 137.98 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.428 -0.795 . . . . 0.0 109.524 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.45 -162.91 29.41 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -111.58 128.81 56.15 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.58 -0.953 . . . . 0.0 109.359 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.546 ' N ' ' CD1' ' A' ' 22' ' ' ILE . 1.8 mp -94.53 125.74 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.533 0.682 . . . . 0.0 109.737 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.7 p -132.7 159.29 40.06 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.836 0.827 . . . . 0.0 110.091 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.9 82.02 0.19 Allowed Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.4 mm -92.1 129.81 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.092 -1.24 . . . . 0.0 110.267 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -133.73 139.1 46.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.534 -0.729 . . . . 0.0 109.132 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -103.28 136.45 43.03 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.766 0.793 . . . . 0.0 109.917 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.593 ' NZ ' ' NH2' ' A' ' 52' ' ' ARG . 53.1 mtmt -144.25 160.24 41.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.488 -0.757 . . . . 0.0 109.317 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -122.11 144.73 48.75 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.626 0.727 . . . . 0.0 109.701 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -142.63 160.92 39.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 109.289 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -93.98 116.23 28.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.293 -0.879 . . . . 0.0 109.889 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 t -109.23 110.2 21.34 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.822 0.82 . . . . 0.0 109.362 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 53.34 33.6 16.07 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.57 0.7 . . . . 0.0 110.722 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.27 -2.01 77.73 Favored Glycine 0 N--CA 1.496 2.643 0 O-C-N 120.962 -1.086 . . . . 0.0 111.047 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.7 p -115.95 125.22 52.25 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.089 -1.242 . . . . 0.0 109.928 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.1 m -69.6 133.42 47.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.55 -0.719 . . . . 0.0 110.094 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -136.71 144.94 44.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.367 -0.833 . . . . 0.0 109.889 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.4 m -83.25 144.83 29.48 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.771 0.796 . . . . 0.0 110.311 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.2 p -140.51 137.81 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.898 . . . . 0.0 108.85 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -102.1 135.29 43.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.436 -0.79 . . . . 0.0 109.495 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.606 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 1.1 mp0 -117.05 152.12 35.35 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.631 0.729 . . . . 0.0 109.176 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.34 -171.86 35.43 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -130.49 139.05 50.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.481 -1.011 . . . . 0.0 109.271 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.2 tt -114.62 130.9 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -123.6 151.56 42.83 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.655 0.741 . . . . 0.0 109.932 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.573 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 30.7 t0 -155.72 -161.87 1.23 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.489 -0.757 . . . . 0.0 109.673 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.573 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 95.8 m-20 -74.26 -3.48 30.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.283 -0.886 . . . . 0.0 110.383 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.504 ' OG1' ' N ' ' A' ' 49' ' ' ALA . 8.1 p -101.15 -62.46 1.24 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.849 -1.157 . . . . 0.0 109.323 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.504 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -171.29 -150.51 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.96 -1.087 . . . . 0.0 110.364 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -135.32 145.63 47.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.514 -0.741 . . . . 0.0 109.894 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.2 tt -150.2 150.2 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.166 -0.959 . . . . 0.0 110.025 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.593 ' NH2' ' NZ ' ' A' ' 28' ' ' LYS . 72.9 ttt180 -73.01 146.55 45.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.457 -0.777 . . . . 0.0 110.383 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.6 pt -132.3 158.6 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.455 -0.778 . . . . 0.0 109.744 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.8 m -143.72 126.54 16.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.178 -0.951 . . . . 0.0 109.073 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.4 t -114.13 128.31 56.32 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.566 -0.709 . . . . 0.0 109.357 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -95.38 121.41 37.02 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.738 0.78 . . . . 0.0 110.95 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.19 -47.72 3.22 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -82.59 135.14 35.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.287 . . . . 0.0 110.674 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.573 ' H ' ' CD ' ' A' ' 59' ' ' GLN . 1.8 pm0 -89.98 165.71 13.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.679 -0.638 . . . . 0.0 110.119 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.6 mt -124.03 158.43 32.15 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.547 0.689 . . . . 0.0 109.478 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -107.51 133.46 51.95 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.376 1.084 . . . . 0.0 109.889 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 63' ' ' SER . 66.2 t0 -60.86 142.79 55.9 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.986 0.898 . . . . 0.0 111.304 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.555 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 2.0 m 50.98 29.57 4.61 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.496 0.665 . . . . 0.0 110.171 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -94.48 129.31 41.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.064 -1.022 . . . . 0.0 110.807 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.6 t -89.55 111.36 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.34 -0.85 . . . . 0.0 108.8 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.27 166.27 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.216 -0.928 . . . . 0.0 110.318 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -118.58 127.11 53.3 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.2 mt -107.01 127.69 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.257 -0.902 . . . . 0.0 109.435 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -111.17 145.46 38.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.699 -0.626 . . . . 0.0 109.72 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.6 t30 63.39 38.68 9.92 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.851 0.834 . . . . 0.0 109.401 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.82 134.94 41.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.812 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.415 HH12 ' HH ' ' A' ' 15' ' ' TYR . 60.5 ttt85 -88.06 136.96 32.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.414 -0.804 . . . . 0.0 110.237 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.0 t -96.62 132.7 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -0.856 . . . . 0.0 109.487 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.7 155.03 48.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 109.394 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -117.87 115.94 25.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.612 -0.68 . . . . 0.0 109.197 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -125.2 134.74 52.25 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.703 0.764 . . . . 0.0 109.812 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.6 m120 56.28 29.68 15.37 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.731 0.777 . . . . 0.0 109.974 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.29 7.84 85.11 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -114.42 134.59 54.88 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.435 -1.038 . . . . 0.0 109.92 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.7 mt -79.91 143.17 34.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.4 -0.813 . . . . 0.0 110.093 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.5 m -151.71 158.67 43.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 109.289 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.2 mt -104.19 127.54 51.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.393 -0.817 . . . . 0.0 109.328 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -107.07 125.43 51.03 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.648 0.737 . . . . 0.0 109.541 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 t -98.43 111.85 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.411 -0.806 . . . . 0.0 109.416 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.07 -179.32 42.97 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 87' ' ' SER . 47.4 p30 -70.89 -18.17 62.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.448 -1.031 . . . . 0.0 109.484 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.509 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 98.7 p -85.33 -7.89 58.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.152 -0.968 . . . . 0.0 109.487 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 m -80.93 165.7 21.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.103 -0.998 . . . . 0.0 110.336 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 24.9 tpt85 -127.66 133.56 49.63 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.549 0.69 . . . . 0.0 109.542 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -114.97 129.62 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.582 -0.699 . . . . 0.0 109.703 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -123.35 117.62 25.64 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.775 0.797 . . . . 0.0 109.067 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 73.6 m -77.36 147.18 36.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.549 -0.72 . . . . 0.0 110.368 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 66.4 t -139.56 82.41 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.029 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -167.83 -32.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.1 t -117.63 132.48 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 121.941 0.877 . . . . 0.0 109.67 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -143.67 89.29 2.05 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.7 mt -145.64 60.31 6.54 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.144 -0.973 . . . . 0.0 109.433 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.97 152.29 80.59 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.519 2.146 . . . . 0.0 112.154 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.6 tp -84.62 -2.23 57.15 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 109.244 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.66 148.47 7.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 110.264 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -80.01 -11.55 59.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.159 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -71.73 129.28 38.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.128 -0.982 . . . . 0.0 110.012 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -70.68 137.34 49.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.408 -0.808 . . . . 0.0 110.789 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -82.11 146.85 29.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.508 -0.745 . . . . 0.0 110.101 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -127.12 129.28 47.62 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.584 0.707 . . . . 0.0 109.655 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.784 -179.884 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 67.0 t0 -65.2 145.27 56.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.572 -0.705 . . . . 0.0 110.318 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.541 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 35.6 tp -71.75 130.23 40.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.554 -0.716 . . . . 0.0 109.782 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.18 164.5 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.417 -0.802 . . . . 0.0 109.648 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -80.29 159.1 25.95 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.608 -0.683 . . . . 0.0 110.569 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.509 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 1.4 mp -63.42 -45.49 97.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.626 -0.671 . . . . 0.0 109.255 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -63.43 -20.31 65.45 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.512 -0.743 . . . . 0.0 109.841 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 8' ' ' ASP . 53.2 t0 -87.44 -2.8 58.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.377 -0.827 . . . . 0.0 109.529 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.0 t -70.04 132.65 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -0.938 . . . . 0.0 110.144 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.7 m -158.24 172.59 18.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.478 -0.764 . . . . 0.0 109.555 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.33 -38.95 93.15 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.427 -0.796 . . . . 0.0 109.652 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.5 t -55.0 -17.13 3.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.388 -0.82 . . . . 0.0 109.8 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.416 ' O ' ' OG1' ' A' ' 13' ' ' THR . 7.4 p -114.37 79.59 5.37 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.462 -0.774 . . . . 0.0 109.113 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.92 -20.63 29.15 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.229 1.953 . . . . 0.0 112.324 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -131.71 110.06 10.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.537 -0.727 . . . . 0.0 109.299 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.9 m -142.21 163.97 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.359 -0.838 . . . . 0.0 110.306 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.3 t -113.0 141.52 46.75 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.2 t -135.33 155.98 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.239 -0.913 . . . . 0.0 109.775 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.0 tt -140.13 132.76 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.329 -0.857 . . . . 0.0 109.384 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.61 -160.51 30.78 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 118.909 -1.615 . . . . 0.0 110.366 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -111.83 136.82 50.62 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.796 -0.826 . . . . 0.0 109.638 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 63' ' ' SER . 92.9 mt -103.5 130.75 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.474 -0.766 . . . . 0.0 109.636 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.4 p -134.86 159.53 41.1 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.508 -0.745 . . . . 0.0 109.787 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.84 78.13 0.39 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.5 mm -95.08 123.37 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.189 -1.183 . . . . 0.0 109.366 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -115.81 137.98 51.57 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -101.61 129.78 47.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.524 -0.735 . . . . 0.0 109.594 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -144.25 161.07 39.85 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.5 137.05 55.0 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.326 -0.859 . . . . 0.0 109.779 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -130.15 153.8 48.17 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.549 ' N ' ' OE1' ' A' ' 31' ' ' GLU . 58.1 mp0 -88.32 136.42 32.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -0.909 . . . . 0.0 109.731 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.7 t -137.03 109.72 7.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.498 -0.751 . . . . 0.0 109.166 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 54.2 t0 58.69 32.04 21.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.523 -0.736 . . . . 0.0 110.134 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.66 11.27 83.2 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.1 m -121.0 130.17 53.69 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.602 -0.94 . . . . 0.0 109.305 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.3 m -80.68 130.44 35.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 109.661 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -132.8 140.54 48.05 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.383 -0.823 . . . . 0.0 109.675 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.2 t -79.86 142.27 35.38 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.385 -0.822 . . . . 0.0 109.701 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 p -133.43 136.53 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -102.08 139.04 38.24 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.469 -0.769 . . . . 0.0 109.359 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -135.79 153.91 51.38 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.391 -0.818 . . . . 0.0 109.779 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.54 -150.37 7.93 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.564 ' HH ' ' NH1' ' A' ' 52' ' ' ARG . 89.4 m-85 -134.77 143.51 47.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.588 -0.948 . . . . 0.0 109.511 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.6 tt -120.94 134.83 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -117.6 148.34 42.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.665 -0.647 . . . . 0.0 109.746 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -136.71 -164.82 1.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -72.15 -19.1 61.82 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.517 -0.739 . . . . 0.0 109.462 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.9 m -93.67 -76.35 0.48 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.28 -0.888 . . . . 0.0 110.087 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.89 -148.68 0.25 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.388 -0.82 . . . . 0.0 109.925 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -144.53 157.01 44.42 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.351 -0.843 . . . . 0.0 110.069 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.2 tt -151.46 157.28 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.24 -0.912 . . . . 0.0 110.011 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.564 ' NH1' ' HH ' ' A' ' 43' ' ' TYR . 60.0 ttt85 -78.8 141.43 37.77 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.469 -0.769 . . . . 0.0 109.531 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.537 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -133.77 164.55 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.558 -0.714 . . . . 0.0 109.744 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.7 p -141.63 151.27 42.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 t -136.51 133.47 36.54 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.436 -0.79 . . . . 0.0 109.114 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -94.4 123.39 37.78 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.303 -0.873 . . . . 0.0 110.922 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.47 -57.41 2.03 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -61.07 130.6 47.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -1.184 . . . . 0.0 110.071 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -84.03 158.0 21.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.456 -0.777 . . . . 0.0 109.82 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.3 mt -120.67 153.22 37.19 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -115.75 130.66 56.93 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.833 0.825 . . . . 0.0 109.507 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 54.8 p-10 -66.28 142.99 57.48 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 110.835 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 22' ' ' ILE . 1.5 m 65.87 4.06 2.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.955 -0.466 . . . . 0.0 110.946 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 21.1 p-10 -81.47 136.27 35.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.632 -1.292 . . . . 0.0 110.154 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 t -95.6 113.29 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.166 -0.959 . . . . 0.0 108.841 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.6 m -139.24 165.53 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.746 0.784 . . . . 0.0 110.23 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -117.78 133.0 56.38 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.9 mt -106.17 129.55 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.511 -0.743 . . . . 0.0 109.137 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -111.36 143.28 42.42 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.638 -0.664 . . . . 0.0 109.538 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.2 t30 60.88 39.42 16.89 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.194 0.521 . . . . 0.0 109.834 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.58 146.47 50.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 0.0 108.969 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -99.99 121.03 40.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.595 -0.691 . . . . 0.0 109.748 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.1 t -83.79 133.91 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.463 -0.773 . . . . 0.0 109.763 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.24 155.19 45.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.249 -0.907 . . . . 0.0 109.326 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -114.12 119.49 37.29 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.534 -0.729 . . . . 0.0 109.29 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -124.42 135.37 53.21 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.617 -0.677 . . . . 0.0 109.614 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.1 m120 54.61 31.69 15.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.703 -0.623 . . . . 0.0 109.58 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.55 10.84 82.85 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -120.37 139.52 52.67 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.471 -1.017 . . . . 0.0 110.113 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.463 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 4.0 mm? -76.84 144.26 39.16 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.825 0.822 . . . . 0.0 110.546 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.9 m -150.92 152.54 33.77 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.2 mt -103.94 128.65 51.47 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.33 -0.856 . . . . 0.0 108.845 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.2 t -109.83 125.92 53.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.642 -0.661 . . . . 0.0 109.491 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.2 t -99.58 109.44 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.32 -177.05 38.94 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.89 -31.71 72.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.725 -0.868 . . . . 0.0 109.765 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.9 m -76.43 -5.76 48.77 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.277 -0.889 . . . . 0.0 109.496 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.6 t -85.09 165.35 17.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.499 -0.751 . . . . 0.0 109.428 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -134.06 137.46 44.66 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.542 -0.724 . . . . 0.0 109.459 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.429 HG21 HD12 ' A' ' 90' ' ' ILE . 96.7 mt -116.05 131.18 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -118.32 130.57 56.1 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.9 p -71.85 152.13 42.88 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.518 -0.739 . . . . 0.0 109.697 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.525 ' C ' ' H ' ' A' ' 95' ' ' VAL . 54.1 t -125.74 133.82 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.524 -0.735 . . . . 0.0 109.628 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.4 t30 68.72 -36.72 0.33 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.811 -0.556 . . . . 0.0 110.22 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.525 ' H ' ' C ' ' A' ' 93' ' ' VAL . 55.4 t -113.91 130.71 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.395 -0.816 . . . . 0.0 109.789 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -159.92 78.79 0.69 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.0 mt -145.78 77.02 12.52 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.359 -0.838 . . . . 0.0 109.053 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -58.97 145.22 98.18 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.81 2.34 . . . . 0.0 112.576 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.4 mt 39.11 -122.28 0.32 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.416 0.627 . . . . 0.0 110.749 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 56.48 44.0 24.98 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -66.1 -43.5 87.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.533 -0.73 . . . . 0.0 110.177 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -109.54 115.08 29.25 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.442 -0.787 . . . . 0.0 109.677 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.548 ' HD1' ' H ' ' A' ' 104' ' ' HIS . 8.1 p80 -88.29 -115.06 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.552 -0.717 . . . . 0.0 109.805 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.548 ' H ' ' HD1' ' A' ' 103' ' ' HIS . 75.8 m80 -67.19 -40.12 86.48 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.536 -0.727 . . . . 0.0 109.527 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.524 ' O ' ' CG ' ' A' ' 106' ' ' HIS . 86.0 t60 41.94 -100.46 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.664 -0.648 . . . . 0.0 110.384 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' A' ' 105' ' ' HIS . 78.3 m80 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.521 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -71.55 149.72 45.44 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.677 0.751 . . . . 0.0 110.087 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.2 tp -71.61 127.38 32.39 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.726 0.774 . . . . 0.0 110.074 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.57 163.93 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.882 0.848 . . . . 0.0 110.381 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.557 ' N ' ' OD2' ' A' ' 8' ' ' ASP . 63.5 mttp -76.89 148.26 36.54 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.856 0.836 . . . . 0.0 110.222 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.9 mm -59.72 -39.4 79.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.454 0.645 . . . . 0.0 109.786 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -62.7 -33.53 75.27 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.67 -0.644 . . . . 0.0 110.369 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.557 ' OD2' ' N ' ' A' ' 5' ' ' LYS . 7.5 p30 -83.32 12.39 5.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.476 -0.765 . . . . 0.0 110.269 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.9 t -71.4 130.2 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.737 0.779 . . . . 0.0 109.743 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.9 p -159.23 165.31 33.87 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.887 0.851 . . . . 0.0 109.983 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.2 mt -62.96 -30.2 71.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.662 -0.649 . . . . 0.0 109.487 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.9 m -52.8 -21.32 4.03 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 13' ' ' THR . 2.4 p -112.05 95.14 28.33 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.68 -18.85 19.26 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.701 2.267 . . . . 0.0 111.411 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -142.39 123.72 14.75 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.573 0.702 . . . . 0.0 109.601 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.5 m -153.74 173.24 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.897 0.856 . . . . 0.0 110.436 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.1 m -128.41 149.43 50.55 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.65 0.738 . . . . 0.0 109.575 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.83 159.17 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.946 0.879 . . . . 0.0 110.403 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.491 ' CD1' ' HE ' ' A' ' 67' ' ' ARG . 97.0 mt -135.92 133.45 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.599 0.714 . . . . 0.0 109.894 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.52 -158.51 25.79 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' O ' ' OE2' ' A' ' 45' ' ' GLU . 36.8 ttpt -112.98 130.51 56.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.624 -0.927 . . . . 0.0 110.194 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.459 ' C ' ' HG1' ' A' ' 23' ' ' THR . 94.6 mt -99.61 133.1 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.404 0.621 . . . . 0.0 109.65 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.459 ' HG1' ' C ' ' A' ' 22' ' ' ILE . 9.5 m -146.0 147.32 31.54 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.806 0.812 . . . . 0.0 110.205 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.42 76.28 1.22 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.476 ' N ' ' CD1' ' A' ' 25' ' ' ILE . 1.4 mp -94.59 115.18 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.647 -0.914 . . . . 0.0 109.865 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -111.55 121.92 46.44 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.573 0.702 . . . . 0.0 109.286 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -88.85 133.33 34.31 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.892 0.853 . . . . 0.0 110.215 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -148.2 151.48 35.59 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.488 0.661 . . . . 0.0 109.341 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 57.7 mp0 -111.8 140.61 46.29 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.831 0.824 . . . . 0.0 110.421 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.472 ' OH ' ' CD1' ' A' ' 56' ' ' PHE . 6.6 p90 -141.5 159.68 41.71 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.757 0.789 . . . . 0.0 109.708 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -91.23 95.93 10.3 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.765 0.793 . . . . 0.0 109.527 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.621 ' O ' ' N ' ' A' ' 34' ' ' GLY . 2.5 t -77.17 -149.5 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.263 0.554 . . . . 0.0 110.169 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -54.11 75.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.732 0.777 . . . . 0.0 110.402 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.621 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 58.83 24.85 58.24 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 t -147.49 141.01 25.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.631 -0.923 . . . . 0.0 109.661 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.8 m -88.61 125.85 35.01 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.682 0.753 . . . . 0.0 110.126 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -136.59 147.31 46.9 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.837 0.827 . . . . 0.0 109.734 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.9 t -81.62 145.01 30.82 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.676 0.75 . . . . 0.0 110.077 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 p -132.89 136.02 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.749 0.785 . . . . 0.0 109.662 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -104.86 130.23 53.03 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.584 0.707 . . . . 0.0 109.183 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -121.86 144.63 48.73 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.831 0.824 . . . . 0.0 109.927 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.54 -171.57 34.51 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -119.69 144.11 47.38 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.97 0.891 . . . . 0.0 110.396 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.68 136.96 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 21' ' ' LYS . 2.4 pm0 -125.31 154.93 41.02 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.037 0.922 . . . . 0.0 110.422 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.561 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 29.5 t0 -143.12 -156.56 0.69 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.507 0.67 . . . . 0.0 109.51 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.561 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 98.5 m-20 -73.82 -19.93 60.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.661 -0.649 . . . . 0.0 109.569 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 41.4 p -94.11 -88.5 0.24 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.584 -0.698 . . . . 0.0 109.486 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.79 -146.09 0.23 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.5 -0.75 . . . . 0.0 110.185 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -148.2 158.42 44.07 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.707 0.765 . . . . 0.0 110.482 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.2 tt -151.02 160.3 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-O 121.935 0.874 . . . . 0.0 110.477 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.8 ttp85 -78.82 145.01 34.51 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.832 0.825 . . . . 0.0 110.621 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.6 pt -131.27 159.6 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.634 0.73 . . . . 0.0 109.816 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.2 m -143.63 118.77 10.11 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.643 0.735 . . . . 0.0 109.695 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.4 p -109.35 142.4 40.34 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.838 0.828 . . . . 0.0 109.79 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.546 ' C ' ' H ' ' A' ' 58' ' ' LYS . 76.1 m-85 -102.72 117.36 34.47 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.64 0.733 . . . . 0.0 110.845 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.25 -31.48 0.26 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.546 ' H ' ' C ' ' A' ' 56' ' ' PHE . 13.9 tptp -66.55 129.94 41.52 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.684 -0.892 . . . . 0.0 110.915 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -83.71 138.0 33.5 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.85 0.833 . . . . 0.0 110.761 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.2 mt -128.47 150.73 50.02 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -109.53 143.66 38.87 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.762 0.792 . . . . 0.0 110.134 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -67.11 137.95 56.72 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.884 0.849 . . . . 0.0 110.182 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.41 ' H ' ' HA ' ' A' ' 23' ' ' THR . 7.3 t 51.68 80.64 0.08 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.725 0.774 . . . . 0.0 109.396 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -153.26 121.83 6.34 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.723 0.773 . . . . 0.0 110.151 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.8 m -74.1 119.46 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.915 0.864 . . . . 0.0 109.487 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.2 m -141.04 167.93 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-O 122.479 1.133 . . . . 0.0 110.242 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.491 ' HE ' ' CD1' ' A' ' 19' ' ' ILE . 39.2 ttm180 -113.76 126.28 55.04 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.031 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 94.0 mt -106.04 118.34 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.638 0.733 . . . . 0.0 109.484 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -122.03 151.43 40.84 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.917 0.865 . . . . 0.0 110.123 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 61.48 37.01 16.84 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.794 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -92.27 147.21 23.1 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.602 -0.687 . . . . 0.0 109.454 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -103.64 153.18 20.91 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.26 1.029 . . . . 0.0 110.839 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.26 132.61 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.738 0.78 . . . . 0.0 109.548 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.26 155.48 43.87 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.758 0.79 . . . . 0.0 110.038 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -112.6 119.21 37.36 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.613 0.72 . . . . 0.0 109.318 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -121.53 132.76 54.88 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.813 0.816 . . . . 0.0 109.881 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 58.04 23.0 9.52 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.334 0.588 . . . . 0.0 109.979 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.91 6.84 81.85 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -117.53 136.64 53.1 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.509 -0.995 . . . . 0.0 110.254 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.7 mt -75.58 145.19 41.39 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.711 0.767 . . . . 0.0 110.181 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 93.9 p -156.9 160.21 38.89 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.626 0.727 . . . . 0.0 109.914 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.7 mt -104.92 108.76 20.43 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.796 0.807 . . . . 0.0 109.082 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.8 m -88.93 141.21 28.68 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.745 0.783 . . . . 0.0 109.748 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.404 ' CG1' ' OG ' ' A' ' 88' ' ' SER . 41.5 t -121.85 126.87 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.871 0.843 . . . . 0.0 109.7 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.66 173.35 25.81 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.29 -17.97 63.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.777 -0.837 . . . . 0.0 109.029 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.0 m -84.55 -5.76 59.32 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.404 ' OG ' ' CG1' ' A' ' 84' ' ' VAL . 13.5 p -76.87 168.97 19.17 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.599 0.714 . . . . 0.0 110.309 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.415 ' NH2' ' OE2' ' A' ' 91' ' ' GLU . 77.6 ttt180 -121.87 123.53 41.97 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.855 0.836 . . . . 0.0 109.856 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.4 mt -124.22 129.04 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.654 0.74 . . . . 0.0 109.746 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.415 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 97.7 mt-10 -126.03 123.12 37.74 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.797 0.808 . . . . 0.0 110.005 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.6 t -74.17 144.12 44.95 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.309 0.576 . . . . 0.0 109.713 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.2 m -114.21 131.87 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-O 121.929 0.871 . . . . 0.0 110.254 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -75.59 167.53 21.73 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.789 0.804 . . . . 0.0 110.359 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 43.4 t 53.36 -101.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.801 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -162.96 88.17 0.6 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.685 0.755 . . . . 0.0 109.311 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 62.9 mt 49.62 77.52 0.46 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.874 -0.516 . . . . 0.0 110.141 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -59.67 146.75 94.54 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.501 2.134 . . . . 0.0 112.248 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.8 132.58 49.9 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.852 0.834 . . . . 0.0 110.322 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -67.07 134.71 52.4 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.621 0.724 . . . . 0.0 110.118 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -151.8 133.19 14.58 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.659 0.742 . . . . 0.0 109.882 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -146.11 91.16 2.04 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.71 0.767 . . . . 0.0 109.278 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.506 ' CG ' ' N ' ' A' ' 104' ' ' HIS . 86.4 t60 -155.65 165.27 37.05 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.742 0.782 . . . . 0.0 109.959 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.506 ' N ' ' CG ' ' A' ' 103' ' ' HIS . 85.9 t60 47.78 82.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.534 0.683 . . . . 0.0 109.903 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.423 ' O ' ' O ' ' A' ' 104' ' ' HIS . 84.4 t60 56.7 156.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.756 0.789 . . . . 0.0 110.617 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.202 -0.904 . . . . 0.0 109.168 -179.976 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 67.9 t0 -171.4 133.28 0.81 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.363 -0.836 . . . . 0.0 109.532 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.446 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 49.7 tp -70.89 127.06 31.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 109.609 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.17 162.64 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.548 -0.72 . . . . 0.0 109.57 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -78.31 154.25 31.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.458 -0.776 . . . . 0.0 110.265 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.98 -43.59 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.464 -0.772 . . . . 0.0 109.475 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -66.79 -18.2 65.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.66 2.6 56.36 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.176 -0.952 . . . . 0.0 109.808 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.7 t -67.03 133.69 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.325 -0.859 . . . . 0.0 110.198 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.5 p -158.02 164.93 36.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.571 -0.705 . . . . 0.0 109.515 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.2 mt -63.96 -22.44 66.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.323 -0.861 . . . . 0.0 109.067 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.9 t -58.23 -17.62 20.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.416 -0.803 . . . . 0.0 109.227 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.9 p -126.34 80.25 69.27 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.525 -0.734 . . . . 0.0 109.563 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.02 -39.98 77.87 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.524 2.149 . . . . 0.0 111.749 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -115.02 130.81 57.02 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.6 m -152.01 178.33 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.224 -0.923 . . . . 0.0 110.185 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.4 m -130.23 131.31 45.47 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.4 m -137.5 161.44 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.197 -0.939 . . . . 0.0 110.147 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.4 tt -143.77 146.57 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.381 -0.824 . . . . 0.0 109.408 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.05 -161.53 35.2 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.047 -1.549 . . . . 0.0 110.476 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -104.45 144.76 31.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.674 -0.898 . . . . 0.0 109.572 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 mm -98.73 132.46 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 56.5 p -134.95 158.09 45.2 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.438 -0.789 . . . . 0.0 109.652 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 25' ' ' ILE . . . 96.01 -72.34 0.86 Allowed Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.444 ' O ' ' O ' ' A' ' 24' ' ' GLY . 24.8 mm 50.01 101.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.458 -1.025 . . . . 0.0 110.158 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -129.66 131.25 46.35 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -93.44 133.3 36.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.307 -0.871 . . . . 0.0 109.637 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -146.76 152.4 38.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.417 -0.802 . . . . 0.0 109.284 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -111.31 144.82 39.87 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.725 -0.609 . . . . 0.0 109.372 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -146.15 164.13 33.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.33 -0.857 . . . . 0.0 109.391 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -87.52 142.73 27.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.643 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.4 t -147.08 110.59 4.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.343 -0.848 . . . . 0.0 108.761 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 55.76 31.7 18.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.702 -0.624 . . . . 0.0 109.609 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.55 14.7 75.41 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.2 p -128.15 134.48 49.09 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.371 -1.076 . . . . 0.0 109.609 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.9 m -83.36 128.84 34.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.542 -0.724 . . . . 0.0 109.668 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -136.42 144.44 44.48 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.416 -0.803 . . . . 0.0 109.295 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.1 p -79.78 153.4 29.21 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.238 -0.914 . . . . 0.0 110.211 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -141.83 140.74 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -103.13 131.45 50.13 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.4 -0.813 . . . . 0.0 109.614 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.485 ' OE1' ' NH2' ' A' ' 52' ' ' ARG . 78.0 mt-30 -121.28 153.52 37.57 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.72 -156.72 14.55 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.644 -1.265 . . . . 0.0 109.953 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -137.36 139.98 41.13 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 tt -116.65 131.06 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.344 -0.847 . . . . 0.0 109.322 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -117.67 155.75 29.38 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.376 0.608 . . . . 0.0 109.824 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -141.12 -146.13 0.19 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.805 . . . . 0.0 109.497 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -78.55 -8.37 58.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.411 -0.805 . . . . 0.0 110.743 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.3 p -113.42 -86.61 0.57 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.279 -0.888 . . . . 0.0 110.697 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.69 -147.72 0.36 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.583 -0.698 . . . . 0.0 110.245 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.8 ptt-85 -148.07 156.23 42.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.47 -0.768 . . . . 0.0 110.203 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.8 tt -142.85 150.19 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.33 -0.856 . . . . 0.0 110.177 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.485 ' NH2' ' OE1' ' A' ' 41' ' ' GLN . 76.5 ttt180 -72.5 136.36 45.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.515 -0.741 . . . . 0.0 109.847 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.528 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -138.67 167.67 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.34 -0.85 . . . . 0.0 109.463 179.403 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 97.4 p -147.74 152.79 38.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 0.0 109.756 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.6 p -135.44 124.55 24.4 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -87.98 130.03 35.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.393 -0.817 . . . . 0.0 110.838 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.35 -48.75 1.5 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -70.68 136.02 48.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.095 -1.238 . . . . 0.0 110.272 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -95.91 153.94 17.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.522 -0.736 . . . . 0.0 109.879 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.8 mt -128.91 157.03 42.74 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.653 -0.655 . . . . 0.0 109.512 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.445 ' OE1' ' OD2' ' A' ' 64' ' ' ASP . 91.1 mt-30 -117.3 135.25 53.97 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.626 0.727 . . . . 0.0 109.954 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.7 t0 -66.71 136.25 55.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.421 -0.799 . . . . 0.0 110.731 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.52 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 0.8 OUTLIER 80.31 -5.4 1.79 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.818 -0.551 . . . . 0.0 110.799 178.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.445 ' OD2' ' OE1' ' A' ' 61' ' ' GLN . 9.8 m-20 -80.8 143.03 33.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.708 -1.245 . . . . 0.0 110.013 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.41 123.81 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.76 160.43 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 110.191 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -122.18 126.17 47.71 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 77.6 mt -110.0 127.43 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -114.88 141.71 47.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.818 -0.551 . . . . 0.0 109.793 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.2 t30 62.91 38.17 11.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.745 -0.597 . . . . 0.0 109.679 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.58 141.92 55.33 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -93.98 121.97 36.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.642 0.734 . . . . 0.0 109.604 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.0 t -82.29 133.12 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.572 -0.705 . . . . 0.0 109.677 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.43 155.49 46.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.495 -0.753 . . . . 0.0 109.066 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -114.42 117.6 31.48 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.538 -0.726 . . . . 0.0 109.346 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -122.2 135.13 54.72 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.718 -0.614 . . . . 0.0 109.383 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 55.09 30.57 14.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.624 -0.672 . . . . 0.0 109.688 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.1 7.22 84.22 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -114.72 135.01 54.64 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.371 -1.076 . . . . 0.0 109.952 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.51 145.85 41.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.589 -0.694 . . . . 0.0 109.984 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.0 p -155.07 161.9 41.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.502 -0.749 . . . . 0.0 109.199 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.4 mt -107.39 127.87 53.96 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.448 -0.782 . . . . 0.0 109.492 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 m -100.58 125.19 46.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.687 -0.633 . . . . 0.0 109.343 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 t -112.4 130.2 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.53 -0.732 . . . . 0.0 109.092 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -153.13 -149.01 5.04 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.45 -42.3 99.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.533 -0.981 . . . . 0.0 110.263 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -60.83 -41.96 96.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.377 -0.827 . . . . 0.0 110.277 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.2 p -78.89 165.93 22.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.265 -0.897 . . . . 0.0 110.44 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -127.38 132.37 50.17 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.6 mt -113.34 129.67 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.537 -0.727 . . . . 0.0 109.092 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -132.27 123.34 26.72 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.433 -0.792 . . . . 0.0 109.081 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.1 p -76.65 156.55 32.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.998 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.1 m -136.33 11.83 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.438 -0.789 . . . . 0.0 109.203 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -87.99 3.78 47.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.417 -0.802 . . . . 0.0 109.221 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.0 p -123.47 134.59 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.478 -0.763 . . . . 0.0 109.586 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -64.75 138.32 58.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.474 -0.766 . . . . 0.0 109.881 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.3 pt -131.42 65.68 76.77 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.529 -0.732 . . . . 0.0 109.048 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.22 153.26 51.18 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.816 2.344 . . . . 0.0 112.477 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 93.2 mt -75.52 149.74 38.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.424 -0.797 . . . . 0.0 110.564 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 63.11 59.27 1.33 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.264 0.554 . . . . 0.0 109.604 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -106.8 103.91 13.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.544 -0.722 . . . . 0.0 109.192 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 44.17 73.22 0.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.5 -0.75 . . . . 0.0 109.96 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -148.48 137.76 21.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.368 -0.832 . . . . 0.0 109.83 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.475 ' C ' ' H ' ' A' ' 106' ' ' HIS . 84.6 t60 -172.08 46.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 105' ' ' HIS . 86.5 t60 48.39 14.28 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.709 -0.619 . . . . 0.0 109.535 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.475 ' H ' ' C ' ' A' ' 104' ' ' HIS . 78.0 m80 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.39 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.486 ' H3 ' ' H ' ' A' ' 2' ' ' ASP . 89.5 p . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.486 ' H ' ' H3 ' ' A' ' 1' ' ' SER . 56.4 p-10 -81.5 171.46 14.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.551 -0.718 . . . . 0.0 110.613 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.5 tp -77.93 125.48 29.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.467 -0.77 . . . . 0.0 109.951 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.66 161.95 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.491 -0.756 . . . . 0.0 109.777 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -78.81 152.58 31.29 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.633 0.73 . . . . 0.0 110.523 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.9 -42.99 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.378 -0.826 . . . . 0.0 109.416 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -67.5 -18.26 64.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.024 -1.048 . . . . 0.0 109.361 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -90.15 -18.64 25.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.144 -0.972 . . . . 0.0 109.55 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.3 t -52.1 135.59 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.198 -0.939 . . . . 0.0 110.501 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.6 p -153.91 166.82 31.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.585 -0.697 . . . . 0.0 109.337 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' A' ' 11' ' ' LEU . 3.6 mm? -68.94 -13.59 62.53 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.405 -0.809 . . . . 0.0 109.508 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.3 p -60.66 -31.19 70.42 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.157 -0.964 . . . . 0.0 109.003 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.44 ' OG1' ' CG1' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -122.95 85.33 50.55 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.17 -39.63 70.86 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.477 2.118 . . . . 0.0 112.018 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -106.52 131.64 53.46 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.56 -0.713 . . . . 0.0 109.887 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.44 ' CG1' ' OG1' ' A' ' 13' ' ' THR . 15.5 m -153.13 -177.25 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.353 -0.842 . . . . 0.0 109.716 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.8 m -137.62 137.91 38.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.432 -0.792 . . . . 0.0 109.09 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.3 m -140.44 161.91 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.388 -0.82 . . . . 0.0 109.822 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.402 ' CD1' ' HE ' ' A' ' 67' ' ' ARG . 86.3 mt -130.43 132.88 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.97 -167.62 37.39 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.054 -1.546 . . . . 0.0 110.017 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -113.01 138.11 50.38 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.709 -0.877 . . . . 0.0 109.432 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.567 ' N ' ' CD1' ' A' ' 22' ' ' ILE . 1.8 mp -97.95 131.33 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.424 -0.798 . . . . 0.0 109.615 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.6 p -133.45 160.31 37.77 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.315 0.579 . . . . 0.0 109.944 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 25' ' ' ILE . . . 100.28 -75.76 0.44 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 24' ' ' GLY . 38.1 mm 58.39 119.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.535 -0.979 . . . . 0.0 110.6 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -145.85 142.41 28.79 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -98.7 130.18 45.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.403 -0.811 . . . . 0.0 109.745 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -141.74 160.76 39.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.361 -0.837 . . . . 0.0 108.952 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 57.9 mp0 -121.84 142.53 50.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.49 -0.756 . . . . 0.0 109.374 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -141.96 160.27 40.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.286 -0.884 . . . . 0.0 108.874 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -90.17 115.65 27.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.982 . . . . 0.0 109.919 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.4 t -110.76 115.14 29.03 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.692 . . . . 0.0 109.214 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 54.38 31.33 14.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.47 -0.769 . . . . 0.0 109.896 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.8 1.8 84.85 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.8 m -117.99 128.69 55.03 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.321 -1.105 . . . . 0.0 109.649 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.1 m -67.99 128.49 36.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 110.381 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -133.1 146.0 51.24 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.43 -0.794 . . . . 0.0 109.58 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.1 m -81.25 144.14 31.78 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.441 -0.787 . . . . 0.0 109.982 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.8 p -136.43 138.96 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.474 -0.766 . . . . 0.0 109.0 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -103.7 131.21 51.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.423 -0.798 . . . . 0.0 108.977 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -124.1 155.76 37.81 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.579 -0.7 . . . . 0.0 109.478 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.38 -160.31 22.93 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -127.59 140.68 51.96 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.605 -0.938 . . . . 0.0 109.62 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 tt -117.73 136.85 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -134.24 151.47 51.31 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.467 -0.771 . . . . 0.0 109.836 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -144.99 -150.12 0.31 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.645 -0.66 . . . . 0.0 109.368 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 31.7 p-10 -85.72 -1.76 57.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 109.732 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.9 p -103.62 -63.0 1.23 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.175 -0.953 . . . . 0.0 109.556 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -166.47 -149.15 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 109.92 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -140.65 151.86 44.93 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.46 -0.775 . . . . 0.0 109.93 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 tt -149.48 158.93 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.188 -0.945 . . . . 0.0 110.196 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.6 mtp85 -71.93 146.98 47.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.9 . . . . 0.0 109.814 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.0 pt -136.76 150.11 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.399 -0.813 . . . . 0.0 110.235 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 t -142.57 138.21 30.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.531 -0.73 . . . . 0.0 109.135 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.3 t -130.35 133.64 46.57 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.508 -0.745 . . . . 0.0 109.175 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -92.87 123.83 36.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.38 -0.825 . . . . 0.0 111.03 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.08 -55.23 3.13 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -70.95 131.81 44.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.875 -1.368 . . . . 0.0 110.403 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -96.69 155.17 16.89 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.499 -0.75 . . . . 0.0 110.085 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.9 mt -123.16 151.68 41.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -103.59 160.5 14.69 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.645 0.736 . . . . 0.0 110.176 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 63' ' ' SER . 38.8 t70 -66.14 150.15 49.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.658 -0.651 . . . . 0.0 111.24 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 22' ' ' ILE . 11.1 p 37.57 42.56 0.37 Allowed 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.31 0.576 . . . . 0.0 110.439 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -90.69 120.1 31.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.229 -0.919 . . . . 0.0 110.031 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.78 110.49 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.5 m -143.78 168.32 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.126 -0.984 . . . . 0.0 110.109 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.402 ' HE ' ' CD1' ' A' ' 19' ' ' ILE . 41.5 ttm180 -118.21 124.37 47.76 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.3 mt -103.7 126.13 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -117.54 141.18 48.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.742 -0.599 . . . . 0.0 109.783 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.3 t30 65.47 37.57 6.06 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.47 0.653 . . . . 0.0 109.837 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.76 137.94 46.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.134 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -86.65 121.19 28.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.537 -0.727 . . . . 0.0 109.96 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.2 t -83.49 133.93 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.458 -0.776 . . . . 0.0 109.586 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -136.57 154.94 50.55 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.284 -0.885 . . . . 0.0 109.449 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -115.49 111.59 20.97 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -116.14 125.96 53.04 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.505 -0.747 . . . . 0.0 109.936 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.5 m120 55.26 33.25 20.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.639 -0.663 . . . . 0.0 110.13 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.26 3.24 88.4 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -111.05 133.63 53.28 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.344 -1.092 . . . . 0.0 109.954 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.2 mt -76.72 148.76 36.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.499 -0.751 . . . . 0.0 110.514 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.0 p -152.99 158.66 42.37 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.1 mt -111.55 126.52 55.07 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.282 -0.886 . . . . 0.0 109.379 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.4 m -107.68 123.55 48.68 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.5 t -99.15 112.0 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.266 -0.897 . . . . 0.0 109.47 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.24 -173.05 31.25 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.62 -35.41 80.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.589 -0.948 . . . . 0.0 109.527 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.0 t -66.84 -16.77 64.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 0.0 109.655 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.9 m -74.98 159.42 31.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 110.141 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.1 ttt85 -124.0 134.51 53.44 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.663 -0.648 . . . . 0.0 109.337 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.411 HD13 HG23 ' A' ' 90' ' ' ILE . 96.9 mt -119.02 131.9 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.683 -0.636 . . . . 0.0 109.527 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -122.28 130.18 52.91 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.6 0.715 . . . . 0.0 109.286 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.4 p -70.6 147.0 49.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.503 -0.748 . . . . 0.0 110.287 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.2 t -126.78 132.55 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.591 -0.693 . . . . 0.0 109.666 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.541 ' CG ' ' H ' ' A' ' 95' ' ' VAL . 61.6 t30 63.99 -167.47 0.21 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.442 0.639 . . . . 0.0 110.645 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.541 ' H ' ' CG ' ' A' ' 94' ' ' ASN . 9.0 p -102.67 129.94 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.453 -0.779 . . . . 0.0 109.921 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 97' ' ' ILE . 19.1 p30 -102.92 -152.58 0.45 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.522 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 35.1 mm -112.85 81.26 4.35 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.435 -0.791 . . . . 0.0 109.754 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.84 156.15 61.06 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.279 1.986 . . . . 0.0 112.154 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' A' ' 99' ' ' LEU . 4.0 mm? 43.27 72.87 0.16 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.775 0.798 . . . . 0.0 110.044 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 102' ' ' HIS . 18.2 pt-20 -101.71 6.57 41.91 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 102' ' ' HIS . 58.0 t-80 -46.02 97.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.941 . . . . 0.0 110.035 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 101' ' ' HIS . 97.3 m-70 41.65 -166.88 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.625 0.726 . . . . 0.0 111.049 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -153.71 138.29 16.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 109.704 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.461 ' CD2' ' O ' ' A' ' 104' ' ' HIS . 56.7 p-80 -171.73 50.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -67.27 -39.76 86.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.562 -0.711 . . . . 0.0 109.753 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.0 t60 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.759 -179.586 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.7 p . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.218 0.533 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -172.94 147.7 1.68 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.324 -0.86 . . . . 0.0 109.433 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.529 ' CD2' ' N ' ' A' ' 3' ' ' LEU . 4.0 mm? -81.94 130.0 34.94 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.378 -0.826 . . . . 0.0 110.248 -178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.79 163.87 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.576 -0.703 . . . . 0.0 109.647 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.61 156.46 27.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.418 -0.801 . . . . 0.0 110.622 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.45 -43.13 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 0.0 109.535 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -67.34 -14.75 63.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.014 -1.054 . . . . 0.0 109.795 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -89.7 -0.03 57.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 109.159 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.11 132.68 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 110.056 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.4 t -158.73 170.25 22.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.358 -0.839 . . . . 0.0 109.619 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 11' ' ' LEU . 3.7 mm? -64.4 -35.45 80.95 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.438 -0.789 . . . . 0.0 109.285 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.7 p -57.96 -20.47 38.15 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.742 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.443 ' O ' ' OG1' ' A' ' 13' ' ' THR . 8.7 p -113.32 79.19 3.75 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.348 -0.845 . . . . 0.0 108.885 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.9 -24.91 39.36 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.254 1.969 . . . . 0.0 112.384 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -125.57 110.1 13.45 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.467 -0.77 . . . . 0.0 109.018 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.8 m -141.65 162.09 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.233 -0.917 . . . . 0.0 110.307 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 t -117.25 135.49 53.77 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.7 m -136.14 161.33 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.278 -0.888 . . . . 0.0 110.171 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.3 tt -139.4 140.74 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.401 -0.812 . . . . 0.0 109.341 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.33 -166.04 36.81 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 118.959 -1.591 . . . . 0.0 110.13 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -106.38 131.08 54.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.557 -0.967 . . . . 0.0 109.625 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.3 mt -102.58 133.7 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.575 -0.703 . . . . 0.0 109.839 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.3 p -135.47 159.6 41.09 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.335 0.588 . . . . 0.0 109.672 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.29 -84.08 0.99 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.5 mm 56.12 107.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.536 -0.979 . . . . 0.0 110.421 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -129.27 138.54 51.7 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -90.48 136.51 33.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 110.372 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -148.66 151.28 34.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.378 -0.826 . . . . 0.0 108.907 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -117.86 144.74 45.14 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.352 -0.842 . . . . 0.0 110.063 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.405 ' N ' ' CD1' ' A' ' 30' ' ' TYR . 10.0 p90 -144.69 162.32 37.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.333 -0.854 . . . . 0.0 109.822 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -80.96 141.64 34.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.42 -0.8 . . . . 0.0 109.823 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.3 t -144.87 106.37 4.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.136 -0.978 . . . . 0.0 109.511 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.5 t0 57.96 33.41 23.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.422 -0.799 . . . . 0.0 110.329 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.66 6.0 87.68 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 92.4 m -126.62 127.44 45.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.372 -1.075 . . . . 0.0 109.31 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.0 m -73.0 134.41 44.66 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.221 -0.924 . . . . 0.0 110.042 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -131.82 143.4 50.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.428 -0.795 . . . . 0.0 109.054 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 86.8 p -87.27 146.07 26.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.214 -0.929 . . . . 0.0 109.813 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.91 140.26 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.384 -0.823 . . . . 0.0 109.547 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -104.82 130.49 52.93 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -121.35 152.77 38.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.454 -0.778 . . . . 0.0 109.417 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.09 -169.23 33.84 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -123.11 138.97 54.53 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.617 -0.931 . . . . 0.0 109.235 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 tt -118.1 143.18 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -133.33 153.21 51.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.574 -0.704 . . . . 0.0 109.621 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.572 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 40.4 t0 -149.17 -164.01 1.92 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.373 -0.83 . . . . 0.0 108.942 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.572 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 60.2 t0 -64.32 -33.75 76.56 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.442 -0.786 . . . . 0.0 109.295 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 p -77.31 -86.9 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 110.281 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.06 -147.06 0.2 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.344 -0.848 . . . . 0.0 110.233 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -143.9 157.96 44.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.475 -0.766 . . . . 0.0 109.454 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.2 tt -153.77 161.52 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.953 -1.092 . . . . 0.0 110.326 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -73.82 145.29 45.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.556 -0.715 . . . . 0.0 109.749 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.4 pt -135.24 152.98 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.198 -0.939 . . . . 0.0 109.499 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.6 p -142.31 129.69 21.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.183 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 58' ' ' LYS . 1.6 t -113.94 121.0 42.58 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -96.27 121.12 37.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.322 -0.861 . . . . 0.0 110.72 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.46 -44.68 2.94 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.423 ' O ' ' OG ' ' A' ' 55' ' ' SER . 70.4 mmtt -78.05 138.77 38.96 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.99 -1.3 . . . . 0.0 110.303 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -94.08 151.76 19.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -0.824 . . . . 0.0 109.923 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.15 157.21 43.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.565 -0.709 . . . . 0.0 109.331 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -112.09 136.89 50.88 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.518 0.675 . . . . 0.0 109.687 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -64.65 142.75 58.32 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.884 0.85 . . . . 0.0 111.222 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.1 t 58.34 81.19 0.16 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.65 0.738 . . . . 0.0 110.268 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -162.69 126.67 3.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.522 -0.736 . . . . 0.0 110.12 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 t -78.12 120.12 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.389 -0.819 . . . . 0.0 109.444 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.43 163.78 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.465 -0.772 . . . . 0.0 109.823 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.4 ttp85 -119.23 128.23 54.0 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.1 mt -107.38 129.32 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.402 -0.811 . . . . 0.0 109.382 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 66.5 t0 -114.64 142.11 46.9 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.544 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 64.6 t30 63.3 40.58 8.5 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.345 0.593 . . . . 0.0 109.918 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.45 148.87 42.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.334 -0.854 . . . . 0.0 109.417 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -100.87 125.53 47.41 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.565 0.698 . . . . 0.0 109.729 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.9 t -89.19 135.28 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.369 -0.832 . . . . 0.0 110.038 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.74 157.0 43.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 0.0 108.889 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -113.36 116.92 30.44 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.454 -0.779 . . . . 0.0 109.44 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -125.94 138.69 53.78 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.425 -0.797 . . . . 0.0 110.094 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 57.04 23.5 8.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.665 -0.647 . . . . 0.0 109.484 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.08 7.88 88.19 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -118.21 137.76 52.79 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.546 -0.973 . . . . 0.0 109.898 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.1 mt -77.12 148.52 35.98 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.425 -0.797 . . . . 0.0 110.212 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.9 p -155.04 161.67 41.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.317 -0.864 . . . . 0.0 109.016 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.4 mt -106.32 125.59 51.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.426 -0.796 . . . . 0.0 109.246 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.9 m -105.66 123.34 47.76 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.5 t -98.97 114.13 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.301 -0.874 . . . . 0.0 108.997 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.57 -177.42 37.02 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -67.42 -27.31 66.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.598 -0.942 . . . . 0.0 109.611 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.1 m -78.8 -6.51 56.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.148 -0.97 . . . . 0.0 109.487 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.7 m -83.66 165.59 18.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.041 -1.037 . . . . 0.0 109.841 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.75 141.05 51.69 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.435 -0.791 . . . . 0.0 109.318 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.03 130.98 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.563 -0.71 . . . . 0.0 109.609 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -123.72 116.32 22.84 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.9 m -77.54 140.2 39.7 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.35 -0.844 . . . . 0.0 110.099 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.2 m -129.75 130.75 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.546 -0.721 . . . . 0.0 109.29 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -105.44 -40.36 5.83 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.456 ' CG1' ' H ' ' A' ' 96' ' ' ASN . 2.1 t -148.2 -139.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.224 -0.922 . . . . 0.0 109.766 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.456 ' H ' ' CG1' ' A' ' 95' ' ' VAL . 17.3 m120 -80.83 -77.08 0.21 Allowed 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.521 0.676 . . . . 0.0 109.418 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.8 pt -144.18 70.84 16.34 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.203 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -77.26 -7.14 16.96 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.438 2.092 . . . . 0.0 110.793 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.0 tp -84.42 128.37 34.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.392 -0.817 . . . . 0.0 110.082 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -153.34 1.41 0.26 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -66.37 -40.95 90.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.368 -0.832 . . . . 0.0 109.816 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -108.53 131.41 54.86 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.398 -0.814 . . . . 0.0 109.7 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.526 ' CG ' ' N ' ' A' ' 104' ' ' HIS . 85.6 t60 -150.24 166.46 29.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.275 -0.89 . . . . 0.0 109.769 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.526 ' N ' ' CG ' ' A' ' 103' ' ' HIS . 86.0 t60 51.18 9.23 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 109.48 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.524 ' H ' ' C ' ' A' ' 103' ' ' HIS . 72.0 m80 -134.96 145.28 47.99 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.353 -0.842 . . . . 0.0 109.699 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.142 -0.932 . . . . 0.0 108.755 179.771 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.2 p . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.74 0.781 . . . . 0.0 108.928 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.3 p30 -83.43 170.94 13.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.363 -0.835 . . . . 0.0 110.489 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.7 tp -81.58 128.48 33.97 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.415 -0.803 . . . . 0.0 109.956 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.01 162.87 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-O 121.719 0.771 . . . . 0.0 110.165 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -77.18 159.47 29.68 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.796 0.808 . . . . 0.0 110.354 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.8 mm -63.78 -42.91 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 121.701 0.762 . . . . 0.0 109.887 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -66.07 -18.08 65.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.193 -0.942 . . . . 0.0 110.486 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 8' ' ' ASP . 59.2 t0 -86.45 -1.79 57.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.858 -1.151 . . . . 0.0 109.384 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 87.1 t -66.29 133.3 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.338 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.4 p -156.16 167.44 30.41 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.508 -0.745 . . . . 0.0 109.357 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.5 -34.96 79.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.821 . . . . 0.0 109.309 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.6 p -56.84 -19.4 17.23 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 109.475 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 13' ' ' THR . 11.1 p -115.23 81.07 7.82 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.835 . . . . 0.0 109.248 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -71.92 -16.08 29.36 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.598 2.199 . . . . 0.0 111.288 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -128.66 110.07 11.89 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.4 m -145.44 161.68 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.357 -0.84 . . . . 0.0 110.397 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.3 t -116.55 136.96 52.55 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.61 160.29 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 121.894 0.854 . . . . 0.0 110.256 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.3 tt -144.36 133.73 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.682 -0.636 . . . . 0.0 109.606 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.82 -162.55 30.33 Favored Glycine 0 N--CA 1.487 2.051 0 C-N-CA 119.693 -1.241 . . . . 0.0 110.019 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -105.98 134.79 48.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.708 -0.878 . . . . 0.0 109.985 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 63' ' ' SER . 97.0 mt -103.64 130.64 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.527 0.679 . . . . 0.0 110.086 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 p -134.15 163.31 29.88 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.49 0.662 . . . . 0.0 109.371 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.479 ' N ' ' OD1' ' A' ' 62' ' ' ASP . . . 97.03 -76.74 0.68 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 24' ' ' GLY . 36.9 mm 57.91 120.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 122.039 0.923 . . . . 0.0 110.405 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -143.63 138.97 29.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.451 -0.781 . . . . 0.0 108.986 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -104.36 130.3 52.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.481 -0.762 . . . . 0.0 109.919 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -144.34 165.29 28.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.545 -0.722 . . . . 0.0 109.402 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -120.57 146.57 46.2 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.593 -0.692 . . . . 0.0 110.008 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -142.6 163.16 33.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 109.85 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.536 ' N ' ' OE1' ' A' ' 31' ' ' GLU . 57.0 mp0 -88.04 114.16 24.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.528 -0.733 . . . . 0.0 109.721 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.8 t -110.77 107.29 16.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.493 -0.755 . . . . 0.0 109.758 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 54.7 t0 54.79 28.56 10.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.533 -0.73 . . . . 0.0 110.526 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.88 8.18 67.55 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.4 m -123.11 127.51 48.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.409 -1.053 . . . . 0.0 109.11 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.9 m -72.83 131.05 41.79 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.392 -0.818 . . . . 0.0 110.402 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -136.89 146.61 45.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.473 -0.767 . . . . 0.0 109.529 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 99.8 p -81.43 148.6 29.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.401 -0.812 . . . . 0.0 110.343 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.32 138.3 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 109.678 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.498 ' CD1' ' O ' ' A' ' 58' ' ' LYS . 83.7 m-85 -104.35 132.72 50.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.447 -0.783 . . . . 0.0 109.481 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -129.2 156.64 43.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.634 -0.666 . . . . 0.0 109.457 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.55 -165.32 31.97 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.045 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -120.36 143.89 48.17 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.698 -0.883 . . . . 0.0 109.798 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 tt -131.85 134.37 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -139.45 155.02 47.85 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.855 0.836 . . . . 0.0 110.553 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.547 ' O ' ' C ' ' A' ' 47' ' ' ASP . 41.8 p-10 -152.89 99.47 2.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.432 -0.792 . . . . 0.0 109.385 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.547 ' C ' ' O ' ' A' ' 46' ' ' ASP . 29.5 p-10 13.72 57.94 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.736 0 CA-C-O 122.169 0.985 . . . . 0.0 110.944 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 46' ' ' ASP . 8.2 m -168.7 -55.6 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -173.39 -167.93 0.42 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.367 -0.833 . . . . 0.0 109.397 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -139.05 149.98 45.24 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.632 0.73 . . . . 0.0 110.482 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.8 tt -147.24 152.81 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.33 -0.856 . . . . 0.0 109.687 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.418 HH21 ' HB2' ' A' ' 79' ' ' TYR . 81.0 mtm-85 -77.53 147.57 35.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.521 -0.737 . . . . 0.0 109.856 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.0 pt -132.48 158.3 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.617 -0.677 . . . . 0.0 109.907 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 t -147.14 127.73 14.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 p -122.89 138.7 54.59 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.477 0.656 . . . . 0.0 109.613 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -97.8 118.15 33.71 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.679 0.752 . . . . 0.0 111.527 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.09 -19.66 1.69 Allowed Glycine 0 N--CA 1.496 2.671 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.608 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.498 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 68.8 mttm -83.63 137.82 33.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.689 -1.477 . . . . 0.0 110.484 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -96.6 140.73 30.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.602 -0.687 . . . . 0.0 110.159 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.1 mt -130.18 153.32 48.67 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.598 -0.689 . . . . 0.0 109.381 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -113.33 155.31 25.4 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.653 0.74 . . . . 0.0 109.893 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 7.7 m-20 -70.78 148.3 48.05 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.92 0.867 . . . . 0.0 110.995 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 22' ' ' ILE . 1.8 m 53.34 32.98 14.68 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.779 0.8 . . . . 0.0 109.409 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -96.84 114.57 26.21 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.353 -0.842 . . . . 0.0 110.573 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.5 m -84.08 117.14 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.343 -0.848 . . . . 0.0 109.889 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.9 m -148.45 175.12 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.501 0.667 . . . . 0.0 109.541 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -122.68 132.26 54.18 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.55 125.28 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.597 -0.689 . . . . 0.0 109.477 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -111.21 152.38 27.16 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 59.57 35.23 22.57 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.708 0.766 . . . . 0.0 109.664 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.65 143.97 56.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.51 -0.744 . . . . 0.0 109.442 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -105.62 118.57 36.93 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.935 0.874 . . . . 0.0 109.572 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -88.91 131.44 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.425 -0.797 . . . . 0.0 110.124 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.46 157.58 41.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.394 -0.816 . . . . 0.0 109.015 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -100.75 125.45 47.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.455 -0.778 . . . . 0.0 109.655 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -115.52 133.18 56.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.61 -0.681 . . . . 0.0 109.354 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m120 67.89 -63.23 0.32 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.627 0.727 . . . . 0.0 109.844 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 176.43 29.15 0.04 OUTLIER Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.418 ' HB2' HH21 ' A' ' 52' ' ' ARG . 31.5 p90 -146.82 155.43 42.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.292 -1.122 . . . . 0.0 109.837 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.8 mt -83.06 145.65 29.15 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.77 0.795 . . . . 0.0 110.974 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.1 t -157.8 163.72 37.75 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 70.7 mt -101.15 130.22 47.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.165 -0.959 . . . . 0.0 109.694 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.6 m -109.88 122.6 47.91 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.665 0.745 . . . . 0.0 109.319 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.6 t -98.62 110.04 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.826 0.822 . . . . 0.0 109.11 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.13 -174.85 40.8 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -71.22 -19.23 62.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.553 -0.969 . . . . 0.0 110.34 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -84.55 -8.83 58.78 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.711 -1.243 . . . . 0.0 109.057 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.497 ' HG ' ' H ' ' A' ' 89' ' ' ARG . 46.8 t -79.34 162.63 25.46 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.395 -0.816 . . . . 0.0 110.434 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.497 ' H ' ' HG ' ' A' ' 88' ' ' SER . 63.2 ttm-85 -129.66 136.37 49.64 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.594 -0.691 . . . . 0.0 109.384 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.84 130.46 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -120.53 132.19 55.06 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.701 0.762 . . . . 0.0 109.128 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.0 m -74.31 147.85 41.91 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.383 0.611 . . . . 0.0 110.525 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.9 t -120.88 132.06 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 94' ' ' ASN . 48.7 p30 -89.92 146.25 24.54 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.651 0.739 . . . . 0.0 110.079 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.541 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 59.7 t -83.36 -77.01 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-O 121.594 0.711 . . . . 0.0 109.137 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 95' ' ' VAL . 16.4 m120 -154.42 105.77 2.69 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.313 -0.867 . . . . 0.0 109.848 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 66.8 mt 42.39 76.86 0.48 Allowed Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.543 -0.723 . . . . 0.0 110.325 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.05 144.78 99.23 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.918 2.412 . . . . 0.0 112.569 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 tt -63.04 -43.58 98.27 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.285 -0.884 . . . . 0.0 109.187 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -57.95 135.35 56.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.237 -0.914 . . . . 0.0 109.8 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -107.49 135.36 49.09 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.834 0.826 . . . . 0.0 109.834 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -57.3 -76.01 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.835 0.826 . . . . 0.0 110.141 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.4 ' O ' ' C ' ' A' ' 104' ' ' HIS . 33.9 m-70 51.82 20.67 1.22 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -0.909 . . . . 0.0 109.044 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 103' ' ' HIS . 71.2 m80 42.99 -111.52 0.18 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.638 -0.664 . . . . 0.0 109.717 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -126.58 1.75 6.86 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.171 -0.956 . . . . 0.0 109.367 179.846 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.495 ' H3 ' ' C ' ' A' ' 16' ' ' VAL . 29.2 m . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.55 0.69 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 65.9 t0 -66.28 145.62 55.54 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.691 0.758 . . . . 0.0 110.313 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.545 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 42.8 tp -70.92 121.78 18.76 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.551 0.691 . . . . 0.0 110.097 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.1 m -137.78 163.65 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 121.582 0.706 . . . . 0.0 109.939 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -76.03 156.85 33.62 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.587 0.708 . . . . 0.0 110.26 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.84 -43.41 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.563 -0.71 . . . . 0.0 109.728 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -62.62 -24.84 67.79 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.403 -0.811 . . . . 0.0 110.382 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -82.62 -0.21 46.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.549 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.2 t -65.76 131.54 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.371 -0.831 . . . . 0.0 110.539 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 99.1 p -160.31 169.3 23.44 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.685 0.755 . . . . 0.0 109.535 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.74 -33.89 76.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.766 . . . . 0.0 109.823 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -59.74 -18.59 44.04 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.243 -0.91 . . . . 0.0 109.271 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 13' ' ' THR . 13.6 p -111.45 80.13 2.54 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.65 -23.19 36.72 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.383 2.055 . . . . 0.0 111.744 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.464 ' C ' ' N ' ' A' ' 1' ' ' SER . 64.0 m-85 -126.22 110.08 13.04 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.495 ' C ' ' H3 ' ' A' ' 1' ' ' SER . 21.9 m -138.15 162.62 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.589 -0.695 . . . . 0.0 110.353 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 t -125.67 134.85 51.7 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.5 m -139.88 162.24 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 121.579 0.704 . . . . 0.0 110.303 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.3 tt -137.98 139.48 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.58 -0.7 . . . . 0.0 109.647 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.76 -162.94 29.85 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.661 -1.257 . . . . 0.0 109.993 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -106.15 144.4 32.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.749 -0.854 . . . . 0.0 109.491 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.5 mm -94.2 130.59 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.302 0.573 . . . . 0.0 110.427 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.2 p -138.42 156.93 47.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.468 -0.77 . . . . 0.0 110.479 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.08 65.84 2.74 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.8 mm -80.21 128.15 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -1.12 . . . . 0.0 110.242 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -134.66 140.93 46.39 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' NZ ' ' OG ' ' A' ' 38' ' ' SER . 51.0 tttp -104.53 134.65 47.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.644 -0.66 . . . . 0.0 109.884 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -140.61 162.73 34.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.645 -0.66 . . . . 0.0 109.716 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -125.76 140.1 52.97 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.754 -0.591 . . . . 0.0 109.72 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -140.38 159.01 43.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.455 -0.778 . . . . 0.0 109.586 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -86.98 111.19 20.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.575 -0.703 . . . . 0.0 109.752 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 p -112.81 119.78 39.19 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.524 0.678 . . . . 0.0 109.807 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.9 t0 55.23 29.71 13.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.619 -0.676 . . . . 0.0 109.916 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.52 5.82 86.45 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.8 m -124.87 128.74 49.13 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.447 -1.031 . . . . 0.0 109.613 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 33.2 m -66.77 130.4 43.03 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.645 -0.659 . . . . 0.0 110.3 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -132.18 143.0 49.65 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.833 0.825 . . . . 0.0 109.612 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.522 ' OG ' ' NZ ' ' A' ' 27' ' ' LYS . 36.6 t -78.25 145.36 35.51 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.425 0.631 . . . . 0.0 110.137 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.79 137.71 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.6 -0.688 . . . . 0.0 109.303 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -103.76 132.7 49.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.72 -0.613 . . . . 0.0 109.456 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -125.41 149.05 48.54 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.7 -165.51 29.84 Favored Glycine 0 N--CA 1.485 1.956 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.139 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -123.28 142.85 50.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.836 -0.802 . . . . 0.0 109.398 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.6 tt -120.39 144.34 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -131.16 150.42 52.15 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.613 0.72 . . . . 0.0 110.162 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.551 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 41.4 t0 -151.76 -166.66 2.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.587 -0.695 . . . . 0.0 109.391 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.551 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 47.6 t0 -70.29 -9.94 57.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 109.938 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.677 ' HG1' ' H ' ' A' ' 49' ' ' ALA . 45.3 p -94.72 -71.31 0.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 109.625 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.677 ' H ' ' HG1' ' A' ' 48' ' ' THR . . . -162.22 -141.13 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.396 -0.815 . . . . 0.0 109.49 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -143.42 151.82 40.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.446 -0.784 . . . . 0.0 109.976 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.6 tt -151.9 161.44 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.712 . . . . 0.0 110.158 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -74.11 147.26 42.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.492 -0.755 . . . . 0.0 109.628 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.0 pt -136.07 154.5 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.482 -0.761 . . . . 0.0 110.042 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.0 t -145.67 131.14 18.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.528 -0.733 . . . . 0.0 109.325 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.9 t -120.39 134.95 55.18 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.459 0.647 . . . . 0.0 109.435 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.428 ' C ' ' H ' ' A' ' 58' ' ' LYS . 62.3 m-85 -95.8 122.14 38.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.518 -0.739 . . . . 0.0 111.021 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.53 -44.45 0.47 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' A' ' 56' ' ' PHE . 9.4 ttmm -79.01 130.99 36.12 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.168 -1.195 . . . . 0.0 110.678 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -91.89 164.59 13.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.51 0.671 . . . . 0.0 110.462 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.6 mt -126.9 157.74 38.59 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -105.8 133.85 49.86 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.327 1.061 . . . . 0.0 110.223 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -69.92 143.89 52.6 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.627 -0.67 . . . . 0.0 111.153 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.5 t 65.12 4.57 2.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -90.81 134.95 34.05 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.478 -0.764 . . . . 0.0 109.942 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.0 t -86.85 121.58 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.59 159.97 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.586 0.708 . . . . 0.0 109.876 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -123.75 125.08 44.11 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.2 mt -99.14 128.05 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -112.53 138.53 49.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.5 t30 62.54 39.24 11.83 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.334 0.587 . . . . 0.0 109.708 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.08 148.41 51.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.417 -0.802 . . . . 0.0 109.605 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -99.57 121.07 40.66 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.736 0.779 . . . . 0.0 109.882 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.6 t -80.87 133.75 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.609 -0.682 . . . . 0.0 109.874 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.44 155.54 42.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.397 -0.814 . . . . 0.0 109.509 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -114.09 119.14 36.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.766 -0.584 . . . . 0.0 109.621 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -118.27 126.2 51.67 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.507 0.67 . . . . 0.0 109.738 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.7 m120 55.63 32.98 20.31 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.454 0.645 . . . . 0.0 110.196 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.15 6.05 89.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.73 133.9 55.08 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.385 -1.068 . . . . 0.0 110.022 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.9 mt -77.54 145.96 36.6 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.484 0.659 . . . . 0.0 110.117 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.8 p -154.34 160.27 41.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.531 -0.73 . . . . 0.0 109.353 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.4 mt -105.58 118.9 37.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.594 -0.692 . . . . 0.0 109.406 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.7 m -98.32 126.89 44.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.672 -0.642 . . . . 0.0 109.403 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 t -103.67 109.44 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.541 -0.725 . . . . 0.0 109.608 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -96.59 -176.24 35.55 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -68.24 -17.01 64.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.515 -0.991 . . . . 0.0 109.605 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 96.8 p -83.08 -9.41 59.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 109.107 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.7 t -88.5 167.85 13.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.457 -0.777 . . . . 0.0 110.14 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.5 tpt85 -132.44 135.05 45.81 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.6 mt -115.65 130.78 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.795 -0.566 . . . . 0.0 109.722 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -119.0 122.3 41.88 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.393 0.616 . . . . 0.0 109.661 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.2 m -80.8 149.16 29.71 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.418 0.628 . . . . 0.0 110.298 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.25 40.14 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -149.16 102.88 3.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.426 -0.796 . . . . 0.0 109.131 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.2 t -63.38 -110.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.624 -0.672 . . . . 0.0 110.828 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 57.63 34.82 25.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.639 -0.663 . . . . 0.0 109.939 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.414 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 17.4 tt -134.33 55.36 14.54 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.617 -0.677 . . . . 0.0 109.506 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 97' ' ' ILE . 40.3 Cg_endo -68.0 152.57 76.65 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.452 2.101 . . . . 0.0 112.843 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.39 141.97 48.71 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.534 0.683 . . . . 0.0 109.915 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -79.02 139.65 38.13 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.597 0.713 . . . . 0.0 110.414 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -154.7 -69.44 0.13 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -75.83 142.95 42.11 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.739 0.781 . . . . 0.0 110.382 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.6 m80 43.97 -167.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.613 0.721 . . . . 0.0 110.778 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -150.55 163.99 37.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.485 -0.759 . . . . 0.0 109.801 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -78.35 130.18 35.86 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.724 0.774 . . . . 0.0 110.202 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.408 ' OXT' ' CG ' ' A' ' 106' ' ' HIS . 84.3 t60 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 117.949 -1.024 . . . . 0.0 108.988 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.3 p . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -75.8 163.22 27.47 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.68 0.752 . . . . 0.0 110.451 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.6 tp -79.93 124.42 28.66 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.562 -0.711 . . . . 0.0 109.878 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.99 163.46 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.443 -0.786 . . . . 0.0 109.724 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -76.16 159.43 30.7 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.683 0.754 . . . . 0.0 110.218 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.1 -42.9 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.527 -0.733 . . . . 0.0 110.037 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 -67.13 -18.52 65.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.903 -1.123 . . . . 0.0 109.617 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -83.57 -2.05 55.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.09 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.7 t -66.69 132.22 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 110.362 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 m -156.45 167.37 30.64 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.517 -0.74 . . . . 0.0 109.392 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.91 -37.65 88.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.338 -0.851 . . . . 0.0 109.716 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 93.8 p -54.71 -22.2 13.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.973 . . . . 0.0 109.31 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.444 ' O ' ' OG1' ' A' ' 13' ' ' THR . 10.7 p -113.03 80.9 4.3 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.75 -21.87 24.56 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.258 1.972 . . . . 0.0 111.673 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -125.26 109.98 13.48 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.399 0.619 . . . . 0.0 109.459 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.8 m -147.16 162.03 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.148 -0.97 . . . . 0.0 110.143 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.2 m -115.0 135.68 53.96 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.46 161.35 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.327 -0.858 . . . . 0.0 110.001 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.2 tt -138.5 137.51 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.377 -0.827 . . . . 0.0 109.711 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.36 -165.06 27.12 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 119.567 -1.301 . . . . 0.0 109.876 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HZ3' ' C ' ' A' ' 63' ' ' SER . 54.5 tttp -105.46 126.85 52.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.652 -0.91 . . . . 0.0 109.069 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.8 mm -83.32 129.51 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-O 121.495 0.664 . . . . 0.0 110.313 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 44.5 p -140.04 163.7 31.99 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.697 0.761 . . . . 0.0 110.035 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.35 89.71 0.01 OUTLIER Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.5 mm -99.61 126.05 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -1.118 . . . . 0.0 109.416 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.494 ' HD1' ' N ' ' A' ' 27' ' ' LYS . 9.4 t-80 -131.13 132.36 44.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' N ' ' HD1' ' A' ' 26' ' ' HIS . 88.4 tttt -98.81 131.52 44.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.431 -0.793 . . . . 0.0 109.547 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -133.71 153.21 51.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.531 -0.731 . . . . 0.0 109.405 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -119.64 139.81 51.62 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.481 0.658 . . . . 0.0 109.799 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -142.0 161.16 38.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.292 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -90.36 99.18 12.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.959 . . . . 0.0 109.157 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.602 ' O ' ' N ' ' A' ' 34' ' ' GLY . 5.3 p -81.27 -156.5 0.15 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.484 -0.76 . . . . 0.0 110.073 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.46 ' N ' ' HG ' ' A' ' 32' ' ' SER . 99.4 m-20 -48.28 82.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.53 0.681 . . . . 0.0 110.142 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 52.8 11.73 1.42 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.419 ' H ' ' C ' ' A' ' 33' ' ' ASP . 87.3 m -135.59 133.37 38.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.222 -1.163 . . . . 0.0 110.001 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.6 m -75.49 129.68 37.66 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.458 -0.776 . . . . 0.0 109.651 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -133.16 145.87 51.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.378 -0.826 . . . . 0.0 109.745 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.6 p -86.18 148.11 25.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.505 -0.747 . . . . 0.0 110.087 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 p -137.9 137.59 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.517 ' CZ ' ' OE1' ' A' ' 59' ' ' GLN . 88.3 m-85 -103.5 135.09 45.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.482 -0.761 . . . . 0.0 109.64 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -125.07 155.22 40.15 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.94 -167.29 34.62 Favored Glycine 0 N--CA 1.482 1.745 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.433 ' HH ' HH21 ' A' ' 52' ' ' ARG . 80.3 m-85 -126.74 141.84 51.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.587 -0.949 . . . . 0.0 109.529 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.7 tt -114.55 143.68 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.45 ' OE2' ' O ' ' A' ' 49' ' ' ALA . 10.1 tp10 -130.46 149.14 52.27 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.582 0.706 . . . . 0.0 109.694 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.557 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 42.7 t0 -148.26 -164.39 2.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.464 -0.772 . . . . 0.0 109.478 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.557 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 96.7 m-20 -73.79 -17.06 61.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 109.657 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.1 m -92.94 -73.82 0.54 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.188 -0.945 . . . . 0.0 109.795 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.45 ' O ' ' OE2' ' A' ' 45' ' ' GLU . . . -154.15 -157.0 0.73 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.727 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -137.76 156.67 47.73 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.497 -0.752 . . . . 0.0 110.229 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 tt -151.4 159.41 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.268 -0.895 . . . . 0.0 110.3 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.433 HH21 ' HH ' ' A' ' 43' ' ' TYR . 42.3 ttm180 -76.15 144.26 40.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.858 . . . . 0.0 109.689 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -130.37 157.37 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.777 0.799 . . . . 0.0 110.245 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.2 t -143.61 134.87 25.85 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.8 t -127.57 131.68 49.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.262 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -102.17 123.25 45.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.441 -0.787 . . . . 0.0 111.011 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.66 -51.17 3.01 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.481 ' NZ ' ' O ' ' A' ' 88' ' ' SER . 98.6 mttt -63.93 135.72 56.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.098 -1.237 . . . . 0.0 110.58 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.517 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 69.8 tp60 -85.16 149.58 25.42 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.688 0.756 . . . . 0.0 110.52 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.2 mt -130.58 157.18 43.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -124.63 148.98 47.58 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.806 0.812 . . . . 0.0 110.051 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.2 p-10 -67.17 146.53 54.13 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.102 0.954 . . . . 0.0 111.377 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.448 ' C ' ' HZ3' ' A' ' 21' ' ' LYS . 4.3 p 47.16 81.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.631 0.729 . . . . 0.0 110.384 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -151.79 124.78 8.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.39 -0.819 . . . . 0.0 110.205 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 t -79.63 114.59 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.352 -0.842 . . . . 0.0 109.266 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.14 163.65 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.494 -0.754 . . . . 0.0 109.795 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -122.71 132.63 54.34 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 78.9 mt -107.14 128.57 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 68.1 t0 -110.34 143.07 41.1 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.548 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 64.6 t30 60.64 39.87 17.2 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.45 149.75 46.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.569 -0.707 . . . . 0.0 109.796 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -102.74 126.79 49.99 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.57 0.7 . . . . 0.0 110.016 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.4 t -92.29 133.0 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.498 -0.751 . . . . 0.0 109.397 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.67 156.27 45.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.148 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -113.0 119.28 37.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.469 -0.769 . . . . 0.0 109.609 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -125.15 134.09 52.56 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.559 0.695 . . . . 0.0 109.555 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 56.13 30.98 17.38 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.468 0.651 . . . . 0.0 109.787 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.77 4.69 77.18 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -114.39 136.62 52.79 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.316 -1.108 . . . . 0.0 109.742 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.91 146.37 37.65 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.655 0.74 . . . . 0.0 110.4 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.9 p -152.74 160.5 43.13 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.443 -0.786 . . . . 0.0 109.155 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.29 126.43 52.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.382 -0.824 . . . . 0.0 109.213 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 t -108.49 129.66 55.28 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.13 112.39 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.67 0.748 . . . . 0.0 109.1 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.71 -177.58 38.24 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -69.64 -17.4 63.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.58 -0.953 . . . . 0.0 109.434 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.3 m -84.91 -12.37 53.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.17 -0.956 . . . . 0.0 109.398 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.481 ' O ' ' NZ ' ' A' ' 58' ' ' LYS . 14.7 m -86.79 163.89 17.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.293 -0.879 . . . . 0.0 109.777 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -126.85 142.66 51.48 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.521 -0.737 . . . . 0.0 109.857 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -118.04 129.79 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -125.25 121.46 34.13 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.698 0.761 . . . . 0.0 109.36 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.0 p -78.57 156.59 29.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.498 -0.751 . . . . 0.0 109.94 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.0 t -121.9 130.39 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.519 -0.738 . . . . 0.0 109.276 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -91.52 103.1 15.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.556 -0.715 . . . . 0.0 109.6 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 96' ' ' ASN . 9.3 p -106.84 -22.22 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.464 ' CG ' ' H ' ' A' ' 97' ' ' ILE . 58.3 t30 42.69 -167.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.577 0.703 . . . . 0.0 110.102 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.481 ' N ' ' HD2' ' A' ' 98' ' ' PRO . 1.7 mp -75.91 -56.14 1.75 Allowed Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.243 -0.911 . . . . 0.0 109.477 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 97' ' ' ILE . 45.8 Cg_endo -64.1 148.28 91.39 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.189 1.926 . . . . 0.0 112.535 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 78.7 mt -83.03 128.78 34.79 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 109.674 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -93.66 124.01 37.37 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.383 -0.823 . . . . 0.0 109.374 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -79.85 133.98 36.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 110.388 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -92.93 110.36 21.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.446 -0.784 . . . . 0.0 109.899 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.657 ' N ' ' HD1' ' A' ' 103' ' ' HIS . 2.2 p-80 -163.79 -53.03 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.529 ' CD2' ' CD2' ' A' ' 103' ' ' HIS . 68.1 m-70 -85.58 -14.36 45.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.419 -0.801 . . . . 0.0 109.288 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -79.29 135.56 36.79 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.306 -0.871 . . . . 0.0 109.949 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 118.071 -0.966 . . . . 0.0 108.929 179.712 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 2' ' ' ASP . 8.7 t . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.408 0.623 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 65.7 t0 -66.86 149.12 51.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.45 -0.782 . . . . 0.0 110.267 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.542 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 50.1 tp -71.69 127.62 33.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.332 -0.855 . . . . 0.0 109.612 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.79 163.62 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.342 -0.849 . . . . 0.0 110.434 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -76.53 154.54 34.47 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.426 0.631 . . . . 0.0 110.38 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.35 -43.22 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 109.604 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 -64.11 -21.04 66.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.146 -0.971 . . . . 0.0 109.964 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -88.07 1.66 53.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.097 -1.002 . . . . 0.0 109.742 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.07 131.78 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.09 -1.006 . . . . 0.0 110.297 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.6 p -158.33 166.45 32.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.441 -0.787 . . . . 0.0 109.67 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.31 -20.5 66.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.402 -0.811 . . . . 0.0 109.185 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.9 t -63.96 -16.3 61.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 109.57 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.4 p -119.82 84.24 31.2 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.48 -0.763 . . . . 0.0 109.11 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.53 -40.67 71.65 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.591 2.194 . . . . 0.0 112.203 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -121.84 127.69 50.82 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.673 -0.642 . . . . 0.0 109.758 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.43 ' C ' ' H3 ' ' A' ' 1' ' ' SER . 16.6 m -144.76 161.61 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.293 -0.879 . . . . 0.0 109.735 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 t -116.59 136.29 53.1 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.84 162.3 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.377 -0.827 . . . . 0.0 109.738 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.06 143.5 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.405 -0.809 . . . . 0.0 109.792 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.16 -161.32 35.07 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -111.73 139.05 47.51 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.439 -1.036 . . . . 0.0 109.604 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.46 ' O ' ' N ' ' A' ' 63' ' ' SER . 97.1 mt -97.93 131.32 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.868 -0.52 . . . . 0.0 109.852 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.3 p -133.7 156.63 47.59 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.468 -0.77 . . . . 0.0 109.952 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.1 71.4 1.01 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.8 mm -79.76 128.6 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.982 -1.305 . . . . 0.0 109.207 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -128.75 131.31 47.86 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -104.61 135.98 44.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.534 -0.729 . . . . 0.0 109.78 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -148.74 156.99 43.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.491 -0.756 . . . . 0.0 109.035 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -111.94 146.02 38.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.567 -0.708 . . . . 0.0 109.655 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.434 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 10.7 p90 -143.55 159.19 42.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.347 -0.846 . . . . 0.0 109.672 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -83.15 136.12 34.56 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.444 -0.785 . . . . 0.0 110.004 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.8 t -147.76 118.24 7.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.376 -0.828 . . . . 0.0 109.158 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 56.53 32.05 20.12 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.749 -0.594 . . . . 0.0 110.176 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.81 13.25 83.33 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.488 ' OG1' ' NZ ' ' A' ' 37' ' ' LYS . 6.1 p -127.76 158.56 37.35 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.323 -1.104 . . . . 0.0 109.892 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.1 m -94.76 123.7 38.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.603 -0.686 . . . . 0.0 109.768 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.488 ' NZ ' ' OG1' ' A' ' 35' ' ' THR . 42.8 mmtm -127.26 141.96 51.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.565 -0.709 . . . . 0.0 109.195 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.1 m -84.81 146.65 27.24 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.621 -0.674 . . . . 0.0 109.816 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.7 137.63 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.521 -0.737 . . . . 0.0 109.169 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -102.49 131.9 48.88 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -127.1 155.0 44.01 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.619 -0.675 . . . . 0.0 109.672 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.6 -166.81 34.32 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.775 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -119.34 139.96 51.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.662 -0.905 . . . . 0.0 109.516 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 tt -122.96 132.99 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -132.84 156.4 47.22 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.28 -0.888 . . . . 0.0 111.142 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -143.67 -144.33 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 23.4 p-10 -88.22 -1.39 57.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 109.14 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.531 ' OG1' ' N ' ' A' ' 49' ' ' ALA . 30.4 p -101.23 -69.69 0.77 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.507 -0.745 . . . . 0.0 109.613 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.531 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -162.86 -148.2 0.13 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 109.788 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -137.92 153.51 49.5 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.497 -0.752 . . . . 0.0 109.901 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.0 tt -152.24 154.87 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.174 -0.954 . . . . 0.0 109.998 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.85 143.42 41.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.419 -0.801 . . . . 0.0 110.355 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.1 pt -132.46 153.9 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.724 -0.61 . . . . 0.0 109.568 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.1 p -143.71 121.34 11.82 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 p -113.36 138.86 49.44 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.603 -0.686 . . . . 0.0 109.418 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.546 ' C ' ' H ' ' A' ' 58' ' ' LYS . 67.7 m-85 -95.91 121.26 37.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.405 -0.809 . . . . 0.0 111.332 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.74 -31.45 0.28 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.546 ' H ' ' C ' ' A' ' 56' ' ' PHE . 68.9 mttm -72.9 135.02 45.03 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.962 -1.316 . . . . 0.0 110.061 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -88.26 155.36 19.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.368 -0.833 . . . . 0.0 109.893 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.7 mt -127.67 152.48 47.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.632 -0.668 . . . . 0.0 109.277 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -114.45 132.41 56.27 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.061 0.934 . . . . 0.0 110.149 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.7 t0 -65.0 139.18 58.73 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.818 0.818 . . . . 0.0 111.622 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.538 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.7 m 61.8 5.53 1.36 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.588 -0.695 . . . . 0.0 110.338 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 65' ' ' VAL . 64.1 t0 -81.78 129.24 34.66 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.005 -1.06 . . . . 0.0 110.26 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.405 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 1.7 m -83.34 119.36 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.7 m -138.16 163.27 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.72 0.771 . . . . 0.0 109.86 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.483 ' NH1' ' OD2' ' A' ' 69' ' ' ASP . 75.7 ttt-85 -123.28 125.53 45.23 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 77.7 mt -107.52 129.02 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.521 -0.737 . . . . 0.0 109.524 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.483 ' OD2' ' NH1' ' A' ' 67' ' ' ARG . 95.4 m-20 -113.76 148.9 35.68 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.415 0.626 . . . . 0.0 109.849 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.485 ' H ' ' H1 ' ' A' ' 1' ' ' SER . 48.2 t-20 60.85 36.95 18.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.734 -0.604 . . . . 0.0 109.546 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.32 133.4 42.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 109.511 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -84.57 131.11 34.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 110.253 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.4 t -87.62 134.14 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.488 -0.757 . . . . 0.0 109.47 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.57 154.74 44.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.152 -0.968 . . . . 0.0 109.527 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -116.48 117.82 30.95 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -126.45 133.17 51.29 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.668 -0.645 . . . . 0.0 109.766 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 56.57 31.79 19.72 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.274 0.559 . . . . 0.0 110.097 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.66 5.11 82.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -113.63 133.1 55.49 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.379 -1.071 . . . . 0.0 110.119 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.64 146.26 36.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.517 -0.739 . . . . 0.0 109.793 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 97.3 p -156.22 161.97 40.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.398 -0.814 . . . . 0.0 109.767 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.2 mt -105.84 130.61 53.78 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.5 t -107.76 127.83 54.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.0 109.413 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.08 107.67 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.46 -0.775 . . . . 0.0 109.356 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -96.0 -177.29 36.39 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -69.14 -17.27 63.81 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.254 -1.145 . . . . 0.0 109.315 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.6 m -84.45 -8.8 58.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.16 -0.963 . . . . 0.0 109.135 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.6 t -85.2 168.19 15.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.404 -0.81 . . . . 0.0 109.75 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -129.25 139.85 51.67 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.475 -0.765 . . . . 0.0 109.882 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.51 130.92 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -122.57 111.11 16.39 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.2 t -73.62 146.68 44.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.531 -0.731 . . . . 0.0 110.12 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 51.6 t -117.31 128.48 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.491 -0.756 . . . . 0.0 109.506 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.428 ' O ' ' O ' ' A' ' 95' ' ' VAL . 62.9 t30 -173.74 -29.09 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.452 ' CG1' ' N ' ' A' ' 96' ' ' ASN . 99.4 t 54.51 162.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.602 0.715 . . . . 0.0 110.733 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.452 ' N ' ' CG1' ' A' ' 95' ' ' VAL . 12.4 t-20 60.09 104.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.82 -0.55 . . . . 0.0 109.647 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.438 ' C ' ' O ' ' A' ' 96' ' ' ASN . 21.5 pt 34.69 59.08 2.29 Favored Pre-proline 0 N--CA 1.499 1.998 0 CA-C-O 121.177 0.513 . . . . 0.0 110.438 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 99' ' ' LEU . 60.0 Cg_endo -71.52 150.82 58.19 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.828 2.352 . . . . 0.0 112.368 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 98' ' ' PRO . 61.0 mt 59.25 124.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.732 0.777 . . . . 0.0 109.799 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 102' ' ' HIS . 98.3 mt-10 -72.65 141.96 48.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.505 -0.747 . . . . 0.0 110.428 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 41.36 -91.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.449 0.642 . . . . 0.0 110.432 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.534 ' N ' ' O ' ' A' ' 100' ' ' GLU . 59.6 t-80 45.84 89.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.661 0.743 . . . . 0.0 109.724 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.716 ' CG ' ' H ' ' A' ' 104' ' ' HIS . 48.3 t60 -76.73 -160.58 0.16 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.556 -0.715 . . . . 0.0 110.364 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.716 ' H ' ' CG ' ' A' ' 103' ' ' HIS . 98.7 m-70 57.65 92.54 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.628 0.727 . . . . 0.0 109.632 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -65.6 -39.72 91.87 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.488 -0.757 . . . . 0.0 109.221 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.578 -179.697 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.09 153.01 36.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.424 -0.797 . . . . 0.0 110.396 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.5 tp -77.19 129.55 36.1 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.315 -0.866 . . . . 0.0 109.786 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.2 m -137.43 162.27 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.626 0.727 . . . . 0.0 109.424 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -88.53 162.44 16.41 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.48 0.657 . . . . 0.0 109.965 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.415 HG22 HD11 ' A' ' 6' ' ' ILE . 96.8 mt -62.63 -42.74 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -72.49 -14.13 61.59 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.2 -0.938 . . . . 0.0 109.701 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -91.38 1.94 56.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.065 -1.022 . . . . 0.0 108.822 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.45 132.97 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 110.567 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.5 p -156.21 162.45 40.17 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.8 mt -71.92 -11.14 60.64 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.225 -0.922 . . . . 0.0 109.155 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.3 p -66.78 -17.83 65.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 13' ' ' THR . 10.4 p -123.04 84.17 50.9 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.51 -0.744 . . . . 0.0 109.528 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.73 -41.5 69.08 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.27 1.98 . . . . 0.0 111.609 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -119.26 131.41 55.78 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.365 0.602 . . . . 0.0 109.918 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.1 m -154.87 -173.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.246 -0.909 . . . . 0.0 109.744 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.8 p -131.39 137.02 48.5 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.49 158.63 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.415 -0.803 . . . . 0.0 109.865 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.5 mt -134.3 133.72 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.83 -171.16 36.6 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 118.741 -1.695 . . . . 0.0 110.351 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -114.67 121.2 42.66 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.766 -0.843 . . . . 0.0 108.984 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.11 133.56 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.929 -0.482 . . . . 0.0 109.727 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.3 p -136.85 158.38 44.58 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.442 0.639 . . . . 0.0 109.732 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.35 83.53 0.07 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.5 mm -85.44 130.76 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.227 -1.161 . . . . 0.0 109.728 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -131.28 136.37 48.12 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -106.37 137.74 43.81 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.469 -0.77 . . . . 0.0 110.308 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -144.35 159.62 42.4 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -133.97 146.5 50.51 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.165 -0.96 . . . . 0.0 110.089 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -144.25 163.76 32.73 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.367 -0.833 . . . . 0.0 109.113 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -83.57 138.46 33.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.314 -0.866 . . . . 0.0 110.828 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 t -152.63 130.71 11.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.841 . . . . 0.0 108.925 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.6 t0 60.86 21.99 12.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.551 -0.718 . . . . 0.0 109.456 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.17 14.44 76.84 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 82.2 p -135.43 148.56 49.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.513 -0.992 . . . . 0.0 109.955 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.3 m -85.25 129.93 34.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.435 -0.791 . . . . 0.0 109.618 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -124.38 143.13 50.77 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.687 0.756 . . . . 0.0 110.029 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.9 m -83.84 141.13 31.57 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.377 0.608 . . . . 0.0 110.123 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 p -137.49 137.63 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -102.51 133.41 47.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.379 -0.826 . . . . 0.0 109.198 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -124.3 158.52 32.39 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.56 -170.56 37.87 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -120.38 142.8 48.84 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.6 -0.941 . . . . 0.0 109.267 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 tt -125.91 140.07 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -132.78 156.9 46.26 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.514 -0.741 . . . . 0.0 110.267 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.562 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 39.4 t0 -146.16 -142.28 0.13 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.562 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 66.3 t0 -87.55 -21.03 25.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.351 -0.843 . . . . 0.0 109.634 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.3 p -91.04 -76.61 0.44 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.086 -1.009 . . . . 0.0 109.866 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.11 -148.47 0.26 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 109.748 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.6 ptt-85 -142.57 159.17 42.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.577 -0.702 . . . . 0.0 109.702 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.4 tt -153.17 162.07 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.039 -1.038 . . . . 0.0 109.969 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -76.53 142.92 40.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.681 -0.637 . . . . 0.0 109.793 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.4 pt -129.22 153.75 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.532 -0.73 . . . . 0.0 109.433 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 p -142.25 132.57 24.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.59 -0.693 . . . . 0.0 109.259 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.2 t -119.23 128.67 54.41 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -92.73 122.76 35.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.183 -0.948 . . . . 0.0 110.409 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.48 -51.29 3.31 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -77.43 134.28 38.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.953 -1.322 . . . . 0.0 110.822 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -93.07 160.0 15.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.584 -0.697 . . . . 0.0 110.116 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.8 mt -121.72 153.55 38.07 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -102.23 147.58 26.48 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.736 0.779 . . . . 0.0 110.32 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 63' ' ' SER . 66.7 t0 -67.23 137.52 56.24 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.998 0.904 . . . . 0.0 111.947 -178.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.541 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 55.5 m 48.79 80.64 0.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.557 0.694 . . . . 0.0 110.803 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -152.46 126.2 8.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.535 -0.728 . . . . 0.0 109.929 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.0 t -80.81 120.23 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.395 -0.816 . . . . 0.0 109.265 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.6 m -138.52 163.99 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.929 0.871 . . . . 0.0 110.575 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -115.69 124.01 49.78 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 87.9 mt -109.5 124.66 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -111.53 144.65 40.42 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.636 -0.665 . . . . 0.0 109.836 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.6 t30 65.42 37.25 6.31 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.554 0.692 . . . . 0.0 109.231 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.38 143.03 53.81 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -96.39 125.76 41.11 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.704 . . . . 0.0 109.536 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.1 t -85.51 130.23 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.811 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.86 141.47 30.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.378 -0.826 . . . . 0.0 108.782 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.417 ' OE1' ' O ' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -116.18 138.03 51.62 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.657 -0.652 . . . . 0.0 109.351 -179.737 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -132.36 135.63 46.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.536 -0.728 . . . . 0.0 109.965 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.2 t30 57.78 24.72 11.06 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.364 0.602 . . . . 0.0 109.703 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.79 33.62 29.83 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -138.33 121.31 16.66 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.321 -1.105 . . . . 0.0 109.48 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.3 mt -67.76 143.74 55.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.616 -0.677 . . . . 0.0 110.449 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.8 m -152.67 154.25 34.93 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.1 mt -101.85 126.5 48.75 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.214 -0.928 . . . . 0.0 109.711 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.7 m -106.91 125.55 51.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.718 -0.614 . . . . 0.0 109.443 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.8 t -98.81 108.33 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.349 -0.845 . . . . 0.0 108.834 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.39 179.82 42.17 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 87' ' ' SER . 38.4 p30 -67.83 -21.03 65.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.545 -0.973 . . . . 0.0 109.546 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.522 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 92.2 p -81.52 -7.96 59.66 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.143 -0.973 . . . . 0.0 109.207 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.5 t -80.42 158.47 25.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.965 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -117.69 127.8 54.28 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.1 mt -111.93 130.32 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.545 -0.722 . . . . 0.0 109.692 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -130.21 114.47 15.71 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.9 m -79.71 131.33 35.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.565 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.5 t -131.6 131.39 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.497 -0.752 . . . . 0.0 109.578 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.8 m120 56.24 36.52 27.59 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.567 -0.708 . . . . 0.0 109.609 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.7 p -63.7 135.19 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.354 -0.841 . . . . 0.0 110.046 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -94.37 150.99 19.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.295 -0.878 . . . . 0.0 109.844 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.6 mm -125.41 69.37 61.32 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.59 156.59 57.53 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.229 1.953 . . . . 0.0 111.957 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 80.5 mt -70.58 146.73 49.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.933 . . . . 0.0 110.36 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -148.64 -22.56 0.32 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.508 ' O ' ' ND1' ' A' ' 101' ' ' HIS . 12.1 p80 -87.41 140.49 29.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 0.0 110.055 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -150.37 36.72 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -153.17 -61.28 0.14 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.483 -0.761 . . . . 0.0 109.62 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.552 ' O ' ' CG ' ' A' ' 105' ' ' HIS . 86.5 t60 -66.39 -40.89 89.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.34 -0.85 . . . . 0.0 109.792 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.552 ' CG ' ' O ' ' A' ' 104' ' ' HIS . 10.9 p80 41.24 -163.25 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.457 0.646 . . . . 0.0 110.711 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.416 ' CG ' ' O ' ' A' ' 105' ' ' HIS . 79.5 m80 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.1 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.447 ' H3 ' ' H ' ' A' ' 2' ' ' ASP . 28.1 t . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.447 ' H ' ' H3 ' ' A' ' 1' ' ' SER . 36.1 p-10 -173.66 140.02 0.75 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.451 -0.781 . . . . 0.0 109.309 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.5 tp -76.19 123.92 26.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.331 -0.856 . . . . 0.0 109.809 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.48 163.66 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.71 0.767 . . . . 0.0 110.142 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -79.29 156.88 27.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.753 -0.592 . . . . 0.0 110.084 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.22 -43.35 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.17 -21.89 66.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 109.609 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -86.87 -1.38 57.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.204 -0.935 . . . . 0.0 109.666 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.6 t -70.3 130.86 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.165 -0.959 . . . . 0.0 110.316 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.2 p -162.73 166.82 23.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.564 -0.71 . . . . 0.0 109.579 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 11' ' ' LEU . 3.7 mm? -67.84 -3.5 9.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -0.8 . . . . 0.0 109.027 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.1 p -63.72 -32.02 73.38 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.362 -0.836 . . . . 0.0 109.472 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 p -114.67 134.42 22.39 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.45 -0.781 . . . . 0.0 109.783 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.69 -55.01 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.151 1.901 . . . . 0.0 112.148 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -115.5 134.88 54.65 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.554 -0.716 . . . . 0.0 110.09 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.8 m -141.4 160.6 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.504 -0.747 . . . . 0.0 109.809 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.4 t -116.05 134.49 54.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.77 162.54 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.447 -0.783 . . . . 0.0 110.1 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.2 tt -140.26 139.48 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.537 -0.727 . . . . 0.0 109.337 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 172.63 -169.0 42.15 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.997 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -106.69 133.07 51.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.541 -0.976 . . . . 0.0 109.414 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.443 ' N ' ' CD1' ' A' ' 22' ' ' ILE . 2.0 mp -94.0 129.98 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.208 0.527 . . . . 0.0 109.907 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.5 p -139.93 155.92 46.92 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.397 -0.814 . . . . 0.0 110.233 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.35 71.26 1.17 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 25' ' ' ILE . 37.2 mm -81.35 130.58 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -1.177 . . . . 0.0 110.329 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -132.83 139.22 47.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -108.82 136.33 48.55 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.475 -0.766 . . . . 0.0 109.922 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -148.51 153.76 38.88 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -114.83 145.22 42.39 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.53 -0.732 . . . . 0.0 109.727 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -138.43 159.72 41.35 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.53 -0.732 . . . . 0.0 109.437 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -91.81 99.12 12.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.432 -0.792 . . . . 0.0 110.192 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 34' ' ' GLY . 8.3 t -77.9 -151.7 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.59 -0.694 . . . . 0.0 109.768 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -54.6 75.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.292 0.568 . . . . 0.0 110.474 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 61.97 19.56 59.05 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.3 m -140.02 133.11 29.54 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.262 -1.14 . . . . 0.0 110.166 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.4 m -78.38 128.86 34.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.327 -0.858 . . . . 0.0 109.367 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -132.72 144.49 50.32 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.397 -0.814 . . . . 0.0 109.945 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.5 p -84.78 146.41 27.39 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.424 -0.798 . . . . 0.0 109.773 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -139.0 138.55 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.613 -0.68 . . . . 0.0 109.46 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -100.36 135.34 41.95 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -127.97 157.36 40.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.621 -0.674 . . . . 0.0 109.433 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.49 -168.2 35.59 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -122.89 141.71 51.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.619 -0.93 . . . . 0.0 109.572 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.14 144.41 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -129.83 153.13 48.58 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.285 0.564 . . . . 0.0 109.643 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 20.6 t0 -144.41 -147.63 0.22 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.441 -0.787 . . . . 0.0 109.614 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.553 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 36.8 t70 -84.65 -7.7 59.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.805 . . . . 0.0 110.982 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.3 p -108.31 -66.18 1.06 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.13 -0.981 . . . . 0.0 109.998 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -157.56 -147.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 109.664 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.7 ptt85 -140.24 154.82 47.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.44 -0.787 . . . . 0.0 110.325 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.9 tt -146.32 161.27 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.523 -0.736 . . . . 0.0 109.939 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.85 145.07 40.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.516 -0.74 . . . . 0.0 110.16 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.6 pt -133.26 153.13 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.536 -0.727 . . . . 0.0 109.969 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 t -144.47 141.6 29.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.726 -0.609 . . . . 0.0 109.365 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.6 p -132.71 137.59 46.96 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.456 -0.777 . . . . 0.0 109.06 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -94.77 125.99 39.79 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.365 -0.835 . . . . 0.0 110.905 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.76 -44.52 0.64 Allowed Glycine 0 N--CA 1.493 2.434 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.804 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -73.95 136.22 43.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.989 -1.3 . . . . 0.0 110.782 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -95.54 158.12 15.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.642 -0.661 . . . . 0.0 110.084 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.4 mt -123.11 153.42 39.99 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -111.93 137.31 50.08 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.669 0.747 . . . . 0.0 110.265 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.462 ' O ' ' OG ' ' A' ' 63' ' ' SER . 24.1 t70 -66.79 136.87 56.11 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.412 0.625 . . . . 0.0 110.907 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 62' ' ' ASP . 12.9 p 66.32 78.84 0.25 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.531 0.682 . . . . 0.0 110.363 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 46.1 p-10 -162.89 121.37 2.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 109.56 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 t -82.96 116.14 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.1 m -137.43 162.06 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.502 -0.749 . . . . 0.0 110.248 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -115.81 126.66 54.3 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.5 mt -106.15 127.31 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -111.68 145.5 39.14 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.251 0.548 . . . . 0.0 109.693 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.4 t30 66.2 35.81 5.85 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.35 136.52 42.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.476 -0.765 . . . . 0.0 109.137 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -91.55 133.51 35.46 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.102 -0.999 . . . . 0.0 110.121 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.2 t -88.1 132.03 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.431 -0.793 . . . . 0.0 109.548 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.03 164.11 26.11 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -122.99 124.27 42.78 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.75 0.786 . . . . 0.0 110.168 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.664 ' O ' ' N ' ' A' ' 78' ' ' GLY . 15.6 m-85 -84.5 -178.0 6.78 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 76' ' ' PHE . 97.6 m-20 -36.98 -18.39 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.074 0.464 . . . . 0.0 110.787 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.664 ' N ' ' O ' ' A' ' 76' ' ' PHE . . . 172.35 29.81 0.03 OUTLIER Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -141.46 140.7 33.62 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.313 -1.11 . . . . 0.0 110.345 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 80.4 mt -77.35 148.95 35.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.418 -0.801 . . . . 0.0 110.07 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.2 p -155.86 159.24 39.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.432 -0.793 . . . . 0.0 109.726 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.3 mt -113.29 126.23 55.16 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 p -106.17 131.12 53.8 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.571 -0.706 . . . . 0.0 109.41 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.4 t -101.13 114.91 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.37 -0.831 . . . . 0.0 109.298 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.37 177.01 37.5 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 37.2 p-10 -68.12 -23.25 64.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.503 -0.998 . . . . 0.0 110.106 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 95.4 p -85.0 -4.11 59.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.022 -1.048 . . . . 0.0 109.496 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.2 t -80.6 172.38 13.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 0.0 109.91 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -129.4 141.71 50.98 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.641 -0.662 . . . . 0.0 109.689 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -123.84 129.59 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -125.7 114.94 19.32 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.528 -0.732 . . . . 0.0 109.368 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.5 p -79.14 155.59 28.63 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.522 -0.736 . . . . 0.0 109.958 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.4 t -135.47 84.67 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.456 -0.778 . . . . 0.0 108.964 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -110.29 -59.34 1.95 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.5 m -114.67 132.35 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.53 0.681 . . . . 0.0 109.775 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.453 ' O ' ' C ' ' A' ' 97' ' ' ILE . 9.7 m120 -62.56 150.23 41.0 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.589 -0.695 . . . . 0.0 110.368 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.453 ' C ' ' O ' ' A' ' 96' ' ' ASN . 8.2 pt 30.74 78.57 0.29 Allowed Pre-proline 0 N--CA 1.5 2.06 0 CA-C-O 120.882 0.373 . . . . 0.0 110.989 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.65 146.44 95.34 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.69 2.26 . . . . 0.0 112.515 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 79.1 mt -89.55 -2.34 58.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.402 -0.811 . . . . 0.0 109.121 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.71 133.04 50.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.178 -0.952 . . . . 0.0 109.623 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' A' ' 102' ' ' HIS . 44.3 p-80 -103.06 108.73 20.03 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.617 0.722 . . . . 0.0 109.838 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.497 ' CD2' ' O ' ' A' ' 106' ' ' HIS . 78.3 m80 44.13 -173.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.771 0.796 . . . . 0.0 110.97 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -66.96 -42.58 84.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.622 -0.674 . . . . 0.0 109.942 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -165.64 -74.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.636 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.675 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 0.2 OUTLIER -94.82 99.37 11.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.386 -0.821 . . . . 0.0 109.86 -179.633 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.497 ' O ' ' CD2' ' A' ' 102' ' ' HIS . 76.5 m80 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.856 -1.069 . . . . 0.0 110.069 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.528 ' H3 ' ' H ' ' A' ' 70' ' ' ASN . 12.2 t . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.287 0.565 . . . . 0.0 109.936 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.461 ' N ' ' OG ' ' A' ' 1' ' ' SER . 99.6 m-20 -72.01 151.07 43.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.44 -0.787 . . . . 0.0 110.143 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.5 tp -74.27 125.06 27.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.411 -0.806 . . . . 0.0 109.742 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.3 m -138.99 162.74 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.474 -0.766 . . . . 0.0 109.21 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.55 ' N ' ' OD2' ' A' ' 8' ' ' ASP . 64.1 mttp -74.65 151.64 39.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 110.527 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.92 -43.03 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.606 -0.684 . . . . 0.0 109.634 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -59.2 -31.94 69.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.473 -0.767 . . . . 0.0 110.562 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.55 ' OD2' ' N ' ' A' ' 5' ' ' LYS . 6.9 p30 -83.43 11.18 7.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.114 -0.991 . . . . 0.0 110.504 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.4 t -68.57 132.24 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.917 . . . . 0.0 110.069 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 m -161.5 170.08 20.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.364 -0.835 . . . . 0.0 110.153 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.27 -34.51 78.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.428 -0.795 . . . . 0.0 109.619 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -50.63 -17.82 0.59 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.457 -0.777 . . . . 0.0 109.743 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 p -121.36 82.92 39.51 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.77 -41.59 61.58 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.43 2.087 . . . . 0.0 112.089 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -121.32 128.81 52.67 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.7 m -144.27 160.3 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.181 -0.949 . . . . 0.0 109.653 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.2 m -116.74 133.6 55.81 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.53 163.06 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.391 -0.818 . . . . 0.0 109.459 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.5 mt -127.58 133.27 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 174.66 -163.56 34.07 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.455 -1.355 . . . . 0.0 109.959 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -125.81 143.52 51.03 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.798 -0.824 . . . . 0.0 109.346 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 63' ' ' SER . 3.8 mp -98.21 132.8 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.378 0.609 . . . . 0.0 110.615 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.7 p -134.49 157.17 47.19 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.327 0.584 . . . . 0.0 109.876 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.85 78.02 0.4 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.519 ' N ' ' CD1' ' A' ' 25' ' ' ILE . 1.4 mp -90.89 120.28 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.267 -1.137 . . . . 0.0 109.614 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -114.74 122.58 46.85 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -86.13 134.65 33.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 110.157 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -146.67 153.33 40.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.383 -0.823 . . . . 0.0 108.861 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -116.3 144.04 44.75 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.434 -0.791 . . . . 0.0 109.64 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -141.64 162.88 34.39 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.229 -0.919 . . . . 0.0 109.327 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -88.08 98.87 11.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.997 . . . . 0.0 109.251 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.567 ' O ' ' N ' ' A' ' 34' ' ' GLY . 9.3 t -84.31 -151.68 0.13 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.488 -0.758 . . . . 0.0 110.188 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 35' ' ' THR . 99.4 m-20 -50.43 84.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.692 -0.63 . . . . 0.0 110.278 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 49.45 15.3 0.73 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.427 ' N ' ' O ' ' A' ' 33' ' ' ASP . 35.7 p -140.24 145.96 38.03 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.321 -1.105 . . . . 0.0 109.372 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.2 m -84.41 129.2 34.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.514 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -129.11 147.1 50.93 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.461 -0.774 . . . . 0.0 109.505 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 p -84.01 152.13 24.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.489 -0.757 . . . . 0.0 109.716 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.3 p -142.62 139.01 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -106.97 132.0 53.41 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -119.0 147.18 44.37 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.555 -0.715 . . . . 0.0 109.18 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.62 -169.67 33.18 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -117.23 141.6 48.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.754 -0.851 . . . . 0.0 109.386 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.2 tt -117.77 144.92 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -134.11 160.46 37.73 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.469 0.652 . . . . 0.0 110.205 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.549 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 45.0 t0 -157.84 -167.01 2.12 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.549 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 98.2 m-20 -68.13 -16.4 63.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.877 . . . . 0.0 109.756 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.3 p -90.0 -73.96 0.5 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.5 -144.68 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 109.788 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -146.49 153.75 40.77 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.976 . . . . 0.0 110.361 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.2 tt -152.93 159.59 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.365 -0.835 . . . . 0.0 109.766 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.5 ttp85 -75.21 146.13 41.45 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.24 -0.912 . . . . 0.0 110.288 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.3 pt -134.99 163.66 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.497 -0.752 . . . . 0.0 110.086 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.7 t -143.72 128.97 18.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.379 -0.826 . . . . 0.0 108.844 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.4 t -113.15 121.88 45.84 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.543 -0.723 . . . . 0.0 109.093 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -97.6 120.09 37.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.448 -0.783 . . . . 0.0 110.397 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.24 -63.21 4.02 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -71.96 136.79 46.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -1.124 . . . . 0.0 110.6 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -96.18 155.8 16.61 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.44 -0.787 . . . . 0.0 109.463 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.5 mt -128.18 161.62 28.87 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.543 -0.723 . . . . 0.0 109.773 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -112.57 152.99 28.22 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 122.108 0.956 . . . . 0.0 110.145 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 63' ' ' SER . 68.2 t0 -63.1 139.22 58.75 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 111.288 -178.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.543 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.7 m 58.59 28.58 17.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.584 -0.698 . . . . 0.0 109.566 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -82.78 114.68 21.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 109.792 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.45 113.5 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.269 -0.894 . . . . 0.0 108.998 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 m -141.19 165.07 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.398 -0.814 . . . . 0.0 110.185 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -106.4 126.3 52.07 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.2 mm -108.15 126.49 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -122.6 143.83 49.5 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.528 ' H ' ' H3 ' ' A' ' 1' ' ' SER . 65.0 t30 62.64 40.94 9.82 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.73 131.5 41.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 0.0 108.989 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -82.4 131.8 35.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.219 -0.926 . . . . 0.0 110.098 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.1 t -91.32 131.19 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.426 -0.797 . . . . 0.0 109.52 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.92 153.25 49.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.448 -0.782 . . . . 0.0 108.96 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -116.18 119.14 34.85 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.538 -0.726 . . . . 0.0 109.278 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -125.02 133.25 53.04 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.604 -0.685 . . . . 0.0 109.496 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.1 m120 55.37 31.26 16.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.707 -0.621 . . . . 0.0 109.94 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.6 6.6 84.83 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.521 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -113.95 133.42 55.48 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.47 -1.018 . . . . 0.0 109.71 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.3 mt -76.68 146.37 38.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.508 -0.745 . . . . 0.0 110.036 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.5 t -154.65 154.13 32.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.518 -0.739 . . . . 0.0 109.016 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.1 mt -103.42 129.51 50.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.379 -0.826 . . . . 0.0 109.114 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.2 t -105.19 128.38 53.37 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.699 -0.626 . . . . 0.0 109.562 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.52 99.94 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -97.08 -169.73 33.52 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -68.89 -17.29 63.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.565 -0.962 . . . . 0.0 109.634 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.8 m -83.12 -8.42 59.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.389 -0.819 . . . . 0.0 109.681 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.6 t -88.9 166.68 13.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 109.982 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -125.1 133.53 52.83 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 94.0 mt -119.29 128.38 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -126.5 132.1 51.47 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.537 -0.727 . . . . 0.0 109.46 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.9 t -66.18 132.79 49.27 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.549 -0.719 . . . . 0.0 110.223 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.6 t -107.11 -52.57 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -134.99 -57.8 0.81 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 96' ' ' ASN . 2.0 t 52.45 29.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.689 -0.632 . . . . 0.0 109.378 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 95' ' ' VAL . 97.3 m-20 58.31 128.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.601 0.715 . . . . 0.0 110.477 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.636 ' N ' ' CD ' ' A' ' 98' ' ' PRO . 1.6 mt -108.99 -34.73 0.15 Allowed Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.724 -0.61 . . . . 0.0 109.687 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 97' ' ' ILE . 80.6 Cg_endo -87.86 -3.37 7.26 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 122.165 1.91 . . . . 0.0 111.468 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 98' ' ' PRO . 10.1 mp 58.21 136.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.579 0.704 . . . . 0.0 110.043 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.86 -179.69 2.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.52 -0.738 . . . . 0.0 110.815 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -68.05 140.95 56.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.613 -0.679 . . . . 0.0 110.172 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -77.4 141.27 39.88 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.46 -0.775 . . . . 0.0 110.545 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 104' ' ' HIS . 32.8 p80 -78.5 -15.74 58.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.506 -0.746 . . . . 0.0 109.314 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' HIS . 85.5 t60 55.72 159.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.464 0.65 . . . . 0.0 110.531 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.42 ' N ' ' CG ' ' A' ' 104' ' ' HIS . 6.7 p80 -152.37 162.28 41.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.433 -0.792 . . . . 0.0 109.561 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.506 ' O ' ' ND1' ' A' ' 106' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.327 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.8 0.81 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 54.3 tp -76.19 124.34 27.31 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.62 0.724 . . . . 0.0 110.348 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.4 m -139.18 164.26 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.829 0.823 . . . . 0.0 110.144 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -80.69 161.02 24.81 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.708 0.766 . . . . 0.0 110.26 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.81 -43.27 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.216 0.531 . . . . 0.0 109.678 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -67.47 -18.8 65.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.783 -0.573 . . . . 0.0 109.649 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -86.04 -0.09 54.7 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.558 -0.714 . . . . 0.0 109.713 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.9 t -67.22 130.16 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.908 0.861 . . . . 0.0 110.344 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.9 p -160.86 167.27 27.01 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.769 0.795 . . . . 0.0 109.971 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.494 HD11 ' NE2' ' A' ' 75' ' ' GLN . 93.7 mt -66.72 -21.62 66.07 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.3 t -61.4 -20.24 62.83 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 51.6 p -124.92 80.96 62.81 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.749 -0.594 . . . . 0.0 109.461 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.73 -40.62 73.5 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.681 2.254 . . . . 0.0 111.705 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -112.8 125.81 54.75 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.647 0.736 . . . . 0.0 109.207 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.4 m -149.76 160.22 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 122.155 0.978 . . . . 0.0 111.058 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.2 t -118.33 134.17 55.27 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.49 162.38 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 121.972 0.891 . . . . 0.0 110.391 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.6 tt -140.97 135.57 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.637 0.732 . . . . 0.0 109.675 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.0 -165.99 37.42 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -113.44 136.67 52.52 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.733 0.777 . . . . 0.0 110.115 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.694 ' N ' HD12 ' A' ' 22' ' ' ILE . 2.5 mp -96.19 137.08 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.475 0.655 . . . . 0.0 109.72 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.4 p -131.1 158.68 39.75 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.009 0.909 . . . . 0.0 110.348 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.62 93.55 0.01 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.8 mm -93.4 124.52 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.804 -0.821 . . . . 0.0 109.829 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -120.39 139.66 52.49 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.807 0.813 . . . . 0.0 109.53 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -108.04 134.46 50.89 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.838 0.828 . . . . 0.0 110.234 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -144.04 154.93 43.76 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.675 0.75 . . . . 0.0 109.452 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -123.54 144.87 49.29 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.842 0.83 . . . . 0.0 110.23 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -144.21 158.44 43.73 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.827 0.822 . . . . 0.0 109.861 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -87.92 115.44 25.39 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.601 0.715 . . . . 0.0 110.075 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 t -113.35 113.07 24.72 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.733 0.778 . . . . 0.0 109.492 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.1 t0 55.93 29.46 14.27 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.279 0.561 . . . . 0.0 109.743 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.99 2.45 80.92 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.4 m -118.13 127.6 53.93 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.758 -0.848 . . . . 0.0 109.928 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.8 m -69.31 129.63 40.33 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.632 0.73 . . . . 0.0 110.317 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -130.99 139.86 50.06 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.746 0.784 . . . . 0.0 109.72 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.5 m -86.26 141.76 29.05 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.015 0.912 . . . . 0.0 110.723 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -136.49 135.53 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.856 0.836 . . . . 0.0 109.485 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -101.61 133.48 46.23 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.692 0.758 . . . . 0.0 109.791 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -121.78 151.96 40.01 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.837 0.827 . . . . 0.0 109.667 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.41 -172.93 39.99 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.593 ' CB ' HH21 ' A' ' 50' ' ' ARG . 68.0 m-85 -117.35 142.99 46.43 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.695 0.759 . . . . 0.0 109.863 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.5 tt -125.84 139.87 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -133.56 159.54 40.14 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.128 0.966 . . . . 0.0 110.653 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 37.3 t0 -145.08 -148.77 0.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.471 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.542 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 97.5 m-20 -80.02 -6.64 57.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.648 -0.657 . . . . 0.0 109.536 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.5 p -105.67 -91.11 0.4 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.73 -0.607 . . . . 0.0 109.888 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.51 -145.14 0.24 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.576 -0.703 . . . . 0.0 110.066 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.593 HH21 ' CB ' ' A' ' 43' ' ' TYR . 17.5 ptm180 -145.89 156.09 43.31 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.821 0.819 . . . . 0.0 110.783 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.8 tt -148.1 161.99 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.911 0.862 . . . . 0.0 110.297 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -79.44 147.77 32.18 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.589 0.709 . . . . 0.0 110.17 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.8 pt -134.98 157.0 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.912 0.863 . . . . 0.0 110.37 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 m -141.35 125.43 17.29 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.649 0.737 . . . . 0.0 109.558 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.5 t -116.43 130.23 56.65 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.963 0.887 . . . . 0.0 109.629 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -98.91 119.49 37.77 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.656 0.741 . . . . 0.0 109.86 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.69 -51.68 4.05 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -71.71 135.14 46.68 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.667 -0.902 . . . . 0.0 110.436 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -89.09 155.58 19.36 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.842 0.83 . . . . 0.0 110.903 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.2 mt -119.34 151.02 39.18 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.57 0.7 . . . . 0.0 109.563 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.406 ' O ' ' OD1' ' A' ' 64' ' ' ASP . 21.5 mp0 -112.49 142.29 45.23 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 122.385 1.088 . . . . 0.0 110.156 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 63' ' ' SER . 68.1 t0 -64.18 135.58 56.43 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.966 0.888 . . . . 0.0 111.876 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.522 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 2.1 p 53.47 23.7 3.58 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.527 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 20.4 p-10 -87.65 126.12 34.77 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.748 0.785 . . . . 0.0 110.426 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 65' ' ' VAL . 1.3 m -82.47 115.8 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-O 121.657 0.742 . . . . 0.0 108.998 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.8 m -140.67 162.77 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 122.041 0.924 . . . . 0.0 110.416 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.525 ' NH1' ' OD1' ' A' ' 69' ' ' ASP . 68.9 ttp85 -117.39 127.82 54.42 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.701 0.762 . . . . 0.0 109.288 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.7 mt -107.25 129.48 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.754 0.787 . . . . 0.0 109.495 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.525 ' OD1' ' NH1' ' A' ' 67' ' ' ARG . 96.5 m-20 -116.41 144.27 44.51 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.688 0.756 . . . . 0.0 109.969 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.1 t30 62.91 39.57 10.33 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.842 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.26 146.74 47.04 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.4 0.619 . . . . 0.0 110.047 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -104.91 125.83 51.34 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.805 0.812 . . . . 0.0 110.095 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.0 t -86.55 133.22 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.699 0.761 . . . . 0.0 110.052 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.7 160.03 43.14 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.848 0.833 . . . . 0.0 109.955 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.494 ' NE2' HD11 ' A' ' 11' ' ' LEU . 77.5 mt-30 -107.44 114.37 28.34 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.699 0.762 . . . . 0.0 110.143 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -115.65 125.45 52.89 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.695 0.759 . . . . 0.0 109.472 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 57.22 29.61 17.0 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.48 13.33 82.75 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -120.27 135.92 54.84 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.831 0.824 . . . . 0.0 109.987 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.2 mt -77.28 143.77 38.62 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.591 0.71 . . . . 0.0 109.899 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.0 p -156.3 163.3 39.69 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.957 0.884 . . . . 0.0 110.491 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.6 mt -103.63 124.11 48.22 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.757 0.789 . . . . 0.0 109.341 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.0 m -103.2 122.76 45.4 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.671 0.748 . . . . 0.0 110.104 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.699 HG11 HD11 ' A' ' 90' ' ' ILE . 6.9 t -99.23 105.55 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.65 0.738 . . . . 0.0 109.596 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.434 ' O ' ' OG ' ' A' ' 88' ' ' SER . . . -91.76 -176.43 42.72 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.82 -16.71 62.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.95 -0.735 . . . . 0.0 109.322 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 87.6 p -85.91 -15.36 41.95 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 85' ' ' GLY . 25.5 p -82.68 167.16 18.5 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.567 0.699 . . . . 0.0 110.05 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -126.74 138.3 53.36 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.785 0.802 . . . . 0.0 109.879 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.699 HD11 HG11 ' A' ' 84' ' ' VAL . 98.2 mt -122.32 127.55 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.493 0.664 . . . . 0.0 109.447 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -124.39 126.59 46.21 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.925 0.869 . . . . 0.0 110.253 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.0 p -76.35 150.02 36.91 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.455 0.645 . . . . 0.0 110.17 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.7 t . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 121.775 0.798 . . . . 0.0 109.712 -179.875 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 55.7 t0 . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.753 0.787 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.539 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 38.8 tp -69.5 128.7 37.45 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.504 0.669 . . . . 0.0 110.027 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.1 m -138.89 163.59 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.9 0.857 . . . . 0.0 109.968 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -75.32 156.65 35.33 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.75 0.786 . . . . 0.0 110.076 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.1 mm -62.65 -44.58 99.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.797 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -68.61 -20.96 64.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.562 -0.711 . . . . 0.0 109.504 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -82.77 -3.86 57.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.539 -0.726 . . . . 0.0 109.166 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.8 t -69.99 128.86 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.975 0.893 . . . . 0.0 109.915 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 12' ' ' SER . 29.7 m -163.6 162.66 24.43 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.566 0.698 . . . . 0.0 109.399 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.7 mt -64.58 -2.31 2.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.784 -0.573 . . . . 0.0 109.555 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.41 ' H ' ' C ' ' A' ' 10' ' ' SER . 78.6 p -61.0 -32.64 72.21 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.6 p -117.07 145.22 35.22 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.729 -0.607 . . . . 0.0 110.168 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.28 -61.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.999 2.466 . . . . 0.0 112.422 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 100.0 m-85 -119.75 136.53 54.4 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.858 0.837 . . . . 0.0 110.339 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.9 m -140.52 164.0 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.688 0.756 . . . . 0.0 109.973 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.431 ' O ' HD12 ' A' ' 3' ' ' LEU . 68.2 m -118.96 145.09 46.09 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.756 0.789 . . . . 0.0 109.494 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.24 160.27 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 122.114 0.959 . . . . 0.0 110.639 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 19' ' ' ILE . 19.5 tt -138.27 130.25 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.665 0.745 . . . . 0.0 109.457 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.58 -156.24 21.53 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -124.93 139.11 54.12 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.919 -0.753 . . . . 0.0 109.839 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.723 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.0 mp -92.2 132.18 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.391 0.615 . . . . 0.0 110.08 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.0 m -125.76 143.87 50.87 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.058 0.932 . . . . 0.0 109.866 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.76 97.02 0.04 OUTLIER Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.6 mm -95.01 125.88 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.962 0.887 . . . . 0.0 110.408 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -123.4 134.51 53.96 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.556 0.693 . . . . 0.0 109.226 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -108.31 132.9 53.23 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.947 0.88 . . . . 0.0 110.037 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -140.76 158.27 44.21 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.772 0.796 . . . . 0.0 109.718 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -120.43 145.05 47.6 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.783 0.801 . . . . 0.0 109.983 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.441 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 13.7 p90 -141.61 159.42 42.27 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.18 0.99 . . . . 0.0 110.088 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -96.69 132.26 42.54 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.532 0.682 . . . . 0.0 109.471 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.0 t -159.16 141.1 13.54 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.743 0.782 . . . . 0.0 110.189 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 55.65 28.37 11.93 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.25 0.548 . . . . 0.0 109.759 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.36 14.66 79.2 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.7 p -135.87 155.06 50.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.61 -0.935 . . . . 0.0 109.874 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.6 m -98.2 126.24 43.58 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.88 0.848 . . . . 0.0 109.818 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.441 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 98.9 mttt -125.62 142.1 51.68 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.819 0.818 . . . . 0.0 109.325 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 90.8 p -84.57 146.37 27.57 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.841 0.829 . . . . 0.0 110.368 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -133.51 136.99 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.822 0.82 . . . . 0.0 109.821 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.514 ' CZ ' ' OE1' ' A' ' 59' ' ' GLN . 94.4 m-85 -101.95 131.2 48.49 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.763 0.792 . . . . 0.0 109.725 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -126.12 155.24 41.96 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.93 0.871 . . . . 0.0 109.943 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.9 -166.93 35.19 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.618 ' CD2' ' NH2' ' A' ' 50' ' ' ARG . 97.2 m-85 -119.79 140.37 50.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.81 -0.818 . . . . 0.0 110.072 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.4 tt -122.79 133.19 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -134.32 156.23 48.84 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 122.277 1.037 . . . . 0.0 110.561 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 48' ' ' THR . 5.4 p30 -168.09 95.32 0.41 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.646 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' THR . 66.8 t0 52.4 -77.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 120.936 0.398 . . . . 0.0 110.571 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.589 ' N ' ' O ' ' A' ' 46' ' ' ASP . 73.9 p -38.62 -80.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.086 0.47 . . . . 0.0 110.456 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.404 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -158.21 -143.67 0.11 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.698 0.761 . . . . 0.0 110.087 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.618 ' NH2' ' CD2' ' A' ' 43' ' ' TYR . 8.9 ptm180 -142.87 150.68 40.18 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.761 0.791 . . . . 0.0 110.4 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.6 tt -146.54 156.26 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.747 0.784 . . . . 0.0 110.085 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -76.69 147.2 37.57 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.735 0.779 . . . . 0.0 109.973 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.2 pt -135.05 154.47 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.644 0.735 . . . . 0.0 110.273 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 t -143.17 133.42 24.54 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.858 0.837 . . . . 0.0 109.551 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 p -131.09 135.28 47.38 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.973 0.892 . . . . 0.0 109.887 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.446 ' C ' ' H ' ' A' ' 58' ' ' LYS . 90.7 m-85 -94.8 122.33 37.3 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.699 0.761 . . . . 0.0 111.025 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.47 -29.46 0.58 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' A' ' 56' ' ' PHE . 98.9 mttt -74.11 136.84 42.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.568 -0.96 . . . . 0.0 110.607 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.514 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 68.7 tp60 -94.68 146.92 23.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.776 0.798 . . . . 0.0 110.495 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.9 mt -129.48 152.44 49.01 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.721 0.772 . . . . 0.0 109.927 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -122.93 137.64 54.89 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.216 1.008 . . . . 0.0 110.074 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 63' ' ' SER . 65.6 t0 -64.78 134.69 54.66 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.865 0.84 . . . . 0.0 111.462 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.53 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 2.8 p 78.29 8.19 2.31 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.862 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 7.3 p-10 -84.45 124.08 30.95 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.307 0.575 . . . . 0.0 110.803 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 t -87.02 116.76 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.637 0.732 . . . . 0.0 109.117 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.48 163.22 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.221 1.01 . . . . 0.0 110.945 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -119.27 128.99 54.68 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.7 mt -106.23 129.45 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.773 0.797 . . . . 0.0 109.543 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -114.81 143.51 44.99 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.849 0.833 . . . . 0.0 110.149 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.6 t30 62.12 37.89 14.19 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.2 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.95 145.7 46.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.583 -0.698 . . . . 0.0 109.426 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -96.04 132.34 41.5 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.828 0.823 . . . . 0.0 110.209 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 89.6 t -83.15 131.66 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 121.532 0.682 . . . . 0.0 109.974 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.64 154.28 43.37 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.683 0.754 . . . . 0.0 109.973 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -119.79 117.38 28.03 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.816 0.817 . . . . 0.0 109.924 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -119.85 131.51 55.29 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.852 0.834 . . . . 0.0 110.01 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.8 t30 56.64 24.32 8.73 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.239 0.542 . . . . 0.0 110.249 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.88 10.51 82.93 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -114.99 138.17 51.15 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.91 0.862 . . . . 0.0 109.755 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 80' ' ' LEU . 3.7 mm? -76.94 141.61 40.4 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.93 0.872 . . . . 0.0 110.699 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.3 p -153.52 159.24 42.19 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.752 0.787 . . . . 0.0 110.008 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.7 mt -108.56 126.39 52.88 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.791 0.805 . . . . 0.0 110.175 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.2 m -101.43 123.54 45.65 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.825 0.822 . . . . 0.0 109.656 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.7 t -101.02 111.29 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.843 0.83 . . . . 0.0 109.204 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.23 -178.71 37.22 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -68.2 -18.35 64.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 122.149 -0.618 . . . . 0.0 109.543 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 97.1 p -87.65 -7.53 57.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.669 -0.645 . . . . 0.0 109.455 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.1 t -83.69 164.92 19.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.456 -0.778 . . . . 0.0 109.556 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -128.54 139.27 52.39 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.754 0.788 . . . . 0.0 109.911 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.15 130.47 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.651 0.739 . . . . 0.0 109.45 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 91' ' ' GLU . 56.7 mp0 -115.72 125.53 52.93 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.83 0.824 . . . . 0.0 109.93 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.0 p -71.33 144.87 49.78 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.596 0.712 . . . . 0.0 110.559 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.2 t . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 121.936 0.874 . . . . 0.0 109.924 -179.772 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 60.5 t0 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.75 0.786 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.532 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 4.9 tt -71.17 133.82 46.46 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.686 -0.634 . . . . 0.0 110.726 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.2 m -135.84 162.91 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-O 121.567 0.698 . . . . 0.0 109.884 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -79.04 155.98 28.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.589 -0.695 . . . . 0.0 110.062 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.9 mt -63.54 -43.66 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.712 -0.618 . . . . 0.0 109.866 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 -72.31 -14.38 61.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.117 -0.989 . . . . 0.0 109.864 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -93.25 2.22 56.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.321 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.51 132.05 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.155 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.3 p -159.35 165.82 32.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.355 -0.841 . . . . 0.0 109.837 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.66 -19.07 65.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.523 -0.735 . . . . 0.0 109.762 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.2 m -57.51 -25.25 59.56 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.118 -0.989 . . . . 0.0 109.24 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 45.8 p -123.29 82.64 52.24 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.46 -40.36 71.79 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.641 2.227 . . . . 0.0 112.088 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -115.87 128.76 56.05 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.419 0.628 . . . . 0.0 109.832 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.2 m -153.04 -176.41 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.445 -0.785 . . . . 0.0 109.906 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.3 m -130.18 144.29 51.28 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.4 m -139.88 162.61 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.376 -0.827 . . . . 0.0 110.245 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 tp -141.52 127.93 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.68 -168.53 38.06 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.058 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -110.27 144.11 39.44 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.621 -0.929 . . . . 0.0 109.545 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.0 mm -95.07 133.44 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.364 0.602 . . . . 0.0 110.254 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -143.02 156.84 44.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.37 -0.831 . . . . 0.0 109.983 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.11 62.14 4.41 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.0 mm -76.94 129.78 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -1.125 . . . . 0.0 110.624 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -130.09 122.69 28.79 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.509 ' NZ ' ' OE2' ' A' ' 29' ' ' GLU . 66.0 tttm -86.41 136.93 32.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.355 -0.841 . . . . 0.0 110.022 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -146.64 139.85 25.57 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.509 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 97.2 mt-10 -115.1 148.15 39.32 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.664 -0.647 . . . . 0.0 110.154 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.541 ' CE2' ' OG ' ' A' ' 32' ' ' SER . 9.8 p90 -147.28 159.29 43.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.819 . . . . 0.0 109.188 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -84.07 119.98 25.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.4 -0.812 . . . . 0.0 110.318 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.541 ' OG ' ' CE2' ' A' ' 30' ' ' TYR . 3.1 m -119.41 114.17 21.91 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 55.36 31.94 17.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.56 -0.713 . . . . 0.0 109.881 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.74 6.43 88.49 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.2 m -120.89 128.56 52.91 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.525 -0.985 . . . . 0.0 109.874 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.4 m -68.25 134.72 50.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.602 -0.686 . . . . 0.0 110.042 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -131.58 147.29 52.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.441 -0.787 . . . . 0.0 109.34 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.5 t -99.9 135.09 41.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.631 -0.668 . . . . 0.0 109.939 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.94 138.09 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -105.41 134.35 48.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.527 -0.733 . . . . 0.0 109.476 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -123.51 150.86 43.42 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.391 0.615 . . . . 0.0 109.385 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.431 ' C ' ' CD1' ' A' ' 53' ' ' ILE . . . -173.82 -147.44 6.0 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.48 ' OH ' ' NH1' ' A' ' 52' ' ' ARG . 79.6 m-85 -132.92 141.58 48.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.573 -0.957 . . . . 0.0 109.549 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 tt -116.04 134.39 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -133.26 150.23 51.93 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.756 0.788 . . . . 0.0 110.719 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 48' ' ' THR . 62.8 t0 -167.36 95.55 0.47 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' THR . 38.8 t70 48.37 -79.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.812 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.601 ' N ' ' O ' ' A' ' 46' ' ' ASP . 14.5 m -36.29 -77.31 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.767 -0.583 . . . . 0.0 110.803 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -161.12 -153.99 0.34 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.032 -1.042 . . . . 0.0 109.426 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 -138.97 152.12 47.42 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.39 0.614 . . . . 0.0 110.572 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.0 tt -150.67 163.52 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.783 . . . . 0.0 110.167 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.48 ' NH1' ' OH ' ' A' ' 43' ' ' TYR . 77.2 mtp85 -79.31 149.19 31.85 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.514 0.673 . . . . 0.0 110.838 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.803 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -141.79 164.44 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.511 -0.743 . . . . 0.0 109.792 179.587 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 p -140.42 127.13 20.39 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -109.98 118.08 35.5 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.619 -0.675 . . . . 0.0 109.21 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.433 ' C ' ' H ' ' A' ' 58' ' ' LYS . 72.1 m-85 -95.4 123.85 39.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.448 -0.782 . . . . 0.0 110.806 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.15 -33.55 0.65 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 56' ' ' PHE . 31.1 mmtp -87.92 130.13 35.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.893 -1.357 . . . . 0.0 109.955 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -90.45 146.41 24.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.501 -0.749 . . . . 0.0 110.283 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.7 mt -132.67 151.39 51.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.625 -0.672 . . . . 0.0 109.346 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -112.34 148.23 34.69 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.948 0.88 . . . . 0.0 110.153 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.6 t0 -65.27 136.68 56.89 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.656 0.741 . . . . 0.0 111.389 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.503 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 3.1 p 75.26 6.73 4.14 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.28 0.562 . . . . 0.0 109.94 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -83.98 122.61 28.99 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.13 -0.981 . . . . 0.0 110.135 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.4 t -85.57 119.19 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.4 160.48 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.422 0.629 . . . . 0.0 109.666 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -116.37 123.51 47.77 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 75.9 mt -107.41 130.36 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.572 -0.705 . . . . 0.0 109.401 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -116.98 144.65 44.33 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.447 0.641 . . . . 0.0 109.911 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.3 t30 64.75 35.86 8.47 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.445 0.64 . . . . 0.0 109.542 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.87 146.21 53.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.425 -0.797 . . . . 0.0 109.164 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.3 ttp85 -100.27 125.18 46.43 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.507 0.67 . . . . 0.0 110.056 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.3 t -85.25 133.3 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.521 -0.737 . . . . 0.0 109.651 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.38 164.85 30.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.365 -0.834 . . . . 0.0 109.349 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -103.33 114.37 28.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.6 -0.687 . . . . 0.0 109.609 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -110.3 121.87 46.32 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 56.05 31.27 17.76 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.411 0.624 . . . . 0.0 109.392 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.89 13.07 83.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -121.47 138.47 54.28 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.514 -0.992 . . . . 0.0 110.059 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.7 mt -71.37 139.8 49.93 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.583 -0.698 . . . . 0.0 110.283 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.66 163.04 40.43 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.8 mt -103.59 127.83 50.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.602 -0.686 . . . . 0.0 109.585 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.4 t -107.38 126.91 53.07 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 t -103.39 106.01 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.484 -0.76 . . . . 0.0 109.79 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -90.83 179.67 42.93 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -65.44 -37.7 87.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.482 -1.011 . . . . 0.0 109.603 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.4 m -60.66 -36.14 77.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 0.0 110.008 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.1 p -63.25 163.21 10.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.192 -0.942 . . . . 0.0 110.328 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -111.35 140.04 46.26 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.722 -0.611 . . . . 0.0 109.525 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.28 131.38 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -128.13 108.65 10.81 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.497 -0.752 . . . . 0.0 109.181 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.9 t -72.69 140.89 48.17 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.49 -0.756 . . . . 0.0 110.132 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.1 t . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.577 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 . . . . . 0 N--CA 1.497 1.916 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.549 HD13 ' N ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -87.26 121.7 30.05 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.149 -0.969 . . . . 0.0 111.528 -174.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.549 ' N ' HD13 ' A' ' 3' ' ' LEU . 31.7 m -131.29 161.63 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -75.75 162.92 27.78 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.813 0.816 . . . . 0.0 110.265 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.5 mm -62.79 -43.51 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.615 -0.678 . . . . 0.0 109.253 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -65.78 -18.21 65.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.383 -0.823 . . . . 0.0 110.055 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -85.28 -0.05 53.51 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.136 -0.977 . . . . 0.0 110.281 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.39 133.05 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.174 -0.954 . . . . 0.0 110.254 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.1 m -157.5 162.8 38.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.473 -0.767 . . . . 0.0 109.742 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.74 -30.16 70.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.376 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -59.33 -20.23 52.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.347 -0.846 . . . . 0.0 109.293 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.404 ' O ' ' OG1' ' A' ' 13' ' ' THR . 11.5 p -118.39 80.2 16.03 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.72 -15.21 33.5 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.015 1.81 . . . . 0.0 112.581 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -133.11 105.97 7.34 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.423 -0.798 . . . . 0.0 109.792 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.1 m -145.57 164.61 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.379 -0.826 . . . . 0.0 109.881 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.1 t -108.54 141.45 40.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.339 -0.85 . . . . 0.0 108.825 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.52 160.27 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.365 -0.834 . . . . 0.0 109.724 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.621 HD12 ' HE ' ' A' ' 67' ' ' ARG . 7.5 tt -142.73 137.35 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.389 -0.819 . . . . 0.0 109.373 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.67 -166.27 35.94 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.227 -1.463 . . . . 0.0 110.683 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -104.57 132.41 50.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.818 -0.813 . . . . 0.0 109.402 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.2 mm -89.29 130.02 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.221 0.534 . . . . 0.0 109.915 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.0 p -137.87 161.54 36.36 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.325 -0.859 . . . . 0.0 109.884 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.57 79.29 0.1 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.8 mm -91.44 120.07 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.193 -1.181 . . . . 0.0 109.709 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -119.56 125.76 49.6 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -93.85 134.43 36.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.284 -0.885 . . . . 0.0 109.967 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -148.12 143.58 27.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.426 -0.796 . . . . 0.0 109.001 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -123.89 144.91 49.47 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.415 -0.803 . . . . 0.0 109.344 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.512 ' CE2' ' OG ' ' A' ' 32' ' ' SER . 24.9 p90 -141.71 160.73 39.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.215 -0.928 . . . . 0.0 109.558 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -79.6 114.52 18.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.56 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.512 ' OG ' ' CE2' ' A' ' 30' ' ' TYR . 5.1 m -109.61 112.82 25.13 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.533 -0.729 . . . . 0.0 109.531 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 53.37 31.07 11.3 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 0.0 110.201 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.67 -2.45 82.52 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.3 p -118.36 124.87 48.8 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.299 -1.118 . . . . 0.0 109.296 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.4 m -69.68 135.67 50.14 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.432 -0.792 . . . . 0.0 110.221 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -131.84 147.87 52.51 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.2 t -96.95 131.79 43.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.506 -0.746 . . . . 0.0 109.747 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.67 135.36 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -104.81 135.53 46.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.528 -0.733 . . . . 0.0 109.129 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -124.56 153.88 41.47 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.445 0.64 . . . . 0.0 109.371 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.76 -151.72 8.41 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -130.37 145.92 51.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.81 -0.818 . . . . 0.0 109.377 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.8 tt -123.57 142.36 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -127.71 151.51 48.89 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.434 0.635 . . . . 0.0 109.667 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.529 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 36.9 t0 -141.78 -153.16 0.45 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.485 -0.759 . . . . 0.0 109.381 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.529 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 95.5 m-20 -78.91 -7.47 58.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.88 . . . . 0.0 109.935 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.5 p -108.75 -85.8 0.52 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.335 -0.853 . . . . 0.0 110.363 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.0 -148.86 0.32 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.473 -0.767 . . . . 0.0 109.622 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -145.44 156.36 43.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.271 -0.893 . . . . 0.0 110.087 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.7 tt -148.91 164.8 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.368 -0.833 . . . . 0.0 109.978 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.63 144.17 35.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.158 -0.964 . . . . 0.0 110.148 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.829 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -135.21 161.23 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.485 -0.759 . . . . 0.0 109.665 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.2 m -137.79 139.98 40.33 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 58' ' ' LYS . 4.7 p -119.58 116.24 25.64 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -96.78 117.09 30.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.382 -0.824 . . . . 0.0 110.273 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.83 -13.26 3.23 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.429 ' O ' ' OG ' ' A' ' 55' ' ' SER . 28.3 mmtp -103.77 107.15 17.89 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.365 -1.08 . . . . 0.0 109.352 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -72.64 145.02 47.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.569 -0.707 . . . . 0.0 109.728 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.1 mt -127.14 153.25 46.27 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -105.75 141.56 36.97 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.613 0.721 . . . . 0.0 109.847 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 63' ' ' SER . 57.1 t0 -66.25 138.42 57.64 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.592 0.711 . . . . 0.0 110.782 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.528 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 5.0 m 61.56 78.85 0.27 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.354 0.597 . . . . 0.0 110.749 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.416 ' CG ' ' O ' ' A' ' 63' ' ' SER . 56.7 m-20 -163.33 126.92 2.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.691 -0.631 . . . . 0.0 109.422 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.7 t -78.24 121.63 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.1 m -137.72 160.67 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.43 -0.794 . . . . 0.0 109.855 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.621 ' HE ' HD12 ' A' ' 19' ' ' ILE . 41.8 ttm180 -117.36 128.74 55.34 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.4 mt -106.95 126.57 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -109.85 141.22 42.85 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.72 -0.612 . . . . 0.0 109.729 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 61.7 t30 62.74 41.01 9.47 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.484 0.659 . . . . 0.0 109.385 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.57 147.31 49.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.422 -0.799 . . . . 0.0 109.087 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -103.37 125.53 50.04 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.537 -0.727 . . . . 0.0 109.578 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.0 t -86.25 132.7 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.482 -0.761 . . . . 0.0 109.69 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.66 152.92 41.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.321 -0.862 . . . . 0.0 109.174 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -107.35 122.3 46.3 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.446 -0.784 . . . . 0.0 109.556 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -126.08 138.91 53.74 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.1 t30 56.25 24.06 7.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.559 -0.713 . . . . 0.0 109.507 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.64 8.35 87.72 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -118.19 138.97 51.95 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.42 -1.047 . . . . 0.0 109.698 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.9 mt -75.53 145.15 41.54 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.629 0.728 . . . . 0.0 110.342 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.5 p -154.77 160.62 41.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.552 -0.717 . . . . 0.0 109.139 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.7 mt -105.16 126.27 51.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.414 -0.804 . . . . 0.0 109.331 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.9 p -109.2 134.37 51.83 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.558 -0.714 . . . . 0.0 109.6 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.8 t -100.51 114.08 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.306 -0.871 . . . . 0.0 108.749 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.14 175.85 44.99 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 87' ' ' SER . 43.3 p-10 -67.43 -24.24 65.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.571 -0.958 . . . . 0.0 109.822 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.453 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 66.2 m -84.17 -6.4 59.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.238 -0.914 . . . . 0.0 109.634 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.9 t -81.96 170.84 15.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.756 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -131.52 141.25 49.69 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.619 -0.675 . . . . 0.0 109.751 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.8 130.51 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.645 -0.66 . . . . 0.0 109.438 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -121.33 120.39 34.92 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.55 0.69 . . . . 0.0 109.374 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.2 m -75.69 147.15 39.64 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.506 -0.746 . . . . 0.0 110.176 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.7 t . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.283 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.9 p30 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.524 0.678 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.554 HD22 ' N ' ' A' ' 3' ' ' LEU . 3.8 mm? -83.7 130.44 34.96 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.457 -0.777 . . . . 0.0 109.994 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.4 m -138.32 161.68 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.544 0.687 . . . . 0.0 109.559 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -86.7 163.55 17.27 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.539 0.685 . . . . 0.0 109.883 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.2 mm -62.87 -43.78 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.613 -0.679 . . . . 0.0 109.85 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -66.76 -18.99 65.65 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.019 -1.051 . . . . 0.0 109.435 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -84.18 -1.68 55.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 0.0 109.566 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.47 131.59 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.204 -0.935 . . . . 0.0 110.136 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.4 t -163.41 160.07 23.04 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.3 -3.66 6.33 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.9 m -59.75 -35.63 74.98 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.63 -0.668 . . . . 0.0 109.248 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.7 p -115.28 133.63 22.69 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.66 -0.65 . . . . 0.0 109.701 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.61 -53.05 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.127 1.885 . . . . 0.0 111.781 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -119.66 130.73 55.2 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.368 0.604 . . . . 0.0 109.866 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.0 m -146.93 163.93 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.537 -0.727 . . . . 0.0 109.591 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.9 t -110.15 138.24 46.8 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.435 -0.791 . . . . 0.0 109.505 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.02 160.52 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.529 -0.732 . . . . 0.0 109.713 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.0 tt -142.96 137.58 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 109.599 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.48 -161.94 28.9 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.866 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -110.4 129.11 55.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.671 -0.899 . . . . 0.0 109.438 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.2 mt -101.75 131.12 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.766 -0.584 . . . . 0.0 109.991 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.474 ' HA ' ' H ' ' A' ' 63' ' ' SER . 23.0 m -145.27 153.45 41.3 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.591 0.71 . . . . 0.0 109.997 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.51 65.18 1.75 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.9 mm -81.58 129.1 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -1.138 . . . . 0.0 109.94 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -123.89 132.71 53.79 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -94.27 134.14 37.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.0 109.876 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -145.21 157.95 43.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.454 -0.779 . . . . 0.0 109.284 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -123.6 144.23 49.72 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.518 -0.739 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -142.38 160.63 39.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.375 -0.828 . . . . 0.0 109.321 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -80.1 148.29 31.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.434 -0.792 . . . . 0.0 109.832 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.581 ' O ' ' N ' ' A' ' 34' ' ' GLY . 34.1 m -144.97 -149.5 0.28 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.474 -0.766 . . . . 0.0 109.114 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -50.95 84.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.758 0.79 . . . . 0.0 110.13 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 47.69 19.98 1.01 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -147.91 151.16 35.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.072 -1.252 . . . . 0.0 110.156 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.8 m -89.66 131.12 35.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.451 -0.78 . . . . 0.0 109.171 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -119.33 146.75 45.03 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.579 0.704 . . . . 0.0 109.942 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 89.2 p -83.77 146.35 28.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.49 -0.757 . . . . 0.0 109.924 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -139.54 137.81 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -104.25 128.9 52.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.499 -0.751 . . . . 0.0 109.401 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -113.85 154.61 27.19 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.18 -169.53 37.79 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -124.85 146.36 49.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.659 -0.906 . . . . 0.0 109.611 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.2 tt -125.39 139.44 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -126.95 149.35 49.88 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.528 -0.732 . . . . 0.0 110.234 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 42.7 t0 -136.13 -160.44 1.05 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.516 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 1.4 p30 -81.29 -3.53 52.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 110.056 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.9 p -107.06 -62.11 1.45 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.278 -0.889 . . . . 0.0 109.438 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -160.71 -151.46 0.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.23 -0.919 . . . . 0.0 109.583 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -144.8 156.96 44.31 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.4 tt -146.63 159.49 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.297 -0.877 . . . . 0.0 110.053 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -76.42 144.5 39.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.381 -0.824 . . . . 0.0 109.697 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.2 pt -128.73 157.96 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.491 -0.756 . . . . 0.0 110.076 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -145.0 126.43 14.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.4 t -114.84 127.52 55.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.486 -0.759 . . . . 0.0 109.492 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -97.44 117.78 32.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.577 -0.702 . . . . 0.0 110.349 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.64 -54.58 4.97 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -70.31 138.18 51.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.128 -1.219 . . . . 0.0 110.669 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -88.41 158.37 18.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.618 -0.676 . . . . 0.0 110.077 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.6 mt -121.27 153.63 37.42 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -106.88 135.47 48.38 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.685 0.755 . . . . 0.0 109.838 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -66.42 136.84 56.32 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.751 0.786 . . . . 0.0 110.948 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.474 ' H ' ' HA ' ' A' ' 23' ' ' THR . 67.0 m 45.82 78.85 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.605 0.717 . . . . 0.0 110.145 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -150.68 126.52 10.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.626 -0.671 . . . . 0.0 109.358 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.5 t -78.55 115.87 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.498 -0.751 . . . . 0.0 109.23 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.1 m -140.58 166.87 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.487 -0.758 . . . . 0.0 109.94 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -121.8 130.38 53.35 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 74.8 mt -107.33 129.55 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.55 -0.719 . . . . 0.0 109.221 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -111.25 143.05 42.64 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.343 0.592 . . . . 0.0 109.955 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.5 t30 62.67 38.61 11.92 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.154 0.502 . . . . 0.0 109.883 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.13 139.2 46.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -0.854 . . . . 0.0 108.98 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -92.61 132.89 36.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.283 -0.886 . . . . 0.0 110.173 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -87.01 132.03 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.456 -0.778 . . . . 0.0 109.828 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.85 155.23 48.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.301 -0.874 . . . . 0.0 109.509 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -120.78 120.27 35.13 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -123.37 132.51 54.0 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.495 0.664 . . . . 0.0 109.602 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 55.84 32.02 18.81 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.42 0.628 . . . . 0.0 109.804 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.54 4.93 81.86 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -112.48 136.23 52.24 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.39 -1.065 . . . . 0.0 109.828 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.42 148.44 37.31 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.694 0.759 . . . . 0.0 110.77 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.0 t -156.25 154.44 30.71 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.5 mt -100.38 127.43 46.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.229 -0.92 . . . . 0.0 109.296 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 m -106.06 124.19 49.18 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.466 0.65 . . . . 0.0 109.354 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.4 t -96.8 112.43 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.291 -0.881 . . . . 0.0 108.919 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.92 178.44 43.71 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.14 -21.16 62.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.653 -0.91 . . . . 0.0 110.254 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.3 p -85.72 -5.44 59.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.167 -0.958 . . . . 0.0 109.28 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.1 p -79.03 167.6 20.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.447 -0.783 . . . . 0.0 109.883 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -131.45 141.74 49.86 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.421 0.629 . . . . 0.0 109.411 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.05 130.98 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -124.9 138.66 54.24 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.558 0.694 . . . . 0.0 109.443 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.2 m -70.58 150.26 46.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.628 -0.67 . . . . 0.0 110.126 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 51.7 t . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.608 0.718 . . . . 0.0 109.438 179.927 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 54.0 t0 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.652 0.739 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.487 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 47.3 tp -74.25 124.45 26.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.474 -0.766 . . . . 0.0 110.09 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 m -140.69 167.46 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.731 0.777 . . . . 0.0 110.116 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.18 156.5 29.81 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.732 0.777 . . . . 0.0 110.556 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.28 -43.09 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.715 -0.615 . . . . 0.0 109.881 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -65.34 -19.45 65.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.933 . . . . 0.0 109.855 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -85.82 -2.29 58.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 109.206 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.7 t -66.83 132.9 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.42 -0.8 . . . . 0.0 110.431 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.5 p -156.55 168.22 28.06 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.637 0.732 . . . . 0.0 109.556 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.36 -37.33 85.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.494 -0.754 . . . . 0.0 109.306 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.4 m -55.94 -20.81 17.6 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.367 -0.833 . . . . 0.0 109.548 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 p -113.77 79.57 4.56 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.65 -20.42 35.39 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.572 2.181 . . . . 0.0 112.036 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -128.07 106.18 8.9 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.581 -0.699 . . . . 0.0 109.549 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.4 m -139.2 162.9 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.61 -0.681 . . . . 0.0 110.123 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.9 t -118.33 135.96 54.0 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.3 m -133.41 162.27 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.773 0.797 . . . . 0.0 110.068 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.61 HD12 ' NH2' ' A' ' 67' ' ' ARG . 5.1 tt -136.64 142.55 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.553 -0.717 . . . . 0.0 109.53 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.65 -167.0 39.72 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.403 -1.379 . . . . 0.0 110.076 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -110.65 133.86 52.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.651 -0.911 . . . . 0.0 109.398 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 63' ' ' SER . 89.0 mt -102.55 132.42 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.254 0.55 . . . . 0.0 109.798 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 t -141.7 158.18 44.14 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.723 0.773 . . . . 0.0 109.944 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.17 53.38 3.48 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 25' ' ' ILE . 1.5 mp -78.14 125.6 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.371 -1.076 . . . . 0.0 109.652 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -126.85 124.21 39.07 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -83.28 128.47 34.52 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.664 0.745 . . . . 0.0 110.043 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -141.61 159.38 42.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.448 -0.782 . . . . 0.0 109.122 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -116.93 140.59 49.29 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.698 -0.626 . . . . 0.0 109.688 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 18.3 p90 -137.29 158.74 43.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -90.01 100.76 13.52 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.664 0.745 . . . . 0.0 110.357 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.596 ' O ' ' N ' ' A' ' 34' ' ' GLY . 10.7 t -82.83 -151.18 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.503 -0.748 . . . . 0.0 110.097 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -55.69 77.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.765 0.793 . . . . 0.0 110.217 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 58.3 23.41 53.25 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.8 m -145.89 133.36 20.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.265 -1.138 . . . . 0.0 109.702 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.4 m -79.82 130.65 35.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.3 -0.875 . . . . 0.0 109.805 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.402 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 68.7 mttm -133.48 148.13 51.7 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.815 0.817 . . . . 0.0 110.129 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.8 t -77.52 144.95 37.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.562 -0.712 . . . . 0.0 110.494 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -140.5 137.81 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.378 -0.826 . . . . 0.0 109.579 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -106.35 132.07 52.82 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.444 -0.785 . . . . 0.0 109.277 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -118.27 153.53 33.78 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.595 -0.691 . . . . 0.0 109.694 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.52 -157.13 16.06 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -135.88 146.8 47.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.483 -1.01 . . . . 0.0 109.643 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 tt -122.0 143.33 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -133.76 152.57 51.91 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.634 0.73 . . . . 0.0 110.027 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -147.86 -157.18 0.79 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.609 0.718 . . . . 0.0 109.725 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -80.33 -7.03 58.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.392 -0.817 . . . . 0.0 109.893 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 49' ' ' ALA . 81.5 p -100.91 -68.64 0.8 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.277 -0.89 . . . . 0.0 109.606 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.401 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -159.78 -148.55 0.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.175 -0.953 . . . . 0.0 109.956 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -144.75 152.57 40.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.126 -0.984 . . . . 0.0 110.362 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.0 tt -150.61 147.98 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.224 -0.922 . . . . 0.0 110.222 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -74.22 138.13 43.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.496 -0.752 . . . . 0.0 109.872 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.85 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -133.58 164.48 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.333 -0.855 . . . . 0.0 110.038 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.1 t -142.09 140.43 32.53 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.428 -0.795 . . . . 0.0 109.297 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.6 t -115.59 129.77 56.63 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.452 0.644 . . . . 0.0 109.512 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -97.66 119.38 36.13 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.583 0.706 . . . . 0.0 110.832 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.85 -46.91 1.8 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.492 ' HE2' HD12 ' A' ' 90' ' ' ILE . 54.4 mtpt -73.6 134.81 43.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.284 -1.127 . . . . 0.0 110.603 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -91.56 153.42 19.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.49 -0.756 . . . . 0.0 110.093 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.9 mt -133.0 157.77 44.37 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.463 0.649 . . . . 0.0 109.649 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -103.12 157.11 17.22 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.016 0.913 . . . . 0.0 110.395 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 62' ' ' ASP . 47.4 p30 -76.71 150.39 36.3 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.66 0.743 . . . . 0.0 111.312 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 22' ' ' ILE . 4.2 p 39.02 36.79 0.17 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.31 0.576 . . . . 0.0 110.073 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 47.1 p-10 -98.96 129.89 45.29 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.489 -0.757 . . . . 0.0 110.353 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.8 t -79.07 112.95 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.601 -0.687 . . . . 0.0 109.207 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.23 164.78 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.43 -0.794 . . . . 0.0 110.148 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.61 ' NH2' HD12 ' A' ' 19' ' ' ILE . 59.6 ttm-85 -119.08 130.12 55.44 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 74.3 mt -105.84 124.84 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.561 -0.712 . . . . 0.0 109.183 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -114.84 142.41 46.59 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.454 0.645 . . . . 0.0 109.714 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.9 t30 63.99 40.35 7.3 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.613 0.721 . . . . 0.0 109.308 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.56 147.02 48.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.603 -0.685 . . . . 0.0 109.829 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -101.97 121.63 42.52 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.6 0.714 . . . . 0.0 109.467 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.16 134.25 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.569 -0.707 . . . . 0.0 110.324 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.37 153.82 45.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.465 -0.772 . . . . 0.0 109.094 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -114.82 114.27 25.33 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.458 -0.776 . . . . 0.0 109.452 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -112.96 126.34 55.37 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.692 0.758 . . . . 0.0 110.187 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 55.73 27.36 10.6 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.321 0.582 . . . . 0.0 110.658 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.84 4.64 84.71 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -112.31 131.04 55.73 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.48 -1.012 . . . . 0.0 109.768 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.02 144.4 40.89 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.747 0.784 . . . . 0.0 110.451 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.7 p -152.89 160.04 43.04 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.9 mt -106.91 131.73 53.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.425 -0.797 . . . . 0.0 109.662 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 t -109.14 125.83 52.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.666 -0.646 . . . . 0.0 109.377 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.455 HG11 HD11 ' A' ' 90' ' ' ILE . 13.4 t -102.85 100.89 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.488 -0.758 . . . . 0.0 109.011 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.46 176.66 49.96 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -65.92 -29.44 69.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.574 -0.956 . . . . 0.0 109.647 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.4 m -74.79 -7.48 53.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 109.433 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.5 p -80.96 167.84 19.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.319 -0.863 . . . . 0.0 110.273 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -125.7 138.12 53.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.545 -0.722 . . . . 0.0 109.347 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.492 HD12 ' HE2' ' A' ' 58' ' ' LYS . 87.0 mt -125.17 129.96 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.536 -0.727 . . . . 0.0 109.65 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -118.71 113.28 20.92 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.3 t -75.05 150.31 38.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.461 -0.775 . . . . 0.0 110.517 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.6 t . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 110.054 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.764 0.792 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.2 tt -75.99 129.75 37.37 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.531 0.681 . . . . 0.0 109.957 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.9 m -140.17 163.62 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.934 0.874 . . . . 0.0 110.834 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -72.88 149.59 43.36 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.78 0.8 . . . . 0.0 110.247 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 92.0 mt -63.74 -42.6 96.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -69.65 -17.22 63.49 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.729 -0.607 . . . . 0.0 109.812 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -92.61 6.44 47.3 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.508 -0.745 . . . . 0.0 109.247 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.56 133.2 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.71 0.767 . . . . 0.0 109.947 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.1 p -153.27 166.85 31.27 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.962 0.887 . . . . 0.0 110.324 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.0 mt -73.07 -9.29 58.57 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.6 m -74.44 -14.72 60.88 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.3 p -121.49 84.09 41.66 Favored Pre-proline 0 N--CA 1.499 1.995 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.39 -41.19 74.84 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.613 2.209 . . . . 0.0 111.594 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -116.89 131.92 56.83 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.761 0.791 . . . . 0.0 109.992 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.4 m -149.77 175.71 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 122.273 1.035 . . . . 0.0 110.617 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.407 ' OG ' ' OD1' ' A' ' 69' ' ' ASP . 48.4 m -134.71 137.17 43.29 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -140.21 163.26 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.074 0.94 . . . . 0.0 110.643 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.6 tt -137.93 135.51 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.709 0.766 . . . . 0.0 109.893 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.29 -168.47 40.97 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -110.95 136.29 50.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.941 -0.741 . . . . 0.0 109.489 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.716 ' N ' HD12 ' A' ' 22' ' ' ILE . 2.4 mp -96.33 133.32 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.406 0.622 . . . . 0.0 109.714 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 t -136.07 159.78 40.65 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.75 0.786 . . . . 0.0 109.929 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 25' ' ' ILE . . . 99.63 -69.29 0.54 Allowed Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 24' ' ' GLY . 25.8 mm 59.11 128.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.844 0.83 . . . . 0.0 110.592 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.74 138.62 21.03 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.437 0.637 . . . . 0.0 109.358 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -106.0 129.13 54.18 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.002 0.906 . . . . 0.0 110.175 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -141.09 157.41 45.34 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.736 0.779 . . . . 0.0 110.074 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 56.5 mp0 -113.99 142.8 45.71 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.806 0.812 . . . . 0.0 110.243 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 31.7 p90 -143.66 161.96 37.19 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.598 0.713 . . . . 0.0 109.485 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -94.19 107.0 18.97 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.751 0.786 . . . . 0.0 110.388 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 34' ' ' GLY . 4.4 p -88.19 -161.54 0.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -52.18 80.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.597 0.713 . . . . 0.0 110.259 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 59.94 11.0 16.05 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 92.8 m -131.86 131.21 42.59 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.863 0.84 . . . . 0.0 110.791 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.2 m -79.48 128.32 33.22 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.55 0.69 . . . . 0.0 109.192 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.451 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 98.6 mttt -136.13 147.83 47.94 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.885 0.85 . . . . 0.0 110.15 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 87.5 p -82.03 149.91 27.86 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.846 0.831 . . . . 0.0 110.019 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -130.64 133.94 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.835 0.826 . . . . 0.0 109.836 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -98.2 133.36 42.74 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -130.62 150.82 51.64 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.742 0.782 . . . . 0.0 109.829 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.72 -169.43 35.31 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -122.24 139.62 53.57 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.622 0.725 . . . . 0.0 109.699 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.2 tt -113.08 136.43 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -121.5 149.79 42.55 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.948 0.88 . . . . 0.0 110.361 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 38.3 t0 -148.8 -164.57 2.05 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.62 0.724 . . . . 0.0 109.479 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.512 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 48.9 t0 -65.04 -38.59 91.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.609 -0.682 . . . . 0.0 109.825 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.1 p -73.22 -85.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.263 0.554 . . . . 0.0 109.712 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -143.49 -142.26 0.13 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.643 0.735 . . . . 0.0 109.971 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.7 ptt85 -148.96 158.32 44.09 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.758 0.79 . . . . 0.0 110.042 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.2 tt -152.65 158.94 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 122.033 0.921 . . . . 0.0 110.631 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.541 ' NH2' ' CG ' ' A' ' 76' ' ' PHE . 51.2 ttp180 -74.47 143.47 44.63 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.705 0.764 . . . . 0.0 110.107 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 pt -133.38 161.39 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.732 0.777 . . . . 0.0 110.327 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.0 m -144.76 138.93 27.5 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.747 0.784 . . . . 0.0 110.19 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 p -134.57 135.55 42.34 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.87 0.843 . . . . 0.0 109.579 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.455 ' C ' ' H ' ' A' ' 58' ' ' LYS . 88.0 m-85 -94.4 124.85 38.67 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.752 0.787 . . . . 0.0 110.796 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.57 -38.56 0.48 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.455 ' H ' ' C ' ' A' ' 56' ' ' PHE . 72.2 mmtt -68.42 133.66 49.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.66 -0.906 . . . . 0.0 110.001 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -97.71 148.49 23.29 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.765 0.793 . . . . 0.0 110.341 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.8 mt -129.94 152.78 49.04 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.568 0.699 . . . . 0.0 109.696 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -115.79 158.38 22.96 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.225 1.012 . . . . 0.0 110.421 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.9 t0 -62.01 138.19 58.34 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.815 0.817 . . . . 0.0 110.873 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.523 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 10.9 t 52.33 31.01 8.77 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.269 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -78.24 112.06 14.84 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.571 -0.705 . . . . 0.0 110.372 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 t -81.2 105.76 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.663 0.744 . . . . 0.0 109.281 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.7 m -140.99 164.65 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.647 0.736 . . . . 0.0 110.113 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.8 ttp85 -115.21 127.83 55.77 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.759 0.79 . . . . 0.0 109.582 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.3 mt -108.39 130.62 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.608 0.718 . . . . 0.0 109.844 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 67.8 t0 -125.32 142.44 51.5 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.556 0.693 . . . . 0.0 109.902 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.55 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 52.6 t30 71.92 35.09 1.39 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.387 0.613 . . . . 0.0 109.949 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.14 141.54 43.68 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.394 0.616 . . . . 0.0 110.407 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -95.17 128.37 41.95 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.755 0.788 . . . . 0.0 109.893 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.8 t -80.64 132.4 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 121.679 0.752 . . . . 0.0 110.179 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -117.92 146.19 44.13 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.744 0.783 . . . . 0.0 109.549 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -108.47 97.64 7.28 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.525 0.679 . . . . 0.0 109.454 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.633 ' O ' ' N ' ' A' ' 78' ' ' GLY . 28.4 m-85 -82.83 -177.88 6.9 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.409 0.624 . . . . 0.0 110.55 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -51.94 75.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.499 0.666 . . . . 0.0 110.493 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 76' ' ' PHE . . . 74.71 15.56 80.64 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -130.62 144.62 51.55 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.565 -0.962 . . . . 0.0 110.395 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.5 mt -103.1 140.35 37.43 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.859 0.838 . . . . 0.0 110.126 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 96.3 p -152.53 163.52 39.41 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.701 0.763 . . . . 0.0 109.854 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.7 mt -106.07 131.03 53.83 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.651 0.739 . . . . 0.0 110.176 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.2 p -107.67 123.97 49.29 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.838 0.828 . . . . 0.0 109.761 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.2 t -100.41 112.26 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.854 0.835 . . . . 0.0 109.6 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -97.19 -179.26 34.22 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -66.11 -29.14 69.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.914 -0.756 . . . . 0.0 109.736 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 89.4 p -78.67 -4.91 51.42 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.8 t -80.39 167.65 19.95 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.467 0.651 . . . . 0.0 110.087 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 24.7 mmt85 -124.96 137.79 54.25 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.716 0.77 . . . . 0.0 109.953 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.8 mt -127.19 130.47 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.511 0.672 . . . . 0.0 110.386 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -124.59 125.76 44.68 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.78 0.8 . . . . 0.0 109.402 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.2 p -75.73 152.95 37.35 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.714 0.768 . . . . 0.0 110.433 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 64.2 t . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.566 0.698 . . . . 0.0 109.399 179.505 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 55.4 t0 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.674 0.749 . . . . 0.0 110.552 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.54 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 43.2 tp -77.6 123.24 26.37 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.425 -0.797 . . . . 0.0 109.744 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.1 m -140.28 165.03 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.385 -0.822 . . . . 0.0 110.067 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.6 157.56 31.84 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.81 0.814 . . . . 0.0 110.492 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 6' ' ' ILE . 2.3 mp -63.97 -42.72 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.619 -0.676 . . . . 0.0 109.256 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -64.25 -24.15 67.56 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.239 -0.913 . . . . 0.0 109.557 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -83.21 -0.16 48.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.952 -1.093 . . . . 0.0 109.496 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.2 131.99 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.074 -1.016 . . . . 0.0 110.562 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.3 p -158.99 167.37 29.54 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.55 -0.719 . . . . 0.0 109.331 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.19 -19.54 66.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.89 . . . . 0.0 108.888 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -63.86 -17.24 62.97 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.318 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.6 p -124.36 82.02 58.38 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.318 -0.864 . . . . 0.0 109.231 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.32 -41.42 66.53 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.958 2.439 . . . . 0.0 112.151 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -119.28 128.1 53.84 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.422 -0.799 . . . . 0.0 109.814 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.6 m -147.17 161.11 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.256 -0.903 . . . . 0.0 110.116 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.5 m -115.46 134.17 55.34 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.69 162.38 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.873 0.844 . . . . 0.0 110.324 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.0 tt -140.49 137.98 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.428 -0.795 . . . . 0.0 109.524 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.45 -162.91 29.41 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' C ' HD12 ' A' ' 22' ' ' ILE . 26.7 ttmt -111.58 128.81 56.15 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.58 -0.953 . . . . 0.0 109.359 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.736 ' N ' HD12 ' A' ' 22' ' ' ILE . 1.8 mp -94.53 125.74 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.533 0.682 . . . . 0.0 109.737 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.7 p -132.7 159.29 40.06 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.836 0.827 . . . . 0.0 110.091 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.9 82.02 0.19 Allowed Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.4 mm -92.1 129.81 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.092 -1.24 . . . . 0.0 110.267 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -133.73 139.1 46.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.534 -0.729 . . . . 0.0 109.132 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -103.28 136.45 43.03 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.766 0.793 . . . . 0.0 109.917 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.593 ' NZ ' ' NH2' ' A' ' 52' ' ' ARG . 53.1 mtmt -144.25 160.24 41.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.488 -0.757 . . . . 0.0 109.317 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -122.11 144.73 48.75 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.626 0.727 . . . . 0.0 109.701 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -142.63 160.92 39.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 109.289 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -93.98 116.23 28.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.293 -0.879 . . . . 0.0 109.889 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 t -109.23 110.2 21.34 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.822 0.82 . . . . 0.0 109.362 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 53.34 33.6 16.07 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.57 0.7 . . . . 0.0 110.722 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.27 -2.01 77.73 Favored Glycine 0 N--CA 1.496 2.643 0 O-C-N 120.962 -1.086 . . . . 0.0 111.047 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.7 p -115.95 125.22 52.25 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.089 -1.242 . . . . 0.0 109.928 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.1 m -69.6 133.42 47.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.55 -0.719 . . . . 0.0 110.094 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -136.71 144.94 44.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.367 -0.833 . . . . 0.0 109.889 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.4 m -83.25 144.83 29.48 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.771 0.796 . . . . 0.0 110.311 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.417 HG22 ' OE1' ' A' ' 41' ' ' GLN . 14.2 p -140.51 137.81 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.898 . . . . 0.0 108.85 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -102.1 135.29 43.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.436 -0.79 . . . . 0.0 109.495 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.606 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 1.1 mp0 -117.05 152.12 35.35 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.631 0.729 . . . . 0.0 109.176 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.34 -171.86 35.43 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -130.49 139.05 50.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.481 -1.011 . . . . 0.0 109.271 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 44' ' ' ILE . 19.2 tt -114.62 130.9 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -123.6 151.56 42.83 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.655 0.741 . . . . 0.0 109.932 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 30.7 t0 -155.72 -161.87 1.23 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.489 -0.757 . . . . 0.0 109.673 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.545 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 95.8 m-20 -74.26 -3.48 30.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.283 -0.886 . . . . 0.0 110.383 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.504 ' OG1' ' N ' ' A' ' 49' ' ' ALA . 8.1 p -101.15 -62.46 1.24 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.849 -1.157 . . . . 0.0 109.323 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.504 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -171.29 -150.51 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.96 -1.087 . . . . 0.0 110.364 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -135.32 145.63 47.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.514 -0.741 . . . . 0.0 109.894 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.2 tt -150.2 150.2 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.166 -0.959 . . . . 0.0 110.025 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.593 ' NH2' ' NZ ' ' A' ' 28' ' ' LYS . 72.9 ttt180 -73.01 146.55 45.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.457 -0.777 . . . . 0.0 110.383 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.6 pt -132.3 158.6 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.455 -0.778 . . . . 0.0 109.744 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.8 m -143.72 126.54 16.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.178 -0.951 . . . . 0.0 109.073 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.4 t -114.13 128.31 56.32 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.566 -0.709 . . . . 0.0 109.357 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -95.38 121.41 37.02 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.738 0.78 . . . . 0.0 110.95 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.19 -47.72 3.22 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -82.59 135.14 35.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.287 . . . . 0.0 110.674 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.665 ' H ' ' CD ' ' A' ' 59' ' ' GLN . 1.8 pm0 -89.98 165.71 13.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.679 -0.638 . . . . 0.0 110.119 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.6 mt -124.03 158.43 32.15 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.547 0.689 . . . . 0.0 109.478 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -107.51 133.46 51.95 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.376 1.084 . . . . 0.0 109.889 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 63' ' ' SER . 66.2 t0 -60.86 142.79 55.9 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.986 0.898 . . . . 0.0 111.304 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.555 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 2.0 m 50.98 29.57 4.61 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.496 0.665 . . . . 0.0 110.171 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -94.48 129.31 41.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.064 -1.022 . . . . 0.0 110.807 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.6 t -89.55 111.36 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.34 -0.85 . . . . 0.0 108.8 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.406 HG22 HD13 ' A' ' 22' ' ' ILE . 17.0 m -139.27 166.27 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.216 -0.928 . . . . 0.0 110.318 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -118.58 127.11 53.3 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.2 mt -107.01 127.69 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.257 -0.902 . . . . 0.0 109.435 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -111.17 145.46 38.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.699 -0.626 . . . . 0.0 109.72 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.6 t30 63.39 38.68 9.92 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.851 0.834 . . . . 0.0 109.401 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.82 134.94 41.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.812 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -88.06 136.96 32.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.414 -0.804 . . . . 0.0 110.237 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.0 t -96.62 132.7 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -0.856 . . . . 0.0 109.487 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.7 155.03 48.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 109.394 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -117.87 115.94 25.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.612 -0.68 . . . . 0.0 109.197 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -125.2 134.74 52.25 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.703 0.764 . . . . 0.0 109.812 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 56.28 29.68 15.37 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.731 0.777 . . . . 0.0 109.974 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.29 7.84 85.11 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -114.42 134.59 54.88 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.435 -1.038 . . . . 0.0 109.92 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.7 mt -79.91 143.17 34.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.4 -0.813 . . . . 0.0 110.093 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.5 m -151.71 158.67 43.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 109.289 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.2 mt -104.19 127.54 51.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.393 -0.817 . . . . 0.0 109.328 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -107.07 125.43 51.03 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.648 0.737 . . . . 0.0 109.541 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 t -98.43 111.85 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.411 -0.806 . . . . 0.0 109.416 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.07 -179.32 42.97 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 87' ' ' SER . 47.4 p30 -70.89 -18.17 62.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.448 -1.031 . . . . 0.0 109.484 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.509 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 98.7 p -85.33 -7.89 58.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.152 -0.968 . . . . 0.0 109.487 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 m -80.93 165.7 21.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.103 -0.998 . . . . 0.0 110.336 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 24.9 tpt85 -127.66 133.56 49.63 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.549 0.69 . . . . 0.0 109.542 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -114.97 129.62 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.582 -0.699 . . . . 0.0 109.703 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -123.35 117.62 25.64 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.775 0.797 . . . . 0.0 109.067 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 73.6 m -77.36 147.18 36.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.549 -0.72 . . . . 0.0 110.368 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.029 179.571 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 67.0 t0 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.477 0.656 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.541 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 35.6 tp -71.75 130.23 40.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.554 -0.716 . . . . 0.0 109.782 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.18 164.5 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.417 -0.802 . . . . 0.0 109.648 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -80.29 159.1 25.95 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.608 -0.683 . . . . 0.0 110.569 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.54 ' N ' HD12 ' A' ' 6' ' ' ILE . 1.4 mp -63.42 -45.49 97.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.626 -0.671 . . . . 0.0 109.255 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -63.43 -20.31 65.45 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.512 -0.743 . . . . 0.0 109.841 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 8' ' ' ASP . 53.2 t0 -87.44 -2.8 58.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.377 -0.827 . . . . 0.0 109.529 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.0 t -70.04 132.65 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -0.938 . . . . 0.0 110.144 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.7 m -158.24 172.59 18.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.478 -0.764 . . . . 0.0 109.555 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.33 -38.95 93.15 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.427 -0.796 . . . . 0.0 109.652 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.5 t -55.0 -17.13 3.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.388 -0.82 . . . . 0.0 109.8 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 p -114.37 79.59 5.37 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.462 -0.774 . . . . 0.0 109.113 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.92 -20.63 29.15 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.229 1.953 . . . . 0.0 112.324 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -131.71 110.06 10.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.537 -0.727 . . . . 0.0 109.299 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.9 m -142.21 163.97 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.359 -0.838 . . . . 0.0 110.306 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.419 ' O ' HD12 ' A' ' 3' ' ' LEU . 25.3 t -113.0 141.52 46.75 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.2 t -135.33 155.98 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.239 -0.913 . . . . 0.0 109.775 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.444 HG23 ' O ' ' A' ' 19' ' ' ILE . 20.0 tt -140.13 132.76 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.329 -0.857 . . . . 0.0 109.384 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.61 -160.51 30.78 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 118.909 -1.615 . . . . 0.0 110.366 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -111.83 136.82 50.62 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.796 -0.826 . . . . 0.0 109.638 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 63' ' ' SER . 92.9 mt -103.5 130.75 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.474 -0.766 . . . . 0.0 109.636 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.4 p -134.86 159.53 41.1 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.508 -0.745 . . . . 0.0 109.787 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.84 78.13 0.39 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.5 mm -95.08 123.37 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.189 -1.183 . . . . 0.0 109.366 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -115.81 137.98 51.57 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -101.61 129.78 47.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.524 -0.735 . . . . 0.0 109.594 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -144.25 161.07 39.85 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.5 137.05 55.0 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.326 -0.859 . . . . 0.0 109.779 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -130.15 153.8 48.17 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 31' ' ' GLU . 58.1 mp0 -88.32 136.42 32.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -0.909 . . . . 0.0 109.731 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.7 t -137.03 109.72 7.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.498 -0.751 . . . . 0.0 109.166 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 54.2 t0 58.69 32.04 21.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.523 -0.736 . . . . 0.0 110.134 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.66 11.27 83.2 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.1 m -121.0 130.17 53.69 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.602 -0.94 . . . . 0.0 109.305 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.3 m -80.68 130.44 35.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 109.661 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -132.8 140.54 48.05 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.383 -0.823 . . . . 0.0 109.675 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.2 t -79.86 142.27 35.38 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.385 -0.822 . . . . 0.0 109.701 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 p -133.43 136.53 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -102.08 139.04 38.24 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.469 -0.769 . . . . 0.0 109.359 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -135.79 153.91 51.38 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.391 -0.818 . . . . 0.0 109.779 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.54 -150.37 7.93 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -134.77 143.51 47.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.588 -0.948 . . . . 0.0 109.511 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.6 tt -120.94 134.83 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -117.6 148.34 42.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.665 -0.647 . . . . 0.0 109.746 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -136.71 -164.82 1.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -72.15 -19.1 61.82 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.517 -0.739 . . . . 0.0 109.462 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.9 m -93.67 -76.35 0.48 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.28 -0.888 . . . . 0.0 110.087 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.89 -148.68 0.25 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.388 -0.82 . . . . 0.0 109.925 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -144.53 157.01 44.42 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.351 -0.843 . . . . 0.0 110.069 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.2 tt -151.46 157.28 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.24 -0.912 . . . . 0.0 110.011 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -78.8 141.43 37.77 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.469 -0.769 . . . . 0.0 109.531 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.856 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -133.77 164.55 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.558 -0.714 . . . . 0.0 109.744 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.7 p -141.63 151.27 42.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 t -136.51 133.47 36.54 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.436 -0.79 . . . . 0.0 109.114 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -94.4 123.39 37.78 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.303 -0.873 . . . . 0.0 110.922 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.47 -57.41 2.03 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -61.07 130.6 47.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -1.184 . . . . 0.0 110.071 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -84.03 158.0 21.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.456 -0.777 . . . . 0.0 109.82 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.3 mt -120.67 153.22 37.19 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -115.75 130.66 56.93 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.833 0.825 . . . . 0.0 109.507 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 62' ' ' ASP . 54.8 p-10 -66.28 142.99 57.48 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 110.835 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 22' ' ' ILE . 1.5 m 65.87 4.06 2.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.955 -0.466 . . . . 0.0 110.946 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 21.1 p-10 -81.47 136.27 35.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.632 -1.292 . . . . 0.0 110.154 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 t -95.6 113.29 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.166 -0.959 . . . . 0.0 108.841 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.6 m -139.24 165.53 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.746 0.784 . . . . 0.0 110.23 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -117.78 133.0 56.38 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.9 mt -106.17 129.55 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.511 -0.743 . . . . 0.0 109.137 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -111.36 143.28 42.42 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.638 -0.664 . . . . 0.0 109.538 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.2 t30 60.88 39.42 16.89 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.194 0.521 . . . . 0.0 109.834 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.58 146.47 50.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 0.0 108.969 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -99.99 121.03 40.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.595 -0.691 . . . . 0.0 109.748 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.1 t -83.79 133.91 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.463 -0.773 . . . . 0.0 109.763 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.24 155.19 45.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.249 -0.907 . . . . 0.0 109.326 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -114.12 119.49 37.29 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.534 -0.729 . . . . 0.0 109.29 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -124.42 135.37 53.21 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.617 -0.677 . . . . 0.0 109.614 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 54.61 31.69 15.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.703 -0.623 . . . . 0.0 109.58 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.55 10.84 82.85 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -120.37 139.52 52.67 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.471 -1.017 . . . . 0.0 110.113 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 80' ' ' LEU . 4.0 mm? -76.84 144.26 39.16 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.825 0.822 . . . . 0.0 110.546 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.9 m -150.92 152.54 33.77 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.2 mt -103.94 128.65 51.47 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.33 -0.856 . . . . 0.0 108.845 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.2 t -109.83 125.92 53.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.642 -0.661 . . . . 0.0 109.491 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.2 t -99.58 109.44 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.32 -177.05 38.94 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.89 -31.71 72.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.725 -0.868 . . . . 0.0 109.765 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.9 m -76.43 -5.76 48.77 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.277 -0.889 . . . . 0.0 109.496 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.6 t -85.09 165.35 17.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.499 -0.751 . . . . 0.0 109.428 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -134.06 137.46 44.66 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.542 -0.724 . . . . 0.0 109.459 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.05 131.18 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -118.32 130.57 56.1 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.9 p -71.85 152.13 42.88 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.518 -0.739 . . . . 0.0 109.697 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.497 1.899 0 O-C-N 121.524 -0.735 . . . . 0.0 109.628 -179.833 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.677 0.751 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 17' ' ' SER . 38.2 tp -71.61 127.38 32.39 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.726 0.774 . . . . 0.0 110.074 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.57 163.93 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.882 0.848 . . . . 0.0 110.381 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.557 ' N ' ' OD2' ' A' ' 8' ' ' ASP . 63.5 mttp -76.89 148.26 36.54 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.856 0.836 . . . . 0.0 110.222 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.9 mm -59.72 -39.4 79.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.454 0.645 . . . . 0.0 109.786 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -62.7 -33.53 75.27 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.67 -0.644 . . . . 0.0 110.369 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.557 ' OD2' ' N ' ' A' ' 5' ' ' LYS . 7.5 p30 -83.32 12.39 5.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.476 -0.765 . . . . 0.0 110.269 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.9 t -71.4 130.2 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.737 0.779 . . . . 0.0 109.743 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.9 p -159.23 165.31 33.87 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.887 0.851 . . . . 0.0 109.983 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.2 mt -62.96 -30.2 71.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.662 -0.649 . . . . 0.0 109.487 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.9 m -52.8 -21.32 4.03 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.437 ' O ' ' OG1' ' A' ' 13' ' ' THR . 2.4 p -112.05 95.14 28.33 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.68 -18.85 19.26 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.701 2.267 . . . . 0.0 111.411 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -142.39 123.72 14.75 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.573 0.702 . . . . 0.0 109.601 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.5 m -153.74 173.24 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.897 0.856 . . . . 0.0 110.436 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.432 ' O ' HD12 ' A' ' 3' ' ' LEU . 43.1 m -128.41 149.43 50.55 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.65 0.738 . . . . 0.0 109.575 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.83 159.17 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.946 0.879 . . . . 0.0 110.403 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.515 ' CD1' ' HE ' ' A' ' 67' ' ' ARG . 97.0 mt -135.92 133.45 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.599 0.714 . . . . 0.0 109.894 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.52 -158.51 25.79 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.404 ' O ' ' OE2' ' A' ' 45' ' ' GLU . 36.8 ttpt -112.98 130.51 56.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.624 -0.927 . . . . 0.0 110.194 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.6 mt -99.61 133.1 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.404 0.621 . . . . 0.0 109.65 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.436 ' HA ' ' H ' ' A' ' 63' ' ' SER . 9.5 m -146.0 147.32 31.54 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.806 0.812 . . . . 0.0 110.205 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.42 76.28 1.22 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.496 ' N ' HD12 ' A' ' 25' ' ' ILE . 1.4 mp -94.59 115.18 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.647 -0.914 . . . . 0.0 109.865 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -111.55 121.92 46.44 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.573 0.702 . . . . 0.0 109.286 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -88.85 133.33 34.31 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.892 0.853 . . . . 0.0 110.215 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -148.2 151.48 35.59 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.488 0.661 . . . . 0.0 109.341 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 57.7 mp0 -111.8 140.61 46.29 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.831 0.824 . . . . 0.0 110.421 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.461 ' OH ' ' CD1' ' A' ' 56' ' ' PHE . 6.6 p90 -141.5 159.68 41.71 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.757 0.789 . . . . 0.0 109.708 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -91.23 95.93 10.3 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.765 0.793 . . . . 0.0 109.527 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.621 ' O ' ' N ' ' A' ' 34' ' ' GLY . 2.5 t -77.17 -149.5 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.263 0.554 . . . . 0.0 110.169 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -54.11 75.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.732 0.777 . . . . 0.0 110.402 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.621 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 58.83 24.85 58.24 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 t -147.49 141.01 25.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.631 -0.923 . . . . 0.0 109.661 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.8 m -88.61 125.85 35.01 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.682 0.753 . . . . 0.0 110.126 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -136.59 147.31 46.9 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.837 0.827 . . . . 0.0 109.734 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.9 t -81.62 145.01 30.82 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.676 0.75 . . . . 0.0 110.077 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 p -132.89 136.02 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.749 0.785 . . . . 0.0 109.662 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -104.86 130.23 53.03 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.584 0.707 . . . . 0.0 109.183 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -121.86 144.63 48.73 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.831 0.824 . . . . 0.0 109.927 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.54 -171.57 34.51 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -119.69 144.11 47.38 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.97 0.891 . . . . 0.0 110.396 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.68 136.96 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 21' ' ' LYS . 2.4 pm0 -125.31 154.93 41.02 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.037 0.922 . . . . 0.0 110.422 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 29.5 t0 -143.12 -156.56 0.69 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.507 0.67 . . . . 0.0 109.51 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.536 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 98.5 m-20 -73.82 -19.93 60.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.661 -0.649 . . . . 0.0 109.569 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 41.4 p -94.11 -88.5 0.24 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.584 -0.698 . . . . 0.0 109.486 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.79 -146.09 0.23 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.5 -0.75 . . . . 0.0 110.185 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -148.2 158.42 44.07 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.707 0.765 . . . . 0.0 110.482 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.2 tt -151.02 160.3 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-O 121.935 0.874 . . . . 0.0 110.477 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.8 ttp85 -78.82 145.01 34.51 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.832 0.825 . . . . 0.0 110.621 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.6 pt -131.27 159.6 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.634 0.73 . . . . 0.0 109.816 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.2 m -143.63 118.77 10.11 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.643 0.735 . . . . 0.0 109.695 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.4 p -109.35 142.4 40.34 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.838 0.828 . . . . 0.0 109.79 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.521 ' C ' ' H ' ' A' ' 58' ' ' LYS . 76.1 m-85 -102.72 117.36 34.47 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.64 0.733 . . . . 0.0 110.845 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.25 -31.48 0.26 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.521 ' H ' ' C ' ' A' ' 56' ' ' PHE . 13.9 tptp -66.55 129.94 41.52 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.684 -0.892 . . . . 0.0 110.915 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -83.71 138.0 33.5 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.85 0.833 . . . . 0.0 110.761 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.2 mt -128.47 150.73 50.02 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -109.53 143.66 38.87 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.762 0.792 . . . . 0.0 110.134 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -67.11 137.95 56.72 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.884 0.849 . . . . 0.0 110.182 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.436 ' H ' ' HA ' ' A' ' 23' ' ' THR . 7.3 t 51.68 80.64 0.08 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.725 0.774 . . . . 0.0 109.396 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -153.26 121.83 6.34 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.723 0.773 . . . . 0.0 110.151 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.465 HG22 ' H ' ' A' ' 65' ' ' VAL . 1.8 m -74.1 119.46 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.915 0.864 . . . . 0.0 109.487 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.2 m -141.04 167.93 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-O 122.479 1.133 . . . . 0.0 110.242 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.515 ' HE ' ' CD1' ' A' ' 19' ' ' ILE . 39.2 ttm180 -113.76 126.28 55.04 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.031 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.413 ' CG2' ' HB2' ' A' ' 71' ' ' ALA . 94.0 mt -106.04 118.34 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.638 0.733 . . . . 0.0 109.484 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -122.03 151.43 40.84 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.917 0.865 . . . . 0.0 110.123 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 61.48 37.01 16.84 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.794 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.413 ' HB2' ' CG2' ' A' ' 68' ' ' ILE . . . -92.27 147.21 23.1 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.602 -0.687 . . . . 0.0 109.454 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -103.64 153.18 20.91 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.26 1.029 . . . . 0.0 110.839 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.26 132.61 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.738 0.78 . . . . 0.0 109.548 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.26 155.48 43.87 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.758 0.79 . . . . 0.0 110.038 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -112.6 119.21 37.36 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.613 0.72 . . . . 0.0 109.318 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -121.53 132.76 54.88 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.813 0.816 . . . . 0.0 109.881 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 58.04 23.0 9.52 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.334 0.588 . . . . 0.0 109.979 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.91 6.84 81.85 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -117.53 136.64 53.1 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.509 -0.995 . . . . 0.0 110.254 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.7 mt -75.58 145.19 41.39 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.711 0.767 . . . . 0.0 110.181 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 93.9 p -156.9 160.21 38.89 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.626 0.727 . . . . 0.0 109.914 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.7 mt -104.92 108.76 20.43 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.796 0.807 . . . . 0.0 109.082 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.8 m -88.93 141.21 28.68 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.745 0.783 . . . . 0.0 109.748 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.431 HG11 HD11 ' A' ' 90' ' ' ILE . 41.5 t -121.85 126.87 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.871 0.843 . . . . 0.0 109.7 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.66 173.35 25.81 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.29 -17.97 63.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.777 -0.837 . . . . 0.0 109.029 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.0 m -84.55 -5.76 59.32 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.404 ' OG ' ' CG1' ' A' ' 84' ' ' VAL . 13.5 p -76.87 168.97 19.17 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.599 0.714 . . . . 0.0 110.309 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.415 ' NH2' ' OE2' ' A' ' 91' ' ' GLU . 77.6 ttt180 -121.87 123.53 41.97 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.855 0.836 . . . . 0.0 109.856 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.431 HD11 HG11 ' A' ' 84' ' ' VAL . 96.4 mt -124.22 129.04 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.654 0.74 . . . . 0.0 109.746 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.415 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 97.7 mt-10 -126.03 123.12 37.74 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.797 0.808 . . . . 0.0 110.005 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.6 t -74.17 144.12 44.95 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.309 0.576 . . . . 0.0 109.713 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 121.929 0.871 . . . . 0.0 110.254 -179.771 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 67.9 t0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.365 0.602 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.446 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 49.7 tp -70.89 127.06 31.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 109.609 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.17 162.64 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.548 -0.72 . . . . 0.0 109.57 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -78.31 154.25 31.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.458 -0.776 . . . . 0.0 110.265 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.98 -43.59 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.464 -0.772 . . . . 0.0 109.475 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -66.79 -18.2 65.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.66 2.6 56.36 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.176 -0.952 . . . . 0.0 109.808 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.7 t -67.03 133.69 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.325 -0.859 . . . . 0.0 110.198 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.5 p -158.02 164.93 36.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.571 -0.705 . . . . 0.0 109.515 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.2 mt -63.96 -22.44 66.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.323 -0.861 . . . . 0.0 109.067 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.9 t -58.23 -17.62 20.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.416 -0.803 . . . . 0.0 109.227 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.9 p -126.34 80.25 69.27 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.525 -0.734 . . . . 0.0 109.563 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.02 -39.98 77.87 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.524 2.149 . . . . 0.0 111.749 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -115.02 130.81 57.02 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.6 m -152.01 178.33 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.224 -0.923 . . . . 0.0 110.185 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.4 m -130.23 131.31 45.47 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.4 m -137.5 161.44 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.197 -0.939 . . . . 0.0 110.147 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.4 tt -143.77 146.57 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.381 -0.824 . . . . 0.0 109.408 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.05 -161.53 35.2 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.047 -1.549 . . . . 0.0 110.476 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -104.45 144.76 31.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.674 -0.898 . . . . 0.0 109.572 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 mm -98.73 132.46 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 56.5 p -134.95 158.09 45.2 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.438 -0.789 . . . . 0.0 109.652 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 25' ' ' ILE . . . 96.01 -72.34 0.86 Allowed Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.444 ' O ' ' O ' ' A' ' 24' ' ' GLY . 24.8 mm 50.01 101.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.458 -1.025 . . . . 0.0 110.158 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -129.66 131.25 46.35 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -93.44 133.3 36.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.307 -0.871 . . . . 0.0 109.637 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -146.76 152.4 38.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.417 -0.802 . . . . 0.0 109.284 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -111.31 144.82 39.87 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.725 -0.609 . . . . 0.0 109.372 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -146.15 164.13 33.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.33 -0.857 . . . . 0.0 109.391 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -87.52 142.73 27.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.643 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.4 t -147.08 110.59 4.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.343 -0.848 . . . . 0.0 108.761 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 55.76 31.7 18.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.702 -0.624 . . . . 0.0 109.609 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.55 14.7 75.41 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.2 p -128.15 134.48 49.09 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.371 -1.076 . . . . 0.0 109.609 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.9 m -83.36 128.84 34.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.542 -0.724 . . . . 0.0 109.668 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -136.42 144.44 44.48 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.416 -0.803 . . . . 0.0 109.295 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.1 p -79.78 153.4 29.21 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.238 -0.914 . . . . 0.0 110.211 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -141.83 140.74 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -103.13 131.45 50.13 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.4 -0.813 . . . . 0.0 109.614 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.485 ' OE1' ' NH2' ' A' ' 52' ' ' ARG . 78.0 mt-30 -121.28 153.52 37.57 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.72 -156.72 14.55 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.644 -1.265 . . . . 0.0 109.953 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -137.36 139.98 41.13 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 44' ' ' ILE . 18.0 tt -116.65 131.06 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.344 -0.847 . . . . 0.0 109.322 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -117.67 155.75 29.38 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.376 0.608 . . . . 0.0 109.824 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -141.12 -146.13 0.19 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.805 . . . . 0.0 109.497 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -78.55 -8.37 58.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.411 -0.805 . . . . 0.0 110.743 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.3 p -113.42 -86.61 0.57 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.279 -0.888 . . . . 0.0 110.697 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.69 -147.72 0.36 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.583 -0.698 . . . . 0.0 110.245 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.8 ptt-85 -148.07 156.23 42.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.47 -0.768 . . . . 0.0 110.203 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.8 tt -142.85 150.19 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.33 -0.856 . . . . 0.0 110.177 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.485 ' NH2' ' OE1' ' A' ' 41' ' ' GLN . 76.5 ttt180 -72.5 136.36 45.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.515 -0.741 . . . . 0.0 109.847 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.8 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -138.67 167.67 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.34 -0.85 . . . . 0.0 109.463 179.403 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 97.4 p -147.74 152.79 38.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 0.0 109.756 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.6 p -135.44 124.55 24.4 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -87.98 130.03 35.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.393 -0.817 . . . . 0.0 110.838 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.35 -48.75 1.5 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.547 ' HD3' HD12 ' A' ' 90' ' ' ILE . 99.1 mttt -70.68 136.02 48.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.095 -1.238 . . . . 0.0 110.272 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -95.91 153.94 17.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.522 -0.736 . . . . 0.0 109.879 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.8 mt -128.91 157.03 42.74 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.653 -0.655 . . . . 0.0 109.512 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.445 ' OE1' ' OD2' ' A' ' 64' ' ' ASP . 91.1 mt-30 -117.3 135.25 53.97 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.626 0.727 . . . . 0.0 109.954 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.7 t0 -66.71 136.25 55.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.421 -0.799 . . . . 0.0 110.731 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.52 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 0.8 OUTLIER 80.31 -5.4 1.79 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.818 -0.551 . . . . 0.0 110.799 178.89 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.445 ' OD2' ' OE1' ' A' ' 61' ' ' GLN . 9.8 m-20 -80.8 143.03 33.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.708 -1.245 . . . . 0.0 110.013 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.41 123.81 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.76 160.43 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 110.191 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -122.18 126.17 47.71 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 77.6 mt -110.0 127.43 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -114.88 141.71 47.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.818 -0.551 . . . . 0.0 109.793 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.2 t30 62.91 38.17 11.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.745 -0.597 . . . . 0.0 109.679 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.58 141.92 55.33 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -93.98 121.97 36.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.642 0.734 . . . . 0.0 109.604 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.0 t -82.29 133.12 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.572 -0.705 . . . . 0.0 109.677 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.43 155.49 46.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.495 -0.753 . . . . 0.0 109.066 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -114.42 117.6 31.48 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.538 -0.726 . . . . 0.0 109.346 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -122.2 135.13 54.72 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.718 -0.614 . . . . 0.0 109.383 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 55.09 30.57 14.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.624 -0.672 . . . . 0.0 109.688 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.1 7.22 84.22 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -114.72 135.01 54.64 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.371 -1.076 . . . . 0.0 109.952 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.51 145.85 41.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.589 -0.694 . . . . 0.0 109.984 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.0 p -155.07 161.9 41.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.502 -0.749 . . . . 0.0 109.199 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.4 mt -107.39 127.87 53.96 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.448 -0.782 . . . . 0.0 109.492 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 m -100.58 125.19 46.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.687 -0.633 . . . . 0.0 109.343 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 t -112.4 130.2 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.53 -0.732 . . . . 0.0 109.092 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -153.13 -149.01 5.04 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.45 -42.3 99.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.533 -0.981 . . . . 0.0 110.263 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -60.83 -41.96 96.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.377 -0.827 . . . . 0.0 110.277 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.2 p -78.89 165.93 22.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.265 -0.897 . . . . 0.0 110.44 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -127.38 132.37 50.17 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.547 HD12 ' HD3' ' A' ' 58' ' ' LYS . 81.6 mt -113.34 129.67 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.537 -0.727 . . . . 0.0 109.092 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -132.27 123.34 26.72 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.433 -0.792 . . . . 0.0 109.081 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.1 p -76.65 156.55 32.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.998 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.438 -0.789 . . . . 0.0 109.203 179.351 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.508 0.67 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.5 tp -77.93 125.48 29.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.467 -0.77 . . . . 0.0 109.951 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.66 161.95 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.491 -0.756 . . . . 0.0 109.777 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -78.81 152.58 31.29 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.633 0.73 . . . . 0.0 110.523 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.9 -42.99 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.378 -0.826 . . . . 0.0 109.416 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -67.5 -18.26 64.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.024 -1.048 . . . . 0.0 109.361 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -90.15 -18.64 25.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.144 -0.972 . . . . 0.0 109.55 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.3 t -52.1 135.59 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.198 -0.939 . . . . 0.0 110.501 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.6 p -153.91 166.82 31.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.585 -0.697 . . . . 0.0 109.337 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 11' ' ' LEU . 3.6 mm? -68.94 -13.59 62.53 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.405 -0.809 . . . . 0.0 109.508 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.3 p -60.66 -31.19 70.42 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.157 -0.964 . . . . 0.0 109.003 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.44 ' OG1' ' CG1' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -122.95 85.33 50.55 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.17 -39.63 70.86 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.477 2.118 . . . . 0.0 112.018 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -106.52 131.64 53.46 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.56 -0.713 . . . . 0.0 109.887 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.44 ' CG1' ' OG1' ' A' ' 13' ' ' THR . 15.5 m -153.13 -177.25 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.353 -0.842 . . . . 0.0 109.716 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.8 m -137.62 137.91 38.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.432 -0.792 . . . . 0.0 109.09 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.3 m -140.44 161.91 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.388 -0.82 . . . . 0.0 109.822 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.447 HD11 ' NE ' ' A' ' 67' ' ' ARG . 86.3 mt -130.43 132.88 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.97 -167.62 37.39 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.054 -1.546 . . . . 0.0 110.017 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.499 ' C ' HD12 ' A' ' 22' ' ' ILE . 50.9 mtpt -113.01 138.11 50.38 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.709 -0.877 . . . . 0.0 109.432 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.762 ' N ' HD12 ' A' ' 22' ' ' ILE . 1.8 mp -97.95 131.33 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.424 -0.798 . . . . 0.0 109.615 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 63' ' ' SER . 79.6 p -133.45 160.31 37.77 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.315 0.579 . . . . 0.0 109.944 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 25' ' ' ILE . . . 100.28 -75.76 0.44 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 24' ' ' GLY . 38.1 mm 58.39 119.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.535 -0.979 . . . . 0.0 110.6 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -145.85 142.41 28.79 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -98.7 130.18 45.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.403 -0.811 . . . . 0.0 109.745 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -141.74 160.76 39.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.361 -0.837 . . . . 0.0 108.952 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 57.9 mp0 -121.84 142.53 50.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.49 -0.756 . . . . 0.0 109.374 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -141.96 160.27 40.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.286 -0.884 . . . . 0.0 108.874 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -90.17 115.65 27.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.982 . . . . 0.0 109.919 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.4 t -110.76 115.14 29.03 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.692 . . . . 0.0 109.214 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 54.38 31.33 14.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.47 -0.769 . . . . 0.0 109.896 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.8 1.8 84.85 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.8 m -117.99 128.69 55.03 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.321 -1.105 . . . . 0.0 109.649 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.1 m -67.99 128.49 36.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 110.381 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -133.1 146.0 51.24 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.43 -0.794 . . . . 0.0 109.58 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.1 m -81.25 144.14 31.78 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.441 -0.787 . . . . 0.0 109.982 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.8 p -136.43 138.96 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.474 -0.766 . . . . 0.0 109.0 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -103.7 131.21 51.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.423 -0.798 . . . . 0.0 108.977 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -124.1 155.76 37.81 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.579 -0.7 . . . . 0.0 109.478 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.38 -160.31 22.93 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -127.59 140.68 51.96 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.605 -0.938 . . . . 0.0 109.62 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.548 ' HB ' HD13 ' A' ' 53' ' ' ILE . 20.4 tt -117.73 136.85 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -134.24 151.47 51.31 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.467 -0.771 . . . . 0.0 109.836 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -144.99 -150.12 0.31 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.645 -0.66 . . . . 0.0 109.368 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 31.7 p-10 -85.72 -1.76 57.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 109.732 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.9 p -103.62 -63.0 1.23 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.175 -0.953 . . . . 0.0 109.556 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -166.47 -149.15 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 109.92 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -140.65 151.86 44.93 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.46 -0.775 . . . . 0.0 109.93 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 tt -149.48 158.93 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.188 -0.945 . . . . 0.0 110.196 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.6 mtp85 -71.93 146.98 47.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.9 . . . . 0.0 109.814 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.702 HD11 HG23 ' A' ' 22' ' ' ILE . 37.0 pt -136.76 150.11 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.399 -0.813 . . . . 0.0 110.235 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 t -142.57 138.21 30.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.531 -0.73 . . . . 0.0 109.135 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.3 t -130.35 133.64 46.57 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.508 -0.745 . . . . 0.0 109.175 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -92.87 123.83 36.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.38 -0.825 . . . . 0.0 111.03 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.08 -55.23 3.13 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -70.95 131.81 44.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.875 -1.368 . . . . 0.0 110.403 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -96.69 155.17 16.89 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.499 -0.75 . . . . 0.0 110.085 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.9 mt -123.16 151.68 41.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -103.59 160.5 14.69 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.645 0.736 . . . . 0.0 110.176 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 63' ' ' SER . 38.8 t70 -66.14 150.15 49.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.658 -0.651 . . . . 0.0 111.24 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 22' ' ' ILE . 11.1 p 37.57 42.56 0.37 Allowed 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.31 0.576 . . . . 0.0 110.439 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -90.69 120.1 31.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.229 -0.919 . . . . 0.0 110.031 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.78 110.49 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.5 m -143.78 168.32 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.126 -0.984 . . . . 0.0 110.109 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.447 ' NE ' HD11 ' A' ' 19' ' ' ILE . 41.5 ttm180 -118.21 124.37 47.76 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.3 mt -103.7 126.13 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -117.54 141.18 48.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.742 -0.599 . . . . 0.0 109.783 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.3 t30 65.47 37.57 6.06 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.47 0.653 . . . . 0.0 109.837 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.76 137.94 46.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.134 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -86.65 121.19 28.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.537 -0.727 . . . . 0.0 109.96 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.2 t -83.49 133.93 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.458 -0.776 . . . . 0.0 109.586 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -136.57 154.94 50.55 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.284 -0.885 . . . . 0.0 109.449 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -115.49 111.59 20.97 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -116.14 125.96 53.04 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.505 -0.747 . . . . 0.0 109.936 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 55.26 33.25 20.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.639 -0.663 . . . . 0.0 110.13 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.26 3.24 88.4 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -111.05 133.63 53.28 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.344 -1.092 . . . . 0.0 109.954 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.2 mt -76.72 148.76 36.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.499 -0.751 . . . . 0.0 110.514 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.0 p -152.99 158.66 42.37 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.1 mt -111.55 126.52 55.07 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.282 -0.886 . . . . 0.0 109.379 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.4 m -107.68 123.55 48.68 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.5 t -99.15 112.0 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.266 -0.897 . . . . 0.0 109.47 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.24 -173.05 31.25 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.62 -35.41 80.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.589 -0.948 . . . . 0.0 109.527 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.0 t -66.84 -16.77 64.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 0.0 109.655 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.9 m -74.98 159.42 31.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 110.141 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.1 ttt85 -124.0 134.51 53.44 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.663 -0.648 . . . . 0.0 109.337 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.02 131.9 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.683 -0.636 . . . . 0.0 109.527 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -122.28 130.18 52.91 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.6 0.715 . . . . 0.0 109.286 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.4 p -70.6 147.0 49.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.503 -0.748 . . . . 0.0 110.287 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.2 t . . . . . 0 N--CA 1.498 1.964 0 O-C-N 121.591 -0.693 . . . . 0.0 109.666 179.61 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.2 t70 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.376 0.608 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.606 HD22 ' N ' ' A' ' 3' ' ' LEU . 4.0 mm? -81.94 130.0 34.94 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.378 -0.826 . . . . 0.0 110.248 -178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.79 163.87 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.576 -0.703 . . . . 0.0 109.647 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.61 156.46 27.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.418 -0.801 . . . . 0.0 110.622 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.45 -43.13 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 0.0 109.535 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -67.34 -14.75 63.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.014 -1.054 . . . . 0.0 109.795 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -89.7 -0.03 57.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 109.159 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.11 132.68 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 110.056 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.4 t -158.73 170.25 22.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.358 -0.839 . . . . 0.0 109.619 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.497 HD22 ' N ' ' A' ' 11' ' ' LEU . 3.7 mm? -64.4 -35.45 80.95 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.438 -0.789 . . . . 0.0 109.285 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.7 p -57.96 -20.47 38.15 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.742 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 p -113.32 79.19 3.75 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.348 -0.845 . . . . 0.0 108.885 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.9 -24.91 39.36 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.254 1.969 . . . . 0.0 112.384 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -125.57 110.1 13.45 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.467 -0.77 . . . . 0.0 109.018 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.8 m -141.65 162.09 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.233 -0.917 . . . . 0.0 110.307 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 t -117.25 135.49 53.77 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.7 m -136.14 161.33 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.278 -0.888 . . . . 0.0 110.171 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.3 tt -139.4 140.74 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.401 -0.812 . . . . 0.0 109.341 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.33 -166.04 36.81 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 118.959 -1.591 . . . . 0.0 110.13 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -106.38 131.08 54.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.557 -0.967 . . . . 0.0 109.625 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.493 HG21 HD11 ' A' ' 25' ' ' ILE . 96.3 mt -102.58 133.7 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.575 -0.703 . . . . 0.0 109.839 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.453 ' HA ' ' H ' ' A' ' 63' ' ' SER . 30.3 p -135.47 159.6 41.09 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.335 0.588 . . . . 0.0 109.672 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.29 -84.08 0.99 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.493 HD11 HG21 ' A' ' 22' ' ' ILE . 49.5 mm 56.12 107.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.536 -0.979 . . . . 0.0 110.421 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -129.27 138.54 51.7 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -90.48 136.51 33.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 110.372 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -148.66 151.28 34.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.378 -0.826 . . . . 0.0 108.907 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -117.86 144.74 45.14 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.352 -0.842 . . . . 0.0 110.063 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.405 ' N ' ' CD1' ' A' ' 30' ' ' TYR . 10.0 p90 -144.69 162.32 37.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.333 -0.854 . . . . 0.0 109.822 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -80.96 141.64 34.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.42 -0.8 . . . . 0.0 109.823 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.3 t -144.87 106.37 4.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.136 -0.978 . . . . 0.0 109.511 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.5 t0 57.96 33.41 23.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.422 -0.799 . . . . 0.0 110.329 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.66 6.0 87.68 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 92.4 m -126.62 127.44 45.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.372 -1.075 . . . . 0.0 109.31 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.0 m -73.0 134.41 44.66 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.221 -0.924 . . . . 0.0 110.042 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -131.82 143.4 50.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.428 -0.795 . . . . 0.0 109.054 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 86.8 p -87.27 146.07 26.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.214 -0.929 . . . . 0.0 109.813 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.91 140.26 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.384 -0.823 . . . . 0.0 109.547 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -104.82 130.49 52.93 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -121.35 152.77 38.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.454 -0.778 . . . . 0.0 109.417 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.09 -169.23 33.84 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -123.11 138.97 54.53 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.617 -0.931 . . . . 0.0 109.235 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 tt -118.1 143.18 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -133.33 153.21 51.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.574 -0.704 . . . . 0.0 109.621 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.53 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 40.4 t0 -149.17 -164.01 1.92 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.373 -0.83 . . . . 0.0 108.942 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.53 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 60.2 t0 -64.32 -33.75 76.56 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.442 -0.786 . . . . 0.0 109.295 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 p -77.31 -86.9 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 110.281 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.06 -147.06 0.2 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.344 -0.848 . . . . 0.0 110.233 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -143.9 157.96 44.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.475 -0.766 . . . . 0.0 109.454 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.2 tt -153.77 161.52 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.953 -1.092 . . . . 0.0 110.326 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -73.82 145.29 45.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.556 -0.715 . . . . 0.0 109.749 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.4 pt -135.24 152.98 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.198 -0.939 . . . . 0.0 109.499 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.6 p -142.31 129.69 21.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.183 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 t -113.94 121.0 42.58 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -96.27 121.12 37.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.322 -0.861 . . . . 0.0 110.72 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.46 -44.68 2.94 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -78.05 138.77 38.96 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.99 -1.3 . . . . 0.0 110.303 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -94.08 151.76 19.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -0.824 . . . . 0.0 109.923 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.15 157.21 43.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.565 -0.709 . . . . 0.0 109.331 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -112.09 136.89 50.88 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.518 0.675 . . . . 0.0 109.687 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -64.65 142.75 58.32 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.884 0.85 . . . . 0.0 111.222 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.453 ' H ' ' HA ' ' A' ' 23' ' ' THR . 11.1 t 58.34 81.19 0.16 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.65 0.738 . . . . 0.0 110.268 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -162.69 126.67 3.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.522 -0.736 . . . . 0.0 110.12 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 t -78.12 120.12 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.389 -0.819 . . . . 0.0 109.444 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.43 163.78 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.465 -0.772 . . . . 0.0 109.823 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.4 ttp85 -119.23 128.23 54.0 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.1 mt -107.38 129.32 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.402 -0.811 . . . . 0.0 109.382 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 66.5 t0 -114.64 142.11 46.9 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.544 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 64.6 t30 63.3 40.58 8.5 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.345 0.593 . . . . 0.0 109.918 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.45 148.87 42.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.334 -0.854 . . . . 0.0 109.417 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -100.87 125.53 47.41 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.565 0.698 . . . . 0.0 109.729 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.9 t -89.19 135.28 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.369 -0.832 . . . . 0.0 110.038 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.74 157.0 43.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 0.0 108.889 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -113.36 116.92 30.44 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.454 -0.779 . . . . 0.0 109.44 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -125.94 138.69 53.78 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.425 -0.797 . . . . 0.0 110.094 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 57.04 23.5 8.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.665 -0.647 . . . . 0.0 109.484 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.08 7.88 88.19 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -118.21 137.76 52.79 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.546 -0.973 . . . . 0.0 109.898 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.1 mt -77.12 148.52 35.98 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.425 -0.797 . . . . 0.0 110.212 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.9 p -155.04 161.67 41.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.317 -0.864 . . . . 0.0 109.016 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.4 mt -106.32 125.59 51.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.426 -0.796 . . . . 0.0 109.246 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.9 m -105.66 123.34 47.76 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.5 t -98.97 114.13 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.301 -0.874 . . . . 0.0 108.997 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.57 -177.42 37.02 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -67.42 -27.31 66.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.598 -0.942 . . . . 0.0 109.611 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.1 m -78.8 -6.51 56.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.148 -0.97 . . . . 0.0 109.487 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.7 m -83.66 165.59 18.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.041 -1.037 . . . . 0.0 109.841 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.75 141.05 51.69 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.435 -0.791 . . . . 0.0 109.318 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.03 130.98 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.563 -0.71 . . . . 0.0 109.609 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -123.72 116.32 22.84 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.9 m -77.54 140.2 39.7 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.35 -0.844 . . . . 0.0 110.099 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.497 1.913 0 O-C-N 121.546 -0.721 . . . . 0.0 109.29 179.47 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.3 p30 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.754 0.788 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.7 tp -81.58 128.48 33.97 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.415 -0.803 . . . . 0.0 109.956 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.01 162.87 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-O 121.719 0.771 . . . . 0.0 110.165 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -77.18 159.47 29.68 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.796 0.808 . . . . 0.0 110.354 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.8 mm -63.78 -42.91 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 121.701 0.762 . . . . 0.0 109.887 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -66.07 -18.08 65.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.193 -0.942 . . . . 0.0 110.486 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 8' ' ' ASP . 59.2 t0 -86.45 -1.79 57.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.858 -1.151 . . . . 0.0 109.384 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 87.1 t -66.29 133.3 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.338 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.4 p -156.16 167.44 30.41 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.508 -0.745 . . . . 0.0 109.357 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.5 -34.96 79.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.821 . . . . 0.0 109.309 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.6 p -56.84 -19.4 17.23 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 109.475 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 13' ' ' THR . 11.1 p -115.23 81.07 7.82 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.835 . . . . 0.0 109.248 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -71.92 -16.08 29.36 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.598 2.199 . . . . 0.0 111.288 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -128.66 110.07 11.89 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.4 m -145.44 161.68 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.357 -0.84 . . . . 0.0 110.397 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.3 t -116.55 136.96 52.55 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.61 160.29 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 121.894 0.854 . . . . 0.0 110.256 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.3 tt -144.36 133.73 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.682 -0.636 . . . . 0.0 109.606 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.82 -162.55 30.33 Favored Glycine 0 N--CA 1.487 2.051 0 C-N-CA 119.693 -1.241 . . . . 0.0 110.019 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -105.98 134.79 48.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.708 -0.878 . . . . 0.0 109.985 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 63' ' ' SER . 97.0 mt -103.64 130.64 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.527 0.679 . . . . 0.0 110.086 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 p -134.15 163.31 29.88 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.49 0.662 . . . . 0.0 109.371 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.479 ' N ' ' OD1' ' A' ' 62' ' ' ASP . . . 97.03 -76.74 0.68 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 24' ' ' GLY . 36.9 mm 57.91 120.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 122.039 0.923 . . . . 0.0 110.405 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -143.63 138.97 29.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.451 -0.781 . . . . 0.0 108.986 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -104.36 130.3 52.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.481 -0.762 . . . . 0.0 109.919 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -144.34 165.29 28.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.545 -0.722 . . . . 0.0 109.402 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -120.57 146.57 46.2 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.593 -0.692 . . . . 0.0 110.008 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -142.6 163.16 33.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 109.85 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.536 ' N ' ' OE1' ' A' ' 31' ' ' GLU . 57.0 mp0 -88.04 114.16 24.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.528 -0.733 . . . . 0.0 109.721 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.8 t -110.77 107.29 16.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.493 -0.755 . . . . 0.0 109.758 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 54.7 t0 54.79 28.56 10.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.533 -0.73 . . . . 0.0 110.526 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.88 8.18 67.55 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.4 m -123.11 127.51 48.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.409 -1.053 . . . . 0.0 109.11 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.9 m -72.83 131.05 41.79 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.392 -0.818 . . . . 0.0 110.402 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -136.89 146.61 45.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.473 -0.767 . . . . 0.0 109.529 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 99.8 p -81.43 148.6 29.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.401 -0.812 . . . . 0.0 110.343 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.32 138.3 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 109.678 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.498 ' CD1' ' O ' ' A' ' 58' ' ' LYS . 83.7 m-85 -104.35 132.72 50.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.447 -0.783 . . . . 0.0 109.481 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -129.2 156.64 43.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.634 -0.666 . . . . 0.0 109.457 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.55 -165.32 31.97 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.045 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -120.36 143.89 48.17 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.698 -0.883 . . . . 0.0 109.798 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 tt -131.85 134.37 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -139.45 155.02 47.85 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.855 0.836 . . . . 0.0 110.553 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.547 ' O ' ' C ' ' A' ' 47' ' ' ASP . 41.8 p-10 -152.89 99.47 2.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.432 -0.792 . . . . 0.0 109.385 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.547 ' C ' ' O ' ' A' ' 46' ' ' ASP . 29.5 p-10 13.72 57.94 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.736 0 CA-C-O 122.169 0.985 . . . . 0.0 110.944 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 46' ' ' ASP . 8.2 m -168.7 -55.6 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -173.39 -167.93 0.42 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.367 -0.833 . . . . 0.0 109.397 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -139.05 149.98 45.24 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.632 0.73 . . . . 0.0 110.482 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.8 tt -147.24 152.81 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.33 -0.856 . . . . 0.0 109.687 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.435 HH21 ' HB2' ' A' ' 79' ' ' TYR . 81.0 mtm-85 -77.53 147.57 35.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.521 -0.737 . . . . 0.0 109.856 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.0 pt -132.48 158.3 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.617 -0.677 . . . . 0.0 109.907 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 t -147.14 127.73 14.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 p -122.89 138.7 54.59 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.477 0.656 . . . . 0.0 109.613 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -97.8 118.15 33.71 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.679 0.752 . . . . 0.0 111.527 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.09 -19.66 1.69 Allowed Glycine 0 N--CA 1.496 2.671 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.608 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.498 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 68.8 mttm -83.63 137.82 33.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.689 -1.477 . . . . 0.0 110.484 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -96.6 140.73 30.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.602 -0.687 . . . . 0.0 110.159 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.1 mt -130.18 153.32 48.67 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.598 -0.689 . . . . 0.0 109.381 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -113.33 155.31 25.4 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.653 0.74 . . . . 0.0 109.893 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 7.7 m-20 -70.78 148.3 48.05 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.92 0.867 . . . . 0.0 110.995 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 22' ' ' ILE . 1.8 m 53.34 32.98 14.68 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.779 0.8 . . . . 0.0 109.409 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -96.84 114.57 26.21 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.353 -0.842 . . . . 0.0 110.573 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.443 HG22 ' H ' ' A' ' 65' ' ' VAL . 1.5 m -84.08 117.14 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.343 -0.848 . . . . 0.0 109.889 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.9 m -148.45 175.12 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.501 0.667 . . . . 0.0 109.541 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -122.68 132.26 54.18 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.55 125.28 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.597 -0.689 . . . . 0.0 109.477 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -111.21 152.38 27.16 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 59.57 35.23 22.57 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.708 0.766 . . . . 0.0 109.664 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.65 143.97 56.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.51 -0.744 . . . . 0.0 109.442 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -105.62 118.57 36.93 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.935 0.874 . . . . 0.0 109.572 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -88.91 131.44 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.425 -0.797 . . . . 0.0 110.124 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.46 157.58 41.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.394 -0.816 . . . . 0.0 109.015 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -100.75 125.45 47.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.455 -0.778 . . . . 0.0 109.655 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.415 ' O ' ' N ' ' A' ' 78' ' ' GLY . 69.8 m-85 -115.52 133.18 56.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.61 -0.681 . . . . 0.0 109.354 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m120 67.89 -63.23 0.32 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.627 0.727 . . . . 0.0 109.844 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 76' ' ' PHE . . . 176.43 29.15 0.04 OUTLIER Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.435 ' HB2' HH21 ' A' ' 52' ' ' ARG . 31.5 p90 -146.82 155.43 42.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.292 -1.122 . . . . 0.0 109.837 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.8 mt -83.06 145.65 29.15 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.77 0.795 . . . . 0.0 110.974 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.1 t -157.8 163.72 37.75 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 70.7 mt -101.15 130.22 47.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.165 -0.959 . . . . 0.0 109.694 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.6 m -109.88 122.6 47.91 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.665 0.745 . . . . 0.0 109.319 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.6 t -98.62 110.04 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.826 0.822 . . . . 0.0 109.11 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.13 -174.85 40.8 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -71.22 -19.23 62.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.553 -0.969 . . . . 0.0 110.34 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -84.55 -8.83 58.78 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.711 -1.243 . . . . 0.0 109.057 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.8 t -79.34 162.63 25.46 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.395 -0.816 . . . . 0.0 110.434 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -129.66 136.37 49.64 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.594 -0.691 . . . . 0.0 109.384 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.84 130.46 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -120.53 132.19 55.06 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.701 0.762 . . . . 0.0 109.128 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.0 m -74.31 147.85 41.91 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.383 0.611 . . . . 0.0 110.525 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.304 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 65.9 t0 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.691 0.758 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.545 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 42.8 tp -70.92 121.78 18.76 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.551 0.691 . . . . 0.0 110.097 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.1 m -137.78 163.65 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 121.582 0.706 . . . . 0.0 109.939 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -76.03 156.85 33.62 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.587 0.708 . . . . 0.0 110.26 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.84 -43.41 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.563 -0.71 . . . . 0.0 109.728 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.491 ' HE ' ' HB2' ' A' ' 49' ' ' ALA . 95.0 mtt180 -62.62 -24.84 67.79 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.403 -0.811 . . . . 0.0 110.382 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -82.62 -0.21 46.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.549 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.2 t -65.76 131.54 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.371 -0.831 . . . . 0.0 110.539 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 99.1 p -160.31 169.3 23.44 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.685 0.755 . . . . 0.0 109.535 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.74 -33.89 76.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.766 . . . . 0.0 109.823 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -59.74 -18.59 44.04 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.243 -0.91 . . . . 0.0 109.271 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.48 ' O ' HG21 ' A' ' 73' ' ' VAL . 13.6 p -111.45 80.13 2.54 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.65 -23.19 36.72 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.383 2.055 . . . . 0.0 111.744 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -126.22 110.08 13.04 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 m -138.15 162.62 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.589 -0.695 . . . . 0.0 110.353 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 t -125.67 134.85 51.7 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.5 m -139.88 162.24 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 121.579 0.704 . . . . 0.0 110.303 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.3 tt -137.98 139.48 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.58 -0.7 . . . . 0.0 109.647 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.76 -162.94 29.85 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.661 -1.257 . . . . 0.0 109.993 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -106.15 144.4 32.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.749 -0.854 . . . . 0.0 109.491 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 25' ' ' ILE . 17.5 mm -94.2 130.59 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.302 0.573 . . . . 0.0 110.427 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.2 p -138.42 156.93 47.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.468 -0.77 . . . . 0.0 110.479 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.08 65.84 2.74 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 22' ' ' ILE . 21.8 mm -80.21 128.15 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -1.12 . . . . 0.0 110.242 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -134.66 140.93 46.39 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -104.53 134.65 47.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.644 -0.66 . . . . 0.0 109.884 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -140.61 162.73 34.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.645 -0.66 . . . . 0.0 109.716 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -125.76 140.1 52.97 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.754 -0.591 . . . . 0.0 109.72 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -140.38 159.01 43.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.455 -0.778 . . . . 0.0 109.586 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -86.98 111.19 20.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.575 -0.703 . . . . 0.0 109.752 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 p -112.81 119.78 39.19 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.524 0.678 . . . . 0.0 109.807 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.9 t0 55.23 29.71 13.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.619 -0.676 . . . . 0.0 109.916 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.52 5.82 86.45 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.8 m -124.87 128.74 49.13 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.447 -1.031 . . . . 0.0 109.613 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 33.2 m -66.77 130.4 43.03 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.645 -0.659 . . . . 0.0 110.3 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -132.18 143.0 49.65 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.833 0.825 . . . . 0.0 109.612 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.6 t -78.25 145.36 35.51 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.425 0.631 . . . . 0.0 110.137 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.79 137.71 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.6 -0.688 . . . . 0.0 109.303 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -103.76 132.7 49.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.72 -0.613 . . . . 0.0 109.456 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -125.41 149.05 48.54 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.7 -165.51 29.84 Favored Glycine 0 N--CA 1.485 1.956 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.139 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -123.28 142.85 50.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.836 -0.802 . . . . 0.0 109.398 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.41 ' HB ' HD13 ' A' ' 53' ' ' ILE . 19.6 tt -120.39 144.34 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -131.16 150.42 52.15 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.613 0.72 . . . . 0.0 110.162 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 41.4 t0 -151.76 -166.66 2.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.587 -0.695 . . . . 0.0 109.391 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.527 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 47.6 t0 -70.29 -9.94 57.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 109.938 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.3 p -94.72 -71.31 0.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 109.625 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.491 ' HB2' ' HE ' ' A' ' 7' ' ' ARG . . . -162.22 -141.13 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.396 -0.815 . . . . 0.0 109.49 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -143.42 151.82 40.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.446 -0.784 . . . . 0.0 109.976 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.6 tt -151.9 161.44 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.712 . . . . 0.0 110.158 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -74.11 147.26 42.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.492 -0.755 . . . . 0.0 109.628 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.41 HD13 ' HB ' ' A' ' 44' ' ' ILE . 43.0 pt -136.07 154.5 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.482 -0.761 . . . . 0.0 110.042 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.0 t -145.67 131.14 18.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.528 -0.733 . . . . 0.0 109.325 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.9 t -120.39 134.95 55.18 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.459 0.647 . . . . 0.0 109.435 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -95.8 122.14 38.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.518 -0.739 . . . . 0.0 111.021 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.53 -44.45 0.47 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.4 ttmm -79.01 130.99 36.12 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.168 -1.195 . . . . 0.0 110.678 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -91.89 164.59 13.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.51 0.671 . . . . 0.0 110.462 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.6 mt -126.9 157.74 38.59 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -105.8 133.85 49.86 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.327 1.061 . . . . 0.0 110.223 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -69.92 143.89 52.6 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.627 -0.67 . . . . 0.0 111.153 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.5 t 65.12 4.57 2.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -90.81 134.95 34.05 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.478 -0.764 . . . . 0.0 109.942 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.0 t -86.85 121.58 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.59 159.97 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.586 0.708 . . . . 0.0 109.876 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -123.75 125.08 44.11 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.2 mt -99.14 128.05 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -112.53 138.53 49.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.5 t30 62.54 39.24 11.83 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.334 0.587 . . . . 0.0 109.708 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.08 148.41 51.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.417 -0.802 . . . . 0.0 109.605 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -99.57 121.07 40.66 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.736 0.779 . . . . 0.0 109.882 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 13' ' ' THR . 84.6 t -80.87 133.75 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.609 -0.682 . . . . 0.0 109.874 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.44 155.54 42.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.397 -0.814 . . . . 0.0 109.509 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -114.09 119.14 36.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.766 -0.584 . . . . 0.0 109.621 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -118.27 126.2 51.67 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.507 0.67 . . . . 0.0 109.738 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 55.63 32.98 20.31 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.454 0.645 . . . . 0.0 110.196 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.15 6.05 89.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.73 133.9 55.08 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.385 -1.068 . . . . 0.0 110.022 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.9 mt -77.54 145.96 36.6 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.484 0.659 . . . . 0.0 110.117 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.8 p -154.34 160.27 41.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.531 -0.73 . . . . 0.0 109.353 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.4 mt -105.58 118.9 37.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.594 -0.692 . . . . 0.0 109.406 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.7 m -98.32 126.89 44.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.672 -0.642 . . . . 0.0 109.403 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 t -103.67 109.44 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.541 -0.725 . . . . 0.0 109.608 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -96.59 -176.24 35.55 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -68.24 -17.01 64.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.515 -0.991 . . . . 0.0 109.605 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 96.8 p -83.08 -9.41 59.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 109.107 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.7 t -88.5 167.85 13.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.457 -0.777 . . . . 0.0 110.14 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.5 tpt85 -132.44 135.05 45.81 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.6 mt -115.65 130.78 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.795 -0.566 . . . . 0.0 109.722 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -119.0 122.3 41.88 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.393 0.616 . . . . 0.0 109.661 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.2 m -80.8 149.16 29.71 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.418 0.628 . . . . 0.0 110.298 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.14 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.68 0.752 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.6 tp -79.93 124.42 28.66 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.562 -0.711 . . . . 0.0 109.878 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.99 163.46 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.443 -0.786 . . . . 0.0 109.724 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -76.16 159.43 30.7 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.683 0.754 . . . . 0.0 110.218 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.1 -42.9 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.527 -0.733 . . . . 0.0 110.037 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 -67.13 -18.52 65.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.903 -1.123 . . . . 0.0 109.617 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -83.57 -2.05 55.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.09 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.7 t -66.69 132.22 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 110.362 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 m -156.45 167.37 30.64 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.517 -0.74 . . . . 0.0 109.392 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.91 -37.65 88.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.338 -0.851 . . . . 0.0 109.716 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 93.8 p -54.71 -22.2 13.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.973 . . . . 0.0 109.31 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.417 ' O ' ' OG1' ' A' ' 13' ' ' THR . 10.7 p -113.03 80.9 4.3 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.75 -21.87 24.56 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.258 1.972 . . . . 0.0 111.673 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -125.26 109.98 13.48 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.399 0.619 . . . . 0.0 109.459 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.8 m -147.16 162.03 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.148 -0.97 . . . . 0.0 110.143 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.2 m -115.0 135.68 53.96 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.46 161.35 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.327 -0.858 . . . . 0.0 110.001 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.2 tt -138.5 137.51 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.377 -0.827 . . . . 0.0 109.711 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.36 -165.06 27.12 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 119.567 -1.301 . . . . 0.0 109.876 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -105.46 126.85 52.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.652 -0.91 . . . . 0.0 109.069 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.8 mm -83.32 129.51 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-O 121.495 0.664 . . . . 0.0 110.313 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 44.5 p -140.04 163.7 31.99 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.697 0.761 . . . . 0.0 110.035 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.35 89.71 0.01 OUTLIER Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.5 mm -99.61 126.05 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -1.118 . . . . 0.0 109.416 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -131.13 132.36 44.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -98.81 131.52 44.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.431 -0.793 . . . . 0.0 109.547 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -133.71 153.21 51.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.531 -0.731 . . . . 0.0 109.405 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -119.64 139.81 51.62 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.481 0.658 . . . . 0.0 109.799 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -142.0 161.16 38.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.292 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -90.36 99.18 12.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.959 . . . . 0.0 109.157 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.602 ' O ' ' N ' ' A' ' 34' ' ' GLY . 5.3 p -81.27 -156.5 0.15 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.484 -0.76 . . . . 0.0 110.073 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -48.28 82.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.53 0.681 . . . . 0.0 110.142 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 52.8 11.73 1.42 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.3 m -135.59 133.37 38.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.222 -1.163 . . . . 0.0 110.001 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.6 m -75.49 129.68 37.66 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.458 -0.776 . . . . 0.0 109.651 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -133.16 145.87 51.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.378 -0.826 . . . . 0.0 109.745 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.6 p -86.18 148.11 25.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.505 -0.747 . . . . 0.0 110.087 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 p -137.9 137.59 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.517 ' CZ ' ' OE1' ' A' ' 59' ' ' GLN . 88.3 m-85 -103.5 135.09 45.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.482 -0.761 . . . . 0.0 109.64 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -125.07 155.22 40.15 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.94 -167.29 34.62 Favored Glycine 0 N--CA 1.482 1.745 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -126.74 141.84 51.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.587 -0.949 . . . . 0.0 109.529 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.7 tt -114.55 143.68 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.45 ' OE2' ' O ' ' A' ' 49' ' ' ALA . 10.1 tp10 -130.46 149.14 52.27 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.582 0.706 . . . . 0.0 109.694 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.517 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 42.7 t0 -148.26 -164.39 2.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.464 -0.772 . . . . 0.0 109.478 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.517 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 96.7 m-20 -73.79 -17.06 61.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 109.657 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.1 m -92.94 -73.82 0.54 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.188 -0.945 . . . . 0.0 109.795 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.45 ' O ' ' OE2' ' A' ' 45' ' ' GLU . . . -154.15 -157.0 0.73 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.727 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -137.76 156.67 47.73 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.497 -0.752 . . . . 0.0 110.229 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 tt -151.4 159.41 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.268 -0.895 . . . . 0.0 110.3 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -76.15 144.26 40.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.858 . . . . 0.0 109.689 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -130.37 157.37 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.777 0.799 . . . . 0.0 110.245 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.2 t -143.61 134.87 25.85 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.8 t -127.57 131.68 49.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.262 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -102.17 123.25 45.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.441 -0.787 . . . . 0.0 111.011 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.66 -51.17 3.01 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.481 ' NZ ' ' O ' ' A' ' 88' ' ' SER . 98.6 mttt -63.93 135.72 56.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.098 -1.237 . . . . 0.0 110.58 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.517 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 69.8 tp60 -85.16 149.58 25.42 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.688 0.756 . . . . 0.0 110.52 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.2 mt -130.58 157.18 43.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -124.63 148.98 47.58 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.806 0.812 . . . . 0.0 110.051 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.2 p-10 -67.17 146.53 54.13 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.102 0.954 . . . . 0.0 111.377 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.3 p 47.16 81.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.631 0.729 . . . . 0.0 110.384 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -151.79 124.78 8.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.39 -0.819 . . . . 0.0 110.205 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 t -79.63 114.59 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.352 -0.842 . . . . 0.0 109.266 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.14 163.65 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.494 -0.754 . . . . 0.0 109.795 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -122.71 132.63 54.34 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 78.9 mt -107.14 128.57 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 68.1 t0 -110.34 143.07 41.1 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.548 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 64.6 t30 60.64 39.87 17.2 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.45 149.75 46.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.569 -0.707 . . . . 0.0 109.796 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -102.74 126.79 49.99 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.57 0.7 . . . . 0.0 110.016 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.4 t -92.29 133.0 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.498 -0.751 . . . . 0.0 109.397 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.67 156.27 45.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.148 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -113.0 119.28 37.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.469 -0.769 . . . . 0.0 109.609 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -125.15 134.09 52.56 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.559 0.695 . . . . 0.0 109.555 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 56.13 30.98 17.38 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.468 0.651 . . . . 0.0 109.787 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.77 4.69 77.18 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -114.39 136.62 52.79 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.316 -1.108 . . . . 0.0 109.742 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.91 146.37 37.65 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.655 0.74 . . . . 0.0 110.4 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.9 p -152.74 160.5 43.13 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.443 -0.786 . . . . 0.0 109.155 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.29 126.43 52.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.382 -0.824 . . . . 0.0 109.213 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 t -108.49 129.66 55.28 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.13 112.39 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.67 0.748 . . . . 0.0 109.1 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.71 -177.58 38.24 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -69.64 -17.4 63.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.58 -0.953 . . . . 0.0 109.434 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.3 m -84.91 -12.37 53.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.17 -0.956 . . . . 0.0 109.398 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.481 ' O ' ' NZ ' ' A' ' 58' ' ' LYS . 14.7 m -86.79 163.89 17.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.293 -0.879 . . . . 0.0 109.777 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -126.85 142.66 51.48 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.521 -0.737 . . . . 0.0 109.857 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -118.04 129.79 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -125.25 121.46 34.13 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.698 0.761 . . . . 0.0 109.36 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.0 p -78.57 156.59 29.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.498 -0.751 . . . . 0.0 109.94 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.519 -0.738 . . . . 0.0 109.276 179.591 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 65.7 t0 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.494 0.664 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.542 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 50.1 tp -71.69 127.62 33.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.332 -0.855 . . . . 0.0 109.612 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.79 163.62 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.342 -0.849 . . . . 0.0 110.434 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -76.53 154.54 34.47 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.426 0.631 . . . . 0.0 110.38 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.35 -43.22 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 109.604 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 -64.11 -21.04 66.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.146 -0.971 . . . . 0.0 109.964 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -88.07 1.66 53.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.097 -1.002 . . . . 0.0 109.742 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.07 131.78 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.09 -1.006 . . . . 0.0 110.297 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.6 p -158.33 166.45 32.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.441 -0.787 . . . . 0.0 109.67 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.31 -20.5 66.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.402 -0.811 . . . . 0.0 109.185 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.9 t -63.96 -16.3 61.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 109.57 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.4 p -119.82 84.24 31.2 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.48 -0.763 . . . . 0.0 109.11 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.53 -40.67 71.65 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.591 2.194 . . . . 0.0 112.203 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -121.84 127.69 50.82 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.673 -0.642 . . . . 0.0 109.758 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.6 m -144.76 161.61 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.293 -0.879 . . . . 0.0 109.735 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 t -116.59 136.29 53.1 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.84 162.3 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.377 -0.827 . . . . 0.0 109.738 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.06 143.5 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.405 -0.809 . . . . 0.0 109.792 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.16 -161.32 35.07 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -111.73 139.05 47.51 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.439 -1.036 . . . . 0.0 109.604 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.46 ' O ' ' N ' ' A' ' 63' ' ' SER . 97.1 mt -97.93 131.32 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.868 -0.52 . . . . 0.0 109.852 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.3 p -133.7 156.63 47.59 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.468 -0.77 . . . . 0.0 109.952 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.1 71.4 1.01 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.8 mm -79.76 128.6 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.982 -1.305 . . . . 0.0 109.207 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -128.75 131.31 47.86 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -104.61 135.98 44.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.534 -0.729 . . . . 0.0 109.78 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -148.74 156.99 43.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.491 -0.756 . . . . 0.0 109.035 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -111.94 146.02 38.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.567 -0.708 . . . . 0.0 109.655 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.434 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 10.7 p90 -143.55 159.19 42.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.347 -0.846 . . . . 0.0 109.672 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -83.15 136.12 34.56 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.444 -0.785 . . . . 0.0 110.004 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.8 t -147.76 118.24 7.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.376 -0.828 . . . . 0.0 109.158 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 56.53 32.05 20.12 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.749 -0.594 . . . . 0.0 110.176 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.81 13.25 83.33 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -127.76 158.56 37.35 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.323 -1.104 . . . . 0.0 109.892 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.1 m -94.76 123.7 38.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.603 -0.686 . . . . 0.0 109.768 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.434 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 42.8 mmtm -127.26 141.96 51.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.565 -0.709 . . . . 0.0 109.195 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.1 m -84.81 146.65 27.24 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.621 -0.674 . . . . 0.0 109.816 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.7 137.63 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.521 -0.737 . . . . 0.0 109.169 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -102.49 131.9 48.88 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -127.1 155.0 44.01 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.619 -0.675 . . . . 0.0 109.672 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.6 -166.81 34.32 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.775 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -119.34 139.96 51.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.662 -0.905 . . . . 0.0 109.516 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 tt -122.96 132.99 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -132.84 156.4 47.22 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.28 -0.888 . . . . 0.0 111.142 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 48' ' ' THR . 53.9 p-10 -143.67 -144.33 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 23.4 p-10 -88.22 -1.39 57.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 109.14 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 49' ' ' ALA . 30.4 p -101.23 -69.69 0.77 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.507 -0.745 . . . . 0.0 109.613 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.536 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -162.86 -148.2 0.13 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 109.788 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -137.92 153.51 49.5 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.497 -0.752 . . . . 0.0 109.901 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.0 tt -152.24 154.87 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.174 -0.954 . . . . 0.0 109.998 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.85 143.42 41.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.419 -0.801 . . . . 0.0 110.355 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.1 pt -132.46 153.9 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.724 -0.61 . . . . 0.0 109.568 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.1 p -143.71 121.34 11.82 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 p -113.36 138.86 49.44 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.603 -0.686 . . . . 0.0 109.418 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.505 ' C ' ' H ' ' A' ' 58' ' ' LYS . 67.7 m-85 -95.91 121.26 37.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.405 -0.809 . . . . 0.0 111.332 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.74 -31.45 0.28 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.505 ' H ' ' C ' ' A' ' 56' ' ' PHE . 68.9 mttm -72.9 135.02 45.03 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.962 -1.316 . . . . 0.0 110.061 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -88.26 155.36 19.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.368 -0.833 . . . . 0.0 109.893 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.7 mt -127.67 152.48 47.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.632 -0.668 . . . . 0.0 109.277 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -114.45 132.41 56.27 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.061 0.934 . . . . 0.0 110.149 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.7 t0 -65.0 139.18 58.73 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.818 0.818 . . . . 0.0 111.622 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.538 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.7 m 61.8 5.53 1.36 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.588 -0.695 . . . . 0.0 110.338 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 65' ' ' VAL . 64.1 t0 -81.78 129.24 34.66 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.005 -1.06 . . . . 0.0 110.26 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.438 ' H ' HG22 ' A' ' 65' ' ' VAL . 1.7 m -83.34 119.36 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.7 m -138.16 163.27 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.72 0.771 . . . . 0.0 109.86 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.483 ' NH1' ' OD2' ' A' ' 69' ' ' ASP . 75.7 ttt-85 -123.28 125.53 45.23 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 77.7 mt -107.52 129.02 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.521 -0.737 . . . . 0.0 109.524 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.483 ' OD2' ' NH1' ' A' ' 67' ' ' ARG . 95.4 m-20 -113.76 148.9 35.68 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.415 0.626 . . . . 0.0 109.849 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 60.85 36.95 18.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.734 -0.604 . . . . 0.0 109.546 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.32 133.4 42.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 109.511 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -84.57 131.11 34.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 110.253 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.4 t -87.62 134.14 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.488 -0.757 . . . . 0.0 109.47 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.57 154.74 44.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.152 -0.968 . . . . 0.0 109.527 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.408 HE21 ' HA2' ' A' ' 78' ' ' GLY . 59.1 tt0 -116.48 117.82 30.95 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -126.45 133.17 51.29 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.668 -0.645 . . . . 0.0 109.766 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 56.57 31.79 19.72 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.274 0.559 . . . . 0.0 110.097 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.408 ' HA2' HE21 ' A' ' 75' ' ' GLN . . . 76.66 5.11 82.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -113.63 133.1 55.49 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.379 -1.071 . . . . 0.0 110.119 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.64 146.26 36.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.517 -0.739 . . . . 0.0 109.793 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 97.3 p -156.22 161.97 40.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.398 -0.814 . . . . 0.0 109.767 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.2 mt -105.84 130.61 53.78 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.5 t -107.76 127.83 54.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.0 109.413 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.08 107.67 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.46 -0.775 . . . . 0.0 109.356 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -96.0 -177.29 36.39 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -69.14 -17.27 63.81 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.254 -1.145 . . . . 0.0 109.315 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.6 m -84.45 -8.8 58.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.16 -0.963 . . . . 0.0 109.135 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.6 t -85.2 168.19 15.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.404 -0.81 . . . . 0.0 109.75 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -129.25 139.85 51.67 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.475 -0.765 . . . . 0.0 109.882 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.51 130.92 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -122.57 111.11 16.39 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.2 t -73.62 146.68 44.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.531 -0.731 . . . . 0.0 110.12 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 51.6 t . . . . . 0 N--CA 1.498 1.939 0 O-C-N 121.491 -0.756 . . . . 0.0 109.506 179.547 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.7 t70 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.403 0.621 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.5 tp -77.19 129.55 36.1 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.315 -0.866 . . . . 0.0 109.786 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.2 m -137.43 162.27 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.626 0.727 . . . . 0.0 109.424 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -88.53 162.44 16.41 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.48 0.657 . . . . 0.0 109.965 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.63 -42.74 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -72.49 -14.13 61.59 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.2 -0.938 . . . . 0.0 109.701 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -91.38 1.94 56.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.065 -1.022 . . . . 0.0 108.822 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.45 132.97 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 110.567 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.5 p -156.21 162.45 40.17 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.8 mt -71.92 -11.14 60.64 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.225 -0.922 . . . . 0.0 109.155 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.3 p -66.78 -17.83 65.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.4 p -123.04 84.17 50.9 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.51 -0.744 . . . . 0.0 109.528 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.73 -41.5 69.08 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.27 1.98 . . . . 0.0 111.609 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -119.26 131.41 55.78 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.365 0.602 . . . . 0.0 109.918 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.1 m -154.87 -173.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.246 -0.909 . . . . 0.0 109.744 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.8 p -131.39 137.02 48.5 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.49 158.63 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.415 -0.803 . . . . 0.0 109.865 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.5 mt -134.3 133.72 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.83 -171.16 36.6 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 118.741 -1.695 . . . . 0.0 110.351 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -114.67 121.2 42.66 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.766 -0.843 . . . . 0.0 108.984 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.617 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.0 mp -89.11 133.56 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.929 -0.482 . . . . 0.0 109.727 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.454 ' HA ' ' H ' ' A' ' 63' ' ' SER . 3.3 p -136.85 158.38 44.58 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.442 0.639 . . . . 0.0 109.732 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.35 83.53 0.07 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.5 mm -85.44 130.76 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.227 -1.161 . . . . 0.0 109.728 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -131.28 136.37 48.12 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -106.37 137.74 43.81 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.469 -0.77 . . . . 0.0 110.308 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -144.35 159.62 42.4 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -133.97 146.5 50.51 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.165 -0.96 . . . . 0.0 110.089 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -144.25 163.76 32.73 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.367 -0.833 . . . . 0.0 109.113 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -83.57 138.46 33.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.314 -0.866 . . . . 0.0 110.828 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 t -152.63 130.71 11.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.841 . . . . 0.0 108.925 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.6 t0 60.86 21.99 12.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.551 -0.718 . . . . 0.0 109.456 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.17 14.44 76.84 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 82.2 p -135.43 148.56 49.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.513 -0.992 . . . . 0.0 109.955 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.3 m -85.25 129.93 34.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.435 -0.791 . . . . 0.0 109.618 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -124.38 143.13 50.77 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.687 0.756 . . . . 0.0 110.029 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.9 m -83.84 141.13 31.57 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.377 0.608 . . . . 0.0 110.123 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 p -137.49 137.63 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -102.51 133.41 47.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.379 -0.826 . . . . 0.0 109.198 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -124.3 158.52 32.39 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.56 -170.56 37.87 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -120.38 142.8 48.84 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.6 -0.941 . . . . 0.0 109.267 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 tt -125.91 140.07 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -132.78 156.9 46.26 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.514 -0.741 . . . . 0.0 110.267 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 39.4 t0 -146.16 -142.28 0.13 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.516 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 66.3 t0 -87.55 -21.03 25.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.351 -0.843 . . . . 0.0 109.634 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.3 p -91.04 -76.61 0.44 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.086 -1.009 . . . . 0.0 109.866 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.11 -148.47 0.26 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 109.748 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.6 ptt-85 -142.57 159.17 42.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.577 -0.702 . . . . 0.0 109.702 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.4 tt -153.17 162.07 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.039 -1.038 . . . . 0.0 109.969 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -76.53 142.92 40.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.681 -0.637 . . . . 0.0 109.793 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.4 pt -129.22 153.75 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.532 -0.73 . . . . 0.0 109.433 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 p -142.25 132.57 24.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.59 -0.693 . . . . 0.0 109.259 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.2 t -119.23 128.67 54.41 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -92.73 122.76 35.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.183 -0.948 . . . . 0.0 110.409 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.48 -51.29 3.31 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -77.43 134.28 38.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.953 -1.322 . . . . 0.0 110.822 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.407 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 15.8 pt20 -93.07 160.0 15.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.584 -0.697 . . . . 0.0 110.116 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.8 mt -121.72 153.55 38.07 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -102.23 147.58 26.48 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.736 0.779 . . . . 0.0 110.32 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 63' ' ' SER . 66.7 t0 -67.23 137.52 56.24 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.998 0.904 . . . . 0.0 111.947 -178.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.541 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 55.5 m 48.79 80.64 0.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.557 0.694 . . . . 0.0 110.803 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -152.46 126.2 8.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.535 -0.728 . . . . 0.0 109.929 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.0 t -80.81 120.23 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.395 -0.816 . . . . 0.0 109.265 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.6 m -138.52 163.99 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.929 0.871 . . . . 0.0 110.575 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -115.69 124.01 49.78 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 87.9 mt -109.5 124.66 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -111.53 144.65 40.42 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.636 -0.665 . . . . 0.0 109.836 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.6 t30 65.42 37.25 6.31 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.554 0.692 . . . . 0.0 109.231 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.38 143.03 53.81 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -96.39 125.76 41.11 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.704 . . . . 0.0 109.536 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.1 t -85.51 130.23 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.811 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.86 141.47 30.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.378 -0.826 . . . . 0.0 108.782 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.567 ' O ' ' NE2' ' A' ' 75' ' ' GLN . 1.4 pp0? -116.18 138.03 51.62 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.657 -0.652 . . . . 0.0 109.351 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -132.36 135.63 46.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.536 -0.728 . . . . 0.0 109.965 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.2 t30 57.78 24.72 11.06 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.364 0.602 . . . . 0.0 109.703 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.79 33.62 29.83 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -138.33 121.31 16.66 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.321 -1.105 . . . . 0.0 109.48 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.3 mt -67.76 143.74 55.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.616 -0.677 . . . . 0.0 110.449 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.8 m -152.67 154.25 34.93 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.1 mt -101.85 126.5 48.75 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.214 -0.928 . . . . 0.0 109.711 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.7 m -106.91 125.55 51.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.718 -0.614 . . . . 0.0 109.443 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.8 t -98.81 108.33 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.349 -0.845 . . . . 0.0 108.834 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.39 179.82 42.17 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 87' ' ' SER . 38.4 p30 -67.83 -21.03 65.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.545 -0.973 . . . . 0.0 109.546 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.522 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 92.2 p -81.52 -7.96 59.66 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.143 -0.973 . . . . 0.0 109.207 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.5 t -80.42 158.47 25.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.965 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -117.69 127.8 54.28 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.1 mt -111.93 130.32 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.545 -0.722 . . . . 0.0 109.692 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -130.21 114.47 15.71 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.9 m -79.71 131.33 35.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.565 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.5 t . . . . . 0 N--CA 1.498 1.932 0 O-C-N 121.497 -0.752 . . . . 0.0 109.578 179.868 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 36.1 p-10 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.5 tp -76.19 123.92 26.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.331 -0.856 . . . . 0.0 109.809 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.48 163.66 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.71 0.767 . . . . 0.0 110.142 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -79.29 156.88 27.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.753 -0.592 . . . . 0.0 110.084 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.22 -43.35 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.408 ' HE ' ' HB2' ' A' ' 49' ' ' ALA . 99.5 mtt180 -65.17 -21.89 66.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 109.609 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -86.87 -1.38 57.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.204 -0.935 . . . . 0.0 109.666 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.6 t -70.3 130.86 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.165 -0.959 . . . . 0.0 110.316 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.407 ' HG ' ' HG ' ' A' ' 12' ' ' SER . 32.2 p -162.73 166.82 23.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.564 -0.71 . . . . 0.0 109.579 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 11' ' ' LEU . 3.7 mm? -67.84 -3.5 9.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -0.8 . . . . 0.0 109.027 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.407 ' HG ' ' HG ' ' A' ' 10' ' ' SER . 78.1 p -63.72 -32.02 73.38 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.362 -0.836 . . . . 0.0 109.472 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 p -114.67 134.42 22.39 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.45 -0.781 . . . . 0.0 109.783 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.69 -55.01 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.151 1.901 . . . . 0.0 112.148 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -115.5 134.88 54.65 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.554 -0.716 . . . . 0.0 110.09 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.8 m -141.4 160.6 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.504 -0.747 . . . . 0.0 109.809 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.4 t -116.05 134.49 54.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.77 162.54 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.447 -0.783 . . . . 0.0 110.1 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.2 tt -140.26 139.48 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.537 -0.727 . . . . 0.0 109.337 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 172.63 -169.0 42.15 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.997 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -106.69 133.07 51.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.541 -0.976 . . . . 0.0 109.414 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.635 ' N ' HD12 ' A' ' 22' ' ' ILE . 2.0 mp -94.0 129.98 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.208 0.527 . . . . 0.0 109.907 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.5 p -139.93 155.92 46.92 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.397 -0.814 . . . . 0.0 110.233 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.35 71.26 1.17 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.2 mm -81.35 130.58 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -1.177 . . . . 0.0 110.329 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -132.83 139.22 47.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -108.82 136.33 48.55 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.475 -0.766 . . . . 0.0 109.922 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -148.51 153.76 38.88 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -114.83 145.22 42.39 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.53 -0.732 . . . . 0.0 109.727 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -138.43 159.72 41.35 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.53 -0.732 . . . . 0.0 109.437 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -91.81 99.12 12.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.432 -0.792 . . . . 0.0 110.192 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 34' ' ' GLY . 8.3 t -77.9 -151.7 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.59 -0.694 . . . . 0.0 109.768 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -54.6 75.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.292 0.568 . . . . 0.0 110.474 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 61.97 19.56 59.05 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.3 m -140.02 133.11 29.54 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.262 -1.14 . . . . 0.0 110.166 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.4 m -78.38 128.86 34.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.327 -0.858 . . . . 0.0 109.367 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -132.72 144.49 50.32 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.397 -0.814 . . . . 0.0 109.945 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.5 p -84.78 146.41 27.39 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.424 -0.798 . . . . 0.0 109.773 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 55' ' ' SER . 9.9 p -139.0 138.55 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.613 -0.68 . . . . 0.0 109.46 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -100.36 135.34 41.95 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -127.97 157.36 40.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.621 -0.674 . . . . 0.0 109.433 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.49 -168.2 35.59 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -122.89 141.71 51.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.619 -0.93 . . . . 0.0 109.572 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.14 144.41 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -129.83 153.13 48.58 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.285 0.564 . . . . 0.0 109.643 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 20.6 t0 -144.41 -147.63 0.22 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.441 -0.787 . . . . 0.0 109.614 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.522 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 36.8 t70 -84.65 -7.7 59.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.805 . . . . 0.0 110.982 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.3 p -108.31 -66.18 1.06 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.13 -0.981 . . . . 0.0 109.998 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.408 ' HB2' ' HE ' ' A' ' 7' ' ' ARG . . . -157.56 -147.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 109.664 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.7 ptt85 -140.24 154.82 47.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.44 -0.787 . . . . 0.0 110.325 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.9 tt -146.32 161.27 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.523 -0.736 . . . . 0.0 109.939 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.85 145.07 40.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.516 -0.74 . . . . 0.0 110.16 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.6 pt -133.26 153.13 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.536 -0.727 . . . . 0.0 109.969 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 t -144.47 141.6 29.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.726 -0.609 . . . . 0.0 109.365 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 39' ' ' VAL . 4.6 p -132.71 137.59 46.96 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.456 -0.777 . . . . 0.0 109.06 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -94.77 125.99 39.79 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.365 -0.835 . . . . 0.0 110.905 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.76 -44.52 0.64 Allowed Glycine 0 N--CA 1.493 2.434 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.804 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -73.95 136.22 43.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.989 -1.3 . . . . 0.0 110.782 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -95.54 158.12 15.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.642 -0.661 . . . . 0.0 110.084 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.4 mt -123.11 153.42 39.99 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -111.93 137.31 50.08 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.669 0.747 . . . . 0.0 110.265 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.451 ' O ' ' OG ' ' A' ' 63' ' ' SER . 24.1 t70 -66.79 136.87 56.11 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.412 0.625 . . . . 0.0 110.907 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 62' ' ' ASP . 12.9 p 66.32 78.84 0.25 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.531 0.682 . . . . 0.0 110.363 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 46.1 p-10 -162.89 121.37 2.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 109.56 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 t -82.96 116.14 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.1 m -137.43 162.06 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.502 -0.749 . . . . 0.0 110.248 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -115.81 126.66 54.3 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.5 mt -106.15 127.31 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -111.68 145.5 39.14 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.251 0.548 . . . . 0.0 109.693 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.4 t30 66.2 35.81 5.85 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.35 136.52 42.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.476 -0.765 . . . . 0.0 109.137 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -91.55 133.51 35.46 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.102 -0.999 . . . . 0.0 110.121 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.2 t -88.1 132.03 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.431 -0.793 . . . . 0.0 109.548 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.03 164.11 26.11 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -122.99 124.27 42.78 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.75 0.786 . . . . 0.0 110.168 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.664 ' O ' ' N ' ' A' ' 78' ' ' GLY . 15.6 m-85 -84.5 -178.0 6.78 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 76' ' ' PHE . 97.6 m-20 -36.98 -18.39 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.074 0.464 . . . . 0.0 110.787 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.664 ' N ' ' O ' ' A' ' 76' ' ' PHE . . . 172.35 29.81 0.03 OUTLIER Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -141.46 140.7 33.62 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.313 -1.11 . . . . 0.0 110.345 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 80.4 mt -77.35 148.95 35.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.418 -0.801 . . . . 0.0 110.07 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.2 p -155.86 159.24 39.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.432 -0.793 . . . . 0.0 109.726 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.3 mt -113.29 126.23 55.16 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 p -106.17 131.12 53.8 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.571 -0.706 . . . . 0.0 109.41 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.4 t -101.13 114.91 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.37 -0.831 . . . . 0.0 109.298 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.37 177.01 37.5 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 37.2 p-10 -68.12 -23.25 64.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.503 -0.998 . . . . 0.0 110.106 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 95.4 p -85.0 -4.11 59.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.022 -1.048 . . . . 0.0 109.496 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.2 t -80.6 172.38 13.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 0.0 109.91 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -129.4 141.71 50.98 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.641 -0.662 . . . . 0.0 109.689 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -123.84 129.59 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -125.7 114.94 19.32 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.528 -0.732 . . . . 0.0 109.368 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.5 p -79.14 155.59 28.63 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.522 -0.736 . . . . 0.0 109.958 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.4 t . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.456 -0.778 . . . . 0.0 108.964 179.376 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.358 0.599 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.5 tp -74.27 125.06 27.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.411 -0.806 . . . . 0.0 109.742 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.3 m -138.99 162.74 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.474 -0.766 . . . . 0.0 109.21 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.549 ' N ' ' OD2' ' A' ' 8' ' ' ASP . 64.1 mttp -74.65 151.64 39.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 110.527 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 9' ' ' VAL . 96.9 mt -61.92 -43.03 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.606 -0.684 . . . . 0.0 109.634 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -59.2 -31.94 69.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.473 -0.767 . . . . 0.0 110.562 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.549 ' OD2' ' N ' ' A' ' 5' ' ' LYS . 6.9 p30 -83.43 11.18 7.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.114 -0.991 . . . . 0.0 110.504 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 6' ' ' ILE . 53.4 t -68.57 132.24 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.917 . . . . 0.0 110.069 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 m -161.5 170.08 20.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.364 -0.835 . . . . 0.0 110.153 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.27 -34.51 78.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.428 -0.795 . . . . 0.0 109.619 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -50.63 -17.82 0.59 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.457 -0.777 . . . . 0.0 109.743 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 p -121.36 82.92 39.51 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.77 -41.59 61.58 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.43 2.087 . . . . 0.0 112.089 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -121.32 128.81 52.67 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.7 m -144.27 160.3 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.181 -0.949 . . . . 0.0 109.653 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.2 m -116.74 133.6 55.81 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.53 163.06 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.391 -0.818 . . . . 0.0 109.459 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.522 HD11 HH12 ' A' ' 67' ' ' ARG . 97.5 mt -127.58 133.27 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 174.66 -163.56 34.07 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.455 -1.355 . . . . 0.0 109.959 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -125.81 143.52 51.03 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.798 -0.824 . . . . 0.0 109.346 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.592 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.8 mp -98.21 132.8 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.378 0.609 . . . . 0.0 110.615 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 63' ' ' SER . 66.7 p -134.49 157.17 47.19 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.327 0.584 . . . . 0.0 109.876 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.85 78.02 0.4 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 25' ' ' ILE . 1.4 mp -90.89 120.28 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.267 -1.137 . . . . 0.0 109.614 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -114.74 122.58 46.85 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -86.13 134.65 33.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 110.157 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -146.67 153.33 40.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.383 -0.823 . . . . 0.0 108.861 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -116.3 144.04 44.75 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.434 -0.791 . . . . 0.0 109.64 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -141.64 162.88 34.39 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.229 -0.919 . . . . 0.0 109.327 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -88.08 98.87 11.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.997 . . . . 0.0 109.251 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.567 ' O ' ' N ' ' A' ' 34' ' ' GLY . 9.3 t -84.31 -151.68 0.13 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.488 -0.758 . . . . 0.0 110.188 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 35' ' ' THR . 99.4 m-20 -50.43 84.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.692 -0.63 . . . . 0.0 110.278 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 49.45 15.3 0.73 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.427 ' N ' ' O ' ' A' ' 33' ' ' ASP . 35.7 p -140.24 145.96 38.03 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.321 -1.105 . . . . 0.0 109.372 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.2 m -84.41 129.2 34.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.514 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -129.11 147.1 50.93 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.461 -0.774 . . . . 0.0 109.505 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 p -84.01 152.13 24.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.489 -0.757 . . . . 0.0 109.716 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.415 HG21 ' CE1' ' A' ' 56' ' ' PHE . 13.3 p -142.62 139.01 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -106.97 132.0 53.41 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -119.0 147.18 44.37 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.555 -0.715 . . . . 0.0 109.18 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.62 -169.67 33.18 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -117.23 141.6 48.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.754 -0.851 . . . . 0.0 109.386 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.2 tt -117.77 144.92 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -134.11 160.46 37.73 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.469 0.652 . . . . 0.0 110.205 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 45.0 t0 -157.84 -167.01 2.12 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.527 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 98.2 m-20 -68.13 -16.4 63.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.877 . . . . 0.0 109.756 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.3 p -90.0 -73.96 0.5 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.5 -144.68 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 109.788 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -146.49 153.75 40.77 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.976 . . . . 0.0 110.361 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.2 tt -152.93 159.59 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.365 -0.835 . . . . 0.0 109.766 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.5 ttp85 -75.21 146.13 41.45 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.24 -0.912 . . . . 0.0 110.288 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 22' ' ' ILE . 42.3 pt -134.99 163.66 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.497 -0.752 . . . . 0.0 110.086 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.7 t -143.72 128.97 18.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.379 -0.826 . . . . 0.0 108.844 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.4 t -113.15 121.88 45.84 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.543 -0.723 . . . . 0.0 109.093 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.415 ' CE1' HG21 ' A' ' 39' ' ' VAL . 90.8 m-85 -97.6 120.09 37.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.448 -0.783 . . . . 0.0 110.397 -178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.24 -63.21 4.02 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -71.96 136.79 46.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -1.124 . . . . 0.0 110.6 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -96.18 155.8 16.61 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.44 -0.787 . . . . 0.0 109.463 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.5 mt -128.18 161.62 28.87 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.543 -0.723 . . . . 0.0 109.773 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -112.57 152.99 28.22 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 122.108 0.956 . . . . 0.0 110.145 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 63' ' ' SER . 68.2 t0 -63.1 139.22 58.75 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 111.288 -178.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.543 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.7 m 58.59 28.58 17.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.584 -0.698 . . . . 0.0 109.566 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -82.78 114.68 21.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 109.792 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.45 113.5 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.269 -0.894 . . . . 0.0 108.998 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 m -141.19 165.07 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.398 -0.814 . . . . 0.0 110.185 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.522 HH12 HD11 ' A' ' 19' ' ' ILE . 59.9 ttm-85 -106.4 126.3 52.07 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.2 mm -108.15 126.49 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -122.6 143.83 49.5 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.0 t30 62.64 40.94 9.82 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.73 131.5 41.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 0.0 108.989 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -82.4 131.8 35.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.219 -0.926 . . . . 0.0 110.098 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.1 t -91.32 131.19 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.426 -0.797 . . . . 0.0 109.52 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.92 153.25 49.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.448 -0.782 . . . . 0.0 108.96 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -116.18 119.14 34.85 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.538 -0.726 . . . . 0.0 109.278 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -125.02 133.25 53.04 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.604 -0.685 . . . . 0.0 109.496 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 55.37 31.26 16.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.707 -0.621 . . . . 0.0 109.94 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.6 6.6 84.83 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.521 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -113.95 133.42 55.48 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.47 -1.018 . . . . 0.0 109.71 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.3 mt -76.68 146.37 38.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.508 -0.745 . . . . 0.0 110.036 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.5 t -154.65 154.13 32.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.518 -0.739 . . . . 0.0 109.016 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.1 mt -103.42 129.51 50.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.379 -0.826 . . . . 0.0 109.114 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.2 t -105.19 128.38 53.37 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.699 -0.626 . . . . 0.0 109.562 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.52 99.94 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -97.08 -169.73 33.52 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -68.89 -17.29 63.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.565 -0.962 . . . . 0.0 109.634 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.8 m -83.12 -8.42 59.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.389 -0.819 . . . . 0.0 109.681 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.6 t -88.9 166.68 13.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 109.982 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -125.1 133.53 52.83 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 94.0 mt -119.29 128.38 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -126.5 132.1 51.47 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.537 -0.727 . . . . 0.0 109.46 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.9 t -66.18 132.79 49.27 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.549 -0.719 . . . . 0.0 110.223 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.265 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -78.01 165.35 24.14 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.8 0.81 . . . . 0.0 110.461 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 54.3 tp -76.19 124.34 27.31 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.62 0.724 . . . . 0.0 110.348 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.4 m -139.18 164.26 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.829 0.823 . . . . 0.0 110.144 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -80.69 161.02 24.81 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.708 0.766 . . . . 0.0 110.26 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.81 -43.27 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.216 0.531 . . . . 0.0 109.678 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -67.47 -18.8 65.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.783 -0.573 . . . . 0.0 109.649 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -86.04 -0.09 54.7 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.558 -0.714 . . . . 0.0 109.713 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.9 t -67.22 130.16 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.908 0.861 . . . . 0.0 110.344 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.9 p -160.86 167.27 27.01 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.769 0.795 . . . . 0.0 109.971 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.494 HD11 ' NE2' ' A' ' 75' ' ' GLN . 93.7 mt -66.72 -21.62 66.07 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.3 t -61.4 -20.24 62.83 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 51.6 p -124.92 80.96 62.81 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.749 -0.594 . . . . 0.0 109.461 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.73 -40.62 73.5 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.681 2.254 . . . . 0.0 111.705 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -112.8 125.81 54.75 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.647 0.736 . . . . 0.0 109.207 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.4 m -149.76 160.22 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 122.155 0.978 . . . . 0.0 111.058 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.2 t -118.33 134.17 55.27 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.49 162.38 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 121.972 0.891 . . . . 0.0 110.391 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.6 tt -140.97 135.57 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.637 0.732 . . . . 0.0 109.675 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.0 -165.99 37.42 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -113.44 136.67 52.52 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.733 0.777 . . . . 0.0 110.115 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.694 ' N ' HD12 ' A' ' 22' ' ' ILE . 2.5 mp -96.19 137.08 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.475 0.655 . . . . 0.0 109.72 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.4 p -131.1 158.68 39.75 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.009 0.909 . . . . 0.0 110.348 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.62 93.55 0.01 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.8 mm -93.4 124.52 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.804 -0.821 . . . . 0.0 109.829 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -120.39 139.66 52.49 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.807 0.813 . . . . 0.0 109.53 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -108.04 134.46 50.89 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.838 0.828 . . . . 0.0 110.234 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -144.04 154.93 43.76 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.675 0.75 . . . . 0.0 109.452 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -123.54 144.87 49.29 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.842 0.83 . . . . 0.0 110.23 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -144.21 158.44 43.73 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.827 0.822 . . . . 0.0 109.861 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -87.92 115.44 25.39 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.601 0.715 . . . . 0.0 110.075 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 t -113.35 113.07 24.72 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.733 0.778 . . . . 0.0 109.492 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.1 t0 55.93 29.46 14.27 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.279 0.561 . . . . 0.0 109.743 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.99 2.45 80.92 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.4 m -118.13 127.6 53.93 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.758 -0.848 . . . . 0.0 109.928 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.8 m -69.31 129.63 40.33 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.632 0.73 . . . . 0.0 110.317 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -130.99 139.86 50.06 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.746 0.784 . . . . 0.0 109.72 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.5 m -86.26 141.76 29.05 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.015 0.912 . . . . 0.0 110.723 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -136.49 135.53 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.856 0.836 . . . . 0.0 109.485 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -101.61 133.48 46.23 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.692 0.758 . . . . 0.0 109.791 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -121.78 151.96 40.01 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.837 0.827 . . . . 0.0 109.667 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.41 -172.93 39.99 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.593 ' CB ' HH21 ' A' ' 50' ' ' ARG . 68.0 m-85 -117.35 142.99 46.43 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.695 0.759 . . . . 0.0 109.863 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.5 tt -125.84 139.87 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -133.56 159.54 40.14 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.128 0.966 . . . . 0.0 110.653 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 37.3 t0 -145.08 -148.77 0.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.471 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.542 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 97.5 m-20 -80.02 -6.64 57.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.648 -0.657 . . . . 0.0 109.536 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.5 p -105.67 -91.11 0.4 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.73 -0.607 . . . . 0.0 109.888 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.51 -145.14 0.24 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.576 -0.703 . . . . 0.0 110.066 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.593 HH21 ' CB ' ' A' ' 43' ' ' TYR . 17.5 ptm180 -145.89 156.09 43.31 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.821 0.819 . . . . 0.0 110.783 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.8 tt -148.1 161.99 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.911 0.862 . . . . 0.0 110.297 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -79.44 147.77 32.18 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.589 0.709 . . . . 0.0 110.17 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.8 pt -134.98 157.0 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.912 0.863 . . . . 0.0 110.37 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 m -141.35 125.43 17.29 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.649 0.737 . . . . 0.0 109.558 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.5 t -116.43 130.23 56.65 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.963 0.887 . . . . 0.0 109.629 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -98.91 119.49 37.77 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.656 0.741 . . . . 0.0 109.86 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.69 -51.68 4.05 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -71.71 135.14 46.68 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.667 -0.902 . . . . 0.0 110.436 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -89.09 155.58 19.36 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.842 0.83 . . . . 0.0 110.903 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.2 mt -119.34 151.02 39.18 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.57 0.7 . . . . 0.0 109.563 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.406 ' O ' ' OD1' ' A' ' 64' ' ' ASP . 21.5 mp0 -112.49 142.29 45.23 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 122.385 1.088 . . . . 0.0 110.156 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 63' ' ' SER . 68.1 t0 -64.18 135.58 56.43 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.966 0.888 . . . . 0.0 111.876 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.522 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 2.1 p 53.47 23.7 3.58 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.527 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 20.4 p-10 -87.65 126.12 34.77 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.748 0.785 . . . . 0.0 110.426 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 65' ' ' VAL . 1.3 m -82.47 115.8 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-O 121.657 0.742 . . . . 0.0 108.998 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.8 m -140.67 162.77 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 122.041 0.924 . . . . 0.0 110.416 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.525 ' NH1' ' OD1' ' A' ' 69' ' ' ASP . 68.9 ttp85 -117.39 127.82 54.42 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.701 0.762 . . . . 0.0 109.288 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.7 mt -107.25 129.48 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.754 0.787 . . . . 0.0 109.495 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.525 ' OD1' ' NH1' ' A' ' 67' ' ' ARG . 96.5 m-20 -116.41 144.27 44.51 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.688 0.756 . . . . 0.0 109.969 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.1 t30 62.91 39.57 10.33 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.842 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.26 146.74 47.04 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.4 0.619 . . . . 0.0 110.047 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -104.91 125.83 51.34 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.805 0.812 . . . . 0.0 110.095 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.0 t -86.55 133.22 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.699 0.761 . . . . 0.0 110.052 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.7 160.03 43.14 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.848 0.833 . . . . 0.0 109.955 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.494 ' NE2' HD11 ' A' ' 11' ' ' LEU . 77.5 mt-30 -107.44 114.37 28.34 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.699 0.762 . . . . 0.0 110.143 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -115.65 125.45 52.89 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.695 0.759 . . . . 0.0 109.472 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 57.22 29.61 17.0 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.48 13.33 82.75 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -120.27 135.92 54.84 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.831 0.824 . . . . 0.0 109.987 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.2 mt -77.28 143.77 38.62 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.591 0.71 . . . . 0.0 109.899 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.0 p -156.3 163.3 39.69 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.957 0.884 . . . . 0.0 110.491 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.6 mt -103.63 124.11 48.22 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.757 0.789 . . . . 0.0 109.341 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.0 m -103.2 122.76 45.4 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.671 0.748 . . . . 0.0 110.104 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.699 HG11 HD11 ' A' ' 90' ' ' ILE . 6.9 t -99.23 105.55 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.65 0.738 . . . . 0.0 109.596 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.434 ' O ' ' OG ' ' A' ' 88' ' ' SER . . . -91.76 -176.43 42.72 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.82 -16.71 62.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.95 -0.735 . . . . 0.0 109.322 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 87.6 p -85.91 -15.36 41.95 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 85' ' ' GLY . 25.5 p -82.68 167.16 18.5 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.567 0.699 . . . . 0.0 110.05 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -126.74 138.3 53.36 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.785 0.802 . . . . 0.0 109.879 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.699 HD11 HG11 ' A' ' 84' ' ' VAL . 98.2 mt -122.32 127.55 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.493 0.664 . . . . 0.0 109.447 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -124.39 126.59 46.21 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.925 0.869 . . . . 0.0 110.253 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.0 p -76.35 150.02 36.91 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.455 0.645 . . . . 0.0 110.17 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.7 t -109.94 98.35 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-O 121.775 0.798 . . . . 0.0 109.712 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -104.92 -0.54 26.91 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.7 m -110.03 128.94 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 CA-C-O 121.834 0.825 . . . . 0.0 110.167 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -73.59 146.18 44.89 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.889 0.852 . . . . 0.0 111.177 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.1 pt -146.07 67.96 12.4 Favored Pre-proline 0 N--CA 1.493 1.713 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.133 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.12 -78.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.584 2.189 . . . . 0.0 111.554 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 100' ' ' GLU . 50.9 mt 61.2 160.03 0.05 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.483 0.659 . . . . 0.0 110.031 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' A' ' 99' ' ' LEU . 97.5 mt-10 51.68 168.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.864 0.84 . . . . 0.0 111.208 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 101' ' ' HIS . 53.5 p-80 -89.2 116.59 27.55 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.725 0.774 . . . . 0.0 109.906 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -87.83 0.27 56.03 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -61.37 -43.14 99.38 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -115.37 137.17 52.33 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.833 0.825 . . . . 0.0 109.869 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -67.66 -35.85 79.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.871 -0.518 . . . . 0.0 109.692 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 117.835 -1.079 . . . . 0.0 109.978 -179.501 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.2 m . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 55.7 t0 -73.17 152.63 41.05 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.753 0.787 . . . . 0.0 110.39 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.539 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 38.8 tp -69.5 128.7 37.45 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.504 0.669 . . . . 0.0 110.027 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.1 m -138.89 163.59 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.9 0.857 . . . . 0.0 109.968 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -75.32 156.65 35.33 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.75 0.786 . . . . 0.0 110.076 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.1 mm -62.65 -44.58 99.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.797 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -68.61 -20.96 64.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.562 -0.711 . . . . 0.0 109.504 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -82.77 -3.86 57.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.539 -0.726 . . . . 0.0 109.166 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.8 t -69.99 128.86 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.975 0.893 . . . . 0.0 109.915 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 12' ' ' SER . 29.7 m -163.6 162.66 24.43 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.566 0.698 . . . . 0.0 109.399 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.7 mt -64.58 -2.31 2.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.784 -0.573 . . . . 0.0 109.555 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.41 ' H ' ' C ' ' A' ' 10' ' ' SER . 78.6 p -61.0 -32.64 72.21 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.6 p -117.07 145.22 35.22 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.729 -0.607 . . . . 0.0 110.168 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.28 -61.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.999 2.466 . . . . 0.0 112.422 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 100.0 m-85 -119.75 136.53 54.4 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.858 0.837 . . . . 0.0 110.339 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.9 m -140.52 164.0 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.688 0.756 . . . . 0.0 109.973 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.431 ' O ' HD12 ' A' ' 3' ' ' LEU . 68.2 m -118.96 145.09 46.09 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.756 0.789 . . . . 0.0 109.494 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.24 160.27 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 122.114 0.959 . . . . 0.0 110.639 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 19' ' ' ILE . 19.5 tt -138.27 130.25 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.665 0.745 . . . . 0.0 109.457 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.58 -156.24 21.53 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -124.93 139.11 54.12 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.919 -0.753 . . . . 0.0 109.839 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.723 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.0 mp -92.2 132.18 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.391 0.615 . . . . 0.0 110.08 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.0 m -125.76 143.87 50.87 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.058 0.932 . . . . 0.0 109.866 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.76 97.02 0.04 OUTLIER Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.6 mm -95.01 125.88 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.962 0.887 . . . . 0.0 110.408 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -123.4 134.51 53.96 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.556 0.693 . . . . 0.0 109.226 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -108.31 132.9 53.23 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.947 0.88 . . . . 0.0 110.037 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -140.76 158.27 44.21 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.772 0.796 . . . . 0.0 109.718 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -120.43 145.05 47.6 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.783 0.801 . . . . 0.0 109.983 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.441 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 13.7 p90 -141.61 159.42 42.27 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.18 0.99 . . . . 0.0 110.088 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -96.69 132.26 42.54 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.532 0.682 . . . . 0.0 109.471 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.0 t -159.16 141.1 13.54 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.743 0.782 . . . . 0.0 110.189 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 55.65 28.37 11.93 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.25 0.548 . . . . 0.0 109.759 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.36 14.66 79.2 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.7 p -135.87 155.06 50.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.61 -0.935 . . . . 0.0 109.874 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.6 m -98.2 126.24 43.58 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.88 0.848 . . . . 0.0 109.818 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.441 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 98.9 mttt -125.62 142.1 51.68 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.819 0.818 . . . . 0.0 109.325 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 90.8 p -84.57 146.37 27.57 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.841 0.829 . . . . 0.0 110.368 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -133.51 136.99 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.822 0.82 . . . . 0.0 109.821 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.514 ' CZ ' ' OE1' ' A' ' 59' ' ' GLN . 94.4 m-85 -101.95 131.2 48.49 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.763 0.792 . . . . 0.0 109.725 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -126.12 155.24 41.96 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.93 0.871 . . . . 0.0 109.943 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.9 -166.93 35.19 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.618 ' CD2' ' NH2' ' A' ' 50' ' ' ARG . 97.2 m-85 -119.79 140.37 50.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.81 -0.818 . . . . 0.0 110.072 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.4 tt -122.79 133.19 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -134.32 156.23 48.84 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 122.277 1.037 . . . . 0.0 110.561 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 48' ' ' THR . 5.4 p30 -168.09 95.32 0.41 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.646 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' THR . 66.8 t0 52.4 -77.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 120.936 0.398 . . . . 0.0 110.571 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.589 ' N ' ' O ' ' A' ' 46' ' ' ASP . 73.9 p -38.62 -80.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.086 0.47 . . . . 0.0 110.456 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.404 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -158.21 -143.67 0.11 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.698 0.761 . . . . 0.0 110.087 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.618 ' NH2' ' CD2' ' A' ' 43' ' ' TYR . 8.9 ptm180 -142.87 150.68 40.18 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.761 0.791 . . . . 0.0 110.4 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.6 tt -146.54 156.26 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.747 0.784 . . . . 0.0 110.085 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -76.69 147.2 37.57 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.735 0.779 . . . . 0.0 109.973 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.2 pt -135.05 154.47 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.644 0.735 . . . . 0.0 110.273 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 t -143.17 133.42 24.54 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.858 0.837 . . . . 0.0 109.551 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 p -131.09 135.28 47.38 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.973 0.892 . . . . 0.0 109.887 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.446 ' C ' ' H ' ' A' ' 58' ' ' LYS . 90.7 m-85 -94.8 122.33 37.3 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.699 0.761 . . . . 0.0 111.025 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.47 -29.46 0.58 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' A' ' 56' ' ' PHE . 98.9 mttt -74.11 136.84 42.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.568 -0.96 . . . . 0.0 110.607 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.514 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 68.7 tp60 -94.68 146.92 23.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.776 0.798 . . . . 0.0 110.495 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.9 mt -129.48 152.44 49.01 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.721 0.772 . . . . 0.0 109.927 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -122.93 137.64 54.89 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.216 1.008 . . . . 0.0 110.074 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 63' ' ' SER . 65.6 t0 -64.78 134.69 54.66 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.865 0.84 . . . . 0.0 111.462 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.53 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 2.8 p 78.29 8.19 2.31 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.862 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 7.3 p-10 -84.45 124.08 30.95 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.307 0.575 . . . . 0.0 110.803 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 t -87.02 116.76 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.637 0.732 . . . . 0.0 109.117 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.48 163.22 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.221 1.01 . . . . 0.0 110.945 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -119.27 128.99 54.68 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.7 mt -106.23 129.45 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.773 0.797 . . . . 0.0 109.543 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -114.81 143.51 44.99 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.849 0.833 . . . . 0.0 110.149 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.6 t30 62.12 37.89 14.19 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.2 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.95 145.7 46.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.583 -0.698 . . . . 0.0 109.426 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -96.04 132.34 41.5 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.828 0.823 . . . . 0.0 110.209 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 89.6 t -83.15 131.66 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 121.532 0.682 . . . . 0.0 109.974 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.64 154.28 43.37 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.683 0.754 . . . . 0.0 109.973 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -119.79 117.38 28.03 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.816 0.817 . . . . 0.0 109.924 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -119.85 131.51 55.29 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.852 0.834 . . . . 0.0 110.01 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.8 t30 56.64 24.32 8.73 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.239 0.542 . . . . 0.0 110.249 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.88 10.51 82.93 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -114.99 138.17 51.15 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.91 0.862 . . . . 0.0 109.755 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 80' ' ' LEU . 3.7 mm? -76.94 141.61 40.4 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.93 0.872 . . . . 0.0 110.699 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.3 p -153.52 159.24 42.19 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.752 0.787 . . . . 0.0 110.008 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.7 mt -108.56 126.39 52.88 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.791 0.805 . . . . 0.0 110.175 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.2 m -101.43 123.54 45.65 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.825 0.822 . . . . 0.0 109.656 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.7 t -101.02 111.29 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.843 0.83 . . . . 0.0 109.204 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.23 -178.71 37.22 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -68.2 -18.35 64.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 122.149 -0.618 . . . . 0.0 109.543 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 97.1 p -87.65 -7.53 57.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.669 -0.645 . . . . 0.0 109.455 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.1 t -83.69 164.92 19.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.456 -0.778 . . . . 0.0 109.556 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -128.54 139.27 52.39 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.754 0.788 . . . . 0.0 109.911 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.15 130.47 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.651 0.739 . . . . 0.0 109.45 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 91' ' ' GLU . 56.7 mp0 -115.72 125.53 52.93 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.83 0.824 . . . . 0.0 109.93 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.0 p -71.33 144.87 49.78 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.596 0.712 . . . . 0.0 110.559 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.2 t -119.27 130.8 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-O 121.936 0.874 . . . . 0.0 109.924 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -132.46 -69.15 0.59 Allowed 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.97 115.59 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-O 121.88 0.847 . . . . 0.0 109.686 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -79.54 154.69 28.62 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.832 0.825 . . . . 0.0 110.419 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.2 mt -139.86 77.65 26.48 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.24 145.06 98.98 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.821 2.347 . . . . 0.0 112.136 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.545 HD23 ' C ' ' A' ' 99' ' ' LEU . 3.3 tt 55.98 93.99 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.778 0.799 . . . . 0.0 109.672 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 101' ' ' HIS . 83.4 tt0 -157.25 84.36 0.92 Allowed 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.74 0.781 . . . . 0.0 109.684 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' A' ' 100' ' ' GLU . 65.4 m170 58.6 129.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.727 0.775 . . . . 0.0 110.528 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.56 166.89 28.87 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.907 0.86 . . . . 0.0 110.445 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.537 ' CG ' ' N ' ' A' ' 104' ' ' HIS . 51.1 p-80 -62.85 -47.44 83.36 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.537 ' N ' ' CG ' ' A' ' 103' ' ' HIS . 85.9 t60 54.11 6.02 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.528 ' H ' ' C ' ' A' ' 103' ' ' HIS . 43.7 m80 -83.37 141.71 31.56 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.722 0.773 . . . . 0.0 110.827 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.1 t60 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 117.881 -1.057 . . . . 0.0 109.061 179.479 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 84.4 p . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 60.5 t0 -72.68 149.61 43.67 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.75 0.786 . . . . 0.0 110.209 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.532 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 4.9 tt -71.17 133.82 46.46 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.686 -0.634 . . . . 0.0 110.726 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.2 m -135.84 162.91 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-O 121.567 0.698 . . . . 0.0 109.884 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -79.04 155.98 28.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.589 -0.695 . . . . 0.0 110.062 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.9 mt -63.54 -43.66 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.712 -0.618 . . . . 0.0 109.866 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 -72.31 -14.38 61.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.117 -0.989 . . . . 0.0 109.864 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -93.25 2.22 56.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.321 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.51 132.05 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.155 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.3 p -159.35 165.82 32.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.355 -0.841 . . . . 0.0 109.837 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.66 -19.07 65.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.523 -0.735 . . . . 0.0 109.762 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.2 m -57.51 -25.25 59.56 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.118 -0.989 . . . . 0.0 109.24 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 45.8 p -123.29 82.64 52.24 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.46 -40.36 71.79 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.641 2.227 . . . . 0.0 112.088 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -115.87 128.76 56.05 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.419 0.628 . . . . 0.0 109.832 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.2 m -153.04 -176.41 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.445 -0.785 . . . . 0.0 109.906 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.3 m -130.18 144.29 51.28 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.4 m -139.88 162.61 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.376 -0.827 . . . . 0.0 110.245 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 tp -141.52 127.93 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.68 -168.53 38.06 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.058 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -110.27 144.11 39.44 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.621 -0.929 . . . . 0.0 109.545 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.0 mm -95.07 133.44 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.364 0.602 . . . . 0.0 110.254 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -143.02 156.84 44.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.37 -0.831 . . . . 0.0 109.983 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.11 62.14 4.41 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.0 mm -76.94 129.78 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -1.125 . . . . 0.0 110.624 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -130.09 122.69 28.79 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.509 ' NZ ' ' OE2' ' A' ' 29' ' ' GLU . 66.0 tttm -86.41 136.93 32.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.355 -0.841 . . . . 0.0 110.022 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -146.64 139.85 25.57 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.509 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 97.2 mt-10 -115.1 148.15 39.32 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.664 -0.647 . . . . 0.0 110.154 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.541 ' CE2' ' OG ' ' A' ' 32' ' ' SER . 9.8 p90 -147.28 159.29 43.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.819 . . . . 0.0 109.188 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -84.07 119.98 25.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.4 -0.812 . . . . 0.0 110.318 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.541 ' OG ' ' CE2' ' A' ' 30' ' ' TYR . 3.1 m -119.41 114.17 21.91 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 55.36 31.94 17.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.56 -0.713 . . . . 0.0 109.881 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.74 6.43 88.49 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.2 m -120.89 128.56 52.91 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.525 -0.985 . . . . 0.0 109.874 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.4 m -68.25 134.72 50.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.602 -0.686 . . . . 0.0 110.042 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -131.58 147.29 52.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.441 -0.787 . . . . 0.0 109.34 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.5 t -99.9 135.09 41.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.631 -0.668 . . . . 0.0 109.939 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.94 138.09 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -105.41 134.35 48.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.527 -0.733 . . . . 0.0 109.476 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -123.51 150.86 43.42 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.391 0.615 . . . . 0.0 109.385 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.431 ' C ' ' CD1' ' A' ' 53' ' ' ILE . . . -173.82 -147.44 6.0 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.48 ' OH ' ' NH1' ' A' ' 52' ' ' ARG . 79.6 m-85 -132.92 141.58 48.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.573 -0.957 . . . . 0.0 109.549 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 tt -116.04 134.39 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -133.26 150.23 51.93 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.756 0.788 . . . . 0.0 110.719 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 48' ' ' THR . 62.8 t0 -167.36 95.55 0.47 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' THR . 38.8 t70 48.37 -79.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.812 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.601 ' N ' ' O ' ' A' ' 46' ' ' ASP . 14.5 m -36.29 -77.31 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.767 -0.583 . . . . 0.0 110.803 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -161.12 -153.99 0.34 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.032 -1.042 . . . . 0.0 109.426 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 -138.97 152.12 47.42 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.39 0.614 . . . . 0.0 110.572 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.0 tt -150.67 163.52 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.783 . . . . 0.0 110.167 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.48 ' NH1' ' OH ' ' A' ' 43' ' ' TYR . 77.2 mtp85 -79.31 149.19 31.85 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.514 0.673 . . . . 0.0 110.838 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.803 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -141.79 164.44 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.511 -0.743 . . . . 0.0 109.792 179.587 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 p -140.42 127.13 20.39 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -109.98 118.08 35.5 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.619 -0.675 . . . . 0.0 109.21 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.433 ' C ' ' H ' ' A' ' 58' ' ' LYS . 72.1 m-85 -95.4 123.85 39.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.448 -0.782 . . . . 0.0 110.806 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.15 -33.55 0.65 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 56' ' ' PHE . 31.1 mmtp -87.92 130.13 35.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.893 -1.357 . . . . 0.0 109.955 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -90.45 146.41 24.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.501 -0.749 . . . . 0.0 110.283 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.7 mt -132.67 151.39 51.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.625 -0.672 . . . . 0.0 109.346 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -112.34 148.23 34.69 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.948 0.88 . . . . 0.0 110.153 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.6 t0 -65.27 136.68 56.89 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.656 0.741 . . . . 0.0 111.389 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.503 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 3.1 p 75.26 6.73 4.14 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.28 0.562 . . . . 0.0 109.94 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -83.98 122.61 28.99 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.13 -0.981 . . . . 0.0 110.135 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.4 t -85.57 119.19 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.4 160.48 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.422 0.629 . . . . 0.0 109.666 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -116.37 123.51 47.77 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 75.9 mt -107.41 130.36 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.572 -0.705 . . . . 0.0 109.401 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -116.98 144.65 44.33 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.447 0.641 . . . . 0.0 109.911 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.3 t30 64.75 35.86 8.47 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.445 0.64 . . . . 0.0 109.542 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.87 146.21 53.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.425 -0.797 . . . . 0.0 109.164 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.3 ttp85 -100.27 125.18 46.43 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.507 0.67 . . . . 0.0 110.056 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.3 t -85.25 133.3 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.521 -0.737 . . . . 0.0 109.651 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.38 164.85 30.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.365 -0.834 . . . . 0.0 109.349 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -103.33 114.37 28.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.6 -0.687 . . . . 0.0 109.609 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -110.3 121.87 46.32 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 56.05 31.27 17.76 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.411 0.624 . . . . 0.0 109.392 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.89 13.07 83.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -121.47 138.47 54.28 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.514 -0.992 . . . . 0.0 110.059 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.7 mt -71.37 139.8 49.93 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.583 -0.698 . . . . 0.0 110.283 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.66 163.04 40.43 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.8 mt -103.59 127.83 50.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.602 -0.686 . . . . 0.0 109.585 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.4 t -107.38 126.91 53.07 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 t -103.39 106.01 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.484 -0.76 . . . . 0.0 109.79 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -90.83 179.67 42.93 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -65.44 -37.7 87.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.482 -1.011 . . . . 0.0 109.603 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.4 m -60.66 -36.14 77.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 0.0 110.008 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.1 p -63.25 163.21 10.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.192 -0.942 . . . . 0.0 110.328 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -111.35 140.04 46.26 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.722 -0.611 . . . . 0.0 109.525 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.28 131.38 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -128.13 108.65 10.81 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.497 -0.752 . . . . 0.0 109.181 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.9 t -72.69 140.89 48.17 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.49 -0.756 . . . . 0.0 110.132 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 94' ' ' ASN . 98.1 t -103.24 -50.88 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 93' ' ' VAL . 13.2 m120 48.94 101.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.627 0.727 . . . . 0.0 110.004 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.5 t -73.61 107.32 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.253 -0.904 . . . . 0.0 110.014 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -156.96 112.03 2.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.513 -0.742 . . . . 0.0 109.019 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.6 pt -145.72 78.63 11.67 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.322 -0.861 . . . . 0.0 109.185 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.57 146.26 91.87 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.657 2.238 . . . . 0.0 112.585 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 99' ' ' LEU . 10.4 mp 56.69 108.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.707 0.765 . . . . 0.0 110.187 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -59.69 144.01 49.14 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.599 0.714 . . . . 0.0 110.607 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -74.36 69.99 1.66 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.514 -0.741 . . . . 0.0 109.511 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -65.14 -40.19 94.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.493 -0.754 . . . . 0.0 109.274 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -70.98 74.36 0.62 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.364 -0.835 . . . . 0.0 109.732 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -65.46 -34.35 78.08 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.505 ' CG ' ' N ' ' A' ' 106' ' ' HIS . 32.1 t-80 55.84 -112.56 0.71 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.674 -0.642 . . . . 0.0 110.328 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.527 ' O ' ' CG ' ' A' ' 106' ' ' HIS . 56.5 p-80 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.205 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 122.032 0.92 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 146.42 158.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.549 HD13 ' N ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -87.26 121.7 30.05 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.149 -0.969 . . . . 0.0 111.528 -174.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.549 ' N ' HD13 ' A' ' 3' ' ' LEU . 31.7 m -131.29 161.63 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -75.75 162.92 27.78 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.813 0.816 . . . . 0.0 110.265 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.5 mm -62.79 -43.51 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.615 -0.678 . . . . 0.0 109.253 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -65.78 -18.21 65.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.383 -0.823 . . . . 0.0 110.055 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -85.28 -0.05 53.51 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.136 -0.977 . . . . 0.0 110.281 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.39 133.05 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.174 -0.954 . . . . 0.0 110.254 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.1 m -157.5 162.8 38.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.473 -0.767 . . . . 0.0 109.742 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.74 -30.16 70.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.376 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -59.33 -20.23 52.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.347 -0.846 . . . . 0.0 109.293 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.404 ' O ' ' OG1' ' A' ' 13' ' ' THR . 11.5 p -118.39 80.2 16.03 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.72 -15.21 33.5 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.015 1.81 . . . . 0.0 112.581 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -133.11 105.97 7.34 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.423 -0.798 . . . . 0.0 109.792 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.1 m -145.57 164.61 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.379 -0.826 . . . . 0.0 109.881 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.1 t -108.54 141.45 40.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.339 -0.85 . . . . 0.0 108.825 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.52 160.27 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.365 -0.834 . . . . 0.0 109.724 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.621 HD12 ' HE ' ' A' ' 67' ' ' ARG . 7.5 tt -142.73 137.35 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.389 -0.819 . . . . 0.0 109.373 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.67 -166.27 35.94 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.227 -1.463 . . . . 0.0 110.683 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -104.57 132.41 50.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.818 -0.813 . . . . 0.0 109.402 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.2 mm -89.29 130.02 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.221 0.534 . . . . 0.0 109.915 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.0 p -137.87 161.54 36.36 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.325 -0.859 . . . . 0.0 109.884 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.57 79.29 0.1 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.8 mm -91.44 120.07 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.193 -1.181 . . . . 0.0 109.709 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -119.56 125.76 49.6 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -93.85 134.43 36.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.284 -0.885 . . . . 0.0 109.967 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -148.12 143.58 27.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.426 -0.796 . . . . 0.0 109.001 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -123.89 144.91 49.47 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.415 -0.803 . . . . 0.0 109.344 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.512 ' CE2' ' OG ' ' A' ' 32' ' ' SER . 24.9 p90 -141.71 160.73 39.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.215 -0.928 . . . . 0.0 109.558 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -79.6 114.52 18.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.56 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.512 ' OG ' ' CE2' ' A' ' 30' ' ' TYR . 5.1 m -109.61 112.82 25.13 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.533 -0.729 . . . . 0.0 109.531 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 53.37 31.07 11.3 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 0.0 110.201 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.67 -2.45 82.52 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.3 p -118.36 124.87 48.8 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.299 -1.118 . . . . 0.0 109.296 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.4 m -69.68 135.67 50.14 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.432 -0.792 . . . . 0.0 110.221 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -131.84 147.87 52.51 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.2 t -96.95 131.79 43.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.506 -0.746 . . . . 0.0 109.747 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.67 135.36 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -104.81 135.53 46.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.528 -0.733 . . . . 0.0 109.129 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -124.56 153.88 41.47 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.445 0.64 . . . . 0.0 109.371 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.76 -151.72 8.41 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -130.37 145.92 51.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.81 -0.818 . . . . 0.0 109.377 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.8 tt -123.57 142.36 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -127.71 151.51 48.89 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.434 0.635 . . . . 0.0 109.667 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.529 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 36.9 t0 -141.78 -153.16 0.45 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.485 -0.759 . . . . 0.0 109.381 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.529 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 95.5 m-20 -78.91 -7.47 58.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.88 . . . . 0.0 109.935 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.5 p -108.75 -85.8 0.52 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.335 -0.853 . . . . 0.0 110.363 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.0 -148.86 0.32 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.473 -0.767 . . . . 0.0 109.622 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -145.44 156.36 43.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.271 -0.893 . . . . 0.0 110.087 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.7 tt -148.91 164.8 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.368 -0.833 . . . . 0.0 109.978 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.63 144.17 35.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.158 -0.964 . . . . 0.0 110.148 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.829 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -135.21 161.23 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.485 -0.759 . . . . 0.0 109.665 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.2 m -137.79 139.98 40.33 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 58' ' ' LYS . 4.7 p -119.58 116.24 25.64 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -96.78 117.09 30.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.382 -0.824 . . . . 0.0 110.273 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.83 -13.26 3.23 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.429 ' O ' ' OG ' ' A' ' 55' ' ' SER . 28.3 mmtp -103.77 107.15 17.89 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.365 -1.08 . . . . 0.0 109.352 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -72.64 145.02 47.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.569 -0.707 . . . . 0.0 109.728 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.1 mt -127.14 153.25 46.27 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -105.75 141.56 36.97 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.613 0.721 . . . . 0.0 109.847 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 63' ' ' SER . 57.1 t0 -66.25 138.42 57.64 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.592 0.711 . . . . 0.0 110.782 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.528 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 5.0 m 61.56 78.85 0.27 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.354 0.597 . . . . 0.0 110.749 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.416 ' CG ' ' O ' ' A' ' 63' ' ' SER . 56.7 m-20 -163.33 126.92 2.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.691 -0.631 . . . . 0.0 109.422 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.7 t -78.24 121.63 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.1 m -137.72 160.67 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.43 -0.794 . . . . 0.0 109.855 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.621 ' HE ' HD12 ' A' ' 19' ' ' ILE . 41.8 ttm180 -117.36 128.74 55.34 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.4 mt -106.95 126.57 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -109.85 141.22 42.85 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.72 -0.612 . . . . 0.0 109.729 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 61.7 t30 62.74 41.01 9.47 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.484 0.659 . . . . 0.0 109.385 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.57 147.31 49.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.422 -0.799 . . . . 0.0 109.087 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -103.37 125.53 50.04 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.537 -0.727 . . . . 0.0 109.578 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.0 t -86.25 132.7 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.482 -0.761 . . . . 0.0 109.69 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.66 152.92 41.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.321 -0.862 . . . . 0.0 109.174 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -107.35 122.3 46.3 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.446 -0.784 . . . . 0.0 109.556 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -126.08 138.91 53.74 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.1 t30 56.25 24.06 7.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.559 -0.713 . . . . 0.0 109.507 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.64 8.35 87.72 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -118.19 138.97 51.95 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.42 -1.047 . . . . 0.0 109.698 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.9 mt -75.53 145.15 41.54 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.629 0.728 . . . . 0.0 110.342 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.5 p -154.77 160.62 41.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.552 -0.717 . . . . 0.0 109.139 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.7 mt -105.16 126.27 51.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.414 -0.804 . . . . 0.0 109.331 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.9 p -109.2 134.37 51.83 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.558 -0.714 . . . . 0.0 109.6 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.8 t -100.51 114.08 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.306 -0.871 . . . . 0.0 108.749 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.14 175.85 44.99 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 87' ' ' SER . 43.3 p-10 -67.43 -24.24 65.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.571 -0.958 . . . . 0.0 109.822 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.453 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 66.2 m -84.17 -6.4 59.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.238 -0.914 . . . . 0.0 109.634 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.9 t -81.96 170.84 15.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.756 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -131.52 141.25 49.69 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.619 -0.675 . . . . 0.0 109.751 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.8 130.51 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.645 -0.66 . . . . 0.0 109.438 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -121.33 120.39 34.92 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.55 0.69 . . . . 0.0 109.374 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.2 m -75.69 147.15 39.64 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.506 -0.746 . . . . 0.0 110.176 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.7 t -136.76 61.69 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -95.81 1.6 53.29 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.32 -0.863 . . . . 0.0 109.645 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.415 HG12 ' H ' ' A' ' 97' ' ' ILE . 55.7 t -120.18 130.18 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.514 -0.741 . . . . 0.0 109.16 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 54.2 p30 -101.24 51.39 0.85 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.488 -0.758 . . . . 0.0 109.056 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.415 ' H ' HG12 ' A' ' 95' ' ' VAL . 11.8 mt -143.85 69.87 16.77 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.428 -0.795 . . . . 0.0 109.31 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.78 -0.76 10.83 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.73 2.287 . . . . 0.0 111.238 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 73.7 mt -71.56 147.08 48.0 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.57 0.7 . . . . 0.0 110.168 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 102' ' ' HIS . 30.0 tp10 58.53 -123.76 1.39 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.593 -0.692 . . . . 0.0 109.951 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 57.8 m170 44.48 -93.88 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.255 -0.903 . . . . 0.0 109.729 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 100' ' ' GLU . 48.1 p-80 -154.97 153.54 31.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 109.34 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.437 ' CD2' ' H ' ' A' ' 103' ' ' HIS . 13.2 p80 -96.5 122.33 39.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.222 -0.924 . . . . 0.0 109.889 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.9 -41.97 90.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.413 -0.805 . . . . 0.0 109.718 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -76.23 143.58 40.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.395 -0.816 . . . . 0.0 110.138 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.549 179.902 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 76.9 p . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.9 p30 -174.45 157.33 2.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.447 -0.783 . . . . 0.0 109.492 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.554 HD22 ' N ' ' A' ' 3' ' ' LEU . 3.8 mm? -83.7 130.44 34.96 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.457 -0.777 . . . . 0.0 109.994 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.4 m -138.32 161.68 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.544 0.687 . . . . 0.0 109.559 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -86.7 163.55 17.27 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.539 0.685 . . . . 0.0 109.883 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.2 mm -62.87 -43.78 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.613 -0.679 . . . . 0.0 109.85 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -66.76 -18.99 65.65 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.019 -1.051 . . . . 0.0 109.435 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -84.18 -1.68 55.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 0.0 109.566 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.47 131.59 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.204 -0.935 . . . . 0.0 110.136 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.4 t -163.41 160.07 23.04 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.3 -3.66 6.33 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.9 m -59.75 -35.63 74.98 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.63 -0.668 . . . . 0.0 109.248 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.7 p -115.28 133.63 22.69 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.66 -0.65 . . . . 0.0 109.701 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.61 -53.05 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.127 1.885 . . . . 0.0 111.781 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -119.66 130.73 55.2 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.368 0.604 . . . . 0.0 109.866 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.0 m -146.93 163.93 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.537 -0.727 . . . . 0.0 109.591 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.9 t -110.15 138.24 46.8 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.435 -0.791 . . . . 0.0 109.505 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.02 160.52 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.529 -0.732 . . . . 0.0 109.713 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.0 tt -142.96 137.58 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 109.599 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.48 -161.94 28.9 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.866 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -110.4 129.11 55.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.671 -0.899 . . . . 0.0 109.438 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.2 mt -101.75 131.12 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.766 -0.584 . . . . 0.0 109.991 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.474 ' HA ' ' H ' ' A' ' 63' ' ' SER . 23.0 m -145.27 153.45 41.3 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.591 0.71 . . . . 0.0 109.997 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.51 65.18 1.75 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.9 mm -81.58 129.1 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -1.138 . . . . 0.0 109.94 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -123.89 132.71 53.79 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -94.27 134.14 37.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.0 109.876 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -145.21 157.95 43.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.454 -0.779 . . . . 0.0 109.284 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -123.6 144.23 49.72 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.518 -0.739 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -142.38 160.63 39.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.375 -0.828 . . . . 0.0 109.321 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -80.1 148.29 31.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.434 -0.792 . . . . 0.0 109.832 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.581 ' O ' ' N ' ' A' ' 34' ' ' GLY . 34.1 m -144.97 -149.5 0.28 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.474 -0.766 . . . . 0.0 109.114 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -50.95 84.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.758 0.79 . . . . 0.0 110.13 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 47.69 19.98 1.01 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -147.91 151.16 35.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.072 -1.252 . . . . 0.0 110.156 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.8 m -89.66 131.12 35.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.451 -0.78 . . . . 0.0 109.171 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -119.33 146.75 45.03 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.579 0.704 . . . . 0.0 109.942 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 89.2 p -83.77 146.35 28.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.49 -0.757 . . . . 0.0 109.924 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -139.54 137.81 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -104.25 128.9 52.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.499 -0.751 . . . . 0.0 109.401 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -113.85 154.61 27.19 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.18 -169.53 37.79 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -124.85 146.36 49.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.659 -0.906 . . . . 0.0 109.611 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.2 tt -125.39 139.44 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -126.95 149.35 49.88 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.528 -0.732 . . . . 0.0 110.234 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 42.7 t0 -136.13 -160.44 1.05 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.516 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 1.4 p30 -81.29 -3.53 52.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 110.056 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.9 p -107.06 -62.11 1.45 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.278 -0.889 . . . . 0.0 109.438 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -160.71 -151.46 0.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.23 -0.919 . . . . 0.0 109.583 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -144.8 156.96 44.31 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.4 tt -146.63 159.49 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.297 -0.877 . . . . 0.0 110.053 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -76.42 144.5 39.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.381 -0.824 . . . . 0.0 109.697 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.2 pt -128.73 157.96 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.491 -0.756 . . . . 0.0 110.076 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -145.0 126.43 14.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.4 t -114.84 127.52 55.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.486 -0.759 . . . . 0.0 109.492 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -97.44 117.78 32.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.577 -0.702 . . . . 0.0 110.349 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.64 -54.58 4.97 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -70.31 138.18 51.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.128 -1.219 . . . . 0.0 110.669 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -88.41 158.37 18.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.618 -0.676 . . . . 0.0 110.077 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.6 mt -121.27 153.63 37.42 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -106.88 135.47 48.38 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.685 0.755 . . . . 0.0 109.838 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -66.42 136.84 56.32 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.751 0.786 . . . . 0.0 110.948 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.474 ' H ' ' HA ' ' A' ' 23' ' ' THR . 67.0 m 45.82 78.85 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.605 0.717 . . . . 0.0 110.145 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -150.68 126.52 10.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.626 -0.671 . . . . 0.0 109.358 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.5 t -78.55 115.87 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.498 -0.751 . . . . 0.0 109.23 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.1 m -140.58 166.87 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.487 -0.758 . . . . 0.0 109.94 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -121.8 130.38 53.35 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 74.8 mt -107.33 129.55 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.55 -0.719 . . . . 0.0 109.221 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -111.25 143.05 42.64 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.343 0.592 . . . . 0.0 109.955 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.5 t30 62.67 38.61 11.92 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.154 0.502 . . . . 0.0 109.883 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.13 139.2 46.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -0.854 . . . . 0.0 108.98 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -92.61 132.89 36.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.283 -0.886 . . . . 0.0 110.173 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -87.01 132.03 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.456 -0.778 . . . . 0.0 109.828 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.85 155.23 48.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.301 -0.874 . . . . 0.0 109.509 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -120.78 120.27 35.13 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -123.37 132.51 54.0 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.495 0.664 . . . . 0.0 109.602 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 55.84 32.02 18.81 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.42 0.628 . . . . 0.0 109.804 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.54 4.93 81.86 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -112.48 136.23 52.24 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.39 -1.065 . . . . 0.0 109.828 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.42 148.44 37.31 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.694 0.759 . . . . 0.0 110.77 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.0 t -156.25 154.44 30.71 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.5 mt -100.38 127.43 46.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.229 -0.92 . . . . 0.0 109.296 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 m -106.06 124.19 49.18 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.466 0.65 . . . . 0.0 109.354 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.4 t -96.8 112.43 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.291 -0.881 . . . . 0.0 108.919 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.92 178.44 43.71 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.14 -21.16 62.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.653 -0.91 . . . . 0.0 110.254 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.3 p -85.72 -5.44 59.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.167 -0.958 . . . . 0.0 109.28 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.1 p -79.03 167.6 20.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.447 -0.783 . . . . 0.0 109.883 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -131.45 141.74 49.86 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.421 0.629 . . . . 0.0 109.411 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.05 130.98 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -124.9 138.66 54.24 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.558 0.694 . . . . 0.0 109.443 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.2 m -70.58 150.26 46.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.628 -0.67 . . . . 0.0 110.126 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 51.7 t -113.63 133.15 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.608 0.718 . . . . 0.0 109.438 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.572 ' C ' ' H ' ' A' ' 96' ' ' ASN . 97.5 m-20 49.28 -118.65 1.13 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.753 -0.592 . . . . 0.0 110.528 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 95' ' ' VAL . 76.9 t 55.52 -0.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.602 -0.686 . . . . 0.0 109.455 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.572 ' H ' ' C ' ' A' ' 94' ' ' ASN . 87.1 m-20 -78.26 176.4 9.32 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.204 -0.935 . . . . 0.0 110.072 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.6 pt -135.87 62.84 49.19 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.26 -5.84 16.61 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 123.154 2.569 . . . . 0.0 111.446 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 100' ' ' GLU . 1.8 tp -46.33 -84.59 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.996 0 O-C-N 121.503 -0.748 . . . . 0.0 111.101 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 99' ' ' LEU . 81.5 tt0 42.2 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.383 -1.448 . . . . 0.0 110.614 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.418 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 93.5 m-70 -65.39 -35.0 79.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.326 -0.859 . . . . 0.0 109.731 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -64.8 144.86 56.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -0.826 . . . . 0.0 110.286 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.418 ' CD2' ' O ' ' A' ' 101' ' ' HIS . 99.1 m-70 -131.67 147.05 52.48 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.636 -0.665 . . . . 0.0 109.71 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -153.43 79.31 1.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.488 -0.758 . . . . 0.0 109.081 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -174.63 37.57 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.961 179.882 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 54.0 t0 -66.74 155.42 38.16 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.652 0.739 . . . . 0.0 110.424 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.487 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 47.3 tp -74.25 124.45 26.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.474 -0.766 . . . . 0.0 110.09 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 m -140.69 167.46 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.731 0.777 . . . . 0.0 110.116 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.18 156.5 29.81 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.732 0.777 . . . . 0.0 110.556 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.28 -43.09 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.715 -0.615 . . . . 0.0 109.881 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -65.34 -19.45 65.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.933 . . . . 0.0 109.855 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -85.82 -2.29 58.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 109.206 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.7 t -66.83 132.9 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.42 -0.8 . . . . 0.0 110.431 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.5 p -156.55 168.22 28.06 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.637 0.732 . . . . 0.0 109.556 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.36 -37.33 85.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.494 -0.754 . . . . 0.0 109.306 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.4 m -55.94 -20.81 17.6 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.367 -0.833 . . . . 0.0 109.548 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 p -113.77 79.57 4.56 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.65 -20.42 35.39 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.572 2.181 . . . . 0.0 112.036 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -128.07 106.18 8.9 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.581 -0.699 . . . . 0.0 109.549 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.4 m -139.2 162.9 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.61 -0.681 . . . . 0.0 110.123 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.9 t -118.33 135.96 54.0 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.3 m -133.41 162.27 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.773 0.797 . . . . 0.0 110.068 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.61 HD12 ' NH2' ' A' ' 67' ' ' ARG . 5.1 tt -136.64 142.55 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.553 -0.717 . . . . 0.0 109.53 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.65 -167.0 39.72 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.403 -1.379 . . . . 0.0 110.076 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -110.65 133.86 52.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.651 -0.911 . . . . 0.0 109.398 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 63' ' ' SER . 89.0 mt -102.55 132.42 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.254 0.55 . . . . 0.0 109.798 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 t -141.7 158.18 44.14 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.723 0.773 . . . . 0.0 109.944 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.17 53.38 3.48 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.548 ' N ' HD12 ' A' ' 25' ' ' ILE . 1.5 mp -78.14 125.6 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.371 -1.076 . . . . 0.0 109.652 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -126.85 124.21 39.07 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -83.28 128.47 34.52 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.664 0.745 . . . . 0.0 110.043 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -141.61 159.38 42.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.448 -0.782 . . . . 0.0 109.122 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -116.93 140.59 49.29 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.698 -0.626 . . . . 0.0 109.688 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 18.3 p90 -137.29 158.74 43.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -90.01 100.76 13.52 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.664 0.745 . . . . 0.0 110.357 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.596 ' O ' ' N ' ' A' ' 34' ' ' GLY . 10.7 t -82.83 -151.18 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.503 -0.748 . . . . 0.0 110.097 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -55.69 77.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.765 0.793 . . . . 0.0 110.217 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 58.3 23.41 53.25 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.8 m -145.89 133.36 20.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.265 -1.138 . . . . 0.0 109.702 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.4 m -79.82 130.65 35.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.3 -0.875 . . . . 0.0 109.805 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.402 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 68.7 mttm -133.48 148.13 51.7 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.815 0.817 . . . . 0.0 110.129 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.8 t -77.52 144.95 37.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.562 -0.712 . . . . 0.0 110.494 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -140.5 137.81 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.378 -0.826 . . . . 0.0 109.579 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -106.35 132.07 52.82 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.444 -0.785 . . . . 0.0 109.277 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -118.27 153.53 33.78 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.595 -0.691 . . . . 0.0 109.694 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.52 -157.13 16.06 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -135.88 146.8 47.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.483 -1.01 . . . . 0.0 109.643 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 tt -122.0 143.33 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -133.76 152.57 51.91 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.634 0.73 . . . . 0.0 110.027 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -147.86 -157.18 0.79 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.609 0.718 . . . . 0.0 109.725 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -80.33 -7.03 58.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.392 -0.817 . . . . 0.0 109.893 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 49' ' ' ALA . 81.5 p -100.91 -68.64 0.8 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.277 -0.89 . . . . 0.0 109.606 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.401 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -159.78 -148.55 0.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.175 -0.953 . . . . 0.0 109.956 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -144.75 152.57 40.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.126 -0.984 . . . . 0.0 110.362 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.0 tt -150.61 147.98 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.224 -0.922 . . . . 0.0 110.222 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -74.22 138.13 43.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.496 -0.752 . . . . 0.0 109.872 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.85 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -133.58 164.48 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.333 -0.855 . . . . 0.0 110.038 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.1 t -142.09 140.43 32.53 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.428 -0.795 . . . . 0.0 109.297 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.6 t -115.59 129.77 56.63 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.452 0.644 . . . . 0.0 109.512 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -97.66 119.38 36.13 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.583 0.706 . . . . 0.0 110.832 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.85 -46.91 1.8 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.492 ' HE2' HD12 ' A' ' 90' ' ' ILE . 54.4 mtpt -73.6 134.81 43.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.284 -1.127 . . . . 0.0 110.603 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -91.56 153.42 19.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.49 -0.756 . . . . 0.0 110.093 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.9 mt -133.0 157.77 44.37 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.463 0.649 . . . . 0.0 109.649 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -103.12 157.11 17.22 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.016 0.913 . . . . 0.0 110.395 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 47.4 p30 -76.71 150.39 36.3 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.66 0.743 . . . . 0.0 111.312 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 22' ' ' ILE . 4.2 p 39.02 36.79 0.17 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.31 0.576 . . . . 0.0 110.073 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 47.1 p-10 -98.96 129.89 45.29 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.489 -0.757 . . . . 0.0 110.353 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.8 t -79.07 112.95 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.601 -0.687 . . . . 0.0 109.207 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.23 164.78 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.43 -0.794 . . . . 0.0 110.148 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.61 ' NH2' HD12 ' A' ' 19' ' ' ILE . 59.6 ttm-85 -119.08 130.12 55.44 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 74.3 mt -105.84 124.84 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.561 -0.712 . . . . 0.0 109.183 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -114.84 142.41 46.59 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.454 0.645 . . . . 0.0 109.714 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.9 t30 63.99 40.35 7.3 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.613 0.721 . . . . 0.0 109.308 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.56 147.02 48.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.603 -0.685 . . . . 0.0 109.829 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -101.97 121.63 42.52 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.6 0.714 . . . . 0.0 109.467 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.16 134.25 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.569 -0.707 . . . . 0.0 110.324 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.37 153.82 45.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.465 -0.772 . . . . 0.0 109.094 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -114.82 114.27 25.33 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.458 -0.776 . . . . 0.0 109.452 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -112.96 126.34 55.37 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.692 0.758 . . . . 0.0 110.187 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 55.73 27.36 10.6 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.321 0.582 . . . . 0.0 110.658 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.84 4.64 84.71 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -112.31 131.04 55.73 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.48 -1.012 . . . . 0.0 109.768 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.02 144.4 40.89 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.747 0.784 . . . . 0.0 110.451 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.7 p -152.89 160.04 43.04 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.9 mt -106.91 131.73 53.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.425 -0.797 . . . . 0.0 109.662 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 t -109.14 125.83 52.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.666 -0.646 . . . . 0.0 109.377 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.455 HG11 HD11 ' A' ' 90' ' ' ILE . 13.4 t -102.85 100.89 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.488 -0.758 . . . . 0.0 109.011 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.46 176.66 49.96 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -65.92 -29.44 69.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.574 -0.956 . . . . 0.0 109.647 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.4 m -74.79 -7.48 53.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 109.433 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.5 p -80.96 167.84 19.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.319 -0.863 . . . . 0.0 110.273 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -125.7 138.12 53.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.545 -0.722 . . . . 0.0 109.347 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.492 HD12 ' HE2' ' A' ' 58' ' ' LYS . 87.0 mt -125.17 129.96 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.536 -0.727 . . . . 0.0 109.65 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -118.71 113.28 20.92 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.3 t -75.05 150.31 38.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.461 -0.775 . . . . 0.0 110.517 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.6 t -84.66 133.39 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 110.054 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -70.15 143.8 52.19 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.787 0.803 . . . . 0.0 110.716 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.84 147.32 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.83 0.824 . . . . 0.0 110.662 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.426 ' O ' ' OD1' ' A' ' 96' ' ' ASN . 56.6 p30 -55.81 152.09 10.33 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.808 0.813 . . . . 0.0 110.888 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.5 mt 56.52 71.64 1.13 Allowed Pre-proline 0 N--CA 1.49 1.55 0 CA-C-O 121.212 0.53 . . . . 0.0 110.122 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -61.78 148.16 93.69 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 123.048 2.498 . . . . 0.0 112.526 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 99' ' ' LEU . 9.5 mp -86.41 111.31 20.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.313 -0.867 . . . . 0.0 109.545 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -97.6 147.27 24.48 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.582 0.706 . . . . 0.0 110.343 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 51.26 46.51 26.35 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.718 0.77 . . . . 0.0 109.945 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -63.13 -43.91 97.05 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.543 -0.723 . . . . 0.0 109.109 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.476 ' O ' ' CG ' ' A' ' 103' ' ' HIS . 49.0 p-80 -159.26 102.35 1.59 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.407 -0.808 . . . . 0.0 109.646 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -66.4 -43.88 84.57 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.477 -0.765 . . . . 0.0 109.612 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -151.82 162.87 40.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.179 -0.951 . . . . 0.0 110.321 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.452 ' O ' ' CG ' ' A' ' 106' ' ' HIS . 55.8 p-80 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.756 -1.116 . . . . 0.0 109.084 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 121.377 0.608 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -69.85 147.32 50.48 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.764 0.792 . . . . 0.0 110.542 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.2 tt -75.99 129.75 37.37 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.531 0.681 . . . . 0.0 109.957 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.9 m -140.17 163.62 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.934 0.874 . . . . 0.0 110.834 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -72.88 149.59 43.36 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.78 0.8 . . . . 0.0 110.247 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 92.0 mt -63.74 -42.6 96.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -69.65 -17.22 63.49 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.729 -0.607 . . . . 0.0 109.812 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -92.61 6.44 47.3 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.508 -0.745 . . . . 0.0 109.247 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.56 133.2 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.71 0.767 . . . . 0.0 109.947 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.1 p -153.27 166.85 31.27 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.962 0.887 . . . . 0.0 110.324 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.0 mt -73.07 -9.29 58.57 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.6 m -74.44 -14.72 60.88 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.3 p -121.49 84.09 41.66 Favored Pre-proline 0 N--CA 1.499 1.995 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.39 -41.19 74.84 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.613 2.209 . . . . 0.0 111.594 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -116.89 131.92 56.83 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.761 0.791 . . . . 0.0 109.992 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.4 m -149.77 175.71 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 122.273 1.035 . . . . 0.0 110.617 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.407 ' OG ' ' OD1' ' A' ' 69' ' ' ASP . 48.4 m -134.71 137.17 43.29 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -140.21 163.26 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.074 0.94 . . . . 0.0 110.643 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.6 tt -137.93 135.51 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.709 0.766 . . . . 0.0 109.893 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.29 -168.47 40.97 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -110.95 136.29 50.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.941 -0.741 . . . . 0.0 109.489 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.716 ' N ' HD12 ' A' ' 22' ' ' ILE . 2.4 mp -96.33 133.32 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.406 0.622 . . . . 0.0 109.714 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 t -136.07 159.78 40.65 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.75 0.786 . . . . 0.0 109.929 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 25' ' ' ILE . . . 99.63 -69.29 0.54 Allowed Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 24' ' ' GLY . 25.8 mm 59.11 128.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.844 0.83 . . . . 0.0 110.592 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.74 138.62 21.03 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.437 0.637 . . . . 0.0 109.358 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -106.0 129.13 54.18 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.002 0.906 . . . . 0.0 110.175 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -141.09 157.41 45.34 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.736 0.779 . . . . 0.0 110.074 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 56.5 mp0 -113.99 142.8 45.71 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.806 0.812 . . . . 0.0 110.243 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 31.7 p90 -143.66 161.96 37.19 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.598 0.713 . . . . 0.0 109.485 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -94.19 107.0 18.97 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.751 0.786 . . . . 0.0 110.388 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 34' ' ' GLY . 4.4 p -88.19 -161.54 0.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -52.18 80.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.597 0.713 . . . . 0.0 110.259 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 59.94 11.0 16.05 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 92.8 m -131.86 131.21 42.59 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.863 0.84 . . . . 0.0 110.791 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.2 m -79.48 128.32 33.22 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.55 0.69 . . . . 0.0 109.192 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.451 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 98.6 mttt -136.13 147.83 47.94 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.885 0.85 . . . . 0.0 110.15 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 87.5 p -82.03 149.91 27.86 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.846 0.831 . . . . 0.0 110.019 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -130.64 133.94 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.835 0.826 . . . . 0.0 109.836 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -98.2 133.36 42.74 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -130.62 150.82 51.64 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.742 0.782 . . . . 0.0 109.829 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.72 -169.43 35.31 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -122.24 139.62 53.57 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.622 0.725 . . . . 0.0 109.699 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.2 tt -113.08 136.43 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -121.5 149.79 42.55 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.948 0.88 . . . . 0.0 110.361 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 38.3 t0 -148.8 -164.57 2.05 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.62 0.724 . . . . 0.0 109.479 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.512 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 48.9 t0 -65.04 -38.59 91.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.609 -0.682 . . . . 0.0 109.825 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.1 p -73.22 -85.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.263 0.554 . . . . 0.0 109.712 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -143.49 -142.26 0.13 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.643 0.735 . . . . 0.0 109.971 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.7 ptt85 -148.96 158.32 44.09 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.758 0.79 . . . . 0.0 110.042 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.2 tt -152.65 158.94 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 122.033 0.921 . . . . 0.0 110.631 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.541 ' NH2' ' CG ' ' A' ' 76' ' ' PHE . 51.2 ttp180 -74.47 143.47 44.63 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.705 0.764 . . . . 0.0 110.107 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 pt -133.38 161.39 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.732 0.777 . . . . 0.0 110.327 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.0 m -144.76 138.93 27.5 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.747 0.784 . . . . 0.0 110.19 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 p -134.57 135.55 42.34 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.87 0.843 . . . . 0.0 109.579 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.455 ' C ' ' H ' ' A' ' 58' ' ' LYS . 88.0 m-85 -94.4 124.85 38.67 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.752 0.787 . . . . 0.0 110.796 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.57 -38.56 0.48 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.455 ' H ' ' C ' ' A' ' 56' ' ' PHE . 72.2 mmtt -68.42 133.66 49.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.66 -0.906 . . . . 0.0 110.001 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -97.71 148.49 23.29 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.765 0.793 . . . . 0.0 110.341 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.8 mt -129.94 152.78 49.04 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.568 0.699 . . . . 0.0 109.696 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -115.79 158.38 22.96 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.225 1.012 . . . . 0.0 110.421 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.9 t0 -62.01 138.19 58.34 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.815 0.817 . . . . 0.0 110.873 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.523 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 10.9 t 52.33 31.01 8.77 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.269 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -78.24 112.06 14.84 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.571 -0.705 . . . . 0.0 110.372 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 t -81.2 105.76 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.663 0.744 . . . . 0.0 109.281 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.7 m -140.99 164.65 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.647 0.736 . . . . 0.0 110.113 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.8 ttp85 -115.21 127.83 55.77 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.759 0.79 . . . . 0.0 109.582 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.3 mt -108.39 130.62 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.608 0.718 . . . . 0.0 109.844 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 67.8 t0 -125.32 142.44 51.5 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.556 0.693 . . . . 0.0 109.902 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.55 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 52.6 t30 71.92 35.09 1.39 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.387 0.613 . . . . 0.0 109.949 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.14 141.54 43.68 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.394 0.616 . . . . 0.0 110.407 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -95.17 128.37 41.95 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.755 0.788 . . . . 0.0 109.893 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.8 t -80.64 132.4 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 121.679 0.752 . . . . 0.0 110.179 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -117.92 146.19 44.13 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.744 0.783 . . . . 0.0 109.549 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -108.47 97.64 7.28 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.525 0.679 . . . . 0.0 109.454 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.633 ' O ' ' N ' ' A' ' 78' ' ' GLY . 28.4 m-85 -82.83 -177.88 6.9 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.409 0.624 . . . . 0.0 110.55 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -51.94 75.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.499 0.666 . . . . 0.0 110.493 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 76' ' ' PHE . . . 74.71 15.56 80.64 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -130.62 144.62 51.55 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.565 -0.962 . . . . 0.0 110.395 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.5 mt -103.1 140.35 37.43 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.859 0.838 . . . . 0.0 110.126 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 96.3 p -152.53 163.52 39.41 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.701 0.763 . . . . 0.0 109.854 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.7 mt -106.07 131.03 53.83 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.651 0.739 . . . . 0.0 110.176 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.2 p -107.67 123.97 49.29 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.838 0.828 . . . . 0.0 109.761 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.2 t -100.41 112.26 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.854 0.835 . . . . 0.0 109.6 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -97.19 -179.26 34.22 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -66.11 -29.14 69.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.914 -0.756 . . . . 0.0 109.736 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 89.4 p -78.67 -4.91 51.42 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.8 t -80.39 167.65 19.95 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.467 0.651 . . . . 0.0 110.087 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 24.7 mmt85 -124.96 137.79 54.25 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.716 0.77 . . . . 0.0 109.953 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.8 mt -127.19 130.47 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.511 0.672 . . . . 0.0 110.386 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -124.59 125.76 44.68 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.78 0.8 . . . . 0.0 109.402 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.2 p -75.73 152.95 37.35 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.714 0.768 . . . . 0.0 110.433 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 64.2 t -143.16 98.31 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.566 0.698 . . . . 0.0 109.399 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -87.23 106.81 18.16 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.594 0.711 . . . . 0.0 109.377 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.487 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 97.0 t -93.8 -85.38 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 95' ' ' VAL . 0.6 OUTLIER 43.16 45.72 4.86 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.335 0.588 . . . . 0.0 109.677 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.2 mt 52.88 74.5 0.77 Allowed Pre-proline 0 N--CA 1.495 1.779 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.26 143.47 28.3 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.608 2.206 . . . . 0.0 113.25 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.434 ' C ' HD12 ' A' ' 99' ' ' LEU . 0.3 OUTLIER -167.31 16.29 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -164.23 126.03 2.3 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.639 0.733 . . . . 0.0 109.629 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.463 ' CG ' ' O ' ' A' ' 101' ' ' HIS . 53.3 t-80 52.32 36.79 20.6 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.41 0.624 . . . . 0.0 109.86 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -65.87 -41.98 90.93 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -79.6 141.16 36.81 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.747 0.784 . . . . 0.0 110.105 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -135.22 10.68 3.53 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.52 ' CG ' ' N ' ' A' ' 106' ' ' HIS . 52.9 p-80 -67.04 -43.31 83.07 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.583 -0.698 . . . . 0.0 109.841 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.52 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 44.6 t-80 . . . . . 0 N--CA 1.499 1.985 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.826 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.484 ' H1 ' ' HA ' ' A' ' 70' ' ' ASN . 25.8 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.61 0.719 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 55.4 t0 -74.56 152.21 39.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 0.0 110.552 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.54 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 43.2 tp -77.6 123.24 26.37 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.425 -0.797 . . . . 0.0 109.744 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.1 m -140.28 165.03 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.385 -0.822 . . . . 0.0 110.067 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.6 157.56 31.84 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.81 0.814 . . . . 0.0 110.492 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 6' ' ' ILE . 2.3 mp -63.97 -42.72 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.619 -0.676 . . . . 0.0 109.256 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -64.25 -24.15 67.56 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.239 -0.913 . . . . 0.0 109.557 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -83.21 -0.16 48.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.952 -1.093 . . . . 0.0 109.496 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.2 131.99 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.074 -1.016 . . . . 0.0 110.562 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.3 p -158.99 167.37 29.54 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.55 -0.719 . . . . 0.0 109.331 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.19 -19.54 66.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.89 . . . . 0.0 108.888 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -63.86 -17.24 62.97 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.318 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.6 p -124.36 82.02 58.38 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.318 -0.864 . . . . 0.0 109.231 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.32 -41.42 66.53 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.958 2.439 . . . . 0.0 112.151 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -119.28 128.1 53.84 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.422 -0.799 . . . . 0.0 109.814 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.6 m -147.17 161.11 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.256 -0.903 . . . . 0.0 110.116 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.5 m -115.46 134.17 55.34 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.69 162.38 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.873 0.844 . . . . 0.0 110.324 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.0 tt -140.49 137.98 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.428 -0.795 . . . . 0.0 109.524 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.45 -162.91 29.41 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' C ' HD12 ' A' ' 22' ' ' ILE . 26.7 ttmt -111.58 128.81 56.15 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.58 -0.953 . . . . 0.0 109.359 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.736 ' N ' HD12 ' A' ' 22' ' ' ILE . 1.8 mp -94.53 125.74 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.533 0.682 . . . . 0.0 109.737 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.7 p -132.7 159.29 40.06 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.836 0.827 . . . . 0.0 110.091 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.9 82.02 0.19 Allowed Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.4 mm -92.1 129.81 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.092 -1.24 . . . . 0.0 110.267 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -133.73 139.1 46.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.534 -0.729 . . . . 0.0 109.132 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -103.28 136.45 43.03 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.766 0.793 . . . . 0.0 109.917 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.593 ' NZ ' ' NH2' ' A' ' 52' ' ' ARG . 53.1 mtmt -144.25 160.24 41.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.488 -0.757 . . . . 0.0 109.317 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -122.11 144.73 48.75 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.626 0.727 . . . . 0.0 109.701 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -142.63 160.92 39.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 109.289 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -93.98 116.23 28.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.293 -0.879 . . . . 0.0 109.889 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 t -109.23 110.2 21.34 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.822 0.82 . . . . 0.0 109.362 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 53.34 33.6 16.07 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.57 0.7 . . . . 0.0 110.722 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.27 -2.01 77.73 Favored Glycine 0 N--CA 1.496 2.643 0 O-C-N 120.962 -1.086 . . . . 0.0 111.047 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.7 p -115.95 125.22 52.25 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.089 -1.242 . . . . 0.0 109.928 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.1 m -69.6 133.42 47.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.55 -0.719 . . . . 0.0 110.094 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -136.71 144.94 44.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.367 -0.833 . . . . 0.0 109.889 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.4 m -83.25 144.83 29.48 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.771 0.796 . . . . 0.0 110.311 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.417 HG22 ' OE1' ' A' ' 41' ' ' GLN . 14.2 p -140.51 137.81 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.898 . . . . 0.0 108.85 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -102.1 135.29 43.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.436 -0.79 . . . . 0.0 109.495 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.606 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 1.1 mp0 -117.05 152.12 35.35 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.631 0.729 . . . . 0.0 109.176 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.34 -171.86 35.43 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -130.49 139.05 50.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.481 -1.011 . . . . 0.0 109.271 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 44' ' ' ILE . 19.2 tt -114.62 130.9 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -123.6 151.56 42.83 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.655 0.741 . . . . 0.0 109.932 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 30.7 t0 -155.72 -161.87 1.23 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.489 -0.757 . . . . 0.0 109.673 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.545 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 95.8 m-20 -74.26 -3.48 30.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.283 -0.886 . . . . 0.0 110.383 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.504 ' OG1' ' N ' ' A' ' 49' ' ' ALA . 8.1 p -101.15 -62.46 1.24 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.849 -1.157 . . . . 0.0 109.323 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.504 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -171.29 -150.51 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.96 -1.087 . . . . 0.0 110.364 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -135.32 145.63 47.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.514 -0.741 . . . . 0.0 109.894 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.2 tt -150.2 150.2 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.166 -0.959 . . . . 0.0 110.025 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.593 ' NH2' ' NZ ' ' A' ' 28' ' ' LYS . 72.9 ttt180 -73.01 146.55 45.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.457 -0.777 . . . . 0.0 110.383 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.6 pt -132.3 158.6 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.455 -0.778 . . . . 0.0 109.744 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.8 m -143.72 126.54 16.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.178 -0.951 . . . . 0.0 109.073 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.4 t -114.13 128.31 56.32 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.566 -0.709 . . . . 0.0 109.357 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -95.38 121.41 37.02 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.738 0.78 . . . . 0.0 110.95 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.19 -47.72 3.22 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -82.59 135.14 35.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.287 . . . . 0.0 110.674 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.665 ' H ' ' CD ' ' A' ' 59' ' ' GLN . 1.8 pm0 -89.98 165.71 13.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.679 -0.638 . . . . 0.0 110.119 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.6 mt -124.03 158.43 32.15 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.547 0.689 . . . . 0.0 109.478 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -107.51 133.46 51.95 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.376 1.084 . . . . 0.0 109.889 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 63' ' ' SER . 66.2 t0 -60.86 142.79 55.9 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.986 0.898 . . . . 0.0 111.304 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.555 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 2.0 m 50.98 29.57 4.61 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.496 0.665 . . . . 0.0 110.171 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -94.48 129.31 41.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.064 -1.022 . . . . 0.0 110.807 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.6 t -89.55 111.36 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.34 -0.85 . . . . 0.0 108.8 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.406 HG22 HD13 ' A' ' 22' ' ' ILE . 17.0 m -139.27 166.27 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.216 -0.928 . . . . 0.0 110.318 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -118.58 127.11 53.3 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.2 mt -107.01 127.69 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.257 -0.902 . . . . 0.0 109.435 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -111.17 145.46 38.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.699 -0.626 . . . . 0.0 109.72 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.484 ' HA ' ' H1 ' ' A' ' 1' ' ' SER . 63.6 t30 63.39 38.68 9.92 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.851 0.834 . . . . 0.0 109.401 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.82 134.94 41.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.812 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -88.06 136.96 32.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.414 -0.804 . . . . 0.0 110.237 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.0 t -96.62 132.7 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -0.856 . . . . 0.0 109.487 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.7 155.03 48.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 109.394 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -117.87 115.94 25.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.612 -0.68 . . . . 0.0 109.197 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -125.2 134.74 52.25 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.703 0.764 . . . . 0.0 109.812 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 56.28 29.68 15.37 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.731 0.777 . . . . 0.0 109.974 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.29 7.84 85.11 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -114.42 134.59 54.88 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.435 -1.038 . . . . 0.0 109.92 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.7 mt -79.91 143.17 34.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.4 -0.813 . . . . 0.0 110.093 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.5 m -151.71 158.67 43.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 109.289 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.2 mt -104.19 127.54 51.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.393 -0.817 . . . . 0.0 109.328 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -107.07 125.43 51.03 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.648 0.737 . . . . 0.0 109.541 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 t -98.43 111.85 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.411 -0.806 . . . . 0.0 109.416 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.07 -179.32 42.97 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 87' ' ' SER . 47.4 p30 -70.89 -18.17 62.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.448 -1.031 . . . . 0.0 109.484 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.509 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 98.7 p -85.33 -7.89 58.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.152 -0.968 . . . . 0.0 109.487 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 m -80.93 165.7 21.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.103 -0.998 . . . . 0.0 110.336 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 24.9 tpt85 -127.66 133.56 49.63 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.549 0.69 . . . . 0.0 109.542 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -114.97 129.62 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.582 -0.699 . . . . 0.0 109.703 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -123.35 117.62 25.64 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.775 0.797 . . . . 0.0 109.067 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 73.6 m -77.36 147.18 36.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.549 -0.72 . . . . 0.0 110.368 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 66.4 t -139.56 82.41 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.029 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -167.83 -32.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.1 t -117.63 132.48 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 121.941 0.877 . . . . 0.0 109.67 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -143.67 89.29 2.05 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.7 mt -145.64 60.31 6.54 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.144 -0.973 . . . . 0.0 109.433 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.97 152.29 80.59 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.519 2.146 . . . . 0.0 112.154 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.6 tp -84.62 -2.23 57.15 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 109.244 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.66 148.47 7.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 110.264 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -80.01 -11.55 59.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.159 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -71.73 129.28 38.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.128 -0.982 . . . . 0.0 110.012 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -70.68 137.34 49.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.408 -0.808 . . . . 0.0 110.789 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -82.11 146.85 29.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.508 -0.745 . . . . 0.0 110.101 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -127.12 129.28 47.62 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.584 0.707 . . . . 0.0 109.655 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.784 -179.884 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.421 ' HB2' ' H ' ' A' ' 70' ' ' ASN . 83.4 p . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 67.0 t0 -65.2 145.27 56.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.572 -0.705 . . . . 0.0 110.318 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.541 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 35.6 tp -71.75 130.23 40.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.554 -0.716 . . . . 0.0 109.782 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.18 164.5 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.417 -0.802 . . . . 0.0 109.648 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -80.29 159.1 25.95 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.608 -0.683 . . . . 0.0 110.569 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.54 ' N ' HD12 ' A' ' 6' ' ' ILE . 1.4 mp -63.42 -45.49 97.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.626 -0.671 . . . . 0.0 109.255 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -63.43 -20.31 65.45 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.512 -0.743 . . . . 0.0 109.841 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 8' ' ' ASP . 53.2 t0 -87.44 -2.8 58.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.377 -0.827 . . . . 0.0 109.529 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.0 t -70.04 132.65 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -0.938 . . . . 0.0 110.144 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.7 m -158.24 172.59 18.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.478 -0.764 . . . . 0.0 109.555 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.33 -38.95 93.15 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.427 -0.796 . . . . 0.0 109.652 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.5 t -55.0 -17.13 3.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.388 -0.82 . . . . 0.0 109.8 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 p -114.37 79.59 5.37 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.462 -0.774 . . . . 0.0 109.113 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.92 -20.63 29.15 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.229 1.953 . . . . 0.0 112.324 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -131.71 110.06 10.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.537 -0.727 . . . . 0.0 109.299 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.9 m -142.21 163.97 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.359 -0.838 . . . . 0.0 110.306 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.419 ' O ' HD12 ' A' ' 3' ' ' LEU . 25.3 t -113.0 141.52 46.75 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.2 t -135.33 155.98 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.239 -0.913 . . . . 0.0 109.775 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.444 HG23 ' O ' ' A' ' 19' ' ' ILE . 20.0 tt -140.13 132.76 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.329 -0.857 . . . . 0.0 109.384 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.61 -160.51 30.78 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 118.909 -1.615 . . . . 0.0 110.366 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -111.83 136.82 50.62 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.796 -0.826 . . . . 0.0 109.638 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 63' ' ' SER . 92.9 mt -103.5 130.75 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.474 -0.766 . . . . 0.0 109.636 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.4 p -134.86 159.53 41.1 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.508 -0.745 . . . . 0.0 109.787 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.84 78.13 0.39 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.5 mm -95.08 123.37 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.189 -1.183 . . . . 0.0 109.366 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -115.81 137.98 51.57 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -101.61 129.78 47.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.524 -0.735 . . . . 0.0 109.594 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -144.25 161.07 39.85 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.5 137.05 55.0 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.326 -0.859 . . . . 0.0 109.779 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -130.15 153.8 48.17 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 31' ' ' GLU . 58.1 mp0 -88.32 136.42 32.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -0.909 . . . . 0.0 109.731 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.7 t -137.03 109.72 7.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.498 -0.751 . . . . 0.0 109.166 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 54.2 t0 58.69 32.04 21.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.523 -0.736 . . . . 0.0 110.134 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.66 11.27 83.2 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.1 m -121.0 130.17 53.69 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.602 -0.94 . . . . 0.0 109.305 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.3 m -80.68 130.44 35.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 109.661 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -132.8 140.54 48.05 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.383 -0.823 . . . . 0.0 109.675 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.2 t -79.86 142.27 35.38 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.385 -0.822 . . . . 0.0 109.701 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 p -133.43 136.53 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -102.08 139.04 38.24 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.469 -0.769 . . . . 0.0 109.359 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -135.79 153.91 51.38 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.391 -0.818 . . . . 0.0 109.779 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.54 -150.37 7.93 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -134.77 143.51 47.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.588 -0.948 . . . . 0.0 109.511 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.6 tt -120.94 134.83 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -117.6 148.34 42.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.665 -0.647 . . . . 0.0 109.746 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -136.71 -164.82 1.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -72.15 -19.1 61.82 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.517 -0.739 . . . . 0.0 109.462 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.9 m -93.67 -76.35 0.48 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.28 -0.888 . . . . 0.0 110.087 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.89 -148.68 0.25 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.388 -0.82 . . . . 0.0 109.925 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -144.53 157.01 44.42 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.351 -0.843 . . . . 0.0 110.069 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.2 tt -151.46 157.28 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.24 -0.912 . . . . 0.0 110.011 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -78.8 141.43 37.77 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.469 -0.769 . . . . 0.0 109.531 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.856 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -133.77 164.55 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.558 -0.714 . . . . 0.0 109.744 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.7 p -141.63 151.27 42.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 t -136.51 133.47 36.54 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.436 -0.79 . . . . 0.0 109.114 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -94.4 123.39 37.78 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.303 -0.873 . . . . 0.0 110.922 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.47 -57.41 2.03 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -61.07 130.6 47.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -1.184 . . . . 0.0 110.071 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -84.03 158.0 21.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.456 -0.777 . . . . 0.0 109.82 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.3 mt -120.67 153.22 37.19 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -115.75 130.66 56.93 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.833 0.825 . . . . 0.0 109.507 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 54.8 p-10 -66.28 142.99 57.48 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 110.835 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 22' ' ' ILE . 1.5 m 65.87 4.06 2.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.955 -0.466 . . . . 0.0 110.946 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 21.1 p-10 -81.47 136.27 35.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.632 -1.292 . . . . 0.0 110.154 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 t -95.6 113.29 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.166 -0.959 . . . . 0.0 108.841 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.6 m -139.24 165.53 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.746 0.784 . . . . 0.0 110.23 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -117.78 133.0 56.38 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.9 mt -106.17 129.55 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.511 -0.743 . . . . 0.0 109.137 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -111.36 143.28 42.42 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.638 -0.664 . . . . 0.0 109.538 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.421 ' H ' ' HB2' ' A' ' 1' ' ' SER . 65.2 t30 60.88 39.42 16.89 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.194 0.521 . . . . 0.0 109.834 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.58 146.47 50.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 0.0 108.969 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -99.99 121.03 40.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.595 -0.691 . . . . 0.0 109.748 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.1 t -83.79 133.91 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.463 -0.773 . . . . 0.0 109.763 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.24 155.19 45.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.249 -0.907 . . . . 0.0 109.326 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -114.12 119.49 37.29 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.534 -0.729 . . . . 0.0 109.29 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -124.42 135.37 53.21 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.617 -0.677 . . . . 0.0 109.614 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 54.61 31.69 15.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.703 -0.623 . . . . 0.0 109.58 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.55 10.84 82.85 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -120.37 139.52 52.67 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.471 -1.017 . . . . 0.0 110.113 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 80' ' ' LEU . 4.0 mm? -76.84 144.26 39.16 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.825 0.822 . . . . 0.0 110.546 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.9 m -150.92 152.54 33.77 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.2 mt -103.94 128.65 51.47 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.33 -0.856 . . . . 0.0 108.845 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.2 t -109.83 125.92 53.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.642 -0.661 . . . . 0.0 109.491 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.2 t -99.58 109.44 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.32 -177.05 38.94 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.89 -31.71 72.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.725 -0.868 . . . . 0.0 109.765 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.9 m -76.43 -5.76 48.77 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.277 -0.889 . . . . 0.0 109.496 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.6 t -85.09 165.35 17.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.499 -0.751 . . . . 0.0 109.428 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -134.06 137.46 44.66 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.542 -0.724 . . . . 0.0 109.459 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.05 131.18 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -118.32 130.57 56.1 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.9 p -71.85 152.13 42.88 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.518 -0.739 . . . . 0.0 109.697 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.494 ' C ' ' H ' ' A' ' 95' ' ' VAL . 54.1 t -125.74 133.82 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.524 -0.735 . . . . 0.0 109.628 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.4 t30 68.72 -36.72 0.33 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.811 -0.556 . . . . 0.0 110.22 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.494 ' H ' ' C ' ' A' ' 93' ' ' VAL . 55.4 t -113.91 130.71 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.395 -0.816 . . . . 0.0 109.789 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -159.92 78.79 0.69 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.0 mt -145.78 77.02 12.52 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.359 -0.838 . . . . 0.0 109.053 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -58.97 145.22 98.18 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.81 2.34 . . . . 0.0 112.576 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.4 mt 39.11 -122.28 0.32 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.416 0.627 . . . . 0.0 110.749 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 56.48 44.0 24.98 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -66.1 -43.5 87.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.533 -0.73 . . . . 0.0 110.177 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -109.54 115.08 29.25 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.442 -0.787 . . . . 0.0 109.677 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.62 ' CD2' ' H ' ' A' ' 103' ' ' HIS . 8.1 p80 -88.29 -115.06 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.552 -0.717 . . . . 0.0 109.805 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.474 ' H ' ' CG ' ' A' ' 103' ' ' HIS . 75.8 m80 -67.19 -40.12 86.48 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.536 -0.727 . . . . 0.0 109.527 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.524 ' O ' ' CG ' ' A' ' 106' ' ' HIS . 49.7 t-80 41.94 -100.46 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.664 -0.648 . . . . 0.0 110.384 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' A' ' 105' ' ' HIS . 78.3 m80 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.521 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -71.55 149.72 45.44 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.677 0.751 . . . . 0.0 110.087 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 17' ' ' SER . 38.2 tp -71.61 127.38 32.39 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.726 0.774 . . . . 0.0 110.074 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.57 163.93 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.882 0.848 . . . . 0.0 110.381 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.557 ' N ' ' OD2' ' A' ' 8' ' ' ASP . 63.5 mttp -76.89 148.26 36.54 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.856 0.836 . . . . 0.0 110.222 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.9 mm -59.72 -39.4 79.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.454 0.645 . . . . 0.0 109.786 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -62.7 -33.53 75.27 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.67 -0.644 . . . . 0.0 110.369 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.557 ' OD2' ' N ' ' A' ' 5' ' ' LYS . 7.5 p30 -83.32 12.39 5.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.476 -0.765 . . . . 0.0 110.269 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.9 t -71.4 130.2 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.737 0.779 . . . . 0.0 109.743 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.9 p -159.23 165.31 33.87 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.887 0.851 . . . . 0.0 109.983 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.2 mt -62.96 -30.2 71.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.662 -0.649 . . . . 0.0 109.487 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.9 m -52.8 -21.32 4.03 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.437 ' O ' ' OG1' ' A' ' 13' ' ' THR . 2.4 p -112.05 95.14 28.33 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.68 -18.85 19.26 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.701 2.267 . . . . 0.0 111.411 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -142.39 123.72 14.75 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.573 0.702 . . . . 0.0 109.601 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.5 m -153.74 173.24 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.897 0.856 . . . . 0.0 110.436 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.432 ' O ' HD12 ' A' ' 3' ' ' LEU . 43.1 m -128.41 149.43 50.55 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.65 0.738 . . . . 0.0 109.575 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.83 159.17 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.946 0.879 . . . . 0.0 110.403 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.515 ' CD1' ' HE ' ' A' ' 67' ' ' ARG . 97.0 mt -135.92 133.45 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.599 0.714 . . . . 0.0 109.894 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.52 -158.51 25.79 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' O ' ' OE2' ' A' ' 45' ' ' GLU . 36.8 ttpt -112.98 130.51 56.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.624 -0.927 . . . . 0.0 110.194 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.6 mt -99.61 133.1 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.404 0.621 . . . . 0.0 109.65 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.436 ' HA ' ' H ' ' A' ' 63' ' ' SER . 9.5 m -146.0 147.32 31.54 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.806 0.812 . . . . 0.0 110.205 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.42 76.28 1.22 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.496 ' N ' HD12 ' A' ' 25' ' ' ILE . 1.4 mp -94.59 115.18 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.647 -0.914 . . . . 0.0 109.865 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -111.55 121.92 46.44 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.573 0.702 . . . . 0.0 109.286 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -88.85 133.33 34.31 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.892 0.853 . . . . 0.0 110.215 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -148.2 151.48 35.59 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.488 0.661 . . . . 0.0 109.341 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.531 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 57.7 mp0 -111.8 140.61 46.29 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.831 0.824 . . . . 0.0 110.421 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.461 ' OH ' ' CD1' ' A' ' 56' ' ' PHE . 6.6 p90 -141.5 159.68 41.71 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.757 0.789 . . . . 0.0 109.708 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -91.23 95.93 10.3 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.765 0.793 . . . . 0.0 109.527 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.621 ' O ' ' N ' ' A' ' 34' ' ' GLY . 2.5 t -77.17 -149.5 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.263 0.554 . . . . 0.0 110.169 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -54.11 75.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.732 0.777 . . . . 0.0 110.402 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.621 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 58.83 24.85 58.24 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 t -147.49 141.01 25.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.631 -0.923 . . . . 0.0 109.661 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.8 m -88.61 125.85 35.01 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.682 0.753 . . . . 0.0 110.126 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -136.59 147.31 46.9 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.837 0.827 . . . . 0.0 109.734 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.9 t -81.62 145.01 30.82 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.676 0.75 . . . . 0.0 110.077 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 p -132.89 136.02 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.749 0.785 . . . . 0.0 109.662 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -104.86 130.23 53.03 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.584 0.707 . . . . 0.0 109.183 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -121.86 144.63 48.73 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.831 0.824 . . . . 0.0 109.927 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.54 -171.57 34.51 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -119.69 144.11 47.38 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.97 0.891 . . . . 0.0 110.396 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.68 136.96 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 21' ' ' LYS . 2.4 pm0 -125.31 154.93 41.02 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.037 0.922 . . . . 0.0 110.422 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 29.5 t0 -143.12 -156.56 0.69 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.507 0.67 . . . . 0.0 109.51 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.536 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 98.5 m-20 -73.82 -19.93 60.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.661 -0.649 . . . . 0.0 109.569 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 41.4 p -94.11 -88.5 0.24 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.584 -0.698 . . . . 0.0 109.486 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.79 -146.09 0.23 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.5 -0.75 . . . . 0.0 110.185 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -148.2 158.42 44.07 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.707 0.765 . . . . 0.0 110.482 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.2 tt -151.02 160.3 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-O 121.935 0.874 . . . . 0.0 110.477 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.8 ttp85 -78.82 145.01 34.51 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.832 0.825 . . . . 0.0 110.621 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.6 pt -131.27 159.6 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.634 0.73 . . . . 0.0 109.816 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.2 m -143.63 118.77 10.11 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.643 0.735 . . . . 0.0 109.695 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.4 p -109.35 142.4 40.34 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.838 0.828 . . . . 0.0 109.79 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.521 ' C ' ' H ' ' A' ' 58' ' ' LYS . 76.1 m-85 -102.72 117.36 34.47 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.64 0.733 . . . . 0.0 110.845 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.25 -31.48 0.26 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.521 ' H ' ' C ' ' A' ' 56' ' ' PHE . 13.9 tptp -66.55 129.94 41.52 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.684 -0.892 . . . . 0.0 110.915 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -83.71 138.0 33.5 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.85 0.833 . . . . 0.0 110.761 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.2 mt -128.47 150.73 50.02 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -109.53 143.66 38.87 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.762 0.792 . . . . 0.0 110.134 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -67.11 137.95 56.72 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.884 0.849 . . . . 0.0 110.182 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.436 ' H ' ' HA ' ' A' ' 23' ' ' THR . 7.3 t 51.68 80.64 0.08 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.725 0.774 . . . . 0.0 109.396 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -153.26 121.83 6.34 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.723 0.773 . . . . 0.0 110.151 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.465 HG22 ' H ' ' A' ' 65' ' ' VAL . 1.8 m -74.1 119.46 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.915 0.864 . . . . 0.0 109.487 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.2 m -141.04 167.93 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-O 122.479 1.133 . . . . 0.0 110.242 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.515 ' HE ' ' CD1' ' A' ' 19' ' ' ILE . 39.2 ttm180 -113.76 126.28 55.04 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.031 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.413 ' CG2' ' HB2' ' A' ' 71' ' ' ALA . 94.0 mt -106.04 118.34 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.638 0.733 . . . . 0.0 109.484 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -122.03 151.43 40.84 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.917 0.865 . . . . 0.0 110.123 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 61.48 37.01 16.84 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.794 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.413 ' HB2' ' CG2' ' A' ' 68' ' ' ILE . . . -92.27 147.21 23.1 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.602 -0.687 . . . . 0.0 109.454 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -103.64 153.18 20.91 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.26 1.029 . . . . 0.0 110.839 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.26 132.61 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.738 0.78 . . . . 0.0 109.548 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.26 155.48 43.87 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.758 0.79 . . . . 0.0 110.038 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -112.6 119.21 37.36 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.613 0.72 . . . . 0.0 109.318 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -121.53 132.76 54.88 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.813 0.816 . . . . 0.0 109.881 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 58.04 23.0 9.52 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.334 0.588 . . . . 0.0 109.979 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.91 6.84 81.85 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -117.53 136.64 53.1 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.509 -0.995 . . . . 0.0 110.254 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.7 mt -75.58 145.19 41.39 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.711 0.767 . . . . 0.0 110.181 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 93.9 p -156.9 160.21 38.89 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.626 0.727 . . . . 0.0 109.914 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.7 mt -104.92 108.76 20.43 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.796 0.807 . . . . 0.0 109.082 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.8 m -88.93 141.21 28.68 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.745 0.783 . . . . 0.0 109.748 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.431 HG11 HD11 ' A' ' 90' ' ' ILE . 41.5 t -121.85 126.87 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.871 0.843 . . . . 0.0 109.7 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.66 173.35 25.81 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.29 -17.97 63.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.777 -0.837 . . . . 0.0 109.029 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.0 m -84.55 -5.76 59.32 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.404 ' OG ' ' CG1' ' A' ' 84' ' ' VAL . 13.5 p -76.87 168.97 19.17 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.599 0.714 . . . . 0.0 110.309 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.415 ' NH2' ' OE2' ' A' ' 91' ' ' GLU . 77.6 ttt180 -121.87 123.53 41.97 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.855 0.836 . . . . 0.0 109.856 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.431 HD11 HG11 ' A' ' 84' ' ' VAL . 96.4 mt -124.22 129.04 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.654 0.74 . . . . 0.0 109.746 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.415 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 97.7 mt-10 -126.03 123.12 37.74 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.797 0.808 . . . . 0.0 110.005 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.6 t -74.17 144.12 44.95 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.309 0.576 . . . . 0.0 109.713 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.2 m -114.21 131.87 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-O 121.929 0.871 . . . . 0.0 110.254 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -75.59 167.53 21.73 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.789 0.804 . . . . 0.0 110.359 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 96' ' ' ASN . 43.4 t 53.36 -101.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.801 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.407 ' N ' HG12 ' A' ' 95' ' ' VAL . 23.3 t-20 -162.96 88.17 0.6 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.685 0.755 . . . . 0.0 109.311 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 62.9 mt 49.62 77.52 0.46 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.874 -0.516 . . . . 0.0 110.141 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -59.67 146.75 94.54 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.501 2.134 . . . . 0.0 112.248 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.8 132.58 49.9 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.852 0.834 . . . . 0.0 110.322 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -67.07 134.71 52.4 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.621 0.724 . . . . 0.0 110.118 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -151.8 133.19 14.58 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.659 0.742 . . . . 0.0 109.882 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -146.11 91.16 2.04 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.71 0.767 . . . . 0.0 109.278 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.506 ' CG ' ' N ' ' A' ' 104' ' ' HIS . 86.4 t60 -155.65 165.27 37.05 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.742 0.782 . . . . 0.0 109.959 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.506 ' N ' ' CG ' ' A' ' 103' ' ' HIS . 85.9 t60 47.78 82.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.534 0.683 . . . . 0.0 109.903 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.423 ' O ' ' O ' ' A' ' 104' ' ' HIS . 84.4 t60 56.7 156.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.756 0.789 . . . . 0.0 110.617 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.202 -0.904 . . . . 0.0 109.168 -179.976 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 67.9 t0 -171.4 133.28 0.81 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.363 -0.836 . . . . 0.0 109.532 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.446 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 49.7 tp -70.89 127.06 31.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 109.609 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.17 162.64 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.548 -0.72 . . . . 0.0 109.57 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -78.31 154.25 31.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.458 -0.776 . . . . 0.0 110.265 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.98 -43.59 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.464 -0.772 . . . . 0.0 109.475 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -66.79 -18.2 65.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.66 2.6 56.36 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.176 -0.952 . . . . 0.0 109.808 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.7 t -67.03 133.69 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.325 -0.859 . . . . 0.0 110.198 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.5 p -158.02 164.93 36.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.571 -0.705 . . . . 0.0 109.515 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.2 mt -63.96 -22.44 66.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.323 -0.861 . . . . 0.0 109.067 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.9 t -58.23 -17.62 20.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.416 -0.803 . . . . 0.0 109.227 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.9 p -126.34 80.25 69.27 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.525 -0.734 . . . . 0.0 109.563 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.02 -39.98 77.87 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.524 2.149 . . . . 0.0 111.749 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -115.02 130.81 57.02 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.6 m -152.01 178.33 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.224 -0.923 . . . . 0.0 110.185 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.4 m -130.23 131.31 45.47 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.4 m -137.5 161.44 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.197 -0.939 . . . . 0.0 110.147 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.4 tt -143.77 146.57 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.381 -0.824 . . . . 0.0 109.408 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.05 -161.53 35.2 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.047 -1.549 . . . . 0.0 110.476 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -104.45 144.76 31.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.674 -0.898 . . . . 0.0 109.572 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 mm -98.73 132.46 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 56.5 p -134.95 158.09 45.2 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.438 -0.789 . . . . 0.0 109.652 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 25' ' ' ILE . . . 96.01 -72.34 0.86 Allowed Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.444 ' O ' ' O ' ' A' ' 24' ' ' GLY . 24.8 mm 50.01 101.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.458 -1.025 . . . . 0.0 110.158 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -129.66 131.25 46.35 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -93.44 133.3 36.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.307 -0.871 . . . . 0.0 109.637 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -146.76 152.4 38.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.417 -0.802 . . . . 0.0 109.284 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -111.31 144.82 39.87 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.725 -0.609 . . . . 0.0 109.372 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -146.15 164.13 33.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.33 -0.857 . . . . 0.0 109.391 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -87.52 142.73 27.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.643 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.4 t -147.08 110.59 4.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.343 -0.848 . . . . 0.0 108.761 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 55.76 31.7 18.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.702 -0.624 . . . . 0.0 109.609 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.55 14.7 75.41 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.2 p -128.15 134.48 49.09 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.371 -1.076 . . . . 0.0 109.609 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.9 m -83.36 128.84 34.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.542 -0.724 . . . . 0.0 109.668 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -136.42 144.44 44.48 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.416 -0.803 . . . . 0.0 109.295 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.1 p -79.78 153.4 29.21 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.238 -0.914 . . . . 0.0 110.211 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -141.83 140.74 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -103.13 131.45 50.13 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.4 -0.813 . . . . 0.0 109.614 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.485 ' OE1' ' NH2' ' A' ' 52' ' ' ARG . 78.0 mt-30 -121.28 153.52 37.57 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.72 -156.72 14.55 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.644 -1.265 . . . . 0.0 109.953 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -137.36 139.98 41.13 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 44' ' ' ILE . 18.0 tt -116.65 131.06 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.344 -0.847 . . . . 0.0 109.322 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -117.67 155.75 29.38 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.376 0.608 . . . . 0.0 109.824 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -141.12 -146.13 0.19 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.805 . . . . 0.0 109.497 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -78.55 -8.37 58.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.411 -0.805 . . . . 0.0 110.743 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.3 p -113.42 -86.61 0.57 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.279 -0.888 . . . . 0.0 110.697 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.69 -147.72 0.36 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.583 -0.698 . . . . 0.0 110.245 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.8 ptt-85 -148.07 156.23 42.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.47 -0.768 . . . . 0.0 110.203 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.8 tt -142.85 150.19 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.33 -0.856 . . . . 0.0 110.177 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.485 ' NH2' ' OE1' ' A' ' 41' ' ' GLN . 76.5 ttt180 -72.5 136.36 45.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.515 -0.741 . . . . 0.0 109.847 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.8 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -138.67 167.67 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.34 -0.85 . . . . 0.0 109.463 179.403 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 97.4 p -147.74 152.79 38.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 0.0 109.756 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.6 p -135.44 124.55 24.4 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -87.98 130.03 35.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.393 -0.817 . . . . 0.0 110.838 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.35 -48.75 1.5 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.547 ' HD3' HD12 ' A' ' 90' ' ' ILE . 99.1 mttt -70.68 136.02 48.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.095 -1.238 . . . . 0.0 110.272 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -95.91 153.94 17.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.522 -0.736 . . . . 0.0 109.879 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.8 mt -128.91 157.03 42.74 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.653 -0.655 . . . . 0.0 109.512 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.445 ' OE1' ' OD2' ' A' ' 64' ' ' ASP . 91.1 mt-30 -117.3 135.25 53.97 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.626 0.727 . . . . 0.0 109.954 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.7 t0 -66.71 136.25 55.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.421 -0.799 . . . . 0.0 110.731 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.52 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 0.8 OUTLIER 80.31 -5.4 1.79 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.818 -0.551 . . . . 0.0 110.799 178.89 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.445 ' OD2' ' OE1' ' A' ' 61' ' ' GLN . 9.8 m-20 -80.8 143.03 33.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.708 -1.245 . . . . 0.0 110.013 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.41 123.81 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.76 160.43 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 110.191 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -122.18 126.17 47.71 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 77.6 mt -110.0 127.43 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -114.88 141.71 47.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.818 -0.551 . . . . 0.0 109.793 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.2 t30 62.91 38.17 11.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.745 -0.597 . . . . 0.0 109.679 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.58 141.92 55.33 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -93.98 121.97 36.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.642 0.734 . . . . 0.0 109.604 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.0 t -82.29 133.12 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.572 -0.705 . . . . 0.0 109.677 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.43 155.49 46.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.495 -0.753 . . . . 0.0 109.066 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -114.42 117.6 31.48 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.538 -0.726 . . . . 0.0 109.346 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -122.2 135.13 54.72 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.718 -0.614 . . . . 0.0 109.383 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 55.09 30.57 14.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.624 -0.672 . . . . 0.0 109.688 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.1 7.22 84.22 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -114.72 135.01 54.64 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.371 -1.076 . . . . 0.0 109.952 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.51 145.85 41.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.589 -0.694 . . . . 0.0 109.984 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.0 p -155.07 161.9 41.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.502 -0.749 . . . . 0.0 109.199 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.4 mt -107.39 127.87 53.96 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.448 -0.782 . . . . 0.0 109.492 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 m -100.58 125.19 46.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.687 -0.633 . . . . 0.0 109.343 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 t -112.4 130.2 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.53 -0.732 . . . . 0.0 109.092 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -153.13 -149.01 5.04 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.45 -42.3 99.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.533 -0.981 . . . . 0.0 110.263 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -60.83 -41.96 96.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.377 -0.827 . . . . 0.0 110.277 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.2 p -78.89 165.93 22.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.265 -0.897 . . . . 0.0 110.44 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -127.38 132.37 50.17 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.547 HD12 ' HD3' ' A' ' 58' ' ' LYS . 81.6 mt -113.34 129.67 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.537 -0.727 . . . . 0.0 109.092 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -132.27 123.34 26.72 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.433 -0.792 . . . . 0.0 109.081 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.1 p -76.65 156.55 32.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.998 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.1 m -136.33 11.83 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.438 -0.789 . . . . 0.0 109.203 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -87.99 3.78 47.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.417 -0.802 . . . . 0.0 109.221 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.0 p -123.47 134.59 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.478 -0.763 . . . . 0.0 109.586 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -64.75 138.32 58.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.474 -0.766 . . . . 0.0 109.881 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.3 pt -131.42 65.68 76.77 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.529 -0.732 . . . . 0.0 109.048 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.22 153.26 51.18 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.816 2.344 . . . . 0.0 112.477 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 93.2 mt -75.52 149.74 38.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.424 -0.797 . . . . 0.0 110.564 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 63.11 59.27 1.33 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.264 0.554 . . . . 0.0 109.604 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -106.8 103.91 13.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.544 -0.722 . . . . 0.0 109.192 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 44.17 73.22 0.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.5 -0.75 . . . . 0.0 109.96 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -148.48 137.76 21.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.368 -0.832 . . . . 0.0 109.83 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.463 ' O ' ' N ' ' A' ' 106' ' ' HIS . 53.3 t-80 -172.08 46.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 105' ' ' HIS . 39.9 t-80 48.39 14.28 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.709 -0.619 . . . . 0.0 109.535 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.463 ' N ' ' O ' ' A' ' 104' ' ' HIS . 78.0 m80 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.39 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 89.5 p . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -81.5 171.46 14.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.551 -0.718 . . . . 0.0 110.613 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.5 tp -77.93 125.48 29.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.467 -0.77 . . . . 0.0 109.951 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.66 161.95 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.491 -0.756 . . . . 0.0 109.777 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -78.81 152.58 31.29 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.633 0.73 . . . . 0.0 110.523 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.9 -42.99 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.378 -0.826 . . . . 0.0 109.416 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -67.5 -18.26 64.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.024 -1.048 . . . . 0.0 109.361 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -90.15 -18.64 25.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.144 -0.972 . . . . 0.0 109.55 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.3 t -52.1 135.59 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.198 -0.939 . . . . 0.0 110.501 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.6 p -153.91 166.82 31.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.585 -0.697 . . . . 0.0 109.337 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 11' ' ' LEU . 3.6 mm? -68.94 -13.59 62.53 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.405 -0.809 . . . . 0.0 109.508 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.3 p -60.66 -31.19 70.42 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.157 -0.964 . . . . 0.0 109.003 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.44 ' OG1' ' CG1' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -122.95 85.33 50.55 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.17 -39.63 70.86 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.477 2.118 . . . . 0.0 112.018 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -106.52 131.64 53.46 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.56 -0.713 . . . . 0.0 109.887 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.44 ' CG1' ' OG1' ' A' ' 13' ' ' THR . 15.5 m -153.13 -177.25 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.353 -0.842 . . . . 0.0 109.716 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.8 m -137.62 137.91 38.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.432 -0.792 . . . . 0.0 109.09 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.3 m -140.44 161.91 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.388 -0.82 . . . . 0.0 109.822 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.447 HD11 ' NE ' ' A' ' 67' ' ' ARG . 86.3 mt -130.43 132.88 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.97 -167.62 37.39 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.054 -1.546 . . . . 0.0 110.017 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.499 ' C ' HD12 ' A' ' 22' ' ' ILE . 50.9 mtpt -113.01 138.11 50.38 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.709 -0.877 . . . . 0.0 109.432 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.762 ' N ' HD12 ' A' ' 22' ' ' ILE . 1.8 mp -97.95 131.33 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.424 -0.798 . . . . 0.0 109.615 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 63' ' ' SER . 79.6 p -133.45 160.31 37.77 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.315 0.579 . . . . 0.0 109.944 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 25' ' ' ILE . . . 100.28 -75.76 0.44 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 24' ' ' GLY . 38.1 mm 58.39 119.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.535 -0.979 . . . . 0.0 110.6 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -145.85 142.41 28.79 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -98.7 130.18 45.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.403 -0.811 . . . . 0.0 109.745 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -141.74 160.76 39.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.361 -0.837 . . . . 0.0 108.952 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 57.9 mp0 -121.84 142.53 50.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.49 -0.756 . . . . 0.0 109.374 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -141.96 160.27 40.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.286 -0.884 . . . . 0.0 108.874 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -90.17 115.65 27.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.982 . . . . 0.0 109.919 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.4 t -110.76 115.14 29.03 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.692 . . . . 0.0 109.214 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 54.38 31.33 14.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.47 -0.769 . . . . 0.0 109.896 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.8 1.8 84.85 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.8 m -117.99 128.69 55.03 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.321 -1.105 . . . . 0.0 109.649 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.1 m -67.99 128.49 36.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 110.381 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -133.1 146.0 51.24 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.43 -0.794 . . . . 0.0 109.58 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.1 m -81.25 144.14 31.78 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.441 -0.787 . . . . 0.0 109.982 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.8 p -136.43 138.96 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.474 -0.766 . . . . 0.0 109.0 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -103.7 131.21 51.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.423 -0.798 . . . . 0.0 108.977 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -124.1 155.76 37.81 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.579 -0.7 . . . . 0.0 109.478 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.38 -160.31 22.93 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -127.59 140.68 51.96 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.605 -0.938 . . . . 0.0 109.62 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.548 ' HB ' HD13 ' A' ' 53' ' ' ILE . 20.4 tt -117.73 136.85 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -134.24 151.47 51.31 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.467 -0.771 . . . . 0.0 109.836 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -144.99 -150.12 0.31 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.645 -0.66 . . . . 0.0 109.368 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 31.7 p-10 -85.72 -1.76 57.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 109.732 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.9 p -103.62 -63.0 1.23 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.175 -0.953 . . . . 0.0 109.556 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -166.47 -149.15 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 109.92 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -140.65 151.86 44.93 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.46 -0.775 . . . . 0.0 109.93 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 tt -149.48 158.93 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.188 -0.945 . . . . 0.0 110.196 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.6 mtp85 -71.93 146.98 47.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.9 . . . . 0.0 109.814 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.702 HD11 HG23 ' A' ' 22' ' ' ILE . 37.0 pt -136.76 150.11 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.399 -0.813 . . . . 0.0 110.235 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 t -142.57 138.21 30.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.531 -0.73 . . . . 0.0 109.135 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.3 t -130.35 133.64 46.57 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.508 -0.745 . . . . 0.0 109.175 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -92.87 123.83 36.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.38 -0.825 . . . . 0.0 111.03 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.08 -55.23 3.13 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -70.95 131.81 44.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.875 -1.368 . . . . 0.0 110.403 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -96.69 155.17 16.89 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.499 -0.75 . . . . 0.0 110.085 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.9 mt -123.16 151.68 41.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -103.59 160.5 14.69 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.645 0.736 . . . . 0.0 110.176 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 63' ' ' SER . 38.8 t70 -66.14 150.15 49.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.658 -0.651 . . . . 0.0 111.24 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 22' ' ' ILE . 11.1 p 37.57 42.56 0.37 Allowed 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.31 0.576 . . . . 0.0 110.439 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -90.69 120.1 31.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.229 -0.919 . . . . 0.0 110.031 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.78 110.49 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.5 m -143.78 168.32 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.126 -0.984 . . . . 0.0 110.109 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.447 ' NE ' HD11 ' A' ' 19' ' ' ILE . 41.5 ttm180 -118.21 124.37 47.76 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.3 mt -103.7 126.13 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -117.54 141.18 48.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.742 -0.599 . . . . 0.0 109.783 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.3 t30 65.47 37.57 6.06 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.47 0.653 . . . . 0.0 109.837 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.76 137.94 46.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.134 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -86.65 121.19 28.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.537 -0.727 . . . . 0.0 109.96 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.2 t -83.49 133.93 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.458 -0.776 . . . . 0.0 109.586 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -136.57 154.94 50.55 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.284 -0.885 . . . . 0.0 109.449 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -115.49 111.59 20.97 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -116.14 125.96 53.04 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.505 -0.747 . . . . 0.0 109.936 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 55.26 33.25 20.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.639 -0.663 . . . . 0.0 110.13 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.26 3.24 88.4 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -111.05 133.63 53.28 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.344 -1.092 . . . . 0.0 109.954 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.2 mt -76.72 148.76 36.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.499 -0.751 . . . . 0.0 110.514 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.0 p -152.99 158.66 42.37 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.1 mt -111.55 126.52 55.07 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.282 -0.886 . . . . 0.0 109.379 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.4 m -107.68 123.55 48.68 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.5 t -99.15 112.0 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.266 -0.897 . . . . 0.0 109.47 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.24 -173.05 31.25 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.62 -35.41 80.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.589 -0.948 . . . . 0.0 109.527 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.0 t -66.84 -16.77 64.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 0.0 109.655 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.9 m -74.98 159.42 31.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 110.141 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.1 ttt85 -124.0 134.51 53.44 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.663 -0.648 . . . . 0.0 109.337 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.02 131.9 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.683 -0.636 . . . . 0.0 109.527 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -122.28 130.18 52.91 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.6 0.715 . . . . 0.0 109.286 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.4 p -70.6 147.0 49.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.503 -0.748 . . . . 0.0 110.287 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.2 t -126.78 132.55 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.591 -0.693 . . . . 0.0 109.666 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.508 ' CG ' ' H ' ' A' ' 95' ' ' VAL . 61.6 t30 63.99 -167.47 0.21 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.442 0.639 . . . . 0.0 110.645 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.508 ' H ' ' CG ' ' A' ' 94' ' ' ASN . 9.0 p -102.67 129.94 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.453 -0.779 . . . . 0.0 109.921 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 97' ' ' ILE . 19.1 p30 -102.92 -152.58 0.45 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.522 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 35.1 mm -112.85 81.26 4.35 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.435 -0.791 . . . . 0.0 109.754 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.84 156.15 61.06 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.279 1.986 . . . . 0.0 112.154 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.499 HD22 ' N ' ' A' ' 99' ' ' LEU . 4.0 mm? 43.27 72.87 0.16 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.775 0.798 . . . . 0.0 110.044 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 102' ' ' HIS . 18.2 pt-20 -101.71 6.57 41.91 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 102' ' ' HIS . 58.0 t-80 -46.02 97.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.941 . . . . 0.0 110.035 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 101' ' ' HIS . 97.3 m-70 41.65 -166.88 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.625 0.726 . . . . 0.0 111.049 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -153.71 138.29 16.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 109.704 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.461 ' CD2' ' O ' ' A' ' 104' ' ' HIS . 56.7 p-80 -171.73 50.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -67.27 -39.76 86.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.562 -0.711 . . . . 0.0 109.753 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.0 t60 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.759 -179.586 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.7 p . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.218 0.533 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -172.94 147.7 1.68 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.324 -0.86 . . . . 0.0 109.433 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.606 HD22 ' N ' ' A' ' 3' ' ' LEU . 4.0 mm? -81.94 130.0 34.94 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.378 -0.826 . . . . 0.0 110.248 -178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.79 163.87 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.576 -0.703 . . . . 0.0 109.647 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.61 156.46 27.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.418 -0.801 . . . . 0.0 110.622 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.45 -43.13 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 0.0 109.535 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -67.34 -14.75 63.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.014 -1.054 . . . . 0.0 109.795 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -89.7 -0.03 57.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 109.159 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.11 132.68 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 110.056 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.4 t -158.73 170.25 22.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.358 -0.839 . . . . 0.0 109.619 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.497 HD22 ' N ' ' A' ' 11' ' ' LEU . 3.7 mm? -64.4 -35.45 80.95 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.438 -0.789 . . . . 0.0 109.285 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.7 p -57.96 -20.47 38.15 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.742 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 p -113.32 79.19 3.75 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.348 -0.845 . . . . 0.0 108.885 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.9 -24.91 39.36 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.254 1.969 . . . . 0.0 112.384 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -125.57 110.1 13.45 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.467 -0.77 . . . . 0.0 109.018 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.8 m -141.65 162.09 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.233 -0.917 . . . . 0.0 110.307 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 t -117.25 135.49 53.77 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.7 m -136.14 161.33 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.278 -0.888 . . . . 0.0 110.171 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.3 tt -139.4 140.74 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.401 -0.812 . . . . 0.0 109.341 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.33 -166.04 36.81 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 118.959 -1.591 . . . . 0.0 110.13 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -106.38 131.08 54.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.557 -0.967 . . . . 0.0 109.625 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.493 HG21 HD11 ' A' ' 25' ' ' ILE . 96.3 mt -102.58 133.7 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.575 -0.703 . . . . 0.0 109.839 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.453 ' HA ' ' H ' ' A' ' 63' ' ' SER . 30.3 p -135.47 159.6 41.09 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.335 0.588 . . . . 0.0 109.672 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.29 -84.08 0.99 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.493 HD11 HG21 ' A' ' 22' ' ' ILE . 49.5 mm 56.12 107.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.536 -0.979 . . . . 0.0 110.421 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -129.27 138.54 51.7 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -90.48 136.51 33.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 110.372 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -148.66 151.28 34.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.378 -0.826 . . . . 0.0 108.907 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -117.86 144.74 45.14 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.352 -0.842 . . . . 0.0 110.063 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.405 ' N ' ' CD1' ' A' ' 30' ' ' TYR . 10.0 p90 -144.69 162.32 37.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.333 -0.854 . . . . 0.0 109.822 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -80.96 141.64 34.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.42 -0.8 . . . . 0.0 109.823 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.3 t -144.87 106.37 4.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.136 -0.978 . . . . 0.0 109.511 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.5 t0 57.96 33.41 23.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.422 -0.799 . . . . 0.0 110.329 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.66 6.0 87.68 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 92.4 m -126.62 127.44 45.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.372 -1.075 . . . . 0.0 109.31 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.0 m -73.0 134.41 44.66 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.221 -0.924 . . . . 0.0 110.042 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -131.82 143.4 50.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.428 -0.795 . . . . 0.0 109.054 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 86.8 p -87.27 146.07 26.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.214 -0.929 . . . . 0.0 109.813 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.91 140.26 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.384 -0.823 . . . . 0.0 109.547 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -104.82 130.49 52.93 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -121.35 152.77 38.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.454 -0.778 . . . . 0.0 109.417 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.09 -169.23 33.84 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -123.11 138.97 54.53 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.617 -0.931 . . . . 0.0 109.235 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 tt -118.1 143.18 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -133.33 153.21 51.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.574 -0.704 . . . . 0.0 109.621 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.53 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 40.4 t0 -149.17 -164.01 1.92 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.373 -0.83 . . . . 0.0 108.942 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.53 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 60.2 t0 -64.32 -33.75 76.56 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.442 -0.786 . . . . 0.0 109.295 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 p -77.31 -86.9 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 110.281 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.06 -147.06 0.2 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.344 -0.848 . . . . 0.0 110.233 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -143.9 157.96 44.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.475 -0.766 . . . . 0.0 109.454 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.2 tt -153.77 161.52 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.953 -1.092 . . . . 0.0 110.326 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -73.82 145.29 45.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.556 -0.715 . . . . 0.0 109.749 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.4 pt -135.24 152.98 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.198 -0.939 . . . . 0.0 109.499 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.6 p -142.31 129.69 21.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.183 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 t -113.94 121.0 42.58 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -96.27 121.12 37.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.322 -0.861 . . . . 0.0 110.72 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.46 -44.68 2.94 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -78.05 138.77 38.96 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.99 -1.3 . . . . 0.0 110.303 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -94.08 151.76 19.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -0.824 . . . . 0.0 109.923 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.15 157.21 43.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.565 -0.709 . . . . 0.0 109.331 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -112.09 136.89 50.88 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.518 0.675 . . . . 0.0 109.687 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -64.65 142.75 58.32 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.884 0.85 . . . . 0.0 111.222 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.453 ' H ' ' HA ' ' A' ' 23' ' ' THR . 11.1 t 58.34 81.19 0.16 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.65 0.738 . . . . 0.0 110.268 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -162.69 126.67 3.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.522 -0.736 . . . . 0.0 110.12 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 t -78.12 120.12 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.389 -0.819 . . . . 0.0 109.444 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.43 163.78 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.465 -0.772 . . . . 0.0 109.823 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.4 ttp85 -119.23 128.23 54.0 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.1 mt -107.38 129.32 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.402 -0.811 . . . . 0.0 109.382 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 66.5 t0 -114.64 142.11 46.9 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.544 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 64.6 t30 63.3 40.58 8.5 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.345 0.593 . . . . 0.0 109.918 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.45 148.87 42.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.334 -0.854 . . . . 0.0 109.417 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -100.87 125.53 47.41 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.565 0.698 . . . . 0.0 109.729 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.9 t -89.19 135.28 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.369 -0.832 . . . . 0.0 110.038 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.74 157.0 43.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 0.0 108.889 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -113.36 116.92 30.44 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.454 -0.779 . . . . 0.0 109.44 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -125.94 138.69 53.78 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.425 -0.797 . . . . 0.0 110.094 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 57.04 23.5 8.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.665 -0.647 . . . . 0.0 109.484 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.08 7.88 88.19 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -118.21 137.76 52.79 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.546 -0.973 . . . . 0.0 109.898 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.1 mt -77.12 148.52 35.98 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.425 -0.797 . . . . 0.0 110.212 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.9 p -155.04 161.67 41.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.317 -0.864 . . . . 0.0 109.016 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.4 mt -106.32 125.59 51.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.426 -0.796 . . . . 0.0 109.246 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.9 m -105.66 123.34 47.76 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.5 t -98.97 114.13 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.301 -0.874 . . . . 0.0 108.997 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.57 -177.42 37.02 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -67.42 -27.31 66.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.598 -0.942 . . . . 0.0 109.611 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.1 m -78.8 -6.51 56.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.148 -0.97 . . . . 0.0 109.487 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.7 m -83.66 165.59 18.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.041 -1.037 . . . . 0.0 109.841 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.75 141.05 51.69 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.435 -0.791 . . . . 0.0 109.318 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.03 130.98 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.563 -0.71 . . . . 0.0 109.609 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -123.72 116.32 22.84 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.9 m -77.54 140.2 39.7 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.35 -0.844 . . . . 0.0 110.099 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.2 m -129.75 130.75 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.546 -0.721 . . . . 0.0 109.29 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -105.44 -40.36 5.83 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 96' ' ' ASN . 2.1 t -148.2 -139.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.224 -0.922 . . . . 0.0 109.766 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.545 ' H ' HG12 ' A' ' 95' ' ' VAL . 17.3 m120 -80.83 -77.08 0.21 Allowed 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.521 0.676 . . . . 0.0 109.418 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.8 pt -144.18 70.84 16.34 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.203 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -77.26 -7.14 16.96 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.438 2.092 . . . . 0.0 110.793 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.0 tp -84.42 128.37 34.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.392 -0.817 . . . . 0.0 110.082 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -153.34 1.41 0.26 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -66.37 -40.95 90.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.368 -0.832 . . . . 0.0 109.816 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -108.53 131.41 54.86 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.398 -0.814 . . . . 0.0 109.7 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.526 ' CG ' ' N ' ' A' ' 104' ' ' HIS . 85.6 t60 -150.24 166.46 29.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.275 -0.89 . . . . 0.0 109.769 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.526 ' N ' ' CG ' ' A' ' 103' ' ' HIS . 86.0 t60 51.18 9.23 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 109.48 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.493 ' H ' ' C ' ' A' ' 103' ' ' HIS . 72.0 m80 -134.96 145.28 47.99 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.353 -0.842 . . . . 0.0 109.699 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.142 -0.932 . . . . 0.0 108.755 179.771 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.2 p . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.74 0.781 . . . . 0.0 108.928 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.3 p30 -83.43 170.94 13.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.363 -0.835 . . . . 0.0 110.489 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.7 tp -81.58 128.48 33.97 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.415 -0.803 . . . . 0.0 109.956 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.01 162.87 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-O 121.719 0.771 . . . . 0.0 110.165 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -77.18 159.47 29.68 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.796 0.808 . . . . 0.0 110.354 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.8 mm -63.78 -42.91 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 121.701 0.762 . . . . 0.0 109.887 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -66.07 -18.08 65.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.193 -0.942 . . . . 0.0 110.486 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 8' ' ' ASP . 59.2 t0 -86.45 -1.79 57.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.858 -1.151 . . . . 0.0 109.384 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 87.1 t -66.29 133.3 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.338 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.4 p -156.16 167.44 30.41 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.508 -0.745 . . . . 0.0 109.357 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.5 -34.96 79.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.821 . . . . 0.0 109.309 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.6 p -56.84 -19.4 17.23 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 109.475 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 13' ' ' THR . 11.1 p -115.23 81.07 7.82 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.835 . . . . 0.0 109.248 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -71.92 -16.08 29.36 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.598 2.199 . . . . 0.0 111.288 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -128.66 110.07 11.89 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.4 m -145.44 161.68 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.357 -0.84 . . . . 0.0 110.397 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.3 t -116.55 136.96 52.55 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.61 160.29 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 121.894 0.854 . . . . 0.0 110.256 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.3 tt -144.36 133.73 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.682 -0.636 . . . . 0.0 109.606 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.82 -162.55 30.33 Favored Glycine 0 N--CA 1.487 2.051 0 C-N-CA 119.693 -1.241 . . . . 0.0 110.019 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -105.98 134.79 48.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.708 -0.878 . . . . 0.0 109.985 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 63' ' ' SER . 97.0 mt -103.64 130.64 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.527 0.679 . . . . 0.0 110.086 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 p -134.15 163.31 29.88 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.49 0.662 . . . . 0.0 109.371 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.479 ' N ' ' OD1' ' A' ' 62' ' ' ASP . . . 97.03 -76.74 0.68 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 24' ' ' GLY . 36.9 mm 57.91 120.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 122.039 0.923 . . . . 0.0 110.405 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -143.63 138.97 29.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.451 -0.781 . . . . 0.0 108.986 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -104.36 130.3 52.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.481 -0.762 . . . . 0.0 109.919 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -144.34 165.29 28.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.545 -0.722 . . . . 0.0 109.402 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -120.57 146.57 46.2 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.593 -0.692 . . . . 0.0 110.008 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -142.6 163.16 33.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 109.85 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.536 ' N ' ' OE1' ' A' ' 31' ' ' GLU . 57.0 mp0 -88.04 114.16 24.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.528 -0.733 . . . . 0.0 109.721 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.8 t -110.77 107.29 16.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.493 -0.755 . . . . 0.0 109.758 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 54.7 t0 54.79 28.56 10.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.533 -0.73 . . . . 0.0 110.526 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.88 8.18 67.55 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.4 m -123.11 127.51 48.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.409 -1.053 . . . . 0.0 109.11 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.9 m -72.83 131.05 41.79 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.392 -0.818 . . . . 0.0 110.402 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -136.89 146.61 45.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.473 -0.767 . . . . 0.0 109.529 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 99.8 p -81.43 148.6 29.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.401 -0.812 . . . . 0.0 110.343 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.32 138.3 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 109.678 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.498 ' CD1' ' O ' ' A' ' 58' ' ' LYS . 83.7 m-85 -104.35 132.72 50.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.447 -0.783 . . . . 0.0 109.481 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -129.2 156.64 43.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.634 -0.666 . . . . 0.0 109.457 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.55 -165.32 31.97 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.045 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -120.36 143.89 48.17 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.698 -0.883 . . . . 0.0 109.798 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 tt -131.85 134.37 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -139.45 155.02 47.85 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.855 0.836 . . . . 0.0 110.553 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.547 ' O ' ' C ' ' A' ' 47' ' ' ASP . 41.8 p-10 -152.89 99.47 2.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.432 -0.792 . . . . 0.0 109.385 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.547 ' C ' ' O ' ' A' ' 46' ' ' ASP . 29.5 p-10 13.72 57.94 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.736 0 CA-C-O 122.169 0.985 . . . . 0.0 110.944 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 46' ' ' ASP . 8.2 m -168.7 -55.6 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -173.39 -167.93 0.42 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.367 -0.833 . . . . 0.0 109.397 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -139.05 149.98 45.24 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.632 0.73 . . . . 0.0 110.482 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.8 tt -147.24 152.81 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.33 -0.856 . . . . 0.0 109.687 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.435 HH21 ' HB2' ' A' ' 79' ' ' TYR . 81.0 mtm-85 -77.53 147.57 35.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.521 -0.737 . . . . 0.0 109.856 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.0 pt -132.48 158.3 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.617 -0.677 . . . . 0.0 109.907 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 t -147.14 127.73 14.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 p -122.89 138.7 54.59 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.477 0.656 . . . . 0.0 109.613 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -97.8 118.15 33.71 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.679 0.752 . . . . 0.0 111.527 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.09 -19.66 1.69 Allowed Glycine 0 N--CA 1.496 2.671 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.608 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.498 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 68.8 mttm -83.63 137.82 33.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.689 -1.477 . . . . 0.0 110.484 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -96.6 140.73 30.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.602 -0.687 . . . . 0.0 110.159 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.1 mt -130.18 153.32 48.67 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.598 -0.689 . . . . 0.0 109.381 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -113.33 155.31 25.4 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.653 0.74 . . . . 0.0 109.893 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 7.7 m-20 -70.78 148.3 48.05 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.92 0.867 . . . . 0.0 110.995 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 22' ' ' ILE . 1.8 m 53.34 32.98 14.68 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.779 0.8 . . . . 0.0 109.409 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -96.84 114.57 26.21 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.353 -0.842 . . . . 0.0 110.573 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.443 HG22 ' H ' ' A' ' 65' ' ' VAL . 1.5 m -84.08 117.14 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.343 -0.848 . . . . 0.0 109.889 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.9 m -148.45 175.12 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.501 0.667 . . . . 0.0 109.541 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -122.68 132.26 54.18 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.55 125.28 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.597 -0.689 . . . . 0.0 109.477 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -111.21 152.38 27.16 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 59.57 35.23 22.57 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.708 0.766 . . . . 0.0 109.664 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.65 143.97 56.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.51 -0.744 . . . . 0.0 109.442 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -105.62 118.57 36.93 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.935 0.874 . . . . 0.0 109.572 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -88.91 131.44 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.425 -0.797 . . . . 0.0 110.124 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.46 157.58 41.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.394 -0.816 . . . . 0.0 109.015 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -100.75 125.45 47.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.455 -0.778 . . . . 0.0 109.655 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.415 ' O ' ' N ' ' A' ' 78' ' ' GLY . 69.8 m-85 -115.52 133.18 56.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.61 -0.681 . . . . 0.0 109.354 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m120 67.89 -63.23 0.32 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.627 0.727 . . . . 0.0 109.844 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 76' ' ' PHE . . . 176.43 29.15 0.04 OUTLIER Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.435 ' HB2' HH21 ' A' ' 52' ' ' ARG . 31.5 p90 -146.82 155.43 42.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.292 -1.122 . . . . 0.0 109.837 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.8 mt -83.06 145.65 29.15 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.77 0.795 . . . . 0.0 110.974 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.1 t -157.8 163.72 37.75 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 70.7 mt -101.15 130.22 47.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.165 -0.959 . . . . 0.0 109.694 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.6 m -109.88 122.6 47.91 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.665 0.745 . . . . 0.0 109.319 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.6 t -98.62 110.04 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.826 0.822 . . . . 0.0 109.11 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.13 -174.85 40.8 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -71.22 -19.23 62.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.553 -0.969 . . . . 0.0 110.34 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -84.55 -8.83 58.78 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.711 -1.243 . . . . 0.0 109.057 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.8 t -79.34 162.63 25.46 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.395 -0.816 . . . . 0.0 110.434 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -129.66 136.37 49.64 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.594 -0.691 . . . . 0.0 109.384 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.84 130.46 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -120.53 132.19 55.06 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.701 0.762 . . . . 0.0 109.128 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.0 m -74.31 147.85 41.91 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.383 0.611 . . . . 0.0 110.525 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.9 t -120.88 132.06 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 94' ' ' ASN . 48.7 p30 -89.92 146.25 24.54 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.651 0.739 . . . . 0.0 110.079 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.7 t -83.36 -77.01 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-O 121.594 0.711 . . . . 0.0 109.137 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -154.42 105.77 2.69 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.313 -0.867 . . . . 0.0 109.848 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 66.8 mt 42.39 76.86 0.48 Allowed Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.543 -0.723 . . . . 0.0 110.325 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.05 144.78 99.23 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.918 2.412 . . . . 0.0 112.569 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.611 HD23 ' O ' ' A' ' 99' ' ' LEU . 2.4 tt -63.04 -43.58 98.27 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.285 -0.884 . . . . 0.0 109.187 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -57.95 135.35 56.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.237 -0.914 . . . . 0.0 109.8 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -107.49 135.36 49.09 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.834 0.826 . . . . 0.0 109.834 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -57.3 -76.01 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.835 0.826 . . . . 0.0 110.141 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.4 ' O ' ' C ' ' A' ' 104' ' ' HIS . 33.9 m-70 51.82 20.67 1.22 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -0.909 . . . . 0.0 109.044 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 103' ' ' HIS . 71.2 m80 42.99 -111.52 0.18 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.638 -0.664 . . . . 0.0 109.717 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -126.58 1.75 6.86 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.171 -0.956 . . . . 0.0 109.367 179.846 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.494 ' H2 ' ' C ' ' A' ' 16' ' ' VAL . 29.2 m . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.55 0.69 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 65.9 t0 -66.28 145.62 55.54 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.691 0.758 . . . . 0.0 110.313 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.545 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 42.8 tp -70.92 121.78 18.76 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.551 0.691 . . . . 0.0 110.097 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.1 m -137.78 163.65 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 121.582 0.706 . . . . 0.0 109.939 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -76.03 156.85 33.62 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.587 0.708 . . . . 0.0 110.26 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.84 -43.41 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.563 -0.71 . . . . 0.0 109.728 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.491 ' HE ' ' HB2' ' A' ' 49' ' ' ALA . 95.0 mtt180 -62.62 -24.84 67.79 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.403 -0.811 . . . . 0.0 110.382 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -82.62 -0.21 46.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.549 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.2 t -65.76 131.54 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.371 -0.831 . . . . 0.0 110.539 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 99.1 p -160.31 169.3 23.44 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.685 0.755 . . . . 0.0 109.535 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.74 -33.89 76.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.766 . . . . 0.0 109.823 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -59.74 -18.59 44.04 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.243 -0.91 . . . . 0.0 109.271 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.48 ' O ' HG21 ' A' ' 73' ' ' VAL . 13.6 p -111.45 80.13 2.54 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.65 -23.19 36.72 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.383 2.055 . . . . 0.0 111.744 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.464 ' C ' ' N ' ' A' ' 1' ' ' SER . 64.0 m-85 -126.22 110.08 13.04 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.494 ' C ' ' H2 ' ' A' ' 1' ' ' SER . 21.9 m -138.15 162.62 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.589 -0.695 . . . . 0.0 110.353 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 t -125.67 134.85 51.7 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.5 m -139.88 162.24 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 121.579 0.704 . . . . 0.0 110.303 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.3 tt -137.98 139.48 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.58 -0.7 . . . . 0.0 109.647 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.76 -162.94 29.85 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.661 -1.257 . . . . 0.0 109.993 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -106.15 144.4 32.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.749 -0.854 . . . . 0.0 109.491 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 25' ' ' ILE . 17.5 mm -94.2 130.59 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.302 0.573 . . . . 0.0 110.427 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.2 p -138.42 156.93 47.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.468 -0.77 . . . . 0.0 110.479 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.08 65.84 2.74 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 22' ' ' ILE . 21.8 mm -80.21 128.15 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -1.12 . . . . 0.0 110.242 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -134.66 140.93 46.39 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -104.53 134.65 47.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.644 -0.66 . . . . 0.0 109.884 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -140.61 162.73 34.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.645 -0.66 . . . . 0.0 109.716 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -125.76 140.1 52.97 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.754 -0.591 . . . . 0.0 109.72 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -140.38 159.01 43.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.455 -0.778 . . . . 0.0 109.586 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -86.98 111.19 20.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.575 -0.703 . . . . 0.0 109.752 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 p -112.81 119.78 39.19 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.524 0.678 . . . . 0.0 109.807 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.9 t0 55.23 29.71 13.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.619 -0.676 . . . . 0.0 109.916 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.52 5.82 86.45 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.8 m -124.87 128.74 49.13 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.447 -1.031 . . . . 0.0 109.613 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 33.2 m -66.77 130.4 43.03 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.645 -0.659 . . . . 0.0 110.3 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -132.18 143.0 49.65 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.833 0.825 . . . . 0.0 109.612 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.6 t -78.25 145.36 35.51 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.425 0.631 . . . . 0.0 110.137 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.79 137.71 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.6 -0.688 . . . . 0.0 109.303 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -103.76 132.7 49.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.72 -0.613 . . . . 0.0 109.456 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -125.41 149.05 48.54 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.7 -165.51 29.84 Favored Glycine 0 N--CA 1.485 1.956 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.139 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -123.28 142.85 50.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.836 -0.802 . . . . 0.0 109.398 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.41 ' HB ' HD13 ' A' ' 53' ' ' ILE . 19.6 tt -120.39 144.34 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -131.16 150.42 52.15 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.613 0.72 . . . . 0.0 110.162 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 41.4 t0 -151.76 -166.66 2.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.587 -0.695 . . . . 0.0 109.391 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.527 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 47.6 t0 -70.29 -9.94 57.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 109.938 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.3 p -94.72 -71.31 0.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 109.625 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.491 ' HB2' ' HE ' ' A' ' 7' ' ' ARG . . . -162.22 -141.13 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.396 -0.815 . . . . 0.0 109.49 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -143.42 151.82 40.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.446 -0.784 . . . . 0.0 109.976 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.6 tt -151.9 161.44 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.712 . . . . 0.0 110.158 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -74.11 147.26 42.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.492 -0.755 . . . . 0.0 109.628 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.41 HD13 ' HB ' ' A' ' 44' ' ' ILE . 43.0 pt -136.07 154.5 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.482 -0.761 . . . . 0.0 110.042 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.0 t -145.67 131.14 18.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.528 -0.733 . . . . 0.0 109.325 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.9 t -120.39 134.95 55.18 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.459 0.647 . . . . 0.0 109.435 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -95.8 122.14 38.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.518 -0.739 . . . . 0.0 111.021 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.53 -44.45 0.47 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.4 ttmm -79.01 130.99 36.12 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.168 -1.195 . . . . 0.0 110.678 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -91.89 164.59 13.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.51 0.671 . . . . 0.0 110.462 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.6 mt -126.9 157.74 38.59 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -105.8 133.85 49.86 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.327 1.061 . . . . 0.0 110.223 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -69.92 143.89 52.6 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.627 -0.67 . . . . 0.0 111.153 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.5 t 65.12 4.57 2.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -90.81 134.95 34.05 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.478 -0.764 . . . . 0.0 109.942 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.0 t -86.85 121.58 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.59 159.97 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.586 0.708 . . . . 0.0 109.876 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -123.75 125.08 44.11 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.2 mt -99.14 128.05 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -112.53 138.53 49.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.5 t30 62.54 39.24 11.83 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.334 0.587 . . . . 0.0 109.708 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.08 148.41 51.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.417 -0.802 . . . . 0.0 109.605 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -99.57 121.07 40.66 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.736 0.779 . . . . 0.0 109.882 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 13' ' ' THR . 84.6 t -80.87 133.75 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.609 -0.682 . . . . 0.0 109.874 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.44 155.54 42.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.397 -0.814 . . . . 0.0 109.509 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -114.09 119.14 36.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.766 -0.584 . . . . 0.0 109.621 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -118.27 126.2 51.67 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.507 0.67 . . . . 0.0 109.738 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 55.63 32.98 20.31 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.454 0.645 . . . . 0.0 110.196 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.15 6.05 89.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.73 133.9 55.08 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.385 -1.068 . . . . 0.0 110.022 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.9 mt -77.54 145.96 36.6 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.484 0.659 . . . . 0.0 110.117 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.8 p -154.34 160.27 41.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.531 -0.73 . . . . 0.0 109.353 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.4 mt -105.58 118.9 37.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.594 -0.692 . . . . 0.0 109.406 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.7 m -98.32 126.89 44.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.672 -0.642 . . . . 0.0 109.403 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 t -103.67 109.44 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.541 -0.725 . . . . 0.0 109.608 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -96.59 -176.24 35.55 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -68.24 -17.01 64.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.515 -0.991 . . . . 0.0 109.605 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 96.8 p -83.08 -9.41 59.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 109.107 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.7 t -88.5 167.85 13.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.457 -0.777 . . . . 0.0 110.14 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.5 tpt85 -132.44 135.05 45.81 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.6 mt -115.65 130.78 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.795 -0.566 . . . . 0.0 109.722 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -119.0 122.3 41.88 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.393 0.616 . . . . 0.0 109.661 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.2 m -80.8 149.16 29.71 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.418 0.628 . . . . 0.0 110.298 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.25 40.14 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -149.16 102.88 3.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.426 -0.796 . . . . 0.0 109.131 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.2 t -63.38 -110.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.624 -0.672 . . . . 0.0 110.828 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 57.63 34.82 25.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.639 -0.663 . . . . 0.0 109.939 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.639 ' O ' HG23 ' A' ' 97' ' ' ILE . 17.4 tt -134.33 55.36 14.54 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.617 -0.677 . . . . 0.0 109.506 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 97' ' ' ILE . 40.3 Cg_endo -68.0 152.57 76.65 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.452 2.101 . . . . 0.0 112.843 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.39 141.97 48.71 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.534 0.683 . . . . 0.0 109.915 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -79.02 139.65 38.13 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.597 0.713 . . . . 0.0 110.414 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -154.7 -69.44 0.13 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -75.83 142.95 42.11 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.739 0.781 . . . . 0.0 110.382 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.6 m80 43.97 -167.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.613 0.721 . . . . 0.0 110.778 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -150.55 163.99 37.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.485 -0.759 . . . . 0.0 109.801 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -78.35 130.18 35.86 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.724 0.774 . . . . 0.0 110.202 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.408 ' OXT' ' CG ' ' A' ' 106' ' ' HIS . 84.3 t60 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 117.949 -1.024 . . . . 0.0 108.988 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.3 p . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -75.8 163.22 27.47 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.68 0.752 . . . . 0.0 110.451 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.6 tp -79.93 124.42 28.66 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.562 -0.711 . . . . 0.0 109.878 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.99 163.46 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.443 -0.786 . . . . 0.0 109.724 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -76.16 159.43 30.7 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.683 0.754 . . . . 0.0 110.218 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.1 -42.9 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.527 -0.733 . . . . 0.0 110.037 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 -67.13 -18.52 65.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.903 -1.123 . . . . 0.0 109.617 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -83.57 -2.05 55.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.09 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.7 t -66.69 132.22 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 110.362 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 m -156.45 167.37 30.64 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.517 -0.74 . . . . 0.0 109.392 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.91 -37.65 88.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.338 -0.851 . . . . 0.0 109.716 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 93.8 p -54.71 -22.2 13.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.973 . . . . 0.0 109.31 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.417 ' O ' ' OG1' ' A' ' 13' ' ' THR . 10.7 p -113.03 80.9 4.3 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.75 -21.87 24.56 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.258 1.972 . . . . 0.0 111.673 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -125.26 109.98 13.48 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.399 0.619 . . . . 0.0 109.459 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.8 m -147.16 162.03 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.148 -0.97 . . . . 0.0 110.143 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.2 m -115.0 135.68 53.96 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.46 161.35 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.327 -0.858 . . . . 0.0 110.001 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.2 tt -138.5 137.51 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.377 -0.827 . . . . 0.0 109.711 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.36 -165.06 27.12 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 119.567 -1.301 . . . . 0.0 109.876 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -105.46 126.85 52.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.652 -0.91 . . . . 0.0 109.069 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.8 mm -83.32 129.51 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-O 121.495 0.664 . . . . 0.0 110.313 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 44.5 p -140.04 163.7 31.99 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.697 0.761 . . . . 0.0 110.035 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.35 89.71 0.01 OUTLIER Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.5 mm -99.61 126.05 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -1.118 . . . . 0.0 109.416 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -131.13 132.36 44.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -98.81 131.52 44.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.431 -0.793 . . . . 0.0 109.547 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -133.71 153.21 51.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.531 -0.731 . . . . 0.0 109.405 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -119.64 139.81 51.62 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.481 0.658 . . . . 0.0 109.799 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -142.0 161.16 38.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.292 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -90.36 99.18 12.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.959 . . . . 0.0 109.157 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.602 ' O ' ' N ' ' A' ' 34' ' ' GLY . 5.3 p -81.27 -156.5 0.15 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.484 -0.76 . . . . 0.0 110.073 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -48.28 82.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.53 0.681 . . . . 0.0 110.142 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 52.8 11.73 1.42 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.3 m -135.59 133.37 38.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.222 -1.163 . . . . 0.0 110.001 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.6 m -75.49 129.68 37.66 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.458 -0.776 . . . . 0.0 109.651 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -133.16 145.87 51.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.378 -0.826 . . . . 0.0 109.745 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.6 p -86.18 148.11 25.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.505 -0.747 . . . . 0.0 110.087 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 p -137.9 137.59 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.517 ' CZ ' ' OE1' ' A' ' 59' ' ' GLN . 88.3 m-85 -103.5 135.09 45.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.482 -0.761 . . . . 0.0 109.64 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -125.07 155.22 40.15 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.94 -167.29 34.62 Favored Glycine 0 N--CA 1.482 1.745 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -126.74 141.84 51.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.587 -0.949 . . . . 0.0 109.529 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.7 tt -114.55 143.68 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.45 ' OE2' ' O ' ' A' ' 49' ' ' ALA . 10.1 tp10 -130.46 149.14 52.27 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.582 0.706 . . . . 0.0 109.694 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.517 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 42.7 t0 -148.26 -164.39 2.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.464 -0.772 . . . . 0.0 109.478 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.517 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 96.7 m-20 -73.79 -17.06 61.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 109.657 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.1 m -92.94 -73.82 0.54 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.188 -0.945 . . . . 0.0 109.795 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.45 ' O ' ' OE2' ' A' ' 45' ' ' GLU . . . -154.15 -157.0 0.73 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.727 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -137.76 156.67 47.73 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.497 -0.752 . . . . 0.0 110.229 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 tt -151.4 159.41 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.268 -0.895 . . . . 0.0 110.3 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -76.15 144.26 40.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.858 . . . . 0.0 109.689 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -130.37 157.37 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.777 0.799 . . . . 0.0 110.245 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.2 t -143.61 134.87 25.85 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.8 t -127.57 131.68 49.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.262 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -102.17 123.25 45.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.441 -0.787 . . . . 0.0 111.011 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.66 -51.17 3.01 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.481 ' NZ ' ' O ' ' A' ' 88' ' ' SER . 98.6 mttt -63.93 135.72 56.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.098 -1.237 . . . . 0.0 110.58 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.517 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 69.8 tp60 -85.16 149.58 25.42 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.688 0.756 . . . . 0.0 110.52 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.2 mt -130.58 157.18 43.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -124.63 148.98 47.58 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.806 0.812 . . . . 0.0 110.051 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.2 p-10 -67.17 146.53 54.13 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.102 0.954 . . . . 0.0 111.377 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.3 p 47.16 81.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.631 0.729 . . . . 0.0 110.384 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -151.79 124.78 8.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.39 -0.819 . . . . 0.0 110.205 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 t -79.63 114.59 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.352 -0.842 . . . . 0.0 109.266 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.14 163.65 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.494 -0.754 . . . . 0.0 109.795 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -122.71 132.63 54.34 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 78.9 mt -107.14 128.57 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 68.1 t0 -110.34 143.07 41.1 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.548 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 64.6 t30 60.64 39.87 17.2 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.45 149.75 46.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.569 -0.707 . . . . 0.0 109.796 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -102.74 126.79 49.99 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.57 0.7 . . . . 0.0 110.016 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.4 t -92.29 133.0 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.498 -0.751 . . . . 0.0 109.397 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.67 156.27 45.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.148 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -113.0 119.28 37.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.469 -0.769 . . . . 0.0 109.609 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -125.15 134.09 52.56 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.559 0.695 . . . . 0.0 109.555 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 56.13 30.98 17.38 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.468 0.651 . . . . 0.0 109.787 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.77 4.69 77.18 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -114.39 136.62 52.79 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.316 -1.108 . . . . 0.0 109.742 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.91 146.37 37.65 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.655 0.74 . . . . 0.0 110.4 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.9 p -152.74 160.5 43.13 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.443 -0.786 . . . . 0.0 109.155 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.29 126.43 52.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.382 -0.824 . . . . 0.0 109.213 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 t -108.49 129.66 55.28 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.13 112.39 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.67 0.748 . . . . 0.0 109.1 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.71 -177.58 38.24 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -69.64 -17.4 63.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.58 -0.953 . . . . 0.0 109.434 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.3 m -84.91 -12.37 53.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.17 -0.956 . . . . 0.0 109.398 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.481 ' O ' ' NZ ' ' A' ' 58' ' ' LYS . 14.7 m -86.79 163.89 17.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.293 -0.879 . . . . 0.0 109.777 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -126.85 142.66 51.48 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.521 -0.737 . . . . 0.0 109.857 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -118.04 129.79 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -125.25 121.46 34.13 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.698 0.761 . . . . 0.0 109.36 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.0 p -78.57 156.59 29.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.498 -0.751 . . . . 0.0 109.94 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.0 t -121.9 130.39 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.519 -0.738 . . . . 0.0 109.276 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -91.52 103.1 15.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.556 -0.715 . . . . 0.0 109.6 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 96' ' ' ASN . 9.3 p -106.84 -22.22 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.448 ' O ' ' O ' ' A' ' 95' ' ' VAL . 58.3 t30 42.69 -167.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.577 0.703 . . . . 0.0 110.102 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.506 ' N ' ' HD2' ' A' ' 98' ' ' PRO . 1.7 mp -75.91 -56.14 1.75 Allowed Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.243 -0.911 . . . . 0.0 109.477 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 97' ' ' ILE . 45.8 Cg_endo -64.1 148.28 91.39 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.189 1.926 . . . . 0.0 112.535 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 78.7 mt -83.03 128.78 34.79 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 109.674 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -93.66 124.01 37.37 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.383 -0.823 . . . . 0.0 109.374 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -79.85 133.98 36.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 110.388 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -92.93 110.36 21.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.446 -0.784 . . . . 0.0 109.899 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' A' ' 103' ' ' HIS . 2.2 p-80 -163.79 -53.03 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.418 ' N ' ' CG ' ' A' ' 103' ' ' HIS . 30.7 m80 -85.58 -14.36 45.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.419 -0.801 . . . . 0.0 109.288 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -79.29 135.56 36.79 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.306 -0.871 . . . . 0.0 109.949 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 118.071 -0.966 . . . . 0.0 108.929 179.712 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 2' ' ' ASP . 8.7 t . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.408 0.623 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 65.7 t0 -66.86 149.12 51.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.45 -0.782 . . . . 0.0 110.267 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.542 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 50.1 tp -71.69 127.62 33.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.332 -0.855 . . . . 0.0 109.612 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.79 163.62 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.342 -0.849 . . . . 0.0 110.434 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -76.53 154.54 34.47 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.426 0.631 . . . . 0.0 110.38 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.35 -43.22 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 109.604 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 -64.11 -21.04 66.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.146 -0.971 . . . . 0.0 109.964 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -88.07 1.66 53.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.097 -1.002 . . . . 0.0 109.742 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.07 131.78 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.09 -1.006 . . . . 0.0 110.297 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.6 p -158.33 166.45 32.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.441 -0.787 . . . . 0.0 109.67 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.31 -20.5 66.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.402 -0.811 . . . . 0.0 109.185 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.9 t -63.96 -16.3 61.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 109.57 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.4 p -119.82 84.24 31.2 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.48 -0.763 . . . . 0.0 109.11 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.53 -40.67 71.65 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.591 2.194 . . . . 0.0 112.203 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -121.84 127.69 50.82 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.673 -0.642 . . . . 0.0 109.758 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.6 m -144.76 161.61 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.293 -0.879 . . . . 0.0 109.735 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 t -116.59 136.29 53.1 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.84 162.3 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.377 -0.827 . . . . 0.0 109.738 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.06 143.5 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.405 -0.809 . . . . 0.0 109.792 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.16 -161.32 35.07 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -111.73 139.05 47.51 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.439 -1.036 . . . . 0.0 109.604 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.46 ' O ' ' N ' ' A' ' 63' ' ' SER . 97.1 mt -97.93 131.32 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.868 -0.52 . . . . 0.0 109.852 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.3 p -133.7 156.63 47.59 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.468 -0.77 . . . . 0.0 109.952 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.1 71.4 1.01 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.8 mm -79.76 128.6 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.982 -1.305 . . . . 0.0 109.207 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -128.75 131.31 47.86 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -104.61 135.98 44.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.534 -0.729 . . . . 0.0 109.78 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -148.74 156.99 43.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.491 -0.756 . . . . 0.0 109.035 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -111.94 146.02 38.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.567 -0.708 . . . . 0.0 109.655 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.434 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 10.7 p90 -143.55 159.19 42.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.347 -0.846 . . . . 0.0 109.672 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -83.15 136.12 34.56 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.444 -0.785 . . . . 0.0 110.004 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.8 t -147.76 118.24 7.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.376 -0.828 . . . . 0.0 109.158 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 56.53 32.05 20.12 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.749 -0.594 . . . . 0.0 110.176 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.81 13.25 83.33 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -127.76 158.56 37.35 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.323 -1.104 . . . . 0.0 109.892 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.1 m -94.76 123.7 38.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.603 -0.686 . . . . 0.0 109.768 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.434 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 42.8 mmtm -127.26 141.96 51.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.565 -0.709 . . . . 0.0 109.195 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.1 m -84.81 146.65 27.24 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.621 -0.674 . . . . 0.0 109.816 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.7 137.63 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.521 -0.737 . . . . 0.0 109.169 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -102.49 131.9 48.88 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -127.1 155.0 44.01 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.619 -0.675 . . . . 0.0 109.672 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.6 -166.81 34.32 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.775 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -119.34 139.96 51.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.662 -0.905 . . . . 0.0 109.516 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 tt -122.96 132.99 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -132.84 156.4 47.22 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.28 -0.888 . . . . 0.0 111.142 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 48' ' ' THR . 53.9 p-10 -143.67 -144.33 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 23.4 p-10 -88.22 -1.39 57.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 109.14 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 49' ' ' ALA . 30.4 p -101.23 -69.69 0.77 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.507 -0.745 . . . . 0.0 109.613 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.536 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -162.86 -148.2 0.13 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 109.788 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -137.92 153.51 49.5 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.497 -0.752 . . . . 0.0 109.901 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.0 tt -152.24 154.87 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.174 -0.954 . . . . 0.0 109.998 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.85 143.42 41.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.419 -0.801 . . . . 0.0 110.355 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.1 pt -132.46 153.9 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.724 -0.61 . . . . 0.0 109.568 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.1 p -143.71 121.34 11.82 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 p -113.36 138.86 49.44 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.603 -0.686 . . . . 0.0 109.418 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.505 ' C ' ' H ' ' A' ' 58' ' ' LYS . 67.7 m-85 -95.91 121.26 37.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.405 -0.809 . . . . 0.0 111.332 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.74 -31.45 0.28 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.505 ' H ' ' C ' ' A' ' 56' ' ' PHE . 68.9 mttm -72.9 135.02 45.03 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.962 -1.316 . . . . 0.0 110.061 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -88.26 155.36 19.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.368 -0.833 . . . . 0.0 109.893 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.7 mt -127.67 152.48 47.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.632 -0.668 . . . . 0.0 109.277 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -114.45 132.41 56.27 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.061 0.934 . . . . 0.0 110.149 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.7 t0 -65.0 139.18 58.73 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.818 0.818 . . . . 0.0 111.622 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.538 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.7 m 61.8 5.53 1.36 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.588 -0.695 . . . . 0.0 110.338 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 65' ' ' VAL . 64.1 t0 -81.78 129.24 34.66 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.005 -1.06 . . . . 0.0 110.26 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.438 ' H ' HG22 ' A' ' 65' ' ' VAL . 1.7 m -83.34 119.36 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.7 m -138.16 163.27 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.72 0.771 . . . . 0.0 109.86 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.483 ' NH1' ' OD2' ' A' ' 69' ' ' ASP . 75.7 ttt-85 -123.28 125.53 45.23 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 77.7 mt -107.52 129.02 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.521 -0.737 . . . . 0.0 109.524 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.483 ' OD2' ' NH1' ' A' ' 67' ' ' ARG . 95.4 m-20 -113.76 148.9 35.68 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.415 0.626 . . . . 0.0 109.849 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 60.85 36.95 18.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.734 -0.604 . . . . 0.0 109.546 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.32 133.4 42.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 109.511 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -84.57 131.11 34.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 110.253 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.4 t -87.62 134.14 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.488 -0.757 . . . . 0.0 109.47 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.57 154.74 44.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.152 -0.968 . . . . 0.0 109.527 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.408 HE21 ' HA2' ' A' ' 78' ' ' GLY . 59.1 tt0 -116.48 117.82 30.95 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -126.45 133.17 51.29 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.668 -0.645 . . . . 0.0 109.766 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 56.57 31.79 19.72 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.274 0.559 . . . . 0.0 110.097 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.408 ' HA2' HE21 ' A' ' 75' ' ' GLN . . . 76.66 5.11 82.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -113.63 133.1 55.49 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.379 -1.071 . . . . 0.0 110.119 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.64 146.26 36.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.517 -0.739 . . . . 0.0 109.793 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 97.3 p -156.22 161.97 40.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.398 -0.814 . . . . 0.0 109.767 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.2 mt -105.84 130.61 53.78 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.5 t -107.76 127.83 54.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.0 109.413 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.08 107.67 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.46 -0.775 . . . . 0.0 109.356 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -96.0 -177.29 36.39 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -69.14 -17.27 63.81 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.254 -1.145 . . . . 0.0 109.315 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.6 m -84.45 -8.8 58.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.16 -0.963 . . . . 0.0 109.135 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.6 t -85.2 168.19 15.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.404 -0.81 . . . . 0.0 109.75 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -129.25 139.85 51.67 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.475 -0.765 . . . . 0.0 109.882 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.51 130.92 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -122.57 111.11 16.39 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.2 t -73.62 146.68 44.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.531 -0.731 . . . . 0.0 110.12 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 51.6 t -117.31 128.48 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.491 -0.756 . . . . 0.0 109.506 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.428 ' O ' ' O ' ' A' ' 95' ' ' VAL . 62.9 t30 -173.74 -29.09 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 96' ' ' ASN . 99.4 t 54.51 162.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.602 0.715 . . . . 0.0 110.733 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.597 ' N ' HG12 ' A' ' 95' ' ' VAL . 12.4 t-20 60.09 104.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.82 -0.55 . . . . 0.0 109.647 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.438 ' C ' ' O ' ' A' ' 96' ' ' ASN . 21.5 pt 34.69 59.08 2.29 Favored Pre-proline 0 N--CA 1.499 1.998 0 CA-C-O 121.177 0.513 . . . . 0.0 110.438 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 99' ' ' LEU . 60.0 Cg_endo -71.52 150.82 58.19 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.828 2.352 . . . . 0.0 112.368 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 98' ' ' PRO . 61.0 mt 59.25 124.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.732 0.777 . . . . 0.0 109.799 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 102' ' ' HIS . 98.3 mt-10 -72.65 141.96 48.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.505 -0.747 . . . . 0.0 110.428 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 41.36 -91.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.449 0.642 . . . . 0.0 110.432 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.534 ' N ' ' O ' ' A' ' 100' ' ' GLU . 59.6 t-80 45.84 89.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.661 0.743 . . . . 0.0 109.724 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.706 ' CG ' ' H ' ' A' ' 104' ' ' HIS . 11.0 t-80 -76.73 -160.58 0.16 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.556 -0.715 . . . . 0.0 110.364 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.706 ' H ' ' CG ' ' A' ' 103' ' ' HIS . 98.7 m-70 57.65 92.54 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.628 0.727 . . . . 0.0 109.632 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -65.6 -39.72 91.87 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.488 -0.757 . . . . 0.0 109.221 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.578 -179.697 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.09 153.01 36.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.424 -0.797 . . . . 0.0 110.396 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.5 tp -77.19 129.55 36.1 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.315 -0.866 . . . . 0.0 109.786 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.2 m -137.43 162.27 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.626 0.727 . . . . 0.0 109.424 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -88.53 162.44 16.41 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.48 0.657 . . . . 0.0 109.965 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.63 -42.74 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -72.49 -14.13 61.59 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.2 -0.938 . . . . 0.0 109.701 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -91.38 1.94 56.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.065 -1.022 . . . . 0.0 108.822 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.45 132.97 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 110.567 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.5 p -156.21 162.45 40.17 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.8 mt -71.92 -11.14 60.64 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.225 -0.922 . . . . 0.0 109.155 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.3 p -66.78 -17.83 65.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.4 p -123.04 84.17 50.9 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.51 -0.744 . . . . 0.0 109.528 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.73 -41.5 69.08 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.27 1.98 . . . . 0.0 111.609 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -119.26 131.41 55.78 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.365 0.602 . . . . 0.0 109.918 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.1 m -154.87 -173.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.246 -0.909 . . . . 0.0 109.744 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.8 p -131.39 137.02 48.5 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.49 158.63 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.415 -0.803 . . . . 0.0 109.865 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.5 mt -134.3 133.72 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.83 -171.16 36.6 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 118.741 -1.695 . . . . 0.0 110.351 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -114.67 121.2 42.66 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.766 -0.843 . . . . 0.0 108.984 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.617 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.0 mp -89.11 133.56 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.929 -0.482 . . . . 0.0 109.727 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.454 ' HA ' ' H ' ' A' ' 63' ' ' SER . 3.3 p -136.85 158.38 44.58 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.442 0.639 . . . . 0.0 109.732 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.35 83.53 0.07 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.5 mm -85.44 130.76 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.227 -1.161 . . . . 0.0 109.728 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -131.28 136.37 48.12 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -106.37 137.74 43.81 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.469 -0.77 . . . . 0.0 110.308 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -144.35 159.62 42.4 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -133.97 146.5 50.51 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.165 -0.96 . . . . 0.0 110.089 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -144.25 163.76 32.73 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.367 -0.833 . . . . 0.0 109.113 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -83.57 138.46 33.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.314 -0.866 . . . . 0.0 110.828 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 t -152.63 130.71 11.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.841 . . . . 0.0 108.925 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.6 t0 60.86 21.99 12.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.551 -0.718 . . . . 0.0 109.456 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.17 14.44 76.84 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 82.2 p -135.43 148.56 49.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.513 -0.992 . . . . 0.0 109.955 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.3 m -85.25 129.93 34.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.435 -0.791 . . . . 0.0 109.618 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -124.38 143.13 50.77 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.687 0.756 . . . . 0.0 110.029 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.9 m -83.84 141.13 31.57 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.377 0.608 . . . . 0.0 110.123 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 p -137.49 137.63 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -102.51 133.41 47.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.379 -0.826 . . . . 0.0 109.198 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -124.3 158.52 32.39 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.56 -170.56 37.87 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -120.38 142.8 48.84 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.6 -0.941 . . . . 0.0 109.267 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 tt -125.91 140.07 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -132.78 156.9 46.26 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.514 -0.741 . . . . 0.0 110.267 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 39.4 t0 -146.16 -142.28 0.13 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.516 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 66.3 t0 -87.55 -21.03 25.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.351 -0.843 . . . . 0.0 109.634 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.3 p -91.04 -76.61 0.44 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.086 -1.009 . . . . 0.0 109.866 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.11 -148.47 0.26 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 109.748 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.6 ptt-85 -142.57 159.17 42.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.577 -0.702 . . . . 0.0 109.702 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.4 tt -153.17 162.07 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.039 -1.038 . . . . 0.0 109.969 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -76.53 142.92 40.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.681 -0.637 . . . . 0.0 109.793 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.4 pt -129.22 153.75 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.532 -0.73 . . . . 0.0 109.433 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 p -142.25 132.57 24.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.59 -0.693 . . . . 0.0 109.259 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.2 t -119.23 128.67 54.41 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -92.73 122.76 35.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.183 -0.948 . . . . 0.0 110.409 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.48 -51.29 3.31 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -77.43 134.28 38.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.953 -1.322 . . . . 0.0 110.822 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.407 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 15.8 pt20 -93.07 160.0 15.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.584 -0.697 . . . . 0.0 110.116 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.8 mt -121.72 153.55 38.07 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -102.23 147.58 26.48 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.736 0.779 . . . . 0.0 110.32 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 63' ' ' SER . 66.7 t0 -67.23 137.52 56.24 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.998 0.904 . . . . 0.0 111.947 -178.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.541 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 55.5 m 48.79 80.64 0.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.557 0.694 . . . . 0.0 110.803 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -152.46 126.2 8.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.535 -0.728 . . . . 0.0 109.929 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.0 t -80.81 120.23 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.395 -0.816 . . . . 0.0 109.265 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.6 m -138.52 163.99 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.929 0.871 . . . . 0.0 110.575 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -115.69 124.01 49.78 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 87.9 mt -109.5 124.66 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -111.53 144.65 40.42 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.636 -0.665 . . . . 0.0 109.836 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.6 t30 65.42 37.25 6.31 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.554 0.692 . . . . 0.0 109.231 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.38 143.03 53.81 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -96.39 125.76 41.11 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.704 . . . . 0.0 109.536 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.1 t -85.51 130.23 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.811 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.86 141.47 30.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.378 -0.826 . . . . 0.0 108.782 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.567 ' O ' ' NE2' ' A' ' 75' ' ' GLN . 1.4 pp0? -116.18 138.03 51.62 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.657 -0.652 . . . . 0.0 109.351 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -132.36 135.63 46.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.536 -0.728 . . . . 0.0 109.965 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.2 t30 57.78 24.72 11.06 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.364 0.602 . . . . 0.0 109.703 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.79 33.62 29.83 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -138.33 121.31 16.66 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.321 -1.105 . . . . 0.0 109.48 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.3 mt -67.76 143.74 55.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.616 -0.677 . . . . 0.0 110.449 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.8 m -152.67 154.25 34.93 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.1 mt -101.85 126.5 48.75 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.214 -0.928 . . . . 0.0 109.711 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.7 m -106.91 125.55 51.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.718 -0.614 . . . . 0.0 109.443 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.8 t -98.81 108.33 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.349 -0.845 . . . . 0.0 108.834 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.39 179.82 42.17 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 87' ' ' SER . 38.4 p30 -67.83 -21.03 65.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.545 -0.973 . . . . 0.0 109.546 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.522 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 92.2 p -81.52 -7.96 59.66 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.143 -0.973 . . . . 0.0 109.207 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.5 t -80.42 158.47 25.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.965 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -117.69 127.8 54.28 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.1 mt -111.93 130.32 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.545 -0.722 . . . . 0.0 109.692 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -130.21 114.47 15.71 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.9 m -79.71 131.33 35.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.565 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.5 t -131.6 131.39 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.497 -0.752 . . . . 0.0 109.578 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 56.24 36.52 27.59 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.567 -0.708 . . . . 0.0 109.609 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.7 p -63.7 135.19 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.354 -0.841 . . . . 0.0 110.046 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -94.37 150.99 19.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.295 -0.878 . . . . 0.0 109.844 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.6 mm -125.41 69.37 61.32 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.59 156.59 57.53 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.229 1.953 . . . . 0.0 111.957 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 80.5 mt -70.58 146.73 49.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.933 . . . . 0.0 110.36 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -148.64 -22.56 0.32 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.508 ' O ' ' ND1' ' A' ' 101' ' ' HIS . 12.1 p80 -87.41 140.49 29.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 0.0 110.055 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -150.37 36.72 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -153.17 -61.28 0.14 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.483 -0.761 . . . . 0.0 109.62 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.552 ' O ' ' CG ' ' A' ' 105' ' ' HIS . 86.5 t60 -66.39 -40.89 89.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.34 -0.85 . . . . 0.0 109.792 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.552 ' CG ' ' O ' ' A' ' 104' ' ' HIS . 10.9 p80 41.24 -163.25 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.457 0.646 . . . . 0.0 110.711 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.416 ' CG ' ' O ' ' A' ' 105' ' ' HIS . 79.5 m80 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.1 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.1 t . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 36.1 p-10 -173.66 140.02 0.75 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.451 -0.781 . . . . 0.0 109.309 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.5 tp -76.19 123.92 26.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.331 -0.856 . . . . 0.0 109.809 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.48 163.66 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.71 0.767 . . . . 0.0 110.142 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -79.29 156.88 27.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.753 -0.592 . . . . 0.0 110.084 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.22 -43.35 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.408 ' HE ' ' HB2' ' A' ' 49' ' ' ALA . 99.5 mtt180 -65.17 -21.89 66.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 109.609 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -86.87 -1.38 57.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.204 -0.935 . . . . 0.0 109.666 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.6 t -70.3 130.86 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.165 -0.959 . . . . 0.0 110.316 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.407 ' HG ' ' HG ' ' A' ' 12' ' ' SER . 32.2 p -162.73 166.82 23.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.564 -0.71 . . . . 0.0 109.579 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 11' ' ' LEU . 3.7 mm? -67.84 -3.5 9.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -0.8 . . . . 0.0 109.027 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.407 ' HG ' ' HG ' ' A' ' 10' ' ' SER . 78.1 p -63.72 -32.02 73.38 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.362 -0.836 . . . . 0.0 109.472 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 p -114.67 134.42 22.39 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.45 -0.781 . . . . 0.0 109.783 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.69 -55.01 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.151 1.901 . . . . 0.0 112.148 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -115.5 134.88 54.65 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.554 -0.716 . . . . 0.0 110.09 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.8 m -141.4 160.6 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.504 -0.747 . . . . 0.0 109.809 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.4 t -116.05 134.49 54.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.77 162.54 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.447 -0.783 . . . . 0.0 110.1 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.2 tt -140.26 139.48 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.537 -0.727 . . . . 0.0 109.337 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 172.63 -169.0 42.15 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.997 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -106.69 133.07 51.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.541 -0.976 . . . . 0.0 109.414 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.635 ' N ' HD12 ' A' ' 22' ' ' ILE . 2.0 mp -94.0 129.98 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.208 0.527 . . . . 0.0 109.907 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.5 p -139.93 155.92 46.92 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.397 -0.814 . . . . 0.0 110.233 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.35 71.26 1.17 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.2 mm -81.35 130.58 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -1.177 . . . . 0.0 110.329 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -132.83 139.22 47.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -108.82 136.33 48.55 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.475 -0.766 . . . . 0.0 109.922 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -148.51 153.76 38.88 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -114.83 145.22 42.39 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.53 -0.732 . . . . 0.0 109.727 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -138.43 159.72 41.35 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.53 -0.732 . . . . 0.0 109.437 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -91.81 99.12 12.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.432 -0.792 . . . . 0.0 110.192 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 34' ' ' GLY . 8.3 t -77.9 -151.7 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.59 -0.694 . . . . 0.0 109.768 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -54.6 75.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.292 0.568 . . . . 0.0 110.474 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 61.97 19.56 59.05 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.3 m -140.02 133.11 29.54 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.262 -1.14 . . . . 0.0 110.166 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.4 m -78.38 128.86 34.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.327 -0.858 . . . . 0.0 109.367 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -132.72 144.49 50.32 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.397 -0.814 . . . . 0.0 109.945 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.5 p -84.78 146.41 27.39 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.424 -0.798 . . . . 0.0 109.773 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 55' ' ' SER . 9.9 p -139.0 138.55 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.613 -0.68 . . . . 0.0 109.46 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -100.36 135.34 41.95 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -127.97 157.36 40.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.621 -0.674 . . . . 0.0 109.433 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.49 -168.2 35.59 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -122.89 141.71 51.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.619 -0.93 . . . . 0.0 109.572 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.14 144.41 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -129.83 153.13 48.58 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.285 0.564 . . . . 0.0 109.643 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 20.6 t0 -144.41 -147.63 0.22 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.441 -0.787 . . . . 0.0 109.614 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.522 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 36.8 t70 -84.65 -7.7 59.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.805 . . . . 0.0 110.982 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.3 p -108.31 -66.18 1.06 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.13 -0.981 . . . . 0.0 109.998 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.408 ' HB2' ' HE ' ' A' ' 7' ' ' ARG . . . -157.56 -147.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 109.664 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.7 ptt85 -140.24 154.82 47.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.44 -0.787 . . . . 0.0 110.325 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.9 tt -146.32 161.27 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.523 -0.736 . . . . 0.0 109.939 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.85 145.07 40.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.516 -0.74 . . . . 0.0 110.16 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.6 pt -133.26 153.13 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.536 -0.727 . . . . 0.0 109.969 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 t -144.47 141.6 29.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.726 -0.609 . . . . 0.0 109.365 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 39' ' ' VAL . 4.6 p -132.71 137.59 46.96 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.456 -0.777 . . . . 0.0 109.06 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -94.77 125.99 39.79 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.365 -0.835 . . . . 0.0 110.905 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.76 -44.52 0.64 Allowed Glycine 0 N--CA 1.493 2.434 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.804 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -73.95 136.22 43.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.989 -1.3 . . . . 0.0 110.782 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -95.54 158.12 15.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.642 -0.661 . . . . 0.0 110.084 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.4 mt -123.11 153.42 39.99 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -111.93 137.31 50.08 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.669 0.747 . . . . 0.0 110.265 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.451 ' O ' ' OG ' ' A' ' 63' ' ' SER . 24.1 t70 -66.79 136.87 56.11 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.412 0.625 . . . . 0.0 110.907 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 62' ' ' ASP . 12.9 p 66.32 78.84 0.25 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.531 0.682 . . . . 0.0 110.363 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 46.1 p-10 -162.89 121.37 2.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 109.56 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 t -82.96 116.14 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.1 m -137.43 162.06 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.502 -0.749 . . . . 0.0 110.248 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -115.81 126.66 54.3 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.5 mt -106.15 127.31 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -111.68 145.5 39.14 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.251 0.548 . . . . 0.0 109.693 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.4 t30 66.2 35.81 5.85 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.35 136.52 42.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.476 -0.765 . . . . 0.0 109.137 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -91.55 133.51 35.46 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.102 -0.999 . . . . 0.0 110.121 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.2 t -88.1 132.03 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.431 -0.793 . . . . 0.0 109.548 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.03 164.11 26.11 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -122.99 124.27 42.78 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.75 0.786 . . . . 0.0 110.168 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.664 ' O ' ' N ' ' A' ' 78' ' ' GLY . 15.6 m-85 -84.5 -178.0 6.78 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 76' ' ' PHE . 97.6 m-20 -36.98 -18.39 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.074 0.464 . . . . 0.0 110.787 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.664 ' N ' ' O ' ' A' ' 76' ' ' PHE . . . 172.35 29.81 0.03 OUTLIER Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -141.46 140.7 33.62 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.313 -1.11 . . . . 0.0 110.345 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 80.4 mt -77.35 148.95 35.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.418 -0.801 . . . . 0.0 110.07 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.2 p -155.86 159.24 39.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.432 -0.793 . . . . 0.0 109.726 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.3 mt -113.29 126.23 55.16 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 p -106.17 131.12 53.8 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.571 -0.706 . . . . 0.0 109.41 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.4 t -101.13 114.91 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.37 -0.831 . . . . 0.0 109.298 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.37 177.01 37.5 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 37.2 p-10 -68.12 -23.25 64.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.503 -0.998 . . . . 0.0 110.106 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 95.4 p -85.0 -4.11 59.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.022 -1.048 . . . . 0.0 109.496 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.2 t -80.6 172.38 13.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 0.0 109.91 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -129.4 141.71 50.98 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.641 -0.662 . . . . 0.0 109.689 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -123.84 129.59 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -125.7 114.94 19.32 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.528 -0.732 . . . . 0.0 109.368 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.5 p -79.14 155.59 28.63 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.522 -0.736 . . . . 0.0 109.958 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.4 t -135.47 84.67 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.456 -0.778 . . . . 0.0 108.964 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -110.29 -59.34 1.95 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.5 m -114.67 132.35 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.53 0.681 . . . . 0.0 109.775 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.453 ' O ' ' C ' ' A' ' 97' ' ' ILE . 98.1 m-20 -62.56 150.23 41.0 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.589 -0.695 . . . . 0.0 110.368 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.453 ' C ' ' O ' ' A' ' 96' ' ' ASN . 8.2 pt 30.74 78.57 0.29 Allowed Pre-proline 0 N--CA 1.5 2.06 0 CA-C-O 120.882 0.373 . . . . 0.0 110.989 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.65 146.44 95.34 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.69 2.26 . . . . 0.0 112.515 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 79.1 mt -89.55 -2.34 58.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.402 -0.811 . . . . 0.0 109.121 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.71 133.04 50.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.178 -0.952 . . . . 0.0 109.623 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' A' ' 102' ' ' HIS . 44.3 p-80 -103.06 108.73 20.03 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.617 0.722 . . . . 0.0 109.838 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' A' ' 101' ' ' HIS . 81.7 m-70 44.13 -173.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.771 0.796 . . . . 0.0 110.97 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -66.96 -42.58 84.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.622 -0.674 . . . . 0.0 109.942 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -165.64 -74.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.636 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.437 ' O ' ' OXT' ' A' ' 106' ' ' HIS . 0.0 OUTLIER -94.82 99.37 11.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.386 -0.821 . . . . 0.0 109.86 -179.633 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.437 ' OXT' ' O ' ' A' ' 105' ' ' HIS . 76.5 m80 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.856 -1.069 . . . . 0.0 110.069 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.461 ' OG ' ' N ' ' A' ' 2' ' ' ASP . 12.2 t . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.287 0.565 . . . . 0.0 109.936 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.461 ' N ' ' OG ' ' A' ' 1' ' ' SER . 99.6 m-20 -72.01 151.07 43.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.44 -0.787 . . . . 0.0 110.143 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.5 tp -74.27 125.06 27.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.411 -0.806 . . . . 0.0 109.742 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.3 m -138.99 162.74 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.474 -0.766 . . . . 0.0 109.21 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.549 ' N ' ' OD2' ' A' ' 8' ' ' ASP . 64.1 mttp -74.65 151.64 39.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 110.527 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 9' ' ' VAL . 96.9 mt -61.92 -43.03 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.606 -0.684 . . . . 0.0 109.634 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -59.2 -31.94 69.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.473 -0.767 . . . . 0.0 110.562 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.549 ' OD2' ' N ' ' A' ' 5' ' ' LYS . 6.9 p30 -83.43 11.18 7.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.114 -0.991 . . . . 0.0 110.504 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 6' ' ' ILE . 53.4 t -68.57 132.24 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.917 . . . . 0.0 110.069 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 m -161.5 170.08 20.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.364 -0.835 . . . . 0.0 110.153 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.27 -34.51 78.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.428 -0.795 . . . . 0.0 109.619 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -50.63 -17.82 0.59 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.457 -0.777 . . . . 0.0 109.743 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 p -121.36 82.92 39.51 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.77 -41.59 61.58 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.43 2.087 . . . . 0.0 112.089 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -121.32 128.81 52.67 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.7 m -144.27 160.3 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.181 -0.949 . . . . 0.0 109.653 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.2 m -116.74 133.6 55.81 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.53 163.06 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.391 -0.818 . . . . 0.0 109.459 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.522 HD11 HH12 ' A' ' 67' ' ' ARG . 97.5 mt -127.58 133.27 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 174.66 -163.56 34.07 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.455 -1.355 . . . . 0.0 109.959 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -125.81 143.52 51.03 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.798 -0.824 . . . . 0.0 109.346 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.592 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.8 mp -98.21 132.8 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.378 0.609 . . . . 0.0 110.615 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 63' ' ' SER . 66.7 p -134.49 157.17 47.19 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.327 0.584 . . . . 0.0 109.876 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.85 78.02 0.4 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.545 ' N ' HD12 ' A' ' 25' ' ' ILE . 1.4 mp -90.89 120.28 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.267 -1.137 . . . . 0.0 109.614 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -114.74 122.58 46.85 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -86.13 134.65 33.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 110.157 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -146.67 153.33 40.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.383 -0.823 . . . . 0.0 108.861 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -116.3 144.04 44.75 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.434 -0.791 . . . . 0.0 109.64 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -141.64 162.88 34.39 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.229 -0.919 . . . . 0.0 109.327 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -88.08 98.87 11.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.997 . . . . 0.0 109.251 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.567 ' O ' ' N ' ' A' ' 34' ' ' GLY . 9.3 t -84.31 -151.68 0.13 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.488 -0.758 . . . . 0.0 110.188 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.427 ' C ' ' N ' ' A' ' 35' ' ' THR . 99.4 m-20 -50.43 84.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.692 -0.63 . . . . 0.0 110.278 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 49.45 15.3 0.73 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.427 ' N ' ' C ' ' A' ' 33' ' ' ASP . 35.7 p -140.24 145.96 38.03 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.321 -1.105 . . . . 0.0 109.372 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.2 m -84.41 129.2 34.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.514 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -129.11 147.1 50.93 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.461 -0.774 . . . . 0.0 109.505 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 p -84.01 152.13 24.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.489 -0.757 . . . . 0.0 109.716 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.415 HG21 ' CE1' ' A' ' 56' ' ' PHE . 13.3 p -142.62 139.01 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -106.97 132.0 53.41 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -119.0 147.18 44.37 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.555 -0.715 . . . . 0.0 109.18 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.62 -169.67 33.18 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -117.23 141.6 48.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.754 -0.851 . . . . 0.0 109.386 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.2 tt -117.77 144.92 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -134.11 160.46 37.73 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.469 0.652 . . . . 0.0 110.205 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 45.0 t0 -157.84 -167.01 2.12 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.527 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 98.2 m-20 -68.13 -16.4 63.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.877 . . . . 0.0 109.756 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.3 p -90.0 -73.96 0.5 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.5 -144.68 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 109.788 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -146.49 153.75 40.77 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.976 . . . . 0.0 110.361 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.2 tt -152.93 159.59 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.365 -0.835 . . . . 0.0 109.766 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.5 ttp85 -75.21 146.13 41.45 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.24 -0.912 . . . . 0.0 110.288 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 22' ' ' ILE . 42.3 pt -134.99 163.66 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.497 -0.752 . . . . 0.0 110.086 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.7 t -143.72 128.97 18.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.379 -0.826 . . . . 0.0 108.844 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.4 t -113.15 121.88 45.84 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.543 -0.723 . . . . 0.0 109.093 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.415 ' CE1' HG21 ' A' ' 39' ' ' VAL . 90.8 m-85 -97.6 120.09 37.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.448 -0.783 . . . . 0.0 110.397 -178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.24 -63.21 4.02 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -71.96 136.79 46.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -1.124 . . . . 0.0 110.6 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -96.18 155.8 16.61 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.44 -0.787 . . . . 0.0 109.463 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.5 mt -128.18 161.62 28.87 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.543 -0.723 . . . . 0.0 109.773 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -112.57 152.99 28.22 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 122.108 0.956 . . . . 0.0 110.145 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 63' ' ' SER . 68.2 t0 -63.1 139.22 58.75 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 111.288 -178.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.543 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.7 m 58.59 28.58 17.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.584 -0.698 . . . . 0.0 109.566 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -82.78 114.68 21.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 109.792 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.45 113.5 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.269 -0.894 . . . . 0.0 108.998 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 m -141.19 165.07 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.398 -0.814 . . . . 0.0 110.185 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.522 HH12 HD11 ' A' ' 19' ' ' ILE . 59.9 ttm-85 -106.4 126.3 52.07 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.2 mm -108.15 126.49 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -122.6 143.83 49.5 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.404 ' HA ' ' H1 ' ' A' ' 1' ' ' SER . 65.0 t30 62.64 40.94 9.82 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.73 131.5 41.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 0.0 108.989 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -82.4 131.8 35.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.219 -0.926 . . . . 0.0 110.098 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.1 t -91.32 131.19 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.426 -0.797 . . . . 0.0 109.52 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.92 153.25 49.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.448 -0.782 . . . . 0.0 108.96 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -116.18 119.14 34.85 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.538 -0.726 . . . . 0.0 109.278 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -125.02 133.25 53.04 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.604 -0.685 . . . . 0.0 109.496 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 55.37 31.26 16.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.707 -0.621 . . . . 0.0 109.94 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.6 6.6 84.83 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.521 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -113.95 133.42 55.48 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.47 -1.018 . . . . 0.0 109.71 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.3 mt -76.68 146.37 38.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.508 -0.745 . . . . 0.0 110.036 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.5 t -154.65 154.13 32.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.518 -0.739 . . . . 0.0 109.016 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.1 mt -103.42 129.51 50.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.379 -0.826 . . . . 0.0 109.114 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.2 t -105.19 128.38 53.37 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.699 -0.626 . . . . 0.0 109.562 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.52 99.94 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -97.08 -169.73 33.52 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -68.89 -17.29 63.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.565 -0.962 . . . . 0.0 109.634 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.8 m -83.12 -8.42 59.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.389 -0.819 . . . . 0.0 109.681 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.6 t -88.9 166.68 13.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 109.982 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -125.1 133.53 52.83 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 94.0 mt -119.29 128.38 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -126.5 132.1 51.47 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.537 -0.727 . . . . 0.0 109.46 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.9 t -66.18 132.79 49.27 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.549 -0.719 . . . . 0.0 110.223 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.6 t -107.11 -52.57 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -134.99 -57.8 0.81 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 96' ' ' ASN . 2.0 t 52.45 29.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.689 -0.632 . . . . 0.0 109.378 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 95' ' ' VAL . 97.3 m-20 58.31 128.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.601 0.715 . . . . 0.0 110.477 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.672 ' H ' ' CD ' ' A' ' 98' ' ' PRO . 1.6 mt -108.99 -34.73 0.15 Allowed Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.724 -0.61 . . . . 0.0 109.687 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.672 ' CD ' ' H ' ' A' ' 97' ' ' ILE . 80.6 Cg_endo -87.86 -3.37 7.26 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 122.165 1.91 . . . . 0.0 111.468 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 99' ' ' LEU . 10.1 mp 58.21 136.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.579 0.704 . . . . 0.0 110.043 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.86 -179.69 2.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.52 -0.738 . . . . 0.0 110.815 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -68.05 140.95 56.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.613 -0.679 . . . . 0.0 110.172 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -77.4 141.27 39.88 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.46 -0.775 . . . . 0.0 110.545 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 104' ' ' HIS . 32.8 p80 -78.5 -15.74 58.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.506 -0.746 . . . . 0.0 109.314 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' HIS . 85.5 t60 55.72 159.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.464 0.65 . . . . 0.0 110.531 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.42 ' N ' ' CG ' ' A' ' 104' ' ' HIS . 27.4 p-80 -152.37 162.28 41.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.433 -0.792 . . . . 0.0 109.561 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.506 ' O ' ' ND1' ' A' ' 106' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.327 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.8 0.81 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 54.3 tp -76.19 124.34 27.31 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.62 0.724 . . . . 0.0 110.348 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.4 m -139.18 164.26 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.829 0.823 . . . . 0.0 110.144 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -80.69 161.02 24.81 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.708 0.766 . . . . 0.0 110.26 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.81 -43.27 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.216 0.531 . . . . 0.0 109.678 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -67.47 -18.8 65.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.783 -0.573 . . . . 0.0 109.649 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -86.04 -0.09 54.7 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.558 -0.714 . . . . 0.0 109.713 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.9 t -67.22 130.16 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.908 0.861 . . . . 0.0 110.344 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.9 p -160.86 167.27 27.01 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.769 0.795 . . . . 0.0 109.971 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.494 HD11 ' NE2' ' A' ' 75' ' ' GLN . 93.7 mt -66.72 -21.62 66.07 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.3 t -61.4 -20.24 62.83 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 51.6 p -124.92 80.96 62.81 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.749 -0.594 . . . . 0.0 109.461 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.73 -40.62 73.5 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.681 2.254 . . . . 0.0 111.705 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -112.8 125.81 54.75 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.647 0.736 . . . . 0.0 109.207 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.4 m -149.76 160.22 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 122.155 0.978 . . . . 0.0 111.058 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.2 t -118.33 134.17 55.27 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.49 162.38 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 121.972 0.891 . . . . 0.0 110.391 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.6 tt -140.97 135.57 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.637 0.732 . . . . 0.0 109.675 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.0 -165.99 37.42 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -113.44 136.67 52.52 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.733 0.777 . . . . 0.0 110.115 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.694 ' N ' HD12 ' A' ' 22' ' ' ILE . 2.5 mp -96.19 137.08 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.475 0.655 . . . . 0.0 109.72 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.4 p -131.1 158.68 39.75 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.009 0.909 . . . . 0.0 110.348 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.62 93.55 0.01 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.8 mm -93.4 124.52 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.804 -0.821 . . . . 0.0 109.829 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -120.39 139.66 52.49 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.807 0.813 . . . . 0.0 109.53 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -108.04 134.46 50.89 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.838 0.828 . . . . 0.0 110.234 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -144.04 154.93 43.76 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.675 0.75 . . . . 0.0 109.452 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -123.54 144.87 49.29 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.842 0.83 . . . . 0.0 110.23 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -144.21 158.44 43.73 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.827 0.822 . . . . 0.0 109.861 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -87.92 115.44 25.39 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.601 0.715 . . . . 0.0 110.075 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 t -113.35 113.07 24.72 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.733 0.778 . . . . 0.0 109.492 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.1 t0 55.93 29.46 14.27 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.279 0.561 . . . . 0.0 109.743 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.99 2.45 80.92 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.4 m -118.13 127.6 53.93 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.758 -0.848 . . . . 0.0 109.928 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.8 m -69.31 129.63 40.33 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.632 0.73 . . . . 0.0 110.317 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -130.99 139.86 50.06 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.746 0.784 . . . . 0.0 109.72 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.5 m -86.26 141.76 29.05 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.015 0.912 . . . . 0.0 110.723 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -136.49 135.53 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.856 0.836 . . . . 0.0 109.485 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -101.61 133.48 46.23 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.692 0.758 . . . . 0.0 109.791 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -121.78 151.96 40.01 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.837 0.827 . . . . 0.0 109.667 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.41 -172.93 39.99 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.593 ' CB ' HH21 ' A' ' 50' ' ' ARG . 68.0 m-85 -117.35 142.99 46.43 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.695 0.759 . . . . 0.0 109.863 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.5 tt -125.84 139.87 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -133.56 159.54 40.14 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.128 0.966 . . . . 0.0 110.653 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 37.3 t0 -145.08 -148.77 0.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.471 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.542 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 97.5 m-20 -80.02 -6.64 57.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.648 -0.657 . . . . 0.0 109.536 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.5 p -105.67 -91.11 0.4 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.73 -0.607 . . . . 0.0 109.888 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.51 -145.14 0.24 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.576 -0.703 . . . . 0.0 110.066 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.593 HH21 ' CB ' ' A' ' 43' ' ' TYR . 17.5 ptm180 -145.89 156.09 43.31 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.821 0.819 . . . . 0.0 110.783 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.8 tt -148.1 161.99 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.911 0.862 . . . . 0.0 110.297 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -79.44 147.77 32.18 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.589 0.709 . . . . 0.0 110.17 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.8 pt -134.98 157.0 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.912 0.863 . . . . 0.0 110.37 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 m -141.35 125.43 17.29 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.649 0.737 . . . . 0.0 109.558 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.5 t -116.43 130.23 56.65 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.963 0.887 . . . . 0.0 109.629 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -98.91 119.49 37.77 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.656 0.741 . . . . 0.0 109.86 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.69 -51.68 4.05 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -71.71 135.14 46.68 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.667 -0.902 . . . . 0.0 110.436 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -89.09 155.58 19.36 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.842 0.83 . . . . 0.0 110.903 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.2 mt -119.34 151.02 39.18 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.57 0.7 . . . . 0.0 109.563 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.406 ' O ' ' OD1' ' A' ' 64' ' ' ASP . 21.5 mp0 -112.49 142.29 45.23 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 122.385 1.088 . . . . 0.0 110.156 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 63' ' ' SER . 68.1 t0 -64.18 135.58 56.43 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.966 0.888 . . . . 0.0 111.876 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.522 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 2.1 p 53.47 23.7 3.58 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.527 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 20.4 p-10 -87.65 126.12 34.77 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.748 0.785 . . . . 0.0 110.426 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 65' ' ' VAL . 1.3 m -82.47 115.8 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-O 121.657 0.742 . . . . 0.0 108.998 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.8 m -140.67 162.77 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 122.041 0.924 . . . . 0.0 110.416 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.525 ' NH1' ' OD1' ' A' ' 69' ' ' ASP . 68.9 ttp85 -117.39 127.82 54.42 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.701 0.762 . . . . 0.0 109.288 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.7 mt -107.25 129.48 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.754 0.787 . . . . 0.0 109.495 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.525 ' OD1' ' NH1' ' A' ' 67' ' ' ARG . 96.5 m-20 -116.41 144.27 44.51 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.688 0.756 . . . . 0.0 109.969 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.1 t30 62.91 39.57 10.33 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.842 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.26 146.74 47.04 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.4 0.619 . . . . 0.0 110.047 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -104.91 125.83 51.34 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.805 0.812 . . . . 0.0 110.095 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.0 t -86.55 133.22 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.699 0.761 . . . . 0.0 110.052 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.7 160.03 43.14 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.848 0.833 . . . . 0.0 109.955 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.494 ' NE2' HD11 ' A' ' 11' ' ' LEU . 77.5 mt-30 -107.44 114.37 28.34 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.699 0.762 . . . . 0.0 110.143 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -115.65 125.45 52.89 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.695 0.759 . . . . 0.0 109.472 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.405 HD22 ' HA ' ' A' ' 77' ' ' ASN . 11.2 m120 57.22 29.61 17.0 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.48 13.33 82.75 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -120.27 135.92 54.84 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.831 0.824 . . . . 0.0 109.987 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.2 mt -77.28 143.77 38.62 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.591 0.71 . . . . 0.0 109.899 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.0 p -156.3 163.3 39.69 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.957 0.884 . . . . 0.0 110.491 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.6 mt -103.63 124.11 48.22 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.757 0.789 . . . . 0.0 109.341 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.0 m -103.2 122.76 45.4 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.671 0.748 . . . . 0.0 110.104 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.699 HG11 HD11 ' A' ' 90' ' ' ILE . 6.9 t -99.23 105.55 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.65 0.738 . . . . 0.0 109.596 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.434 ' O ' ' OG ' ' A' ' 88' ' ' SER . . . -91.76 -176.43 42.72 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.82 -16.71 62.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.95 -0.735 . . . . 0.0 109.322 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 87.6 p -85.91 -15.36 41.95 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 85' ' ' GLY . 25.5 p -82.68 167.16 18.5 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.567 0.699 . . . . 0.0 110.05 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -126.74 138.3 53.36 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.785 0.802 . . . . 0.0 109.879 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.699 HD11 HG11 ' A' ' 84' ' ' VAL . 98.2 mt -122.32 127.55 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.493 0.664 . . . . 0.0 109.447 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -124.39 126.59 46.21 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.925 0.869 . . . . 0.0 110.253 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.0 p -76.35 150.02 36.91 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.455 0.645 . . . . 0.0 110.17 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.7 t . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 121.775 0.798 . . . . 0.0 109.712 -179.875 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 55.7 t0 . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.753 0.787 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.539 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 38.8 tp -69.5 128.7 37.45 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.504 0.669 . . . . 0.0 110.027 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.1 m -138.89 163.59 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.9 0.857 . . . . 0.0 109.968 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -75.32 156.65 35.33 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.75 0.786 . . . . 0.0 110.076 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.1 mm -62.65 -44.58 99.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.797 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -68.61 -20.96 64.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.562 -0.711 . . . . 0.0 109.504 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -82.77 -3.86 57.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.539 -0.726 . . . . 0.0 109.166 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.8 t -69.99 128.86 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.975 0.893 . . . . 0.0 109.915 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 12' ' ' SER . 29.7 m -163.6 162.66 24.43 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.566 0.698 . . . . 0.0 109.399 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.7 mt -64.58 -2.31 2.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.784 -0.573 . . . . 0.0 109.555 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.41 ' H ' ' C ' ' A' ' 10' ' ' SER . 78.6 p -61.0 -32.64 72.21 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.6 p -117.07 145.22 35.22 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.729 -0.607 . . . . 0.0 110.168 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.28 -61.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.999 2.466 . . . . 0.0 112.422 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 100.0 m-85 -119.75 136.53 54.4 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.858 0.837 . . . . 0.0 110.339 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.9 m -140.52 164.0 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.688 0.756 . . . . 0.0 109.973 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.431 ' O ' HD12 ' A' ' 3' ' ' LEU . 68.2 m -118.96 145.09 46.09 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.756 0.789 . . . . 0.0 109.494 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.24 160.27 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 122.114 0.959 . . . . 0.0 110.639 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 19' ' ' ILE . 19.5 tt -138.27 130.25 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.665 0.745 . . . . 0.0 109.457 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.58 -156.24 21.53 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -124.93 139.11 54.12 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.919 -0.753 . . . . 0.0 109.839 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.723 HD12 ' N ' ' A' ' 22' ' ' ILE . 3.0 mp -92.2 132.18 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.391 0.615 . . . . 0.0 110.08 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.0 m -125.76 143.87 50.87 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.058 0.932 . . . . 0.0 109.866 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.76 97.02 0.04 OUTLIER Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.6 mm -95.01 125.88 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.962 0.887 . . . . 0.0 110.408 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -123.4 134.51 53.96 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.556 0.693 . . . . 0.0 109.226 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -108.31 132.9 53.23 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.947 0.88 . . . . 0.0 110.037 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -140.76 158.27 44.21 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.772 0.796 . . . . 0.0 109.718 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -120.43 145.05 47.6 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.783 0.801 . . . . 0.0 109.983 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.441 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 13.7 p90 -141.61 159.42 42.27 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.18 0.99 . . . . 0.0 110.088 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -96.69 132.26 42.54 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.532 0.682 . . . . 0.0 109.471 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.0 t -159.16 141.1 13.54 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.743 0.782 . . . . 0.0 110.189 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 55.65 28.37 11.93 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.25 0.548 . . . . 0.0 109.759 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.36 14.66 79.2 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.7 p -135.87 155.06 50.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.61 -0.935 . . . . 0.0 109.874 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.6 m -98.2 126.24 43.58 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.88 0.848 . . . . 0.0 109.818 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.441 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 98.9 mttt -125.62 142.1 51.68 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.819 0.818 . . . . 0.0 109.325 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 90.8 p -84.57 146.37 27.57 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.841 0.829 . . . . 0.0 110.368 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -133.51 136.99 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.822 0.82 . . . . 0.0 109.821 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.514 ' CZ ' ' OE1' ' A' ' 59' ' ' GLN . 94.4 m-85 -101.95 131.2 48.49 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.763 0.792 . . . . 0.0 109.725 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -126.12 155.24 41.96 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.93 0.871 . . . . 0.0 109.943 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.9 -166.93 35.19 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.618 ' CD2' ' NH2' ' A' ' 50' ' ' ARG . 97.2 m-85 -119.79 140.37 50.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.81 -0.818 . . . . 0.0 110.072 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.4 tt -122.79 133.19 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -134.32 156.23 48.84 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 122.277 1.037 . . . . 0.0 110.561 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 48' ' ' THR . 5.4 p30 -168.09 95.32 0.41 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.646 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' THR . 66.8 t0 52.4 -77.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 120.936 0.398 . . . . 0.0 110.571 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.589 ' N ' ' O ' ' A' ' 46' ' ' ASP . 73.9 p -38.62 -80.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.086 0.47 . . . . 0.0 110.456 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.404 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -158.21 -143.67 0.11 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.698 0.761 . . . . 0.0 110.087 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.618 ' NH2' ' CD2' ' A' ' 43' ' ' TYR . 8.9 ptm180 -142.87 150.68 40.18 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.761 0.791 . . . . 0.0 110.4 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.6 tt -146.54 156.26 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.747 0.784 . . . . 0.0 110.085 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -76.69 147.2 37.57 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.735 0.779 . . . . 0.0 109.973 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.2 pt -135.05 154.47 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.644 0.735 . . . . 0.0 110.273 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 t -143.17 133.42 24.54 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.858 0.837 . . . . 0.0 109.551 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 p -131.09 135.28 47.38 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.973 0.892 . . . . 0.0 109.887 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.446 ' C ' ' H ' ' A' ' 58' ' ' LYS . 90.7 m-85 -94.8 122.33 37.3 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.699 0.761 . . . . 0.0 111.025 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.47 -29.46 0.58 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' A' ' 56' ' ' PHE . 98.9 mttt -74.11 136.84 42.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.568 -0.96 . . . . 0.0 110.607 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.514 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 68.7 tp60 -94.68 146.92 23.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.776 0.798 . . . . 0.0 110.495 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.9 mt -129.48 152.44 49.01 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.721 0.772 . . . . 0.0 109.927 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -122.93 137.64 54.89 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.216 1.008 . . . . 0.0 110.074 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 63' ' ' SER . 65.6 t0 -64.78 134.69 54.66 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.865 0.84 . . . . 0.0 111.462 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.53 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 2.8 p 78.29 8.19 2.31 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.862 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 7.3 p-10 -84.45 124.08 30.95 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.307 0.575 . . . . 0.0 110.803 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 t -87.02 116.76 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.637 0.732 . . . . 0.0 109.117 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.48 163.22 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.221 1.01 . . . . 0.0 110.945 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -119.27 128.99 54.68 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.7 mt -106.23 129.45 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.773 0.797 . . . . 0.0 109.543 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -114.81 143.51 44.99 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.849 0.833 . . . . 0.0 110.149 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.6 t30 62.12 37.89 14.19 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.2 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.95 145.7 46.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.583 -0.698 . . . . 0.0 109.426 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -96.04 132.34 41.5 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.828 0.823 . . . . 0.0 110.209 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 89.6 t -83.15 131.66 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 121.532 0.682 . . . . 0.0 109.974 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.64 154.28 43.37 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.683 0.754 . . . . 0.0 109.973 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -119.79 117.38 28.03 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.816 0.817 . . . . 0.0 109.924 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -119.85 131.51 55.29 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.852 0.834 . . . . 0.0 110.01 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.8 t30 56.64 24.32 8.73 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.239 0.542 . . . . 0.0 110.249 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.88 10.51 82.93 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -114.99 138.17 51.15 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.91 0.862 . . . . 0.0 109.755 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 80' ' ' LEU . 3.7 mm? -76.94 141.61 40.4 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.93 0.872 . . . . 0.0 110.699 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.3 p -153.52 159.24 42.19 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.752 0.787 . . . . 0.0 110.008 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.7 mt -108.56 126.39 52.88 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.791 0.805 . . . . 0.0 110.175 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.2 m -101.43 123.54 45.65 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.825 0.822 . . . . 0.0 109.656 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.7 t -101.02 111.29 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.843 0.83 . . . . 0.0 109.204 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.23 -178.71 37.22 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -68.2 -18.35 64.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 122.149 -0.618 . . . . 0.0 109.543 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 97.1 p -87.65 -7.53 57.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.669 -0.645 . . . . 0.0 109.455 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.1 t -83.69 164.92 19.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.456 -0.778 . . . . 0.0 109.556 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -128.54 139.27 52.39 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.754 0.788 . . . . 0.0 109.911 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.15 130.47 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.651 0.739 . . . . 0.0 109.45 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 91' ' ' GLU . 56.7 mp0 -115.72 125.53 52.93 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.83 0.824 . . . . 0.0 109.93 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.0 p -71.33 144.87 49.78 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.596 0.712 . . . . 0.0 110.559 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.2 t . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 121.936 0.874 . . . . 0.0 109.924 -179.772 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 60.5 t0 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.75 0.786 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.532 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 4.9 tt -71.17 133.82 46.46 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.686 -0.634 . . . . 0.0 110.726 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.2 m -135.84 162.91 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-O 121.567 0.698 . . . . 0.0 109.884 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -79.04 155.98 28.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.589 -0.695 . . . . 0.0 110.062 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.9 mt -63.54 -43.66 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.712 -0.618 . . . . 0.0 109.866 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 -72.31 -14.38 61.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.117 -0.989 . . . . 0.0 109.864 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -93.25 2.22 56.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.321 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.51 132.05 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.155 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.3 p -159.35 165.82 32.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.355 -0.841 . . . . 0.0 109.837 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.66 -19.07 65.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.523 -0.735 . . . . 0.0 109.762 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.2 m -57.51 -25.25 59.56 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.118 -0.989 . . . . 0.0 109.24 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 45.8 p -123.29 82.64 52.24 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.46 -40.36 71.79 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.641 2.227 . . . . 0.0 112.088 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -115.87 128.76 56.05 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.419 0.628 . . . . 0.0 109.832 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.2 m -153.04 -176.41 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.445 -0.785 . . . . 0.0 109.906 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.3 m -130.18 144.29 51.28 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.4 m -139.88 162.61 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.376 -0.827 . . . . 0.0 110.245 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 tp -141.52 127.93 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.68 -168.53 38.06 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.058 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -110.27 144.11 39.44 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.621 -0.929 . . . . 0.0 109.545 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.0 mm -95.07 133.44 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.364 0.602 . . . . 0.0 110.254 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -143.02 156.84 44.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.37 -0.831 . . . . 0.0 109.983 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.11 62.14 4.41 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.0 mm -76.94 129.78 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -1.125 . . . . 0.0 110.624 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -130.09 122.69 28.79 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.509 ' NZ ' ' OE2' ' A' ' 29' ' ' GLU . 66.0 tttm -86.41 136.93 32.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.355 -0.841 . . . . 0.0 110.022 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -146.64 139.85 25.57 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.509 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 97.2 mt-10 -115.1 148.15 39.32 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.664 -0.647 . . . . 0.0 110.154 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.541 ' CE2' ' OG ' ' A' ' 32' ' ' SER . 9.8 p90 -147.28 159.29 43.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.819 . . . . 0.0 109.188 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -84.07 119.98 25.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.4 -0.812 . . . . 0.0 110.318 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.541 ' OG ' ' CE2' ' A' ' 30' ' ' TYR . 3.1 m -119.41 114.17 21.91 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 55.36 31.94 17.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.56 -0.713 . . . . 0.0 109.881 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.74 6.43 88.49 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.2 m -120.89 128.56 52.91 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.525 -0.985 . . . . 0.0 109.874 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.4 m -68.25 134.72 50.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.602 -0.686 . . . . 0.0 110.042 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -131.58 147.29 52.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.441 -0.787 . . . . 0.0 109.34 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.5 t -99.9 135.09 41.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.631 -0.668 . . . . 0.0 109.939 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.94 138.09 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -105.41 134.35 48.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.527 -0.733 . . . . 0.0 109.476 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -123.51 150.86 43.42 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.391 0.615 . . . . 0.0 109.385 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.431 ' C ' ' CD1' ' A' ' 53' ' ' ILE . . . -173.82 -147.44 6.0 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.48 ' OH ' ' NH1' ' A' ' 52' ' ' ARG . 79.6 m-85 -132.92 141.58 48.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.573 -0.957 . . . . 0.0 109.549 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 tt -116.04 134.39 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -133.26 150.23 51.93 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.756 0.788 . . . . 0.0 110.719 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 48' ' ' THR . 62.8 t0 -167.36 95.55 0.47 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' THR . 38.8 t70 48.37 -79.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.812 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.601 ' N ' ' O ' ' A' ' 46' ' ' ASP . 14.5 m -36.29 -77.31 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.767 -0.583 . . . . 0.0 110.803 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -161.12 -153.99 0.34 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.032 -1.042 . . . . 0.0 109.426 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 -138.97 152.12 47.42 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.39 0.614 . . . . 0.0 110.572 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.0 tt -150.67 163.52 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.783 . . . . 0.0 110.167 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.48 ' NH1' ' OH ' ' A' ' 43' ' ' TYR . 77.2 mtp85 -79.31 149.19 31.85 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.514 0.673 . . . . 0.0 110.838 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.803 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -141.79 164.44 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.511 -0.743 . . . . 0.0 109.792 179.587 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 p -140.42 127.13 20.39 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -109.98 118.08 35.5 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.619 -0.675 . . . . 0.0 109.21 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.433 ' C ' ' H ' ' A' ' 58' ' ' LYS . 72.1 m-85 -95.4 123.85 39.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.448 -0.782 . . . . 0.0 110.806 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.15 -33.55 0.65 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 56' ' ' PHE . 31.1 mmtp -87.92 130.13 35.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.893 -1.357 . . . . 0.0 109.955 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -90.45 146.41 24.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.501 -0.749 . . . . 0.0 110.283 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.7 mt -132.67 151.39 51.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.625 -0.672 . . . . 0.0 109.346 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -112.34 148.23 34.69 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.948 0.88 . . . . 0.0 110.153 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.6 t0 -65.27 136.68 56.89 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.656 0.741 . . . . 0.0 111.389 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.503 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 3.1 p 75.26 6.73 4.14 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.28 0.562 . . . . 0.0 109.94 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -83.98 122.61 28.99 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.13 -0.981 . . . . 0.0 110.135 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.4 t -85.57 119.19 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.4 160.48 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.422 0.629 . . . . 0.0 109.666 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -116.37 123.51 47.77 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 75.9 mt -107.41 130.36 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.572 -0.705 . . . . 0.0 109.401 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -116.98 144.65 44.33 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.447 0.641 . . . . 0.0 109.911 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.3 t30 64.75 35.86 8.47 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.445 0.64 . . . . 0.0 109.542 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.87 146.21 53.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.425 -0.797 . . . . 0.0 109.164 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.3 ttp85 -100.27 125.18 46.43 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.507 0.67 . . . . 0.0 110.056 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.3 t -85.25 133.3 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.521 -0.737 . . . . 0.0 109.651 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.38 164.85 30.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.365 -0.834 . . . . 0.0 109.349 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -103.33 114.37 28.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.6 -0.687 . . . . 0.0 109.609 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -110.3 121.87 46.32 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.6 m120 56.05 31.27 17.76 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.411 0.624 . . . . 0.0 109.392 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.89 13.07 83.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -121.47 138.47 54.28 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.514 -0.992 . . . . 0.0 110.059 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.7 mt -71.37 139.8 49.93 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.583 -0.698 . . . . 0.0 110.283 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.66 163.04 40.43 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.8 mt -103.59 127.83 50.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.602 -0.686 . . . . 0.0 109.585 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.4 t -107.38 126.91 53.07 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 t -103.39 106.01 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.484 -0.76 . . . . 0.0 109.79 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -90.83 179.67 42.93 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -65.44 -37.7 87.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.482 -1.011 . . . . 0.0 109.603 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.4 m -60.66 -36.14 77.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 0.0 110.008 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.1 p -63.25 163.21 10.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.192 -0.942 . . . . 0.0 110.328 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -111.35 140.04 46.26 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.722 -0.611 . . . . 0.0 109.525 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.28 131.38 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -128.13 108.65 10.81 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.497 -0.752 . . . . 0.0 109.181 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.9 t -72.69 140.89 48.17 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.49 -0.756 . . . . 0.0 110.132 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.1 t . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.577 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 . . . . . 0 N--CA 1.497 1.916 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.549 HD13 ' N ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -87.26 121.7 30.05 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.149 -0.969 . . . . 0.0 111.528 -174.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.549 ' N ' HD13 ' A' ' 3' ' ' LEU . 31.7 m -131.29 161.63 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -75.75 162.92 27.78 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.813 0.816 . . . . 0.0 110.265 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.5 mm -62.79 -43.51 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.615 -0.678 . . . . 0.0 109.253 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -65.78 -18.21 65.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.383 -0.823 . . . . 0.0 110.055 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -85.28 -0.05 53.51 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.136 -0.977 . . . . 0.0 110.281 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.39 133.05 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.174 -0.954 . . . . 0.0 110.254 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.1 m -157.5 162.8 38.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.473 -0.767 . . . . 0.0 109.742 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.74 -30.16 70.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.376 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -59.33 -20.23 52.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.347 -0.846 . . . . 0.0 109.293 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.404 ' O ' ' OG1' ' A' ' 13' ' ' THR . 11.5 p -118.39 80.2 16.03 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.72 -15.21 33.5 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.015 1.81 . . . . 0.0 112.581 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -133.11 105.97 7.34 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.423 -0.798 . . . . 0.0 109.792 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.1 m -145.57 164.61 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.379 -0.826 . . . . 0.0 109.881 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.1 t -108.54 141.45 40.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.339 -0.85 . . . . 0.0 108.825 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.52 160.27 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.365 -0.834 . . . . 0.0 109.724 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.621 HD12 ' HE ' ' A' ' 67' ' ' ARG . 7.5 tt -142.73 137.35 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.389 -0.819 . . . . 0.0 109.373 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.67 -166.27 35.94 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.227 -1.463 . . . . 0.0 110.683 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -104.57 132.41 50.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.818 -0.813 . . . . 0.0 109.402 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.2 mm -89.29 130.02 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.221 0.534 . . . . 0.0 109.915 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.0 p -137.87 161.54 36.36 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.325 -0.859 . . . . 0.0 109.884 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.57 79.29 0.1 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.8 mm -91.44 120.07 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.193 -1.181 . . . . 0.0 109.709 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -119.56 125.76 49.6 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -93.85 134.43 36.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.284 -0.885 . . . . 0.0 109.967 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -148.12 143.58 27.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.426 -0.796 . . . . 0.0 109.001 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -123.89 144.91 49.47 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.415 -0.803 . . . . 0.0 109.344 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.512 ' CE2' ' OG ' ' A' ' 32' ' ' SER . 24.9 p90 -141.71 160.73 39.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.215 -0.928 . . . . 0.0 109.558 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -79.6 114.52 18.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.56 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.512 ' OG ' ' CE2' ' A' ' 30' ' ' TYR . 5.1 m -109.61 112.82 25.13 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.533 -0.729 . . . . 0.0 109.531 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 53.37 31.07 11.3 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 0.0 110.201 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.67 -2.45 82.52 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.3 p -118.36 124.87 48.8 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.299 -1.118 . . . . 0.0 109.296 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.4 m -69.68 135.67 50.14 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.432 -0.792 . . . . 0.0 110.221 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -131.84 147.87 52.51 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.2 t -96.95 131.79 43.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.506 -0.746 . . . . 0.0 109.747 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.67 135.36 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -104.81 135.53 46.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.528 -0.733 . . . . 0.0 109.129 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -124.56 153.88 41.47 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.445 0.64 . . . . 0.0 109.371 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.76 -151.72 8.41 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -130.37 145.92 51.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.81 -0.818 . . . . 0.0 109.377 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.8 tt -123.57 142.36 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -127.71 151.51 48.89 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.434 0.635 . . . . 0.0 109.667 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.529 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 36.9 t0 -141.78 -153.16 0.45 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.485 -0.759 . . . . 0.0 109.381 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.529 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 95.5 m-20 -78.91 -7.47 58.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.88 . . . . 0.0 109.935 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.5 p -108.75 -85.8 0.52 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.335 -0.853 . . . . 0.0 110.363 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.0 -148.86 0.32 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.473 -0.767 . . . . 0.0 109.622 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -145.44 156.36 43.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.271 -0.893 . . . . 0.0 110.087 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.7 tt -148.91 164.8 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.368 -0.833 . . . . 0.0 109.978 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.63 144.17 35.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.158 -0.964 . . . . 0.0 110.148 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.829 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -135.21 161.23 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.485 -0.759 . . . . 0.0 109.665 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.2 m -137.79 139.98 40.33 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 58' ' ' LYS . 4.7 p -119.58 116.24 25.64 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -96.78 117.09 30.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.382 -0.824 . . . . 0.0 110.273 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.83 -13.26 3.23 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.429 ' O ' ' OG ' ' A' ' 55' ' ' SER . 28.3 mmtp -103.77 107.15 17.89 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.365 -1.08 . . . . 0.0 109.352 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -72.64 145.02 47.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.569 -0.707 . . . . 0.0 109.728 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.1 mt -127.14 153.25 46.27 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -105.75 141.56 36.97 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.613 0.721 . . . . 0.0 109.847 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 63' ' ' SER . 57.1 t0 -66.25 138.42 57.64 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.592 0.711 . . . . 0.0 110.782 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.528 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 5.0 m 61.56 78.85 0.27 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.354 0.597 . . . . 0.0 110.749 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.416 ' CG ' ' O ' ' A' ' 63' ' ' SER . 56.7 m-20 -163.33 126.92 2.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.691 -0.631 . . . . 0.0 109.422 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.7 t -78.24 121.63 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.1 m -137.72 160.67 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.43 -0.794 . . . . 0.0 109.855 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.621 ' HE ' HD12 ' A' ' 19' ' ' ILE . 41.8 ttm180 -117.36 128.74 55.34 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.4 mt -106.95 126.57 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -109.85 141.22 42.85 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.72 -0.612 . . . . 0.0 109.729 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 61.7 t30 62.74 41.01 9.47 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.484 0.659 . . . . 0.0 109.385 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.57 147.31 49.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.422 -0.799 . . . . 0.0 109.087 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -103.37 125.53 50.04 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.537 -0.727 . . . . 0.0 109.578 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.0 t -86.25 132.7 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.482 -0.761 . . . . 0.0 109.69 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.66 152.92 41.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.321 -0.862 . . . . 0.0 109.174 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -107.35 122.3 46.3 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.446 -0.784 . . . . 0.0 109.556 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -126.08 138.91 53.74 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.1 t30 56.25 24.06 7.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.559 -0.713 . . . . 0.0 109.507 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.64 8.35 87.72 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -118.19 138.97 51.95 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.42 -1.047 . . . . 0.0 109.698 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.9 mt -75.53 145.15 41.54 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.629 0.728 . . . . 0.0 110.342 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.5 p -154.77 160.62 41.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.552 -0.717 . . . . 0.0 109.139 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.7 mt -105.16 126.27 51.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.414 -0.804 . . . . 0.0 109.331 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.9 p -109.2 134.37 51.83 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.558 -0.714 . . . . 0.0 109.6 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.8 t -100.51 114.08 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.306 -0.871 . . . . 0.0 108.749 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.14 175.85 44.99 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 87' ' ' SER . 43.3 p-10 -67.43 -24.24 65.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.571 -0.958 . . . . 0.0 109.822 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.453 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 66.2 m -84.17 -6.4 59.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.238 -0.914 . . . . 0.0 109.634 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.9 t -81.96 170.84 15.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.756 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -131.52 141.25 49.69 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.619 -0.675 . . . . 0.0 109.751 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.8 130.51 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.645 -0.66 . . . . 0.0 109.438 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -121.33 120.39 34.92 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.55 0.69 . . . . 0.0 109.374 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.2 m -75.69 147.15 39.64 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.506 -0.746 . . . . 0.0 110.176 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.7 t . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.283 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.9 p30 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.524 0.678 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.554 ' N ' HD22 ' A' ' 3' ' ' LEU . 3.8 mm? -83.7 130.44 34.96 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.457 -0.777 . . . . 0.0 109.994 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.4 m -138.32 161.68 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.544 0.687 . . . . 0.0 109.559 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -86.7 163.55 17.27 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.539 0.685 . . . . 0.0 109.883 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.2 mm -62.87 -43.78 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.613 -0.679 . . . . 0.0 109.85 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -66.76 -18.99 65.65 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.019 -1.051 . . . . 0.0 109.435 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -84.18 -1.68 55.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 0.0 109.566 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.47 131.59 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.204 -0.935 . . . . 0.0 110.136 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.4 t -163.41 160.07 23.04 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.3 -3.66 6.33 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.9 m -59.75 -35.63 74.98 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.63 -0.668 . . . . 0.0 109.248 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.7 p -115.28 133.63 22.69 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.66 -0.65 . . . . 0.0 109.701 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.61 -53.05 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.127 1.885 . . . . 0.0 111.781 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -119.66 130.73 55.2 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.368 0.604 . . . . 0.0 109.866 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.0 m -146.93 163.93 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.537 -0.727 . . . . 0.0 109.591 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.9 t -110.15 138.24 46.8 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.435 -0.791 . . . . 0.0 109.505 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.02 160.52 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.529 -0.732 . . . . 0.0 109.713 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.0 tt -142.96 137.58 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 109.599 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.48 -161.94 28.9 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.866 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -110.4 129.11 55.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.671 -0.899 . . . . 0.0 109.438 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.2 mt -101.75 131.12 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.766 -0.584 . . . . 0.0 109.991 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.474 ' HA ' ' H ' ' A' ' 63' ' ' SER . 23.0 m -145.27 153.45 41.3 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.591 0.71 . . . . 0.0 109.997 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.51 65.18 1.75 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.9 mm -81.58 129.1 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -1.138 . . . . 0.0 109.94 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -123.89 132.71 53.79 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -94.27 134.14 37.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.0 109.876 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -145.21 157.95 43.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.454 -0.779 . . . . 0.0 109.284 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -123.6 144.23 49.72 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.518 -0.739 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -142.38 160.63 39.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.375 -0.828 . . . . 0.0 109.321 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -80.1 148.29 31.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.434 -0.792 . . . . 0.0 109.832 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.581 ' O ' ' N ' ' A' ' 34' ' ' GLY . 34.1 m -144.97 -149.5 0.28 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.474 -0.766 . . . . 0.0 109.114 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -50.95 84.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.758 0.79 . . . . 0.0 110.13 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 47.69 19.98 1.01 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -147.91 151.16 35.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.072 -1.252 . . . . 0.0 110.156 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.8 m -89.66 131.12 35.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.451 -0.78 . . . . 0.0 109.171 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -119.33 146.75 45.03 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.579 0.704 . . . . 0.0 109.942 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 89.2 p -83.77 146.35 28.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.49 -0.757 . . . . 0.0 109.924 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -139.54 137.81 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -104.25 128.9 52.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.499 -0.751 . . . . 0.0 109.401 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -113.85 154.61 27.19 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.18 -169.53 37.79 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -124.85 146.36 49.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.659 -0.906 . . . . 0.0 109.611 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.2 tt -125.39 139.44 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -126.95 149.35 49.88 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.528 -0.732 . . . . 0.0 110.234 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 42.7 t0 -136.13 -160.44 1.05 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.516 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 1.4 p30 -81.29 -3.53 52.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 110.056 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.9 p -107.06 -62.11 1.45 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.278 -0.889 . . . . 0.0 109.438 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -160.71 -151.46 0.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.23 -0.919 . . . . 0.0 109.583 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -144.8 156.96 44.31 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.4 tt -146.63 159.49 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.297 -0.877 . . . . 0.0 110.053 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -76.42 144.5 39.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.381 -0.824 . . . . 0.0 109.697 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.2 pt -128.73 157.96 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.491 -0.756 . . . . 0.0 110.076 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -145.0 126.43 14.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.4 t -114.84 127.52 55.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.486 -0.759 . . . . 0.0 109.492 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -97.44 117.78 32.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.577 -0.702 . . . . 0.0 110.349 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.64 -54.58 4.97 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -70.31 138.18 51.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.128 -1.219 . . . . 0.0 110.669 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -88.41 158.37 18.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.618 -0.676 . . . . 0.0 110.077 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.6 mt -121.27 153.63 37.42 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -106.88 135.47 48.38 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.685 0.755 . . . . 0.0 109.838 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -66.42 136.84 56.32 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.751 0.786 . . . . 0.0 110.948 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.474 ' H ' ' HA ' ' A' ' 23' ' ' THR . 67.0 m 45.82 78.85 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.605 0.717 . . . . 0.0 110.145 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -150.68 126.52 10.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.626 -0.671 . . . . 0.0 109.358 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.5 t -78.55 115.87 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.498 -0.751 . . . . 0.0 109.23 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.1 m -140.58 166.87 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.487 -0.758 . . . . 0.0 109.94 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -121.8 130.38 53.35 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 74.8 mt -107.33 129.55 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.55 -0.719 . . . . 0.0 109.221 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -111.25 143.05 42.64 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.343 0.592 . . . . 0.0 109.955 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.5 t30 62.67 38.61 11.92 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.154 0.502 . . . . 0.0 109.883 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.13 139.2 46.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -0.854 . . . . 0.0 108.98 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -92.61 132.89 36.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.283 -0.886 . . . . 0.0 110.173 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -87.01 132.03 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.456 -0.778 . . . . 0.0 109.828 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.85 155.23 48.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.301 -0.874 . . . . 0.0 109.509 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -120.78 120.27 35.13 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -123.37 132.51 54.0 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.495 0.664 . . . . 0.0 109.602 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 55.84 32.02 18.81 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.42 0.628 . . . . 0.0 109.804 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.54 4.93 81.86 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -112.48 136.23 52.24 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.39 -1.065 . . . . 0.0 109.828 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.42 148.44 37.31 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.694 0.759 . . . . 0.0 110.77 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.0 t -156.25 154.44 30.71 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.5 mt -100.38 127.43 46.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.229 -0.92 . . . . 0.0 109.296 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 m -106.06 124.19 49.18 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.466 0.65 . . . . 0.0 109.354 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.4 t -96.8 112.43 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.291 -0.881 . . . . 0.0 108.919 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.92 178.44 43.71 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.14 -21.16 62.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.653 -0.91 . . . . 0.0 110.254 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.3 p -85.72 -5.44 59.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.167 -0.958 . . . . 0.0 109.28 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.1 p -79.03 167.6 20.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.447 -0.783 . . . . 0.0 109.883 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -131.45 141.74 49.86 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.421 0.629 . . . . 0.0 109.411 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.05 130.98 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -124.9 138.66 54.24 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.558 0.694 . . . . 0.0 109.443 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.2 m -70.58 150.26 46.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.628 -0.67 . . . . 0.0 110.126 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 51.7 t . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.608 0.718 . . . . 0.0 109.438 179.927 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 54.0 t0 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.652 0.739 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.487 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 47.3 tp -74.25 124.45 26.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.474 -0.766 . . . . 0.0 110.09 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 m -140.69 167.46 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.731 0.777 . . . . 0.0 110.116 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.18 156.5 29.81 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.732 0.777 . . . . 0.0 110.556 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.28 -43.09 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.715 -0.615 . . . . 0.0 109.881 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -65.34 -19.45 65.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.933 . . . . 0.0 109.855 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -85.82 -2.29 58.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 109.206 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.7 t -66.83 132.9 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.42 -0.8 . . . . 0.0 110.431 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.5 p -156.55 168.22 28.06 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.637 0.732 . . . . 0.0 109.556 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.36 -37.33 85.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.494 -0.754 . . . . 0.0 109.306 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.4 m -55.94 -20.81 17.6 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.367 -0.833 . . . . 0.0 109.548 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 p -113.77 79.57 4.56 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.65 -20.42 35.39 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.572 2.181 . . . . 0.0 112.036 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -128.07 106.18 8.9 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.581 -0.699 . . . . 0.0 109.549 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.4 m -139.2 162.9 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.61 -0.681 . . . . 0.0 110.123 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.9 t -118.33 135.96 54.0 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.3 m -133.41 162.27 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.773 0.797 . . . . 0.0 110.068 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.61 HD12 ' NH2' ' A' ' 67' ' ' ARG . 5.1 tt -136.64 142.55 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.553 -0.717 . . . . 0.0 109.53 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.65 -167.0 39.72 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.403 -1.379 . . . . 0.0 110.076 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -110.65 133.86 52.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.651 -0.911 . . . . 0.0 109.398 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 63' ' ' SER . 89.0 mt -102.55 132.42 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.254 0.55 . . . . 0.0 109.798 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 t -141.7 158.18 44.14 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.723 0.773 . . . . 0.0 109.944 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.17 53.38 3.48 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.548 ' N ' HD12 ' A' ' 25' ' ' ILE . 1.5 mp -78.14 125.6 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.371 -1.076 . . . . 0.0 109.652 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -126.85 124.21 39.07 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -83.28 128.47 34.52 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.664 0.745 . . . . 0.0 110.043 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -141.61 159.38 42.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.448 -0.782 . . . . 0.0 109.122 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -116.93 140.59 49.29 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.698 -0.626 . . . . 0.0 109.688 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 18.3 p90 -137.29 158.74 43.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -90.01 100.76 13.52 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.664 0.745 . . . . 0.0 110.357 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.596 ' O ' ' N ' ' A' ' 34' ' ' GLY . 10.7 t -82.83 -151.18 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.503 -0.748 . . . . 0.0 110.097 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -55.69 77.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.765 0.793 . . . . 0.0 110.217 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 58.3 23.41 53.25 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.8 m -145.89 133.36 20.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.265 -1.138 . . . . 0.0 109.702 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.4 m -79.82 130.65 35.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.3 -0.875 . . . . 0.0 109.805 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.402 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 68.7 mttm -133.48 148.13 51.7 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.815 0.817 . . . . 0.0 110.129 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.8 t -77.52 144.95 37.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.562 -0.712 . . . . 0.0 110.494 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -140.5 137.81 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.378 -0.826 . . . . 0.0 109.579 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -106.35 132.07 52.82 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.444 -0.785 . . . . 0.0 109.277 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -118.27 153.53 33.78 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.595 -0.691 . . . . 0.0 109.694 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.52 -157.13 16.06 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -135.88 146.8 47.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.483 -1.01 . . . . 0.0 109.643 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 tt -122.0 143.33 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -133.76 152.57 51.91 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.634 0.73 . . . . 0.0 110.027 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -147.86 -157.18 0.79 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.609 0.718 . . . . 0.0 109.725 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -80.33 -7.03 58.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.392 -0.817 . . . . 0.0 109.893 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 49' ' ' ALA . 81.5 p -100.91 -68.64 0.8 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.277 -0.89 . . . . 0.0 109.606 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.401 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -159.78 -148.55 0.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.175 -0.953 . . . . 0.0 109.956 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -144.75 152.57 40.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.126 -0.984 . . . . 0.0 110.362 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.0 tt -150.61 147.98 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.224 -0.922 . . . . 0.0 110.222 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -74.22 138.13 43.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.496 -0.752 . . . . 0.0 109.872 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.85 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -133.58 164.48 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.333 -0.855 . . . . 0.0 110.038 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.1 t -142.09 140.43 32.53 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.428 -0.795 . . . . 0.0 109.297 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.6 t -115.59 129.77 56.63 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.452 0.644 . . . . 0.0 109.512 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -97.66 119.38 36.13 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.583 0.706 . . . . 0.0 110.832 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.85 -46.91 1.8 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.492 ' HE2' HD12 ' A' ' 90' ' ' ILE . 54.4 mtpt -73.6 134.81 43.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.284 -1.127 . . . . 0.0 110.603 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -91.56 153.42 19.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.49 -0.756 . . . . 0.0 110.093 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.9 mt -133.0 157.77 44.37 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.463 0.649 . . . . 0.0 109.649 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -103.12 157.11 17.22 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.016 0.913 . . . . 0.0 110.395 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 47.4 p30 -76.71 150.39 36.3 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.66 0.743 . . . . 0.0 111.312 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 22' ' ' ILE . 4.2 p 39.02 36.79 0.17 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.31 0.576 . . . . 0.0 110.073 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 47.1 p-10 -98.96 129.89 45.29 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.489 -0.757 . . . . 0.0 110.353 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.8 t -79.07 112.95 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.601 -0.687 . . . . 0.0 109.207 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.23 164.78 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.43 -0.794 . . . . 0.0 110.148 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.61 ' NH2' HD12 ' A' ' 19' ' ' ILE . 59.6 ttm-85 -119.08 130.12 55.44 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 74.3 mt -105.84 124.84 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.561 -0.712 . . . . 0.0 109.183 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -114.84 142.41 46.59 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.454 0.645 . . . . 0.0 109.714 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.9 t30 63.99 40.35 7.3 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.613 0.721 . . . . 0.0 109.308 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.56 147.02 48.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.603 -0.685 . . . . 0.0 109.829 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -101.97 121.63 42.52 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.6 0.714 . . . . 0.0 109.467 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.16 134.25 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.569 -0.707 . . . . 0.0 110.324 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.37 153.82 45.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.465 -0.772 . . . . 0.0 109.094 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -114.82 114.27 25.33 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.458 -0.776 . . . . 0.0 109.452 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -112.96 126.34 55.37 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.692 0.758 . . . . 0.0 110.187 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 55.73 27.36 10.6 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.321 0.582 . . . . 0.0 110.658 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.84 4.64 84.71 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -112.31 131.04 55.73 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.48 -1.012 . . . . 0.0 109.768 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.02 144.4 40.89 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.747 0.784 . . . . 0.0 110.451 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.7 p -152.89 160.04 43.04 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.9 mt -106.91 131.73 53.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.425 -0.797 . . . . 0.0 109.662 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 t -109.14 125.83 52.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.666 -0.646 . . . . 0.0 109.377 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.455 HG11 HD11 ' A' ' 90' ' ' ILE . 13.4 t -102.85 100.89 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.488 -0.758 . . . . 0.0 109.011 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.46 176.66 49.96 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -65.92 -29.44 69.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.574 -0.956 . . . . 0.0 109.647 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.4 m -74.79 -7.48 53.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 109.433 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.5 p -80.96 167.84 19.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.319 -0.863 . . . . 0.0 110.273 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -125.7 138.12 53.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.545 -0.722 . . . . 0.0 109.347 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.492 HD12 ' HE2' ' A' ' 58' ' ' LYS . 87.0 mt -125.17 129.96 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.536 -0.727 . . . . 0.0 109.65 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -118.71 113.28 20.92 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.3 t -75.05 150.31 38.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.461 -0.775 . . . . 0.0 110.517 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.6 t . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 110.054 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.764 0.792 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.2 tt -75.99 129.75 37.37 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.531 0.681 . . . . 0.0 109.957 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.9 m -140.17 163.62 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.934 0.874 . . . . 0.0 110.834 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -72.88 149.59 43.36 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.78 0.8 . . . . 0.0 110.247 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 92.0 mt -63.74 -42.6 96.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -69.65 -17.22 63.49 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.729 -0.607 . . . . 0.0 109.812 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -92.61 6.44 47.3 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.508 -0.745 . . . . 0.0 109.247 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.56 133.2 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.71 0.767 . . . . 0.0 109.947 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.1 p -153.27 166.85 31.27 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.962 0.887 . . . . 0.0 110.324 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.0 mt -73.07 -9.29 58.57 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.6 m -74.44 -14.72 60.88 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.3 p -121.49 84.09 41.66 Favored Pre-proline 0 N--CA 1.499 1.995 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.39 -41.19 74.84 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.613 2.209 . . . . 0.0 111.594 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -116.89 131.92 56.83 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.761 0.791 . . . . 0.0 109.992 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.4 m -149.77 175.71 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 122.273 1.035 . . . . 0.0 110.617 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.407 ' OG ' ' OD1' ' A' ' 69' ' ' ASP . 48.4 m -134.71 137.17 43.29 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -140.21 163.26 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.074 0.94 . . . . 0.0 110.643 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.6 tt -137.93 135.51 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.709 0.766 . . . . 0.0 109.893 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.29 -168.47 40.97 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -110.95 136.29 50.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.941 -0.741 . . . . 0.0 109.489 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.716 ' N ' HD12 ' A' ' 22' ' ' ILE . 2.4 mp -96.33 133.32 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.406 0.622 . . . . 0.0 109.714 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 t -136.07 159.78 40.65 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.75 0.786 . . . . 0.0 109.929 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 25' ' ' ILE . . . 99.63 -69.29 0.54 Allowed Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 24' ' ' GLY . 25.8 mm 59.11 128.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.844 0.83 . . . . 0.0 110.592 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.74 138.62 21.03 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.437 0.637 . . . . 0.0 109.358 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -106.0 129.13 54.18 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.002 0.906 . . . . 0.0 110.175 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -141.09 157.41 45.34 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.736 0.779 . . . . 0.0 110.074 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 56.5 mp0 -113.99 142.8 45.71 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.806 0.812 . . . . 0.0 110.243 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 31.7 p90 -143.66 161.96 37.19 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.598 0.713 . . . . 0.0 109.485 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -94.19 107.0 18.97 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.751 0.786 . . . . 0.0 110.388 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 34' ' ' GLY . 4.4 p -88.19 -161.54 0.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -52.18 80.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.597 0.713 . . . . 0.0 110.259 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 59.94 11.0 16.05 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 92.8 m -131.86 131.21 42.59 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.863 0.84 . . . . 0.0 110.791 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.2 m -79.48 128.32 33.22 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.55 0.69 . . . . 0.0 109.192 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.451 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 98.6 mttt -136.13 147.83 47.94 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.885 0.85 . . . . 0.0 110.15 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 87.5 p -82.03 149.91 27.86 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.846 0.831 . . . . 0.0 110.019 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -130.64 133.94 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.835 0.826 . . . . 0.0 109.836 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -98.2 133.36 42.74 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -130.62 150.82 51.64 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.742 0.782 . . . . 0.0 109.829 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.72 -169.43 35.31 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -122.24 139.62 53.57 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.622 0.725 . . . . 0.0 109.699 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.2 tt -113.08 136.43 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -121.5 149.79 42.55 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.948 0.88 . . . . 0.0 110.361 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 38.3 t0 -148.8 -164.57 2.05 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.62 0.724 . . . . 0.0 109.479 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.512 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 48.9 t0 -65.04 -38.59 91.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.609 -0.682 . . . . 0.0 109.825 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.1 p -73.22 -85.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.263 0.554 . . . . 0.0 109.712 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -143.49 -142.26 0.13 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.643 0.735 . . . . 0.0 109.971 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.7 ptt85 -148.96 158.32 44.09 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.758 0.79 . . . . 0.0 110.042 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.2 tt -152.65 158.94 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 122.033 0.921 . . . . 0.0 110.631 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.541 ' NH2' ' CG ' ' A' ' 76' ' ' PHE . 51.2 ttp180 -74.47 143.47 44.63 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.705 0.764 . . . . 0.0 110.107 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 pt -133.38 161.39 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.732 0.777 . . . . 0.0 110.327 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.0 m -144.76 138.93 27.5 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.747 0.784 . . . . 0.0 110.19 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 p -134.57 135.55 42.34 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.87 0.843 . . . . 0.0 109.579 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.455 ' C ' ' H ' ' A' ' 58' ' ' LYS . 88.0 m-85 -94.4 124.85 38.67 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.752 0.787 . . . . 0.0 110.796 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.57 -38.56 0.48 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.455 ' H ' ' C ' ' A' ' 56' ' ' PHE . 72.2 mmtt -68.42 133.66 49.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.66 -0.906 . . . . 0.0 110.001 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -97.71 148.49 23.29 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.765 0.793 . . . . 0.0 110.341 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.8 mt -129.94 152.78 49.04 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.568 0.699 . . . . 0.0 109.696 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -115.79 158.38 22.96 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.225 1.012 . . . . 0.0 110.421 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.9 t0 -62.01 138.19 58.34 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.815 0.817 . . . . 0.0 110.873 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.523 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 10.9 t 52.33 31.01 8.77 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.269 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -78.24 112.06 14.84 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.571 -0.705 . . . . 0.0 110.372 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 t -81.2 105.76 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.663 0.744 . . . . 0.0 109.281 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.7 m -140.99 164.65 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.647 0.736 . . . . 0.0 110.113 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.8 ttp85 -115.21 127.83 55.77 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.759 0.79 . . . . 0.0 109.582 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.3 mt -108.39 130.62 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.608 0.718 . . . . 0.0 109.844 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 67.8 t0 -125.32 142.44 51.5 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.556 0.693 . . . . 0.0 109.902 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.55 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 52.6 t30 71.92 35.09 1.39 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.387 0.613 . . . . 0.0 109.949 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.14 141.54 43.68 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.394 0.616 . . . . 0.0 110.407 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -95.17 128.37 41.95 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.755 0.788 . . . . 0.0 109.893 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.8 t -80.64 132.4 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 121.679 0.752 . . . . 0.0 110.179 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -117.92 146.19 44.13 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.744 0.783 . . . . 0.0 109.549 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -108.47 97.64 7.28 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.525 0.679 . . . . 0.0 109.454 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.633 ' O ' ' N ' ' A' ' 78' ' ' GLY . 28.4 m-85 -82.83 -177.88 6.9 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.409 0.624 . . . . 0.0 110.55 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -51.94 75.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.499 0.666 . . . . 0.0 110.493 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 76' ' ' PHE . . . 74.71 15.56 80.64 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -130.62 144.62 51.55 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.565 -0.962 . . . . 0.0 110.395 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.5 mt -103.1 140.35 37.43 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.859 0.838 . . . . 0.0 110.126 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 96.3 p -152.53 163.52 39.41 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.701 0.763 . . . . 0.0 109.854 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.7 mt -106.07 131.03 53.83 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.651 0.739 . . . . 0.0 110.176 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.2 p -107.67 123.97 49.29 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.838 0.828 . . . . 0.0 109.761 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.2 t -100.41 112.26 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.854 0.835 . . . . 0.0 109.6 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -97.19 -179.26 34.22 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -66.11 -29.14 69.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.914 -0.756 . . . . 0.0 109.736 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 89.4 p -78.67 -4.91 51.42 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.8 t -80.39 167.65 19.95 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.467 0.651 . . . . 0.0 110.087 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 24.7 mmt85 -124.96 137.79 54.25 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.716 0.77 . . . . 0.0 109.953 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.8 mt -127.19 130.47 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.511 0.672 . . . . 0.0 110.386 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -124.59 125.76 44.68 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.78 0.8 . . . . 0.0 109.402 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.2 p -75.73 152.95 37.35 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.714 0.768 . . . . 0.0 110.433 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 64.2 t . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.566 0.698 . . . . 0.0 109.399 179.505 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 55.4 t0 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.674 0.749 . . . . 0.0 110.552 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.54 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 43.2 tp -77.6 123.24 26.37 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.425 -0.797 . . . . 0.0 109.744 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.1 m -140.28 165.03 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.385 -0.822 . . . . 0.0 110.067 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.6 157.56 31.84 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.81 0.814 . . . . 0.0 110.492 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 6' ' ' ILE . 2.3 mp -63.97 -42.72 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.619 -0.676 . . . . 0.0 109.256 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -64.25 -24.15 67.56 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.239 -0.913 . . . . 0.0 109.557 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -83.21 -0.16 48.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.952 -1.093 . . . . 0.0 109.496 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.2 131.99 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.074 -1.016 . . . . 0.0 110.562 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.3 p -158.99 167.37 29.54 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.55 -0.719 . . . . 0.0 109.331 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.19 -19.54 66.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.89 . . . . 0.0 108.888 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -63.86 -17.24 62.97 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.318 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.6 p -124.36 82.02 58.38 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.318 -0.864 . . . . 0.0 109.231 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.32 -41.42 66.53 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.958 2.439 . . . . 0.0 112.151 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -119.28 128.1 53.84 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.422 -0.799 . . . . 0.0 109.814 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.6 m -147.17 161.11 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.256 -0.903 . . . . 0.0 110.116 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.5 m -115.46 134.17 55.34 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.69 162.38 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.873 0.844 . . . . 0.0 110.324 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.0 tt -140.49 137.98 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.428 -0.795 . . . . 0.0 109.524 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.45 -162.91 29.41 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' C ' HD12 ' A' ' 22' ' ' ILE . 26.7 ttmt -111.58 128.81 56.15 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.58 -0.953 . . . . 0.0 109.359 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.736 HD12 ' N ' ' A' ' 22' ' ' ILE . 1.8 mp -94.53 125.74 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.533 0.682 . . . . 0.0 109.737 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.7 p -132.7 159.29 40.06 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.836 0.827 . . . . 0.0 110.091 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.9 82.02 0.19 Allowed Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.4 mm -92.1 129.81 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.092 -1.24 . . . . 0.0 110.267 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -133.73 139.1 46.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.534 -0.729 . . . . 0.0 109.132 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -103.28 136.45 43.03 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.766 0.793 . . . . 0.0 109.917 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.593 ' NZ ' ' NH2' ' A' ' 52' ' ' ARG . 53.1 mtmt -144.25 160.24 41.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.488 -0.757 . . . . 0.0 109.317 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -122.11 144.73 48.75 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.626 0.727 . . . . 0.0 109.701 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -142.63 160.92 39.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 109.289 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -93.98 116.23 28.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.293 -0.879 . . . . 0.0 109.889 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 t -109.23 110.2 21.34 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.822 0.82 . . . . 0.0 109.362 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 53.34 33.6 16.07 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.57 0.7 . . . . 0.0 110.722 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.27 -2.01 77.73 Favored Glycine 0 N--CA 1.496 2.643 0 O-C-N 120.962 -1.086 . . . . 0.0 111.047 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.7 p -115.95 125.22 52.25 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.089 -1.242 . . . . 0.0 109.928 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.1 m -69.6 133.42 47.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.55 -0.719 . . . . 0.0 110.094 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -136.71 144.94 44.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.367 -0.833 . . . . 0.0 109.889 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.4 m -83.25 144.83 29.48 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.771 0.796 . . . . 0.0 110.311 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.417 HG22 ' OE1' ' A' ' 41' ' ' GLN . 14.2 p -140.51 137.81 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.898 . . . . 0.0 108.85 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -102.1 135.29 43.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.436 -0.79 . . . . 0.0 109.495 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.606 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 1.1 mp0 -117.05 152.12 35.35 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.631 0.729 . . . . 0.0 109.176 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.34 -171.86 35.43 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -130.49 139.05 50.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.481 -1.011 . . . . 0.0 109.271 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 44' ' ' ILE . 19.2 tt -114.62 130.9 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -123.6 151.56 42.83 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.655 0.741 . . . . 0.0 109.932 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 30.7 t0 -155.72 -161.87 1.23 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.489 -0.757 . . . . 0.0 109.673 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.545 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 95.8 m-20 -74.26 -3.48 30.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.283 -0.886 . . . . 0.0 110.383 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.504 ' OG1' ' N ' ' A' ' 49' ' ' ALA . 8.1 p -101.15 -62.46 1.24 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.849 -1.157 . . . . 0.0 109.323 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.504 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -171.29 -150.51 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.96 -1.087 . . . . 0.0 110.364 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -135.32 145.63 47.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.514 -0.741 . . . . 0.0 109.894 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.2 tt -150.2 150.2 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.166 -0.959 . . . . 0.0 110.025 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.593 ' NH2' ' NZ ' ' A' ' 28' ' ' LYS . 72.9 ttt180 -73.01 146.55 45.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.457 -0.777 . . . . 0.0 110.383 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.6 pt -132.3 158.6 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.455 -0.778 . . . . 0.0 109.744 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.8 m -143.72 126.54 16.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.178 -0.951 . . . . 0.0 109.073 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.4 t -114.13 128.31 56.32 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.566 -0.709 . . . . 0.0 109.357 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -95.38 121.41 37.02 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.738 0.78 . . . . 0.0 110.95 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.19 -47.72 3.22 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -82.59 135.14 35.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.287 . . . . 0.0 110.674 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.665 ' CD ' ' H ' ' A' ' 59' ' ' GLN . 1.8 pm0 -89.98 165.71 13.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.679 -0.638 . . . . 0.0 110.119 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.6 mt -124.03 158.43 32.15 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.547 0.689 . . . . 0.0 109.478 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -107.51 133.46 51.95 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.376 1.084 . . . . 0.0 109.889 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 63' ' ' SER . 66.2 t0 -60.86 142.79 55.9 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.986 0.898 . . . . 0.0 111.304 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.555 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 2.0 m 50.98 29.57 4.61 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.496 0.665 . . . . 0.0 110.171 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -94.48 129.31 41.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.064 -1.022 . . . . 0.0 110.807 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.6 t -89.55 111.36 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.34 -0.85 . . . . 0.0 108.8 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.406 HG22 HD13 ' A' ' 22' ' ' ILE . 17.0 m -139.27 166.27 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.216 -0.928 . . . . 0.0 110.318 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -118.58 127.11 53.3 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.2 mt -107.01 127.69 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.257 -0.902 . . . . 0.0 109.435 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -111.17 145.46 38.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.699 -0.626 . . . . 0.0 109.72 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.6 t30 63.39 38.68 9.92 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.851 0.834 . . . . 0.0 109.401 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.82 134.94 41.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.812 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -88.06 136.96 32.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.414 -0.804 . . . . 0.0 110.237 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.0 t -96.62 132.7 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -0.856 . . . . 0.0 109.487 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.7 155.03 48.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 109.394 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -117.87 115.94 25.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.612 -0.68 . . . . 0.0 109.197 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -125.2 134.74 52.25 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.703 0.764 . . . . 0.0 109.812 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.6 m120 56.28 29.68 15.37 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.731 0.777 . . . . 0.0 109.974 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.29 7.84 85.11 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -114.42 134.59 54.88 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.435 -1.038 . . . . 0.0 109.92 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.7 mt -79.91 143.17 34.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.4 -0.813 . . . . 0.0 110.093 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.5 m -151.71 158.67 43.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 109.289 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.2 mt -104.19 127.54 51.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.393 -0.817 . . . . 0.0 109.328 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -107.07 125.43 51.03 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.648 0.737 . . . . 0.0 109.541 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 t -98.43 111.85 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.411 -0.806 . . . . 0.0 109.416 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.07 -179.32 42.97 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 87' ' ' SER . 47.4 p30 -70.89 -18.17 62.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.448 -1.031 . . . . 0.0 109.484 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.509 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 98.7 p -85.33 -7.89 58.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.152 -0.968 . . . . 0.0 109.487 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 m -80.93 165.7 21.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.103 -0.998 . . . . 0.0 110.336 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 24.9 tpt85 -127.66 133.56 49.63 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.549 0.69 . . . . 0.0 109.542 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -114.97 129.62 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.582 -0.699 . . . . 0.0 109.703 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -123.35 117.62 25.64 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.775 0.797 . . . . 0.0 109.067 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 73.6 m -77.36 147.18 36.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.549 -0.72 . . . . 0.0 110.368 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.029 179.571 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 67.0 t0 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.477 0.656 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.541 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 35.6 tp -71.75 130.23 40.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.554 -0.716 . . . . 0.0 109.782 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.18 164.5 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.417 -0.802 . . . . 0.0 109.648 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -80.29 159.1 25.95 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.608 -0.683 . . . . 0.0 110.569 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.54 ' N ' HD12 ' A' ' 6' ' ' ILE . 1.4 mp -63.42 -45.49 97.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.626 -0.671 . . . . 0.0 109.255 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -63.43 -20.31 65.45 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.512 -0.743 . . . . 0.0 109.841 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 8' ' ' ASP . 53.2 t0 -87.44 -2.8 58.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.377 -0.827 . . . . 0.0 109.529 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.0 t -70.04 132.65 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -0.938 . . . . 0.0 110.144 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.7 m -158.24 172.59 18.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.478 -0.764 . . . . 0.0 109.555 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.33 -38.95 93.15 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.427 -0.796 . . . . 0.0 109.652 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.5 t -55.0 -17.13 3.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.388 -0.82 . . . . 0.0 109.8 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 p -114.37 79.59 5.37 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.462 -0.774 . . . . 0.0 109.113 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.92 -20.63 29.15 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.229 1.953 . . . . 0.0 112.324 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -131.71 110.06 10.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.537 -0.727 . . . . 0.0 109.299 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.9 m -142.21 163.97 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.359 -0.838 . . . . 0.0 110.306 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.419 ' O ' HD12 ' A' ' 3' ' ' LEU . 25.3 t -113.0 141.52 46.75 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.2 t -135.33 155.98 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.239 -0.913 . . . . 0.0 109.775 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 19' ' ' ILE . 20.0 tt -140.13 132.76 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.329 -0.857 . . . . 0.0 109.384 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.61 -160.51 30.78 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 118.909 -1.615 . . . . 0.0 110.366 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -111.83 136.82 50.62 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.796 -0.826 . . . . 0.0 109.638 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 63' ' ' SER . 92.9 mt -103.5 130.75 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.474 -0.766 . . . . 0.0 109.636 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.4 p -134.86 159.53 41.1 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.508 -0.745 . . . . 0.0 109.787 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.84 78.13 0.39 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.5 mm -95.08 123.37 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.189 -1.183 . . . . 0.0 109.366 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -115.81 137.98 51.57 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -101.61 129.78 47.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.524 -0.735 . . . . 0.0 109.594 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -144.25 161.07 39.85 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.5 137.05 55.0 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.326 -0.859 . . . . 0.0 109.779 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -130.15 153.8 48.17 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 58.1 mp0 -88.32 136.42 32.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -0.909 . . . . 0.0 109.731 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.7 t -137.03 109.72 7.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.498 -0.751 . . . . 0.0 109.166 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 54.2 t0 58.69 32.04 21.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.523 -0.736 . . . . 0.0 110.134 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.66 11.27 83.2 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.1 m -121.0 130.17 53.69 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.602 -0.94 . . . . 0.0 109.305 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.3 m -80.68 130.44 35.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 109.661 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -132.8 140.54 48.05 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.383 -0.823 . . . . 0.0 109.675 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.2 t -79.86 142.27 35.38 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.385 -0.822 . . . . 0.0 109.701 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 p -133.43 136.53 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -102.08 139.04 38.24 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.469 -0.769 . . . . 0.0 109.359 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -135.79 153.91 51.38 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.391 -0.818 . . . . 0.0 109.779 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.54 -150.37 7.93 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -134.77 143.51 47.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.588 -0.948 . . . . 0.0 109.511 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.6 tt -120.94 134.83 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -117.6 148.34 42.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.665 -0.647 . . . . 0.0 109.746 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -136.71 -164.82 1.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -72.15 -19.1 61.82 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.517 -0.739 . . . . 0.0 109.462 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.9 m -93.67 -76.35 0.48 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.28 -0.888 . . . . 0.0 110.087 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.89 -148.68 0.25 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.388 -0.82 . . . . 0.0 109.925 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -144.53 157.01 44.42 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.351 -0.843 . . . . 0.0 110.069 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.2 tt -151.46 157.28 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.24 -0.912 . . . . 0.0 110.011 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -78.8 141.43 37.77 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.469 -0.769 . . . . 0.0 109.531 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.856 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -133.77 164.55 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.558 -0.714 . . . . 0.0 109.744 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.7 p -141.63 151.27 42.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 t -136.51 133.47 36.54 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.436 -0.79 . . . . 0.0 109.114 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -94.4 123.39 37.78 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.303 -0.873 . . . . 0.0 110.922 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.47 -57.41 2.03 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -61.07 130.6 47.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -1.184 . . . . 0.0 110.071 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -84.03 158.0 21.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.456 -0.777 . . . . 0.0 109.82 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.3 mt -120.67 153.22 37.19 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -115.75 130.66 56.93 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.833 0.825 . . . . 0.0 109.507 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 54.8 p-10 -66.28 142.99 57.48 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 110.835 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 22' ' ' ILE . 1.5 m 65.87 4.06 2.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.955 -0.466 . . . . 0.0 110.946 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 21.1 p-10 -81.47 136.27 35.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.632 -1.292 . . . . 0.0 110.154 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 t -95.6 113.29 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.166 -0.959 . . . . 0.0 108.841 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.6 m -139.24 165.53 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.746 0.784 . . . . 0.0 110.23 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -117.78 133.0 56.38 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.9 mt -106.17 129.55 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.511 -0.743 . . . . 0.0 109.137 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -111.36 143.28 42.42 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.638 -0.664 . . . . 0.0 109.538 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.2 t30 60.88 39.42 16.89 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.194 0.521 . . . . 0.0 109.834 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.58 146.47 50.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 0.0 108.969 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -99.99 121.03 40.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.595 -0.691 . . . . 0.0 109.748 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.1 t -83.79 133.91 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.463 -0.773 . . . . 0.0 109.763 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.24 155.19 45.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.249 -0.907 . . . . 0.0 109.326 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -114.12 119.49 37.29 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.534 -0.729 . . . . 0.0 109.29 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -124.42 135.37 53.21 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.617 -0.677 . . . . 0.0 109.614 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.1 m120 54.61 31.69 15.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.703 -0.623 . . . . 0.0 109.58 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.55 10.84 82.85 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -120.37 139.52 52.67 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.471 -1.017 . . . . 0.0 110.113 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 80' ' ' LEU . 4.0 mm? -76.84 144.26 39.16 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.825 0.822 . . . . 0.0 110.546 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.9 m -150.92 152.54 33.77 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.2 mt -103.94 128.65 51.47 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.33 -0.856 . . . . 0.0 108.845 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.2 t -109.83 125.92 53.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.642 -0.661 . . . . 0.0 109.491 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.2 t -99.58 109.44 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.32 -177.05 38.94 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.89 -31.71 72.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.725 -0.868 . . . . 0.0 109.765 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.9 m -76.43 -5.76 48.77 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.277 -0.889 . . . . 0.0 109.496 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.6 t -85.09 165.35 17.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.499 -0.751 . . . . 0.0 109.428 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -134.06 137.46 44.66 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.542 -0.724 . . . . 0.0 109.459 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.05 131.18 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -118.32 130.57 56.1 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.9 p -71.85 152.13 42.88 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.518 -0.739 . . . . 0.0 109.697 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.497 1.899 0 O-C-N 121.524 -0.735 . . . . 0.0 109.628 -179.833 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.677 0.751 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 17' ' ' SER . 38.2 tp -71.61 127.38 32.39 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.726 0.774 . . . . 0.0 110.074 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.57 163.93 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.882 0.848 . . . . 0.0 110.381 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.557 ' N ' ' OD2' ' A' ' 8' ' ' ASP . 63.5 mttp -76.89 148.26 36.54 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.856 0.836 . . . . 0.0 110.222 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.9 mm -59.72 -39.4 79.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.454 0.645 . . . . 0.0 109.786 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -62.7 -33.53 75.27 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.67 -0.644 . . . . 0.0 110.369 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.557 ' OD2' ' N ' ' A' ' 5' ' ' LYS . 7.5 p30 -83.32 12.39 5.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.476 -0.765 . . . . 0.0 110.269 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.9 t -71.4 130.2 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.737 0.779 . . . . 0.0 109.743 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.9 p -159.23 165.31 33.87 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.887 0.851 . . . . 0.0 109.983 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.2 mt -62.96 -30.2 71.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.662 -0.649 . . . . 0.0 109.487 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.9 m -52.8 -21.32 4.03 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.437 ' O ' ' OG1' ' A' ' 13' ' ' THR . 2.4 p -112.05 95.14 28.33 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.68 -18.85 19.26 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.701 2.267 . . . . 0.0 111.411 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -142.39 123.72 14.75 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.573 0.702 . . . . 0.0 109.601 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.5 m -153.74 173.24 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.897 0.856 . . . . 0.0 110.436 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.432 ' O ' HD12 ' A' ' 3' ' ' LEU . 43.1 m -128.41 149.43 50.55 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.65 0.738 . . . . 0.0 109.575 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.83 159.17 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.946 0.879 . . . . 0.0 110.403 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.515 ' CD1' ' HE ' ' A' ' 67' ' ' ARG . 97.0 mt -135.92 133.45 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.599 0.714 . . . . 0.0 109.894 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.52 -158.51 25.79 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.404 ' O ' ' OE2' ' A' ' 45' ' ' GLU . 36.8 ttpt -112.98 130.51 56.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.624 -0.927 . . . . 0.0 110.194 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.6 mt -99.61 133.1 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.404 0.621 . . . . 0.0 109.65 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.436 ' HA ' ' H ' ' A' ' 63' ' ' SER . 9.5 m -146.0 147.32 31.54 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.806 0.812 . . . . 0.0 110.205 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.42 76.28 1.22 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 25' ' ' ILE . 1.4 mp -94.59 115.18 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.647 -0.914 . . . . 0.0 109.865 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -111.55 121.92 46.44 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.573 0.702 . . . . 0.0 109.286 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -88.85 133.33 34.31 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.892 0.853 . . . . 0.0 110.215 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -148.2 151.48 35.59 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.488 0.661 . . . . 0.0 109.341 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 57.7 mp0 -111.8 140.61 46.29 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.831 0.824 . . . . 0.0 110.421 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.461 ' OH ' ' CD1' ' A' ' 56' ' ' PHE . 6.6 p90 -141.5 159.68 41.71 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.757 0.789 . . . . 0.0 109.708 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -91.23 95.93 10.3 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.765 0.793 . . . . 0.0 109.527 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.621 ' O ' ' N ' ' A' ' 34' ' ' GLY . 2.5 t -77.17 -149.5 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.263 0.554 . . . . 0.0 110.169 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -54.11 75.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.732 0.777 . . . . 0.0 110.402 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.621 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 58.83 24.85 58.24 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 t -147.49 141.01 25.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.631 -0.923 . . . . 0.0 109.661 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.8 m -88.61 125.85 35.01 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.682 0.753 . . . . 0.0 110.126 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -136.59 147.31 46.9 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.837 0.827 . . . . 0.0 109.734 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.9 t -81.62 145.01 30.82 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.676 0.75 . . . . 0.0 110.077 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 p -132.89 136.02 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.749 0.785 . . . . 0.0 109.662 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -104.86 130.23 53.03 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.584 0.707 . . . . 0.0 109.183 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -121.86 144.63 48.73 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.831 0.824 . . . . 0.0 109.927 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.54 -171.57 34.51 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -119.69 144.11 47.38 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.97 0.891 . . . . 0.0 110.396 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.68 136.96 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 21' ' ' LYS . 2.4 pm0 -125.31 154.93 41.02 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.037 0.922 . . . . 0.0 110.422 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 29.5 t0 -143.12 -156.56 0.69 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.507 0.67 . . . . 0.0 109.51 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.536 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 98.5 m-20 -73.82 -19.93 60.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.661 -0.649 . . . . 0.0 109.569 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 41.4 p -94.11 -88.5 0.24 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.584 -0.698 . . . . 0.0 109.486 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.79 -146.09 0.23 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.5 -0.75 . . . . 0.0 110.185 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -148.2 158.42 44.07 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.707 0.765 . . . . 0.0 110.482 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.2 tt -151.02 160.3 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-O 121.935 0.874 . . . . 0.0 110.477 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.8 ttp85 -78.82 145.01 34.51 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.832 0.825 . . . . 0.0 110.621 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.6 pt -131.27 159.6 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.634 0.73 . . . . 0.0 109.816 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.2 m -143.63 118.77 10.11 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.643 0.735 . . . . 0.0 109.695 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.4 p -109.35 142.4 40.34 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.838 0.828 . . . . 0.0 109.79 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.521 ' C ' ' H ' ' A' ' 58' ' ' LYS . 76.1 m-85 -102.72 117.36 34.47 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.64 0.733 . . . . 0.0 110.845 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.25 -31.48 0.26 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.521 ' H ' ' C ' ' A' ' 56' ' ' PHE . 13.9 tptp -66.55 129.94 41.52 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.684 -0.892 . . . . 0.0 110.915 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -83.71 138.0 33.5 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.85 0.833 . . . . 0.0 110.761 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.2 mt -128.47 150.73 50.02 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -109.53 143.66 38.87 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.762 0.792 . . . . 0.0 110.134 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -67.11 137.95 56.72 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.884 0.849 . . . . 0.0 110.182 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.436 ' H ' ' HA ' ' A' ' 23' ' ' THR . 7.3 t 51.68 80.64 0.08 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.725 0.774 . . . . 0.0 109.396 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -153.26 121.83 6.34 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.723 0.773 . . . . 0.0 110.151 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.465 HG22 ' H ' ' A' ' 65' ' ' VAL . 1.8 m -74.1 119.46 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.915 0.864 . . . . 0.0 109.487 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.2 m -141.04 167.93 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-O 122.479 1.133 . . . . 0.0 110.242 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.515 ' HE ' ' CD1' ' A' ' 19' ' ' ILE . 39.2 ttm180 -113.76 126.28 55.04 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.031 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.413 ' CG2' ' HB2' ' A' ' 71' ' ' ALA . 94.0 mt -106.04 118.34 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.638 0.733 . . . . 0.0 109.484 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -122.03 151.43 40.84 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.917 0.865 . . . . 0.0 110.123 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 61.48 37.01 16.84 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.794 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.413 ' HB2' ' CG2' ' A' ' 68' ' ' ILE . . . -92.27 147.21 23.1 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.602 -0.687 . . . . 0.0 109.454 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -103.64 153.18 20.91 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.26 1.029 . . . . 0.0 110.839 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.26 132.61 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.738 0.78 . . . . 0.0 109.548 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.26 155.48 43.87 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.758 0.79 . . . . 0.0 110.038 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -112.6 119.21 37.36 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.613 0.72 . . . . 0.0 109.318 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -121.53 132.76 54.88 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.813 0.816 . . . . 0.0 109.881 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 58.04 23.0 9.52 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.334 0.588 . . . . 0.0 109.979 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.91 6.84 81.85 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -117.53 136.64 53.1 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.509 -0.995 . . . . 0.0 110.254 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.7 mt -75.58 145.19 41.39 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.711 0.767 . . . . 0.0 110.181 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 93.9 p -156.9 160.21 38.89 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.626 0.727 . . . . 0.0 109.914 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.7 mt -104.92 108.76 20.43 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.796 0.807 . . . . 0.0 109.082 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.8 m -88.93 141.21 28.68 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.745 0.783 . . . . 0.0 109.748 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.431 HG11 HD11 ' A' ' 90' ' ' ILE . 41.5 t -121.85 126.87 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.871 0.843 . . . . 0.0 109.7 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.66 173.35 25.81 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.29 -17.97 63.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.777 -0.837 . . . . 0.0 109.029 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.0 m -84.55 -5.76 59.32 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.404 ' OG ' ' CG1' ' A' ' 84' ' ' VAL . 13.5 p -76.87 168.97 19.17 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.599 0.714 . . . . 0.0 110.309 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.415 ' NH2' ' OE2' ' A' ' 91' ' ' GLU . 77.6 ttt180 -121.87 123.53 41.97 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.855 0.836 . . . . 0.0 109.856 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.431 HD11 HG11 ' A' ' 84' ' ' VAL . 96.4 mt -124.22 129.04 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.654 0.74 . . . . 0.0 109.746 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.415 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 97.7 mt-10 -126.03 123.12 37.74 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.797 0.808 . . . . 0.0 110.005 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.6 t -74.17 144.12 44.95 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.309 0.576 . . . . 0.0 109.713 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 121.929 0.871 . . . . 0.0 110.254 -179.771 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 67.9 t0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.365 0.602 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.446 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 49.7 tp -70.89 127.06 31.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 109.609 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.17 162.64 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.548 -0.72 . . . . 0.0 109.57 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -78.31 154.25 31.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.458 -0.776 . . . . 0.0 110.265 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.98 -43.59 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.464 -0.772 . . . . 0.0 109.475 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -66.79 -18.2 65.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.66 2.6 56.36 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.176 -0.952 . . . . 0.0 109.808 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.7 t -67.03 133.69 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.325 -0.859 . . . . 0.0 110.198 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.5 p -158.02 164.93 36.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.571 -0.705 . . . . 0.0 109.515 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.2 mt -63.96 -22.44 66.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.323 -0.861 . . . . 0.0 109.067 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.9 t -58.23 -17.62 20.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.416 -0.803 . . . . 0.0 109.227 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.9 p -126.34 80.25 69.27 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.525 -0.734 . . . . 0.0 109.563 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.02 -39.98 77.87 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.524 2.149 . . . . 0.0 111.749 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -115.02 130.81 57.02 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.6 m -152.01 178.33 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.224 -0.923 . . . . 0.0 110.185 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.4 m -130.23 131.31 45.47 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.4 m -137.5 161.44 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.197 -0.939 . . . . 0.0 110.147 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.4 tt -143.77 146.57 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.381 -0.824 . . . . 0.0 109.408 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.05 -161.53 35.2 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.047 -1.549 . . . . 0.0 110.476 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -104.45 144.76 31.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.674 -0.898 . . . . 0.0 109.572 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 mm -98.73 132.46 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 56.5 p -134.95 158.09 45.2 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.438 -0.789 . . . . 0.0 109.652 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 25' ' ' ILE . . . 96.01 -72.34 0.86 Allowed Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.444 ' O ' ' O ' ' A' ' 24' ' ' GLY . 24.8 mm 50.01 101.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.458 -1.025 . . . . 0.0 110.158 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -129.66 131.25 46.35 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -93.44 133.3 36.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.307 -0.871 . . . . 0.0 109.637 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -146.76 152.4 38.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.417 -0.802 . . . . 0.0 109.284 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -111.31 144.82 39.87 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.725 -0.609 . . . . 0.0 109.372 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -146.15 164.13 33.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.33 -0.857 . . . . 0.0 109.391 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -87.52 142.73 27.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.643 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.4 t -147.08 110.59 4.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.343 -0.848 . . . . 0.0 108.761 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 55.76 31.7 18.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.702 -0.624 . . . . 0.0 109.609 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.55 14.7 75.41 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.2 p -128.15 134.48 49.09 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.371 -1.076 . . . . 0.0 109.609 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.9 m -83.36 128.84 34.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.542 -0.724 . . . . 0.0 109.668 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -136.42 144.44 44.48 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.416 -0.803 . . . . 0.0 109.295 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.1 p -79.78 153.4 29.21 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.238 -0.914 . . . . 0.0 110.211 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -141.83 140.74 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -103.13 131.45 50.13 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.4 -0.813 . . . . 0.0 109.614 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.485 ' OE1' ' NH2' ' A' ' 52' ' ' ARG . 78.0 mt-30 -121.28 153.52 37.57 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.72 -156.72 14.55 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.644 -1.265 . . . . 0.0 109.953 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -137.36 139.98 41.13 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 44' ' ' ILE . 18.0 tt -116.65 131.06 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.344 -0.847 . . . . 0.0 109.322 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -117.67 155.75 29.38 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.376 0.608 . . . . 0.0 109.824 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -141.12 -146.13 0.19 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.805 . . . . 0.0 109.497 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -78.55 -8.37 58.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.411 -0.805 . . . . 0.0 110.743 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.3 p -113.42 -86.61 0.57 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.279 -0.888 . . . . 0.0 110.697 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.69 -147.72 0.36 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.583 -0.698 . . . . 0.0 110.245 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.8 ptt-85 -148.07 156.23 42.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.47 -0.768 . . . . 0.0 110.203 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.8 tt -142.85 150.19 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.33 -0.856 . . . . 0.0 110.177 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.485 ' NH2' ' OE1' ' A' ' 41' ' ' GLN . 76.5 ttt180 -72.5 136.36 45.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.515 -0.741 . . . . 0.0 109.847 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.8 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -138.67 167.67 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.34 -0.85 . . . . 0.0 109.463 179.403 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 97.4 p -147.74 152.79 38.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 0.0 109.756 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.6 p -135.44 124.55 24.4 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -87.98 130.03 35.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.393 -0.817 . . . . 0.0 110.838 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.35 -48.75 1.5 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.547 ' HD3' HD12 ' A' ' 90' ' ' ILE . 99.1 mttt -70.68 136.02 48.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.095 -1.238 . . . . 0.0 110.272 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -95.91 153.94 17.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.522 -0.736 . . . . 0.0 109.879 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.8 mt -128.91 157.03 42.74 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.653 -0.655 . . . . 0.0 109.512 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.445 ' OE1' ' OD2' ' A' ' 64' ' ' ASP . 91.1 mt-30 -117.3 135.25 53.97 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.626 0.727 . . . . 0.0 109.954 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.7 t0 -66.71 136.25 55.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.421 -0.799 . . . . 0.0 110.731 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.52 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 0.8 OUTLIER 80.31 -5.4 1.79 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.818 -0.551 . . . . 0.0 110.799 178.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.445 ' OD2' ' OE1' ' A' ' 61' ' ' GLN . 9.8 m-20 -80.8 143.03 33.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.708 -1.245 . . . . 0.0 110.013 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.41 123.81 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.76 160.43 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 110.191 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -122.18 126.17 47.71 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 77.6 mt -110.0 127.43 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -114.88 141.71 47.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.818 -0.551 . . . . 0.0 109.793 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.2 t30 62.91 38.17 11.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.745 -0.597 . . . . 0.0 109.679 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.58 141.92 55.33 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -93.98 121.97 36.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.642 0.734 . . . . 0.0 109.604 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.0 t -82.29 133.12 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.572 -0.705 . . . . 0.0 109.677 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.43 155.49 46.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.495 -0.753 . . . . 0.0 109.066 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -114.42 117.6 31.48 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.538 -0.726 . . . . 0.0 109.346 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -122.2 135.13 54.72 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.718 -0.614 . . . . 0.0 109.383 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 55.09 30.57 14.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.624 -0.672 . . . . 0.0 109.688 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.1 7.22 84.22 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -114.72 135.01 54.64 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.371 -1.076 . . . . 0.0 109.952 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.51 145.85 41.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.589 -0.694 . . . . 0.0 109.984 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.0 p -155.07 161.9 41.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.502 -0.749 . . . . 0.0 109.199 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.4 mt -107.39 127.87 53.96 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.448 -0.782 . . . . 0.0 109.492 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 m -100.58 125.19 46.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.687 -0.633 . . . . 0.0 109.343 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 t -112.4 130.2 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.53 -0.732 . . . . 0.0 109.092 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -153.13 -149.01 5.04 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.45 -42.3 99.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.533 -0.981 . . . . 0.0 110.263 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -60.83 -41.96 96.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.377 -0.827 . . . . 0.0 110.277 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.2 p -78.89 165.93 22.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.265 -0.897 . . . . 0.0 110.44 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -127.38 132.37 50.17 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.547 HD12 ' HD3' ' A' ' 58' ' ' LYS . 81.6 mt -113.34 129.67 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.537 -0.727 . . . . 0.0 109.092 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -132.27 123.34 26.72 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.433 -0.792 . . . . 0.0 109.081 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.1 p -76.65 156.55 32.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.998 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.438 -0.789 . . . . 0.0 109.203 179.351 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.508 0.67 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.5 tp -77.93 125.48 29.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.467 -0.77 . . . . 0.0 109.951 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.66 161.95 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.491 -0.756 . . . . 0.0 109.777 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -78.81 152.58 31.29 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.633 0.73 . . . . 0.0 110.523 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.9 -42.99 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.378 -0.826 . . . . 0.0 109.416 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -67.5 -18.26 64.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.024 -1.048 . . . . 0.0 109.361 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -90.15 -18.64 25.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.144 -0.972 . . . . 0.0 109.55 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.3 t -52.1 135.59 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.198 -0.939 . . . . 0.0 110.501 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.6 p -153.91 166.82 31.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.585 -0.697 . . . . 0.0 109.337 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.53 ' N ' HD22 ' A' ' 11' ' ' LEU . 3.6 mm? -68.94 -13.59 62.53 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.405 -0.809 . . . . 0.0 109.508 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.3 p -60.66 -31.19 70.42 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.157 -0.964 . . . . 0.0 109.003 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.44 ' OG1' ' CG1' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -122.95 85.33 50.55 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.17 -39.63 70.86 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.477 2.118 . . . . 0.0 112.018 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -106.52 131.64 53.46 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.56 -0.713 . . . . 0.0 109.887 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.44 ' CG1' ' OG1' ' A' ' 13' ' ' THR . 15.5 m -153.13 -177.25 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.353 -0.842 . . . . 0.0 109.716 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.8 m -137.62 137.91 38.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.432 -0.792 . . . . 0.0 109.09 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.3 m -140.44 161.91 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.388 -0.82 . . . . 0.0 109.822 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.447 HD11 ' NE ' ' A' ' 67' ' ' ARG . 86.3 mt -130.43 132.88 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.97 -167.62 37.39 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.054 -1.546 . . . . 0.0 110.017 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.499 ' C ' HD12 ' A' ' 22' ' ' ILE . 50.9 mtpt -113.01 138.11 50.38 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.709 -0.877 . . . . 0.0 109.432 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.762 ' N ' HD12 ' A' ' 22' ' ' ILE . 1.8 mp -97.95 131.33 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.424 -0.798 . . . . 0.0 109.615 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 63' ' ' SER . 79.6 p -133.45 160.31 37.77 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.315 0.579 . . . . 0.0 109.944 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 25' ' ' ILE . . . 100.28 -75.76 0.44 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 24' ' ' GLY . 38.1 mm 58.39 119.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.535 -0.979 . . . . 0.0 110.6 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -145.85 142.41 28.79 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -98.7 130.18 45.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.403 -0.811 . . . . 0.0 109.745 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -141.74 160.76 39.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.361 -0.837 . . . . 0.0 108.952 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 57.9 mp0 -121.84 142.53 50.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.49 -0.756 . . . . 0.0 109.374 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -141.96 160.27 40.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.286 -0.884 . . . . 0.0 108.874 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -90.17 115.65 27.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.982 . . . . 0.0 109.919 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.4 t -110.76 115.14 29.03 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.692 . . . . 0.0 109.214 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 54.38 31.33 14.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.47 -0.769 . . . . 0.0 109.896 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.8 1.8 84.85 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.8 m -117.99 128.69 55.03 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.321 -1.105 . . . . 0.0 109.649 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.1 m -67.99 128.49 36.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 110.381 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -133.1 146.0 51.24 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.43 -0.794 . . . . 0.0 109.58 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.1 m -81.25 144.14 31.78 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.441 -0.787 . . . . 0.0 109.982 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.8 p -136.43 138.96 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.474 -0.766 . . . . 0.0 109.0 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -103.7 131.21 51.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.423 -0.798 . . . . 0.0 108.977 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -124.1 155.76 37.81 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.579 -0.7 . . . . 0.0 109.478 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.38 -160.31 22.93 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -127.59 140.68 51.96 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.605 -0.938 . . . . 0.0 109.62 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.548 ' HB ' HD13 ' A' ' 53' ' ' ILE . 20.4 tt -117.73 136.85 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -134.24 151.47 51.31 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.467 -0.771 . . . . 0.0 109.836 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -144.99 -150.12 0.31 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.645 -0.66 . . . . 0.0 109.368 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 31.7 p-10 -85.72 -1.76 57.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 109.732 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.9 p -103.62 -63.0 1.23 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.175 -0.953 . . . . 0.0 109.556 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -166.47 -149.15 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 109.92 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -140.65 151.86 44.93 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.46 -0.775 . . . . 0.0 109.93 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 tt -149.48 158.93 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.188 -0.945 . . . . 0.0 110.196 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.6 mtp85 -71.93 146.98 47.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.9 . . . . 0.0 109.814 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.702 HD11 HG23 ' A' ' 22' ' ' ILE . 37.0 pt -136.76 150.11 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.399 -0.813 . . . . 0.0 110.235 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 t -142.57 138.21 30.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.531 -0.73 . . . . 0.0 109.135 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.3 t -130.35 133.64 46.57 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.508 -0.745 . . . . 0.0 109.175 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -92.87 123.83 36.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.38 -0.825 . . . . 0.0 111.03 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.08 -55.23 3.13 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -70.95 131.81 44.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.875 -1.368 . . . . 0.0 110.403 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -96.69 155.17 16.89 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.499 -0.75 . . . . 0.0 110.085 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.9 mt -123.16 151.68 41.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -103.59 160.5 14.69 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.645 0.736 . . . . 0.0 110.176 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 63' ' ' SER . 38.8 t70 -66.14 150.15 49.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.658 -0.651 . . . . 0.0 111.24 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 22' ' ' ILE . 11.1 p 37.57 42.56 0.37 Allowed 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.31 0.576 . . . . 0.0 110.439 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -90.69 120.1 31.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.229 -0.919 . . . . 0.0 110.031 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.78 110.49 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.5 m -143.78 168.32 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.126 -0.984 . . . . 0.0 110.109 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.447 ' NE ' HD11 ' A' ' 19' ' ' ILE . 41.5 ttm180 -118.21 124.37 47.76 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.3 mt -103.7 126.13 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -117.54 141.18 48.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.742 -0.599 . . . . 0.0 109.783 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.3 t30 65.47 37.57 6.06 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.47 0.653 . . . . 0.0 109.837 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.76 137.94 46.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.134 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -86.65 121.19 28.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.537 -0.727 . . . . 0.0 109.96 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.2 t -83.49 133.93 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.458 -0.776 . . . . 0.0 109.586 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -136.57 154.94 50.55 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.284 -0.885 . . . . 0.0 109.449 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -115.49 111.59 20.97 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -116.14 125.96 53.04 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.505 -0.747 . . . . 0.0 109.936 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.5 m120 55.26 33.25 20.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.639 -0.663 . . . . 0.0 110.13 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.26 3.24 88.4 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -111.05 133.63 53.28 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.344 -1.092 . . . . 0.0 109.954 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.2 mt -76.72 148.76 36.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.499 -0.751 . . . . 0.0 110.514 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.0 p -152.99 158.66 42.37 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.1 mt -111.55 126.52 55.07 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.282 -0.886 . . . . 0.0 109.379 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.4 m -107.68 123.55 48.68 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.5 t -99.15 112.0 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.266 -0.897 . . . . 0.0 109.47 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.24 -173.05 31.25 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.62 -35.41 80.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.589 -0.948 . . . . 0.0 109.527 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.0 t -66.84 -16.77 64.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 0.0 109.655 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.9 m -74.98 159.42 31.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 110.141 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.1 ttt85 -124.0 134.51 53.44 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.663 -0.648 . . . . 0.0 109.337 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.02 131.9 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.683 -0.636 . . . . 0.0 109.527 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -122.28 130.18 52.91 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.6 0.715 . . . . 0.0 109.286 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.4 p -70.6 147.0 49.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.503 -0.748 . . . . 0.0 110.287 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.2 t . . . . . 0 N--CA 1.498 1.964 0 O-C-N 121.591 -0.693 . . . . 0.0 109.666 179.61 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.2 t70 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.376 0.608 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.606 ' N ' HD22 ' A' ' 3' ' ' LEU . 4.0 mm? -81.94 130.0 34.94 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.378 -0.826 . . . . 0.0 110.248 -178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.79 163.87 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.576 -0.703 . . . . 0.0 109.647 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.61 156.46 27.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.418 -0.801 . . . . 0.0 110.622 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.45 -43.13 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 0.0 109.535 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -67.34 -14.75 63.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.014 -1.054 . . . . 0.0 109.795 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -89.7 -0.03 57.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 109.159 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.11 132.68 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 110.056 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.4 t -158.73 170.25 22.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.358 -0.839 . . . . 0.0 109.619 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.497 ' N ' HD22 ' A' ' 11' ' ' LEU . 3.7 mm? -64.4 -35.45 80.95 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.438 -0.789 . . . . 0.0 109.285 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.7 p -57.96 -20.47 38.15 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.742 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 p -113.32 79.19 3.75 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.348 -0.845 . . . . 0.0 108.885 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.9 -24.91 39.36 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.254 1.969 . . . . 0.0 112.384 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -125.57 110.1 13.45 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.467 -0.77 . . . . 0.0 109.018 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.8 m -141.65 162.09 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.233 -0.917 . . . . 0.0 110.307 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 t -117.25 135.49 53.77 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.7 m -136.14 161.33 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.278 -0.888 . . . . 0.0 110.171 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.3 tt -139.4 140.74 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.401 -0.812 . . . . 0.0 109.341 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.33 -166.04 36.81 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 118.959 -1.591 . . . . 0.0 110.13 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -106.38 131.08 54.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.557 -0.967 . . . . 0.0 109.625 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.493 HG21 HD11 ' A' ' 25' ' ' ILE . 96.3 mt -102.58 133.7 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.575 -0.703 . . . . 0.0 109.839 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.453 ' HA ' ' H ' ' A' ' 63' ' ' SER . 30.3 p -135.47 159.6 41.09 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.335 0.588 . . . . 0.0 109.672 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.29 -84.08 0.99 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.493 HD11 HG21 ' A' ' 22' ' ' ILE . 49.5 mm 56.12 107.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.536 -0.979 . . . . 0.0 110.421 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -129.27 138.54 51.7 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -90.48 136.51 33.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 110.372 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -148.66 151.28 34.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.378 -0.826 . . . . 0.0 108.907 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -117.86 144.74 45.14 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.352 -0.842 . . . . 0.0 110.063 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.405 ' N ' ' CD1' ' A' ' 30' ' ' TYR . 10.0 p90 -144.69 162.32 37.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.333 -0.854 . . . . 0.0 109.822 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -80.96 141.64 34.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.42 -0.8 . . . . 0.0 109.823 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.3 t -144.87 106.37 4.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.136 -0.978 . . . . 0.0 109.511 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.5 t0 57.96 33.41 23.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.422 -0.799 . . . . 0.0 110.329 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.66 6.0 87.68 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 92.4 m -126.62 127.44 45.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.372 -1.075 . . . . 0.0 109.31 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.0 m -73.0 134.41 44.66 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.221 -0.924 . . . . 0.0 110.042 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -131.82 143.4 50.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.428 -0.795 . . . . 0.0 109.054 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 86.8 p -87.27 146.07 26.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.214 -0.929 . . . . 0.0 109.813 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.91 140.26 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.384 -0.823 . . . . 0.0 109.547 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -104.82 130.49 52.93 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -121.35 152.77 38.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.454 -0.778 . . . . 0.0 109.417 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.09 -169.23 33.84 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -123.11 138.97 54.53 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.617 -0.931 . . . . 0.0 109.235 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 tt -118.1 143.18 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -133.33 153.21 51.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.574 -0.704 . . . . 0.0 109.621 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.53 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 40.4 t0 -149.17 -164.01 1.92 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.373 -0.83 . . . . 0.0 108.942 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.53 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 60.2 t0 -64.32 -33.75 76.56 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.442 -0.786 . . . . 0.0 109.295 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 p -77.31 -86.9 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 110.281 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.06 -147.06 0.2 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.344 -0.848 . . . . 0.0 110.233 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -143.9 157.96 44.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.475 -0.766 . . . . 0.0 109.454 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.2 tt -153.77 161.52 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.953 -1.092 . . . . 0.0 110.326 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -73.82 145.29 45.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.556 -0.715 . . . . 0.0 109.749 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.4 pt -135.24 152.98 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.198 -0.939 . . . . 0.0 109.499 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.6 p -142.31 129.69 21.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.183 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 t -113.94 121.0 42.58 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -96.27 121.12 37.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.322 -0.861 . . . . 0.0 110.72 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.46 -44.68 2.94 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -78.05 138.77 38.96 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.99 -1.3 . . . . 0.0 110.303 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -94.08 151.76 19.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -0.824 . . . . 0.0 109.923 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.15 157.21 43.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.565 -0.709 . . . . 0.0 109.331 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -112.09 136.89 50.88 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.518 0.675 . . . . 0.0 109.687 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -64.65 142.75 58.32 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.884 0.85 . . . . 0.0 111.222 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.453 ' H ' ' HA ' ' A' ' 23' ' ' THR . 11.1 t 58.34 81.19 0.16 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.65 0.738 . . . . 0.0 110.268 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -162.69 126.67 3.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.522 -0.736 . . . . 0.0 110.12 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 t -78.12 120.12 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.389 -0.819 . . . . 0.0 109.444 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.43 163.78 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.465 -0.772 . . . . 0.0 109.823 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.4 ttp85 -119.23 128.23 54.0 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.1 mt -107.38 129.32 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.402 -0.811 . . . . 0.0 109.382 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 66.5 t0 -114.64 142.11 46.9 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.544 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 64.6 t30 63.3 40.58 8.5 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.345 0.593 . . . . 0.0 109.918 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.45 148.87 42.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.334 -0.854 . . . . 0.0 109.417 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -100.87 125.53 47.41 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.565 0.698 . . . . 0.0 109.729 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.9 t -89.19 135.28 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.369 -0.832 . . . . 0.0 110.038 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.74 157.0 43.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 0.0 108.889 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -113.36 116.92 30.44 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.454 -0.779 . . . . 0.0 109.44 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -125.94 138.69 53.78 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.425 -0.797 . . . . 0.0 110.094 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 57.04 23.5 8.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.665 -0.647 . . . . 0.0 109.484 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.08 7.88 88.19 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -118.21 137.76 52.79 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.546 -0.973 . . . . 0.0 109.898 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.1 mt -77.12 148.52 35.98 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.425 -0.797 . . . . 0.0 110.212 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.9 p -155.04 161.67 41.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.317 -0.864 . . . . 0.0 109.016 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.4 mt -106.32 125.59 51.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.426 -0.796 . . . . 0.0 109.246 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.9 m -105.66 123.34 47.76 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.5 t -98.97 114.13 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.301 -0.874 . . . . 0.0 108.997 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.57 -177.42 37.02 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -67.42 -27.31 66.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.598 -0.942 . . . . 0.0 109.611 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.1 m -78.8 -6.51 56.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.148 -0.97 . . . . 0.0 109.487 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.7 m -83.66 165.59 18.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.041 -1.037 . . . . 0.0 109.841 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.75 141.05 51.69 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.435 -0.791 . . . . 0.0 109.318 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.03 130.98 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.563 -0.71 . . . . 0.0 109.609 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -123.72 116.32 22.84 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.9 m -77.54 140.2 39.7 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.35 -0.844 . . . . 0.0 110.099 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.497 1.913 0 O-C-N 121.546 -0.721 . . . . 0.0 109.29 179.47 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.3 p30 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.754 0.788 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.7 tp -81.58 128.48 33.97 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.415 -0.803 . . . . 0.0 109.956 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.01 162.87 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-O 121.719 0.771 . . . . 0.0 110.165 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -77.18 159.47 29.68 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.796 0.808 . . . . 0.0 110.354 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.8 mm -63.78 -42.91 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 121.701 0.762 . . . . 0.0 109.887 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -66.07 -18.08 65.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.193 -0.942 . . . . 0.0 110.486 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 8' ' ' ASP . 59.2 t0 -86.45 -1.79 57.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.858 -1.151 . . . . 0.0 109.384 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 87.1 t -66.29 133.3 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.338 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.4 p -156.16 167.44 30.41 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.508 -0.745 . . . . 0.0 109.357 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.5 -34.96 79.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.821 . . . . 0.0 109.309 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.6 p -56.84 -19.4 17.23 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 109.475 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 13' ' ' THR . 11.1 p -115.23 81.07 7.82 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.835 . . . . 0.0 109.248 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -71.92 -16.08 29.36 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.598 2.199 . . . . 0.0 111.288 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -128.66 110.07 11.89 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.4 m -145.44 161.68 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.357 -0.84 . . . . 0.0 110.397 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.3 t -116.55 136.96 52.55 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.61 160.29 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 121.894 0.854 . . . . 0.0 110.256 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.3 tt -144.36 133.73 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.682 -0.636 . . . . 0.0 109.606 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.82 -162.55 30.33 Favored Glycine 0 N--CA 1.487 2.051 0 C-N-CA 119.693 -1.241 . . . . 0.0 110.019 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -105.98 134.79 48.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.708 -0.878 . . . . 0.0 109.985 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 63' ' ' SER . 97.0 mt -103.64 130.64 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.527 0.679 . . . . 0.0 110.086 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 p -134.15 163.31 29.88 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.49 0.662 . . . . 0.0 109.371 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.479 ' N ' ' OD1' ' A' ' 62' ' ' ASP . . . 97.03 -76.74 0.68 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 24' ' ' GLY . 36.9 mm 57.91 120.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 122.039 0.923 . . . . 0.0 110.405 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -143.63 138.97 29.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.451 -0.781 . . . . 0.0 108.986 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -104.36 130.3 52.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.481 -0.762 . . . . 0.0 109.919 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -144.34 165.29 28.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.545 -0.722 . . . . 0.0 109.402 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -120.57 146.57 46.2 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.593 -0.692 . . . . 0.0 110.008 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -142.6 163.16 33.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 109.85 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 57.0 mp0 -88.04 114.16 24.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.528 -0.733 . . . . 0.0 109.721 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.8 t -110.77 107.29 16.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.493 -0.755 . . . . 0.0 109.758 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 54.7 t0 54.79 28.56 10.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.533 -0.73 . . . . 0.0 110.526 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.88 8.18 67.55 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.4 m -123.11 127.51 48.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.409 -1.053 . . . . 0.0 109.11 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.9 m -72.83 131.05 41.79 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.392 -0.818 . . . . 0.0 110.402 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -136.89 146.61 45.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.473 -0.767 . . . . 0.0 109.529 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 99.8 p -81.43 148.6 29.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.401 -0.812 . . . . 0.0 110.343 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.32 138.3 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 109.678 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.498 ' CD1' ' O ' ' A' ' 58' ' ' LYS . 83.7 m-85 -104.35 132.72 50.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.447 -0.783 . . . . 0.0 109.481 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -129.2 156.64 43.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.634 -0.666 . . . . 0.0 109.457 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.55 -165.32 31.97 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.045 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -120.36 143.89 48.17 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.698 -0.883 . . . . 0.0 109.798 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 tt -131.85 134.37 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -139.45 155.02 47.85 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.855 0.836 . . . . 0.0 110.553 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.547 ' O ' ' C ' ' A' ' 47' ' ' ASP . 41.8 p-10 -152.89 99.47 2.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.432 -0.792 . . . . 0.0 109.385 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.547 ' C ' ' O ' ' A' ' 46' ' ' ASP . 29.5 p-10 13.72 57.94 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.736 0 CA-C-O 122.169 0.985 . . . . 0.0 110.944 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 46' ' ' ASP . 8.2 m -168.7 -55.6 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -173.39 -167.93 0.42 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.367 -0.833 . . . . 0.0 109.397 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -139.05 149.98 45.24 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.632 0.73 . . . . 0.0 110.482 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.8 tt -147.24 152.81 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.33 -0.856 . . . . 0.0 109.687 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.435 HH21 ' HB2' ' A' ' 79' ' ' TYR . 81.0 mtm-85 -77.53 147.57 35.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.521 -0.737 . . . . 0.0 109.856 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.0 pt -132.48 158.3 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.617 -0.677 . . . . 0.0 109.907 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 t -147.14 127.73 14.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 p -122.89 138.7 54.59 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.477 0.656 . . . . 0.0 109.613 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -97.8 118.15 33.71 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.679 0.752 . . . . 0.0 111.527 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.09 -19.66 1.69 Allowed Glycine 0 N--CA 1.496 2.671 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.608 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.498 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 68.8 mttm -83.63 137.82 33.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.689 -1.477 . . . . 0.0 110.484 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -96.6 140.73 30.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.602 -0.687 . . . . 0.0 110.159 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.1 mt -130.18 153.32 48.67 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.598 -0.689 . . . . 0.0 109.381 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -113.33 155.31 25.4 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.653 0.74 . . . . 0.0 109.893 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 7.7 m-20 -70.78 148.3 48.05 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.92 0.867 . . . . 0.0 110.995 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 22' ' ' ILE . 1.8 m 53.34 32.98 14.68 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.779 0.8 . . . . 0.0 109.409 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -96.84 114.57 26.21 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.353 -0.842 . . . . 0.0 110.573 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.443 HG22 ' H ' ' A' ' 65' ' ' VAL . 1.5 m -84.08 117.14 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.343 -0.848 . . . . 0.0 109.889 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.9 m -148.45 175.12 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.501 0.667 . . . . 0.0 109.541 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -122.68 132.26 54.18 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.55 125.28 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.597 -0.689 . . . . 0.0 109.477 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -111.21 152.38 27.16 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 59.57 35.23 22.57 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.708 0.766 . . . . 0.0 109.664 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.65 143.97 56.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.51 -0.744 . . . . 0.0 109.442 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -105.62 118.57 36.93 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.935 0.874 . . . . 0.0 109.572 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -88.91 131.44 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.425 -0.797 . . . . 0.0 110.124 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.46 157.58 41.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.394 -0.816 . . . . 0.0 109.015 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -100.75 125.45 47.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.455 -0.778 . . . . 0.0 109.655 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.415 ' O ' ' N ' ' A' ' 78' ' ' GLY . 69.8 m-85 -115.52 133.18 56.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.61 -0.681 . . . . 0.0 109.354 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m120 67.89 -63.23 0.32 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.627 0.727 . . . . 0.0 109.844 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 76' ' ' PHE . . . 176.43 29.15 0.04 OUTLIER Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.435 ' HB2' HH21 ' A' ' 52' ' ' ARG . 31.5 p90 -146.82 155.43 42.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.292 -1.122 . . . . 0.0 109.837 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.8 mt -83.06 145.65 29.15 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.77 0.795 . . . . 0.0 110.974 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.1 t -157.8 163.72 37.75 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 70.7 mt -101.15 130.22 47.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.165 -0.959 . . . . 0.0 109.694 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.6 m -109.88 122.6 47.91 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.665 0.745 . . . . 0.0 109.319 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.6 t -98.62 110.04 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.826 0.822 . . . . 0.0 109.11 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.13 -174.85 40.8 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -71.22 -19.23 62.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.553 -0.969 . . . . 0.0 110.34 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -84.55 -8.83 58.78 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.711 -1.243 . . . . 0.0 109.057 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.8 t -79.34 162.63 25.46 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.395 -0.816 . . . . 0.0 110.434 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -129.66 136.37 49.64 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.594 -0.691 . . . . 0.0 109.384 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.84 130.46 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -120.53 132.19 55.06 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.701 0.762 . . . . 0.0 109.128 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.0 m -74.31 147.85 41.91 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.383 0.611 . . . . 0.0 110.525 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.304 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 65.9 t0 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.691 0.758 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.545 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 42.8 tp -70.92 121.78 18.76 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.551 0.691 . . . . 0.0 110.097 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.1 m -137.78 163.65 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 121.582 0.706 . . . . 0.0 109.939 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -76.03 156.85 33.62 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.587 0.708 . . . . 0.0 110.26 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.84 -43.41 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.563 -0.71 . . . . 0.0 109.728 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.491 ' HE ' ' HB2' ' A' ' 49' ' ' ALA . 95.0 mtt180 -62.62 -24.84 67.79 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.403 -0.811 . . . . 0.0 110.382 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -82.62 -0.21 46.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.549 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.2 t -65.76 131.54 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.371 -0.831 . . . . 0.0 110.539 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 99.1 p -160.31 169.3 23.44 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.685 0.755 . . . . 0.0 109.535 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.74 -33.89 76.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.766 . . . . 0.0 109.823 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -59.74 -18.59 44.04 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.243 -0.91 . . . . 0.0 109.271 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.48 ' O ' HG21 ' A' ' 73' ' ' VAL . 13.6 p -111.45 80.13 2.54 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.65 -23.19 36.72 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.383 2.055 . . . . 0.0 111.744 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -126.22 110.08 13.04 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 m -138.15 162.62 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.589 -0.695 . . . . 0.0 110.353 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 t -125.67 134.85 51.7 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.5 m -139.88 162.24 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 121.579 0.704 . . . . 0.0 110.303 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.3 tt -137.98 139.48 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.58 -0.7 . . . . 0.0 109.647 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.76 -162.94 29.85 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.661 -1.257 . . . . 0.0 109.993 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -106.15 144.4 32.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.749 -0.854 . . . . 0.0 109.491 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 25' ' ' ILE . 17.5 mm -94.2 130.59 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.302 0.573 . . . . 0.0 110.427 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.2 p -138.42 156.93 47.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.468 -0.77 . . . . 0.0 110.479 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.08 65.84 2.74 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 22' ' ' ILE . 21.8 mm -80.21 128.15 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -1.12 . . . . 0.0 110.242 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -134.66 140.93 46.39 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -104.53 134.65 47.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.644 -0.66 . . . . 0.0 109.884 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -140.61 162.73 34.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.645 -0.66 . . . . 0.0 109.716 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -125.76 140.1 52.97 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.754 -0.591 . . . . 0.0 109.72 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -140.38 159.01 43.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.455 -0.778 . . . . 0.0 109.586 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -86.98 111.19 20.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.575 -0.703 . . . . 0.0 109.752 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 p -112.81 119.78 39.19 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.524 0.678 . . . . 0.0 109.807 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.9 t0 55.23 29.71 13.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.619 -0.676 . . . . 0.0 109.916 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.52 5.82 86.45 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.8 m -124.87 128.74 49.13 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.447 -1.031 . . . . 0.0 109.613 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 33.2 m -66.77 130.4 43.03 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.645 -0.659 . . . . 0.0 110.3 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -132.18 143.0 49.65 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.833 0.825 . . . . 0.0 109.612 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.6 t -78.25 145.36 35.51 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.425 0.631 . . . . 0.0 110.137 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.79 137.71 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.6 -0.688 . . . . 0.0 109.303 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -103.76 132.7 49.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.72 -0.613 . . . . 0.0 109.456 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -125.41 149.05 48.54 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.7 -165.51 29.84 Favored Glycine 0 N--CA 1.485 1.956 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.139 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -123.28 142.85 50.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.836 -0.802 . . . . 0.0 109.398 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.41 ' HB ' HD13 ' A' ' 53' ' ' ILE . 19.6 tt -120.39 144.34 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -131.16 150.42 52.15 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.613 0.72 . . . . 0.0 110.162 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 41.4 t0 -151.76 -166.66 2.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.587 -0.695 . . . . 0.0 109.391 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.527 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 47.6 t0 -70.29 -9.94 57.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 109.938 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.3 p -94.72 -71.31 0.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 109.625 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.491 ' HB2' ' HE ' ' A' ' 7' ' ' ARG . . . -162.22 -141.13 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.396 -0.815 . . . . 0.0 109.49 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -143.42 151.82 40.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.446 -0.784 . . . . 0.0 109.976 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.6 tt -151.9 161.44 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.712 . . . . 0.0 110.158 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -74.11 147.26 42.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.492 -0.755 . . . . 0.0 109.628 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.41 HD13 ' HB ' ' A' ' 44' ' ' ILE . 43.0 pt -136.07 154.5 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.482 -0.761 . . . . 0.0 110.042 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.0 t -145.67 131.14 18.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.528 -0.733 . . . . 0.0 109.325 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.9 t -120.39 134.95 55.18 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.459 0.647 . . . . 0.0 109.435 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -95.8 122.14 38.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.518 -0.739 . . . . 0.0 111.021 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.53 -44.45 0.47 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.4 ttmm -79.01 130.99 36.12 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.168 -1.195 . . . . 0.0 110.678 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -91.89 164.59 13.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.51 0.671 . . . . 0.0 110.462 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.6 mt -126.9 157.74 38.59 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -105.8 133.85 49.86 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.327 1.061 . . . . 0.0 110.223 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -69.92 143.89 52.6 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.627 -0.67 . . . . 0.0 111.153 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.5 t 65.12 4.57 2.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -90.81 134.95 34.05 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.478 -0.764 . . . . 0.0 109.942 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.0 t -86.85 121.58 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.59 159.97 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.586 0.708 . . . . 0.0 109.876 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -123.75 125.08 44.11 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.2 mt -99.14 128.05 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -112.53 138.53 49.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.5 t30 62.54 39.24 11.83 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.334 0.587 . . . . 0.0 109.708 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.08 148.41 51.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.417 -0.802 . . . . 0.0 109.605 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -99.57 121.07 40.66 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.736 0.779 . . . . 0.0 109.882 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 13' ' ' THR . 84.6 t -80.87 133.75 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.609 -0.682 . . . . 0.0 109.874 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.44 155.54 42.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.397 -0.814 . . . . 0.0 109.509 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -114.09 119.14 36.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.766 -0.584 . . . . 0.0 109.621 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -118.27 126.2 51.67 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.507 0.67 . . . . 0.0 109.738 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.7 m120 55.63 32.98 20.31 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.454 0.645 . . . . 0.0 110.196 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.15 6.05 89.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.73 133.9 55.08 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.385 -1.068 . . . . 0.0 110.022 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.9 mt -77.54 145.96 36.6 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.484 0.659 . . . . 0.0 110.117 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.8 p -154.34 160.27 41.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.531 -0.73 . . . . 0.0 109.353 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.4 mt -105.58 118.9 37.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.594 -0.692 . . . . 0.0 109.406 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.7 m -98.32 126.89 44.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.672 -0.642 . . . . 0.0 109.403 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 t -103.67 109.44 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.541 -0.725 . . . . 0.0 109.608 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -96.59 -176.24 35.55 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -68.24 -17.01 64.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.515 -0.991 . . . . 0.0 109.605 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 96.8 p -83.08 -9.41 59.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 109.107 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.7 t -88.5 167.85 13.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.457 -0.777 . . . . 0.0 110.14 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.5 tpt85 -132.44 135.05 45.81 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.6 mt -115.65 130.78 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.795 -0.566 . . . . 0.0 109.722 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -119.0 122.3 41.88 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.393 0.616 . . . . 0.0 109.661 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.2 m -80.8 149.16 29.71 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.418 0.628 . . . . 0.0 110.298 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.14 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.68 0.752 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.6 tp -79.93 124.42 28.66 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.562 -0.711 . . . . 0.0 109.878 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.99 163.46 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.443 -0.786 . . . . 0.0 109.724 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -76.16 159.43 30.7 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.683 0.754 . . . . 0.0 110.218 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.1 -42.9 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.527 -0.733 . . . . 0.0 110.037 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 -67.13 -18.52 65.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.903 -1.123 . . . . 0.0 109.617 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -83.57 -2.05 55.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.09 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.7 t -66.69 132.22 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 110.362 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 m -156.45 167.37 30.64 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.517 -0.74 . . . . 0.0 109.392 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.91 -37.65 88.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.338 -0.851 . . . . 0.0 109.716 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 93.8 p -54.71 -22.2 13.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.973 . . . . 0.0 109.31 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.417 ' O ' ' OG1' ' A' ' 13' ' ' THR . 10.7 p -113.03 80.9 4.3 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.75 -21.87 24.56 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.258 1.972 . . . . 0.0 111.673 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -125.26 109.98 13.48 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.399 0.619 . . . . 0.0 109.459 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.8 m -147.16 162.03 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.148 -0.97 . . . . 0.0 110.143 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.2 m -115.0 135.68 53.96 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.46 161.35 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.327 -0.858 . . . . 0.0 110.001 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.2 tt -138.5 137.51 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.377 -0.827 . . . . 0.0 109.711 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.36 -165.06 27.12 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 119.567 -1.301 . . . . 0.0 109.876 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -105.46 126.85 52.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.652 -0.91 . . . . 0.0 109.069 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.8 mm -83.32 129.51 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-O 121.495 0.664 . . . . 0.0 110.313 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 44.5 p -140.04 163.7 31.99 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.697 0.761 . . . . 0.0 110.035 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.35 89.71 0.01 OUTLIER Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.5 mm -99.61 126.05 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -1.118 . . . . 0.0 109.416 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -131.13 132.36 44.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -98.81 131.52 44.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.431 -0.793 . . . . 0.0 109.547 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -133.71 153.21 51.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.531 -0.731 . . . . 0.0 109.405 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -119.64 139.81 51.62 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.481 0.658 . . . . 0.0 109.799 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -142.0 161.16 38.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.292 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -90.36 99.18 12.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.959 . . . . 0.0 109.157 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.602 ' O ' ' N ' ' A' ' 34' ' ' GLY . 5.3 p -81.27 -156.5 0.15 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.484 -0.76 . . . . 0.0 110.073 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -48.28 82.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.53 0.681 . . . . 0.0 110.142 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 52.8 11.73 1.42 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.3 m -135.59 133.37 38.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.222 -1.163 . . . . 0.0 110.001 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.6 m -75.49 129.68 37.66 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.458 -0.776 . . . . 0.0 109.651 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -133.16 145.87 51.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.378 -0.826 . . . . 0.0 109.745 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.6 p -86.18 148.11 25.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.505 -0.747 . . . . 0.0 110.087 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 p -137.9 137.59 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.517 ' CZ ' ' OE1' ' A' ' 59' ' ' GLN . 88.3 m-85 -103.5 135.09 45.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.482 -0.761 . . . . 0.0 109.64 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -125.07 155.22 40.15 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.94 -167.29 34.62 Favored Glycine 0 N--CA 1.482 1.745 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -126.74 141.84 51.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.587 -0.949 . . . . 0.0 109.529 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.7 tt -114.55 143.68 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.45 ' OE2' ' O ' ' A' ' 49' ' ' ALA . 10.1 tp10 -130.46 149.14 52.27 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.582 0.706 . . . . 0.0 109.694 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.517 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 42.7 t0 -148.26 -164.39 2.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.464 -0.772 . . . . 0.0 109.478 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.517 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 96.7 m-20 -73.79 -17.06 61.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 109.657 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.1 m -92.94 -73.82 0.54 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.188 -0.945 . . . . 0.0 109.795 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.45 ' O ' ' OE2' ' A' ' 45' ' ' GLU . . . -154.15 -157.0 0.73 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.727 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -137.76 156.67 47.73 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.497 -0.752 . . . . 0.0 110.229 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 tt -151.4 159.41 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.268 -0.895 . . . . 0.0 110.3 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -76.15 144.26 40.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.858 . . . . 0.0 109.689 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -130.37 157.37 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.777 0.799 . . . . 0.0 110.245 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.2 t -143.61 134.87 25.85 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.8 t -127.57 131.68 49.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.262 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -102.17 123.25 45.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.441 -0.787 . . . . 0.0 111.011 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.66 -51.17 3.01 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.481 ' NZ ' ' O ' ' A' ' 88' ' ' SER . 98.6 mttt -63.93 135.72 56.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.098 -1.237 . . . . 0.0 110.58 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.517 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 69.8 tp60 -85.16 149.58 25.42 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.688 0.756 . . . . 0.0 110.52 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.2 mt -130.58 157.18 43.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -124.63 148.98 47.58 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.806 0.812 . . . . 0.0 110.051 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.2 p-10 -67.17 146.53 54.13 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.102 0.954 . . . . 0.0 111.377 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.3 p 47.16 81.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.631 0.729 . . . . 0.0 110.384 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -151.79 124.78 8.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.39 -0.819 . . . . 0.0 110.205 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 t -79.63 114.59 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.352 -0.842 . . . . 0.0 109.266 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.14 163.65 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.494 -0.754 . . . . 0.0 109.795 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -122.71 132.63 54.34 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 78.9 mt -107.14 128.57 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 68.1 t0 -110.34 143.07 41.1 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.548 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 64.6 t30 60.64 39.87 17.2 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.45 149.75 46.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.569 -0.707 . . . . 0.0 109.796 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -102.74 126.79 49.99 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.57 0.7 . . . . 0.0 110.016 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.4 t -92.29 133.0 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.498 -0.751 . . . . 0.0 109.397 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.67 156.27 45.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.148 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -113.0 119.28 37.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.469 -0.769 . . . . 0.0 109.609 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -125.15 134.09 52.56 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.559 0.695 . . . . 0.0 109.555 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 56.13 30.98 17.38 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.468 0.651 . . . . 0.0 109.787 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.77 4.69 77.18 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -114.39 136.62 52.79 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.316 -1.108 . . . . 0.0 109.742 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.91 146.37 37.65 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.655 0.74 . . . . 0.0 110.4 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.9 p -152.74 160.5 43.13 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.443 -0.786 . . . . 0.0 109.155 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.29 126.43 52.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.382 -0.824 . . . . 0.0 109.213 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 t -108.49 129.66 55.28 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.13 112.39 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.67 0.748 . . . . 0.0 109.1 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.71 -177.58 38.24 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -69.64 -17.4 63.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.58 -0.953 . . . . 0.0 109.434 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.3 m -84.91 -12.37 53.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.17 -0.956 . . . . 0.0 109.398 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.481 ' O ' ' NZ ' ' A' ' 58' ' ' LYS . 14.7 m -86.79 163.89 17.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.293 -0.879 . . . . 0.0 109.777 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -126.85 142.66 51.48 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.521 -0.737 . . . . 0.0 109.857 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -118.04 129.79 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -125.25 121.46 34.13 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.698 0.761 . . . . 0.0 109.36 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.0 p -78.57 156.59 29.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.498 -0.751 . . . . 0.0 109.94 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.519 -0.738 . . . . 0.0 109.276 179.591 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 65.7 t0 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.494 0.664 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.542 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 50.1 tp -71.69 127.62 33.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.332 -0.855 . . . . 0.0 109.612 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.79 163.62 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.342 -0.849 . . . . 0.0 110.434 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -76.53 154.54 34.47 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.426 0.631 . . . . 0.0 110.38 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.35 -43.22 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 109.604 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 -64.11 -21.04 66.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.146 -0.971 . . . . 0.0 109.964 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -88.07 1.66 53.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.097 -1.002 . . . . 0.0 109.742 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.07 131.78 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.09 -1.006 . . . . 0.0 110.297 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.6 p -158.33 166.45 32.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.441 -0.787 . . . . 0.0 109.67 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.31 -20.5 66.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.402 -0.811 . . . . 0.0 109.185 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.9 t -63.96 -16.3 61.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 109.57 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.4 p -119.82 84.24 31.2 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.48 -0.763 . . . . 0.0 109.11 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.53 -40.67 71.65 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.591 2.194 . . . . 0.0 112.203 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -121.84 127.69 50.82 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.673 -0.642 . . . . 0.0 109.758 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.6 m -144.76 161.61 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.293 -0.879 . . . . 0.0 109.735 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 t -116.59 136.29 53.1 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.84 162.3 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.377 -0.827 . . . . 0.0 109.738 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.06 143.5 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.405 -0.809 . . . . 0.0 109.792 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.16 -161.32 35.07 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -111.73 139.05 47.51 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.439 -1.036 . . . . 0.0 109.604 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.46 ' O ' ' N ' ' A' ' 63' ' ' SER . 97.1 mt -97.93 131.32 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.868 -0.52 . . . . 0.0 109.852 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.3 p -133.7 156.63 47.59 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.468 -0.77 . . . . 0.0 109.952 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.1 71.4 1.01 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.8 mm -79.76 128.6 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.982 -1.305 . . . . 0.0 109.207 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -128.75 131.31 47.86 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -104.61 135.98 44.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.534 -0.729 . . . . 0.0 109.78 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -148.74 156.99 43.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.491 -0.756 . . . . 0.0 109.035 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -111.94 146.02 38.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.567 -0.708 . . . . 0.0 109.655 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.434 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 10.7 p90 -143.55 159.19 42.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.347 -0.846 . . . . 0.0 109.672 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -83.15 136.12 34.56 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.444 -0.785 . . . . 0.0 110.004 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.8 t -147.76 118.24 7.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.376 -0.828 . . . . 0.0 109.158 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 56.53 32.05 20.12 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.749 -0.594 . . . . 0.0 110.176 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.81 13.25 83.33 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -127.76 158.56 37.35 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.323 -1.104 . . . . 0.0 109.892 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.1 m -94.76 123.7 38.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.603 -0.686 . . . . 0.0 109.768 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.434 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 42.8 mmtm -127.26 141.96 51.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.565 -0.709 . . . . 0.0 109.195 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.1 m -84.81 146.65 27.24 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.621 -0.674 . . . . 0.0 109.816 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.7 137.63 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.521 -0.737 . . . . 0.0 109.169 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -102.49 131.9 48.88 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -127.1 155.0 44.01 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.619 -0.675 . . . . 0.0 109.672 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.6 -166.81 34.32 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.775 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -119.34 139.96 51.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.662 -0.905 . . . . 0.0 109.516 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 tt -122.96 132.99 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -132.84 156.4 47.22 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.28 -0.888 . . . . 0.0 111.142 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 48' ' ' THR . 53.9 p-10 -143.67 -144.33 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 23.4 p-10 -88.22 -1.39 57.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 109.14 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 49' ' ' ALA . 30.4 p -101.23 -69.69 0.77 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.507 -0.745 . . . . 0.0 109.613 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.536 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -162.86 -148.2 0.13 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 109.788 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -137.92 153.51 49.5 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.497 -0.752 . . . . 0.0 109.901 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.0 tt -152.24 154.87 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.174 -0.954 . . . . 0.0 109.998 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.85 143.42 41.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.419 -0.801 . . . . 0.0 110.355 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.1 pt -132.46 153.9 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.724 -0.61 . . . . 0.0 109.568 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.1 p -143.71 121.34 11.82 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 p -113.36 138.86 49.44 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.603 -0.686 . . . . 0.0 109.418 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.505 ' C ' ' H ' ' A' ' 58' ' ' LYS . 67.7 m-85 -95.91 121.26 37.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.405 -0.809 . . . . 0.0 111.332 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.74 -31.45 0.28 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.505 ' H ' ' C ' ' A' ' 56' ' ' PHE . 68.9 mttm -72.9 135.02 45.03 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.962 -1.316 . . . . 0.0 110.061 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -88.26 155.36 19.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.368 -0.833 . . . . 0.0 109.893 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.7 mt -127.67 152.48 47.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.632 -0.668 . . . . 0.0 109.277 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -114.45 132.41 56.27 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.061 0.934 . . . . 0.0 110.149 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.7 t0 -65.0 139.18 58.73 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.818 0.818 . . . . 0.0 111.622 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.538 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.7 m 61.8 5.53 1.36 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.588 -0.695 . . . . 0.0 110.338 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 65' ' ' VAL . 64.1 t0 -81.78 129.24 34.66 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.005 -1.06 . . . . 0.0 110.26 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.438 ' H ' HG22 ' A' ' 65' ' ' VAL . 1.7 m -83.34 119.36 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.7 m -138.16 163.27 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.72 0.771 . . . . 0.0 109.86 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.483 ' NH1' ' OD2' ' A' ' 69' ' ' ASP . 75.7 ttt-85 -123.28 125.53 45.23 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 77.7 mt -107.52 129.02 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.521 -0.737 . . . . 0.0 109.524 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.483 ' OD2' ' NH1' ' A' ' 67' ' ' ARG . 95.4 m-20 -113.76 148.9 35.68 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.415 0.626 . . . . 0.0 109.849 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 60.85 36.95 18.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.734 -0.604 . . . . 0.0 109.546 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.32 133.4 42.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 109.511 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -84.57 131.11 34.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 110.253 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.4 t -87.62 134.14 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.488 -0.757 . . . . 0.0 109.47 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.57 154.74 44.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.152 -0.968 . . . . 0.0 109.527 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.408 HE21 ' HA2' ' A' ' 78' ' ' GLY . 59.1 tt0 -116.48 117.82 30.95 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -126.45 133.17 51.29 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.668 -0.645 . . . . 0.0 109.766 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 56.57 31.79 19.72 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.274 0.559 . . . . 0.0 110.097 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.408 ' HA2' HE21 ' A' ' 75' ' ' GLN . . . 76.66 5.11 82.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -113.63 133.1 55.49 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.379 -1.071 . . . . 0.0 110.119 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.64 146.26 36.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.517 -0.739 . . . . 0.0 109.793 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 97.3 p -156.22 161.97 40.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.398 -0.814 . . . . 0.0 109.767 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.2 mt -105.84 130.61 53.78 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.5 t -107.76 127.83 54.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.0 109.413 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.08 107.67 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.46 -0.775 . . . . 0.0 109.356 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -96.0 -177.29 36.39 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -69.14 -17.27 63.81 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.254 -1.145 . . . . 0.0 109.315 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.6 m -84.45 -8.8 58.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.16 -0.963 . . . . 0.0 109.135 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.6 t -85.2 168.19 15.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.404 -0.81 . . . . 0.0 109.75 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -129.25 139.85 51.67 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.475 -0.765 . . . . 0.0 109.882 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.51 130.92 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -122.57 111.11 16.39 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.2 t -73.62 146.68 44.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.531 -0.731 . . . . 0.0 110.12 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 51.6 t . . . . . 0 N--CA 1.498 1.939 0 O-C-N 121.491 -0.756 . . . . 0.0 109.506 179.547 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.7 t70 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.403 0.621 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.5 tp -77.19 129.55 36.1 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.315 -0.866 . . . . 0.0 109.786 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.2 m -137.43 162.27 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.626 0.727 . . . . 0.0 109.424 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -88.53 162.44 16.41 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.48 0.657 . . . . 0.0 109.965 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.63 -42.74 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -72.49 -14.13 61.59 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.2 -0.938 . . . . 0.0 109.701 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -91.38 1.94 56.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.065 -1.022 . . . . 0.0 108.822 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.45 132.97 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 110.567 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.5 p -156.21 162.45 40.17 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.8 mt -71.92 -11.14 60.64 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.225 -0.922 . . . . 0.0 109.155 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.3 p -66.78 -17.83 65.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.4 p -123.04 84.17 50.9 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.51 -0.744 . . . . 0.0 109.528 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.73 -41.5 69.08 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.27 1.98 . . . . 0.0 111.609 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -119.26 131.41 55.78 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.365 0.602 . . . . 0.0 109.918 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.1 m -154.87 -173.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.246 -0.909 . . . . 0.0 109.744 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.8 p -131.39 137.02 48.5 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.49 158.63 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.415 -0.803 . . . . 0.0 109.865 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.5 mt -134.3 133.72 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.83 -171.16 36.6 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 118.741 -1.695 . . . . 0.0 110.351 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -114.67 121.2 42.66 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.766 -0.843 . . . . 0.0 108.984 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.617 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.0 mp -89.11 133.56 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.929 -0.482 . . . . 0.0 109.727 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.454 ' HA ' ' H ' ' A' ' 63' ' ' SER . 3.3 p -136.85 158.38 44.58 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.442 0.639 . . . . 0.0 109.732 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.35 83.53 0.07 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.5 mm -85.44 130.76 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.227 -1.161 . . . . 0.0 109.728 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -131.28 136.37 48.12 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -106.37 137.74 43.81 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.469 -0.77 . . . . 0.0 110.308 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -144.35 159.62 42.4 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -133.97 146.5 50.51 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.165 -0.96 . . . . 0.0 110.089 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -144.25 163.76 32.73 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.367 -0.833 . . . . 0.0 109.113 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -83.57 138.46 33.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.314 -0.866 . . . . 0.0 110.828 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 t -152.63 130.71 11.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.841 . . . . 0.0 108.925 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.6 t0 60.86 21.99 12.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.551 -0.718 . . . . 0.0 109.456 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.17 14.44 76.84 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 82.2 p -135.43 148.56 49.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.513 -0.992 . . . . 0.0 109.955 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.3 m -85.25 129.93 34.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.435 -0.791 . . . . 0.0 109.618 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -124.38 143.13 50.77 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.687 0.756 . . . . 0.0 110.029 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.9 m -83.84 141.13 31.57 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.377 0.608 . . . . 0.0 110.123 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 p -137.49 137.63 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -102.51 133.41 47.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.379 -0.826 . . . . 0.0 109.198 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -124.3 158.52 32.39 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.56 -170.56 37.87 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -120.38 142.8 48.84 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.6 -0.941 . . . . 0.0 109.267 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 tt -125.91 140.07 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -132.78 156.9 46.26 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.514 -0.741 . . . . 0.0 110.267 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 39.4 t0 -146.16 -142.28 0.13 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.516 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 66.3 t0 -87.55 -21.03 25.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.351 -0.843 . . . . 0.0 109.634 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.3 p -91.04 -76.61 0.44 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.086 -1.009 . . . . 0.0 109.866 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.11 -148.47 0.26 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 109.748 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.6 ptt-85 -142.57 159.17 42.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.577 -0.702 . . . . 0.0 109.702 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.4 tt -153.17 162.07 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.039 -1.038 . . . . 0.0 109.969 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -76.53 142.92 40.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.681 -0.637 . . . . 0.0 109.793 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.4 pt -129.22 153.75 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.532 -0.73 . . . . 0.0 109.433 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 p -142.25 132.57 24.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.59 -0.693 . . . . 0.0 109.259 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.2 t -119.23 128.67 54.41 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -92.73 122.76 35.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.183 -0.948 . . . . 0.0 110.409 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.48 -51.29 3.31 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -77.43 134.28 38.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.953 -1.322 . . . . 0.0 110.822 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.407 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 15.8 pt20 -93.07 160.0 15.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.584 -0.697 . . . . 0.0 110.116 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.8 mt -121.72 153.55 38.07 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -102.23 147.58 26.48 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.736 0.779 . . . . 0.0 110.32 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 63' ' ' SER . 66.7 t0 -67.23 137.52 56.24 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.998 0.904 . . . . 0.0 111.947 -178.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.541 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 55.5 m 48.79 80.64 0.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.557 0.694 . . . . 0.0 110.803 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -152.46 126.2 8.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.535 -0.728 . . . . 0.0 109.929 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.0 t -80.81 120.23 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.395 -0.816 . . . . 0.0 109.265 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.6 m -138.52 163.99 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.929 0.871 . . . . 0.0 110.575 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -115.69 124.01 49.78 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 87.9 mt -109.5 124.66 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -111.53 144.65 40.42 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.636 -0.665 . . . . 0.0 109.836 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.6 t30 65.42 37.25 6.31 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.554 0.692 . . . . 0.0 109.231 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.38 143.03 53.81 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -96.39 125.76 41.11 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.704 . . . . 0.0 109.536 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.1 t -85.51 130.23 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.811 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.86 141.47 30.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.378 -0.826 . . . . 0.0 108.782 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.417 ' O ' ' OE1' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -116.18 138.03 51.62 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.657 -0.652 . . . . 0.0 109.351 -179.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -132.36 135.63 46.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.536 -0.728 . . . . 0.0 109.965 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.2 t30 57.78 24.72 11.06 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.364 0.602 . . . . 0.0 109.703 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.79 33.62 29.83 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -138.33 121.31 16.66 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.321 -1.105 . . . . 0.0 109.48 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.3 mt -67.76 143.74 55.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.616 -0.677 . . . . 0.0 110.449 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.8 m -152.67 154.25 34.93 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.1 mt -101.85 126.5 48.75 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.214 -0.928 . . . . 0.0 109.711 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.7 m -106.91 125.55 51.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.718 -0.614 . . . . 0.0 109.443 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.8 t -98.81 108.33 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.349 -0.845 . . . . 0.0 108.834 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.39 179.82 42.17 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 87' ' ' SER . 38.4 p30 -67.83 -21.03 65.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.545 -0.973 . . . . 0.0 109.546 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.522 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 92.2 p -81.52 -7.96 59.66 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.143 -0.973 . . . . 0.0 109.207 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.5 t -80.42 158.47 25.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.965 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -117.69 127.8 54.28 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.1 mt -111.93 130.32 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.545 -0.722 . . . . 0.0 109.692 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -130.21 114.47 15.71 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.9 m -79.71 131.33 35.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.565 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.5 t . . . . . 0 N--CA 1.498 1.932 0 O-C-N 121.497 -0.752 . . . . 0.0 109.578 179.868 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 36.1 p-10 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.5 tp -76.19 123.92 26.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.331 -0.856 . . . . 0.0 109.809 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.48 163.66 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.71 0.767 . . . . 0.0 110.142 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -79.29 156.88 27.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.753 -0.592 . . . . 0.0 110.084 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.22 -43.35 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.408 ' HE ' ' HB2' ' A' ' 49' ' ' ALA . 99.5 mtt180 -65.17 -21.89 66.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 109.609 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -86.87 -1.38 57.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.204 -0.935 . . . . 0.0 109.666 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.6 t -70.3 130.86 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.165 -0.959 . . . . 0.0 110.316 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.407 ' HG ' ' HG ' ' A' ' 12' ' ' SER . 32.2 p -162.73 166.82 23.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.564 -0.71 . . . . 0.0 109.579 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.503 ' N ' HD22 ' A' ' 11' ' ' LEU . 3.7 mm? -67.84 -3.5 9.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -0.8 . . . . 0.0 109.027 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.407 ' HG ' ' HG ' ' A' ' 10' ' ' SER . 78.1 p -63.72 -32.02 73.38 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.362 -0.836 . . . . 0.0 109.472 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 p -114.67 134.42 22.39 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.45 -0.781 . . . . 0.0 109.783 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.69 -55.01 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.151 1.901 . . . . 0.0 112.148 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -115.5 134.88 54.65 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.554 -0.716 . . . . 0.0 110.09 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.8 m -141.4 160.6 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.504 -0.747 . . . . 0.0 109.809 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.4 t -116.05 134.49 54.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.77 162.54 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.447 -0.783 . . . . 0.0 110.1 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.2 tt -140.26 139.48 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.537 -0.727 . . . . 0.0 109.337 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 172.63 -169.0 42.15 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.997 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -106.69 133.07 51.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.541 -0.976 . . . . 0.0 109.414 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.635 ' N ' HD12 ' A' ' 22' ' ' ILE . 2.0 mp -94.0 129.98 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.208 0.527 . . . . 0.0 109.907 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.5 p -139.93 155.92 46.92 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.397 -0.814 . . . . 0.0 110.233 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.35 71.26 1.17 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.2 mm -81.35 130.58 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -1.177 . . . . 0.0 110.329 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -132.83 139.22 47.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -108.82 136.33 48.55 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.475 -0.766 . . . . 0.0 109.922 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -148.51 153.76 38.88 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -114.83 145.22 42.39 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.53 -0.732 . . . . 0.0 109.727 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -138.43 159.72 41.35 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.53 -0.732 . . . . 0.0 109.437 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -91.81 99.12 12.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.432 -0.792 . . . . 0.0 110.192 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 34' ' ' GLY . 8.3 t -77.9 -151.7 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.59 -0.694 . . . . 0.0 109.768 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -54.6 75.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.292 0.568 . . . . 0.0 110.474 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 61.97 19.56 59.05 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.3 m -140.02 133.11 29.54 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.262 -1.14 . . . . 0.0 110.166 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.4 m -78.38 128.86 34.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.327 -0.858 . . . . 0.0 109.367 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -132.72 144.49 50.32 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.397 -0.814 . . . . 0.0 109.945 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.5 p -84.78 146.41 27.39 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.424 -0.798 . . . . 0.0 109.773 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 55' ' ' SER . 9.9 p -139.0 138.55 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.613 -0.68 . . . . 0.0 109.46 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -100.36 135.34 41.95 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -127.97 157.36 40.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.621 -0.674 . . . . 0.0 109.433 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.49 -168.2 35.59 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -122.89 141.71 51.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.619 -0.93 . . . . 0.0 109.572 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.14 144.41 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -129.83 153.13 48.58 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.285 0.564 . . . . 0.0 109.643 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 20.6 t0 -144.41 -147.63 0.22 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.441 -0.787 . . . . 0.0 109.614 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.522 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 36.8 t70 -84.65 -7.7 59.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.805 . . . . 0.0 110.982 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.3 p -108.31 -66.18 1.06 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.13 -0.981 . . . . 0.0 109.998 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.408 ' HB2' ' HE ' ' A' ' 7' ' ' ARG . . . -157.56 -147.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 109.664 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.7 ptt85 -140.24 154.82 47.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.44 -0.787 . . . . 0.0 110.325 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.9 tt -146.32 161.27 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.523 -0.736 . . . . 0.0 109.939 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.85 145.07 40.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.516 -0.74 . . . . 0.0 110.16 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.6 pt -133.26 153.13 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.536 -0.727 . . . . 0.0 109.969 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 t -144.47 141.6 29.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.726 -0.609 . . . . 0.0 109.365 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 39' ' ' VAL . 4.6 p -132.71 137.59 46.96 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.456 -0.777 . . . . 0.0 109.06 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -94.77 125.99 39.79 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.365 -0.835 . . . . 0.0 110.905 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.76 -44.52 0.64 Allowed Glycine 0 N--CA 1.493 2.434 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.804 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -73.95 136.22 43.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.989 -1.3 . . . . 0.0 110.782 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -95.54 158.12 15.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.642 -0.661 . . . . 0.0 110.084 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.4 mt -123.11 153.42 39.99 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -111.93 137.31 50.08 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.669 0.747 . . . . 0.0 110.265 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.451 ' O ' ' OG ' ' A' ' 63' ' ' SER . 24.1 t70 -66.79 136.87 56.11 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.412 0.625 . . . . 0.0 110.907 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 62' ' ' ASP . 12.9 p 66.32 78.84 0.25 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.531 0.682 . . . . 0.0 110.363 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 46.1 p-10 -162.89 121.37 2.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 109.56 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 t -82.96 116.14 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.1 m -137.43 162.06 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.502 -0.749 . . . . 0.0 110.248 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -115.81 126.66 54.3 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.5 mt -106.15 127.31 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -111.68 145.5 39.14 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.251 0.548 . . . . 0.0 109.693 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.4 t30 66.2 35.81 5.85 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.35 136.52 42.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.476 -0.765 . . . . 0.0 109.137 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -91.55 133.51 35.46 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.102 -0.999 . . . . 0.0 110.121 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.2 t -88.1 132.03 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.431 -0.793 . . . . 0.0 109.548 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.03 164.11 26.11 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -122.99 124.27 42.78 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.75 0.786 . . . . 0.0 110.168 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.664 ' O ' ' N ' ' A' ' 78' ' ' GLY . 15.6 m-85 -84.5 -178.0 6.78 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 76' ' ' PHE . 97.6 m-20 -36.98 -18.39 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.074 0.464 . . . . 0.0 110.787 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.664 ' N ' ' O ' ' A' ' 76' ' ' PHE . . . 172.35 29.81 0.03 OUTLIER Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -141.46 140.7 33.62 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.313 -1.11 . . . . 0.0 110.345 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 80.4 mt -77.35 148.95 35.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.418 -0.801 . . . . 0.0 110.07 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.2 p -155.86 159.24 39.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.432 -0.793 . . . . 0.0 109.726 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.3 mt -113.29 126.23 55.16 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 p -106.17 131.12 53.8 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.571 -0.706 . . . . 0.0 109.41 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.4 t -101.13 114.91 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.37 -0.831 . . . . 0.0 109.298 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.37 177.01 37.5 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 37.2 p-10 -68.12 -23.25 64.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.503 -0.998 . . . . 0.0 110.106 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 95.4 p -85.0 -4.11 59.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.022 -1.048 . . . . 0.0 109.496 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.2 t -80.6 172.38 13.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 0.0 109.91 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -129.4 141.71 50.98 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.641 -0.662 . . . . 0.0 109.689 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -123.84 129.59 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -125.7 114.94 19.32 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.528 -0.732 . . . . 0.0 109.368 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.5 p -79.14 155.59 28.63 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.522 -0.736 . . . . 0.0 109.958 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.4 t . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.456 -0.778 . . . . 0.0 108.964 179.376 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.358 0.599 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.5 tp -74.27 125.06 27.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.411 -0.806 . . . . 0.0 109.742 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.3 m -138.99 162.74 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.474 -0.766 . . . . 0.0 109.21 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.549 ' N ' ' OD2' ' A' ' 8' ' ' ASP . 64.1 mttp -74.65 151.64 39.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 110.527 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 9' ' ' VAL . 96.9 mt -61.92 -43.03 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.606 -0.684 . . . . 0.0 109.634 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -59.2 -31.94 69.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.473 -0.767 . . . . 0.0 110.562 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.549 ' OD2' ' N ' ' A' ' 5' ' ' LYS . 6.9 p30 -83.43 11.18 7.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.114 -0.991 . . . . 0.0 110.504 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 6' ' ' ILE . 53.4 t -68.57 132.24 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.917 . . . . 0.0 110.069 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 m -161.5 170.08 20.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.364 -0.835 . . . . 0.0 110.153 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.27 -34.51 78.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.428 -0.795 . . . . 0.0 109.619 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -50.63 -17.82 0.59 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.457 -0.777 . . . . 0.0 109.743 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 p -121.36 82.92 39.51 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.77 -41.59 61.58 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.43 2.087 . . . . 0.0 112.089 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -121.32 128.81 52.67 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.7 m -144.27 160.3 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.181 -0.949 . . . . 0.0 109.653 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.2 m -116.74 133.6 55.81 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.53 163.06 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.391 -0.818 . . . . 0.0 109.459 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.522 HD11 HH12 ' A' ' 67' ' ' ARG . 97.5 mt -127.58 133.27 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 174.66 -163.56 34.07 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.455 -1.355 . . . . 0.0 109.959 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -125.81 143.52 51.03 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.798 -0.824 . . . . 0.0 109.346 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.592 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.8 mp -98.21 132.8 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.378 0.609 . . . . 0.0 110.615 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 63' ' ' SER . 66.7 p -134.49 157.17 47.19 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.327 0.584 . . . . 0.0 109.876 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.85 78.02 0.4 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.545 ' N ' HD12 ' A' ' 25' ' ' ILE . 1.4 mp -90.89 120.28 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.267 -1.137 . . . . 0.0 109.614 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -114.74 122.58 46.85 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -86.13 134.65 33.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 110.157 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -146.67 153.33 40.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.383 -0.823 . . . . 0.0 108.861 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -116.3 144.04 44.75 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.434 -0.791 . . . . 0.0 109.64 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -141.64 162.88 34.39 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.229 -0.919 . . . . 0.0 109.327 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -88.08 98.87 11.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.997 . . . . 0.0 109.251 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.567 ' O ' ' N ' ' A' ' 34' ' ' GLY . 9.3 t -84.31 -151.68 0.13 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.488 -0.758 . . . . 0.0 110.188 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.427 ' O ' ' N ' ' A' ' 35' ' ' THR . 99.4 m-20 -50.43 84.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.692 -0.63 . . . . 0.0 110.278 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 49.45 15.3 0.73 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.427 ' N ' ' O ' ' A' ' 33' ' ' ASP . 35.7 p -140.24 145.96 38.03 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.321 -1.105 . . . . 0.0 109.372 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.2 m -84.41 129.2 34.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.514 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -129.11 147.1 50.93 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.461 -0.774 . . . . 0.0 109.505 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 p -84.01 152.13 24.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.489 -0.757 . . . . 0.0 109.716 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.415 HG21 ' CE1' ' A' ' 56' ' ' PHE . 13.3 p -142.62 139.01 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -106.97 132.0 53.41 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -119.0 147.18 44.37 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.555 -0.715 . . . . 0.0 109.18 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.62 -169.67 33.18 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -117.23 141.6 48.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.754 -0.851 . . . . 0.0 109.386 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.2 tt -117.77 144.92 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -134.11 160.46 37.73 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.469 0.652 . . . . 0.0 110.205 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 45.0 t0 -157.84 -167.01 2.12 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.527 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 98.2 m-20 -68.13 -16.4 63.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.877 . . . . 0.0 109.756 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.3 p -90.0 -73.96 0.5 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.5 -144.68 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 109.788 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -146.49 153.75 40.77 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.976 . . . . 0.0 110.361 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.2 tt -152.93 159.59 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.365 -0.835 . . . . 0.0 109.766 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.5 ttp85 -75.21 146.13 41.45 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.24 -0.912 . . . . 0.0 110.288 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 22' ' ' ILE . 42.3 pt -134.99 163.66 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.497 -0.752 . . . . 0.0 110.086 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.7 t -143.72 128.97 18.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.379 -0.826 . . . . 0.0 108.844 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.4 t -113.15 121.88 45.84 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.543 -0.723 . . . . 0.0 109.093 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.415 ' CE1' HG21 ' A' ' 39' ' ' VAL . 90.8 m-85 -97.6 120.09 37.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.448 -0.783 . . . . 0.0 110.397 -178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.24 -63.21 4.02 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -71.96 136.79 46.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -1.124 . . . . 0.0 110.6 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -96.18 155.8 16.61 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.44 -0.787 . . . . 0.0 109.463 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.5 mt -128.18 161.62 28.87 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.543 -0.723 . . . . 0.0 109.773 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -112.57 152.99 28.22 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 122.108 0.956 . . . . 0.0 110.145 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 63' ' ' SER . 68.2 t0 -63.1 139.22 58.75 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 111.288 -178.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.543 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.7 m 58.59 28.58 17.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.584 -0.698 . . . . 0.0 109.566 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -82.78 114.68 21.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 109.792 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.45 113.5 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.269 -0.894 . . . . 0.0 108.998 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 m -141.19 165.07 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.398 -0.814 . . . . 0.0 110.185 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.522 HH12 HD11 ' A' ' 19' ' ' ILE . 59.9 ttm-85 -106.4 126.3 52.07 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.2 mm -108.15 126.49 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -122.6 143.83 49.5 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.0 t30 62.64 40.94 9.82 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.73 131.5 41.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 0.0 108.989 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -82.4 131.8 35.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.219 -0.926 . . . . 0.0 110.098 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.1 t -91.32 131.19 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.426 -0.797 . . . . 0.0 109.52 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.92 153.25 49.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.448 -0.782 . . . . 0.0 108.96 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -116.18 119.14 34.85 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.538 -0.726 . . . . 0.0 109.278 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -125.02 133.25 53.04 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.604 -0.685 . . . . 0.0 109.496 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.1 m120 55.37 31.26 16.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.707 -0.621 . . . . 0.0 109.94 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.6 6.6 84.83 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.521 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -113.95 133.42 55.48 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.47 -1.018 . . . . 0.0 109.71 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.3 mt -76.68 146.37 38.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.508 -0.745 . . . . 0.0 110.036 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.5 t -154.65 154.13 32.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.518 -0.739 . . . . 0.0 109.016 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.1 mt -103.42 129.51 50.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.379 -0.826 . . . . 0.0 109.114 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.2 t -105.19 128.38 53.37 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.699 -0.626 . . . . 0.0 109.562 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.52 99.94 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -97.08 -169.73 33.52 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -68.89 -17.29 63.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.565 -0.962 . . . . 0.0 109.634 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.8 m -83.12 -8.42 59.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.389 -0.819 . . . . 0.0 109.681 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.6 t -88.9 166.68 13.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 109.982 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -125.1 133.53 52.83 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 94.0 mt -119.29 128.38 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -126.5 132.1 51.47 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.537 -0.727 . . . . 0.0 109.46 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.9 t -66.18 132.79 49.27 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.549 -0.719 . . . . 0.0 110.223 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.265 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -78.01 165.35 24.14 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.8 0.81 . . . . 0.0 110.461 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 54.3 tp -76.19 124.34 27.31 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.62 0.724 . . . . 0.0 110.348 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.4 m -139.18 164.26 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.829 0.823 . . . . 0.0 110.144 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -80.69 161.02 24.81 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.708 0.766 . . . . 0.0 110.26 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.81 -43.27 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.216 0.531 . . . . 0.0 109.678 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -67.47 -18.8 65.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.783 -0.573 . . . . 0.0 109.649 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -86.04 -0.09 54.7 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.558 -0.714 . . . . 0.0 109.713 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.9 t -67.22 130.16 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.908 0.861 . . . . 0.0 110.344 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.9 p -160.86 167.27 27.01 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.769 0.795 . . . . 0.0 109.971 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.494 HD11 ' NE2' ' A' ' 75' ' ' GLN . 93.7 mt -66.72 -21.62 66.07 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.3 t -61.4 -20.24 62.83 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 51.6 p -124.92 80.96 62.81 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.749 -0.594 . . . . 0.0 109.461 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.73 -40.62 73.5 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.681 2.254 . . . . 0.0 111.705 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -112.8 125.81 54.75 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.647 0.736 . . . . 0.0 109.207 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.4 m -149.76 160.22 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 122.155 0.978 . . . . 0.0 111.058 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.2 t -118.33 134.17 55.27 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.7 m -135.49 162.38 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 121.972 0.891 . . . . 0.0 110.391 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.6 tt -140.97 135.57 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.637 0.732 . . . . 0.0 109.675 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.0 -165.99 37.42 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -113.44 136.67 52.52 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.733 0.777 . . . . 0.0 110.115 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.694 ' N ' HD12 ' A' ' 22' ' ' ILE . 2.5 mp -96.19 137.08 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 CA-C-O 121.475 0.655 . . . . 0.0 109.72 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.4 p -131.1 158.68 39.75 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.009 0.909 . . . . 0.0 110.348 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.62 93.55 0.01 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.8 mm -93.4 124.52 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.804 -0.821 . . . . 0.0 109.829 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -120.39 139.66 52.49 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.807 0.813 . . . . 0.0 109.53 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -108.04 134.46 50.89 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.838 0.828 . . . . 0.0 110.234 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -144.04 154.93 43.76 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.675 0.75 . . . . 0.0 109.452 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -123.54 144.87 49.29 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.842 0.83 . . . . 0.0 110.23 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -144.21 158.44 43.73 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.827 0.822 . . . . 0.0 109.861 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -87.92 115.44 25.39 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.601 0.715 . . . . 0.0 110.075 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 t -113.35 113.07 24.72 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.733 0.778 . . . . 0.0 109.492 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 47.1 t0 55.93 29.46 14.27 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.279 0.561 . . . . 0.0 109.743 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.99 2.45 80.92 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.4 m -118.13 127.6 53.93 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.758 -0.848 . . . . 0.0 109.928 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.8 m -69.31 129.63 40.33 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.632 0.73 . . . . 0.0 110.317 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -130.99 139.86 50.06 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.746 0.784 . . . . 0.0 109.72 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.5 m -86.26 141.76 29.05 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.015 0.912 . . . . 0.0 110.723 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -136.49 135.53 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.856 0.836 . . . . 0.0 109.485 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -101.61 133.48 46.23 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.692 0.758 . . . . 0.0 109.791 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -121.78 151.96 40.01 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.837 0.827 . . . . 0.0 109.667 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.41 -172.93 39.99 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.593 ' CB ' HH21 ' A' ' 50' ' ' ARG . 68.0 m-85 -117.35 142.99 46.43 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.695 0.759 . . . . 0.0 109.863 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.5 tt -125.84 139.87 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -133.56 159.54 40.14 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.128 0.966 . . . . 0.0 110.653 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 37.3 t0 -145.08 -148.77 0.25 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.471 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.542 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 97.5 m-20 -80.02 -6.64 57.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.648 -0.657 . . . . 0.0 109.536 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.5 p -105.67 -91.11 0.4 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.73 -0.607 . . . . 0.0 109.888 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -133.51 -145.14 0.24 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.576 -0.703 . . . . 0.0 110.066 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.593 HH21 ' CB ' ' A' ' 43' ' ' TYR . 17.5 ptm180 -145.89 156.09 43.31 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.821 0.819 . . . . 0.0 110.783 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.8 tt -148.1 161.99 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.911 0.862 . . . . 0.0 110.297 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -79.44 147.77 32.18 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.589 0.709 . . . . 0.0 110.17 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.8 pt -134.98 157.0 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.912 0.863 . . . . 0.0 110.37 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 m -141.35 125.43 17.29 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.649 0.737 . . . . 0.0 109.558 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.5 t -116.43 130.23 56.65 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.963 0.887 . . . . 0.0 109.629 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -98.91 119.49 37.77 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.656 0.741 . . . . 0.0 109.86 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.69 -51.68 4.05 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -71.71 135.14 46.68 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.667 -0.902 . . . . 0.0 110.436 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -89.09 155.58 19.36 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.842 0.83 . . . . 0.0 110.903 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.2 mt -119.34 151.02 39.18 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.57 0.7 . . . . 0.0 109.563 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.406 ' O ' ' OD1' ' A' ' 64' ' ' ASP . 21.5 mp0 -112.49 142.29 45.23 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 122.385 1.088 . . . . 0.0 110.156 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 63' ' ' SER . 68.1 t0 -64.18 135.58 56.43 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.966 0.888 . . . . 0.0 111.876 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.522 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 2.1 p 53.47 23.7 3.58 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.527 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 20.4 p-10 -87.65 126.12 34.77 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.748 0.785 . . . . 0.0 110.426 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 65' ' ' VAL . 1.3 m -82.47 115.8 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-O 121.657 0.742 . . . . 0.0 108.998 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.8 m -140.67 162.77 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 122.041 0.924 . . . . 0.0 110.416 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.525 ' NH1' ' OD1' ' A' ' 69' ' ' ASP . 68.9 ttp85 -117.39 127.82 54.42 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.701 0.762 . . . . 0.0 109.288 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.7 mt -107.25 129.48 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-O 121.754 0.787 . . . . 0.0 109.495 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.525 ' OD1' ' NH1' ' A' ' 67' ' ' ARG . 96.5 m-20 -116.41 144.27 44.51 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.688 0.756 . . . . 0.0 109.969 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.1 t30 62.91 39.57 10.33 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.842 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.26 146.74 47.04 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.4 0.619 . . . . 0.0 110.047 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.5 ttp85 -104.91 125.83 51.34 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.805 0.812 . . . . 0.0 110.095 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.0 t -86.55 133.22 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.699 0.761 . . . . 0.0 110.052 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.7 160.03 43.14 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.848 0.833 . . . . 0.0 109.955 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.494 ' NE2' HD11 ' A' ' 11' ' ' LEU . 77.5 mt-30 -107.44 114.37 28.34 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.699 0.762 . . . . 0.0 110.143 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -115.65 125.45 52.89 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.695 0.759 . . . . 0.0 109.472 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.405 HD22 ' HA ' ' A' ' 77' ' ' ASN . 11.2 m120 57.22 29.61 17.0 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.48 13.33 82.75 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -120.27 135.92 54.84 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.831 0.824 . . . . 0.0 109.987 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.2 mt -77.28 143.77 38.62 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.591 0.71 . . . . 0.0 109.899 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.0 p -156.3 163.3 39.69 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.957 0.884 . . . . 0.0 110.491 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.6 mt -103.63 124.11 48.22 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.757 0.789 . . . . 0.0 109.341 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.0 m -103.2 122.76 45.4 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.671 0.748 . . . . 0.0 110.104 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.699 HG11 HD11 ' A' ' 90' ' ' ILE . 6.9 t -99.23 105.55 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.65 0.738 . . . . 0.0 109.596 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.434 ' O ' ' OG ' ' A' ' 88' ' ' SER . . . -91.76 -176.43 42.72 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.82 -16.71 62.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.95 -0.735 . . . . 0.0 109.322 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 87.6 p -85.91 -15.36 41.95 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 85' ' ' GLY . 25.5 p -82.68 167.16 18.5 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.567 0.699 . . . . 0.0 110.05 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -126.74 138.3 53.36 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.785 0.802 . . . . 0.0 109.879 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.699 HD11 HG11 ' A' ' 84' ' ' VAL . 98.2 mt -122.32 127.55 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.493 0.664 . . . . 0.0 109.447 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -124.39 126.59 46.21 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.925 0.869 . . . . 0.0 110.253 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.0 p -76.35 150.02 36.91 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.455 0.645 . . . . 0.0 110.17 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.7 t -109.94 98.35 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-O 121.775 0.798 . . . . 0.0 109.712 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -104.92 -0.54 26.91 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.7 m -110.03 128.94 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 CA-C-O 121.834 0.825 . . . . 0.0 110.167 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -73.59 146.18 44.89 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.889 0.852 . . . . 0.0 111.177 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.1 pt -146.07 67.96 12.4 Favored Pre-proline 0 N--CA 1.493 1.713 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.133 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.12 -78.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.584 2.189 . . . . 0.0 111.554 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 100' ' ' GLU . 50.9 mt 61.2 160.03 0.05 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.483 0.659 . . . . 0.0 110.031 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' A' ' 99' ' ' LEU . 97.5 mt-10 51.68 168.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.864 0.84 . . . . 0.0 111.208 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.47 ' O ' ' CG ' ' A' ' 101' ' ' HIS . 53.5 p-80 -89.2 116.59 27.55 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.725 0.774 . . . . 0.0 109.906 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -87.83 0.27 56.03 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -61.37 -43.14 99.38 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -115.37 137.17 52.33 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.833 0.825 . . . . 0.0 109.869 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.488 ' CE1' ' CE1' ' A' ' 106' ' ' HIS . 39.3 p-80 -67.66 -35.85 79.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.871 -0.518 . . . . 0.0 109.692 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.488 ' CE1' ' CE1' ' A' ' 105' ' ' HIS . 78.1 m80 . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 117.835 -1.079 . . . . 0.0 109.978 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.2 m . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 55.7 t0 -73.17 152.63 41.05 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.753 0.787 . . . . 0.0 110.39 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.539 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 38.8 tp -69.5 128.7 37.45 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.504 0.669 . . . . 0.0 110.027 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.1 m -138.89 163.59 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.9 0.857 . . . . 0.0 109.968 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -75.32 156.65 35.33 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.75 0.786 . . . . 0.0 110.076 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.1 mm -62.65 -44.58 99.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.797 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -68.61 -20.96 64.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.562 -0.711 . . . . 0.0 109.504 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -82.77 -3.86 57.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.539 -0.726 . . . . 0.0 109.166 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.8 t -69.99 128.86 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.975 0.893 . . . . 0.0 109.915 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 12' ' ' SER . 29.7 m -163.6 162.66 24.43 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.566 0.698 . . . . 0.0 109.399 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.7 mt -64.58 -2.31 2.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.784 -0.573 . . . . 0.0 109.555 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.41 ' H ' ' C ' ' A' ' 10' ' ' SER . 78.6 p -61.0 -32.64 72.21 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.6 p -117.07 145.22 35.22 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.729 -0.607 . . . . 0.0 110.168 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.28 -61.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.999 2.466 . . . . 0.0 112.422 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 100.0 m-85 -119.75 136.53 54.4 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.858 0.837 . . . . 0.0 110.339 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.9 m -140.52 164.0 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.688 0.756 . . . . 0.0 109.973 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.431 ' O ' HD12 ' A' ' 3' ' ' LEU . 68.2 m -118.96 145.09 46.09 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.756 0.789 . . . . 0.0 109.494 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.24 160.27 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 122.114 0.959 . . . . 0.0 110.639 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 19' ' ' ILE . 19.5 tt -138.27 130.25 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.665 0.745 . . . . 0.0 109.457 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.58 -156.24 21.53 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -124.93 139.11 54.12 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.919 -0.753 . . . . 0.0 109.839 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.723 HD12 ' N ' ' A' ' 22' ' ' ILE . 3.0 mp -92.2 132.18 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.391 0.615 . . . . 0.0 110.08 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.0 m -125.76 143.87 50.87 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.058 0.932 . . . . 0.0 109.866 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.76 97.02 0.04 OUTLIER Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.6 mm -95.01 125.88 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.962 0.887 . . . . 0.0 110.408 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -123.4 134.51 53.96 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.556 0.693 . . . . 0.0 109.226 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -108.31 132.9 53.23 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.947 0.88 . . . . 0.0 110.037 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -140.76 158.27 44.21 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.772 0.796 . . . . 0.0 109.718 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -120.43 145.05 47.6 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.783 0.801 . . . . 0.0 109.983 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.441 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 13.7 p90 -141.61 159.42 42.27 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.18 0.99 . . . . 0.0 110.088 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -96.69 132.26 42.54 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.532 0.682 . . . . 0.0 109.471 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.0 t -159.16 141.1 13.54 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.743 0.782 . . . . 0.0 110.189 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 55.65 28.37 11.93 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.25 0.548 . . . . 0.0 109.759 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.36 14.66 79.2 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.7 p -135.87 155.06 50.89 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.61 -0.935 . . . . 0.0 109.874 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.6 m -98.2 126.24 43.58 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.88 0.848 . . . . 0.0 109.818 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.441 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 98.9 mttt -125.62 142.1 51.68 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.819 0.818 . . . . 0.0 109.325 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 90.8 p -84.57 146.37 27.57 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.841 0.829 . . . . 0.0 110.368 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -133.51 136.99 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.822 0.82 . . . . 0.0 109.821 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.514 ' CZ ' ' OE1' ' A' ' 59' ' ' GLN . 94.4 m-85 -101.95 131.2 48.49 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.763 0.792 . . . . 0.0 109.725 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -126.12 155.24 41.96 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.93 0.871 . . . . 0.0 109.943 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.9 -166.93 35.19 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.618 ' CD2' ' NH2' ' A' ' 50' ' ' ARG . 97.2 m-85 -119.79 140.37 50.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.81 -0.818 . . . . 0.0 110.072 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.4 tt -122.79 133.19 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -134.32 156.23 48.84 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 122.277 1.037 . . . . 0.0 110.561 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 48' ' ' THR . 5.4 p30 -168.09 95.32 0.41 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.646 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 48' ' ' THR . 66.8 t0 52.4 -77.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 120.936 0.398 . . . . 0.0 110.571 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.589 ' N ' ' O ' ' A' ' 46' ' ' ASP . 73.9 p -38.62 -80.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.086 0.47 . . . . 0.0 110.456 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.404 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -158.21 -143.67 0.11 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.698 0.761 . . . . 0.0 110.087 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.618 ' NH2' ' CD2' ' A' ' 43' ' ' TYR . 8.9 ptm180 -142.87 150.68 40.18 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.761 0.791 . . . . 0.0 110.4 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.6 tt -146.54 156.26 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.747 0.784 . . . . 0.0 110.085 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -76.69 147.2 37.57 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.735 0.779 . . . . 0.0 109.973 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.2 pt -135.05 154.47 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.644 0.735 . . . . 0.0 110.273 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 t -143.17 133.42 24.54 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.858 0.837 . . . . 0.0 109.551 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 p -131.09 135.28 47.38 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.973 0.892 . . . . 0.0 109.887 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.446 ' C ' ' H ' ' A' ' 58' ' ' LYS . 90.7 m-85 -94.8 122.33 37.3 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.699 0.761 . . . . 0.0 111.025 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.47 -29.46 0.58 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' A' ' 56' ' ' PHE . 98.9 mttt -74.11 136.84 42.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.568 -0.96 . . . . 0.0 110.607 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.514 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 68.7 tp60 -94.68 146.92 23.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.776 0.798 . . . . 0.0 110.495 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.9 mt -129.48 152.44 49.01 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.721 0.772 . . . . 0.0 109.927 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -122.93 137.64 54.89 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.216 1.008 . . . . 0.0 110.074 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 63' ' ' SER . 65.6 t0 -64.78 134.69 54.66 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.865 0.84 . . . . 0.0 111.462 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.53 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 2.8 p 78.29 8.19 2.31 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.862 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 7.3 p-10 -84.45 124.08 30.95 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.307 0.575 . . . . 0.0 110.803 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 t -87.02 116.76 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.637 0.732 . . . . 0.0 109.117 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.48 163.22 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.221 1.01 . . . . 0.0 110.945 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -119.27 128.99 54.68 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.7 mt -106.23 129.45 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.773 0.797 . . . . 0.0 109.543 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -114.81 143.51 44.99 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.849 0.833 . . . . 0.0 110.149 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.6 t30 62.12 37.89 14.19 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.2 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.95 145.7 46.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.583 -0.698 . . . . 0.0 109.426 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -96.04 132.34 41.5 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.828 0.823 . . . . 0.0 110.209 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 89.6 t -83.15 131.66 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 121.532 0.682 . . . . 0.0 109.974 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.64 154.28 43.37 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.683 0.754 . . . . 0.0 109.973 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -119.79 117.38 28.03 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.816 0.817 . . . . 0.0 109.924 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -119.85 131.51 55.29 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.852 0.834 . . . . 0.0 110.01 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.8 t30 56.64 24.32 8.73 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.239 0.542 . . . . 0.0 110.249 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.88 10.51 82.93 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -114.99 138.17 51.15 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.91 0.862 . . . . 0.0 109.755 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 80' ' ' LEU . 3.7 mm? -76.94 141.61 40.4 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.93 0.872 . . . . 0.0 110.699 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.3 p -153.52 159.24 42.19 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.752 0.787 . . . . 0.0 110.008 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.7 mt -108.56 126.39 52.88 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.791 0.805 . . . . 0.0 110.175 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.2 m -101.43 123.54 45.65 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.825 0.822 . . . . 0.0 109.656 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.7 t -101.02 111.29 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 CA-C-O 121.843 0.83 . . . . 0.0 109.204 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.23 -178.71 37.22 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -68.2 -18.35 64.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 122.149 -0.618 . . . . 0.0 109.543 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 97.1 p -87.65 -7.53 57.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.669 -0.645 . . . . 0.0 109.455 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.1 t -83.69 164.92 19.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.456 -0.778 . . . . 0.0 109.556 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -128.54 139.27 52.39 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.754 0.788 . . . . 0.0 109.911 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.15 130.47 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.651 0.739 . . . . 0.0 109.45 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.532 ' N ' ' OE1' ' A' ' 91' ' ' GLU . 56.7 mp0 -115.72 125.53 52.93 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.83 0.824 . . . . 0.0 109.93 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.0 p -71.33 144.87 49.78 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.596 0.712 . . . . 0.0 110.559 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 55.2 t -119.27 130.8 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-O 121.936 0.874 . . . . 0.0 109.924 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -132.46 -69.15 0.59 Allowed 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -126.97 115.59 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-O 121.88 0.847 . . . . 0.0 109.686 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -79.54 154.69 28.62 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.832 0.825 . . . . 0.0 110.419 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.2 mt -139.86 77.65 26.48 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.24 145.06 98.98 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.821 2.347 . . . . 0.0 112.136 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.545 ' C ' HD23 ' A' ' 99' ' ' LEU . 3.3 tt 55.98 93.99 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.778 0.799 . . . . 0.0 109.672 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 101' ' ' HIS . 83.4 tt0 -157.25 84.36 0.92 Allowed 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.74 0.781 . . . . 0.0 109.684 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' A' ' 100' ' ' GLU . 65.4 m170 58.6 129.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.727 0.775 . . . . 0.0 110.528 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.475 ' N ' ' CD2' ' A' ' 102' ' ' HIS . 0.3 OUTLIER -150.56 166.89 28.87 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.907 0.86 . . . . 0.0 110.445 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.537 ' CG ' ' N ' ' A' ' 104' ' ' HIS . 51.1 p-80 -62.85 -47.44 83.36 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.537 ' N ' ' CG ' ' A' ' 103' ' ' HIS . 85.9 t60 54.11 6.02 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.528 ' H ' ' C ' ' A' ' 103' ' ' HIS . 94.5 m-70 -83.37 141.71 31.56 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.722 0.773 . . . . 0.0 110.827 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.1 t60 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 117.881 -1.057 . . . . 0.0 109.061 179.479 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 84.4 p . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 60.5 t0 -72.68 149.61 43.67 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.75 0.786 . . . . 0.0 110.209 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.532 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 4.9 tt -71.17 133.82 46.46 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.686 -0.634 . . . . 0.0 110.726 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.2 m -135.84 162.91 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-O 121.567 0.698 . . . . 0.0 109.884 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -79.04 155.98 28.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.589 -0.695 . . . . 0.0 110.062 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 93.9 mt -63.54 -43.66 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.712 -0.618 . . . . 0.0 109.866 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 -72.31 -14.38 61.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.117 -0.989 . . . . 0.0 109.864 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -93.25 2.22 56.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.321 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.51 132.05 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 0.0 110.155 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.3 p -159.35 165.82 32.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.355 -0.841 . . . . 0.0 109.837 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.66 -19.07 65.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.523 -0.735 . . . . 0.0 109.762 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.2 m -57.51 -25.25 59.56 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.118 -0.989 . . . . 0.0 109.24 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 45.8 p -123.29 82.64 52.24 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.46 -40.36 71.79 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.641 2.227 . . . . 0.0 112.088 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -115.87 128.76 56.05 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.419 0.628 . . . . 0.0 109.832 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.2 m -153.04 -176.41 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.445 -0.785 . . . . 0.0 109.906 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.3 m -130.18 144.29 51.28 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.4 m -139.88 162.61 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.376 -0.827 . . . . 0.0 110.245 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.3 tp -141.52 127.93 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.68 -168.53 38.06 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.058 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -110.27 144.11 39.44 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.621 -0.929 . . . . 0.0 109.545 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.0 mm -95.07 133.44 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.364 0.602 . . . . 0.0 110.254 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 t -143.02 156.84 44.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.37 -0.831 . . . . 0.0 109.983 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.11 62.14 4.41 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.0 mm -76.94 129.78 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -1.125 . . . . 0.0 110.624 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -130.09 122.69 28.79 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.509 ' NZ ' ' OE2' ' A' ' 29' ' ' GLU . 66.0 tttm -86.41 136.93 32.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.355 -0.841 . . . . 0.0 110.022 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -146.64 139.85 25.57 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.509 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 97.2 mt-10 -115.1 148.15 39.32 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.664 -0.647 . . . . 0.0 110.154 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.541 ' CE2' ' OG ' ' A' ' 32' ' ' SER . 9.8 p90 -147.28 159.29 43.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.819 . . . . 0.0 109.188 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -84.07 119.98 25.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.4 -0.812 . . . . 0.0 110.318 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.541 ' OG ' ' CE2' ' A' ' 30' ' ' TYR . 3.1 m -119.41 114.17 21.91 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 55.36 31.94 17.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.56 -0.713 . . . . 0.0 109.881 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.74 6.43 88.49 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.2 m -120.89 128.56 52.91 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.525 -0.985 . . . . 0.0 109.874 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.4 m -68.25 134.72 50.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.602 -0.686 . . . . 0.0 110.042 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -131.58 147.29 52.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.441 -0.787 . . . . 0.0 109.34 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.5 t -99.9 135.09 41.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.631 -0.668 . . . . 0.0 109.939 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.94 138.09 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -105.41 134.35 48.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.527 -0.733 . . . . 0.0 109.476 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -123.51 150.86 43.42 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.391 0.615 . . . . 0.0 109.385 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.431 ' C ' ' CD1' ' A' ' 53' ' ' ILE . . . -173.82 -147.44 6.0 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.48 ' OH ' ' NH1' ' A' ' 52' ' ' ARG . 79.6 m-85 -132.92 141.58 48.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.573 -0.957 . . . . 0.0 109.549 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 tt -116.04 134.39 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -133.26 150.23 51.93 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.756 0.788 . . . . 0.0 110.719 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 48' ' ' THR . 62.8 t0 -167.36 95.55 0.47 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' THR . 38.8 t70 48.37 -79.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.812 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.601 ' N ' ' O ' ' A' ' 46' ' ' ASP . 14.5 m -36.29 -77.31 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.767 -0.583 . . . . 0.0 110.803 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -161.12 -153.99 0.34 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.032 -1.042 . . . . 0.0 109.426 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 -138.97 152.12 47.42 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.39 0.614 . . . . 0.0 110.572 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.0 tt -150.67 163.52 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.783 . . . . 0.0 110.167 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.48 ' NH1' ' OH ' ' A' ' 43' ' ' TYR . 77.2 mtp85 -79.31 149.19 31.85 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.514 0.673 . . . . 0.0 110.838 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.803 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -141.79 164.44 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.511 -0.743 . . . . 0.0 109.792 179.587 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 p -140.42 127.13 20.39 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 t -109.98 118.08 35.5 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.619 -0.675 . . . . 0.0 109.21 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.433 ' C ' ' H ' ' A' ' 58' ' ' LYS . 72.1 m-85 -95.4 123.85 39.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.448 -0.782 . . . . 0.0 110.806 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.15 -33.55 0.65 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 56' ' ' PHE . 31.1 mmtp -87.92 130.13 35.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.893 -1.357 . . . . 0.0 109.955 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -90.45 146.41 24.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.501 -0.749 . . . . 0.0 110.283 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.7 mt -132.67 151.39 51.97 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.625 -0.672 . . . . 0.0 109.346 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -112.34 148.23 34.69 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.948 0.88 . . . . 0.0 110.153 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.6 t0 -65.27 136.68 56.89 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.656 0.741 . . . . 0.0 111.389 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.503 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 3.1 p 75.26 6.73 4.14 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.28 0.562 . . . . 0.0 109.94 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -83.98 122.61 28.99 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.13 -0.981 . . . . 0.0 110.135 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.4 t -85.57 119.19 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.4 160.48 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.422 0.629 . . . . 0.0 109.666 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -116.37 123.51 47.77 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 75.9 mt -107.41 130.36 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.572 -0.705 . . . . 0.0 109.401 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -116.98 144.65 44.33 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.447 0.641 . . . . 0.0 109.911 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.3 t30 64.75 35.86 8.47 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.445 0.64 . . . . 0.0 109.542 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.87 146.21 53.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.425 -0.797 . . . . 0.0 109.164 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.3 ttp85 -100.27 125.18 46.43 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.507 0.67 . . . . 0.0 110.056 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.3 t -85.25 133.3 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.521 -0.737 . . . . 0.0 109.651 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.38 164.85 30.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.365 -0.834 . . . . 0.0 109.349 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -103.33 114.37 28.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.6 -0.687 . . . . 0.0 109.609 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -110.3 121.87 46.32 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.6 m120 56.05 31.27 17.76 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.411 0.624 . . . . 0.0 109.392 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.89 13.07 83.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -121.47 138.47 54.28 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.514 -0.992 . . . . 0.0 110.059 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.7 mt -71.37 139.8 49.93 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.583 -0.698 . . . . 0.0 110.283 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.66 163.04 40.43 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.8 mt -103.59 127.83 50.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.602 -0.686 . . . . 0.0 109.585 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.4 t -107.38 126.91 53.07 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 t -103.39 106.01 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.484 -0.76 . . . . 0.0 109.79 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -90.83 179.67 42.93 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -65.44 -37.7 87.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.482 -1.011 . . . . 0.0 109.603 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.4 m -60.66 -36.14 77.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 0.0 110.008 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.1 p -63.25 163.21 10.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.192 -0.942 . . . . 0.0 110.328 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -111.35 140.04 46.26 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.722 -0.611 . . . . 0.0 109.525 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.28 131.38 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -128.13 108.65 10.81 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.497 -0.752 . . . . 0.0 109.181 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.9 t -72.69 140.89 48.17 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.49 -0.756 . . . . 0.0 110.132 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 94' ' ' ASN . 98.1 t -103.24 -50.88 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 93' ' ' VAL . 13.2 m120 48.94 101.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.627 0.727 . . . . 0.0 110.004 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.5 t -73.61 107.32 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.253 -0.904 . . . . 0.0 110.014 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -156.96 112.03 2.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.513 -0.742 . . . . 0.0 109.019 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.6 pt -145.72 78.63 11.67 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.322 -0.861 . . . . 0.0 109.185 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.57 146.26 91.87 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.657 2.238 . . . . 0.0 112.585 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 99' ' ' LEU . 10.4 mp 56.69 108.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.707 0.765 . . . . 0.0 110.187 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -59.69 144.01 49.14 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.599 0.714 . . . . 0.0 110.607 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -74.36 69.99 1.66 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.514 -0.741 . . . . 0.0 109.511 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -65.14 -40.19 94.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.493 -0.754 . . . . 0.0 109.274 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -70.98 74.36 0.62 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.364 -0.835 . . . . 0.0 109.732 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -65.46 -34.35 78.08 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.505 ' CG ' ' N ' ' A' ' 106' ' ' HIS . 83.9 t60 55.84 -112.56 0.71 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.674 -0.642 . . . . 0.0 110.328 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.527 ' O ' ' CG ' ' A' ' 106' ' ' HIS . 56.5 p-80 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.205 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 122.032 0.92 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 146.42 158.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.549 HD13 ' N ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -87.26 121.7 30.05 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.149 -0.969 . . . . 0.0 111.528 -174.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.549 ' N ' HD13 ' A' ' 3' ' ' LEU . 31.7 m -131.29 161.63 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -75.75 162.92 27.78 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.813 0.816 . . . . 0.0 110.265 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.5 mm -62.79 -43.51 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.615 -0.678 . . . . 0.0 109.253 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -65.78 -18.21 65.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.383 -0.823 . . . . 0.0 110.055 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -85.28 -0.05 53.51 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.136 -0.977 . . . . 0.0 110.281 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.39 133.05 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.174 -0.954 . . . . 0.0 110.254 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.1 m -157.5 162.8 38.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.473 -0.767 . . . . 0.0 109.742 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.74 -30.16 70.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.376 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -59.33 -20.23 52.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.347 -0.846 . . . . 0.0 109.293 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.404 ' O ' ' OG1' ' A' ' 13' ' ' THR . 11.5 p -118.39 80.2 16.03 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -70.72 -15.21 33.5 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.015 1.81 . . . . 0.0 112.581 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -133.11 105.97 7.34 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.423 -0.798 . . . . 0.0 109.792 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.1 m -145.57 164.61 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.379 -0.826 . . . . 0.0 109.881 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.1 t -108.54 141.45 40.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.339 -0.85 . . . . 0.0 108.825 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.52 160.27 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.365 -0.834 . . . . 0.0 109.724 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.621 HD12 ' HE ' ' A' ' 67' ' ' ARG . 7.5 tt -142.73 137.35 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.389 -0.819 . . . . 0.0 109.373 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.67 -166.27 35.94 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.227 -1.463 . . . . 0.0 110.683 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -104.57 132.41 50.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.818 -0.813 . . . . 0.0 109.402 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.2 mm -89.29 130.02 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 121.221 0.534 . . . . 0.0 109.915 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.0 p -137.87 161.54 36.36 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.325 -0.859 . . . . 0.0 109.884 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.57 79.29 0.1 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.8 mm -91.44 120.07 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.193 -1.181 . . . . 0.0 109.709 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -119.56 125.76 49.6 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -93.85 134.43 36.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.284 -0.885 . . . . 0.0 109.967 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -148.12 143.58 27.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.426 -0.796 . . . . 0.0 109.001 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -123.89 144.91 49.47 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.415 -0.803 . . . . 0.0 109.344 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.512 ' CE2' ' OG ' ' A' ' 32' ' ' SER . 24.9 p90 -141.71 160.73 39.57 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.215 -0.928 . . . . 0.0 109.558 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.2 tp10 -79.6 114.52 18.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.56 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.512 ' OG ' ' CE2' ' A' ' 30' ' ' TYR . 5.1 m -109.61 112.82 25.13 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.533 -0.729 . . . . 0.0 109.531 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 53.37 31.07 11.3 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.42 -0.8 . . . . 0.0 110.201 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.67 -2.45 82.52 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.3 p -118.36 124.87 48.8 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.299 -1.118 . . . . 0.0 109.296 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.4 m -69.68 135.67 50.14 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.432 -0.792 . . . . 0.0 110.221 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -131.84 147.87 52.51 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.2 t -96.95 131.79 43.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.506 -0.746 . . . . 0.0 109.747 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.67 135.36 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -104.81 135.53 46.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.528 -0.733 . . . . 0.0 109.129 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -124.56 153.88 41.47 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.445 0.64 . . . . 0.0 109.371 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.76 -151.72 8.41 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -130.37 145.92 51.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.81 -0.818 . . . . 0.0 109.377 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.8 tt -123.57 142.36 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -127.71 151.51 48.89 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.434 0.635 . . . . 0.0 109.667 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.529 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 36.9 t0 -141.78 -153.16 0.45 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.485 -0.759 . . . . 0.0 109.381 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.529 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 95.5 m-20 -78.91 -7.47 58.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.88 . . . . 0.0 109.935 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.5 p -108.75 -85.8 0.52 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.335 -0.853 . . . . 0.0 110.363 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.0 -148.86 0.32 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.473 -0.767 . . . . 0.0 109.622 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -145.44 156.36 43.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.271 -0.893 . . . . 0.0 110.087 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.7 tt -148.91 164.8 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.368 -0.833 . . . . 0.0 109.978 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.63 144.17 35.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.158 -0.964 . . . . 0.0 110.148 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.829 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -135.21 161.23 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.485 -0.759 . . . . 0.0 109.665 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.2 m -137.79 139.98 40.33 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 58' ' ' LYS . 4.7 p -119.58 116.24 25.64 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -96.78 117.09 30.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.382 -0.824 . . . . 0.0 110.273 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.83 -13.26 3.23 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.429 ' O ' ' OG ' ' A' ' 55' ' ' SER . 28.3 mmtp -103.77 107.15 17.89 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.365 -1.08 . . . . 0.0 109.352 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -72.64 145.02 47.58 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.569 -0.707 . . . . 0.0 109.728 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.1 mt -127.14 153.25 46.27 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -105.75 141.56 36.97 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.613 0.721 . . . . 0.0 109.847 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 63' ' ' SER . 57.1 t0 -66.25 138.42 57.64 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.592 0.711 . . . . 0.0 110.782 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.528 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 5.0 m 61.56 78.85 0.27 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.354 0.597 . . . . 0.0 110.749 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.416 ' CG ' ' O ' ' A' ' 63' ' ' SER . 56.7 m-20 -163.33 126.92 2.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.691 -0.631 . . . . 0.0 109.422 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.7 t -78.24 121.63 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.1 m -137.72 160.67 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.43 -0.794 . . . . 0.0 109.855 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.621 ' HE ' HD12 ' A' ' 19' ' ' ILE . 41.8 ttm180 -117.36 128.74 55.34 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.4 mt -106.95 126.57 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -109.85 141.22 42.85 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.72 -0.612 . . . . 0.0 109.729 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 61.7 t30 62.74 41.01 9.47 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.484 0.659 . . . . 0.0 109.385 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.57 147.31 49.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.422 -0.799 . . . . 0.0 109.087 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -103.37 125.53 50.04 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.537 -0.727 . . . . 0.0 109.578 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.0 t -86.25 132.7 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.482 -0.761 . . . . 0.0 109.69 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.66 152.92 41.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.321 -0.862 . . . . 0.0 109.174 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -107.35 122.3 46.3 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.446 -0.784 . . . . 0.0 109.556 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -126.08 138.91 53.74 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.1 t30 56.25 24.06 7.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.559 -0.713 . . . . 0.0 109.507 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.64 8.35 87.72 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -118.19 138.97 51.95 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.42 -1.047 . . . . 0.0 109.698 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.9 mt -75.53 145.15 41.54 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.629 0.728 . . . . 0.0 110.342 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.5 p -154.77 160.62 41.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.552 -0.717 . . . . 0.0 109.139 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.7 mt -105.16 126.27 51.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.414 -0.804 . . . . 0.0 109.331 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.9 p -109.2 134.37 51.83 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.558 -0.714 . . . . 0.0 109.6 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.8 t -100.51 114.08 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.306 -0.871 . . . . 0.0 108.749 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -88.14 175.85 44.99 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 87' ' ' SER . 43.3 p-10 -67.43 -24.24 65.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.571 -0.958 . . . . 0.0 109.822 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.453 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 66.2 m -84.17 -6.4 59.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.238 -0.914 . . . . 0.0 109.634 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.9 t -81.96 170.84 15.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.756 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -131.52 141.25 49.69 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.619 -0.675 . . . . 0.0 109.751 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.8 130.51 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.645 -0.66 . . . . 0.0 109.438 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -121.33 120.39 34.92 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.55 0.69 . . . . 0.0 109.374 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.2 m -75.69 147.15 39.64 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.506 -0.746 . . . . 0.0 110.176 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.7 t -136.76 61.69 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -95.81 1.6 53.29 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.32 -0.863 . . . . 0.0 109.645 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.415 HG12 ' H ' ' A' ' 97' ' ' ILE . 55.7 t -120.18 130.18 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.514 -0.741 . . . . 0.0 109.16 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 54.2 p30 -101.24 51.39 0.85 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.488 -0.758 . . . . 0.0 109.056 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.415 ' H ' HG12 ' A' ' 95' ' ' VAL . 11.8 mt -143.85 69.87 16.77 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.428 -0.795 . . . . 0.0 109.31 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.78 -0.76 10.83 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.73 2.287 . . . . 0.0 111.238 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 73.7 mt -71.56 147.08 48.0 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.57 0.7 . . . . 0.0 110.168 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 102' ' ' HIS . 30.0 tp10 58.53 -123.76 1.39 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.593 -0.692 . . . . 0.0 109.951 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 57.8 m170 44.48 -93.88 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.255 -0.903 . . . . 0.0 109.729 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 100' ' ' GLU . 48.1 p-80 -154.97 153.54 31.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 109.34 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.437 ' CD2' ' H ' ' A' ' 103' ' ' HIS . 13.2 p80 -96.5 122.33 39.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.222 -0.924 . . . . 0.0 109.889 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.9 -41.97 90.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.413 -0.805 . . . . 0.0 109.718 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -76.23 143.58 40.91 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.395 -0.816 . . . . 0.0 110.138 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.549 179.902 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 76.9 p . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.9 p30 -174.45 157.33 2.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.447 -0.783 . . . . 0.0 109.492 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.554 ' N ' HD22 ' A' ' 3' ' ' LEU . 3.8 mm? -83.7 130.44 34.96 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.457 -0.777 . . . . 0.0 109.994 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.4 m -138.32 161.68 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.544 0.687 . . . . 0.0 109.559 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -86.7 163.55 17.27 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.539 0.685 . . . . 0.0 109.883 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.2 mm -62.87 -43.78 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.613 -0.679 . . . . 0.0 109.85 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -66.76 -18.99 65.65 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.019 -1.051 . . . . 0.0 109.435 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -84.18 -1.68 55.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 0.0 109.566 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.47 131.59 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.204 -0.935 . . . . 0.0 110.136 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.4 t -163.41 160.07 23.04 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.3 -3.66 6.33 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.9 m -59.75 -35.63 74.98 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.63 -0.668 . . . . 0.0 109.248 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.7 p -115.28 133.63 22.69 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.66 -0.65 . . . . 0.0 109.701 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.61 -53.05 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.127 1.885 . . . . 0.0 111.781 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -119.66 130.73 55.2 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.368 0.604 . . . . 0.0 109.866 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.0 m -146.93 163.93 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.537 -0.727 . . . . 0.0 109.591 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.9 t -110.15 138.24 46.8 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.435 -0.791 . . . . 0.0 109.505 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -134.02 160.52 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.529 -0.732 . . . . 0.0 109.713 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.0 tt -142.96 137.58 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 109.599 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.48 -161.94 28.9 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.866 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -110.4 129.11 55.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.671 -0.899 . . . . 0.0 109.438 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.2 mt -101.75 131.12 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.766 -0.584 . . . . 0.0 109.991 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.474 ' HA ' ' H ' ' A' ' 63' ' ' SER . 23.0 m -145.27 153.45 41.3 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.591 0.71 . . . . 0.0 109.997 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.51 65.18 1.75 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.9 mm -81.58 129.1 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -1.138 . . . . 0.0 109.94 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -123.89 132.71 53.79 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -94.27 134.14 37.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.0 109.876 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -145.21 157.95 43.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.454 -0.779 . . . . 0.0 109.284 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -123.6 144.23 49.72 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.518 -0.739 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -142.38 160.63 39.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.375 -0.828 . . . . 0.0 109.321 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -80.1 148.29 31.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.434 -0.792 . . . . 0.0 109.832 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.581 ' O ' ' N ' ' A' ' 34' ' ' GLY . 34.1 m -144.97 -149.5 0.28 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.474 -0.766 . . . . 0.0 109.114 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -50.95 84.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.758 0.79 . . . . 0.0 110.13 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 47.69 19.98 1.01 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -147.91 151.16 35.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.072 -1.252 . . . . 0.0 110.156 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.8 m -89.66 131.12 35.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.451 -0.78 . . . . 0.0 109.171 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -119.33 146.75 45.03 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.579 0.704 . . . . 0.0 109.942 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 89.2 p -83.77 146.35 28.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.49 -0.757 . . . . 0.0 109.924 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -139.54 137.81 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -104.25 128.9 52.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.499 -0.751 . . . . 0.0 109.401 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -113.85 154.61 27.19 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.18 -169.53 37.79 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -124.85 146.36 49.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.659 -0.906 . . . . 0.0 109.611 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.2 tt -125.39 139.44 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -126.95 149.35 49.88 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.528 -0.732 . . . . 0.0 110.234 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 42.7 t0 -136.13 -160.44 1.05 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.516 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 1.4 p30 -81.29 -3.53 52.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 110.056 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.9 p -107.06 -62.11 1.45 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.278 -0.889 . . . . 0.0 109.438 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -160.71 -151.46 0.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.23 -0.919 . . . . 0.0 109.583 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -144.8 156.96 44.31 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.4 tt -146.63 159.49 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.297 -0.877 . . . . 0.0 110.053 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -76.42 144.5 39.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.381 -0.824 . . . . 0.0 109.697 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.2 pt -128.73 157.96 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.491 -0.756 . . . . 0.0 110.076 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -145.0 126.43 14.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.4 t -114.84 127.52 55.76 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.486 -0.759 . . . . 0.0 109.492 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -97.44 117.78 32.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.577 -0.702 . . . . 0.0 110.349 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.64 -54.58 4.97 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -70.31 138.18 51.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.128 -1.219 . . . . 0.0 110.669 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -88.41 158.37 18.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.618 -0.676 . . . . 0.0 110.077 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.6 mt -121.27 153.63 37.42 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -106.88 135.47 48.38 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.685 0.755 . . . . 0.0 109.838 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -66.42 136.84 56.32 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.751 0.786 . . . . 0.0 110.948 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.474 ' H ' ' HA ' ' A' ' 23' ' ' THR . 67.0 m 45.82 78.85 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.605 0.717 . . . . 0.0 110.145 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -150.68 126.52 10.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.626 -0.671 . . . . 0.0 109.358 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.5 t -78.55 115.87 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.498 -0.751 . . . . 0.0 109.23 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.1 m -140.58 166.87 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.487 -0.758 . . . . 0.0 109.94 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -121.8 130.38 53.35 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 74.8 mt -107.33 129.55 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.55 -0.719 . . . . 0.0 109.221 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -111.25 143.05 42.64 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.343 0.592 . . . . 0.0 109.955 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.5 t30 62.67 38.61 11.92 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.154 0.502 . . . . 0.0 109.883 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.13 139.2 46.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -0.854 . . . . 0.0 108.98 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -92.61 132.89 36.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.283 -0.886 . . . . 0.0 110.173 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -87.01 132.03 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.456 -0.778 . . . . 0.0 109.828 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.85 155.23 48.28 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.301 -0.874 . . . . 0.0 109.509 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -120.78 120.27 35.13 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -123.37 132.51 54.0 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.495 0.664 . . . . 0.0 109.602 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 55.84 32.02 18.81 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.42 0.628 . . . . 0.0 109.804 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.54 4.93 81.86 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -112.48 136.23 52.24 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.39 -1.065 . . . . 0.0 109.828 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.42 148.44 37.31 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.694 0.759 . . . . 0.0 110.77 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.0 t -156.25 154.44 30.71 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.5 mt -100.38 127.43 46.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.229 -0.92 . . . . 0.0 109.296 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 m -106.06 124.19 49.18 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.466 0.65 . . . . 0.0 109.354 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.4 t -96.8 112.43 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.291 -0.881 . . . . 0.0 108.919 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.92 178.44 43.71 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.14 -21.16 62.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.653 -0.91 . . . . 0.0 110.254 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.3 p -85.72 -5.44 59.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.167 -0.958 . . . . 0.0 109.28 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.1 p -79.03 167.6 20.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.447 -0.783 . . . . 0.0 109.883 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -131.45 141.74 49.86 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.421 0.629 . . . . 0.0 109.411 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.05 130.98 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -124.9 138.66 54.24 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.558 0.694 . . . . 0.0 109.443 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.2 m -70.58 150.26 46.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.628 -0.67 . . . . 0.0 110.126 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 51.7 t -113.63 133.15 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.608 0.718 . . . . 0.0 109.438 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.572 ' C ' ' H ' ' A' ' 96' ' ' ASN . 97.5 m-20 49.28 -118.65 1.13 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.753 -0.592 . . . . 0.0 110.528 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.584 ' O ' HG12 ' A' ' 95' ' ' VAL . 76.9 t 55.52 -0.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.602 -0.686 . . . . 0.0 109.455 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.572 ' H ' ' C ' ' A' ' 94' ' ' ASN . 23.3 m120 -78.26 176.4 9.32 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.204 -0.935 . . . . 0.0 110.072 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.6 pt -135.87 62.84 49.19 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.26 -5.84 16.61 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 123.154 2.569 . . . . 0.0 111.446 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 100' ' ' GLU . 1.8 tp -46.33 -84.59 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.996 0 O-C-N 121.503 -0.748 . . . . 0.0 111.101 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 99' ' ' LEU . 81.5 tt0 42.2 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.355 0 O-C-N 120.383 -1.448 . . . . 0.0 110.614 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.418 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 93.5 m-70 -65.39 -35.0 79.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.326 -0.859 . . . . 0.0 109.731 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -64.8 144.86 56.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.378 -0.826 . . . . 0.0 110.286 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.418 ' CD2' ' O ' ' A' ' 101' ' ' HIS . 99.1 m-70 -131.67 147.05 52.48 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.636 -0.665 . . . . 0.0 109.71 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -153.43 79.31 1.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.488 -0.758 . . . . 0.0 109.081 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -174.63 37.57 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.961 179.882 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 54.0 t0 -66.74 155.42 38.16 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.652 0.739 . . . . 0.0 110.424 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.487 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 47.3 tp -74.25 124.45 26.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.474 -0.766 . . . . 0.0 110.09 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 m -140.69 167.46 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.731 0.777 . . . . 0.0 110.116 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.18 156.5 29.81 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.732 0.777 . . . . 0.0 110.556 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.28 -43.09 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.715 -0.615 . . . . 0.0 109.881 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -65.34 -19.45 65.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.933 . . . . 0.0 109.855 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -85.82 -2.29 58.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 109.206 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.7 t -66.83 132.9 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.42 -0.8 . . . . 0.0 110.431 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.5 p -156.55 168.22 28.06 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.637 0.732 . . . . 0.0 109.556 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.36 -37.33 85.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.494 -0.754 . . . . 0.0 109.306 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.4 m -55.94 -20.81 17.6 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.367 -0.833 . . . . 0.0 109.548 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 p -113.77 79.57 4.56 Favored Pre-proline 0 N--CA 1.495 1.801 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.65 -20.42 35.39 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.572 2.181 . . . . 0.0 112.036 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -128.07 106.18 8.9 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.581 -0.699 . . . . 0.0 109.549 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.4 m -139.2 162.9 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.61 -0.681 . . . . 0.0 110.123 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.9 t -118.33 135.96 54.0 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.3 m -133.41 162.27 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.773 0.797 . . . . 0.0 110.068 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.61 HD12 ' NH2' ' A' ' 67' ' ' ARG . 5.1 tt -136.64 142.55 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.553 -0.717 . . . . 0.0 109.53 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.65 -167.0 39.72 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.403 -1.379 . . . . 0.0 110.076 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -110.65 133.86 52.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.651 -0.911 . . . . 0.0 109.398 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.514 ' O ' ' N ' ' A' ' 63' ' ' SER . 89.0 mt -102.55 132.42 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.254 0.55 . . . . 0.0 109.798 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 t -141.7 158.18 44.14 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.723 0.773 . . . . 0.0 109.944 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.17 53.38 3.48 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 25' ' ' ILE . 1.5 mp -78.14 125.6 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.371 -1.076 . . . . 0.0 109.652 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -126.85 124.21 39.07 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -83.28 128.47 34.52 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.664 0.745 . . . . 0.0 110.043 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -141.61 159.38 42.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.448 -0.782 . . . . 0.0 109.122 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -116.93 140.59 49.29 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.698 -0.626 . . . . 0.0 109.688 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 18.3 p90 -137.29 158.74 43.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.511 -0.743 . . . . 0.0 109.511 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -90.01 100.76 13.52 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.664 0.745 . . . . 0.0 110.357 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.596 ' O ' ' N ' ' A' ' 34' ' ' GLY . 10.7 t -82.83 -151.18 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.503 -0.748 . . . . 0.0 110.097 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -55.69 77.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.765 0.793 . . . . 0.0 110.217 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 58.3 23.41 53.25 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.8 m -145.89 133.36 20.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.265 -1.138 . . . . 0.0 109.702 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.4 m -79.82 130.65 35.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.3 -0.875 . . . . 0.0 109.805 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.402 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 68.7 mttm -133.48 148.13 51.7 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.815 0.817 . . . . 0.0 110.129 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.8 t -77.52 144.95 37.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.562 -0.712 . . . . 0.0 110.494 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -140.5 137.81 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.378 -0.826 . . . . 0.0 109.579 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -106.35 132.07 52.82 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.444 -0.785 . . . . 0.0 109.277 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -118.27 153.53 33.78 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.595 -0.691 . . . . 0.0 109.694 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.52 -157.13 16.06 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -135.88 146.8 47.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.483 -1.01 . . . . 0.0 109.643 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 tt -122.0 143.33 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -133.76 152.57 51.91 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.634 0.73 . . . . 0.0 110.027 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -147.86 -157.18 0.79 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.609 0.718 . . . . 0.0 109.725 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -80.33 -7.03 58.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.392 -0.817 . . . . 0.0 109.893 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.401 ' OG1' ' N ' ' A' ' 49' ' ' ALA . 81.5 p -100.91 -68.64 0.8 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.277 -0.89 . . . . 0.0 109.606 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.401 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -159.78 -148.55 0.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.175 -0.953 . . . . 0.0 109.956 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -144.75 152.57 40.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.126 -0.984 . . . . 0.0 110.362 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.0 tt -150.61 147.98 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.224 -0.922 . . . . 0.0 110.222 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -74.22 138.13 43.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.496 -0.752 . . . . 0.0 109.872 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.85 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -133.58 164.48 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.333 -0.855 . . . . 0.0 110.038 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.1 t -142.09 140.43 32.53 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.428 -0.795 . . . . 0.0 109.297 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.6 t -115.59 129.77 56.63 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.452 0.644 . . . . 0.0 109.512 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -97.66 119.38 36.13 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.583 0.706 . . . . 0.0 110.832 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.85 -46.91 1.8 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.492 ' HE2' HD12 ' A' ' 90' ' ' ILE . 54.4 mtpt -73.6 134.81 43.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.284 -1.127 . . . . 0.0 110.603 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -91.56 153.42 19.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.49 -0.756 . . . . 0.0 110.093 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.9 mt -133.0 157.77 44.37 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.463 0.649 . . . . 0.0 109.649 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -103.12 157.11 17.22 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.016 0.913 . . . . 0.0 110.395 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 47.4 p30 -76.71 150.39 36.3 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.66 0.743 . . . . 0.0 111.312 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 22' ' ' ILE . 4.2 p 39.02 36.79 0.17 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.31 0.576 . . . . 0.0 110.073 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 47.1 p-10 -98.96 129.89 45.29 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.489 -0.757 . . . . 0.0 110.353 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.8 t -79.07 112.95 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.601 -0.687 . . . . 0.0 109.207 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.23 164.78 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.43 -0.794 . . . . 0.0 110.148 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.61 ' NH2' HD12 ' A' ' 19' ' ' ILE . 59.6 ttm-85 -119.08 130.12 55.44 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 74.3 mt -105.84 124.84 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.561 -0.712 . . . . 0.0 109.183 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -114.84 142.41 46.59 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.454 0.645 . . . . 0.0 109.714 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.9 t30 63.99 40.35 7.3 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.613 0.721 . . . . 0.0 109.308 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.56 147.02 48.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.603 -0.685 . . . . 0.0 109.829 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -101.97 121.63 42.52 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.6 0.714 . . . . 0.0 109.467 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.6 t -85.16 134.25 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.569 -0.707 . . . . 0.0 110.324 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.37 153.82 45.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.465 -0.772 . . . . 0.0 109.094 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -114.82 114.27 25.33 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.458 -0.776 . . . . 0.0 109.452 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -112.96 126.34 55.37 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.692 0.758 . . . . 0.0 110.187 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 55.73 27.36 10.6 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.321 0.582 . . . . 0.0 110.658 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.84 4.64 84.71 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -112.31 131.04 55.73 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.48 -1.012 . . . . 0.0 109.768 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.02 144.4 40.89 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.747 0.784 . . . . 0.0 110.451 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.7 p -152.89 160.04 43.04 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.9 mt -106.91 131.73 53.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.425 -0.797 . . . . 0.0 109.662 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 t -109.14 125.83 52.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.666 -0.646 . . . . 0.0 109.377 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.455 HG11 HD11 ' A' ' 90' ' ' ILE . 13.4 t -102.85 100.89 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.488 -0.758 . . . . 0.0 109.011 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.46 176.66 49.96 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -65.92 -29.44 69.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.574 -0.956 . . . . 0.0 109.647 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.4 m -74.79 -7.48 53.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 109.433 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.5 p -80.96 167.84 19.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.319 -0.863 . . . . 0.0 110.273 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -125.7 138.12 53.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.545 -0.722 . . . . 0.0 109.347 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.492 HD12 ' HE2' ' A' ' 58' ' ' LYS . 87.0 mt -125.17 129.96 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.536 -0.727 . . . . 0.0 109.65 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -118.71 113.28 20.92 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.3 t -75.05 150.31 38.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.461 -0.775 . . . . 0.0 110.517 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.6 t -84.66 133.39 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 110.054 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -70.15 143.8 52.19 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.787 0.803 . . . . 0.0 110.716 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.84 147.32 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.83 0.824 . . . . 0.0 110.662 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 96' ' ' ASN . 56.6 p30 -55.81 152.09 10.33 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.808 0.813 . . . . 0.0 110.888 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.5 mt 56.52 71.64 1.13 Allowed Pre-proline 0 N--CA 1.49 1.55 0 CA-C-O 121.212 0.53 . . . . 0.0 110.122 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -61.78 148.16 93.69 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 123.048 2.498 . . . . 0.0 112.526 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 99' ' ' LEU . 9.5 mp -86.41 111.31 20.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.313 -0.867 . . . . 0.0 109.545 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -97.6 147.27 24.48 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.582 0.706 . . . . 0.0 110.343 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 51.26 46.51 26.35 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.718 0.77 . . . . 0.0 109.945 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -63.13 -43.91 97.05 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.543 -0.723 . . . . 0.0 109.109 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.476 ' CG ' ' O ' ' A' ' 103' ' ' HIS . 49.0 p-80 -159.26 102.35 1.59 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.407 -0.808 . . . . 0.0 109.646 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -66.4 -43.88 84.57 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.477 -0.765 . . . . 0.0 109.612 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -151.82 162.87 40.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.179 -0.951 . . . . 0.0 110.321 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.452 ' CG ' ' O ' ' A' ' 106' ' ' HIS . 55.8 p-80 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.756 -1.116 . . . . 0.0 109.084 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 121.377 0.608 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -69.85 147.32 50.48 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.764 0.792 . . . . 0.0 110.542 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.2 tt -75.99 129.75 37.37 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.531 0.681 . . . . 0.0 109.957 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.9 m -140.17 163.62 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.934 0.874 . . . . 0.0 110.834 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -72.88 149.59 43.36 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.78 0.8 . . . . 0.0 110.247 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 92.0 mt -63.74 -42.6 96.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -69.65 -17.22 63.49 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.729 -0.607 . . . . 0.0 109.812 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -92.61 6.44 47.3 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.508 -0.745 . . . . 0.0 109.247 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.4 t -66.56 133.2 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 CA-C-O 121.71 0.767 . . . . 0.0 109.947 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.1 p -153.27 166.85 31.27 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.962 0.887 . . . . 0.0 110.324 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.0 mt -73.07 -9.29 58.57 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.6 m -74.44 -14.72 60.88 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.3 p -121.49 84.09 41.66 Favored Pre-proline 0 N--CA 1.499 1.995 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.39 -41.19 74.84 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.613 2.209 . . . . 0.0 111.594 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -116.89 131.92 56.83 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.761 0.791 . . . . 0.0 109.992 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.4 m -149.77 175.71 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 122.273 1.035 . . . . 0.0 110.617 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.407 ' OG ' ' OD1' ' A' ' 69' ' ' ASP . 48.4 m -134.71 137.17 43.29 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -140.21 163.26 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.074 0.94 . . . . 0.0 110.643 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.6 tt -137.93 135.51 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 121.709 0.766 . . . . 0.0 109.893 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.29 -168.47 40.97 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -110.95 136.29 50.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.941 -0.741 . . . . 0.0 109.489 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.716 HD12 ' N ' ' A' ' 22' ' ' ILE . 2.4 mp -96.33 133.32 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.406 0.622 . . . . 0.0 109.714 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 t -136.07 159.78 40.65 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.75 0.786 . . . . 0.0 109.929 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 25' ' ' ILE . . . 99.63 -69.29 0.54 Allowed Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 24' ' ' GLY . 25.8 mm 59.11 128.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.844 0.83 . . . . 0.0 110.592 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.74 138.62 21.03 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.437 0.637 . . . . 0.0 109.358 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -106.0 129.13 54.18 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.002 0.906 . . . . 0.0 110.175 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -141.09 157.41 45.34 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.736 0.779 . . . . 0.0 110.074 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 56.5 mp0 -113.99 142.8 45.71 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.806 0.812 . . . . 0.0 110.243 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 31.7 p90 -143.66 161.96 37.19 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.598 0.713 . . . . 0.0 109.485 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -94.19 107.0 18.97 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.751 0.786 . . . . 0.0 110.388 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 34' ' ' GLY . 4.4 p -88.19 -161.54 0.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -52.18 80.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.597 0.713 . . . . 0.0 110.259 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 59.94 11.0 16.05 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 92.8 m -131.86 131.21 42.59 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.863 0.84 . . . . 0.0 110.791 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.2 m -79.48 128.32 33.22 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.55 0.69 . . . . 0.0 109.192 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.451 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 98.6 mttt -136.13 147.83 47.94 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.885 0.85 . . . . 0.0 110.15 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 87.5 p -82.03 149.91 27.86 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.846 0.831 . . . . 0.0 110.019 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -130.64 133.94 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.835 0.826 . . . . 0.0 109.836 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -98.2 133.36 42.74 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -130.62 150.82 51.64 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.742 0.782 . . . . 0.0 109.829 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.72 -169.43 35.31 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -122.24 139.62 53.57 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.622 0.725 . . . . 0.0 109.699 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.2 tt -113.08 136.43 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -121.5 149.79 42.55 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.948 0.88 . . . . 0.0 110.361 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 38.3 t0 -148.8 -164.57 2.05 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.62 0.724 . . . . 0.0 109.479 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.512 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 48.9 t0 -65.04 -38.59 91.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.609 -0.682 . . . . 0.0 109.825 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.1 p -73.22 -85.56 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.263 0.554 . . . . 0.0 109.712 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -143.49 -142.26 0.13 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.643 0.735 . . . . 0.0 109.971 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.7 ptt85 -148.96 158.32 44.09 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.758 0.79 . . . . 0.0 110.042 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.2 tt -152.65 158.94 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 122.033 0.921 . . . . 0.0 110.631 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.541 ' NH2' ' CG ' ' A' ' 76' ' ' PHE . 51.2 ttp180 -74.47 143.47 44.63 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.705 0.764 . . . . 0.0 110.107 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 pt -133.38 161.39 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.732 0.777 . . . . 0.0 110.327 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.0 m -144.76 138.93 27.5 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.747 0.784 . . . . 0.0 110.19 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 p -134.57 135.55 42.34 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.87 0.843 . . . . 0.0 109.579 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.455 ' C ' ' H ' ' A' ' 58' ' ' LYS . 88.0 m-85 -94.4 124.85 38.67 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.752 0.787 . . . . 0.0 110.796 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.57 -38.56 0.48 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.455 ' H ' ' C ' ' A' ' 56' ' ' PHE . 72.2 mmtt -68.42 133.66 49.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.66 -0.906 . . . . 0.0 110.001 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -97.71 148.49 23.29 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.765 0.793 . . . . 0.0 110.341 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.8 mt -129.94 152.78 49.04 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.568 0.699 . . . . 0.0 109.696 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -115.79 158.38 22.96 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.225 1.012 . . . . 0.0 110.421 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.9 t0 -62.01 138.19 58.34 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.815 0.817 . . . . 0.0 110.873 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.523 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 10.9 t 52.33 31.01 8.77 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.269 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -78.24 112.06 14.84 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.571 -0.705 . . . . 0.0 110.372 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 t -81.2 105.76 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.663 0.744 . . . . 0.0 109.281 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.7 m -140.99 164.65 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.647 0.736 . . . . 0.0 110.113 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.8 ttp85 -115.21 127.83 55.77 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.759 0.79 . . . . 0.0 109.582 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.3 mt -108.39 130.62 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.608 0.718 . . . . 0.0 109.844 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 67.8 t0 -125.32 142.44 51.5 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.556 0.693 . . . . 0.0 109.902 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.55 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 52.6 t30 71.92 35.09 1.39 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.387 0.613 . . . . 0.0 109.949 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.14 141.54 43.68 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.394 0.616 . . . . 0.0 110.407 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -95.17 128.37 41.95 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.755 0.788 . . . . 0.0 109.893 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.8 t -80.64 132.4 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-O 121.679 0.752 . . . . 0.0 110.179 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -117.92 146.19 44.13 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.744 0.783 . . . . 0.0 109.549 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -108.47 97.64 7.28 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.525 0.679 . . . . 0.0 109.454 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.633 ' O ' ' N ' ' A' ' 78' ' ' GLY . 28.4 m-85 -82.83 -177.88 6.9 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.409 0.624 . . . . 0.0 110.55 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -51.94 75.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.499 0.666 . . . . 0.0 110.493 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 76' ' ' PHE . . . 74.71 15.56 80.64 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -130.62 144.62 51.55 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.565 -0.962 . . . . 0.0 110.395 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.5 mt -103.1 140.35 37.43 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.859 0.838 . . . . 0.0 110.126 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 96.3 p -152.53 163.52 39.41 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.701 0.763 . . . . 0.0 109.854 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.7 mt -106.07 131.03 53.83 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.651 0.739 . . . . 0.0 110.176 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.2 p -107.67 123.97 49.29 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.838 0.828 . . . . 0.0 109.761 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.2 t -100.41 112.26 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.854 0.835 . . . . 0.0 109.6 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -97.19 -179.26 34.22 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -66.11 -29.14 69.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.914 -0.756 . . . . 0.0 109.736 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 89.4 p -78.67 -4.91 51.42 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.8 t -80.39 167.65 19.95 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.467 0.651 . . . . 0.0 110.087 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 24.7 mmt85 -124.96 137.79 54.25 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.716 0.77 . . . . 0.0 109.953 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.8 mt -127.19 130.47 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.511 0.672 . . . . 0.0 110.386 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -124.59 125.76 44.68 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.78 0.8 . . . . 0.0 109.402 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.2 p -75.73 152.95 37.35 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.714 0.768 . . . . 0.0 110.433 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 64.2 t -143.16 98.31 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.566 0.698 . . . . 0.0 109.399 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -87.23 106.81 18.16 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.594 0.711 . . . . 0.0 109.377 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.418 ' O ' ' CG ' ' A' ' 96' ' ' ASN . 97.0 t -93.8 -85.38 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 95' ' ' VAL . 21.3 p30 43.16 45.72 4.86 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.335 0.588 . . . . 0.0 109.677 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.2 mt 52.88 74.5 0.77 Allowed Pre-proline 0 N--CA 1.495 1.779 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.26 143.47 28.3 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.608 2.206 . . . . 0.0 113.25 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.434 HD12 ' C ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -167.31 16.29 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -164.23 126.03 2.3 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.639 0.733 . . . . 0.0 109.629 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.463 ' CG ' ' O ' ' A' ' 101' ' ' HIS . 53.3 t-80 52.32 36.79 20.6 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.41 0.624 . . . . 0.0 109.86 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -65.87 -41.98 90.93 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -79.6 141.16 36.81 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.747 0.784 . . . . 0.0 110.105 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -135.22 10.68 3.53 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.52 ' CG ' ' N ' ' A' ' 106' ' ' HIS . 52.9 p-80 -67.04 -43.31 83.07 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.583 -0.698 . . . . 0.0 109.841 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.52 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 86.2 t60 . . . . . 0 N--CA 1.499 1.985 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.826 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.484 ' H1 ' ' HA ' ' A' ' 70' ' ' ASN . 25.8 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.61 0.719 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 55.4 t0 -74.56 152.21 39.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.311 -0.868 . . . . 0.0 110.552 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.54 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 43.2 tp -77.6 123.24 26.37 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.425 -0.797 . . . . 0.0 109.744 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.1 m -140.28 165.03 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.385 -0.822 . . . . 0.0 110.067 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.6 157.56 31.84 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.81 0.814 . . . . 0.0 110.492 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 6' ' ' ILE . 2.3 mp -63.97 -42.72 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.619 -0.676 . . . . 0.0 109.256 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -64.25 -24.15 67.56 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.239 -0.913 . . . . 0.0 109.557 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -83.21 -0.16 48.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.952 -1.093 . . . . 0.0 109.496 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.2 131.99 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.074 -1.016 . . . . 0.0 110.562 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.3 p -158.99 167.37 29.54 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.55 -0.719 . . . . 0.0 109.331 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.19 -19.54 66.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.89 . . . . 0.0 108.888 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -63.86 -17.24 62.97 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.318 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.6 p -124.36 82.02 58.38 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.318 -0.864 . . . . 0.0 109.231 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.32 -41.42 66.53 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.958 2.439 . . . . 0.0 112.151 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -119.28 128.1 53.84 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.422 -0.799 . . . . 0.0 109.814 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.6 m -147.17 161.11 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.256 -0.903 . . . . 0.0 110.116 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.5 m -115.46 134.17 55.34 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.69 162.38 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.873 0.844 . . . . 0.0 110.324 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.0 tt -140.49 137.98 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.428 -0.795 . . . . 0.0 109.524 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.45 -162.91 29.41 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' C ' HD12 ' A' ' 22' ' ' ILE . 26.7 ttmt -111.58 128.81 56.15 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.58 -0.953 . . . . 0.0 109.359 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.736 HD12 ' N ' ' A' ' 22' ' ' ILE . 1.8 mp -94.53 125.74 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.533 0.682 . . . . 0.0 109.737 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.7 p -132.7 159.29 40.06 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.836 0.827 . . . . 0.0 110.091 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.9 82.02 0.19 Allowed Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.4 mm -92.1 129.81 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.092 -1.24 . . . . 0.0 110.267 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -133.73 139.1 46.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.534 -0.729 . . . . 0.0 109.132 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -103.28 136.45 43.03 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.766 0.793 . . . . 0.0 109.917 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.593 ' NZ ' ' NH2' ' A' ' 52' ' ' ARG . 53.1 mtmt -144.25 160.24 41.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.488 -0.757 . . . . 0.0 109.317 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -122.11 144.73 48.75 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.626 0.727 . . . . 0.0 109.701 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -142.63 160.92 39.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 109.289 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -93.98 116.23 28.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.293 -0.879 . . . . 0.0 109.889 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 t -109.23 110.2 21.34 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.822 0.82 . . . . 0.0 109.362 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 53.34 33.6 16.07 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.57 0.7 . . . . 0.0 110.722 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.27 -2.01 77.73 Favored Glycine 0 N--CA 1.496 2.643 0 O-C-N 120.962 -1.086 . . . . 0.0 111.047 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.7 p -115.95 125.22 52.25 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.089 -1.242 . . . . 0.0 109.928 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.1 m -69.6 133.42 47.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.55 -0.719 . . . . 0.0 110.094 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -136.71 144.94 44.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.367 -0.833 . . . . 0.0 109.889 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.4 m -83.25 144.83 29.48 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.771 0.796 . . . . 0.0 110.311 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.417 HG22 ' OE1' ' A' ' 41' ' ' GLN . 14.2 p -140.51 137.81 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.898 . . . . 0.0 108.85 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -102.1 135.29 43.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.436 -0.79 . . . . 0.0 109.495 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.606 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 1.1 mp0 -117.05 152.12 35.35 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.631 0.729 . . . . 0.0 109.176 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.34 -171.86 35.43 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -130.49 139.05 50.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.481 -1.011 . . . . 0.0 109.271 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 44' ' ' ILE . 19.2 tt -114.62 130.9 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -123.6 151.56 42.83 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.655 0.741 . . . . 0.0 109.932 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 30.7 t0 -155.72 -161.87 1.23 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.489 -0.757 . . . . 0.0 109.673 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.545 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 95.8 m-20 -74.26 -3.48 30.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.283 -0.886 . . . . 0.0 110.383 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.504 ' OG1' ' N ' ' A' ' 49' ' ' ALA . 8.1 p -101.15 -62.46 1.24 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.849 -1.157 . . . . 0.0 109.323 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.504 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -171.29 -150.51 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.96 -1.087 . . . . 0.0 110.364 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -135.32 145.63 47.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.514 -0.741 . . . . 0.0 109.894 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.2 tt -150.2 150.2 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.166 -0.959 . . . . 0.0 110.025 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.593 ' NH2' ' NZ ' ' A' ' 28' ' ' LYS . 72.9 ttt180 -73.01 146.55 45.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.457 -0.777 . . . . 0.0 110.383 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.6 pt -132.3 158.6 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.455 -0.778 . . . . 0.0 109.744 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.8 m -143.72 126.54 16.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.178 -0.951 . . . . 0.0 109.073 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.4 t -114.13 128.31 56.32 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.566 -0.709 . . . . 0.0 109.357 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -95.38 121.41 37.02 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.738 0.78 . . . . 0.0 110.95 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.19 -47.72 3.22 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -82.59 135.14 35.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.013 -1.287 . . . . 0.0 110.674 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.665 ' CD ' ' H ' ' A' ' 59' ' ' GLN . 1.8 pm0 -89.98 165.71 13.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.679 -0.638 . . . . 0.0 110.119 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.6 mt -124.03 158.43 32.15 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.547 0.689 . . . . 0.0 109.478 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -107.51 133.46 51.95 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.376 1.084 . . . . 0.0 109.889 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 63' ' ' SER . 66.2 t0 -60.86 142.79 55.9 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.986 0.898 . . . . 0.0 111.304 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.555 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 2.0 m 50.98 29.57 4.61 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.496 0.665 . . . . 0.0 110.171 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -94.48 129.31 41.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.064 -1.022 . . . . 0.0 110.807 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.6 t -89.55 111.36 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.34 -0.85 . . . . 0.0 108.8 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.406 HG22 HD13 ' A' ' 22' ' ' ILE . 17.0 m -139.27 166.27 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.216 -0.928 . . . . 0.0 110.318 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -118.58 127.11 53.3 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.2 mt -107.01 127.69 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.257 -0.902 . . . . 0.0 109.435 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -111.17 145.46 38.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.699 -0.626 . . . . 0.0 109.72 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.484 ' HA ' ' H1 ' ' A' ' 1' ' ' SER . 63.6 t30 63.39 38.68 9.92 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.851 0.834 . . . . 0.0 109.401 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.82 134.94 41.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.812 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -88.06 136.96 32.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.414 -0.804 . . . . 0.0 110.237 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.0 t -96.62 132.7 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -0.856 . . . . 0.0 109.487 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.7 155.03 48.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 109.394 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -117.87 115.94 25.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.612 -0.68 . . . . 0.0 109.197 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -125.2 134.74 52.25 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.703 0.764 . . . . 0.0 109.812 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.6 m120 56.28 29.68 15.37 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.731 0.777 . . . . 0.0 109.974 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.29 7.84 85.11 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -114.42 134.59 54.88 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.435 -1.038 . . . . 0.0 109.92 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.7 mt -79.91 143.17 34.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.4 -0.813 . . . . 0.0 110.093 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.5 m -151.71 158.67 43.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 109.289 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.2 mt -104.19 127.54 51.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.393 -0.817 . . . . 0.0 109.328 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.2 m -107.07 125.43 51.03 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.648 0.737 . . . . 0.0 109.541 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 t -98.43 111.85 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.411 -0.806 . . . . 0.0 109.416 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.07 -179.32 42.97 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 87' ' ' SER . 47.4 p30 -70.89 -18.17 62.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.448 -1.031 . . . . 0.0 109.484 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.509 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 98.7 p -85.33 -7.89 58.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.152 -0.968 . . . . 0.0 109.487 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.4 m -80.93 165.7 21.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.103 -0.998 . . . . 0.0 110.336 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 24.9 tpt85 -127.66 133.56 49.63 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.549 0.69 . . . . 0.0 109.542 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -114.97 129.62 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.582 -0.699 . . . . 0.0 109.703 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -123.35 117.62 25.64 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.775 0.797 . . . . 0.0 109.067 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 73.6 m -77.36 147.18 36.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.549 -0.72 . . . . 0.0 110.368 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 66.4 t -139.56 82.41 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.029 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -167.83 -32.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 56.1 t -117.63 132.48 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 121.941 0.877 . . . . 0.0 109.67 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -143.67 89.29 2.05 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.7 mt -145.64 60.31 6.54 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.144 -0.973 . . . . 0.0 109.433 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.97 152.29 80.59 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.519 2.146 . . . . 0.0 112.154 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.6 tp -84.62 -2.23 57.15 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 109.244 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.66 148.47 7.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 110.264 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -80.01 -11.55 59.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.159 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -71.73 129.28 38.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.128 -0.982 . . . . 0.0 110.012 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -70.68 137.34 49.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.408 -0.808 . . . . 0.0 110.789 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -82.11 146.85 29.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.508 -0.745 . . . . 0.0 110.101 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -127.12 129.28 47.62 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.584 0.707 . . . . 0.0 109.655 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.784 -179.884 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.421 ' HB2' ' H ' ' A' ' 70' ' ' ASN . 83.4 p . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 67.0 t0 -65.2 145.27 56.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.572 -0.705 . . . . 0.0 110.318 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.541 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 35.6 tp -71.75 130.23 40.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.554 -0.716 . . . . 0.0 109.782 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.18 164.5 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.417 -0.802 . . . . 0.0 109.648 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -80.29 159.1 25.95 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.608 -0.683 . . . . 0.0 110.569 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.54 ' N ' HD12 ' A' ' 6' ' ' ILE . 1.4 mp -63.42 -45.49 97.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.626 -0.671 . . . . 0.0 109.255 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -63.43 -20.31 65.45 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.512 -0.743 . . . . 0.0 109.841 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 8' ' ' ASP . 53.2 t0 -87.44 -2.8 58.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.377 -0.827 . . . . 0.0 109.529 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.0 t -70.04 132.65 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -0.938 . . . . 0.0 110.144 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.7 m -158.24 172.59 18.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.478 -0.764 . . . . 0.0 109.555 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.33 -38.95 93.15 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.427 -0.796 . . . . 0.0 109.652 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.5 t -55.0 -17.13 3.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.388 -0.82 . . . . 0.0 109.8 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 p -114.37 79.59 5.37 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.462 -0.774 . . . . 0.0 109.113 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.92 -20.63 29.15 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.229 1.953 . . . . 0.0 112.324 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -131.71 110.06 10.62 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.537 -0.727 . . . . 0.0 109.299 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.9 m -142.21 163.97 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.359 -0.838 . . . . 0.0 110.306 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.419 ' O ' HD12 ' A' ' 3' ' ' LEU . 25.3 t -113.0 141.52 46.75 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.2 t -135.33 155.98 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.239 -0.913 . . . . 0.0 109.775 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 19' ' ' ILE . 20.0 tt -140.13 132.76 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.329 -0.857 . . . . 0.0 109.384 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.61 -160.51 30.78 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 118.909 -1.615 . . . . 0.0 110.366 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -111.83 136.82 50.62 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.796 -0.826 . . . . 0.0 109.638 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 63' ' ' SER . 92.9 mt -103.5 130.75 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.474 -0.766 . . . . 0.0 109.636 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.4 p -134.86 159.53 41.1 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.508 -0.745 . . . . 0.0 109.787 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.84 78.13 0.39 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.5 mm -95.08 123.37 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.189 -1.183 . . . . 0.0 109.366 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -115.81 137.98 51.57 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -101.61 129.78 47.8 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.524 -0.735 . . . . 0.0 109.594 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -144.25 161.07 39.85 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.5 137.05 55.0 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.326 -0.859 . . . . 0.0 109.779 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -130.15 153.8 48.17 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 58.1 mp0 -88.32 136.42 32.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -0.909 . . . . 0.0 109.731 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.7 t -137.03 109.72 7.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.498 -0.751 . . . . 0.0 109.166 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 54.2 t0 58.69 32.04 21.77 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.523 -0.736 . . . . 0.0 110.134 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.66 11.27 83.2 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 97.1 m -121.0 130.17 53.69 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.602 -0.94 . . . . 0.0 109.305 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.3 m -80.68 130.44 35.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 109.661 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -132.8 140.54 48.05 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.383 -0.823 . . . . 0.0 109.675 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.2 t -79.86 142.27 35.38 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.385 -0.822 . . . . 0.0 109.701 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 p -133.43 136.53 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -102.08 139.04 38.24 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.469 -0.769 . . . . 0.0 109.359 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -135.79 153.91 51.38 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.391 -0.818 . . . . 0.0 109.779 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.54 -150.37 7.93 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -134.77 143.51 47.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.588 -0.948 . . . . 0.0 109.511 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.6 tt -120.94 134.83 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -117.6 148.34 42.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.665 -0.647 . . . . 0.0 109.746 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -136.71 -164.82 1.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -72.15 -19.1 61.82 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.517 -0.739 . . . . 0.0 109.462 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.9 m -93.67 -76.35 0.48 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.28 -0.888 . . . . 0.0 110.087 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.89 -148.68 0.25 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.388 -0.82 . . . . 0.0 109.925 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -144.53 157.01 44.42 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.351 -0.843 . . . . 0.0 110.069 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.2 tt -151.46 157.28 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.24 -0.912 . . . . 0.0 110.011 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -78.8 141.43 37.77 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.469 -0.769 . . . . 0.0 109.531 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.856 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -133.77 164.55 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.558 -0.714 . . . . 0.0 109.744 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.7 p -141.63 151.27 42.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 t -136.51 133.47 36.54 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.436 -0.79 . . . . 0.0 109.114 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -94.4 123.39 37.78 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.303 -0.873 . . . . 0.0 110.922 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.47 -57.41 2.03 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -61.07 130.6 47.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -1.184 . . . . 0.0 110.071 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -84.03 158.0 21.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.456 -0.777 . . . . 0.0 109.82 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 86.3 mt -120.67 153.22 37.19 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -115.75 130.66 56.93 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.833 0.825 . . . . 0.0 109.507 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 54.8 p-10 -66.28 142.99 57.48 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 110.835 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 22' ' ' ILE . 1.5 m 65.87 4.06 2.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.955 -0.466 . . . . 0.0 110.946 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 21.1 p-10 -81.47 136.27 35.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.632 -1.292 . . . . 0.0 110.154 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 t -95.6 113.29 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.166 -0.959 . . . . 0.0 108.841 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.6 m -139.24 165.53 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.746 0.784 . . . . 0.0 110.23 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -117.78 133.0 56.38 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.9 mt -106.17 129.55 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.511 -0.743 . . . . 0.0 109.137 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -111.36 143.28 42.42 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.638 -0.664 . . . . 0.0 109.538 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.421 ' H ' ' HB2' ' A' ' 1' ' ' SER . 65.2 t30 60.88 39.42 16.89 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.194 0.521 . . . . 0.0 109.834 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.58 146.47 50.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.359 -0.838 . . . . 0.0 108.969 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -99.99 121.03 40.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.595 -0.691 . . . . 0.0 109.748 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.1 t -83.79 133.91 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.463 -0.773 . . . . 0.0 109.763 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.24 155.19 45.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.249 -0.907 . . . . 0.0 109.326 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -114.12 119.49 37.29 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.534 -0.729 . . . . 0.0 109.29 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -124.42 135.37 53.21 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.617 -0.677 . . . . 0.0 109.614 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.1 m120 54.61 31.69 15.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.703 -0.623 . . . . 0.0 109.58 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.55 10.84 82.85 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -120.37 139.52 52.67 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.471 -1.017 . . . . 0.0 110.113 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 80' ' ' LEU . 4.0 mm? -76.84 144.26 39.16 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.825 0.822 . . . . 0.0 110.546 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.9 m -150.92 152.54 33.77 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.2 mt -103.94 128.65 51.47 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.33 -0.856 . . . . 0.0 108.845 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.2 t -109.83 125.92 53.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.642 -0.661 . . . . 0.0 109.491 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.2 t -99.58 109.44 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.32 -177.05 38.94 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.89 -31.71 72.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.725 -0.868 . . . . 0.0 109.765 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.9 m -76.43 -5.76 48.77 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.277 -0.889 . . . . 0.0 109.496 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.6 t -85.09 165.35 17.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.499 -0.751 . . . . 0.0 109.428 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -134.06 137.46 44.66 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.542 -0.724 . . . . 0.0 109.459 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.05 131.18 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -118.32 130.57 56.1 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.9 p -71.85 152.13 42.88 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.518 -0.739 . . . . 0.0 109.697 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.494 ' C ' ' H ' ' A' ' 95' ' ' VAL . 54.1 t -125.74 133.82 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.524 -0.735 . . . . 0.0 109.628 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.4 t30 68.72 -36.72 0.33 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.811 -0.556 . . . . 0.0 110.22 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.494 ' H ' ' C ' ' A' ' 93' ' ' VAL . 55.4 t -113.91 130.71 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.395 -0.816 . . . . 0.0 109.789 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -159.92 78.79 0.69 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.0 mt -145.78 77.02 12.52 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.359 -0.838 . . . . 0.0 109.053 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -58.97 145.22 98.18 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.81 2.34 . . . . 0.0 112.576 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.4 mt 39.11 -122.28 0.32 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.416 0.627 . . . . 0.0 110.749 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 56.48 44.0 24.98 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -66.1 -43.5 87.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.533 -0.73 . . . . 0.0 110.177 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -109.54 115.08 29.25 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.442 -0.787 . . . . 0.0 109.677 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.62 ' H ' ' CD2' ' A' ' 103' ' ' HIS . 8.1 p80 -88.29 -115.06 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.552 -0.717 . . . . 0.0 109.805 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.474 ' H ' ' CG ' ' A' ' 103' ' ' HIS . 75.8 m80 -67.19 -40.12 86.48 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.536 -0.727 . . . . 0.0 109.527 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.524 ' O ' ' CG ' ' A' ' 106' ' ' HIS . 86.0 t60 41.94 -100.46 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.664 -0.648 . . . . 0.0 110.384 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' A' ' 105' ' ' HIS . 78.3 m80 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.521 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -71.55 149.72 45.44 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.677 0.751 . . . . 0.0 110.087 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 17' ' ' SER . 38.2 tp -71.61 127.38 32.39 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.726 0.774 . . . . 0.0 110.074 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.57 163.93 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.882 0.848 . . . . 0.0 110.381 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.557 ' N ' ' OD2' ' A' ' 8' ' ' ASP . 63.5 mttp -76.89 148.26 36.54 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.856 0.836 . . . . 0.0 110.222 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.9 mm -59.72 -39.4 79.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 121.454 0.645 . . . . 0.0 109.786 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -62.7 -33.53 75.27 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.67 -0.644 . . . . 0.0 110.369 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.557 ' OD2' ' N ' ' A' ' 5' ' ' LYS . 7.5 p30 -83.32 12.39 5.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.476 -0.765 . . . . 0.0 110.269 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.9 t -71.4 130.2 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.737 0.779 . . . . 0.0 109.743 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.9 p -159.23 165.31 33.87 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.887 0.851 . . . . 0.0 109.983 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.2 mt -62.96 -30.2 71.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.662 -0.649 . . . . 0.0 109.487 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.9 m -52.8 -21.32 4.03 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.437 ' O ' ' OG1' ' A' ' 13' ' ' THR . 2.4 p -112.05 95.14 28.33 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -74.68 -18.85 19.26 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.701 2.267 . . . . 0.0 111.411 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -142.39 123.72 14.75 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.573 0.702 . . . . 0.0 109.601 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.5 m -153.74 173.24 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 121.897 0.856 . . . . 0.0 110.436 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.432 ' O ' HD12 ' A' ' 3' ' ' LEU . 43.1 m -128.41 149.43 50.55 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.65 0.738 . . . . 0.0 109.575 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.83 159.17 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.946 0.879 . . . . 0.0 110.403 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.515 ' CD1' ' HE ' ' A' ' 67' ' ' ARG . 97.0 mt -135.92 133.45 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-O 121.599 0.714 . . . . 0.0 109.894 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.52 -158.51 25.79 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' O ' ' OE2' ' A' ' 45' ' ' GLU . 36.8 ttpt -112.98 130.51 56.1 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.624 -0.927 . . . . 0.0 110.194 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.6 mt -99.61 133.1 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.404 0.621 . . . . 0.0 109.65 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.436 ' HA ' ' H ' ' A' ' 63' ' ' SER . 9.5 m -146.0 147.32 31.54 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.806 0.812 . . . . 0.0 110.205 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.42 76.28 1.22 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 25' ' ' ILE . 1.4 mp -94.59 115.18 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.647 -0.914 . . . . 0.0 109.865 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -111.55 121.92 46.44 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.573 0.702 . . . . 0.0 109.286 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -88.85 133.33 34.31 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.892 0.853 . . . . 0.0 110.215 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -148.2 151.48 35.59 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.488 0.661 . . . . 0.0 109.341 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 57.7 mp0 -111.8 140.61 46.29 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.831 0.824 . . . . 0.0 110.421 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.461 ' OH ' ' CD1' ' A' ' 56' ' ' PHE . 6.6 p90 -141.5 159.68 41.71 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.757 0.789 . . . . 0.0 109.708 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -91.23 95.93 10.3 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.765 0.793 . . . . 0.0 109.527 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.621 ' O ' ' N ' ' A' ' 34' ' ' GLY . 2.5 t -77.17 -149.5 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.263 0.554 . . . . 0.0 110.169 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -54.11 75.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.732 0.777 . . . . 0.0 110.402 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.621 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 58.83 24.85 58.24 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 t -147.49 141.01 25.43 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.631 -0.923 . . . . 0.0 109.661 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.8 m -88.61 125.85 35.01 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.682 0.753 . . . . 0.0 110.126 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -136.59 147.31 46.9 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.837 0.827 . . . . 0.0 109.734 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.9 t -81.62 145.01 30.82 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.676 0.75 . . . . 0.0 110.077 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 p -132.89 136.02 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.749 0.785 . . . . 0.0 109.662 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -104.86 130.23 53.03 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.584 0.707 . . . . 0.0 109.183 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -121.86 144.63 48.73 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.831 0.824 . . . . 0.0 109.927 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.54 -171.57 34.51 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -119.69 144.11 47.38 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.97 0.891 . . . . 0.0 110.396 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.68 136.96 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' OE2' ' O ' ' A' ' 21' ' ' LYS . 2.4 pm0 -125.31 154.93 41.02 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.037 0.922 . . . . 0.0 110.422 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 29.5 t0 -143.12 -156.56 0.69 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.507 0.67 . . . . 0.0 109.51 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.536 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 98.5 m-20 -73.82 -19.93 60.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.661 -0.649 . . . . 0.0 109.569 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 41.4 p -94.11 -88.5 0.24 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.584 -0.698 . . . . 0.0 109.486 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.79 -146.09 0.23 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.5 -0.75 . . . . 0.0 110.185 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -148.2 158.42 44.07 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.707 0.765 . . . . 0.0 110.482 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.2 tt -151.02 160.3 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-O 121.935 0.874 . . . . 0.0 110.477 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.8 ttp85 -78.82 145.01 34.51 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.832 0.825 . . . . 0.0 110.621 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.6 pt -131.27 159.6 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.634 0.73 . . . . 0.0 109.816 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.2 m -143.63 118.77 10.11 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.643 0.735 . . . . 0.0 109.695 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.4 p -109.35 142.4 40.34 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.838 0.828 . . . . 0.0 109.79 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.521 ' C ' ' H ' ' A' ' 58' ' ' LYS . 76.1 m-85 -102.72 117.36 34.47 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.64 0.733 . . . . 0.0 110.845 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.25 -31.48 0.26 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.521 ' H ' ' C ' ' A' ' 56' ' ' PHE . 13.9 tptp -66.55 129.94 41.52 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.684 -0.892 . . . . 0.0 110.915 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -83.71 138.0 33.5 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.85 0.833 . . . . 0.0 110.761 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 98.2 mt -128.47 150.73 50.02 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -109.53 143.66 38.87 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.762 0.792 . . . . 0.0 110.134 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -67.11 137.95 56.72 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.884 0.849 . . . . 0.0 110.182 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.436 ' H ' ' HA ' ' A' ' 23' ' ' THR . 7.3 t 51.68 80.64 0.08 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.725 0.774 . . . . 0.0 109.396 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -153.26 121.83 6.34 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.723 0.773 . . . . 0.0 110.151 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.465 HG22 ' H ' ' A' ' 65' ' ' VAL . 1.8 m -74.1 119.46 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.915 0.864 . . . . 0.0 109.487 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.2 m -141.04 167.93 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-O 122.479 1.133 . . . . 0.0 110.242 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.515 ' HE ' ' CD1' ' A' ' 19' ' ' ILE . 39.2 ttm180 -113.76 126.28 55.04 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.031 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.413 ' CG2' ' HB2' ' A' ' 71' ' ' ALA . 94.0 mt -106.04 118.34 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.638 0.733 . . . . 0.0 109.484 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -122.03 151.43 40.84 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.917 0.865 . . . . 0.0 110.123 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 61.48 37.01 16.84 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.794 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.413 ' HB2' ' CG2' ' A' ' 68' ' ' ILE . . . -92.27 147.21 23.1 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.602 -0.687 . . . . 0.0 109.454 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -103.64 153.18 20.91 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.26 1.029 . . . . 0.0 110.839 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.26 132.61 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.738 0.78 . . . . 0.0 109.548 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.26 155.48 43.87 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.758 0.79 . . . . 0.0 110.038 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -112.6 119.21 37.36 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.613 0.72 . . . . 0.0 109.318 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -121.53 132.76 54.88 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.813 0.816 . . . . 0.0 109.881 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 58.04 23.0 9.52 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.334 0.588 . . . . 0.0 109.979 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.91 6.84 81.85 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -117.53 136.64 53.1 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.509 -0.995 . . . . 0.0 110.254 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.7 mt -75.58 145.19 41.39 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.711 0.767 . . . . 0.0 110.181 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 93.9 p -156.9 160.21 38.89 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.626 0.727 . . . . 0.0 109.914 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.7 mt -104.92 108.76 20.43 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.796 0.807 . . . . 0.0 109.082 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.8 m -88.93 141.21 28.68 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.745 0.783 . . . . 0.0 109.748 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.431 HG11 HD11 ' A' ' 90' ' ' ILE . 41.5 t -121.85 126.87 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.871 0.843 . . . . 0.0 109.7 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.66 173.35 25.81 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -69.29 -17.97 63.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.777 -0.837 . . . . 0.0 109.029 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.0 m -84.55 -5.76 59.32 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.404 ' OG ' ' CG1' ' A' ' 84' ' ' VAL . 13.5 p -76.87 168.97 19.17 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.599 0.714 . . . . 0.0 110.309 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.415 ' NH2' ' OE2' ' A' ' 91' ' ' GLU . 77.6 ttt180 -121.87 123.53 41.97 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.855 0.836 . . . . 0.0 109.856 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.431 HD11 HG11 ' A' ' 84' ' ' VAL . 96.4 mt -124.22 129.04 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.654 0.74 . . . . 0.0 109.746 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.415 ' OE2' ' NH2' ' A' ' 89' ' ' ARG . 97.7 mt-10 -126.03 123.12 37.74 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.797 0.808 . . . . 0.0 110.005 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.6 t -74.17 144.12 44.95 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.309 0.576 . . . . 0.0 109.713 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.2 m -114.21 131.87 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-O 121.929 0.871 . . . . 0.0 110.254 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -75.59 167.53 21.73 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.789 0.804 . . . . 0.0 110.359 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 96' ' ' ASN . 43.4 t 53.36 -101.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.801 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.407 ' N ' HG12 ' A' ' 95' ' ' VAL . 23.3 t-20 -162.96 88.17 0.6 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.685 0.755 . . . . 0.0 109.311 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 62.9 mt 49.62 77.52 0.46 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.874 -0.516 . . . . 0.0 110.141 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -59.67 146.75 94.54 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.501 2.134 . . . . 0.0 112.248 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.8 132.58 49.9 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.852 0.834 . . . . 0.0 110.322 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -67.07 134.71 52.4 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.621 0.724 . . . . 0.0 110.118 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -151.8 133.19 14.58 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.659 0.742 . . . . 0.0 109.882 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -146.11 91.16 2.04 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.71 0.767 . . . . 0.0 109.278 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.506 ' CG ' ' N ' ' A' ' 104' ' ' HIS . 86.4 t60 -155.65 165.27 37.05 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.742 0.782 . . . . 0.0 109.959 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.506 ' N ' ' CG ' ' A' ' 103' ' ' HIS . 85.9 t60 47.78 82.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.534 0.683 . . . . 0.0 109.903 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.423 ' O ' ' O ' ' A' ' 104' ' ' HIS . 84.4 t60 56.7 156.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.756 0.789 . . . . 0.0 110.617 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.202 -0.904 . . . . 0.0 109.168 -179.976 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.1 m . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 67.9 t0 -171.4 133.28 0.81 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.363 -0.836 . . . . 0.0 109.532 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.446 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 49.7 tp -70.89 127.06 31.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.826 . . . . 0.0 109.609 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.17 162.64 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.548 -0.72 . . . . 0.0 109.57 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -78.31 154.25 31.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.458 -0.776 . . . . 0.0 110.265 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.98 -43.59 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.464 -0.772 . . . . 0.0 109.475 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -66.79 -18.2 65.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.255 -0.903 . . . . 0.0 110.088 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.66 2.6 56.36 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.176 -0.952 . . . . 0.0 109.808 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.7 t -67.03 133.69 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.325 -0.859 . . . . 0.0 110.198 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.5 p -158.02 164.93 36.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.571 -0.705 . . . . 0.0 109.515 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 61.2 mt -63.96 -22.44 66.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.323 -0.861 . . . . 0.0 109.067 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.9 t -58.23 -17.62 20.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.416 -0.803 . . . . 0.0 109.227 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.9 p -126.34 80.25 69.27 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.525 -0.734 . . . . 0.0 109.563 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.02 -39.98 77.87 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.524 2.149 . . . . 0.0 111.749 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -115.02 130.81 57.02 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.6 m -152.01 178.33 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.224 -0.923 . . . . 0.0 110.185 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.4 m -130.23 131.31 45.47 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.4 m -137.5 161.44 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.197 -0.939 . . . . 0.0 110.147 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.4 tt -143.77 146.57 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.381 -0.824 . . . . 0.0 109.408 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.05 -161.53 35.2 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.047 -1.549 . . . . 0.0 110.476 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -104.45 144.76 31.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.674 -0.898 . . . . 0.0 109.572 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 mm -98.73 132.46 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 56.5 p -134.95 158.09 45.2 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.438 -0.789 . . . . 0.0 109.652 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 25' ' ' ILE . . . 96.01 -72.34 0.86 Allowed Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.444 ' O ' ' O ' ' A' ' 24' ' ' GLY . 24.8 mm 50.01 101.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.458 -1.025 . . . . 0.0 110.158 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -129.66 131.25 46.35 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -93.44 133.3 36.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.307 -0.871 . . . . 0.0 109.637 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -146.76 152.4 38.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.417 -0.802 . . . . 0.0 109.284 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -111.31 144.82 39.87 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.725 -0.609 . . . . 0.0 109.372 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -146.15 164.13 33.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.33 -0.857 . . . . 0.0 109.391 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -87.52 142.73 27.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.329 -0.857 . . . . 0.0 109.643 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.4 t -147.08 110.59 4.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.343 -0.848 . . . . 0.0 108.761 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 55.76 31.7 18.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.702 -0.624 . . . . 0.0 109.609 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.55 14.7 75.41 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.2 p -128.15 134.48 49.09 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.371 -1.076 . . . . 0.0 109.609 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.9 m -83.36 128.84 34.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.542 -0.724 . . . . 0.0 109.668 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -136.42 144.44 44.48 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.416 -0.803 . . . . 0.0 109.295 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.1 p -79.78 153.4 29.21 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.238 -0.914 . . . . 0.0 110.211 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -141.83 140.74 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -103.13 131.45 50.13 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.4 -0.813 . . . . 0.0 109.614 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.485 ' OE1' ' NH2' ' A' ' 52' ' ' ARG . 78.0 mt-30 -121.28 153.52 37.57 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.72 -156.72 14.55 Favored Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.644 -1.265 . . . . 0.0 109.953 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -137.36 139.98 41.13 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 44' ' ' ILE . 18.0 tt -116.65 131.06 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.344 -0.847 . . . . 0.0 109.322 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -117.67 155.75 29.38 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.376 0.608 . . . . 0.0 109.824 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -141.12 -146.13 0.19 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.805 . . . . 0.0 109.497 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -78.55 -8.37 58.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.411 -0.805 . . . . 0.0 110.743 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.3 p -113.42 -86.61 0.57 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.279 -0.888 . . . . 0.0 110.697 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.69 -147.72 0.36 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.583 -0.698 . . . . 0.0 110.245 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.8 ptt-85 -148.07 156.23 42.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.47 -0.768 . . . . 0.0 110.203 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.8 tt -142.85 150.19 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.33 -0.856 . . . . 0.0 110.177 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.485 ' NH2' ' OE1' ' A' ' 41' ' ' GLN . 76.5 ttt180 -72.5 136.36 45.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.515 -0.741 . . . . 0.0 109.847 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.8 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -138.67 167.67 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.34 -0.85 . . . . 0.0 109.463 179.403 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 97.4 p -147.74 152.79 38.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.901 . . . . 0.0 109.756 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.6 p -135.44 124.55 24.4 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -87.98 130.03 35.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.393 -0.817 . . . . 0.0 110.838 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.35 -48.75 1.5 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.547 ' HD3' HD12 ' A' ' 90' ' ' ILE . 99.1 mttt -70.68 136.02 48.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.095 -1.238 . . . . 0.0 110.272 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -95.91 153.94 17.49 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.522 -0.736 . . . . 0.0 109.879 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.8 mt -128.91 157.03 42.74 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.653 -0.655 . . . . 0.0 109.512 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.445 ' OE1' ' OD2' ' A' ' 64' ' ' ASP . 91.1 mt-30 -117.3 135.25 53.97 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.626 0.727 . . . . 0.0 109.954 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.7 t0 -66.71 136.25 55.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.421 -0.799 . . . . 0.0 110.731 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.52 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 0.8 OUTLIER 80.31 -5.4 1.79 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.818 -0.551 . . . . 0.0 110.799 178.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.445 ' OD2' ' OE1' ' A' ' 61' ' ' GLN . 9.8 m-20 -80.8 143.03 33.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.708 -1.245 . . . . 0.0 110.013 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.41 123.81 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.76 160.43 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.427 -0.796 . . . . 0.0 110.191 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -122.18 126.17 47.71 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 77.6 mt -110.0 127.43 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -114.88 141.71 47.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.818 -0.551 . . . . 0.0 109.793 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.2 t30 62.91 38.17 11.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.745 -0.597 . . . . 0.0 109.679 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.58 141.92 55.33 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -93.98 121.97 36.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.642 0.734 . . . . 0.0 109.604 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.0 t -82.29 133.12 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.572 -0.705 . . . . 0.0 109.677 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.43 155.49 46.7 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.495 -0.753 . . . . 0.0 109.066 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -114.42 117.6 31.48 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.538 -0.726 . . . . 0.0 109.346 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -122.2 135.13 54.72 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.718 -0.614 . . . . 0.0 109.383 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 55.09 30.57 14.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.624 -0.672 . . . . 0.0 109.688 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.1 7.22 84.22 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -114.72 135.01 54.64 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.371 -1.076 . . . . 0.0 109.952 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.51 145.85 41.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.589 -0.694 . . . . 0.0 109.984 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.0 p -155.07 161.9 41.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.502 -0.749 . . . . 0.0 109.199 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.4 mt -107.39 127.87 53.96 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.448 -0.782 . . . . 0.0 109.492 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 m -100.58 125.19 46.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.687 -0.633 . . . . 0.0 109.343 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 t -112.4 130.2 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.53 -0.732 . . . . 0.0 109.092 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -153.13 -149.01 5.04 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.45 -42.3 99.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.533 -0.981 . . . . 0.0 110.263 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -60.83 -41.96 96.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.377 -0.827 . . . . 0.0 110.277 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.2 p -78.89 165.93 22.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.265 -0.897 . . . . 0.0 110.44 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -127.38 132.37 50.17 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.547 HD12 ' HD3' ' A' ' 58' ' ' LYS . 81.6 mt -113.34 129.67 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.537 -0.727 . . . . 0.0 109.092 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -132.27 123.34 26.72 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.433 -0.792 . . . . 0.0 109.081 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.1 p -76.65 156.55 32.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.998 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.1 m -136.33 11.83 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.438 -0.789 . . . . 0.0 109.203 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -87.99 3.78 47.5 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.417 -0.802 . . . . 0.0 109.221 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.0 p -123.47 134.59 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.478 -0.763 . . . . 0.0 109.586 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -64.75 138.32 58.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.474 -0.766 . . . . 0.0 109.881 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.3 pt -131.42 65.68 76.77 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.529 -0.732 . . . . 0.0 109.048 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.22 153.26 51.18 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.816 2.344 . . . . 0.0 112.477 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 93.2 mt -75.52 149.74 38.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.424 -0.797 . . . . 0.0 110.564 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 63.11 59.27 1.33 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.264 0.554 . . . . 0.0 109.604 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -106.8 103.91 13.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.544 -0.722 . . . . 0.0 109.192 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 44.17 73.22 0.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.5 -0.75 . . . . 0.0 109.96 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -148.48 137.76 21.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.368 -0.832 . . . . 0.0 109.83 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.463 ' O ' ' N ' ' A' ' 106' ' ' HIS . 84.6 t60 -172.08 46.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 105' ' ' HIS . 86.5 t60 48.39 14.28 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.709 -0.619 . . . . 0.0 109.535 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.463 ' N ' ' O ' ' A' ' 104' ' ' HIS . 78.0 m80 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.39 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 89.5 p . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -81.5 171.46 14.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.551 -0.718 . . . . 0.0 110.613 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.5 tp -77.93 125.48 29.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.467 -0.77 . . . . 0.0 109.951 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.66 161.95 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.491 -0.756 . . . . 0.0 109.777 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -78.81 152.58 31.29 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.633 0.73 . . . . 0.0 110.523 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.9 -42.99 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.378 -0.826 . . . . 0.0 109.416 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -67.5 -18.26 64.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.024 -1.048 . . . . 0.0 109.361 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -90.15 -18.64 25.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.144 -0.972 . . . . 0.0 109.55 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.3 t -52.1 135.59 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.198 -0.939 . . . . 0.0 110.501 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.6 p -153.91 166.82 31.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.585 -0.697 . . . . 0.0 109.337 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 11' ' ' LEU . 3.6 mm? -68.94 -13.59 62.53 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.405 -0.809 . . . . 0.0 109.508 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.3 p -60.66 -31.19 70.42 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.157 -0.964 . . . . 0.0 109.003 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.44 ' OG1' ' CG1' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -122.95 85.33 50.55 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.17 -39.63 70.86 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.477 2.118 . . . . 0.0 112.018 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -106.52 131.64 53.46 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.56 -0.713 . . . . 0.0 109.887 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.44 ' CG1' ' OG1' ' A' ' 13' ' ' THR . 15.5 m -153.13 -177.25 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.353 -0.842 . . . . 0.0 109.716 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.8 m -137.62 137.91 38.96 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.432 -0.792 . . . . 0.0 109.09 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.3 m -140.44 161.91 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.388 -0.82 . . . . 0.0 109.822 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.447 HD11 ' NE ' ' A' ' 67' ' ' ARG . 86.3 mt -130.43 132.88 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.97 -167.62 37.39 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.054 -1.546 . . . . 0.0 110.017 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.499 ' C ' HD12 ' A' ' 22' ' ' ILE . 50.9 mtpt -113.01 138.11 50.38 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.709 -0.877 . . . . 0.0 109.432 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.762 HD12 ' N ' ' A' ' 22' ' ' ILE . 1.8 mp -97.95 131.33 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.424 -0.798 . . . . 0.0 109.615 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 63' ' ' SER . 79.6 p -133.45 160.31 37.77 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.315 0.579 . . . . 0.0 109.944 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 25' ' ' ILE . . . 100.28 -75.76 0.44 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 24' ' ' GLY . 38.1 mm 58.39 119.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.535 -0.979 . . . . 0.0 110.6 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -145.85 142.41 28.79 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -98.7 130.18 45.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.403 -0.811 . . . . 0.0 109.745 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -141.74 160.76 39.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.361 -0.837 . . . . 0.0 108.952 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 29' ' ' GLU . 57.9 mp0 -121.84 142.53 50.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.49 -0.756 . . . . 0.0 109.374 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -141.96 160.27 40.55 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.286 -0.884 . . . . 0.0 108.874 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -90.17 115.65 27.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.128 -0.982 . . . . 0.0 109.919 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.4 t -110.76 115.14 29.03 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.692 . . . . 0.0 109.214 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 54.38 31.33 14.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.47 -0.769 . . . . 0.0 109.896 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.8 1.8 84.85 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.8 m -117.99 128.69 55.03 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.321 -1.105 . . . . 0.0 109.649 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.1 m -67.99 128.49 36.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 110.381 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -133.1 146.0 51.24 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.43 -0.794 . . . . 0.0 109.58 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.1 m -81.25 144.14 31.78 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.441 -0.787 . . . . 0.0 109.982 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.8 p -136.43 138.96 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.474 -0.766 . . . . 0.0 109.0 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -103.7 131.21 51.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.423 -0.798 . . . . 0.0 108.977 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -124.1 155.76 37.81 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.579 -0.7 . . . . 0.0 109.478 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.38 -160.31 22.93 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -127.59 140.68 51.96 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.605 -0.938 . . . . 0.0 109.62 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.548 ' HB ' HD13 ' A' ' 53' ' ' ILE . 20.4 tt -117.73 136.85 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -134.24 151.47 51.31 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.467 -0.771 . . . . 0.0 109.836 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -144.99 -150.12 0.31 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.645 -0.66 . . . . 0.0 109.368 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 31.7 p-10 -85.72 -1.76 57.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 109.732 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.9 p -103.62 -63.0 1.23 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.175 -0.953 . . . . 0.0 109.556 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -166.47 -149.15 0.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 109.92 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -140.65 151.86 44.93 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.46 -0.775 . . . . 0.0 109.93 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 tt -149.48 158.93 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.188 -0.945 . . . . 0.0 110.196 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.6 mtp85 -71.93 146.98 47.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.9 . . . . 0.0 109.814 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.702 HD11 HG23 ' A' ' 22' ' ' ILE . 37.0 pt -136.76 150.11 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.399 -0.813 . . . . 0.0 110.235 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 t -142.57 138.21 30.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.531 -0.73 . . . . 0.0 109.135 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.3 t -130.35 133.64 46.57 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.508 -0.745 . . . . 0.0 109.175 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -92.87 123.83 36.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.38 -0.825 . . . . 0.0 111.03 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.08 -55.23 3.13 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -70.95 131.81 44.27 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.875 -1.368 . . . . 0.0 110.403 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -96.69 155.17 16.89 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.499 -0.75 . . . . 0.0 110.085 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.9 mt -123.16 151.68 41.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -103.59 160.5 14.69 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.645 0.736 . . . . 0.0 110.176 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 63' ' ' SER . 38.8 t70 -66.14 150.15 49.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.658 -0.651 . . . . 0.0 111.24 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 22' ' ' ILE . 11.1 p 37.57 42.56 0.37 Allowed 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.31 0.576 . . . . 0.0 110.439 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -90.69 120.1 31.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.229 -0.919 . . . . 0.0 110.031 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.78 110.49 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.5 m -143.78 168.32 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.126 -0.984 . . . . 0.0 110.109 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.447 ' NE ' HD11 ' A' ' 19' ' ' ILE . 41.5 ttm180 -118.21 124.37 47.76 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.3 mt -103.7 126.13 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -117.54 141.18 48.67 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.742 -0.599 . . . . 0.0 109.783 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.3 t30 65.47 37.57 6.06 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.47 0.653 . . . . 0.0 109.837 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.76 137.94 46.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.134 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -86.65 121.19 28.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.537 -0.727 . . . . 0.0 109.96 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.2 t -83.49 133.93 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.458 -0.776 . . . . 0.0 109.586 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -136.57 154.94 50.55 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.284 -0.885 . . . . 0.0 109.449 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -115.49 111.59 20.97 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -116.14 125.96 53.04 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.505 -0.747 . . . . 0.0 109.936 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.5 m120 55.26 33.25 20.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.639 -0.663 . . . . 0.0 110.13 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.26 3.24 88.4 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -111.05 133.63 53.28 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.344 -1.092 . . . . 0.0 109.954 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.2 mt -76.72 148.76 36.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.499 -0.751 . . . . 0.0 110.514 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.0 p -152.99 158.66 42.37 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.1 mt -111.55 126.52 55.07 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.282 -0.886 . . . . 0.0 109.379 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.4 m -107.68 123.55 48.68 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.5 t -99.15 112.0 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.266 -0.897 . . . . 0.0 109.47 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.24 -173.05 31.25 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.62 -35.41 80.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.589 -0.948 . . . . 0.0 109.527 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.0 t -66.84 -16.77 64.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 0.0 109.655 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.9 m -74.98 159.42 31.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 110.141 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.1 ttt85 -124.0 134.51 53.44 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.663 -0.648 . . . . 0.0 109.337 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.02 131.9 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.683 -0.636 . . . . 0.0 109.527 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -122.28 130.18 52.91 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.6 0.715 . . . . 0.0 109.286 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.4 p -70.6 147.0 49.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.503 -0.748 . . . . 0.0 110.287 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.2 t -126.78 132.55 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.591 -0.693 . . . . 0.0 109.666 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.508 ' CG ' ' H ' ' A' ' 95' ' ' VAL . 61.6 t30 63.99 -167.47 0.21 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.442 0.639 . . . . 0.0 110.645 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.508 ' H ' ' CG ' ' A' ' 94' ' ' ASN . 9.0 p -102.67 129.94 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.453 -0.779 . . . . 0.0 109.921 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 97' ' ' ILE . 19.1 p30 -102.92 -152.58 0.45 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.522 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 35.1 mm -112.85 81.26 4.35 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.435 -0.791 . . . . 0.0 109.754 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.84 156.15 61.06 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.279 1.986 . . . . 0.0 112.154 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.499 HD22 ' N ' ' A' ' 99' ' ' LEU . 4.0 mm? 43.27 72.87 0.16 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.775 0.798 . . . . 0.0 110.044 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 102' ' ' HIS . 18.2 pt-20 -101.71 6.57 41.91 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 102' ' ' HIS . 58.0 t-80 -46.02 97.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.941 . . . . 0.0 110.035 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 101' ' ' HIS . 97.3 m-70 41.65 -166.88 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.625 0.726 . . . . 0.0 111.049 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -153.71 138.29 16.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.354 -0.841 . . . . 0.0 109.704 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.461 ' O ' ' CD2' ' A' ' 104' ' ' HIS . 56.7 p-80 -171.73 50.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -67.27 -39.76 86.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.562 -0.711 . . . . 0.0 109.753 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 86.0 t60 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.759 -179.586 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.7 p . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.218 0.533 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -172.94 147.7 1.68 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.324 -0.86 . . . . 0.0 109.433 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.606 ' N ' HD22 ' A' ' 3' ' ' LEU . 4.0 mm? -81.94 130.0 34.94 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.378 -0.826 . . . . 0.0 110.248 -178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.79 163.87 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.576 -0.703 . . . . 0.0 109.647 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.61 156.46 27.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.418 -0.801 . . . . 0.0 110.622 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.45 -43.13 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.404 -0.81 . . . . 0.0 109.535 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -67.34 -14.75 63.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.014 -1.054 . . . . 0.0 109.795 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -89.7 -0.03 57.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 109.159 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.11 132.68 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.185 -0.947 . . . . 0.0 110.056 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.4 t -158.73 170.25 22.57 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.358 -0.839 . . . . 0.0 109.619 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.497 ' N ' HD22 ' A' ' 11' ' ' LEU . 3.7 mm? -64.4 -35.45 80.95 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.438 -0.789 . . . . 0.0 109.285 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.7 p -57.96 -20.47 38.15 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.742 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 p -113.32 79.19 3.75 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.348 -0.845 . . . . 0.0 108.885 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.9 -24.91 39.36 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.254 1.969 . . . . 0.0 112.384 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -125.57 110.1 13.45 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.467 -0.77 . . . . 0.0 109.018 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.8 m -141.65 162.09 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.233 -0.917 . . . . 0.0 110.307 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 t -117.25 135.49 53.77 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.7 m -136.14 161.33 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.278 -0.888 . . . . 0.0 110.171 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.3 tt -139.4 140.74 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.401 -0.812 . . . . 0.0 109.341 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.33 -166.04 36.81 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 118.959 -1.591 . . . . 0.0 110.13 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -106.38 131.08 54.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.557 -0.967 . . . . 0.0 109.625 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.493 HG21 HD11 ' A' ' 25' ' ' ILE . 96.3 mt -102.58 133.7 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.575 -0.703 . . . . 0.0 109.839 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.453 ' HA ' ' H ' ' A' ' 63' ' ' SER . 30.3 p -135.47 159.6 41.09 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.335 0.588 . . . . 0.0 109.672 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.29 -84.08 0.99 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.493 HD11 HG21 ' A' ' 22' ' ' ILE . 49.5 mm 56.12 107.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.536 -0.979 . . . . 0.0 110.421 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -129.27 138.54 51.7 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -90.48 136.51 33.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 110.372 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -148.66 151.28 34.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.378 -0.826 . . . . 0.0 108.907 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -117.86 144.74 45.14 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.352 -0.842 . . . . 0.0 110.063 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.405 ' N ' ' CD1' ' A' ' 30' ' ' TYR . 10.0 p90 -144.69 162.32 37.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.333 -0.854 . . . . 0.0 109.822 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -80.96 141.64 34.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.42 -0.8 . . . . 0.0 109.823 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.3 t -144.87 106.37 4.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.136 -0.978 . . . . 0.0 109.511 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.5 t0 57.96 33.41 23.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.422 -0.799 . . . . 0.0 110.329 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.66 6.0 87.68 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 92.4 m -126.62 127.44 45.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.372 -1.075 . . . . 0.0 109.31 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.0 m -73.0 134.41 44.66 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.221 -0.924 . . . . 0.0 110.042 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -131.82 143.4 50.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.428 -0.795 . . . . 0.0 109.054 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 86.8 p -87.27 146.07 26.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.214 -0.929 . . . . 0.0 109.813 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.91 140.26 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.384 -0.823 . . . . 0.0 109.547 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -104.82 130.49 52.93 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -121.35 152.77 38.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.454 -0.778 . . . . 0.0 109.417 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.09 -169.23 33.84 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -123.11 138.97 54.53 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.617 -0.931 . . . . 0.0 109.235 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.3 tt -118.1 143.18 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -133.33 153.21 51.78 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.574 -0.704 . . . . 0.0 109.621 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.53 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 40.4 t0 -149.17 -164.01 1.92 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.373 -0.83 . . . . 0.0 108.942 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.53 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 60.2 t0 -64.32 -33.75 76.56 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.442 -0.786 . . . . 0.0 109.295 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 p -77.31 -86.9 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 110.281 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.06 -147.06 0.2 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.344 -0.848 . . . . 0.0 110.233 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -143.9 157.96 44.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.475 -0.766 . . . . 0.0 109.454 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.2 tt -153.77 161.52 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.953 -1.092 . . . . 0.0 110.326 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -73.82 145.29 45.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.556 -0.715 . . . . 0.0 109.749 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.4 pt -135.24 152.98 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.198 -0.939 . . . . 0.0 109.499 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.6 p -142.31 129.69 21.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.183 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 t -113.94 121.0 42.58 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -96.27 121.12 37.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.322 -0.861 . . . . 0.0 110.72 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.46 -44.68 2.94 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -78.05 138.77 38.96 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.99 -1.3 . . . . 0.0 110.303 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -94.08 151.76 19.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.381 -0.824 . . . . 0.0 109.923 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.15 157.21 43.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.565 -0.709 . . . . 0.0 109.331 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -112.09 136.89 50.88 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.518 0.675 . . . . 0.0 109.687 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -64.65 142.75 58.32 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.884 0.85 . . . . 0.0 111.222 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.453 ' H ' ' HA ' ' A' ' 23' ' ' THR . 11.1 t 58.34 81.19 0.16 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.65 0.738 . . . . 0.0 110.268 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -162.69 126.67 3.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.522 -0.736 . . . . 0.0 110.12 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 t -78.12 120.12 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.389 -0.819 . . . . 0.0 109.444 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.43 163.78 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.465 -0.772 . . . . 0.0 109.823 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.4 ttp85 -119.23 128.23 54.0 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.1 mt -107.38 129.32 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.402 -0.811 . . . . 0.0 109.382 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 66.5 t0 -114.64 142.11 46.9 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.544 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 64.6 t30 63.3 40.58 8.5 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.345 0.593 . . . . 0.0 109.918 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.45 148.87 42.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.334 -0.854 . . . . 0.0 109.417 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -100.87 125.53 47.41 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.565 0.698 . . . . 0.0 109.729 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.9 t -89.19 135.28 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.369 -0.832 . . . . 0.0 110.038 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.74 157.0 43.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 0.0 108.889 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -113.36 116.92 30.44 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.454 -0.779 . . . . 0.0 109.44 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -125.94 138.69 53.78 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.425 -0.797 . . . . 0.0 110.094 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 57.04 23.5 8.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.665 -0.647 . . . . 0.0 109.484 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.08 7.88 88.19 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -118.21 137.76 52.79 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.546 -0.973 . . . . 0.0 109.898 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.1 mt -77.12 148.52 35.98 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.425 -0.797 . . . . 0.0 110.212 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 89.9 p -155.04 161.67 41.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.317 -0.864 . . . . 0.0 109.016 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.4 mt -106.32 125.59 51.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.426 -0.796 . . . . 0.0 109.246 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.9 m -105.66 123.34 47.76 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.5 t -98.97 114.13 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.301 -0.874 . . . . 0.0 108.997 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -95.57 -177.42 37.02 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -67.42 -27.31 66.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.598 -0.942 . . . . 0.0 109.611 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.1 m -78.8 -6.51 56.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.148 -0.97 . . . . 0.0 109.487 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.7 m -83.66 165.59 18.83 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.041 -1.037 . . . . 0.0 109.841 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.75 141.05 51.69 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.435 -0.791 . . . . 0.0 109.318 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.03 130.98 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.563 -0.71 . . . . 0.0 109.609 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -123.72 116.32 22.84 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.9 m -77.54 140.2 39.7 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.35 -0.844 . . . . 0.0 110.099 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.2 m -129.75 130.75 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.546 -0.721 . . . . 0.0 109.29 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -105.44 -40.36 5.83 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 96' ' ' ASN . 2.1 t -148.2 -139.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.224 -0.922 . . . . 0.0 109.766 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.545 ' H ' HG12 ' A' ' 95' ' ' VAL . 17.3 m120 -80.83 -77.08 0.21 Allowed 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.521 0.676 . . . . 0.0 109.418 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.8 pt -144.18 70.84 16.34 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.203 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -77.26 -7.14 16.96 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.438 2.092 . . . . 0.0 110.793 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.0 tp -84.42 128.37 34.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.392 -0.817 . . . . 0.0 110.082 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -153.34 1.41 0.26 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -66.37 -40.95 90.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.368 -0.832 . . . . 0.0 109.816 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -108.53 131.41 54.86 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.398 -0.814 . . . . 0.0 109.7 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.526 ' CG ' ' N ' ' A' ' 104' ' ' HIS . 85.6 t60 -150.24 166.46 29.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.275 -0.89 . . . . 0.0 109.769 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.526 ' N ' ' CG ' ' A' ' 103' ' ' HIS . 86.0 t60 51.18 9.23 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 109.48 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.493 ' H ' ' C ' ' A' ' 103' ' ' HIS . 72.0 m80 -134.96 145.28 47.99 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.353 -0.842 . . . . 0.0 109.699 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.142 -0.932 . . . . 0.0 108.755 179.771 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.2 p . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.74 0.781 . . . . 0.0 108.928 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.3 p30 -83.43 170.94 13.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.363 -0.835 . . . . 0.0 110.489 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.7 tp -81.58 128.48 33.97 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.415 -0.803 . . . . 0.0 109.956 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.01 162.87 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-O 121.719 0.771 . . . . 0.0 110.165 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -77.18 159.47 29.68 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.796 0.808 . . . . 0.0 110.354 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.8 mm -63.78 -42.91 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 121.701 0.762 . . . . 0.0 109.887 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -66.07 -18.08 65.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.193 -0.942 . . . . 0.0 110.486 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 8' ' ' ASP . 59.2 t0 -86.45 -1.79 57.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.858 -1.151 . . . . 0.0 109.384 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 87.1 t -66.29 133.3 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 110.338 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.4 p -156.16 167.44 30.41 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.508 -0.745 . . . . 0.0 109.357 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.5 -34.96 79.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.821 . . . . 0.0 109.309 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.6 p -56.84 -19.4 17.23 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 109.475 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' A' ' 13' ' ' THR . 11.1 p -115.23 81.07 7.82 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.365 -0.835 . . . . 0.0 109.248 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -71.92 -16.08 29.36 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.598 2.199 . . . . 0.0 111.288 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -128.66 110.07 11.89 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.4 m -145.44 161.68 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.357 -0.84 . . . . 0.0 110.397 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.3 t -116.55 136.96 52.55 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.61 160.29 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 CA-C-O 121.894 0.854 . . . . 0.0 110.256 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 14.3 tt -144.36 133.73 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.682 -0.636 . . . . 0.0 109.606 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.82 -162.55 30.33 Favored Glycine 0 N--CA 1.487 2.051 0 C-N-CA 119.693 -1.241 . . . . 0.0 110.019 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -105.98 134.79 48.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.708 -0.878 . . . . 0.0 109.985 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 63' ' ' SER . 97.0 mt -103.64 130.64 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.527 0.679 . . . . 0.0 110.086 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 p -134.15 163.31 29.88 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.49 0.662 . . . . 0.0 109.371 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.479 ' N ' ' OD1' ' A' ' 62' ' ' ASP . . . 97.03 -76.74 0.68 Allowed Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 24' ' ' GLY . 36.9 mm 57.91 120.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 122.039 0.923 . . . . 0.0 110.405 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -143.63 138.97 29.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.451 -0.781 . . . . 0.0 108.986 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -104.36 130.3 52.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.481 -0.762 . . . . 0.0 109.919 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -144.34 165.29 28.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.545 -0.722 . . . . 0.0 109.402 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -120.57 146.57 46.2 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.593 -0.692 . . . . 0.0 110.008 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -142.6 163.16 33.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 109.85 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 57.0 mp0 -88.04 114.16 24.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.528 -0.733 . . . . 0.0 109.721 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.8 t -110.77 107.29 16.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.493 -0.755 . . . . 0.0 109.758 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 54.7 t0 54.79 28.56 10.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.533 -0.73 . . . . 0.0 110.526 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.88 8.18 67.55 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.4 m -123.11 127.51 48.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.409 -1.053 . . . . 0.0 109.11 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.9 m -72.83 131.05 41.79 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.392 -0.818 . . . . 0.0 110.402 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -136.89 146.61 45.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.473 -0.767 . . . . 0.0 109.529 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 99.8 p -81.43 148.6 29.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.401 -0.812 . . . . 0.0 110.343 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.32 138.3 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 109.678 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.498 ' CD1' ' O ' ' A' ' 58' ' ' LYS . 83.7 m-85 -104.35 132.72 50.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.447 -0.783 . . . . 0.0 109.481 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -129.2 156.64 43.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.634 -0.666 . . . . 0.0 109.457 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.55 -165.32 31.97 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.045 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -120.36 143.89 48.17 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.698 -0.883 . . . . 0.0 109.798 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 tt -131.85 134.37 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -139.45 155.02 47.85 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.855 0.836 . . . . 0.0 110.553 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.547 ' O ' ' C ' ' A' ' 47' ' ' ASP . 41.8 p-10 -152.89 99.47 2.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.432 -0.792 . . . . 0.0 109.385 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.547 ' C ' ' O ' ' A' ' 46' ' ' ASP . 29.5 p-10 13.72 57.94 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.736 0 CA-C-O 122.169 0.985 . . . . 0.0 110.944 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 46' ' ' ASP . 8.2 m -168.7 -55.6 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -173.39 -167.93 0.42 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.367 -0.833 . . . . 0.0 109.397 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -139.05 149.98 45.24 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.632 0.73 . . . . 0.0 110.482 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.8 tt -147.24 152.81 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.33 -0.856 . . . . 0.0 109.687 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.435 HH21 ' HB2' ' A' ' 79' ' ' TYR . 81.0 mtm-85 -77.53 147.57 35.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.521 -0.737 . . . . 0.0 109.856 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.0 pt -132.48 158.3 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.617 -0.677 . . . . 0.0 109.907 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 t -147.14 127.73 14.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 p -122.89 138.7 54.59 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.477 0.656 . . . . 0.0 109.613 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -97.8 118.15 33.71 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.679 0.752 . . . . 0.0 111.527 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.09 -19.66 1.69 Allowed Glycine 0 N--CA 1.496 2.671 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.608 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.498 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 68.8 mttm -83.63 137.82 33.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.689 -1.477 . . . . 0.0 110.484 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -96.6 140.73 30.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.602 -0.687 . . . . 0.0 110.159 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.1 mt -130.18 153.32 48.67 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.598 -0.689 . . . . 0.0 109.381 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -113.33 155.31 25.4 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.653 0.74 . . . . 0.0 109.893 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 7.7 m-20 -70.78 148.3 48.05 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.92 0.867 . . . . 0.0 110.995 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 22' ' ' ILE . 1.8 m 53.34 32.98 14.68 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.779 0.8 . . . . 0.0 109.409 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -96.84 114.57 26.21 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.353 -0.842 . . . . 0.0 110.573 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.443 HG22 ' H ' ' A' ' 65' ' ' VAL . 1.5 m -84.08 117.14 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.343 -0.848 . . . . 0.0 109.889 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.9 m -148.45 175.12 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.501 0.667 . . . . 0.0 109.541 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -122.68 132.26 54.18 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.55 125.28 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.597 -0.689 . . . . 0.0 109.477 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -111.21 152.38 27.16 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 59.57 35.23 22.57 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.708 0.766 . . . . 0.0 109.664 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.65 143.97 56.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.51 -0.744 . . . . 0.0 109.442 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -105.62 118.57 36.93 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.935 0.874 . . . . 0.0 109.572 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 t -88.91 131.44 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.425 -0.797 . . . . 0.0 110.124 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.46 157.58 41.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.394 -0.816 . . . . 0.0 109.015 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -100.75 125.45 47.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.455 -0.778 . . . . 0.0 109.655 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.415 ' O ' ' N ' ' A' ' 78' ' ' GLY . 69.8 m-85 -115.52 133.18 56.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.61 -0.681 . . . . 0.0 109.354 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m120 67.89 -63.23 0.32 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.627 0.727 . . . . 0.0 109.844 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 76' ' ' PHE . . . 176.43 29.15 0.04 OUTLIER Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.435 ' HB2' HH21 ' A' ' 52' ' ' ARG . 31.5 p90 -146.82 155.43 42.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.292 -1.122 . . . . 0.0 109.837 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.8 mt -83.06 145.65 29.15 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.77 0.795 . . . . 0.0 110.974 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.1 t -157.8 163.72 37.75 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 70.7 mt -101.15 130.22 47.18 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.165 -0.959 . . . . 0.0 109.694 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.6 m -109.88 122.6 47.91 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.665 0.745 . . . . 0.0 109.319 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.6 t -98.62 110.04 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.826 0.822 . . . . 0.0 109.11 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.13 -174.85 40.8 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -71.22 -19.23 62.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.553 -0.969 . . . . 0.0 110.34 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -84.55 -8.83 58.78 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.711 -1.243 . . . . 0.0 109.057 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.8 t -79.34 162.63 25.46 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.395 -0.816 . . . . 0.0 110.434 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -129.66 136.37 49.64 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.594 -0.691 . . . . 0.0 109.384 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.84 130.46 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -120.53 132.19 55.06 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.701 0.762 . . . . 0.0 109.128 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.0 m -74.31 147.85 41.91 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.383 0.611 . . . . 0.0 110.525 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.9 t -120.88 132.06 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 94' ' ' ASN . 48.7 p30 -89.92 146.25 24.54 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.651 0.739 . . . . 0.0 110.079 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.541 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 59.7 t -83.36 -77.01 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-O 121.594 0.711 . . . . 0.0 109.137 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 95' ' ' VAL . 16.4 m120 -154.42 105.77 2.69 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.313 -0.867 . . . . 0.0 109.848 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 66.8 mt 42.39 76.86 0.48 Allowed Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.543 -0.723 . . . . 0.0 110.325 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -59.05 144.78 99.23 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.918 2.412 . . . . 0.0 112.569 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.611 HD23 ' O ' ' A' ' 99' ' ' LEU . 2.4 tt -63.04 -43.58 98.27 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.285 -0.884 . . . . 0.0 109.187 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -57.95 135.35 56.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.237 -0.914 . . . . 0.0 109.8 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -107.49 135.36 49.09 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.834 0.826 . . . . 0.0 109.834 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -57.3 -76.01 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.835 0.826 . . . . 0.0 110.141 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.4 ' O ' ' C ' ' A' ' 104' ' ' HIS . 33.9 m-70 51.82 20.67 1.22 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -0.909 . . . . 0.0 109.044 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 103' ' ' HIS . 71.2 m80 42.99 -111.52 0.18 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.638 -0.664 . . . . 0.0 109.717 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -126.58 1.75 6.86 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.171 -0.956 . . . . 0.0 109.367 179.846 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.494 ' H2 ' ' C ' ' A' ' 16' ' ' VAL . 29.2 m . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.55 0.69 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 65.9 t0 -66.28 145.62 55.54 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.691 0.758 . . . . 0.0 110.313 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.545 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 42.8 tp -70.92 121.78 18.76 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.551 0.691 . . . . 0.0 110.097 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.1 m -137.78 163.65 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 121.582 0.706 . . . . 0.0 109.939 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -76.03 156.85 33.62 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.587 0.708 . . . . 0.0 110.26 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.84 -43.41 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.563 -0.71 . . . . 0.0 109.728 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.491 ' HE ' ' HB2' ' A' ' 49' ' ' ALA . 95.0 mtt180 -62.62 -24.84 67.79 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.403 -0.811 . . . . 0.0 110.382 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -82.62 -0.21 46.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.549 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.2 t -65.76 131.54 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.371 -0.831 . . . . 0.0 110.539 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 99.1 p -160.31 169.3 23.44 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.685 0.755 . . . . 0.0 109.535 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.74 -33.89 76.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.766 . . . . 0.0 109.823 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -59.74 -18.59 44.04 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.243 -0.91 . . . . 0.0 109.271 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.48 ' O ' HG21 ' A' ' 73' ' ' VAL . 13.6 p -111.45 80.13 2.54 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.65 -23.19 36.72 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.383 2.055 . . . . 0.0 111.744 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.464 ' C ' ' N ' ' A' ' 1' ' ' SER . 64.0 m-85 -126.22 110.08 13.04 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.494 ' C ' ' H2 ' ' A' ' 1' ' ' SER . 21.9 m -138.15 162.62 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.589 -0.695 . . . . 0.0 110.353 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 t -125.67 134.85 51.7 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.5 m -139.88 162.24 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 121.579 0.704 . . . . 0.0 110.303 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.3 tt -137.98 139.48 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.58 -0.7 . . . . 0.0 109.647 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.76 -162.94 29.85 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.661 -1.257 . . . . 0.0 109.993 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -106.15 144.4 32.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.749 -0.854 . . . . 0.0 109.491 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 25' ' ' ILE . 17.5 mm -94.2 130.59 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.302 0.573 . . . . 0.0 110.427 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.2 p -138.42 156.93 47.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.468 -0.77 . . . . 0.0 110.479 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.08 65.84 2.74 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 22' ' ' ILE . 21.8 mm -80.21 128.15 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -1.12 . . . . 0.0 110.242 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -134.66 140.93 46.39 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -104.53 134.65 47.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.644 -0.66 . . . . 0.0 109.884 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -140.61 162.73 34.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.645 -0.66 . . . . 0.0 109.716 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -125.76 140.1 52.97 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.754 -0.591 . . . . 0.0 109.72 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -140.38 159.01 43.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.455 -0.778 . . . . 0.0 109.586 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -86.98 111.19 20.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.575 -0.703 . . . . 0.0 109.752 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 p -112.81 119.78 39.19 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.524 0.678 . . . . 0.0 109.807 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.9 t0 55.23 29.71 13.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.619 -0.676 . . . . 0.0 109.916 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.52 5.82 86.45 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.8 m -124.87 128.74 49.13 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.447 -1.031 . . . . 0.0 109.613 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 33.2 m -66.77 130.4 43.03 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.645 -0.659 . . . . 0.0 110.3 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -132.18 143.0 49.65 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.833 0.825 . . . . 0.0 109.612 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.6 t -78.25 145.36 35.51 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 121.425 0.631 . . . . 0.0 110.137 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.79 137.71 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.6 -0.688 . . . . 0.0 109.303 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -103.76 132.7 49.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.72 -0.613 . . . . 0.0 109.456 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -125.41 149.05 48.54 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.7 -165.51 29.84 Favored Glycine 0 N--CA 1.485 1.956 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.139 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -123.28 142.85 50.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.836 -0.802 . . . . 0.0 109.398 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.41 ' HB ' HD13 ' A' ' 53' ' ' ILE . 19.6 tt -120.39 144.34 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -131.16 150.42 52.15 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.613 0.72 . . . . 0.0 110.162 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 41.4 t0 -151.76 -166.66 2.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.587 -0.695 . . . . 0.0 109.391 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.527 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 47.6 t0 -70.29 -9.94 57.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 109.938 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.3 p -94.72 -71.31 0.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 109.625 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.491 ' HB2' ' HE ' ' A' ' 7' ' ' ARG . . . -162.22 -141.13 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.396 -0.815 . . . . 0.0 109.49 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -143.42 151.82 40.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.446 -0.784 . . . . 0.0 109.976 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.6 tt -151.9 161.44 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.712 . . . . 0.0 110.158 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -74.11 147.26 42.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.492 -0.755 . . . . 0.0 109.628 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.41 HD13 ' HB ' ' A' ' 44' ' ' ILE . 43.0 pt -136.07 154.5 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.482 -0.761 . . . . 0.0 110.042 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.0 t -145.67 131.14 18.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.528 -0.733 . . . . 0.0 109.325 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.9 t -120.39 134.95 55.18 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.459 0.647 . . . . 0.0 109.435 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -95.8 122.14 38.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.518 -0.739 . . . . 0.0 111.021 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.53 -44.45 0.47 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.4 ttmm -79.01 130.99 36.12 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.168 -1.195 . . . . 0.0 110.678 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -91.89 164.59 13.61 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.51 0.671 . . . . 0.0 110.462 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.6 mt -126.9 157.74 38.59 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -105.8 133.85 49.86 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.327 1.061 . . . . 0.0 110.223 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -69.92 143.89 52.6 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.627 -0.67 . . . . 0.0 111.153 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.5 t 65.12 4.57 2.61 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -90.81 134.95 34.05 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.478 -0.764 . . . . 0.0 109.942 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.0 t -86.85 121.58 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.59 159.97 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.586 0.708 . . . . 0.0 109.876 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -123.75 125.08 44.11 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.2 mt -99.14 128.05 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -112.53 138.53 49.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.5 t30 62.54 39.24 11.83 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.334 0.587 . . . . 0.0 109.708 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.08 148.41 51.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.417 -0.802 . . . . 0.0 109.605 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -99.57 121.07 40.66 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.736 0.779 . . . . 0.0 109.882 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 13' ' ' THR . 84.6 t -80.87 133.75 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.609 -0.682 . . . . 0.0 109.874 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.44 155.54 42.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.397 -0.814 . . . . 0.0 109.509 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -114.09 119.14 36.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.766 -0.584 . . . . 0.0 109.621 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -118.27 126.2 51.67 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.507 0.67 . . . . 0.0 109.738 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.7 m120 55.63 32.98 20.31 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.454 0.645 . . . . 0.0 110.196 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.15 6.05 89.37 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -113.73 133.9 55.08 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.385 -1.068 . . . . 0.0 110.022 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.9 mt -77.54 145.96 36.6 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.484 0.659 . . . . 0.0 110.117 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.8 p -154.34 160.27 41.62 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.531 -0.73 . . . . 0.0 109.353 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.4 mt -105.58 118.9 37.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.594 -0.692 . . . . 0.0 109.406 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.7 m -98.32 126.89 44.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.672 -0.642 . . . . 0.0 109.403 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 t -103.67 109.44 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.541 -0.725 . . . . 0.0 109.608 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -96.59 -176.24 35.55 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -68.24 -17.01 64.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.515 -0.991 . . . . 0.0 109.605 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 96.8 p -83.08 -9.41 59.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 109.107 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.7 t -88.5 167.85 13.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.457 -0.777 . . . . 0.0 110.14 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.5 tpt85 -132.44 135.05 45.81 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.6 mt -115.65 130.78 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.795 -0.566 . . . . 0.0 109.722 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -119.0 122.3 41.88 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.393 0.616 . . . . 0.0 109.661 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.2 m -80.8 149.16 29.71 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.418 0.628 . . . . 0.0 110.298 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.25 40.14 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -149.16 102.88 3.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.426 -0.796 . . . . 0.0 109.131 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.2 t -63.38 -110.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.624 -0.672 . . . . 0.0 110.828 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 57.63 34.82 25.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.639 -0.663 . . . . 0.0 109.939 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.639 ' O ' HG23 ' A' ' 97' ' ' ILE . 17.4 tt -134.33 55.36 14.54 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.617 -0.677 . . . . 0.0 109.506 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 97' ' ' ILE . 40.3 Cg_endo -68.0 152.57 76.65 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.452 2.101 . . . . 0.0 112.843 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.39 141.97 48.71 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.534 0.683 . . . . 0.0 109.915 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -79.02 139.65 38.13 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.597 0.713 . . . . 0.0 110.414 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -154.7 -69.44 0.13 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -75.83 142.95 42.11 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.739 0.781 . . . . 0.0 110.382 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.6 m80 43.97 -167.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.613 0.721 . . . . 0.0 110.778 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -150.55 163.99 37.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.485 -0.759 . . . . 0.0 109.801 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -78.35 130.18 35.86 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.724 0.774 . . . . 0.0 110.202 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.408 ' OXT' ' CG ' ' A' ' 106' ' ' HIS . 84.3 t60 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 117.949 -1.024 . . . . 0.0 108.988 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.3 p . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -75.8 163.22 27.47 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.68 0.752 . . . . 0.0 110.451 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.6 tp -79.93 124.42 28.66 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.562 -0.711 . . . . 0.0 109.878 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.99 163.46 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.443 -0.786 . . . . 0.0 109.724 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -76.16 159.43 30.7 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.683 0.754 . . . . 0.0 110.218 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.1 -42.9 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.527 -0.733 . . . . 0.0 110.037 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 -67.13 -18.52 65.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.903 -1.123 . . . . 0.0 109.617 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -83.57 -2.05 55.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.09 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.7 t -66.69 132.22 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 110.362 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 m -156.45 167.37 30.64 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.517 -0.74 . . . . 0.0 109.392 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.91 -37.65 88.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.338 -0.851 . . . . 0.0 109.716 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 93.8 p -54.71 -22.2 13.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.973 . . . . 0.0 109.31 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.417 ' O ' ' OG1' ' A' ' 13' ' ' THR . 10.7 p -113.03 80.9 4.3 Favored Pre-proline 0 N--CA 1.494 1.767 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.75 -21.87 24.56 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.258 1.972 . . . . 0.0 111.673 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -125.26 109.98 13.48 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.399 0.619 . . . . 0.0 109.459 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.8 m -147.16 162.03 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.148 -0.97 . . . . 0.0 110.143 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.2 m -115.0 135.68 53.96 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.46 161.35 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.327 -0.858 . . . . 0.0 110.001 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.2 tt -138.5 137.51 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.377 -0.827 . . . . 0.0 109.711 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.36 -165.06 27.12 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 119.567 -1.301 . . . . 0.0 109.876 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -105.46 126.85 52.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.652 -0.91 . . . . 0.0 109.069 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.8 mm -83.32 129.51 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-O 121.495 0.664 . . . . 0.0 110.313 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 44.5 p -140.04 163.7 31.99 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.697 0.761 . . . . 0.0 110.035 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.35 89.71 0.01 OUTLIER Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.5 mm -99.61 126.05 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -1.118 . . . . 0.0 109.416 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -131.13 132.36 44.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -98.81 131.52 44.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.431 -0.793 . . . . 0.0 109.547 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -133.71 153.21 51.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.531 -0.731 . . . . 0.0 109.405 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -119.64 139.81 51.62 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.481 0.658 . . . . 0.0 109.799 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -142.0 161.16 38.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.292 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -90.36 99.18 12.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.959 . . . . 0.0 109.157 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.602 ' O ' ' N ' ' A' ' 34' ' ' GLY . 5.3 p -81.27 -156.5 0.15 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.484 -0.76 . . . . 0.0 110.073 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -48.28 82.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.53 0.681 . . . . 0.0 110.142 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 52.8 11.73 1.42 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.3 m -135.59 133.37 38.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.222 -1.163 . . . . 0.0 110.001 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.6 m -75.49 129.68 37.66 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.458 -0.776 . . . . 0.0 109.651 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -133.16 145.87 51.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.378 -0.826 . . . . 0.0 109.745 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.6 p -86.18 148.11 25.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.505 -0.747 . . . . 0.0 110.087 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 p -137.9 137.59 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.517 ' CZ ' ' OE1' ' A' ' 59' ' ' GLN . 88.3 m-85 -103.5 135.09 45.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.482 -0.761 . . . . 0.0 109.64 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -125.07 155.22 40.15 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.94 -167.29 34.62 Favored Glycine 0 N--CA 1.482 1.745 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -126.74 141.84 51.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.587 -0.949 . . . . 0.0 109.529 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.7 tt -114.55 143.68 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.45 ' OE2' ' O ' ' A' ' 49' ' ' ALA . 10.1 tp10 -130.46 149.14 52.27 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.582 0.706 . . . . 0.0 109.694 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.517 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 42.7 t0 -148.26 -164.39 2.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.464 -0.772 . . . . 0.0 109.478 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.517 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 96.7 m-20 -73.79 -17.06 61.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 109.657 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.1 m -92.94 -73.82 0.54 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.188 -0.945 . . . . 0.0 109.795 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.45 ' O ' ' OE2' ' A' ' 45' ' ' GLU . . . -154.15 -157.0 0.73 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.727 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -137.76 156.67 47.73 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.497 -0.752 . . . . 0.0 110.229 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 tt -151.4 159.41 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.268 -0.895 . . . . 0.0 110.3 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -76.15 144.26 40.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.328 -0.858 . . . . 0.0 109.689 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -130.37 157.37 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.777 0.799 . . . . 0.0 110.245 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.2 t -143.61 134.87 25.85 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.8 t -127.57 131.68 49.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.262 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -102.17 123.25 45.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.441 -0.787 . . . . 0.0 111.011 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.66 -51.17 3.01 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.481 ' NZ ' ' O ' ' A' ' 88' ' ' SER . 98.6 mttt -63.93 135.72 56.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.098 -1.237 . . . . 0.0 110.58 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.517 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 69.8 tp60 -85.16 149.58 25.42 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.688 0.756 . . . . 0.0 110.52 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.2 mt -130.58 157.18 43.42 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -124.63 148.98 47.58 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.806 0.812 . . . . 0.0 110.051 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 52.2 p-10 -67.17 146.53 54.13 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.102 0.954 . . . . 0.0 111.377 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.3 p 47.16 81.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.631 0.729 . . . . 0.0 110.384 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -151.79 124.78 8.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.39 -0.819 . . . . 0.0 110.205 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 t -79.63 114.59 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.352 -0.842 . . . . 0.0 109.266 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.14 163.65 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.494 -0.754 . . . . 0.0 109.795 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -122.71 132.63 54.34 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 78.9 mt -107.14 128.57 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 70' ' ' ASN . 68.1 t0 -110.34 143.07 41.1 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.548 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 64.6 t30 60.64 39.87 17.2 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.45 149.75 46.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.569 -0.707 . . . . 0.0 109.796 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -102.74 126.79 49.99 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.57 0.7 . . . . 0.0 110.016 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.4 t -92.29 133.0 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.498 -0.751 . . . . 0.0 109.397 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.67 156.27 45.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 0.0 109.148 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -113.0 119.28 37.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.469 -0.769 . . . . 0.0 109.609 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -125.15 134.09 52.56 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.559 0.695 . . . . 0.0 109.555 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 56.13 30.98 17.38 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.468 0.651 . . . . 0.0 109.787 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.77 4.69 77.18 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -114.39 136.62 52.79 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.316 -1.108 . . . . 0.0 109.742 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.9 mt -76.91 146.37 37.65 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.655 0.74 . . . . 0.0 110.4 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 88.9 p -152.74 160.5 43.13 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.443 -0.786 . . . . 0.0 109.155 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.29 126.43 52.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.382 -0.824 . . . . 0.0 109.213 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 t -108.49 129.66 55.28 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.13 112.39 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.67 0.748 . . . . 0.0 109.1 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.71 -177.58 38.24 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -69.64 -17.4 63.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.58 -0.953 . . . . 0.0 109.434 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.3 m -84.91 -12.37 53.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.17 -0.956 . . . . 0.0 109.398 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.481 ' O ' ' NZ ' ' A' ' 58' ' ' LYS . 14.7 m -86.79 163.89 17.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.293 -0.879 . . . . 0.0 109.777 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -126.85 142.66 51.48 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.521 -0.737 . . . . 0.0 109.857 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -118.04 129.79 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -125.25 121.46 34.13 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.698 0.761 . . . . 0.0 109.36 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.0 p -78.57 156.59 29.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.498 -0.751 . . . . 0.0 109.94 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.0 t -121.9 130.39 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.519 -0.738 . . . . 0.0 109.276 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -91.52 103.1 15.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.556 -0.715 . . . . 0.0 109.6 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 96' ' ' ASN . 9.3 p -106.84 -22.22 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.448 ' O ' ' O ' ' A' ' 95' ' ' VAL . 58.3 t30 42.69 -167.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.577 0.703 . . . . 0.0 110.102 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.506 ' N ' ' HD2' ' A' ' 98' ' ' PRO . 1.7 mp -75.91 -56.14 1.75 Allowed Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.243 -0.911 . . . . 0.0 109.477 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 97' ' ' ILE . 45.8 Cg_endo -64.1 148.28 91.39 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.189 1.926 . . . . 0.0 112.535 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 78.7 mt -83.03 128.78 34.79 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 109.674 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -93.66 124.01 37.37 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.383 -0.823 . . . . 0.0 109.374 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -79.85 133.98 36.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 110.388 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -92.93 110.36 21.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.446 -0.784 . . . . 0.0 109.899 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' A' ' 103' ' ' HIS . 2.2 p-80 -163.79 -53.03 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.529 ' CD2' ' CD2' ' A' ' 103' ' ' HIS . 68.1 m-70 -85.58 -14.36 45.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.419 -0.801 . . . . 0.0 109.288 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -79.29 135.56 36.79 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.306 -0.871 . . . . 0.0 109.949 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 118.071 -0.966 . . . . 0.0 108.929 179.712 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 2' ' ' ASP . 8.7 t . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.408 0.623 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 3' ' ' LEU . 65.7 t0 -66.86 149.12 51.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.45 -0.782 . . . . 0.0 110.267 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.542 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 50.1 tp -71.69 127.62 33.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.332 -0.855 . . . . 0.0 109.612 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.79 163.62 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.342 -0.849 . . . . 0.0 110.434 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -76.53 154.54 34.47 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.426 0.631 . . . . 0.0 110.38 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.35 -43.22 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 109.604 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 -64.11 -21.04 66.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.146 -0.971 . . . . 0.0 109.964 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -88.07 1.66 53.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.097 -1.002 . . . . 0.0 109.742 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.07 131.78 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.09 -1.006 . . . . 0.0 110.297 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.6 p -158.33 166.45 32.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.441 -0.787 . . . . 0.0 109.67 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.31 -20.5 66.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.402 -0.811 . . . . 0.0 109.185 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.9 t -63.96 -16.3 61.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 109.57 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.4 p -119.82 84.24 31.2 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.48 -0.763 . . . . 0.0 109.11 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.53 -40.67 71.65 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.591 2.194 . . . . 0.0 112.203 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -121.84 127.69 50.82 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.673 -0.642 . . . . 0.0 109.758 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.6 m -144.76 161.61 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.293 -0.879 . . . . 0.0 109.735 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 t -116.59 136.29 53.1 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.84 162.3 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.377 -0.827 . . . . 0.0 109.738 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.06 143.5 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.405 -0.809 . . . . 0.0 109.792 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.16 -161.32 35.07 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -111.73 139.05 47.51 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.439 -1.036 . . . . 0.0 109.604 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.46 ' O ' ' N ' ' A' ' 63' ' ' SER . 97.1 mt -97.93 131.32 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.868 -0.52 . . . . 0.0 109.852 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.3 p -133.7 156.63 47.59 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.468 -0.77 . . . . 0.0 109.952 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.1 71.4 1.01 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.8 mm -79.76 128.6 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.982 -1.305 . . . . 0.0 109.207 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -128.75 131.31 47.86 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -104.61 135.98 44.99 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.534 -0.729 . . . . 0.0 109.78 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -148.74 156.99 43.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.491 -0.756 . . . . 0.0 109.035 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -111.94 146.02 38.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.567 -0.708 . . . . 0.0 109.655 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.434 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 10.7 p90 -143.55 159.19 42.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.347 -0.846 . . . . 0.0 109.672 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -83.15 136.12 34.56 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.444 -0.785 . . . . 0.0 110.004 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.8 t -147.76 118.24 7.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.376 -0.828 . . . . 0.0 109.158 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 56.53 32.05 20.12 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.749 -0.594 . . . . 0.0 110.176 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.81 13.25 83.33 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -127.76 158.56 37.35 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.323 -1.104 . . . . 0.0 109.892 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.1 m -94.76 123.7 38.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.603 -0.686 . . . . 0.0 109.768 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.434 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 42.8 mmtm -127.26 141.96 51.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.565 -0.709 . . . . 0.0 109.195 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.1 m -84.81 146.65 27.24 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.621 -0.674 . . . . 0.0 109.816 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.7 137.63 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.521 -0.737 . . . . 0.0 109.169 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -102.49 131.9 48.88 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -127.1 155.0 44.01 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.619 -0.675 . . . . 0.0 109.672 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -176.6 -166.81 34.32 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.37 -1.395 . . . . 0.0 109.775 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -119.34 139.96 51.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.662 -0.905 . . . . 0.0 109.516 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 tt -122.96 132.99 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -132.84 156.4 47.22 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.28 -0.888 . . . . 0.0 111.142 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 48' ' ' THR . 53.9 p-10 -143.67 -144.33 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 23.4 p-10 -88.22 -1.39 57.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 109.14 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 49' ' ' ALA . 30.4 p -101.23 -69.69 0.77 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.507 -0.745 . . . . 0.0 109.613 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.536 ' N ' ' OG1' ' A' ' 48' ' ' THR . . . -162.86 -148.2 0.13 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.271 -0.893 . . . . 0.0 109.788 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -137.92 153.51 49.5 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.497 -0.752 . . . . 0.0 109.901 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.0 tt -152.24 154.87 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.174 -0.954 . . . . 0.0 109.998 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.85 143.42 41.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.419 -0.801 . . . . 0.0 110.355 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.1 pt -132.46 153.9 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.724 -0.61 . . . . 0.0 109.568 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.1 p -143.71 121.34 11.82 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 p -113.36 138.86 49.44 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.603 -0.686 . . . . 0.0 109.418 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.505 ' C ' ' H ' ' A' ' 58' ' ' LYS . 67.7 m-85 -95.91 121.26 37.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.405 -0.809 . . . . 0.0 111.332 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.74 -31.45 0.28 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.505 ' H ' ' C ' ' A' ' 56' ' ' PHE . 68.9 mttm -72.9 135.02 45.03 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.962 -1.316 . . . . 0.0 110.061 -179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -88.26 155.36 19.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.368 -0.833 . . . . 0.0 109.893 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.7 mt -127.67 152.48 47.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.632 -0.668 . . . . 0.0 109.277 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -114.45 132.41 56.27 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.061 0.934 . . . . 0.0 110.149 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 63' ' ' SER . 67.7 t0 -65.0 139.18 58.73 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.818 0.818 . . . . 0.0 111.622 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.538 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.7 m 61.8 5.53 1.36 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.588 -0.695 . . . . 0.0 110.338 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 65' ' ' VAL . 64.1 t0 -81.78 129.24 34.66 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.005 -1.06 . . . . 0.0 110.26 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.438 ' H ' HG22 ' A' ' 65' ' ' VAL . 1.7 m -83.34 119.36 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.7 m -138.16 163.27 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.72 0.771 . . . . 0.0 109.86 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.483 ' NH1' ' OD2' ' A' ' 69' ' ' ASP . 75.7 ttt-85 -123.28 125.53 45.23 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 77.7 mt -107.52 129.02 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.521 -0.737 . . . . 0.0 109.524 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.483 ' OD2' ' NH1' ' A' ' 67' ' ' ARG . 95.4 m-20 -113.76 148.9 35.68 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.415 0.626 . . . . 0.0 109.849 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 60.85 36.95 18.86 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.734 -0.604 . . . . 0.0 109.546 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.32 133.4 42.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 109.511 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -84.57 131.11 34.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 110.253 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 91.4 t -87.62 134.14 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.488 -0.757 . . . . 0.0 109.47 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.57 154.74 44.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.152 -0.968 . . . . 0.0 109.527 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.408 HE21 ' HA2' ' A' ' 78' ' ' GLY . 59.1 tt0 -116.48 117.82 30.95 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -126.45 133.17 51.29 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.668 -0.645 . . . . 0.0 109.766 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 56.57 31.79 19.72 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.274 0.559 . . . . 0.0 110.097 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.408 ' HA2' HE21 ' A' ' 75' ' ' GLN . . . 76.66 5.11 82.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -113.63 133.1 55.49 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.379 -1.071 . . . . 0.0 110.119 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.64 146.26 36.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.517 -0.739 . . . . 0.0 109.793 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 97.3 p -156.22 161.97 40.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.398 -0.814 . . . . 0.0 109.767 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.2 mt -105.84 130.61 53.78 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.5 t -107.76 127.83 54.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.0 109.413 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.08 107.67 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.46 -0.775 . . . . 0.0 109.356 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -96.0 -177.29 36.39 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -69.14 -17.27 63.81 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.254 -1.145 . . . . 0.0 109.315 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.6 m -84.45 -8.8 58.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.16 -0.963 . . . . 0.0 109.135 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.6 t -85.2 168.19 15.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.404 -0.81 . . . . 0.0 109.75 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -129.25 139.85 51.67 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.475 -0.765 . . . . 0.0 109.882 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.51 130.92 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -122.57 111.11 16.39 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.2 t -73.62 146.68 44.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.531 -0.731 . . . . 0.0 110.12 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 51.6 t -117.31 128.48 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.491 -0.756 . . . . 0.0 109.506 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.428 ' O ' ' O ' ' A' ' 95' ' ' VAL . 62.9 t30 -173.74 -29.09 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 96' ' ' ASN . 99.4 t 54.51 162.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.602 0.715 . . . . 0.0 110.733 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.597 ' N ' HG12 ' A' ' 95' ' ' VAL . 12.4 t-20 60.09 104.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.82 -0.55 . . . . 0.0 109.647 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.438 ' C ' ' O ' ' A' ' 96' ' ' ASN . 21.5 pt 34.69 59.08 2.29 Favored Pre-proline 0 N--CA 1.499 1.998 0 CA-C-O 121.177 0.513 . . . . 0.0 110.438 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 99' ' ' LEU . 60.0 Cg_endo -71.52 150.82 58.19 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.828 2.352 . . . . 0.0 112.368 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 98' ' ' PRO . 61.0 mt 59.25 124.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.732 0.777 . . . . 0.0 109.799 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 102' ' ' HIS . 98.3 mt-10 -72.65 141.96 48.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.505 -0.747 . . . . 0.0 110.428 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 41.36 -91.19 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.449 0.642 . . . . 0.0 110.432 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.534 ' N ' ' O ' ' A' ' 100' ' ' GLU . 59.6 t-80 45.84 89.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.661 0.743 . . . . 0.0 109.724 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.706 ' CG ' ' H ' ' A' ' 104' ' ' HIS . 48.3 t60 -76.73 -160.58 0.16 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.556 -0.715 . . . . 0.0 110.364 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.706 ' H ' ' CG ' ' A' ' 103' ' ' HIS . 98.7 m-70 57.65 92.54 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.628 0.727 . . . . 0.0 109.632 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -65.6 -39.72 91.87 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.488 -0.757 . . . . 0.0 109.221 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.578 -179.697 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.09 153.01 36.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.424 -0.797 . . . . 0.0 110.396 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.5 tp -77.19 129.55 36.1 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.315 -0.866 . . . . 0.0 109.786 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.2 m -137.43 162.27 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.626 0.727 . . . . 0.0 109.424 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -88.53 162.44 16.41 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.48 0.657 . . . . 0.0 109.965 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.63 -42.74 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -72.49 -14.13 61.59 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.2 -0.938 . . . . 0.0 109.701 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -91.38 1.94 56.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.065 -1.022 . . . . 0.0 108.822 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.45 132.97 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 110.567 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.5 p -156.21 162.45 40.17 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.8 mt -71.92 -11.14 60.64 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.225 -0.922 . . . . 0.0 109.155 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.3 p -66.78 -17.83 65.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.4 p -123.04 84.17 50.9 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.51 -0.744 . . . . 0.0 109.528 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.73 -41.5 69.08 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.27 1.98 . . . . 0.0 111.609 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -119.26 131.41 55.78 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.365 0.602 . . . . 0.0 109.918 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.1 m -154.87 -173.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.246 -0.909 . . . . 0.0 109.744 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.8 p -131.39 137.02 48.5 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.49 158.63 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.415 -0.803 . . . . 0.0 109.865 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.5 mt -134.3 133.72 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.83 -171.16 36.6 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 118.741 -1.695 . . . . 0.0 110.351 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -114.67 121.2 42.66 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.766 -0.843 . . . . 0.0 108.984 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.617 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.0 mp -89.11 133.56 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.929 -0.482 . . . . 0.0 109.727 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.454 ' HA ' ' H ' ' A' ' 63' ' ' SER . 3.3 p -136.85 158.38 44.58 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.442 0.639 . . . . 0.0 109.732 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.35 83.53 0.07 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.5 mm -85.44 130.76 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.227 -1.161 . . . . 0.0 109.728 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -131.28 136.37 48.12 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -106.37 137.74 43.81 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.469 -0.77 . . . . 0.0 110.308 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -144.35 159.62 42.4 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -133.97 146.5 50.51 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.165 -0.96 . . . . 0.0 110.089 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -144.25 163.76 32.73 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.367 -0.833 . . . . 0.0 109.113 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -83.57 138.46 33.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.314 -0.866 . . . . 0.0 110.828 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 t -152.63 130.71 11.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.841 . . . . 0.0 108.925 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 53.6 t0 60.86 21.99 12.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.551 -0.718 . . . . 0.0 109.456 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.17 14.44 76.84 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 82.2 p -135.43 148.56 49.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.513 -0.992 . . . . 0.0 109.955 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.3 m -85.25 129.93 34.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.435 -0.791 . . . . 0.0 109.618 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -124.38 143.13 50.77 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.687 0.756 . . . . 0.0 110.029 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.9 m -83.84 141.13 31.57 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.377 0.608 . . . . 0.0 110.123 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 p -137.49 137.63 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -102.51 133.41 47.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.379 -0.826 . . . . 0.0 109.198 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -124.3 158.52 32.39 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.56 -170.56 37.87 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -120.38 142.8 48.84 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.6 -0.941 . . . . 0.0 109.267 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 tt -125.91 140.07 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -132.78 156.9 46.26 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.514 -0.741 . . . . 0.0 110.267 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 39.4 t0 -146.16 -142.28 0.13 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.516 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 66.3 t0 -87.55 -21.03 25.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.351 -0.843 . . . . 0.0 109.634 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.3 p -91.04 -76.61 0.44 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.086 -1.009 . . . . 0.0 109.866 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.11 -148.47 0.26 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 109.748 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.6 ptt-85 -142.57 159.17 42.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.577 -0.702 . . . . 0.0 109.702 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.4 tt -153.17 162.07 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.039 -1.038 . . . . 0.0 109.969 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -76.53 142.92 40.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.681 -0.637 . . . . 0.0 109.793 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.4 pt -129.22 153.75 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.532 -0.73 . . . . 0.0 109.433 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 p -142.25 132.57 24.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.59 -0.693 . . . . 0.0 109.259 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.2 t -119.23 128.67 54.41 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -92.73 122.76 35.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.183 -0.948 . . . . 0.0 110.409 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.48 -51.29 3.31 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -77.43 134.28 38.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.953 -1.322 . . . . 0.0 110.822 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.407 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 15.8 pt20 -93.07 160.0 15.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.584 -0.697 . . . . 0.0 110.116 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.8 mt -121.72 153.55 38.07 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -102.23 147.58 26.48 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.736 0.779 . . . . 0.0 110.32 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 63' ' ' SER . 66.7 t0 -67.23 137.52 56.24 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.998 0.904 . . . . 0.0 111.947 -178.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.541 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 55.5 m 48.79 80.64 0.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.557 0.694 . . . . 0.0 110.803 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -152.46 126.2 8.94 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.535 -0.728 . . . . 0.0 109.929 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.0 t -80.81 120.23 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.395 -0.816 . . . . 0.0 109.265 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.6 m -138.52 163.99 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.929 0.871 . . . . 0.0 110.575 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -115.69 124.01 49.78 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 87.9 mt -109.5 124.66 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -111.53 144.65 40.42 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.636 -0.665 . . . . 0.0 109.836 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.6 t30 65.42 37.25 6.31 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.554 0.692 . . . . 0.0 109.231 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.38 143.03 53.81 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -96.39 125.76 41.11 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.704 . . . . 0.0 109.536 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.1 t -85.51 130.23 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.811 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.86 141.47 30.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.378 -0.826 . . . . 0.0 108.782 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.417 ' O ' ' OE1' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -116.18 138.03 51.62 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.657 -0.652 . . . . 0.0 109.351 -179.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -132.36 135.63 46.28 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.536 -0.728 . . . . 0.0 109.965 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.2 t30 57.78 24.72 11.06 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.364 0.602 . . . . 0.0 109.703 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.79 33.62 29.83 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -138.33 121.31 16.66 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.321 -1.105 . . . . 0.0 109.48 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.3 mt -67.76 143.74 55.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.616 -0.677 . . . . 0.0 110.449 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.8 m -152.67 154.25 34.93 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.1 mt -101.85 126.5 48.75 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.214 -0.928 . . . . 0.0 109.711 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.7 m -106.91 125.55 51.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.718 -0.614 . . . . 0.0 109.443 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.8 t -98.81 108.33 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.349 -0.845 . . . . 0.0 108.834 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.39 179.82 42.17 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 87' ' ' SER . 38.4 p30 -67.83 -21.03 65.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.545 -0.973 . . . . 0.0 109.546 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.522 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 92.2 p -81.52 -7.96 59.66 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.143 -0.973 . . . . 0.0 109.207 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.5 t -80.42 158.47 25.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.965 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -117.69 127.8 54.28 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.1 mt -111.93 130.32 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.545 -0.722 . . . . 0.0 109.692 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -130.21 114.47 15.71 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.9 m -79.71 131.33 35.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.565 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.5 t -131.6 131.39 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.497 -0.752 . . . . 0.0 109.578 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.8 m120 56.24 36.52 27.59 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.567 -0.708 . . . . 0.0 109.609 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.7 p -63.7 135.19 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.354 -0.841 . . . . 0.0 110.046 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -94.37 150.99 19.75 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.295 -0.878 . . . . 0.0 109.844 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.6 mm -125.41 69.37 61.32 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.59 156.59 57.53 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.229 1.953 . . . . 0.0 111.957 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 80.5 mt -70.58 146.73 49.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.933 . . . . 0.0 110.36 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -148.64 -22.56 0.32 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.508 ' O ' ' ND1' ' A' ' 101' ' ' HIS . 12.1 p80 -87.41 140.49 29.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 0.0 110.055 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -150.37 36.72 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -153.17 -61.28 0.14 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.483 -0.761 . . . . 0.0 109.62 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.552 ' O ' ' CG ' ' A' ' 105' ' ' HIS . 86.5 t60 -66.39 -40.89 89.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.34 -0.85 . . . . 0.0 109.792 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.552 ' CG ' ' O ' ' A' ' 104' ' ' HIS . 10.9 p80 41.24 -163.25 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.457 0.646 . . . . 0.0 110.711 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.416 ' CG ' ' O ' ' A' ' 105' ' ' HIS . 79.5 m80 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.1 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.1 t . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 36.1 p-10 -173.66 140.02 0.75 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.451 -0.781 . . . . 0.0 109.309 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.5 tp -76.19 123.92 26.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.331 -0.856 . . . . 0.0 109.809 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.48 163.66 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.71 0.767 . . . . 0.0 110.142 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -79.29 156.88 27.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.753 -0.592 . . . . 0.0 110.084 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 94.4 mt -63.22 -43.35 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.408 ' HE ' ' HB2' ' A' ' 49' ' ' ALA . 99.5 mtt180 -65.17 -21.89 66.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 109.609 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -86.87 -1.38 57.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.204 -0.935 . . . . 0.0 109.666 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.6 t -70.3 130.86 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.165 -0.959 . . . . 0.0 110.316 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.407 ' HG ' ' HG ' ' A' ' 12' ' ' SER . 32.2 p -162.73 166.82 23.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.564 -0.71 . . . . 0.0 109.579 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 11' ' ' LEU . 3.7 mm? -67.84 -3.5 9.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.42 -0.8 . . . . 0.0 109.027 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.407 ' HG ' ' HG ' ' A' ' 10' ' ' SER . 78.1 p -63.72 -32.02 73.38 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.362 -0.836 . . . . 0.0 109.472 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 p -114.67 134.42 22.39 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.45 -0.781 . . . . 0.0 109.783 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.69 -55.01 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.151 1.901 . . . . 0.0 112.148 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -115.5 134.88 54.65 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.554 -0.716 . . . . 0.0 110.09 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.8 m -141.4 160.6 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.504 -0.747 . . . . 0.0 109.809 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.4 t -116.05 134.49 54.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.77 162.54 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.447 -0.783 . . . . 0.0 110.1 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.2 tt -140.26 139.48 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.537 -0.727 . . . . 0.0 109.337 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 172.63 -169.0 42.15 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.997 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -106.69 133.07 51.92 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.541 -0.976 . . . . 0.0 109.414 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.635 HD12 ' N ' ' A' ' 22' ' ' ILE . 2.0 mp -94.0 129.98 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.208 0.527 . . . . 0.0 109.907 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.5 p -139.93 155.92 46.92 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.397 -0.814 . . . . 0.0 110.233 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.35 71.26 1.17 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.2 mm -81.35 130.58 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -1.177 . . . . 0.0 110.329 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -132.83 139.22 47.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -108.82 136.33 48.55 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.475 -0.766 . . . . 0.0 109.922 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -148.51 153.76 38.88 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -114.83 145.22 42.39 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.53 -0.732 . . . . 0.0 109.727 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -138.43 159.72 41.35 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.53 -0.732 . . . . 0.0 109.437 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -91.81 99.12 12.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.432 -0.792 . . . . 0.0 110.192 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 34' ' ' GLY . 8.3 t -77.9 -151.7 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.59 -0.694 . . . . 0.0 109.768 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -54.6 75.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.292 0.568 . . . . 0.0 110.474 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 61.97 19.56 59.05 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.3 m -140.02 133.11 29.54 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.262 -1.14 . . . . 0.0 110.166 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.4 m -78.38 128.86 34.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.327 -0.858 . . . . 0.0 109.367 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -132.72 144.49 50.32 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.397 -0.814 . . . . 0.0 109.945 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.5 p -84.78 146.41 27.39 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.424 -0.798 . . . . 0.0 109.773 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 55' ' ' SER . 9.9 p -139.0 138.55 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.613 -0.68 . . . . 0.0 109.46 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -100.36 135.34 41.95 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -127.97 157.36 40.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.621 -0.674 . . . . 0.0 109.433 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.49 -168.2 35.59 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -122.89 141.71 51.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.619 -0.93 . . . . 0.0 109.572 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.1 tt -121.14 144.41 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -129.83 153.13 48.58 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.285 0.564 . . . . 0.0 109.643 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 20.6 t0 -144.41 -147.63 0.22 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.441 -0.787 . . . . 0.0 109.614 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.522 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 36.8 t70 -84.65 -7.7 59.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.805 . . . . 0.0 110.982 -178.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.3 p -108.31 -66.18 1.06 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.13 -0.981 . . . . 0.0 109.998 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.408 ' HB2' ' HE ' ' A' ' 7' ' ' ARG . . . -157.56 -147.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 109.664 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.7 ptt85 -140.24 154.82 47.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.44 -0.787 . . . . 0.0 110.325 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.9 tt -146.32 161.27 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.523 -0.736 . . . . 0.0 109.939 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.85 145.07 40.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.516 -0.74 . . . . 0.0 110.16 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.6 pt -133.26 153.13 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.536 -0.727 . . . . 0.0 109.969 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 t -144.47 141.6 29.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.726 -0.609 . . . . 0.0 109.365 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 39' ' ' VAL . 4.6 p -132.71 137.59 46.96 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.456 -0.777 . . . . 0.0 109.06 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -94.77 125.99 39.79 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.365 -0.835 . . . . 0.0 110.905 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.76 -44.52 0.64 Allowed Glycine 0 N--CA 1.493 2.434 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.804 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -73.95 136.22 43.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.989 -1.3 . . . . 0.0 110.782 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -95.54 158.12 15.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.642 -0.661 . . . . 0.0 110.084 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.4 mt -123.11 153.42 39.99 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -111.93 137.31 50.08 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.669 0.747 . . . . 0.0 110.265 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.451 ' O ' ' OG ' ' A' ' 63' ' ' SER . 24.1 t70 -66.79 136.87 56.11 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.412 0.625 . . . . 0.0 110.907 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 62' ' ' ASP . 12.9 p 66.32 78.84 0.25 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.531 0.682 . . . . 0.0 110.363 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 46.1 p-10 -162.89 121.37 2.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 109.56 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 t -82.96 116.14 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.1 m -137.43 162.06 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.502 -0.749 . . . . 0.0 110.248 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -115.81 126.66 54.3 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.5 mt -106.15 127.31 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -111.68 145.5 39.14 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.251 0.548 . . . . 0.0 109.693 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.4 t30 66.2 35.81 5.85 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.35 136.52 42.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.476 -0.765 . . . . 0.0 109.137 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -91.55 133.51 35.46 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.102 -0.999 . . . . 0.0 110.121 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.2 t -88.1 132.03 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.431 -0.793 . . . . 0.0 109.548 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.03 164.11 26.11 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -122.99 124.27 42.78 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.75 0.786 . . . . 0.0 110.168 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.664 ' O ' ' N ' ' A' ' 78' ' ' GLY . 15.6 m-85 -84.5 -178.0 6.78 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 76' ' ' PHE . 97.6 m-20 -36.98 -18.39 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.074 0.464 . . . . 0.0 110.787 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.664 ' N ' ' O ' ' A' ' 76' ' ' PHE . . . 172.35 29.81 0.03 OUTLIER Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -141.46 140.7 33.62 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.313 -1.11 . . . . 0.0 110.345 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 80.4 mt -77.35 148.95 35.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.418 -0.801 . . . . 0.0 110.07 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.2 p -155.86 159.24 39.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.432 -0.793 . . . . 0.0 109.726 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.3 mt -113.29 126.23 55.16 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.0 p -106.17 131.12 53.8 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.571 -0.706 . . . . 0.0 109.41 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.4 t -101.13 114.91 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.37 -0.831 . . . . 0.0 109.298 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -93.37 177.01 37.5 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 37.2 p-10 -68.12 -23.25 64.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.503 -0.998 . . . . 0.0 110.106 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 95.4 p -85.0 -4.11 59.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.022 -1.048 . . . . 0.0 109.496 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.2 t -80.6 172.38 13.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 0.0 109.91 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -129.4 141.71 50.98 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.641 -0.662 . . . . 0.0 109.689 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -123.84 129.59 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -125.7 114.94 19.32 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.528 -0.732 . . . . 0.0 109.368 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.5 p -79.14 155.59 28.63 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.522 -0.736 . . . . 0.0 109.958 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.4 t -135.47 84.67 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.456 -0.778 . . . . 0.0 108.964 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -110.29 -59.34 1.95 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.5 m -114.67 132.35 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.53 0.681 . . . . 0.0 109.775 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.453 ' O ' ' C ' ' A' ' 97' ' ' ILE . 9.7 m120 -62.56 150.23 41.0 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.589 -0.695 . . . . 0.0 110.368 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.453 ' C ' ' O ' ' A' ' 96' ' ' ASN . 8.2 pt 30.74 78.57 0.29 Allowed Pre-proline 0 N--CA 1.5 2.06 0 CA-C-O 120.882 0.373 . . . . 0.0 110.989 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -59.65 146.44 95.34 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.69 2.26 . . . . 0.0 112.515 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 79.1 mt -89.55 -2.34 58.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.402 -0.811 . . . . 0.0 109.121 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.71 133.04 50.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.178 -0.952 . . . . 0.0 109.623 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' A' ' 102' ' ' HIS . 44.3 p-80 -103.06 108.73 20.03 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.617 0.722 . . . . 0.0 109.838 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.497 ' CD2' ' O ' ' A' ' 106' ' ' HIS . 78.3 m80 44.13 -173.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.771 0.796 . . . . 0.0 110.97 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -66.96 -42.58 84.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.622 -0.674 . . . . 0.0 109.942 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -165.64 -74.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.636 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.755 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 0.2 OUTLIER -94.82 99.37 11.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.386 -0.821 . . . . 0.0 109.86 -179.633 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.497 ' O ' ' CD2' ' A' ' 102' ' ' HIS . 76.5 m80 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.856 -1.069 . . . . 0.0 110.069 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.461 ' OG ' ' N ' ' A' ' 2' ' ' ASP . 12.2 t . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.287 0.565 . . . . 0.0 109.936 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.461 ' N ' ' OG ' ' A' ' 1' ' ' SER . 99.6 m-20 -72.01 151.07 43.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.44 -0.787 . . . . 0.0 110.143 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.5 tp -74.27 125.06 27.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.411 -0.806 . . . . 0.0 109.742 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.3 m -138.99 162.74 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.474 -0.766 . . . . 0.0 109.21 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.549 ' N ' ' OD2' ' A' ' 8' ' ' ASP . 64.1 mttp -74.65 151.64 39.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 110.527 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 9' ' ' VAL . 96.9 mt -61.92 -43.03 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.606 -0.684 . . . . 0.0 109.634 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -59.2 -31.94 69.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.473 -0.767 . . . . 0.0 110.562 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.549 ' OD2' ' N ' ' A' ' 5' ' ' LYS . 6.9 p30 -83.43 11.18 7.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.114 -0.991 . . . . 0.0 110.504 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 6' ' ' ILE . 53.4 t -68.57 132.24 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.917 . . . . 0.0 110.069 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 m -161.5 170.08 20.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.364 -0.835 . . . . 0.0 110.153 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.27 -34.51 78.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.428 -0.795 . . . . 0.0 109.619 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -50.63 -17.82 0.59 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.457 -0.777 . . . . 0.0 109.743 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 p -121.36 82.92 39.51 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.77 -41.59 61.58 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.43 2.087 . . . . 0.0 112.089 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -121.32 128.81 52.67 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.7 m -144.27 160.3 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.181 -0.949 . . . . 0.0 109.653 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.2 m -116.74 133.6 55.81 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.53 163.06 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.391 -0.818 . . . . 0.0 109.459 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.522 HD11 HH12 ' A' ' 67' ' ' ARG . 97.5 mt -127.58 133.27 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 174.66 -163.56 34.07 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.455 -1.355 . . . . 0.0 109.959 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -125.81 143.52 51.03 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.798 -0.824 . . . . 0.0 109.346 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.592 HD12 ' N ' ' A' ' 22' ' ' ILE . 3.8 mp -98.21 132.8 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.378 0.609 . . . . 0.0 110.615 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 63' ' ' SER . 66.7 p -134.49 157.17 47.19 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.327 0.584 . . . . 0.0 109.876 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.85 78.02 0.4 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 25' ' ' ILE . 1.4 mp -90.89 120.28 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.267 -1.137 . . . . 0.0 109.614 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -114.74 122.58 46.85 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -86.13 134.65 33.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 110.157 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -146.67 153.33 40.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.383 -0.823 . . . . 0.0 108.861 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -116.3 144.04 44.75 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.434 -0.791 . . . . 0.0 109.64 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -141.64 162.88 34.39 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.229 -0.919 . . . . 0.0 109.327 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -88.08 98.87 11.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.997 . . . . 0.0 109.251 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.567 ' O ' ' N ' ' A' ' 34' ' ' GLY . 9.3 t -84.31 -151.68 0.13 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.488 -0.758 . . . . 0.0 110.188 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.427 ' C ' ' N ' ' A' ' 35' ' ' THR . 99.4 m-20 -50.43 84.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.692 -0.63 . . . . 0.0 110.278 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 32' ' ' SER . . . 49.45 15.3 0.73 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.427 ' N ' ' C ' ' A' ' 33' ' ' ASP . 35.7 p -140.24 145.96 38.03 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.321 -1.105 . . . . 0.0 109.372 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.2 m -84.41 129.2 34.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 109.514 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -129.11 147.1 50.93 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.461 -0.774 . . . . 0.0 109.505 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 p -84.01 152.13 24.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.489 -0.757 . . . . 0.0 109.716 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.415 HG21 ' CE1' ' A' ' 56' ' ' PHE . 13.3 p -142.62 139.01 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -106.97 132.0 53.41 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -119.0 147.18 44.37 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.555 -0.715 . . . . 0.0 109.18 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.62 -169.67 33.18 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -117.23 141.6 48.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.754 -0.851 . . . . 0.0 109.386 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.2 tt -117.77 144.92 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -134.11 160.46 37.73 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.469 0.652 . . . . 0.0 110.205 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 47' ' ' ASP . 45.0 t0 -157.84 -167.01 2.12 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.527 ' H ' ' CG ' ' A' ' 46' ' ' ASP . 98.2 m-20 -68.13 -16.4 63.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.877 . . . . 0.0 109.756 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.3 p -90.0 -73.96 0.5 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.5 -144.68 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 109.788 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -146.49 153.75 40.77 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.976 . . . . 0.0 110.361 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.2 tt -152.93 159.59 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.365 -0.835 . . . . 0.0 109.766 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.5 ttp85 -75.21 146.13 41.45 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.24 -0.912 . . . . 0.0 110.288 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 22' ' ' ILE . 42.3 pt -134.99 163.66 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.497 -0.752 . . . . 0.0 110.086 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.7 t -143.72 128.97 18.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.379 -0.826 . . . . 0.0 108.844 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.4 t -113.15 121.88 45.84 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.543 -0.723 . . . . 0.0 109.093 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.415 ' CE1' HG21 ' A' ' 39' ' ' VAL . 90.8 m-85 -97.6 120.09 37.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.448 -0.783 . . . . 0.0 110.397 -178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.24 -63.21 4.02 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -71.96 136.79 46.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -1.124 . . . . 0.0 110.6 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -96.18 155.8 16.61 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.44 -0.787 . . . . 0.0 109.463 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.5 mt -128.18 161.62 28.87 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.543 -0.723 . . . . 0.0 109.773 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -112.57 152.99 28.22 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 122.108 0.956 . . . . 0.0 110.145 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 63' ' ' SER . 68.2 t0 -63.1 139.22 58.75 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 111.288 -178.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.543 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.7 m 58.59 28.58 17.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.584 -0.698 . . . . 0.0 109.566 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -82.78 114.68 21.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 109.792 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.45 113.5 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.269 -0.894 . . . . 0.0 108.998 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.2 m -141.19 165.07 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.398 -0.814 . . . . 0.0 110.185 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.522 HH12 HD11 ' A' ' 19' ' ' ILE . 59.9 ttm-85 -106.4 126.3 52.07 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.2 mm -108.15 126.49 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -122.6 143.83 49.5 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.404 ' HA ' ' H1 ' ' A' ' 1' ' ' SER . 65.0 t30 62.64 40.94 9.82 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.73 131.5 41.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 0.0 108.989 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -82.4 131.8 35.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.219 -0.926 . . . . 0.0 110.098 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.1 t -91.32 131.19 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.426 -0.797 . . . . 0.0 109.52 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.92 153.25 49.53 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.448 -0.782 . . . . 0.0 108.96 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -116.18 119.14 34.85 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.538 -0.726 . . . . 0.0 109.278 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -125.02 133.25 53.04 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.604 -0.685 . . . . 0.0 109.496 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.1 m120 55.37 31.26 16.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.707 -0.621 . . . . 0.0 109.94 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.6 6.6 84.83 Favored Glycine 0 N--CA 1.492 2.373 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.521 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -113.95 133.42 55.48 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.47 -1.018 . . . . 0.0 109.71 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.3 mt -76.68 146.37 38.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.508 -0.745 . . . . 0.0 110.036 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.5 t -154.65 154.13 32.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.518 -0.739 . . . . 0.0 109.016 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.1 mt -103.42 129.51 50.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.379 -0.826 . . . . 0.0 109.114 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.2 t -105.19 128.38 53.37 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.699 -0.626 . . . . 0.0 109.562 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.52 99.94 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -97.08 -169.73 33.52 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -68.89 -17.29 63.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.565 -0.962 . . . . 0.0 109.634 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 75.8 m -83.12 -8.42 59.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.389 -0.819 . . . . 0.0 109.681 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.6 t -88.9 166.68 13.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 109.982 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -125.1 133.53 52.83 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 94.0 mt -119.29 128.38 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -126.5 132.1 51.47 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.537 -0.727 . . . . 0.0 109.46 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.9 t -66.18 132.79 49.27 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.549 -0.719 . . . . 0.0 110.223 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.6 t -107.11 -52.57 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -134.99 -57.8 0.81 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 96' ' ' ASN . 2.0 t 52.45 29.99 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.689 -0.632 . . . . 0.0 109.378 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 95' ' ' VAL . 97.3 m-20 58.31 128.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.601 0.715 . . . . 0.0 110.477 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.672 ' H ' ' CD ' ' A' ' 98' ' ' PRO . 1.6 mt -108.99 -34.73 0.15 Allowed Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.724 -0.61 . . . . 0.0 109.687 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.672 ' CD ' ' H ' ' A' ' 97' ' ' ILE . 80.6 Cg_endo -87.86 -3.37 7.26 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 122.165 1.91 . . . . 0.0 111.468 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 99' ' ' LEU . 10.1 mp 58.21 136.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.579 0.704 . . . . 0.0 110.043 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.86 -179.69 2.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.52 -0.738 . . . . 0.0 110.815 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -68.05 140.95 56.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.613 -0.679 . . . . 0.0 110.172 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -77.4 141.27 39.88 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.46 -0.775 . . . . 0.0 110.545 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 104' ' ' HIS . 32.8 p80 -78.5 -15.74 58.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.506 -0.746 . . . . 0.0 109.314 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' HIS . 85.5 t60 55.72 159.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.464 0.65 . . . . 0.0 110.531 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.42 ' N ' ' CG ' ' A' ' 104' ' ' HIS . 6.7 p80 -152.37 162.28 41.4 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.433 -0.792 . . . . 0.0 109.561 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.506 ' ND1' ' O ' ' A' ' 106' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.327 179.824 . . . . . . . . 2 2 . 1 stop_ save_